Citrus Sinensis ID: 021233
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | 2.2.26 [Sep-21-2011] | |||||||
| Q6NLQ6 | 538 | Calcium-dependent protein | yes | no | 0.984 | 0.576 | 0.838 | 1e-153 | |
| Q38873 | 535 | Calcium-dependent protein | no | no | 0.984 | 0.579 | 0.791 | 1e-150 | |
| Q42438 | 533 | Calcium-dependent protein | no | no | 0.984 | 0.581 | 0.783 | 1e-147 | |
| P93759 | 530 | Calcium-dependent protein | no | no | 0.974 | 0.579 | 0.780 | 1e-147 | |
| Q8W4I7 | 528 | Calcium-dependent protein | no | no | 0.965 | 0.575 | 0.734 | 1e-134 | |
| Q9SSF8 | 541 | Calcium-dependent protein | no | no | 0.971 | 0.565 | 0.712 | 1e-126 | |
| Q9M9V8 | 545 | Calcium-dependent protein | no | no | 0.971 | 0.561 | 0.711 | 1e-126 | |
| Q9SIQ7 | 582 | Calcium-dependent protein | no | no | 0.984 | 0.532 | 0.626 | 1e-116 | |
| Q9FMP5 | 528 | Calcium-dependent protein | no | no | 0.844 | 0.503 | 0.655 | 1e-104 | |
| Q38870 | 646 | Calcium-dependent protein | no | no | 0.949 | 0.462 | 0.590 | 1e-103 |
| >sp|Q6NLQ6|CDPKW_ARATH Calcium-dependent protein kinase 32 OS=Arabidopsis thaliana GN=CPK32 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 540 bits (1390), Expect = e-153, Method: Compositional matrix adjust.
Identities = 265/316 (83%), Positives = 283/316 (89%), Gaps = 6/316 (1%)
Query: 1 MGNCCVTPAAAKQG--KKKTNKKKQNPFSIDYGTHHQGNGGH----KLCVLKEPTGREIE 54
MGNCC T + Q K K +KKQNPFSIDYG HH G G KL VL +PTGREIE
Sbjct: 1 MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+Y LGRELGRGEFG+TYLCTD+E D FACKSI KKKLRTAVDIEDVRREV+IMRH+P+
Sbjct: 61 SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N+V LK+TYED+ AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI+EVVQ+CHK
Sbjct: 121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
HGVMHRDLKPENFLF NKKETAPLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL+RK
Sbjct: 241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300
Query: 295 MLDPDPKRRLTAQQVL 310
MLDPD KRRLTAQQVL
Sbjct: 301 MLDPDQKRRLTAQQVL 316
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Functions as regulator of the calcium-mediated abscisic acid (ABA) signaling pathway. Phosphorylates ABA-responsive transcription factor ABF4 in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q38873|CDPK7_ARATH Calcium-dependent protein kinase 7 OS=Arabidopsis thaliana GN=CPK7 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 530 bits (1364), Expect = e-150, Method: Compositional matrix adjust.
Identities = 247/312 (79%), Positives = 280/312 (89%), Gaps = 2/312 (0%)
Query: 1 MGNCCVTPAAA-KQGKKKTNKKKQNPF-SIDYGTHHQGNGGHKLCVLKEPTGREIEERYE 58
MGNCC P++A Q K+ K K NPF S +Y T + G KL VLK+PTG +I +Y+
Sbjct: 1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGRE+GRGEFGITYLCTD+E G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+PKH N+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKD++EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTIVEVVQ+CHK GVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKET+ LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VS++AKDLVRKML+P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 299 DPKRRLTAQQVL 310
DPK+RLTA QVL
Sbjct: 301 DPKKRLTAAQVL 312
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42438|CDPK8_ARATH Calcium-dependent protein kinase 8 OS=Arabidopsis thaliana GN=CPK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 521 bits (1342), Expect = e-147, Method: Compositional matrix adjust.
Identities = 243/310 (78%), Positives = 272/310 (87%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCC +P + KK K K NPF + T + G KL VLK+PTG +I Y+LG
Sbjct: 1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTGFKLSVLKDPTGHDISLMYDLG 60
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RE+GRGEFGITYLCTD + G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+P+H NIV
Sbjct: 61 REVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIVS 120
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKD +EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQ+CHKHGVMHR
Sbjct: 121 LKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMHR 180
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKET+ LKAIDFGLSVFFKPGE F+EIVGSPYYMAPEVL+RNYGPEVD+
Sbjct: 181 DLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVDI 240
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VSE AKDLVRKML+PDP
Sbjct: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPDP 300
Query: 301 KRRLTAQQVL 310
K+RL+A QVL
Sbjct: 301 KKRLSAAQVL 310
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93759|CDPKE_ARATH Calcium-dependent protein kinase 14 OS=Arabidopsis thaliana GN=CPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 521 bits (1341), Expect = e-147, Method: Compositional matrix adjust.
Identities = 242/310 (78%), Positives = 277/310 (89%), Gaps = 3/310 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCC T + Q K+K K NPFS +YG HH G KL VLKEPTG EI+++Y+LG
Sbjct: 1 MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDG---LKLIVLKEPTGHEIKQKYKLG 57
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFG+TYLCT+ E G+ FACKSI KKKL+T++DIEDV+REV+IMR +P+H NIV
Sbjct: 58 RELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVT 117
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK+TYEDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V KTI+EVVQMCHKHGVMHR
Sbjct: 118 LKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHR 177
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+R+YG E+D+
Sbjct: 178 DLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDI 237
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETE GVA+AI++SV+DF+RDPWPKVS+NAKDL++KML PDP
Sbjct: 238 WSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDP 297
Query: 301 KRRLTAQQVL 310
+RRLTAQQVL
Sbjct: 298 RRRLTAQQVL 307
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8W4I7|CDPKD_ARATH Calcium-dependent protein kinase 13 OS=Arabidopsis thaliana GN=CPK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 479 bits (1232), Expect = e-134, Method: Compositional matrix adjust.
Identities = 230/313 (73%), Positives = 261/313 (83%), Gaps = 9/313 (2%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHK---LCVLKEPTGREIEERY 57
MGNCC +PAA + K+N +S GG K + VL + IE+RY
Sbjct: 1 MGNCCRSPAAVAREDVKSN------YSGHDHARKDAAGGKKSAPIRVLSDVPKENIEDRY 54
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
L RELGRGEFG+TYLC +R + D ACKSISK+KLRTAVDIEDV+REV IM+HLPK +
Sbjct: 55 LLDRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSS 114
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV 177
IV LK+ EDD AVHLVMELCEGGELFDRIVARGHYTERAAA VTKTIVEVVQ+CHKHGV
Sbjct: 115 IVTLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGV 174
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 237
+HRDLKPENFLFANKKE +PLKAIDFGLS+FFKPGEKFSEIVGSPYYMAPEVLKRNYGPE
Sbjct: 175 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 234
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
+D+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R V+DF+R+PWP +SE AK+LVR+ML+
Sbjct: 235 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLE 294
Query: 298 PDPKRRLTAQQVL 310
PDPKRRLTA+QVL
Sbjct: 295 PDPKRRLTAKQVL 307
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSF8|CDPKU_ARATH Calcium-dependent protein kinase 30 OS=Arabidopsis thaliana GN=CPK30 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1164), Expect = e-126, Method: Compositional matrix adjust.
Identities = 225/316 (71%), Positives = 255/316 (80%), Gaps = 10/316 (3%)
Query: 1 MGNC--CVT--PAAAK--QGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIE 54
MGNC CV P +K Q KK +++NP+ G L V+ +I
Sbjct: 1 MGNCIACVKFDPDNSKPNQKKKPPRGRQRNPYDDPDGLRTHA----PLRVIPMSHQSQIS 56
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++Y LGRELGRGEFGITYLCTDRE +A ACKSISK+KLRTAVD+EDVRREV IM LP+
Sbjct: 57 DKYILGRELGRGEFGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPE 116
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N+V LK TYED+ VHLVMELCEGGELFDRIVARGHYTERAAA V +TI EVV+MCH
Sbjct: 117 HPNVVKLKATYEDNENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHV 176
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
+GVMHRDLKPENFLFANKKE + LKAIDFGLSV FKPGE+F+EIVGSPYYMAPEVLKRNY
Sbjct: 177 NGVMHRDLKPENFLFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNY 236
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPEVDVWSAGVILYILLCGVPPFWAETEQGVA AI+R VLDF+RDPW ++SE+AK LV++
Sbjct: 237 GPEVDVWSAGVILYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQ 296
Query: 295 MLDPDPKRRLTAQQVL 310
ML+PD +RLTAQQVL
Sbjct: 297 MLEPDSTKRLTAQQVL 312
|
May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Acts as a calcium sensor involved in the hormone-signaling pathways. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M9V8|CDPKA_ARATH Calcium-dependent protein kinase 10 OS=Arabidopsis thaliana GN=CPK10 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1156), Expect = e-126, Method: Compositional matrix adjust.
Identities = 229/322 (71%), Positives = 260/322 (80%), Gaps = 16/322 (4%)
Query: 1 MGNC--CVTP-----AAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKE----PT 49
MGNC CV P + + KK +K NPF+ D+ + VLK+
Sbjct: 1 MGNCNACVRPDSKESKPSSKPKKPNRDRKLNPFAGDFT-----RSPAPIRVLKDVIPMSN 55
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+I ++Y LGRELGRGEFGITYLCTDRE +A ACKSISK+KLRTAVDIEDVRREV IM
Sbjct: 56 QTQISDKYILGRELGRGEFGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIM 115
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
LP+H N+V LK +YED+ VHLVMELCEGGELFDRIVARGHYTERAAAAV +TI EVV
Sbjct: 116 STLPEHPNVVKLKASYEDNENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVV 175
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
MCH +GVMHRDLKPENFLFANKKE +PLKAIDFGLSVFFKPG+KF+EIVGSPYYMAPEV
Sbjct: 176 MMCHSNGVMHRDLKPENFLFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEV 235
Query: 230 LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
LKR+YGP VDVWSAGVI+YILLCGVPPFWAETEQGVA AI+R VLDF+RDPWP++SE+AK
Sbjct: 236 LKRDYGPGVDVWSAGVIIYILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAK 295
Query: 290 DLVRKMLDPDPKRRLTAQQVLG 311
LV++MLDPDP +RLTAQQVL
Sbjct: 296 SLVKQMLDPDPTKRLTAQQVLA 317
|
May play a role in signal transduction pathways that involve calcium as a second messenger. May be a positive regulator controlling stress signal transduction. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SIQ7|CDPKO_ARATH Calcium-dependent protein kinase 24 OS=Arabidopsis thaliana GN=CPK24 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 417 bits (1073), Expect = e-116, Method: Compositional matrix adjust.
Identities = 200/319 (62%), Positives = 245/319 (76%), Gaps = 9/319 (2%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGT---HHQGNGGHKLC------VLKEPTGR 51
MG+C +P K+ +++ + S N +L VL EP G
Sbjct: 1 MGSCVSSPLKGSPFGKRPVRRRHSSNSRTSSVPRFDSSTNLSRRLIFQPPSRVLPEPIGD 60
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
I +Y+LG+ELGRGEFG+T+ C + + FACK ISK+KLRT +D+EDVRREV+IMR
Sbjct: 61 GIHLKYDLGKELGRGEFGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRC 120
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
LPKH NIV K+ +ED AV+LVME+CEGGELFDRIV+RGHYTERAAA+V KTI+EVV++
Sbjct: 121 LPKHPNIVSFKEAFEDKDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKV 180
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231
CH+HGV+HRDLKPENFLF+N ETA LKAIDFGLS+FFKP ++F+EIVGSPYYMAPEVL+
Sbjct: 181 CHEHGVIHRDLKPENFLFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLR 240
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
RNYGPE+DVWSAGVILYILLCGVPPFWAETE+G+A AI+R +DF RDPWPKVS AK+L
Sbjct: 241 RNYGPEIDVWSAGVILYILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKEL 300
Query: 292 VRKMLDPDPKRRLTAQQVL 310
V+ MLD +P RLT Q+VL
Sbjct: 301 VKNMLDANPYSRLTVQEVL 319
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FMP5|CDPKH_ARATH Calcium-dependent protein kinase 17 OS=Arabidopsis thaliana GN=CPK17 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (973), Expect = e-104, Method: Compositional matrix adjust.
Identities = 175/267 (65%), Positives = 210/267 (78%), Gaps = 1/267 (0%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
VL P +++ Y LG+ELGRG+FG+T+LCT + G FACK+I+K+KL DIEDVR
Sbjct: 61 VLGRPM-EDVKASYSLGKELGRGQFGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVR 119
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV IM HL NIV LK YED +VHLVMELC GGELFDRI+A+GHY+ERAAA++ +
Sbjct: 120 REVQIMHHLTGQPNIVELKGAYEDKHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLR 179
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
TIV++V CH GV+HRDLKPENFL NK E +PLKA DFGLSVF+KPGE F +IVGS Y
Sbjct: 180 TIVQIVHTCHSMGVIHRDLKPENFLLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAY 239
Query: 224 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
Y+APEVLKR YGPE D+WS GV+LYILLCGVPPFWAE+E G+ AI+R +DF DPWP
Sbjct: 240 YIAPEVLKRKYGPEADIWSIGVMLYILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPS 299
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVL 310
+S AKDLV+KML+ DPK+RLTA QVL
Sbjct: 300 ISPQAKDLVKKMLNSDPKQRLTAAQVL 326
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q38870|CDPK2_ARATH Calcium-dependent protein kinase 2 OS=Arabidopsis thaliana GN=CPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (964), Expect = e-103, Method: Compositional matrix adjust.
Identities = 179/303 (59%), Positives = 222/303 (73%), Gaps = 4/303 (1%)
Query: 8 PAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE 67
P + K +T + Q P + G VL+ T +E Y LGR+LG+G+
Sbjct: 141 PETTSETKPETKAEPQKP---KHMRRVSSAGLRTESVLQRKT-ENFKEFYSLGRKLGQGQ 196
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG T+LC ++ G+ +ACKSISK+KL T D+EDVRRE+ IM HL H N++ +K YED
Sbjct: 197 FGTTFLCLEKGTGNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYED 256
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
AVHLVMELC GGELFDRI+ RGHYTER AA + +TIV V++ CH GVMHRDLKPENF
Sbjct: 257 VVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENF 316
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LF +++E + LK IDFGLS+FFKP E F+++VGSPYY+APEVL++ YGPE DVWSAGVI+
Sbjct: 317 LFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIV 376
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILL GVPPFWAETEQG+ + ++ LDF DPWP +SE+AKDLVRKML DPKRRLTA
Sbjct: 377 YILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAH 436
Query: 308 QVL 310
QVL
Sbjct: 437 QVL 439
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| 337729587 | 530 | calcium-dependent protein kinase [Hevea | 0.977 | 0.581 | 0.893 | 1e-160 | |
| 317106768 | 531 | JMS10C05.3 [Jatropha curcas] | 0.974 | 0.578 | 0.877 | 1e-159 | |
| 359481709 | 526 | PREDICTED: calcium-dependent protein kin | 0.971 | 0.581 | 0.880 | 1e-158 | |
| 260408334 | 550 | calcium dependent protein kinase 32 [Gos | 0.984 | 0.563 | 0.871 | 1e-158 | |
| 224138018 | 532 | calcium dependent protein kinase 7 [Popu | 0.980 | 0.580 | 0.858 | 1e-156 | |
| 356504799 | 534 | PREDICTED: calcium-dependent protein kin | 0.984 | 0.580 | 0.852 | 1e-155 | |
| 255577483 | 529 | calcium-dependent protein kinase, putati | 0.971 | 0.578 | 0.861 | 1e-154 | |
| 343126682 | 534 | calcium-dependent protein kinase [Dimoca | 0.984 | 0.580 | 0.862 | 1e-154 | |
| 2665890 | 529 | calcium-dependent protein kinase [Fragar | 0.965 | 0.574 | 0.858 | 1e-154 | |
| 449466099 | 535 | PREDICTED: calcium-dependent protein kin | 0.984 | 0.579 | 0.843 | 1e-153 |
| >gi|337729587|gb|AEI70328.1| calcium-dependent protein kinase [Hevea brasiliensis] | Back alignment and taxonomy information |
|---|
Score = 571 bits (1472), Expect = e-160, Method: Compositional matrix adjust.
Identities = 277/310 (89%), Positives = 289/310 (93%), Gaps = 2/310 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCCVTP+ A + + K NKKKQNPF+IDYG H HKL VLK+PTGREIE+RYELG
Sbjct: 1 MGNCCVTPSTASKHEHKKNKKKQNPFAIDYG--HSNGVQHKLTVLKDPTGREIEQRYELG 58
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFGITYLCTD+E D FACKSISKKKLRTAVDIEDVRREV IMRHLPKH NIV
Sbjct: 59 RELGRGEFGITYLCTDKETRDTFACKSISKKKLRTAVDIEDVRREVQIMRHLPKHPNIVS 118
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR
Sbjct: 119 LKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 178
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETA LKAIDFGLSVFFKPGEKF+EIVGSPYYMAPEVLKRNYGPEVDV
Sbjct: 179 DLKPENFLFANKKETAALKAIDFGLSVFFKPGEKFNEIVGSPYYMAPEVLKRNYGPEVDV 238
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPDP
Sbjct: 239 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVKKMLDPDP 298
Query: 301 KRRLTAQQVL 310
KRRLTAQQVL
Sbjct: 299 KRRLTAQQVL 308
|
Source: Hevea brasiliensis Species: Hevea brasiliensis Genus: Hevea Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|317106768|dbj|BAJ53260.1| JMS10C05.3 [Jatropha curcas] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1464), Expect = e-159, Method: Compositional matrix adjust.
Identities = 273/311 (87%), Positives = 286/311 (91%), Gaps = 4/311 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNG-GHKLCVLKEPTGREIEERYEL 59
MGNCCVTP+A K +KKKQNPF+IDYG Q NG HKL VLKEPTGREIE+RYEL
Sbjct: 1 MGNCCVTPSAVPSPDNKKHKKKQNPFAIDYG---QNNGVHHKLTVLKEPTGREIEQRYEL 57
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
G ELGRGEFGITYLCTD+E + +ACKSISKKKLRTAVDIEDVRREV IMRHLPKH NIV
Sbjct: 58 GGELGRGEFGITYLCTDKETAEKYACKSISKKKLRTAVDIEDVRREVQIMRHLPKHPNIV 117
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK GVMH
Sbjct: 118 SLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKQGVMH 177
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 178 RDLKPENFLFANKKETAALKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 237
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 238 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVKKMLDPD 297
Query: 300 PKRRLTAQQVL 310
P RRLTAQQVL
Sbjct: 298 PNRRLTAQQVL 308
|
Source: Jatropha curcas Species: Jatropha curcas Genus: Jatropha Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359481709|ref|XP_002283549.2| PREDICTED: calcium-dependent protein kinase 32-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1455), Expect = e-158, Method: Compositional matrix adjust.
Identities = 273/310 (88%), Positives = 291/310 (93%), Gaps = 4/310 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCCVTP +++ K KKKQNPFS+DY + QGNGG KL VLK+PTGREIE RYELG
Sbjct: 1 MGNCCVTPVPSEK---KKGKKKQNPFSLDYAAN-QGNGGSKLSVLKDPTGREIELRYELG 56
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFGIT+LCTD+ GD +ACKSISKKKLRTAVDI+DVRREV+IM+HLPKH NIV
Sbjct: 57 RELGRGEFGITHLCTDKSTGDVYACKSISKKKLRTAVDIDDVRREVEIMKHLPKHPNIVT 116
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR
Sbjct: 117 LKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 176
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETAPLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVDV
Sbjct: 177 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGERFTEIVGSPYYMAPEVLKRNYGPEVDV 236
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF+RDPWPKVSENAKDLV+KMLDPDP
Sbjct: 237 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFKRDPWPKVSENAKDLVKKMLDPDP 296
Query: 301 KRRLTAQQVL 310
KRRL+AQ+VL
Sbjct: 297 KRRLSAQEVL 306
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|260408334|gb|ACX37460.1| calcium dependent protein kinase 32 [Gossypium hirsutum] | Back alignment and taxonomy information |
|---|
Score = 563 bits (1452), Expect = e-158, Method: Compositional matrix adjust.
Identities = 272/312 (87%), Positives = 290/312 (92%), Gaps = 2/312 (0%)
Query: 1 MGNCCVTPA--AAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYE 58
MGNCC TP+ A+ + K+K KKKQNPFS+DYG H GNGGHKL VL +PTG EIE+RYE
Sbjct: 1 MGNCCATPSTTASHEKKEKKGKKKQNPFSLDYGQRHHGNGGHKLTVLNDPTGGEIEQRYE 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGRELGRGEFGIT+LCTD+E GD FACKSISKKKLRTAVDIEDVRREV+IM+HLP H NI
Sbjct: 61 LGRELGRGEFGITFLCTDKETGDTFACKSISKKKLRTAVDIEDVRREVEIMKHLPHHPNI 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ+CHKHGVM
Sbjct: 121 VTLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQVCHKHGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKETA LK+IDFGLSVFFKPGE F+EIVGSPYYMAPEVLKRNYG EV
Sbjct: 181 HRDLKPENFLFANKKETAALKSIDFGLSVFFKPGEIFTEIVGSPYYMAPEVLKRNYGREV 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDLVRKML+P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVRKMLNP 300
Query: 299 DPKRRLTAQQVL 310
DPKRRLTAQ+VL
Sbjct: 301 DPKRRLTAQEVL 312
|
Source: Gossypium hirsutum Species: Gossypium hirsutum Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224138018|ref|XP_002322709.1| calcium dependent protein kinase 7 [Populus trichocarpa] gi|222867339|gb|EEF04470.1| calcium dependent protein kinase 7 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1438), Expect = e-156, Method: Compositional matrix adjust.
Identities = 266/310 (85%), Positives = 291/310 (93%), Gaps = 1/310 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELG 60
MGNCCVTP +KK +KKKQNPF++D+G H++G HKL VL++PTG+EIE+RYELG
Sbjct: 1 MGNCCVTPPGVPDHEKKKHKKKQNPFALDFGHHNRGTN-HKLIVLRDPTGKEIEQRYELG 59
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RELGRGEFGITYLCTD+E G+ FACKSISKKKLRTAVDIEDVRREV+IM+ +P+H N+V
Sbjct: 60 RELGRGEFGITYLCTDKETGENFACKSISKKKLRTAVDIEDVRREVEIMKQMPQHPNLVT 119
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LKDTYEDD+AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ+CH+HGVMHR
Sbjct: 120 LKDTYEDDSAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQICHEHGVMHR 179
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLF NKKE APLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVDV
Sbjct: 180 DLKPENFLFGNKKENAPLKAIDFGLSVFFKPGERFTEIVGSPYYMAPEVLKRNYGPEVDV 239
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVSENAKDLVRKMLDPDP
Sbjct: 240 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSENAKDLVRKMLDPDP 299
Query: 301 KRRLTAQQVL 310
KRRLTAQQVL
Sbjct: 300 KRRLTAQQVL 309
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504799|ref|XP_003521182.1| PREDICTED: calcium-dependent protein kinase 32-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1424), Expect = e-155, Method: Compositional matrix adjust.
Identities = 265/311 (85%), Positives = 281/311 (90%), Gaps = 1/311 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKK-QNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYEL 59
MGNCC TP+ + KK K K +NPF+IDYG + G KL VLK PTGREIE RYEL
Sbjct: 1 MGNCCATPSTDETANKKGKKGKKENPFAIDYGFNATAANGSKLTVLKSPTGREIEARYEL 60
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
GRELGRGEFGITYLCTD+ G+ ACKSISKKKLRTA+DIEDVRREV+IMRHLP+H NIV
Sbjct: 61 GRELGRGEFGITYLCTDKGTGEELACKSISKKKLRTAIDIEDVRREVEIMRHLPQHANIV 120
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK GVMH
Sbjct: 121 TLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKQGVMH 180
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKETA LKAIDFGLSVFFKPGEKF+EIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 181 RDLKPENFLFANKKETAALKAIDFGLSVFFKPGEKFNEIVGSPYYMAPEVLKRNYGPEVD 240
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 241 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDPD 300
Query: 300 PKRRLTAQQVL 310
PKRRLTAQ VL
Sbjct: 301 PKRRLTAQDVL 311
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577483|ref|XP_002529620.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223530905|gb|EEF32765.1| calcium-dependent protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1418), Expect = e-154, Method: Compositional matrix adjust.
Identities = 268/311 (86%), Positives = 287/311 (92%), Gaps = 5/311 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNG-GHKLCVLKEPTGREIEERYEL 59
MGNCC TP + + K KKK NPFSIDYG + NG H+L VLK+PTGREIE+RYEL
Sbjct: 1 MGNCCATPPSDPH-ENKKYKKKPNPFSIDYGLN---NGVSHRLTVLKDPTGREIEQRYEL 56
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
G ELGRGEFG+TYLCTD+E+G+ FACKSISKKKLRTAVDIEDVRREV IM+HLPKH NIV
Sbjct: 57 GGELGRGEFGVTYLCTDKESGEKFACKSISKKKLRTAVDIEDVRREVQIMKHLPKHPNIV 116
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIV+RGHYTERAAAAVTKTIVEVVQMCHKHGVMH
Sbjct: 117 SLKDTYEDDNAVHLVMELCEGGELFDRIVSRGHYTERAAAAVTKTIVEVVQMCHKHGVMH 176
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKE+A LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGPEVD
Sbjct: 177 RDLKPENFLFANKKESAALKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGPEVD 236
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 237 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDPD 296
Query: 300 PKRRLTAQQVL 310
PKRRLTAQQVL
Sbjct: 297 PKRRLTAQQVL 307
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|343126682|gb|AEL88279.1| calcium-dependent protein kinase [Dimocarpus longan] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-154, Method: Compositional matrix adjust.
Identities = 269/312 (86%), Positives = 284/312 (91%), Gaps = 2/312 (0%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQ-NPFSIDYG-THHQGNGGHKLCVLKEPTGREIEERYE 58
MG CC +PAA KK+ +KK+ N FSIDYG HH GN GHKLCVLKEPTGREIE+RYE
Sbjct: 1 MGICCGSPAADNHHKKQKKQKKKPNQFSIDYGVNHHHGNDGHKLCVLKEPTGREIEQRYE 60
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LGREL RGEFG+TYLCTD+ N + FACKSISKKKLRTAVDIEDVRREV IMRHLP+H NI
Sbjct: 61 LGRELRRGEFGVTYLCTDKSNAETFACKSISKKKLRTAVDIEDVRREVAIMRHLPQHPNI 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKDTYEDD AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM
Sbjct: 121 VTLKDTYEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENF FANK+ETA LKAIDFG S+FFKPGE+FSE VGSPYYMA EVLKRNYGPEV
Sbjct: 181 HRDLKPENFFFANKQETAALKAIDFGCSIFFKPGERFSERVGSPYYMALEVLKRNYGPEV 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILL GVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLVRKMLDP
Sbjct: 241 DVWSAGVILYILLSGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVRKMLDP 300
Query: 299 DPKRRLTAQQVL 310
DPKRRLTAQQVL
Sbjct: 301 DPKRRLTAQQVL 312
|
Source: Dimocarpus longan Species: Dimocarpus longan Genus: Dimocarpus Family: Sapindaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|2665890|gb|AAB88537.1| calcium-dependent protein kinase [Fragaria x ananassa] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-154, Method: Compositional matrix adjust.
Identities = 267/311 (85%), Positives = 283/311 (90%), Gaps = 7/311 (2%)
Query: 1 MGNCCVTPAAAKQGKKKTNKK-KQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYEL 59
MGNCCVTP + G NKK K NPF+IDY NGG KL VLK PTG EIE+ YEL
Sbjct: 1 MGNCCVTPP--QTGSPLKNKKNKPNPFAIDYVV---ANGG-KLSVLKNPTGTEIEQTYEL 54
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
GRELGRGEFGITYLCTD+ + +ACKSISK+KLRTAVDIEDVRREV+IM+HLPKH NIV
Sbjct: 55 GRELGRGEFGITYLCTDKATNENYACKSISKQKLRTAVDIEDVRREVEIMKHLPKHPNIV 114
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKDTYEDD AVHLVMELCEGGELFDRIV+RGHYTERAAAAVTKTIVEVVQMCHKHGVMH
Sbjct: 115 SLKDTYEDDNAVHLVMELCEGGELFDRIVSRGHYTERAAAAVTKTIVEVVQMCHKHGVMH 174
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE+FSEIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 175 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGERFSEIVGSPYYMAPEVLRRNYGPEVD 234
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLV+KMLDPD
Sbjct: 235 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVVDFKRDPWPKVSDNAKDLVKKMLDPD 294
Query: 300 PKRRLTAQQVL 310
PKRRLTAQQVL
Sbjct: 295 PKRRLTAQQVL 305
|
Source: Fragaria x ananassa Species: Fragaria x ananassa Genus: Fragaria Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449466099|ref|XP_004150764.1| PREDICTED: calcium-dependent protein kinase 7-like [Cucumis sativus] gi|449508351|ref|XP_004163290.1| PREDICTED: calcium-dependent protein kinase 7-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1411), Expect = e-153, Method: Compositional matrix adjust.
Identities = 265/314 (84%), Positives = 282/314 (89%), Gaps = 4/314 (1%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQ-NPFSIDYGTHH--QGNGG-HKLCVLKEPTGREIEER 56
MGNCCV P + + K +KK+ NPFS+DYG +H GNGG HKL VL PTG EI +
Sbjct: 1 MGNCCVAPPRNPEDQNKGKRKKKPNPFSVDYGVNHFAGGNGGSHKLTVLTNPTGCEIGLQ 60
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YELGRELGRGEFGIT+LCTD+ G+ FACKSISKKKLRTA+DIEDVRREV IMRHLPKHQ
Sbjct: 61 YELGRELGRGEFGITHLCTDKVTGEKFACKSISKKKLRTAIDIEDVRREVQIMRHLPKHQ 120
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV LKDT+EDD AVHLVMELCEGGELFDRIVARGHYTERAAA VTKTIVEVVQMCHK G
Sbjct: 121 NIVSLKDTFEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAVVTKTIVEVVQMCHKQG 180
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGP 236
VMHRDLKPENFLF NKKE APLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNYGP
Sbjct: 181 VMHRDLKPENFLFGNKKENAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNYGP 240
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWPKVS+NAKDLVRKML
Sbjct: 241 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPKVSDNAKDLVRKML 300
Query: 297 DPDPKRRLTAQQVL 310
DPDPKRRLTAQ VL
Sbjct: 301 DPDPKRRLTAQGVL 314
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 315 | ||||||
| TAIR|locus:2103498 | 538 | CPK32 "calcium-dependent prote | 0.984 | 0.576 | 0.775 | 1.4e-128 | |
| TAIR|locus:505006616 | 535 | CPK7 "calmodulin-domain protei | 0.984 | 0.579 | 0.740 | 1.7e-123 | |
| TAIR|locus:2150230 | 533 | CDPK19 "calcium-dependent prot | 0.980 | 0.579 | 0.739 | 4e-122 | |
| TAIR|locus:2054386 | 530 | CPK14 "calcium-dependent prote | 0.974 | 0.579 | 0.722 | 3.6e-121 | |
| TAIR|locus:2074338 | 528 | CPK13 "calcium-dependent prote | 0.965 | 0.575 | 0.690 | 1.4e-112 | |
| TAIR|locus:2011201 | 545 | CDPK1 "calcium-dependent prote | 0.771 | 0.445 | 0.827 | 1.5e-108 | |
| TAIR|locus:2027227 | 541 | CPK30 "calcium-dependent prote | 0.771 | 0.449 | 0.814 | 2.5e-106 | |
| TAIR|locus:2061290 | 582 | CPK24 "AT2G31500" [Arabidopsis | 0.771 | 0.417 | 0.728 | 1.3e-98 | |
| TAIR|locus:2177023 | 528 | CPK17 "calcium-dependent prote | 0.771 | 0.460 | 0.674 | 1.7e-89 | |
| TAIR|locus:2075885 | 646 | CPK2 "calmodulin-domain protei | 0.771 | 0.376 | 0.666 | 2.2e-89 |
| TAIR|locus:2103498 CPK32 "calcium-dependent protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1262 (449.3 bits), Expect = 1.4e-128, P = 1.4e-128
Identities = 245/316 (77%), Positives = 260/316 (82%)
Query: 1 MGNCCVTPA--AAXXXXXXXXXXXXXPFSIDYGTHHQGN--GGH--KLCVLKEPTXXXXX 54
MGNCC T A PFSIDYG HH G GG KL VL +PT
Sbjct: 1 MGNCCGTAGSLAQNDNKPKKGRKKQNPFSIDYGLHHGGGDGGGRPLKLIVLNDPTGREIE 60
Query: 55 XXXXXXXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
FG+TYLCTD+E D FACKSI KKKLRTAVDIEDVRREV+IMRH+P+
Sbjct: 61 SKYTLGRELGRGEFGVTYLCTDKETDDVFACKSILKKKLRTAVDIEDVRREVEIMRHMPE 120
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H N+V LK+TYED+ AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI+EVVQ+CHK
Sbjct: 121 HPNVVTLKETYEDEHAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIMEVVQVCHK 180
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNY 234
HGVMHRDLKPENFLF NKKETAPLKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVLKRNY
Sbjct: 181 HGVMHRDLKPENFLFGNKKETAPLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLKRNY 240
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
GPEVD+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL+RK
Sbjct: 241 GPEVDIWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLIRK 300
Query: 295 MLDPDPKRRLTAQQVL 310
MLDPD KRRLTAQQVL
Sbjct: 301 MLDPDQKRRLTAQQVL 316
|
|
| TAIR|locus:505006616 CPK7 "calmodulin-domain protein kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1214 (432.4 bits), Expect = 1.7e-123, P = 1.7e-123
Identities = 231/312 (74%), Positives = 259/312 (83%)
Query: 1 MGNCCVTPAAAXXXXXXXX-XXXXXPF-SIDYGTHHQGNGGHKLCVLKEPTXXXXXXXXX 58
MGNCC P++A PF S +Y T + G KL VLK+PT
Sbjct: 1 MGNCCGNPSSATNQSKQGKPKNKNNPFYSNEYATTDRSGAGFKLSVLKDPTGHDISLQYD 60
Query: 59 XXXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
FGITYLCTD+E G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+PKH N+
Sbjct: 61 LGREVGRGEFGITYLCTDKETGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPKHPNV 120
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V LKD++EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTIVEVVQ+CHK GVM
Sbjct: 121 VSLKDSFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTIVEVVQICHKQGVM 180
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEV 238
HRDLKPENFLFANKKET+ LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+RNYGPE+
Sbjct: 181 HRDLKPENFLFANKKETSALKAIDFGLSVFFKPGEQFNEIVGSPYYMAPEVLRRNYGPEI 240
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VS++AKDLVRKML+P
Sbjct: 241 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSDSAKDLVRKMLEP 300
Query: 299 DPKRRLTAQQVL 310
DPK+RLTA QVL
Sbjct: 301 DPKKRLTAAQVL 312
|
|
| TAIR|locus:2150230 CDPK19 "calcium-dependent protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1201 (427.8 bits), Expect = 4.0e-122, P = 4.0e-122
Identities = 230/311 (73%), Positives = 255/311 (81%)
Query: 1 MGNCCVTPAAAXXXXXXXXXXXXXPF-SIDYGTHHQGNGGHKLCVLKEPTXXXXXXXXXX 59
MGNCC +P + PF S Y T+ G G KL VLK+PT
Sbjct: 1 MGNCCASPGSETGSKKGKPKIKSNPFYSEAYTTNGSGTG-FKLSVLKDPTGHDISLMYDL 59
Query: 60 XXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
FGITYLCTD + G+ +ACKSISKKKLRTAVDIEDVRREV+IM+H+P+H NIV
Sbjct: 60 GREVGRGEFGITYLCTDIKTGEKYACKSISKKKLRTAVDIEDVRREVEIMKHMPRHPNIV 119
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
LKD +EDD AVH+VMELCEGGELFDRIVARGHYTERAAAAV KTI+EVVQ+CHKHGVMH
Sbjct: 120 SLKDAFEDDDAVHIVMELCEGGELFDRIVARGHYTERAAAAVMKTILEVVQICHKHGVMH 179
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVD 239
RDLKPENFLFANKKET+ LKAIDFGLSVFFKPGE F+EIVGSPYYMAPEVL+RNYGPEVD
Sbjct: 180 RDLKPENFLFANKKETSALKAIDFGLSVFFKPGEGFNEIVGSPYYMAPEVLRRNYGPEVD 239
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WSAGVILYILLCGVPPFWAETEQGVAQAIIRSV+DF+RDPWP+VSE AKDLVRKML+PD
Sbjct: 240 IWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVIDFKRDPWPRVSETAKDLVRKMLEPD 299
Query: 300 PKRRLTAQQVL 310
PK+RL+A QVL
Sbjct: 300 PKKRLSAAQVL 310
|
|
| TAIR|locus:2054386 CPK14 "calcium-dependent protein kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1192 (424.7 bits), Expect = 3.6e-121, P = 3.6e-121
Identities = 224/310 (72%), Positives = 254/310 (81%)
Query: 1 MGNCCVTPAAAXXXXXXXXXXXXXPFSIDYGTHHQGNGGHKLCVLKEPTXXXXXXXXXXX 60
MGNCC T + PFS +YG HH G KL VLKEPT
Sbjct: 1 MGNCCGTAGSLIQDKQKKGFKLPNPFSNEYGNHHDGL---KLIVLKEPTGHEIKQKYKLG 57
Query: 61 XXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
FG+TYLCT+ E G+ FACKSI KKKL+T++DIEDV+REV+IMR +P+H NIV
Sbjct: 58 RELGRGEFGVTYLCTEIETGEIFACKSILKKKLKTSIDIEDVKREVEIMRQMPEHPNIVT 117
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK+TYEDD AVHLVMELCEGGELFDRIVARGHYTERAAA+V KTI+EVVQMCHKHGVMHR
Sbjct: 118 LKETYEDDKAVHLVMELCEGGELFDRIVARGHYTERAAASVIKTIIEVVQMCHKHGVMHR 177
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDV 240
DLKPENFLFANKKETA LKAIDFGLSVFFKPGE+F+EIVGSPYYMAPEVL+R+YG E+D+
Sbjct: 178 DLKPENFLFANKKETASLKAIDFGLSVFFKPGERFNEIVGSPYYMAPEVLRRSYGQEIDI 237
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WSAGVILYILLCGVPPFWAETE GVA+AI++SV+DF+RDPWPKVS+NAKDL++KML PDP
Sbjct: 238 WSAGVILYILLCGVPPFWAETEHGVAKAILKSVIDFKRDPWPKVSDNAKDLIKKMLHPDP 297
Query: 301 KRRLTAQQVL 310
+RRLTAQQVL
Sbjct: 298 RRRLTAQQVL 307
|
|
| TAIR|locus:2074338 CPK13 "calcium-dependent protein kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1111 (396.2 bits), Expect = 1.4e-112, P = 1.4e-112
Identities = 216/313 (69%), Positives = 244/313 (77%)
Query: 1 MGNCCVTPAAAXXXXXXXXXXXXXPFSIDYGTHHQGNGGHK---LCVLKEPTXXXXXXXX 57
MGNCC +PAA D+ GG K + VL +
Sbjct: 1 MGNCCRSPAAVAREDVKSNYSGH-----DHA-RKDAAGGKKSAPIRVLSDVPKENIEDRY 54
Query: 58 XXXXXXXXXXFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
FG+TYLC +R + D ACKSISK+KLRTAVDIEDV+REV IM+HLPK +
Sbjct: 55 LLDRELGRGEFGVTYLCIERSSRDLLACKSISKRKLRTAVDIEDVKREVAIMKHLPKSSS 114
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV 177
IV LK+ EDD AVHLVMELCEGGELFDRIVARGHYTERAAA VTKTIVEVVQ+CHKHGV
Sbjct: 115 IVTLKEACEDDNAVHLVMELCEGGELFDRIVARGHYTERAAAGVTKTIVEVVQLCHKHGV 174
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 237
+HRDLKPENFLFANKKE +PLKAIDFGLS+FFKPGEKFSEIVGSPYYMAPEVLKRNYGPE
Sbjct: 175 IHRDLKPENFLFANKKENSPLKAIDFGLSIFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE 234
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
+D+WSAGVILYILLCGVPPFWAE+EQGVAQAI+R V+DF+R+PWP +SE AK+LVR+ML+
Sbjct: 235 IDIWSAGVILYILLCGVPPFWAESEQGVAQAILRGVIDFKREPWPNISETAKNLVRQMLE 294
Query: 298 PDPKRRLTAQQVL 310
PDPKRRLTA+QVL
Sbjct: 295 PDPKRRLTAKQVL 307
|
|
| TAIR|locus:2011201 CDPK1 "calcium-dependent protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1073 (382.8 bits), Expect = 1.5e-108, P = 1.5e-108
Identities = 201/243 (82%), Positives = 222/243 (91%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FGITYLCTDRE +A ACKSISK+KLRTAVDIEDVRREV IM LP+H N+V LK +YED
Sbjct: 74 FGITYLCTDRETHEALACKSISKRKLRTAVDIEDVRREVAIMSTLPEHPNVVKLKASYED 133
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
+ VHLVMELCEGGELFDRIVARGHYTERAAAAV +TI EVV MCH +GVMHRDLKPENF
Sbjct: 134 NENVHLVMELCEGGELFDRIVARGHYTERAAAAVARTIAEVVMMCHSNGVMHRDLKPENF 193
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LFANKKE +PLKAIDFGLSVFFKPG+KF+EIVGSPYYMAPEVLKR+YGP VDVWSAGVI+
Sbjct: 194 LFANKKENSPLKAIDFGLSVFFKPGDKFTEIVGSPYYMAPEVLKRDYGPGVDVWSAGVII 253
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAETEQGVA AI+R VLDF+RDPWP++SE+AK LV++MLDPDP +RLTAQ
Sbjct: 254 YILLCGVPPFWAETEQGVALAILRGVLDFKRDPWPQISESAKSLVKQMLDPDPTKRLTAQ 313
Query: 308 QVL 310
QVL
Sbjct: 314 QVL 316
|
|
| TAIR|locus:2027227 CPK30 "calcium-dependent protein kinase 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1052 (375.4 bits), Expect = 2.5e-106, P = 2.5e-106
Identities = 198/243 (81%), Positives = 219/243 (90%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FGITYLCTDRE +A ACKSISK+KLRTAVD+EDVRREV IM LP+H N+V LK TYED
Sbjct: 70 FGITYLCTDRETREALACKSISKRKLRTAVDVEDVRREVTIMSTLPEHPNVVKLKATYED 129
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
+ VHLVMELCEGGELFDRIVARGHYTERAAA V +TI EVV+MCH +GVMHRDLKPENF
Sbjct: 130 NENVHLVMELCEGGELFDRIVARGHYTERAAATVARTIAEVVRMCHVNGVMHRDLKPENF 189
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LFANKKE + LKAIDFGLSV FKPGE+F+EIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL
Sbjct: 190 LFANKKENSALKAIDFGLSVLFKPGERFTEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 249
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAETEQGVA AI+R VLDF+RDPW ++SE+AK LV++ML+PD +RLTAQ
Sbjct: 250 YILLCGVPPFWAETEQGVALAILRGVLDFKRDPWSQISESAKSLVKQMLEPDSTKRLTAQ 309
Query: 308 QVL 310
QVL
Sbjct: 310 QVL 312
|
|
| TAIR|locus:2061290 CPK24 "AT2G31500" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
Identities = 177/243 (72%), Positives = 211/243 (86%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG+T+ C + + FACK ISK+KLRT +D+EDVRREV+IMR LPKH NIV K+ +ED
Sbjct: 77 FGVTHECIEISTRERFACKRISKEKLRTEIDVEDVRREVEIMRCLPKHPNIVSFKEAFED 136
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
AV+LVME+CEGGELFDRIV+RGHYTERAAA+V KTI+EVV++CH+HGV+HRDLKPENF
Sbjct: 137 KDAVYLVMEICEGGELFDRIVSRGHYTERAAASVAKTILEVVKVCHEHGVIHRDLKPENF 196
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LF+N ETA LKAIDFGLS+FFKP ++F+EIVGSPYYMAPEVL+RNYGPE+DVWSAGVIL
Sbjct: 197 LFSNGTETAQLKAIDFGLSIFFKPAQRFNEIVGSPYYMAPEVLRRNYGPEIDVWSAGVIL 256
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAETE+G+A AI+R +DF RDPWPKVS AK+LV+ MLD +P RLT Q
Sbjct: 257 YILLCGVPPFWAETEEGIAHAIVRGNIDFERDPWPKVSHEAKELVKNMLDANPYSRLTVQ 316
Query: 308 QVL 310
+VL
Sbjct: 317 EVL 319
|
|
| TAIR|locus:2177023 CPK17 "calcium-dependent protein kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 1.7e-89, P = 1.7e-89
Identities = 164/243 (67%), Positives = 194/243 (79%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG+T+LCT + G FACK+I+K+KL DIEDVRREV IM HL NIV LK YED
Sbjct: 84 FGVTHLCTQKATGHQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYED 143
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
+VHLVMELC GGELFDRI+A+GHY+ERAAA++ +TIV++V CH GV+HRDLKPENF
Sbjct: 144 KHSVHLVMELCAGGELFDRIIAKGHYSERAAASLLRTIVQIVHTCHSMGVIHRDLKPENF 203
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
L NK E +PLKA DFGLSVF+KPGE F +IVGS YY+APEVLKR YGPE D+WS GV+L
Sbjct: 204 LLLNKDENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLKRKYGPEADIWSIGVML 263
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILLCGVPPFWAE+E G+ AI+R +DF DPWP +S AKDLV+KML+ DPK+RLTA
Sbjct: 264 YILLCGVPPFWAESENGIFNAILRGHVDFSSDPWPSISPQAKDLVKKMLNSDPKQRLTAA 323
Query: 308 QVL 310
QVL
Sbjct: 324 QVL 326
|
|
| TAIR|locus:2075885 CPK2 "calmodulin-domain protein kinase cdpk isoform 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 892 (319.1 bits), Expect = 2.2e-89, P = 2.2e-89
Identities = 162/243 (66%), Positives = 196/243 (80%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG T+LC ++ G+ +ACKSISK+KL T D+EDVRRE+ IM HL H N++ +K YED
Sbjct: 197 FGTTFLCLEKGTGNEYACKSISKRKLLTDEDVEDVRREIQIMHHLAGHPNVISIKGAYED 256
Query: 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187
AVHLVMELC GGELFDRI+ RGHYTER AA + +TIV V++ CH GVMHRDLKPENF
Sbjct: 257 VVAVHLVMELCSGGELFDRIIQRGHYTERKAAELARTIVGVLEACHSLGVMHRDLKPENF 316
Query: 188 LFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247
LF +++E + LK IDFGLS+FFKP E F+++VGSPYY+APEVL++ YGPE DVWSAGVI+
Sbjct: 317 LFVSREEDSLLKTIDFGLSMFFKPDEVFTDVVGSPYYVAPEVLRKRYGPESDVWSAGVIV 376
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
YILL GVPPFWAETEQG+ + ++ LDF DPWP +SE+AKDLVRKML DPKRRLTA
Sbjct: 377 YILLSGVPPFWAETEQGIFEQVLHGDLDFSSDPWPSISESAKDLVRKMLVRDPKRRLTAH 436
Query: 308 QVL 310
QVL
Sbjct: 437 QVL 439
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q6NLQ6 | CDPKW_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8386 | 0.9841 | 0.5762 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00025568001 | SubName- Full=Chromosome chr8 scaffold_34, whole genome shotgun sequence; (526 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | GSVIVG00027665001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (769 aa) | • | 0.800 | |||||||
 | GSVIVG00022728001 | SubName- Full=Chromosome chr14 scaffold_27, whole genome shotgun sequence; (873 aa) | • | 0.800 | |||||||
 | GSVIVG00006233001 | SubName- Full=Chromosome chr1 scaffold_166, whole genome shotgun sequence; (805 aa) | • | 0.800 | |||||||
 | GSVIVG00002525001 | SubName- Full=Chromosome chr2 scaffold_132, whole genome shotgun sequence; (943 aa) | • | 0.800 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 315 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-101 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-92 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-67 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-61 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-60 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-57 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-53 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-52 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-48 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-48 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-45 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-44 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-44 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-43 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-42 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-42 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-42 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-41 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-40 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-39 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-38 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-38 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-37 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-36 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-35 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-35 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-35 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-35 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-34 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-34 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-34 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-34 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-33 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-33 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-33 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-33 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-32 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-32 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-31 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-31 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-31 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-30 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-30 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-30 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-29 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-29 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-29 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-29 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-29 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-29 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-29 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-29 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-29 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-29 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-28 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-28 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-28 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-28 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-27 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-27 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-27 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-27 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-27 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-26 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-26 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-26 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-26 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-26 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-26 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-26 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-26 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-26 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-25 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-25 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-25 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-25 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-25 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-25 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-25 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-24 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-24 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-24 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-24 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-23 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-23 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-23 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-22 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-22 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-22 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-21 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-21 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-20 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-20 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-20 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-20 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-20 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-17 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 9e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 7e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.002 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 297 bits (762), Expect = e-101
Identities = 112/255 (43%), Positives = 149/255 (58%), Gaps = 7/255 (2%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ +LG G FG YL D++ G A K I KKK++ D E + RE+ I++ L KH
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKL-KHP 57
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV L D +ED+ ++LVME CEGG+LFD + RG +E A + I+ ++ H G
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YG 235
++HRDLKPEN L +K DFGL+ PGEK + VG+P YMAPEVL YG
Sbjct: 118 IVHRDLKPENILLDEDGH---VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG 174
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD+WS GVILY LL G PPF + + I P +S AKDL+RK+
Sbjct: 175 KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 296 LDPDPKRRLTAQQVL 310
L DP++RLTA++ L
Sbjct: 235 LVKDPEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 4e-92
Identities = 110/261 (42%), Positives = 147/261 (56%), Gaps = 13/261 (4%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YEL R+LG G FG Y + G A K + K+ ++ D RRE+ I+R L H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRL-SHP 58
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV L D +ED ++LVME CEGG+LFD + G +E A + I+ ++ H +G
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLK--RN 233
++HRDLKPEN L +K DFGL+ K + VG+P+YMAPEVL
Sbjct: 119 IIHRDLKPENILLDENGV---VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----DFRRDPWPKVSENAK 289
YGP+VDVWS GVILY LL G PPF E +IR +L +F W SE AK
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 290 DLVRKMLDPDPKRRLTAQQVL 310
DL++K L+ DP +R TA+++L
Sbjct: 235 DLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 3e-67
Identities = 86/246 (34%), Positives = 131/246 (53%), Gaps = 10/246 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + KKK+ ++E E +I+ + H IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLH 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + ++LV+E GGELF + G ++E A IV ++ H G+++RDL
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
KPEN L +K DFGL+ G + + G+P Y+APEVL YG VD
Sbjct: 120 KPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDW 176
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PPF+AE + + + I++ L F P +S A+DL+ +L DP
Sbjct: 177 WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF---P-EFLSPEARDLISGLLQKDP 232
Query: 301 KRRLTA 306
+RL +
Sbjct: 233 TKRLGS 238
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-61
Identities = 89/252 (35%), Positives = 125/252 (49%), Gaps = 44/252 (17%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG G FG YL D++ G A K I K+ + + E++ RE++I++ L H NIV L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKL-NHPNIVKLY 57
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
+ED+ ++LVME CEGG L D + G +E + I+E ++ H +G++HRD
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKRN--YGPEV 238
LKPEN L + +K DFGLS IVG+P YMAPEVL Y +
Sbjct: 118 LKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D+WS GVILY L KDL+RKML
Sbjct: 176 DIWSLGVILYEL-----------------------------------PELKDLIRKMLQK 200
Query: 299 DPKRRLTAQQVL 310
DP++R +A+++L
Sbjct: 201 DPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-60
Identities = 79/269 (29%), Positives = 136/269 (50%), Gaps = 30/269 (11%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+YE+ +++G+G FG YL + +G + K I + + ED EV I++ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKL-NH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEV-VQ 170
NI+ +++E+ + +VME +GG+L +I + + E + I++ VQ
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-------EQILDWFVQ 111
Query: 171 MC------HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSP 222
+C H ++HRD+KP+N FL +N +K DFG+S V + +VG+P
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGL----VKLGDFGISKVLSSTVDLAKTVVGTP 167
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
YY++PE+ + Y + D+WS G +LY L PF E +A I++ + P
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKG--QYPPIP- 224
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ S ++LV +L DP+ R + Q+L
Sbjct: 225 SQYSSELRNLVSSLLQKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 6e-57
Identities = 85/257 (33%), Positives = 132/257 (51%), Gaps = 16/257 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+ +G +G +L + GD +A K I K + ++ V E DI+ + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLY 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++LVME GG+L + G E A IV ++ H +G++HRDL
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 183 KPENFLFANKKETAPLKAIDFGLSVF---------FKPGEKFSEIVGSPYYMAPEV-LKR 232
KP+N L + LK DFGLS ++ IVG+P Y+APEV L +
Sbjct: 120 KPDNILIDSNGH---LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ VD WS G ILY L G+PPF ET + + Q I+ +++ D +VS+ A DL+
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234
Query: 293 RKMLDPDPKRRLTAQQV 309
K+L PDP++RL A+ +
Sbjct: 235 SKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 2e-56
Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 29/273 (10%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
++ G+ +G G F L ++E +A K + K++L ++ V+ E +++ L H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
I+ L T++D+ ++ V+E GEL I G E+ I+ ++ H G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI------------------ 218
++HRDLKPEN L +K DFG + P
Sbjct: 123 IIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 219 ---VGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274
VG+ Y++PE+L G D+W+ G I+Y +L G PPF E Q I++
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239
Query: 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
F P +AKDL+ K+L DP+ RL
Sbjct: 240 SFP----PNFPPDAKDLIEKLLVLDPQDRLGVN 268
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 5e-53
Identities = 83/262 (31%), Positives = 127/262 (48%), Gaps = 14/262 (5%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+ G LGRG FG YL D++ G+ A KS+ + + ++E + RE+ I+ L +H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSL-QH 58
Query: 116 QNIVCLKDTYEDDTAVHL--VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
NIV + D+ L +E GG L + G E T+ I+E + H
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---IVGSPYYMAPEVL 230
+G++HRD+K N L + +K DFG + E + G+PY+MAPEV+
Sbjct: 119 SNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENA 288
+ YG D+WS G + + G PP W+E A+ + P+ +SE A
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP-WSELGN-PMAALYKIGSSGEPPEIPEHLSEEA 233
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
KD +RK L DPK+R TA ++L
Sbjct: 234 KDFLRKCLRRDPKKRPTADELL 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 176 bits (447), Expect = 2e-52
Identities = 91/277 (32%), Positives = 135/277 (48%), Gaps = 28/277 (10%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
Y + R+LG G FG YL DR+ A K ++KK + ++E RE+ I+ L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCH 173
NIV L D ++D+ +++LVME +GG L D + G +E A + I+ ++ H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-------EKFSEIVGSPYYMA 226
G++HRD+KPEN L ++ +K IDFGL+ S VG+P YMA
Sbjct: 119 SKGIIHRDIKPENILL--DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 227 PEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL-------- 274
PEVL D+WS G+ LY LL G+PPF E ++ +L
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 275 -DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+S+ A DL++K+L DPK RL++ L
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 2e-52
Identities = 83/258 (32%), Positives = 133/258 (51%), Gaps = 14/258 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ ++G+G FG Y + G A K I KL + E + E+ I++ KH
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKC-KHP 57
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKH 175
NIV +Y + +VME C GG L D + + TE A V K +++ ++ H +
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NY 234
G++HRD+K N L + E +K IDFGLS + + +VG+PY+MAPEV+ Y
Sbjct: 118 GIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-SVLDFRRDPWP-KVSENAKDLV 292
+ D+WS G+ L G PP+ +E +A+ + + P K S+ KD +
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231
Query: 293 RKMLDPDPKRRLTAQQVL 310
+K L +P++R TA+Q+L
Sbjct: 232 KKCLQKNPEKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-48
Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 41/288 (14%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
RY++ +G G GI + DRE G+ A K ++ ++L + RE+ ++ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP-NQALREIKALQAC-QH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHK 174
+V L D + + LVME +L + + E + + +++ V H
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGSPYYMAPEVL-- 230
+G+MHRDLKP N L + LK DFGL+ F E +S V + +Y APE+L
Sbjct: 118 NGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 231 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL--------------- 274
R Y P VD+W+ G I LL G P F E + + Q AI+ L
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEETWPGLTSLP 232
Query: 275 DF--------RRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
D+ + P P S A DL++ +L DP +RL+A + L
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 5e-48
Identities = 81/247 (32%), Positives = 126/247 (51%), Gaps = 13/247 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG G FG L + FA K + K+ + E + E +I+ H IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLY 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++D ++++ME C GGEL+ + RG + E A +V + H G+++RDL
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVW 241
KPEN L + +K +DFG + K G+K G+P Y+APE+ L + Y VD W
Sbjct: 120 KPENLLLDSN---GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYW 176
Query: 242 SAGVILYILLCGVPPFWAETE--QGVAQAIIRSV--LDFRRDPWPKVSENAKDLVRKMLD 297
S G++LY LL G PPF + E + I++ L+F + + AKDL++++L
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLR 232
Query: 298 PDPKRRL 304
+P+ RL
Sbjct: 233 RNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 81/249 (32%), Positives = 131/249 (52%), Gaps = 11/249 (4%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E + LG G FG L + +G +A K +SK K+ +E V E I++ + +H
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L +++DD+ ++LVME GGELF + G + E A +V ++ H
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD 121
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYG 235
+++RDLKPEN L + +K DFG + K + G+P Y+APE+ L + YG
Sbjct: 122 IVYRDLKPENLLLDS---DGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGYG 176
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD W+ G+++Y +L G PPF+ + + + I+ + F P S +AKDL+R +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF---P-SFFSPDAKDLIRNL 232
Query: 296 LDPDPKRRL 304
L D +RL
Sbjct: 233 LQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-45
Identities = 90/282 (31%), Positives = 135/282 (47%), Gaps = 36/282 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +E+ + +GRG FG +L D++ G +A K + K + I VR E DI+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-AD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
IV L +++D+ ++LVME GG+L + ++ + + E A +V + HK
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLS--------------------------VF 208
G +HRD+KP+N L +K DFGL V
Sbjct: 120 LGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 209 FKPGEK----FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
+ ++ + VG+P Y+APEVL+ YG E D WS GVILY +L G PPF+++T Q
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236
Query: 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
II R P P VS A DL+ ++L DP+ RL
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLG 277
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 4e-44
Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 14/259 (5%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y+LG +GRG FG+ Y + E GD A K IS +K++ ++ + +E+D++++L KH
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNL-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
NIV + E ++++++E E G L I G + E A +++ + H+
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLKRNY 234
GV+HRD+K N L K L DFG++ + + +VG+PY+MAPEV+
Sbjct: 119 GVIHRDIKAANILT-TKDGVVKLA--DFGVATKLNDVSKDDASVVGTPYWMAPEVI-EMS 174
Query: 235 GPEV--DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDL 291
G D+WS G + LL G PP++ + A+ R V D P P+ +S KD
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYY---DLNPMAALFRIVQD-DHPPLPEGISPELKDF 230
Query: 292 VRKMLDPDPKRRLTAQQVL 310
+ + DP R TA+Q+L
Sbjct: 231 LMQCFQKDPNLRPTAKQLL 249
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 8e-44
Identities = 83/266 (31%), Positives = 131/266 (49%), Gaps = 24/266 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACK--SISKKKLRTAVDIEDVRREVDIMRH 111
E Y+ ++G G G Y TDR G A K + K+ + E+ IM+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII------NEILIMKD 71
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY---TERAAAAVTKTIVEV 168
KH NIV D+Y + +VME +GG L D + ++ E A V + +++
Sbjct: 72 C-KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQG 128
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAP 227
++ H V+HRD+K +N L + +K DFG + K K + +VG+PY+MAP
Sbjct: 129 LEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI--IRSVLDFRRDPWPKV 284
EV+KR YGP+VD+WS G++ + G PP+ E +A+ I + K
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP---LRALFLITTKGIPPLKNPEKW 242
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
S KD + K L DP++R +A+++L
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-43
Identities = 75/249 (30%), Positives = 119/249 (47%), Gaps = 6/249 (2%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+EL R +G+G FG + R+ FA K ++K+K + +V E I++ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L +++D+ ++LV++L GG+L + + ++E IV ++ H G
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYG 235
++HRD+KP+N L E + DF ++ P + G+P YMAPEVL R Y
Sbjct: 121 IIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYS 177
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD WS GV Y L G P+ + Q I S A D + K+
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-IRAKQETADVLYPATWSTEAIDAINKL 236
Query: 296 LDPDPKRRL 304
L+ DP++RL
Sbjct: 237 LERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-42
Identities = 79/247 (31%), Positives = 121/247 (48%), Gaps = 7/247 (2%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ + +G FG YL R GD FA K + K + + +V+ E IM + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L +++ ++LVME GG+ I G E A +V V+ H+ G++HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE-VD 239
D+KPEN L +T LK DFGLS + G + + VG+P Y+APE + + D
Sbjct: 122 DIKPENLLI---DQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
WS G +++ L G PPF AET V I+ +++ + S A DL+ ++L D
Sbjct: 176 WWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
Query: 300 PKRRLTA 306
P +RL A
Sbjct: 236 PAKRLGA 242
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 84/248 (33%), Positives = 124/248 (50%), Gaps = 12/248 (4%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G+G +G +L ++ G+ A K + K L ++ V E DI+ K + +V L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSEWLVKL 66
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
++DD ++L ME GG+ + G +E A + E V H+ G +HRD
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD 126
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
LKPENFL + +K DFGLS + +VGSP YMAPEVL+ + Y VD
Sbjct: 127 LKPENFLI---DASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDY 181
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----DPWPKVSENAKDLVRKML 296
WS G +LY LCG PPF T + + +R DP +S+ A DL+ K++
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241
Query: 297 DPDPKRRL 304
+ DP RR
Sbjct: 242 N-DPSRRF 248
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 7e-42
Identities = 82/287 (28%), Positives = 124/287 (43%), Gaps = 42/287 (14%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPK 114
Y+ ++G G +G+ Y D+ G+ A K I KLR + RE+ +++ L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI---KLRFESEGIPKTALREIKLLKEL-N 56
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
H NI+ L D + ++LV E + +L + E + +++ + C
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFC 114
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL- 230
H HG++HRDLKPEN L LK DFGL+ F P ++ V + +Y APE+L
Sbjct: 115 HSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 231 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------------QGVAQAII 270
+ Y VD+WS G I LL P F ++E
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231
Query: 271 RSVLDFR---RDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVL 310
F P PK+ S A DL+ +ML DP +R+TA+Q L
Sbjct: 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 79/288 (27%), Positives = 134/288 (46%), Gaps = 45/288 (15%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHL 112
YE +LG G +G+ Y D++ G+ A K K+R + E + RE+ +++ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
KH NIV L D + ++LV E C+ + D+ G + ++ ++ +
Sbjct: 56 -KHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLA 112
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEV 229
CH H ++HRDLKP+N + N+ LK DFGL+ F P ++ V + +Y APE+
Sbjct: 113 YCHSHRILHRDLKPQN-ILINRDGV--LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------SVL 274
L ++Y VD+WS G I ++ G P F ++E I + + L
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229
Query: 275 DFRRDPWPK------------VSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ +PK + DL+ KML +P +R++A++ L
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 93/292 (31%), Positives = 139/292 (47%), Gaps = 52/292 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPK 114
Y++ ++LG G FG YL ++E G+ A K + KKK + E+ REV +R L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYS---WEECMNLREVKSLRKLNE 56
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMC 172
H NIV LK+ + ++ ++ V E EG L+ + R ++E ++ I++ +
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232
HKHG HRDLKPEN L + E +K DFGL+ + +++ V + +Y APE+L R
Sbjct: 116 HKHGFFHRDLKPENLLVSG-PEV--VKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 233 --NYGPEVDVWSAGVI---LYIL---------------LCGV-----PPFWAETEQGVAQ 267
+Y VD+W+ G I LY L +C V W E + +A
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-LAS 231
Query: 268 AIIRSVLDFR---------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
L FR P S A DL++ ML DPK+R TA Q L
Sbjct: 232 K-----LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 3e-39
Identities = 88/266 (33%), Positives = 133/266 (50%), Gaps = 20/266 (7%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDA---FACKSISK----KKLRTAVDIEDVRREVDIM 109
+EL R LG G +G +L DA +A K + K +K +TA E R E ++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTA---EHTRTERQVL 58
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ + +V L ++ DT +HL+++ GGELF + R H+TE IV +
Sbjct: 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS--EIVGSPYYMAP 227
H+ G+++RD+K EN L + DFGLS F E+ G+ YMAP
Sbjct: 119 DHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 228 EVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK- 283
EV++ + VD WS GV+ + LL G PF + EQ I R +L + P+PK
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-SKPPFPKT 234
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQV 309
+S A+D ++K+L+ DPK+RL A
Sbjct: 235 MSAEARDFIQKLLEKDPKKRLGANGA 260
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 41/288 (14%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHL 112
RYE G++LG G + + Y D+E G A K I +K+ + ++ RE+ +++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINF-TALREIKLLQEL 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTKTIVEVV 169
KH NI+ L D + + ++LV E E + D+ + T + + +
Sbjct: 60 -KHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV---LTPADIKSYMLMTLRGL 115
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPE 228
+ H + ++HRDLKP N L A+ LK DFGL+ F P K + V + +Y APE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172
Query: 229 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
+L R+YG VD+WS G I LL VP +++ I ++ + WP V
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 285 ----------------------SENAKDLVRKMLDPDPKRRLTAQQVL 310
S++A DL++++L +P +R+TA+Q L
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-38
Identities = 74/253 (29%), Positives = 128/253 (50%), Gaps = 15/253 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ E + +G G FG +L DR + +A K ++ ++ + V E +++ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H I+ L T D ++++ME GGELF + G ++ IV ++ H
Sbjct: 60 HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN- 233
+++RDLKPEN L + +K DFG + K ++ + G+P Y+APEV++
Sbjct: 120 KEIVYRDLKPENILLDKEGH---IKLTDFGFAK--KLRDRTWTLCGTPEYLAPEVIQSKG 174
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR--DPWPKVSENAKDL 291
+ VD W+ G+++Y +L G PPF+ + G+ + I+ L+F R D + AKDL
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLY------AKDL 228
Query: 292 VRKMLDPDPKRRL 304
++K+L D RRL
Sbjct: 229 IKKLLVVDRTRRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 84/269 (31%), Positives = 129/269 (47%), Gaps = 23/269 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ +G+G FG + +G K I + T + + + EV+I+R L KH
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHP 59
Query: 117 NIV--CLKDTYEDDTAVHLVMELCEGGELFDRI----VARGHYTERAAAAVTKTIVEVVQ 170
NIV + + +++VME CEGG+L I R + E + ++ +
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 171 MCH-----KHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKF-SEIVGSPY 223
CH + V+HRDLKP N FL AN +K DFGL+ F VG+PY
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGHDSSFAKTYVGTPY 175
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
YM+PE L Y + D+WS G ++Y L PPF A + +A I FRR P
Sbjct: 176 YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--KFRRIP-Y 232
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLG 311
+ S ++++ ML+ DP +R + +++L
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 77/267 (28%), Positives = 126/267 (47%), Gaps = 20/267 (7%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
R++ G ++G G FG Y + + G+ A K I + I+++ E+ ++ L KH
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELL-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
N+V V++ ME C GG L + + E T ++E + H H
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-----GEKFSEIVGSPYYMAPEVL 230
G++HRD+KP N + +K DFG +V K GE+ + G+P YMAPEV+
Sbjct: 119 GIVHRDIKPANIFLDHN---GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 231 KRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP---K 283
+G D+WS G ++ + G P W+E + I+ V + P P +
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDN--EFQIMFHVGAGHKPPIPDSLQ 232
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVL 310
+S KD + + L+ DPK+R TA ++L
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-36
Identities = 92/302 (30%), Positives = 139/302 (46%), Gaps = 65/302 (21%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
+YE+ +G G +G+ C ++ G+ A K K + + D EDV+ REV ++R
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLR 55
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTER-----AAAAVTKTI 165
L +H+NIV LK+ + ++LV E E L E AV I
Sbjct: 56 QL-RHENIVNLKEAFRRKGRLYLVFEYVERTLL--------ELLEASPGGLPPDAVRSYI 106
Query: 166 VEVVQ---MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--KPGEKFSEIVG 220
+++Q CH H ++HRD+KPEN L E+ LK DFG + +P ++ V
Sbjct: 107 WQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVA 163
Query: 221 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA-IIRSVL--- 274
+ +Y APE+L NYG VDVW+ G I+ LL G P F +++ + Q +I+ L
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQKCLGPL 221
Query: 275 ------DFRRDP------WP--------------KVSENAKDLVRKMLDPDPKRRLTAQQ 308
F +P +P KVS A D ++ L DPK RLT +
Sbjct: 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
Query: 309 VL 310
+L
Sbjct: 282 LL 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-35
Identities = 79/261 (30%), Positives = 121/261 (46%), Gaps = 16/261 (6%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y R LG+G FG L E+ K ++ +L D E+ I+ L +H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLL-QH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCH 173
NI+ + + DD + + ME GG L+D+IV + + E IV V H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS---EIVGSPYYMAPEVL 230
K G++HRD+K N +F K +K DFG+S G ++S +VG+PYYM+PE+
Sbjct: 119 KAGILHRDIKTLN-IFLTK--AGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELC 173
Query: 231 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ Y + D+W+ G +LY LL F A + I++ + S
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVY---SSELI 230
Query: 290 DLVRKMLDPDPKRRLTAQQVL 310
LV +L DP++R TA +VL
Sbjct: 231 SLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 4e-35
Identities = 69/262 (26%), Positives = 118/262 (45%), Gaps = 20/262 (7%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLP 113
E + LG+G G+ Y + G +A K I E+ R RE+ +R
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKI------HVDGDEEFRKQLLRELKTLRSCE 57
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+V + + + +V+E +GG L D + G E A + + I++ + H
Sbjct: 58 -SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 174 -KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVLK 231
K ++HRD+KP N L +K E +K DFG+S + ++ + VG+ YM+PE ++
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK--VSENA 288
+Y D+WS G+ L G PF Q +++++ D P S
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPF-LPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
+D + L DPK+R +A ++L
Sbjct: 233 RDFISACLQKDPKKRPSAAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 6e-35
Identities = 89/266 (33%), Positives = 129/266 (48%), Gaps = 25/266 (9%)
Query: 56 RYELGR--ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
R L ++G G GI + TD+ G A K K LR E + EV IMR
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQ 74
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H NIV + +Y + +VME EGG L D IV E A V +++ + H
Sbjct: 75 -HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKR 232
GV+HRD+K ++ L +K DFG + K + +VG+PY+MAPEV+ R
Sbjct: 133 AQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVS 285
YG EVD+WS G+++ ++ G PP++ E QA+ R R + P KVS
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKR----IRDNLPPKLKNLHKVS 242
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLG 311
+ + +ML DP +R TA ++L
Sbjct: 243 PRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 8e-35
Identities = 77/249 (30%), Positives = 129/249 (51%), Gaps = 11/249 (4%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+G LG G FG + + G+ +A K + K+++ ++ V +E I+ L H
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHP 78
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
IV + +++D+ V+ ++E GGELF + G + A +V + H
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYG 235
+++RDLKPEN L NK +K DFG + K ++ + G+P Y+APEV++ + +G
Sbjct: 139 IIYRDLKPENLLLDNKGH---VKVTDFGFAK--KVPDRTFTLCGTPEYLAPEVIQSKGHG 193
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD W+ GV+LY + G PPF+ +T + + I+ L F W A+DLV+ +
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGL 249
Query: 296 LDPDPKRRL 304
L D +RL
Sbjct: 250 LQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 18/263 (6%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACK--SISKKKLRTAVDIEDVRREVDIMRHLP 113
R+ G LG G FG Y + ++GD FA K S++ ++ + +E+ ++ L
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H NIV T ++ +++ +EL GG L + G + E T+ I+ ++ H
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSPYYMAPEVL 230
+HRD+K N L +K DFG++ K +FS GSPY+MAPEV+
Sbjct: 120 DRNTVHRDIKGANILVDTNGV---VKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVI 173
Query: 231 KR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
+ YG D+WS G + + G PP W++ E A+ + P P +S+
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP-WSQLEG--VAAVFKIGRSKELPPIPDHLSDE 230
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
AKD + K L DP R TA ++L
Sbjct: 231 AKDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 80/259 (30%), Positives = 134/259 (51%), Gaps = 13/259 (5%)
Query: 57 YELGRELGRGEFGITYL---CTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHL 112
+EL + LG G +G +L T + G +A K + K L + A +E R E +++ H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ +V L ++ + +HL+++ GGE+F + R +++E + I+ ++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEV 229
HK G+++RD+K EN L ++ DFGLS F EK +S G+ YMAPE+
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVV---LTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEI 177
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ K +G VD WS G++++ LL G PF E E+ + R +L +
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237
Query: 288 AKDLVRKMLDPDPKRRLTA 306
A+DL+ K+L DPK+RL A
Sbjct: 238 AQDLLHKLLRKDPKKRLGA 256
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-34
Identities = 80/258 (31%), Positives = 134/258 (51%), Gaps = 14/258 (5%)
Query: 57 YELGRELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHL 112
+EL + LG G +G +L + ++G +A K + K + + A E R E ++ H+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ +V L ++ DT +HL+++ GGELF + R + E+ + IV ++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--KPGEKFSEIVGSPYYMAPEVL 230
HK G+++RD+K EN L + DFGLS F E+ G+ YMAP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVV---LTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 231 K---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSE 286
+ + VD WS GV++Y LL G PF + E+ I R +L P+P+ +S
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEMSA 237
Query: 287 NAKDLVRKMLDPDPKRRL 304
AKD+++++L DPK+RL
Sbjct: 238 LAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 84/294 (28%), Positives = 132/294 (44%), Gaps = 52/294 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE ++G G +G Y +++ G+ A K I + + I +R E+ +++ L +H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKL-RHP 58
Query: 117 NIVCLKD--TYEDDTAVHLVMELCEGGELFD--RIVARG--HYTERAAAAVTKTIVEVVQ 170
NIV LK+ T + ++++V E + D ++ +TE K ++E +Q
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP--GEKFSEIVGSPYYMAPE 228
H +G++HRD+K N L N LK DFGL+ + ++ V + +Y PE
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 229 VL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---SVLDFRRDPWPK 283
+L YGPEVD+WS G IL L G P F TE + I S D + WP
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD---ENWPG 228
Query: 284 V---------------------------SENAKDLVRKMLDPDPKRRLTAQQVL 310
V +A DL+ K+L DPK+R++A Q L
Sbjct: 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 85/251 (33%), Positives = 133/251 (52%), Gaps = 11/251 (4%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G G GI + T + +G A K K LR E + EV IMR +H+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDY-QHENVVEM 82
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
++Y + +VME EGG L D IV E AAV +++ + + H GV+HRD
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 182 LKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVD 239
+K ++ L + +K DFG K + +VG+PY+MAPE++ R YGPEVD
Sbjct: 142 IKSDSILLTHDGR---VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WS G+++ ++ G PP++ E A +IR L + KVS + K + ++L D
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 300 PKRRLTAQQVL 310
P +R TA ++L
Sbjct: 258 PAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-33
Identities = 80/263 (30%), Positives = 130/263 (49%), Gaps = 17/263 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPK 114
+ G+ LG+G FG YLC D + G A K + T ++ + E+ ++++L +
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-Q 62
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+ IV DD + + ME GG + D++ A G TE T+ I+E V+ H
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFG----LSVFFKPGEKFSEIVGSPYYMAPEVL 230
+ ++HRD+K N L + +K DFG L G + G+PY+M+PEV+
Sbjct: 123 NMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 231 K-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--PKVSEN 287
YG + DVWS G + +L PP WAE E A A I + +P VS +
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPQLPSHVSPD 235
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
A++ +R+ + K+R +A+++L
Sbjct: 236 ARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 81/262 (30%), Positives = 129/262 (49%), Gaps = 20/262 (7%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHLPK 114
R EL +GRG +G Y G A K I+ L T D + D++REV ++ L +
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIIN---LDTPDDDVSDIQREVALLSQLRQ 58
Query: 115 HQ--NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQM 171
Q NI +Y + ++ME EGG + R + + G E+ + + + ++ ++
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAEKYISVIIREVLVALKY 116
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVL 230
HK GV+HRD+K N L N T +K DFG++ K S VG+PY+MAPEV+
Sbjct: 117 IHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 231 K--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
+ Y + D+WS G+ +Y + G PP+ I +S R S+
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPP--RLEDNGYSKLL 231
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
++ V LD +PK RL+A+++L
Sbjct: 232 REFVAACLDEEPKERLSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 91/304 (29%), Positives = 132/304 (43%), Gaps = 66/304 (21%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHL 112
RYEL + +G G +G+ D+ G A K IS D+ D + RE+ ++RHL
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKIS----NVFDDLIDAKRILREIKLLRHL 56
Query: 113 PKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+H+NI+ L D + ED V++V EL E +L I + T+
Sbjct: 57 -RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFL----- 109
Query: 168 VVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----FSE 217
Q+ H V+HRDLKP N + N LK DFGL+ P E +E
Sbjct: 110 -YQILRGLKYLHSANVIHRDLKPSN-ILVNSNCD--LKICDFGLARGVDPDEDEKGFLTE 165
Query: 218 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVIL--------------YI----LLC---GV 254
V + +Y APE+L Y +D+WS G I YI L+ G
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225
Query: 255 PPFWAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTA 306
P E + + A+ ++S+ + P P S A DL+ KML DPK+R+TA
Sbjct: 226 PS--EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283
Query: 307 QQVL 310
+ L
Sbjct: 284 DEAL 287
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-33
Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 49/284 (17%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG FG L ++ G +A K + K ++ + VR E DI+ + +V L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-ADNPWVVKLY 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++D+ ++L+ME GG++ ++ + +TE + + HK G +HRD+
Sbjct: 68 YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDI 127
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFK---------------PGEKFSEI--------- 218
KP+N L K +K DFGL K P I
Sbjct: 128 KPDNLLLDAKGH---IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 219 ---------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETE 262
VG+P Y+APEV L+ Y E D WS GVI+Y +L G PPF ++
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
Query: 263 QGVAQAII--RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
Q + II + L F + +S AKDL++++ + +RRL
Sbjct: 245 QETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLC-CEAERRL 285
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 7e-33
Identities = 81/254 (31%), Positives = 127/254 (50%), Gaps = 18/254 (7%)
Query: 61 RELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQ 116
+ LG+G +G + T + G FA K + K + R D + E +I+ + KH
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHP 60
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
IV L ++ ++L++E GGELF + G + E A I ++ H+ G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGL---SVFFKPGEKFSEIVGSPYYMAPEVLKRN 233
+++RDLKPEN L + +K DFGL S+ G G+ YMAPE+L R+
Sbjct: 121 IIYRDLKPENILLDAQGH---VKLTDFGLCKESIH--EGTVTHTFCGTIEYMAPEILMRS 175
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+G VD WS G ++Y +L G PPF AE + I++ L+ P ++ A+DL+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLL 231
Query: 293 RKMLDPDPKRRLTA 306
+K+L +P RL A
Sbjct: 232 KKLLKRNPSSRLGA 245
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 83/263 (31%), Positives = 121/263 (46%), Gaps = 37/263 (14%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG FG + ++ GD +A K + K L + E DI+ + I L+
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQ 67
Query: 123 DTYEDDTAVHLVMELCEGGEL----------FDRIVARGHYTERAAAAVTKTIVEVVQMC 172
++D ++LVME GG+L FD +A+ + E +V +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE---------LVLAIHSV 118
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSEI-VGSPYYMAPEVL 230
H+ G +HRD+KPEN L T +K DFG + + S++ VG+P Y+APEVL
Sbjct: 119 HQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 231 -------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPW 281
K YG E D WS GVI Y ++ G PF T I+ + L F D
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPED-- 233
Query: 282 PKVSENAKDLVRKMLDPDPKRRL 304
PKVS + DL++ +L K RL
Sbjct: 234 PKVSSDFLDLIQSLL-CGQKERL 255
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 75/265 (28%), Positives = 125/265 (47%), Gaps = 22/265 (8%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE--DVRREVDIMRHLP 113
+++ ++LG+G +G Y + +A K + L + E D E+ I+ +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALK---EVDLGSMSQKEREDAVNEIRILASV- 56
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVV 169
H NI+ K+ + D + +VME G+L I R E+ + ++ +
Sbjct: 57 NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 170 QMCHKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
Q H+ ++HRDLK N L AN +K D G+S K ++I G+P+YMAPE
Sbjct: 117 QALHEQKILHRDLKSANILLVANDL----VKIGDLGISKVLKKNMAKTQI-GTPHYMAPE 171
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-SE 286
V K R Y + D+WS G +LY + PPF A + Q + + R + P P + S+
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG----KYPPIPPIYSQ 227
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVLG 311
+ ++ +R ML PK R ++L
Sbjct: 228 DLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 76/252 (30%), Positives = 131/252 (51%), Gaps = 17/252 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH--LPKHQNIVC 120
+G+G FG Y ++ +A K +SKK++ ++ E +I+ L + IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK +++ D+ ++LV + GGELF + G ++E A +V ++ HK+ +++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKP----GEKFSEIVGSPYYMAPEVL--KRNY 234
DLKPEN L T + DFGLS K + + G+ Y+APEVL ++ Y
Sbjct: 121 DLKPENILL---DATGHIALCDFGLS---KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
VD WS GV+++ + CG PF+AE Q + + I + F ++ +S+ + V+
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN---VLSDEGRQFVKG 231
Query: 295 MLDPDPKRRLTA 306
+L+ +P+ RL A
Sbjct: 232 LLNRNPQHRLGA 243
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 81/271 (29%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ +E+ ELG G FG Y +E G A K I ++ + ++ED E+DI+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSEC- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
KH NIV L + Y + + +++E C+GG L ++ TE V + ++E +
Sbjct: 60 KHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVL- 230
H H V+HRDLK N L + +K DFG+S K +K +G+PY+MAPEV+
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV- 284
Y + D+WS G+ L L PP E +R +L + P +
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPH-HELN------PMRVLLKILKSEPPTLD 229
Query: 285 -----SENAKDLVRKMLDPDPKRRLTAQQVL 310
S + D ++ L DP R TA ++L
Sbjct: 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-32
Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 13/260 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE +++ +LG G +G Y +E G A K + ++ D++++ +E+ I++
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC- 55
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
IV +Y +T + +VME C G + D + TE AA+ ++ ++
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLK 231
H + +HRD+K N L + + K DFG+S K + ++G+P++MAPEV++
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 232 R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y + D+WS G+ + G PP+ I DP K S D
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDP-EKWSPEFND 231
Query: 291 LVRKMLDPDPKRRLTAQQVL 310
V+K L DP+ R +A Q+L
Sbjct: 232 FVKKCLVKDPEERPSAIQLL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 81/290 (27%), Positives = 131/290 (45%), Gaps = 49/290 (16%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIMRHLPK 114
Y++ ++G G F R+ G +A K + KK + +E V RE+ +R L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFK---SLEQVNNLREIQALRRLSP 56
Query: 115 HQNIVCLKDTYEDDTA--VHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQM 171
H NI+ L + D + LV EL + L++ I R E+ + +++ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFG--LSVFFKPGEKFSEIVGSPYYMAPEV 229
H++G+ HRD+KPEN L K + LK DFG ++ KP ++E + + +Y APE
Sbjct: 116 MHRNGIFHRDIKPENILI--KDDI--LKLADFGSCRGIYSKP--PYTEYISTRWYRAPEC 169
Query: 230 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL-------DFRRD 279
L + YGP++D+W+ G + + +L P F E + Q A I VL +
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFR 227
Query: 280 PW-------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
P S DL++K+L DP R+TA+Q L
Sbjct: 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 39/277 (14%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG+G+ G +L + G FA K + KK++ ++ V E +I+ L H +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPT 65
Query: 121 LKDTYEDDTAVHLVMELCEGGELFD-RIVARGHY-TERAAAAVTKTIVEVVQMCHKHGVM 178
L +++ +T + LVM+ C GGELF G +E A ++ ++ H G++
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLS------------------------------VF 208
+RDLKPEN L E+ + DF LS
Sbjct: 126 YRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 209 FKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
+P + + VG+ Y+APEV+ + +G VD W+ G++LY +L G PF
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
I++ + F P VS +A+DL+RK+L DP +RL
Sbjct: 243 NILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 86/252 (34%), Positives = 127/252 (50%), Gaps = 11/252 (4%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G G GI + T++ G A K K LR E + EV IMR H+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDY-HHENVVDM 84
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
++Y + +VME EGG L D IV E A V +++ + H GV+HRD
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 182 LKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVD 239
+K ++ L + +K DFG K K +VG+PY+MAPEV+ R YG EVD
Sbjct: 144 IKSDSILLTSDGR---IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
+WS G+++ ++ G PP++ E A IR L R KVS + + ML +
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259
Query: 300 PKRRLTAQQVLG 311
P +R TAQ++L
Sbjct: 260 PSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 77/269 (28%), Positives = 127/269 (47%), Gaps = 33/269 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHLP 113
E + L +G+G FG Y D+ A K I L A D IED+++E+ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQC- 56
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ I ++ + + ++ME C GG D ++ G E A + + ++ ++ H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE------KFSEIVGSPYYMAP 227
+ G +HRD+K N L + E +K DFG+S G+ K + VG+P++MAP
Sbjct: 116 EEGKIHRDIKAANILLS---EEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAP 167
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
EV+K++ Y + D+WS G+ L G PP V I + +P P +
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------KNNP-PSLEG 220
Query: 285 ---SENAKDLVRKMLDPDPKRRLTAQQVL 310
S+ KD V L+ DPK R +A+++L
Sbjct: 221 NKFSKPFKDFVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-31
Identities = 83/257 (32%), Positives = 136/257 (52%), Gaps = 23/257 (8%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
++G G GI + ++ +G A K + LR E + EV IMR +HQN+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDY-QHQNVVEM 83
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
+Y + ++ME +GG L D IV++ E A V +++++ + H GV+HRD
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 182 LKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVD 239
+K ++ L +K DFG K K +VG+PY+MAPEV+ R YG EVD
Sbjct: 143 IKSDSILLTLDGR---VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVD 199
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVSENAKDLVR 293
+WS G+++ ++ G PP+++++ QA+ R R P P K+S +D +
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP---VQAMKR----LRDSPPPKLKNAHKISPVLRDFLE 252
Query: 294 KMLDPDPKRRLTAQQVL 310
+ML +P+ R TAQ++L
Sbjct: 253 RMLTREPQERATAQELL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-31
Identities = 76/269 (28%), Positives = 126/269 (46%), Gaps = 24/269 (8%)
Query: 57 YELGRELGRGEFGITY--LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YEL +G G + Y +C N + A K I +K +T ++++R+EV M
Sbjct: 3 YELIEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQT--SVDELRKEVQAM-SQCN 57
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFD---RIVARGHYTERAAAAVTKTIVEVVQM 171
H N+V ++ + LVM GG L D RG E A V K +++ ++
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF-FKPGEKFSE----IVGSPYYMA 226
H +G +HRD+K N L E +K DFG+S G++ + VG+P +MA
Sbjct: 118 LHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 227 PEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPW 281
PEV++ Y + D+WS G+ L G P+ V +++ L+ D +
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD-Y 233
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
K S++ + ++ L DP +R TA+++L
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-31
Identities = 76/267 (28%), Positives = 137/267 (51%), Gaps = 24/267 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ +++G+G+F + Y +G A K + ++ A +D +E+D+++ L H
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC--- 172
N++ ++ ++ +++V+EL + G+L I H+ ++ +TI + VQ+C
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 173 ---HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFF--KPGEKFSEIVGSPYYMA 226
H +MHRD+KP N F+ A +K D GL FF K S +VG+PYYM+
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHS-LVGTPYYMS 174
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVLDFRRDPWPK 283
PE + N Y + D+WS G +LY + PF+ + + + I + D+ P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPPLPADH 232
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVL 310
SE +DLV + ++PDP++R VL
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 46/292 (15%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHL 112
YE E+G G +G Y D G + ++ KK+R + E + RE+ +++ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG-----RFVALKKVRVPLSEEGIPLSTLREIALLKQL 55
Query: 113 PK--HQNIV-----CLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTK 163
H NIV C + + + LV E + + G + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
++ V H H ++HRDLKP+N L + + +K DFGL+ + + +V + +
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLARIYSFEMALTSVVVTLW 171
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII------------ 270
Y APEVL ++ Y VD+WS G I L P F +E I
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231
Query: 271 ------RSVLDFR-----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLG 311
RS + P++ E DL++KML +P +R++A + L
Sbjct: 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 78/247 (31%), Positives = 117/247 (47%), Gaps = 11/247 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVC 120
LG+G FG C + G +ACK + KK+L R + +++ IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR---FIVS 57
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L +E + LVM L GG+L I G + E A I+ ++ H+ ++
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPE 237
+RDLKPEN L + ++ D GL+V K G+K G+P YMAPEVL+ Y
Sbjct: 118 YRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
VD ++ G LY ++ G PF E+ + + R L+ + K S AKDL +L
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234
Query: 298 PDPKRRL 304
DP++RL
Sbjct: 235 KDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 83/257 (32%), Positives = 129/257 (50%), Gaps = 16/257 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +++ + +GRG FG L + + +A K +SK ++ D E DIM H
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-AN 101
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+ IV L ++DD +++VME GG+L + +++ E+ A T +V + H
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIHS 160
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEI-VGSPYYMAPEVLKR 232
G +HRD+KP+N L ++ LK DFG + G + VG+P Y++PEVLK
Sbjct: 161 MGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 233 N-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPWPKVS 285
YG E D WS GV LY +L G PF+A++ G I+ ++ L F D ++S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD--IEIS 275
Query: 286 ENAKDLVRKMLDPDPKR 302
+ AKDL+ L R
Sbjct: 276 KQAKDLICAFLTDREVR 292
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 71/258 (27%), Positives = 122/258 (47%), Gaps = 10/258 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+YE R +GRG FGI +LC + + K I +++ T + + E +++ L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLL-SH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCH 173
NI+ + + +D A+ +VME GG L + I R + E I+ + H
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-R 232
++HRDLK +N L +K + +K DFG+S K +VG+P Y++PE+ + +
Sbjct: 119 TKLILHRDLKTQNILL-DKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y + D+W+ G +LY L F A + I+ D + S + + L+
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD---RYSPDLRQLI 233
Query: 293 RKMLDPDPKRRLTAQQVL 310
ML+ DP +R Q++
Sbjct: 234 LSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-30
Identities = 81/267 (30%), Positives = 135/267 (50%), Gaps = 24/267 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSI--SKKKLRTAVDIEDVRREVDIMRHLPK 114
+ LG+ LG+G FG YLC D + G A K + + T+ ++ + E+ ++++L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-L 62
Query: 115 HQNIV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H+ IV CL+D E + + ME GG + D++ + G TE T+ I+E V
Sbjct: 63 HERIVQYYGCLRDPME--RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK----PGEKFSEIVGSPYYMA 226
H + ++HRD+K N L + +K DFG S + G + G+PY+M+
Sbjct: 121 YLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--PK 283
PEV+ YG + D+WS G + +L PP WAE E A A I + +P P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP-WAEFE---AMAAIFKIATQPTNPVLPPH 233
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVL 310
VS++ +D ++++ + K R +A ++L
Sbjct: 234 VSDHCRDFLKRIF-VEAKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 76/249 (30%), Positives = 123/249 (49%), Gaps = 15/249 (6%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG+G FG L + + +A K + K + D+E E ++ KH +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + VME GG+L I G + E A IV +Q H+ G+++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFK----PGEKFSEIVGSPYYMAPEVLK-RNYG 235
DLK +N L ++ +K DFG+ K G S G+P Y+APE+L + YG
Sbjct: 121 DLKLDNVLLDSEGH---IKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
P VD W+ GV+LY +L G PF + E + Q+I+ + + R W +S+ AK +++
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--W--LSKEAKSILKSF 230
Query: 296 LDPDPKRRL 304
L +P++RL
Sbjct: 231 LTKNPEKRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 79/285 (27%), Positives = 123/285 (43%), Gaps = 48/285 (16%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-----VRREVDIMRHLPKHQ 116
+LG G + Y +R G+ A K I +D E+ RE+ +M+ L KH+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIH-------LDAEEGTPSTAIREISLMKEL-KHE 58
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV---TKTIVEVVQMCH 173
NIV L D + + LV E + +L + G V T +++ + CH
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL-- 230
++ V+HRDLKP+N L + E LK DFGL+ F P FS V + +Y AP+VL
Sbjct: 118 ENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 231 KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE---- 286
R Y +D+WS G I+ ++ G P F + I R + WP +S+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 287 ---------------------NAKDLVRKMLDPDPKRRLTAQQVL 310
DL+ ++L +P+ R++A L
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 8e-30
Identities = 84/269 (31%), Positives = 126/269 (46%), Gaps = 24/269 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+E YEL + +G G +G Y D G+ A K I KL D E +++E+ +++
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKEC- 57
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVVQMC 172
+H NIV +Y + +VME C GG L D V RG +E A V + ++ +
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL- 230
H+ G +HRD+K N L E +K DFG+S K +G+PY+MAPEV
Sbjct: 118 HETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
K Y + D+W+ G+ L PP + I +S P PK+ +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF----PP-PKLKDK 229
Query: 288 AK------DLVRKMLDPDPKRRLTAQQVL 310
K D ++K L DPK+R TA ++L
Sbjct: 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLL 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 36/274 (13%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
LG++LG G FG Y + G A K++ K+ + IE+ RE IMR L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKL- 58
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC- 172
H N+V L ++ +++VME EGG+L + ++ +++
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL---------SLSDLLSFAL 109
Query: 173 ---------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG-SP 222
+HRDL N L +K DFGLS + + + G P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 223 Y-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+MAPE LK + + DVWS GV+L+ I G P+ + + V + + +R
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN---GYRLP 223
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313
P DL+ + DP+ R T +++ +
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-29
Identities = 84/281 (29%), Positives = 134/281 (47%), Gaps = 50/281 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E + + G +G YL +E FA K I+K+ L I+ V E DI+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAE 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGE---LFDRI------VARGHYTERAAAAVTKTI 165
+ +V + ++E + +VME EGG+ L I +AR ++ E A
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLA------ 113
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--------------KP 211
++ H +G++HRDLKP+N L + +K DFGLS K
Sbjct: 114 ---LEYLHNYGIVHRDLKPDNLLITS---MGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 212 GEKFS--EIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQ 267
+F ++ G+P Y+APEV L++ YG VD W+ G+ILY L G PF+ +T E+ Q
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227
Query: 268 AIIRSVLDFRRDPWPK----VSENAKDLVRKMLDPDPKRRL 304
I + WP+ + +A+DL+ ++L +P RL
Sbjct: 228 VISDDIE------WPEGDEALPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 77/294 (26%), Positives = 130/294 (44%), Gaps = 51/294 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-------VRREVD 107
E+YE ++G G +G+ + C +RE G A K V+ ED RE+
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF--------VESEDDPVIKKIALREIR 52
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIV 166
+++ L KH N+V L + + +HLV E C+ + + + E + +
Sbjct: 53 MLKQL-KHPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTL 110
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSEIVGSPYYM 225
+ V CHKH +HRD+KPEN L + + +K DFG + +++ V + +Y
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGDDYTDYVATRWYR 167
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------- 276
APE+L YGP VDVW+ G + LL G P + +++ I +++ D
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 277 ----------------RRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
R+P +P +S A ++ L DP RL+ +++L
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 80/259 (30%), Positives = 131/259 (50%), Gaps = 11/259 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A I + L+ E + E+ +MR
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNLQQQPKKELIINEILVMRE-N 74
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 134 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P K+S +D
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 249
Query: 292 VRKMLDPDPKRRLTAQQVL 310
+ + LD D ++R +A+++L
Sbjct: 250 LNRCLDMDVEKRGSAKELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 85/268 (31%), Positives = 133/268 (49%), Gaps = 27/268 (10%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+Y + R +G G FG L + +A K I K ++ +ED R+E ++ + KH
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KH 57
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC-- 172
NIV K+++E D +++VME C+GG+L +I +R TI++ VQMC
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDLMQKI-----KLQRGKLFPEDTILQWFVQMCLG 112
Query: 173 ----HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMA 226
H+ V+HRD+K +N FL N K +K DFG + + PG VG+PYY+
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGK----VKLGDFGSARLLTSPGAYACTYVGTPYYVP 168
Query: 227 PEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KV 284
PE+ + Y + D+WS G ILY L PF A + +I V P P
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA----NSWKNLILKVCQGSYKPLPSHY 224
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLGK 312
S + L+++M +P+ R +A +L +
Sbjct: 225 SYELRSLIKQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 80/246 (32%), Positives = 121/246 (49%), Gaps = 14/246 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVC 120
LG+G FG L ++ G +A K I KK++ A D +V + R L +H +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKD--EVAHTLTESRVLQNTRHPFLTA 59
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK +++ + VME GGELF + ++E A IV + H V++R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEV 238
DLK EN + + +K DFGL G G+P Y+APEVL+ N YG V
Sbjct: 120 DLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D W GV++Y ++CG PF+ + + + + I+ + F R +S AK L+ +L
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKK 232
Query: 299 DPKRRL 304
DPK+RL
Sbjct: 233 DPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 91/294 (30%), Positives = 135/294 (45%), Gaps = 49/294 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
EI RY + +G G FG+ D+ G A K I K T V + RE+ +++H
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKH 65
Query: 112 LPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
L +H+NI+ L D + ED ++ V EL G R++ ++ I+
Sbjct: 66 L-RHENIISLSDIFISPLED---IYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
++ H GV+HRDLKP N L E LK DFGL+ P + + V + YY AP
Sbjct: 120 GLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYYRAP 174
Query: 228 EVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL-----DF--- 276
E++ + Y EVD+WSAG I +L G P F + V Q +II +L D
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH--VNQFSIITDLLGTPPDDVINT 232
Query: 277 --------------RRDPWP------KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+R+P P +A DL+ KML DP++R++A + L
Sbjct: 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-29
Identities = 85/297 (28%), Positives = 129/297 (43%), Gaps = 51/297 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ ++G G +G Y D++ G+ A K + + I +R E+ I+R L H+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQL-NHR 66
Query: 117 NIVCLKDTYEDDT----------AVHLVMELCEG---GELFDRIVARGHYTERAAAAVTK 163
NIV LK+ D A +LV E + G L +V H++E + K
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV---HFSEDHIKSFMK 123
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGS 221
++E + CHK +HRD+K N L NK + +K DFGL+ + E ++ V +
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLADFGLARLYNSEESRPYTNKVIT 180
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+Y PE+L + YGP +DVWS G IL L P F A E + I R
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240
Query: 280 PWPKVSE--------------------------NAKDLVRKMLDPDPKRRLTAQQVL 310
WP V + A DL+ ML DP +R TA++ L
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 80/259 (30%), Positives = 132/259 (50%), Gaps = 11/259 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A K ++ L+ E + E+ +MR
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN- 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
KH NIV D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 133 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P K+S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIFRDF 248
Query: 292 VRKMLDPDPKRRLTAQQVL 310
+ + L+ D ++R +A+++L
Sbjct: 249 LNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 8e-29
Identities = 78/259 (30%), Positives = 133/259 (51%), Gaps = 11/259 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G + D G A K I+ +K E + E+ +M+ L
Sbjct: 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK---ELIINEILVMKEL- 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D++ + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 133 ANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P K+S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSPIFRDF 248
Query: 292 VRKMLDPDPKRRLTAQQVL 310
+ + L+ D ++R +A+++L
Sbjct: 249 LNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 9e-29
Identities = 79/263 (30%), Positives = 130/263 (49%), Gaps = 22/263 (8%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSIS--KKKLRTAVDIEDVRREVDIMRHLPKHQN 117
G+ LG+G FG YLC D + G A K + + T+ ++ + E+ ++++L +H+
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHER 65
Query: 118 IV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
IV CL+D E + + ME GG + D++ A G TE T+ I+E + H
Sbjct: 66 IVQYYGCLRDRAE--KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFG----LSVFFKPGEKFSEIVGSPYYMAPEV 229
+ ++HRD+K N L + +K DFG L G + G+PY+M+PEV
Sbjct: 124 SNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 230 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
+ YG + DVWS G + +L PP WAE E AI + P +SE+
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTNPQLPSHISEH 237
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
A+D + + + + R +A+++L
Sbjct: 238 ARDFLGCIF-VEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-28
Identities = 80/251 (31%), Positives = 120/251 (47%), Gaps = 7/251 (2%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + Q +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVN 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ + GG+L I G+ + E A I+ ++ H+ +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L + ++ D GL+V GE VG+ YMAPEVL + Y
Sbjct: 125 YRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W G ++Y ++ G PF E+ + + R VL+ K SE AK + + +L
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241
Query: 298 PDPKRRLTAQQ 308
DPK+RL Q+
Sbjct: 242 KDPKQRLGCQE 252
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 77/270 (28%), Positives = 140/270 (51%), Gaps = 30/270 (11%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+Y +++G G FG L +E+G + K I+ K+ + E+ R+EV ++ ++ KH
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNM-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC-- 172
NIV ++++E++ +++VM+ CEGG+L+ +I A+ R I++ VQ+C
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ-----RGVLFPEDQILDWFVQICLA 113
Query: 173 ----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
H ++HRD+K +N +F K T L DFG++ V E +G+PYY++P
Sbjct: 114 LKHVHDRKILHRDIKSQN-IFLTKDGTIKLG--DFGIARVLNSTVELARTCIGTPYYLSP 170
Query: 228 EVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
E+ + R Y + D+W+ G +LY + F A + + IIR +P V
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG-------SYPPVSS 223
Query: 285 --SENAKDLVRKMLDPDPKRRLTAQQVLGK 312
S + ++LV ++ +P+ R + +L K
Sbjct: 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 76/246 (30%), Positives = 119/246 (48%), Gaps = 9/246 (3%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG L +E+G +A K + K + D+E E I+ H +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + VME GG+L I + E A I + H G+++R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEV 238
DLK +N L ++ K DFG+ G+ S G+P Y+APE+L+ YGP V
Sbjct: 121 DLKLDNVLLDHEGHC---KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSV 177
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D W+ GV+LY +LCG PF AE E + +AI+ + + W +S++A D+++ +
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--PTW--LSQDAVDILKAFMTK 233
Query: 299 DPKRRL 304
+P RL
Sbjct: 234 NPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 74/244 (30%), Positives = 119/244 (48%), Gaps = 10/244 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTALK 61
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GGELF + +TE A IV ++ H V++RD+
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K EN + +K DFGL G G+P Y+APEVL+ N YG VD
Sbjct: 122 KLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W GV++Y ++CG PF+ + + + + I+ + F R +S AK L+ +L DP
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 234
Query: 301 KRRL 304
K+RL
Sbjct: 235 KQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 82/273 (30%), Positives = 129/273 (47%), Gaps = 23/273 (8%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAF-ACKSIS-------KKKLRTAVDIEDVRREVDI 108
Y + LG G FG Y + NG A K I+ K K I D+ EV I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG---GELFDRIVARG-HYTERAAAAVTKT 164
++ +H NIV T+ ++ +++VM+L EG GE F+ + + +TE +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 165 IVEVVQMCHKHG-VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+V ++ HK ++HRDL P N + + DFGL+ +P K + +VG+
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT---ITDFGLAKQKQPESKLTSVVGTIL 178
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
Y PE++K YG + DVW+ G ILY + PPF++ +A I+ +V +P P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY----EPLP 234
Query: 283 K--VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313
+ SE+ D++ L PD + R QV I
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-27
Identities = 76/248 (30%), Positives = 119/248 (47%), Gaps = 10/248 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG C R G +ACK ++KK+L+ E E I+ + + IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVVQMCHKHGVM 178
++ T + LVM + GG+L I + E A T I+ ++ H+ ++
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEVLK-RNYGP 236
+RDLKPEN L N ++ D GL+V K G K G+P +MAPE+L+ Y
Sbjct: 120 YRDLKPENVLLDNDGN---VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
VD ++ GV LY ++ PF A E+ + + + +L+ K S +K +L
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236
Query: 297 DPDPKRRL 304
DP++RL
Sbjct: 237 AKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 79/259 (30%), Positives = 130/259 (50%), Gaps = 11/259 (4%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A K ++ L+ E + E+ +MR
Sbjct: 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRE-N 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D+Y + +VME GG L D +V E AAV + ++ + H
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG P + K S +VG+PY+MAPEV+ R
Sbjct: 133 SNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 189
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
YGP+VD+WS G++ ++ G PP+ E I + ++P ++S +D
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP-ERLSAVFRDF 248
Query: 292 VRKMLDPDPKRRLTAQQVL 310
+ + L+ D RR +A+++L
Sbjct: 249 LNRCLEMDVDRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 81/293 (27%), Positives = 131/293 (44%), Gaps = 41/293 (13%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R + E +L R +G G +GI Y D +G+ A K + R + I +R E+ ++
Sbjct: 4 RSVTEFEKLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61
Query: 111 HLPKHQNIVCLKDTYEDD--TAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIV 166
+L +H NIV LK+ ++ LVME CE L D + ++E + ++
Sbjct: 62 NL-RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLL 118
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYM 225
+Q H++ ++HRDLK N L +K LK DFGL+ + P + + V + +Y
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------ 271
APE+L Y +D+W+ G IL LL P ++E II+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235
Query: 272 -------SVLDFRRDPW-------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ P+ P +SE L+ +L DPK+R TA++ L
Sbjct: 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 70/274 (25%), Positives = 110/274 (40%), Gaps = 35/274 (12%)
Query: 58 ELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
LG++LG G FG Y T A K++ K+ + IE+ RE IMR L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRKL- 58
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC- 172
H NIV L ++ + +VME GG+L D + ++ +++
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL--------SLSDLLSFAL 110
Query: 173 ---------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG-SP 222
+HRDL N L +K DFGLS + + G P
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 223 Y-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+MAPE LK + + DVWS GV+L+ I G P+ + V + + + +R
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK---GYRLP 224
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313
P L+ + DP+ R T +++ +
Sbjct: 225 KPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-27
Identities = 79/246 (32%), Positives = 120/246 (48%), Gaps = 14/246 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVC 120
+G+G FG R+ +A K+I K + R+ V R V + P IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCP---FIVP 57
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
LK +++ ++LV+ GGELF + G + A T ++ ++ HK V++R
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLKPEN L + DFGL + K +K + G+P Y+APE+L Y V
Sbjct: 118 DLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV 174
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298
D W+ GV+LY +L G+PPF+ E + + I++ L F +AKDL+ +L
Sbjct: 175 DWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSR 230
Query: 299 DPKRRL 304
DP RRL
Sbjct: 231 DPTRRL 236
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 78/266 (29%), Positives = 118/266 (44%), Gaps = 25/266 (9%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
G LG+G +G Y C G A K + + L + E ++ EVD+++ L KH
Sbjct: 5 GEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHV 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV T DD + + ME GG + + G E TK I++ V H +
Sbjct: 63 NIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFG-------LSVFFKPGEKFSEIVGSPYYMAPEV 229
V+HRD+K N + +K IDFG + + + G+PY+MAPEV
Sbjct: 123 VVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 230 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV---- 284
+ + YG + D+WS G ++ + G PP A ++ A I + R P++
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP-LASMDRLAAMFYIGA----HRGLMPRLPDSF 234
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
S A D V L D R +A Q+L
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-27
Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 42/289 (14%)
Query: 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
L +PTG +EL +G G +G Y ++ G A K + + E+++
Sbjct: 1 LPDPTGI-----FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKE 51
Query: 105 EVDIMRHLPKHQNIV------CLKDTYEDDTAVHLVMELCEGG---ELFDRIVARGH-YT 154
E +I+R H NI K+ +D + LVMELC GG +L + +G
Sbjct: 52 EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111
Query: 155 ERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGE 213
E A + + + + H++ V+HRD+K +N L + A +K +DFG+S
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168
Query: 214 KFSEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQ 267
+ + +G+PY+MAPEV+ + P+ DVWS G+ L G PP
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-------CDM 221
Query: 268 AIIRSVLDFRRDPWPKVSENAK------DLVRKMLDPDPKRRLTAQQVL 310
+R++ R+P P + D + + L + ++R +++L
Sbjct: 222 HPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELL 270
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-27
Identities = 71/265 (26%), Positives = 125/265 (47%), Gaps = 21/265 (7%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSI------SKKKLRTAVDIEDVRREVDIMRHLP 113
G +G G FG YL + +G+ A K + + K R ++ + RE+ +++ L
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL- 63
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H+NIV + D +++ +E GG + + G + E + I++ + H
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-------VFFKPGEKFSEIVGSPYYMA 226
G++HRD+K N L NK +K DFG+S + K + GS ++MA
Sbjct: 124 NRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PEV+K+ Y + D+WS G ++ +L G P + + Q QAI + + + +S
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP-FPDCTQ--LQAIFKIGENASPEIPSNIS 237
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVL 310
A D + K + D +R TA ++L
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 75/245 (30%), Positives = 122/245 (49%), Gaps = 11/245 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALK 61
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRD 181
+++ + VME GGELF + ++E A IV + H + V++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 182 LKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVD 239
LK EN + + +K DFGL K G G+P Y+APEVL+ N YG VD
Sbjct: 122 LKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 178
Query: 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299
W GV++Y ++CG PF+ + + + + I+ + F R P+ AK L+ +L D
Sbjct: 179 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPE----AKSLLSGLLKKD 234
Query: 300 PKRRL 304
PK+RL
Sbjct: 235 PKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-26
Identities = 81/268 (30%), Positives = 130/268 (48%), Gaps = 22/268 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSI--SKKKLRTAVDIEDVRREVDIMRHL 112
+ LG+ LGRG FG YLC D + G A K + T+ ++ + E+ ++++L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 113 PKHQNIV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
+H IV CL+D E ++ +E GG + D++ A G TE T+ I++
Sbjct: 62 -RHDRIVQYYGCLRDPEEKKLSI--FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQG 118
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS----VFFKPGEKFSEIVGSPYY 224
V H + ++HRD+K N L + +K DFG S G + G+PY+
Sbjct: 119 VSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 225 MAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
M+PEV+ YG + DVWS + +L PP WAE E AI + + P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP-WAEYE--AMAAIFKIATQPTKPMLPD 232
Query: 284 -VSENAKDLVRKMLDPDPKRRLTAQQVL 310
VS+ +D ++++ + KRR TA+ +L
Sbjct: 233 GVSDACRDFLKQIF-VEEKRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 71/256 (27%), Positives = 126/256 (49%), Gaps = 16/256 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ +++GRG+F Y T + A K + ++ A +D +E+D+++ L H
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC--- 172
N++ D++ +D +++V+EL + G+L I ++ ++ +T+ + VQ+C
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIK---YFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 173 ---HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPE 228
H VMHRD+KP N T +K D GL FF + +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ N Y + D+WS G +LY + PF+ + + D+ P SE
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236
Query: 288 AKDLVRKMLDPDPKRR 303
++LV + PDP +R
Sbjct: 237 LRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 81/247 (32%), Positives = 124/247 (50%), Gaps = 16/247 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E YE+ + +GRG FG L + +A K +SK ++ D E DIM
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FAN 101
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+V L ++DD +++VME GG+L + +++ E+ A T +V + H
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHS 160
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGE-KFSEIVGSPYYMAPEVLKR 232
G +HRD+KP+N L ++ LK DFG + K G + VG+P Y++PEVLK
Sbjct: 161 MGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 233 N-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPWPKVS 285
YG E D WS GV LY +L G PF+A++ G I+ ++ L F D +S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD--NDIS 275
Query: 286 ENAKDLV 292
+ AK+L+
Sbjct: 276 KEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 72/247 (29%), Positives = 121/247 (48%), Gaps = 16/247 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ +G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTSLK 61
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ + VME GGELF + ++E IV + H +++RDL
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPG----EKFSEIVGSPYYMAPEVLKRN-YGPE 237
K EN + + +K DFGL K G G+P Y+APEVL+ N YG
Sbjct: 122 KLENLML---DKDGHIKITDFGLC---KEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
VD W GV++Y ++CG PF+ + + + + I+ + F R +S +AK L+ +L
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR----TLSADAKSLLSGLLI 231
Query: 298 PDPKRRL 304
DP +RL
Sbjct: 232 KDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 88/300 (29%), Positives = 134/300 (44%), Gaps = 55/300 (18%)
Query: 56 RYELGRELGRGEFGITYLC----TDRENGDAFACKSISK---KKLRTAVDIEDVRREVDI 108
RYEL +ELG+G +GI +C + + A K I+ KK+ + RE+ +
Sbjct: 1 RYELIKELGQGAYGI--VCSARNAETSEEETVAIKKITNVFSKKILAKRAL----RELKL 54
Query: 109 MRHLPKHQNIVCLKD----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
+RH H+NI CL D + ++L EL E +L I + T+ +
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQ 113
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-----EKFSEIV 219
I+ ++ H V+HRDLKP N L E LK DFGL+ F +E V
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGFSENPGENAGFMTEYV 170
Query: 220 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA------------------ 259
+ +Y APE++ ++Y +DVWS G IL LL P F
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230
Query: 260 -ETEQGV----AQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
ET + AQ IRS+ + + P +P + A DL+ K+L DP +R++ ++ L
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 74/247 (29%), Positives = 119/247 (48%), Gaps = 7/247 (2%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVS 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ + GG+L I G+ + E+ A + ++ + ++
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L ++ ++ D GL+V GE VG+ YMAPEV+ Y
Sbjct: 125 YRDLKPENILLDDRGH---IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W G ++Y ++ G PF E+ + + R V + + + K SE+AK + R +L
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 298 PDPKRRL 304
+PK RL
Sbjct: 242 KNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 78/294 (26%), Positives = 135/294 (45%), Gaps = 44/294 (14%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ +RY+ +G G +G D + G A K +S+ ++A+ + RE+ +++H
Sbjct: 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYRELRLLKH 70
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H+N++ L D + ED V+LV L G +L + IV ++ + I
Sbjct: 71 M-DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQI 127
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H G++HRDLKP N + N E LK +DFGL+ ++ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSN-IAVN--EDCELKILDFGLAR--HTDDEMTGYVATRWYR 182
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILL---------------------CGVPP--FWAE 260
APE++ +Y VD+WS G I+ LL G P +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242
Query: 261 TEQGVAQAIIRSVLDFRR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
A+ I+S+ + + + + A DL+ KML DP +R+TA + L
Sbjct: 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 87/310 (28%), Positives = 134/310 (43%), Gaps = 69/310 (22%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+ I +YE+ ++LG+G +GI + DR + A K I R A D + RE+ ++
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQ 61
Query: 111 HLPKHQNIVCLKDTY--EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
L H NIV L + E+D ++LV E E +L H A + I+E
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DL--------H------AVIRANILED 106
Query: 169 VQMC-------------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214
V H V+HRDLKP N L + +K DFGL+ E+
Sbjct: 107 VHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEEN 163
Query: 215 -----FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF---------- 257
++ V + +Y APE+L Y VD+WS G IL +L G P F
Sbjct: 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223
Query: 258 ------WAETEQGVAQ-------AIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDP 300
+ + + ++ S+ R P PK S++A DL++K+L +P
Sbjct: 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNP 283
Query: 301 KRRLTAQQVL 310
+RLTA++ L
Sbjct: 284 NKRLTAEEAL 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 68/259 (26%), Positives = 121/259 (46%), Gaps = 14/259 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ ++G+G FG+ + + + +A K I K+ + E+ E ++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKL-DSS 59
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGH-YTERAAAAVTKTIVEVVQMCHK 174
I+ +++ D +++VME E G+L + RG E I+ + H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPEVLK-R 232
++HRD+K N LF + + +K D G++ F+ IVG+PYY++PE+ + +
Sbjct: 120 KKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KVSENAKDL 291
Y + DVW+ GV+LY G PF A QG A+I ++ P S+ L
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANN-QG---ALILKIIRGVFPPVSQMYSQQLAQL 232
Query: 292 VRKMLDPDPKRRLTAQQVL 310
+ + L D ++R Q+L
Sbjct: 233 IDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 70/246 (28%), Positives = 119/246 (48%), Gaps = 9/246 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +G +A K + KK + + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDV 240
KPEN L ++ + DFGL + + S G+P Y+APEVL K+ Y VD
Sbjct: 123 KPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + P +S +A+ L+ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR 235
Query: 301 KRRLTA 306
+RL A
Sbjct: 236 TKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 17/263 (6%)
Query: 47 EPTGREIEERYE---LGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDV 102
+ R+ + +YE R LG G FG L T + E+ A K K K+ ++ V
Sbjct: 19 KEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
E I+ ++ H V L +++D++ ++LV+E GGE F + +
Sbjct: 79 FSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYA 137
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
IV + + +++RDLKPEN L + +K DFG + + + G+P
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVD--TRTYTLCGTP 192
Query: 223 YYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
Y+APE+L +G D W+ G+ +Y +L G PPF+A + Q I+ ++ F
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF----- 247
Query: 282 PK-VSENAKDLVRKMLDPDPKRR 303
PK + N K L++K+L D +R
Sbjct: 248 PKFLDNNCKHLMKKLLSHDLTKR 270
|
Length = 340 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 74/256 (28%), Positives = 124/256 (48%), Gaps = 16/256 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ + +++GRG+F Y T +G A K + L A D +E+D+++ L H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC--- 172
N++ ++ +D +++V+EL + G+L I H+ ++ KT+ + VQ+C
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 173 ---HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPE 228
H VMHRD+KP N T +K D GL FF + +VG+PYYM+PE
Sbjct: 120 EHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ N Y + D+WS G +LY + PF+ + + D+ P SE
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236
Query: 288 AKDLVRKMLDPDPKRR 303
+ LV ++PDP++R
Sbjct: 237 LRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-26
Identities = 69/254 (27%), Positives = 120/254 (47%), Gaps = 9/254 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +A K + KK + + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDV 240
KPEN L ++ + DFGL + S G+P Y+APEVL K+ Y VD
Sbjct: 123 KPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + P ++ +A+ L+ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR 235
Query: 301 KRRLTAQQVLGKIE 314
+RL A+ +I+
Sbjct: 236 TKRLGAKDDFMEIK 249
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 81/244 (33%), Positives = 122/244 (50%), Gaps = 9/244 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + FA K++ K + D+E E ++ +H + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I + G + E A I+ +Q HK G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N L + +K DFG+ GE K S G+P Y+APE+LK + Y VD
Sbjct: 123 KLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PF E E + +I+ F R W +S+ AKD + K+ + DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W--ISKEAKDCLSKLFERDP 235
Query: 301 KRRL 304
+RL
Sbjct: 236 TKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLPKHQN 117
++G G +G+ Y +++ G + ++ KK+R + E V RE+ +++ L +H N
Sbjct: 7 KIGEGTYGVVYKGRNKKTG-----QIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPN 60
Query: 118 IVCLKDTYEDDTAVHLVMEL--CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
IVCL+D ++ ++L+ E + + D + + + I++ + CH
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL--KR 232
V+HRDLKP+N L NK +K DFGL+ F P ++ V + +Y APEVL
Sbjct: 121 RVLHRDLKPQNLLIDNK---GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS------- 285
Y VD+WS G I + P F ++E I R + D WP V+
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237
Query: 286 ------------------ENAKDLVRKMLDPDPKRRLTAQQVL 310
E+ DL+ KML DP +R++A++ L
Sbjct: 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 77/250 (30%), Positives = 119/250 (47%), Gaps = 7/250 (2%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVS 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ L GG+L I G + E A I ++ H+ ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L + ++ D GL+V G+ VG+ YMAPEV+K Y
Sbjct: 125 YRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W+ G +LY ++ G PF ++ + + R V + + + K S +A+ L + +L
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 298 PDPKRRLTAQ 307
DPK RL Q
Sbjct: 242 KDPKERLGCQ 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE-DVRREVDIMRHLPKHQ 116
EL R LG G G C + G FA K+I+ D++ + RE++I + K
Sbjct: 5 ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITT---DPNPDLQKQILRELEINKSC-KSP 59
Query: 117 NIVCLKDTY--EDDTAVHLVMELCEGGEL---FDRIVARGHYT-ERAAAAVTKTIVEVVQ 170
IV + E +++ + ME CEGG L + ++ RG E+ + +++++ +
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMA 226
H ++HRD+KP N L K + +K DFG+S GE + + G+ +YMA
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNSLAGTFTGTSFYMA 171
Query: 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIR-SVLDFRRD 279
PE ++ + Y DVWS G+ L + PF E E + I+ + + +
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 280 PWPKV--SENAKDLVRKMLDPDPKRRLTAQQVL 310
P + SE KD +++ L+ DP RR T +L
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 56/302 (18%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK-----LRTAVDIEDVRREV 106
++ RY+ +G G +G+ T + G A K IS + RT RE+
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-------REI 54
Query: 107 DIMRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
I+R KH+NI+ + D ++E V++V EL E +L+ +++ H +
Sbjct: 55 KILRRF-KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYF 111
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS----E 217
I+ ++ H V+HRDLKP N L LK DFGL+ P + E
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 218 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF------------------ 257
V + +Y APE++ + Y +D+WS G IL +L P F
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 258 -WAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQ 308
E + A+ I+S+ + PW P A DL+ KML +P +R+T ++
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288
Query: 309 VL 310
L
Sbjct: 289 AL 290
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 72/257 (28%), Positives = 123/257 (47%), Gaps = 15/257 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +G +A K + KK + + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV----GSPYYMAPEVLKRN-YGPE 237
KPEN L ++ DFGL K G S+ G+P Y+APEV+++ Y
Sbjct: 123 KPENILLDSQGHVV---LTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
VD W G +LY +L G+PPF+ + I+ L R P S A ++ ++L+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLE 232
Query: 298 PDPKRRLTAQQVLGKIE 314
D +RRL A++ +I+
Sbjct: 233 KDRQRRLGAKEDFLEIQ 249
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 77/247 (31%), Positives = 118/247 (47%), Gaps = 7/247 (2%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R LG+G FG C R G +ACK + KK+++ E I+ + + +V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVS 64
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVM 178
L YE A+ LV+ L GG+L I G+ + E A I ++ H+ ++
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV 124
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPE 237
+RDLKPEN L + ++ D GL+V GE VG+ YMAPEV+K Y
Sbjct: 125 YRDLKPENILLDDYGH---IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D W G ++Y ++ G PF E+ + + R V + + + K SE A+ + R++L
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 298 PDPKRRL 304
DP RL
Sbjct: 242 KDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 77/278 (27%), Positives = 121/278 (43%), Gaps = 47/278 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E + +GRG FG L ++ G +A K + K + + +R E DI+
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+V + +++D ++L+ME GG++ ++ + TE V + H+
Sbjct: 61 LW-VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-------------------- 214
G +HRD+KP+N L +K +K DFGL K +
Sbjct: 120 LGFIHRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 215 -----------------FSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPP 256
FS VG+P Y+APEV + Y D WS GVI+Y +L G PP
Sbjct: 177 NSKRKAETWKRNRRQLAFS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 257 FWAETEQGVAQAII--RSVLDFRRDPWPKVSENAKDLV 292
F +ET Q + ++ + L F P +SE AKDL+
Sbjct: 236 FCSETPQETYKKVMNWKETLIF--PPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E+ + RE+G G FG Y D + A K +S ++ +D+ +EV ++ L
Sbjct: 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL- 72
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
+H N + K Y + LVME C G ++ + V + E AA+ ++ +
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAY 130
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL- 230
H H +HRD+K N L E +K DFG + P F VG+PY+MAPEV+
Sbjct: 131 LHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF---VGTPYWMAPEVIL 184
Query: 231 ---KRNYGPEVDVWSAGV 245
+ Y +VDVWS G+
Sbjct: 185 AMDEGQYDGKVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 81/293 (27%), Positives = 122/293 (41%), Gaps = 58/293 (19%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN--I 118
+ +G G FG L + +A K++ K + V+ E DI L + N +
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI---LAEADNEWV 63
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V L +++D ++ VM+ GG++ ++ G + E A + ++ HK G +
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFK--------------------PGEKFSEI 218
HRD+KP+N L +K DFGL F+ P E++SEI
Sbjct: 124 HRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEI 180
Query: 219 ------------------------VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCG 253
VG+P Y+APEVL R Y D WS GVILY +L G
Sbjct: 181 DRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240
Query: 254 VPPFWAETEQGVAQAII--RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
PPF A+T +I + L K+S A DL+ + L + RL
Sbjct: 241 QPPFLADTPAETQLKVINWETTLHI--PSQAKLSREASDLILR-LCCGAEDRL 290
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 70/247 (28%), Positives = 116/247 (46%), Gaps = 9/247 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +G +A K + KK + + + E +++ KH +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A + + H +++RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
KPEN L ++ DFGL +P E S G+P Y+APEVL++ Y VD
Sbjct: 123 KPENILLDSQGHVV---LTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + A DL+ +L D
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ 235
Query: 301 KRRLTAQ 307
+RRL A+
Sbjct: 236 RRRLGAK 242
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 77/259 (29%), Positives = 133/259 (51%), Gaps = 17/259 (6%)
Query: 44 VLKEPTGREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV 102
++++ +++ E Y++ + +GRG FG L + + +A K +SK ++ D
Sbjct: 31 IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
E DIM +V L ++DD +++VME GG+L + +++ E+ A T
Sbjct: 91 WEERDIMA-FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYT 148
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVG 220
+V + H G++HRD+KP+N L + LK DFG + + VG
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVG 205
Query: 221 SPYYMAPEVLKRN-----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSV 273
+P Y++PEVLK YG E D WS GV L+ +L G PF+A++ G I+ ++
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS 265
Query: 274 LDFRRDPWPKVSENAKDLV 292
L+F D ++S++AK+L+
Sbjct: 266 LNFPED--VEISKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRH 111
+YE ++G G +G + +RE + A K ++R D E V RE+ +++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDEGVPSSALREICLLKE 55
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVV 169
L KH+NIV L D D + LV E C+ + FD G + +++ +
Sbjct: 56 L-KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGL 112
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPE 228
CH H V+HRDLKP+N L E LK DFGL+ F P +S V + +Y P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVRCYSAEVVTLWYRPPD 169
Query: 229 VL--KRNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
VL + Y +D+WSAG I L G P F + I R + + WP VS
Sbjct: 170 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229
Query: 286 E-------------------------NAKDLVRKMLDPDPKRRLTAQQVL 310
+ +DL++ +L +P +R++A++ L
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 74/251 (29%), Positives = 125/251 (49%), Gaps = 18/251 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--HQNIVC 120
LGRG FG L ++ G+ +A K++ K + ++E + E I H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + V VME GG+L I ++E A +V +Q H++ +++R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFK----PGEKFSEIVGSPYYMAPEVL-KRNYG 235
DLK +N L + +K DFGL K G++ S G+P ++APEVL + +Y
Sbjct: 126 DLKLDNLLLDTE---GFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSYT 179
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
VD W GV++Y +L G PF + E+ V +I+ + + R +S A ++R++
Sbjct: 180 RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR----FLSREAISIMRRL 235
Query: 296 LDPDPKRRLTA 306
L +P+RRL +
Sbjct: 236 LRRNPERRLGS 246
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 68/244 (27%), Positives = 115/244 (47%), Gaps = 9/244 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D++ E I+ KH + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GG+L +I + E + + + H+HGV++RDL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDV 240
K +N L K DFG+ G + G+P Y+APE+L+ YGP VD
Sbjct: 123 KLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W+ GV++Y ++ G PPF A+ E + ++I+ D W +S+ A +++ + +P
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFMTKNP 235
Query: 301 KRRL 304
+RL
Sbjct: 236 NKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 49/299 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E++ +Y + +GRG +GI + E + A K I+ +D + RE+ ++RH
Sbjct: 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANA-FDNRIDAKRTLREIKLLRH 60
Query: 112 LPKHQNIVCLKD--------TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
L H+N++ +KD + D V++V EL + +L I + ++
Sbjct: 61 L-DHENVIAIKDIMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLY 115
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLF-ANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGS 221
++ ++ H V+HRDLKP N L AN LK DFGL+ + G+ +E V +
Sbjct: 116 QLLRGLKYIHSANVLHRDLKPSNLLLNAN----CDLKICDFGLARTTSEKGDFMTEYVVT 171
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA------------------ET 261
+Y APE+L Y +DVWS G I LL P F E
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231
Query: 262 EQGV-----AQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLG 311
+ G A+ IRS+ R +P + A DL+ KML DP +R+T ++ L
Sbjct: 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 54/306 (17%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+YE ++G+G FG + ++ A K + + + I +R E+ I++ L KH
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR-EIKILQLL-KH 70
Query: 116 QNIVCLKD--------TYEDDTAVHLVMELCE---GGELFDRIVARGHYTERAAAAVTKT 164
+N+V L + + +LV E CE G L ++ V +T V K
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKVMKM 127
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-----KFSEIV 219
++ + H++ ++HRD+K N L + LK DFGL+ F + +++ V
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 220 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277
+ +Y PE+L +R+YGP +D+W AG I+ + P TEQ I +
Sbjct: 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244
Query: 278 RDPWPKV----------------------------SENAKDLVRKMLDPDPKRRLTAQQV 309
+ WP V +A DL+ K+L DP +R+ A
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304
Query: 310 LGKIEF 315
L F
Sbjct: 305 LNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-24
Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 23/272 (8%)
Query: 53 IEERYELGRE-----LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
+E YE LG+G +GI Y D A K I ++ R ++ + E+
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIA 57
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKT 164
+ +L KH+NIV + ++ + ME GG L + ++ E+ TK
Sbjct: 58 LHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ 116
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPY 223
I+E ++ H + ++HRD+K +N L + +K DFG S +E G+
Sbjct: 117 ILEGLKYLHDNQIVHRDIKGDNVLV--NTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174
Query: 224 YMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
YMAPEV+ R YG D+WS G + + G PPF E G QA + V F+ P
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---IELGEPQAAMFKVGMFKIHP 231
Query: 281 W--PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+S AK+ + + +PDP +R +A +L
Sbjct: 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-24
Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 49/277 (17%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E + +GRG FG L ++ G +A K + K + + +R E DI+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V + +++D ++L+ME GG++ ++ + +E A V + H+ G
Sbjct: 63 -VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--------------PGEKFS------ 216
+HRD+KP+N L K +K DFGL K P FS
Sbjct: 122 FIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 217 ----------------EIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWA 259
VG+P Y+APEV ++ Y D WS GVI+Y +L G PPF +
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 260 ETEQGVAQAIIRSVLDFRRD----PWPKVSENAKDLV 292
ET Q R V++++ P +SE AKDL+
Sbjct: 239 ET----PQETYRKVMNWKETLVFPPEVPISEKAKDLI 271
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 5e-24
Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 33/268 (12%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
ELG G G+ R G A K+I + ++ + RE+DI+
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQI-----LRELDILHKC-NSPY 60
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVE-VVQMCHK 174
IV + ++ + + ME +GG L D+I +G ER + +++ + + K
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPEVL 230
H ++HRD+KP N L ++ + +K DFG+S G+ + + VG+ YMAPE +
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ---IKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-----QAIIRSVLDFRRDPWPKV 284
+ N Y + D+WS G+ L L G P+ E + Q I+ R P K
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE--PPPRLPSGKF 229
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLGK 312
S + +D V L DP+ R + +++L
Sbjct: 230 SPDFQDFVNLCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 6e-24
Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
++YE ++G G +G+ Y DR + +I+ KK+R + E V RE+ +++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIREISLLK 56
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV-- 168
+ +H NIV L+D + ++LV E + + + H A +++
Sbjct: 57 EM-QHGNIVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYL 108
Query: 169 ------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGS 221
+ CH H V+HRDLKP+N L + T LK DFGL+ F P F+ V +
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIPVRTFTHEVVT 166
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+Y APE+L R+Y VD+WS G I ++ P F ++E I R + +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226
Query: 280 PWPKVSE-------------------------NAKDLVRKMLDPDPKRRLTAQQVL 310
WP V+ DL+ KML DP +R+TA+ L
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282
|
Length = 294 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 6e-24
Identities = 74/247 (29%), Positives = 118/247 (47%), Gaps = 15/247 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG +L + FA K++ K + D+E E ++ +H + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I + + A I+ +Q H G+++RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVL-KRNYGPEVDV 240
K +N L +K DFG+ G+ K G+P Y+APE+L + Y VD
Sbjct: 123 KLDNILLDTDGH---IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--WPK-VSENAKDLVRKMLD 297
WS GV+LY +L G PF E+ + Q+I R D +P+ ++ AKD++ K+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSI-------RMDNPCYPRWLTREAKDILVKLFV 232
Query: 298 PDPKRRL 304
+P+RRL
Sbjct: 233 REPERRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-24
Identities = 73/244 (29%), Positives = 120/244 (49%), Gaps = 9/244 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + G+ FA K++ K + D+E E ++ ++ + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I +G + A IV +Q H G+++RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N + +K DFG+ G+ + S G+P Y+APE+L+ Y VD
Sbjct: 123 KLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PF + E + ++I + R W +++ +KD++ K+ + DP
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEKLFERDP 235
Query: 301 KRRL 304
RRL
Sbjct: 236 TRRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 9e-24
Identities = 71/282 (25%), Positives = 126/282 (44%), Gaps = 46/282 (16%)
Query: 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-- 123
G +G+ Y D++ G+ A K + +K + I +R E++I+ L +H NIV +K+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKL-QHPNIVTVKEVV 73
Query: 124 TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV----EVVQMCHKHGVMH 179
+ +++VME E +L + + + K ++ V H + ++H
Sbjct: 74 VGSNLDKIYMVMEYVEH-DLKSLM---ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH 129
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL--KRNYGP 236
RDLK N L N+ LK DFGL+ + P + ++++V + +Y APE+L + Y
Sbjct: 130 RDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-------------- 282
+D+WS G I LL P F ++E I + + WP
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFT 246
Query: 283 --------------KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+S+N DL+ ++L DP +R++A+ L
Sbjct: 247 KYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-23
Identities = 70/262 (26%), Positives = 126/262 (48%), Gaps = 13/262 (4%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
RYE+ +++G G FG YL + + + K I K+ + E ++EV ++ + KH
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKM-KH 58
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARG-HYTERAAAAVTKTIVEVVQMCH 173
NIV +++++ + +VME C+GG+L RI RG ++E + I ++ H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-VGSPYYMAPEVLK- 231
++HRD+K +N + A L DFG++ + + VG+PYY++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLG--DFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW-PKVSENAKD 290
R Y + D+WS G +LY L PF + I + P P S + +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG----YFAPISPNFSRDLRS 232
Query: 291 LVRKMLDPDPKRRLTAQQVLGK 312
L+ ++ P+ R + +L +
Sbjct: 233 LISQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 80/270 (29%), Positives = 133/270 (49%), Gaps = 35/270 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +E+ + +GRG FG + + G +A K ++K ++ + R E D++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELF-------DRI---VARGHYTERAAAAVTKT 164
+ I L ++D+ ++LVM+ GG+L DR+ +AR + E
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE--------- 110
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI-VGSP 222
+V + H+ G +HRD+KP+N L + ++ DFG + G S + VG+P
Sbjct: 111 MVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 223 YYMAPEVL------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--RSVL 274
Y++PE+L K YGPE D WS GV +Y +L G PF+AE+ I+ +
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF 227
Query: 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
F D VSE AKDL+R+++ P+ RL
Sbjct: 228 QFPPDV-TDVSEEAKDLIRRLICS-PETRL 255
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 75/255 (29%), Positives = 124/255 (48%), Gaps = 20/255 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+ + +GRG FG + + FA K ++K ++ + R E D++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCH 173
+Q I L ++D+ ++LVM+ GG+L + E A +V + H
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFG--LSVFFKPGEKFSEIVGSPYYMAPEVL- 230
+ +HRD+KP+N L ++ DFG L + + S VG+P Y++PE+L
Sbjct: 120 QLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP--- 282
K YGPE D WS GV +Y +L G PF+AE+ I+ F+ +P
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ---FPAQV 233
Query: 283 -KVSENAKDLVRKML 296
VSE+AKDL+R+++
Sbjct: 234 TDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 70/247 (28%), Positives = 115/247 (46%), Gaps = 15/247 (6%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L I G + E A I + H G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 183 KPENFLFANKKETAPLKAIDFGL---SVFFKPGEKFSEIVGSPYYMAPE-VLKRNYGPEV 238
K +N + +K DFG+ ++F G+ G+P Y+APE + + YG V
Sbjct: 128 KLDNVML---DAEGHIKIADFGMCKENIF--GGKTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLD 297
D W+ GV+LY +L G PPF E E + Q+I+ + + PK +S+ A + + +L
Sbjct: 183 DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----PKSLSKEAVSICKGLLT 237
Query: 298 PDPKRRL 304
P +RL
Sbjct: 238 KHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-23
Identities = 82/266 (30%), Positives = 126/266 (47%), Gaps = 18/266 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE +E+ ELG G FG Y ++E G A K I K + ++ED E+DI+
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQM 171
H NIV L D + + + +++E C GG + D ++ TE V K +E +
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNY 118
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVL 230
H++ ++HRDLK N LF + +K DFG+S + ++ +G+PY+MAPEV+
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 231 ------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
R Y + DVWS G+ L + PP V I +S P +
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRW 234
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
S KD ++K L+ + R T Q+L
Sbjct: 235 SSEFKDFLKKCLEKNVDARWTTTQLL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 85/288 (29%), Positives = 137/288 (47%), Gaps = 41/288 (14%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ +++G G FG +L + + F K+IS + L+ + V EV++MR L KH+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMREL-KHK 72
Query: 117 NIVCLKDTY--EDDTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQ 170
NIV D + + + ++++ME C+ G+L I G E A +T+ ++ +
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 171 MCH--KHG-----VMHRDLKPENFLF-------------ANKKETAPLKAI-DFGLSVFF 209
CH K G V+HRDLKP+N AN P+ I DFGLS
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 210 KPGEKFSEIVGSPYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266
VG+PYY +PE+L ++Y + D+W+ G I+Y L G PF A
Sbjct: 193 GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK------A 246
Query: 267 QAIIRSVLDFRRDPWPKVSENAKD---LVRKMLDPDPKRRLTAQQVLG 311
+ + + +R P + +K+ L++ +L+ K R +A Q LG
Sbjct: 247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 67/255 (26%), Positives = 121/255 (47%), Gaps = 18/255 (7%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R +GRG + L ++ +A K + K+ + DI+ V+ E + H +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ ++ + V+E GG+L + + E A + I + H+ G+++R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLK +N L ++ +K D+G+ +PG+ S G+P Y+APE+L+ +YG V
Sbjct: 121 DLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 239 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
D W+ GV+++ ++ G PF TE + Q I+ + R +S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAA 233
Query: 290 DLVRKMLDPDPKRRL 304
+++ L+ DPK RL
Sbjct: 234 SVLKSFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-23
Identities = 82/296 (27%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
+ YE ++G G +G Y D+ G K ++ KK R +D E + RE+ +++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTG-----KLVALKKTRLEMDEEGIPPTALREISLLQ 55
Query: 111 HLPKHQNIV---CLKDTYEDD--TAVHLVME-LCEGGELFDRIVARGHYTERAAAAVTKT 164
L + IV ++ E + +++LV E L + F RG A +
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 165 IVEVVQ---MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVG 220
+ ++++ CHKHGVMHRDLKP+N L +K LK D GL F P + ++ +
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGLGRAFSIPVKSYTHEIV 173
Query: 221 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
+ +Y APEVL +Y VD+WS G I + P F ++E I + +
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTE 233
Query: 279 DPWPKV------------------------SENAKDLVRKMLDPDPKRRLTAQQVL 310
WP V S DL++KML DP +R++A+ L
Sbjct: 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 65/201 (32%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
E+G G FG Y T+ + A K +S +T +D+ +EV ++ L KH N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEY 86
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
K Y + LVME C G V + E AA+T ++ + H H ++HRD
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL----KRNYGPE 237
+K N L E +K DFG + P F VG+PY+MAPEV+ + Y +
Sbjct: 147 IKAGNILLT---EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGK 200
Query: 238 VDVWSAGVILYILLCGVPPFW 258
VDVWS G+ L PP +
Sbjct: 201 VDVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-23
Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLPKHQN 117
++G G +G+ Y ++ G + ++ KK+R + E V RE+ +++ L H N
Sbjct: 7 KIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPN 60
Query: 118 IVCLKDTYEDDTAVHLVME-LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
IV L D + ++LV E L + + F + +++ + CH H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL--KRN 233
V+HRDLKP+N L +K DFGL+ F P ++ V + +Y APE+L +
Sbjct: 121 VLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS-------- 285
Y VD+WS G I ++ F ++E I R++ WP V+
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237
Query: 286 -----------------ENAKDLVRKMLDPDPKRRLTAQQVL 310
E+ +DL+ +ML DP +R++A+ L
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-23
Identities = 78/284 (27%), Positives = 118/284 (41%), Gaps = 53/284 (18%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG G FG L + +A K++ KK + + V+ E DI+ ++ +V
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWVVR 65
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L +++D ++ VM+ GG++ ++ G + E A + V+ HK G +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFF------------------------------- 209
D+KP+N L +K DFGL F
Sbjct: 126 DIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 210 -------KPGEKFS----------EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL 251
KP E+ + +VG+P Y+APEVL R Y D WS GVILY +L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
G PPF A+T +I P K+S A DL+ K+
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 70/260 (26%), Positives = 119/260 (45%), Gaps = 16/260 (6%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R +GRG + L ++N +A K + K+ + DI+ V+ E + + +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ + + LV+E GG+L + + E A I + H+ G+++R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLK +N L +K D+G+ PG+ S G+P Y+APE+L+ YG V
Sbjct: 121 DLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 239 DVWSAGVILYILLCGVPPF-------WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
D W+ GV+++ ++ G PF TE + Q I+ + R +S A +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR----FLSVKASHV 233
Query: 292 VRKMLDPDPKRRLTAQQVLG 311
++ L+ DPK RL Q G
Sbjct: 234 LKGFLNKDPKERLGCQPQTG 253
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 5e-23
Identities = 75/255 (29%), Positives = 115/255 (45%), Gaps = 15/255 (5%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
RE+G G FG Y D N + A K +S ++ +D+ +EV ++ L +H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
+ Y + LVME C G V + E AAVT ++ + H H ++HR
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL----KRNYGP 236
D+K N L + E +K DFG + P F VG+PY+MAPEV+ + Y
Sbjct: 140 DVKAGNILLS---EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDG 193
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-FRRDPWPKVSENAKDLVRKM 295
+VDVWS G+ L PP + I ++ + W SE ++ V
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSC 250
Query: 296 LDPDPKRRLTAQQVL 310
L P+ R T++ +L
Sbjct: 251 LQKIPQDRPTSEVLL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 7e-23
Identities = 75/264 (28%), Positives = 125/264 (47%), Gaps = 19/264 (7%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED--VRREVDIMRHLPK 114
Y R +G+G +G L R +G + I K LR A E +E ++ L K
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYV---IKKLNLRNASRRERKAAEQEAQLLSQL-K 57
Query: 115 HQNIVCLKDTYE-DDTAVHLVMELCEGGELFDRIV-ARGHY-TERAAAAVTKTIVEVVQM 171
H NIV ++++E +D +++VM CEGG+L+ ++ +G E I +Q
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVL 230
H+ ++HRDLK +N T +K D G++ V + S ++G+PYYM+PE+
Sbjct: 118 LHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174
Query: 231 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENA 288
+ Y + DVW+ G +Y + F A+ + II L P PK S
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----PPMPKDYSPEL 230
Query: 289 KDLVRKMLDPDPKRRLTAQQVLGK 312
+L+ ML P++R + + +L +
Sbjct: 231 GELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 9e-23
Identities = 80/266 (30%), Positives = 124/266 (46%), Gaps = 20/266 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+ ELG G FG Y ++E G A K I K + ++ED E++I+
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-N 67
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTKTIVEVVQM 171
H IV L + D + +++E C GG + D I+ RG TE + + ++E +Q
Sbjct: 68 HPYIVKLLGAFYWDGKLWIMIEFCPGGAV-DAIMLELDRG-LTEPQIQVICRQMLEALQY 125
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVL 230
H ++HRDLK N L + +K DFG+S K ++ +G+PY+MAPEV+
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 231 ------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
Y + D+WS G+ L + PP V I +S P K
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP-SKW 241
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
S +D ++ LD P+ R +A Q+L
Sbjct: 242 SMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 9e-23
Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 21/280 (7%)
Query: 45 LKEPTGREI------EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD 98
LK+P E+ E+ + RE+G G FG Y D + A K +S ++
Sbjct: 9 LKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK 68
Query: 99 IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
+D+ +EV ++ + KH N + K Y + LVME C G V + E
Sbjct: 69 WQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI 127
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
AA+T ++ + H H ++HRD+K N L E +K DFG + P F
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPANSF--- 181
Query: 219 VGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS-V 273
VG+PY+MAPEV+ + Y +VDVWS G+ L PP + I ++
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 241
Query: 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313
+ + W S+ ++ V L P+ R T++++L +
Sbjct: 242 PTLQSNEW---SDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 82/297 (27%), Positives = 129/297 (43%), Gaps = 62/297 (20%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHL 112
Y+ ++G G +G+ Y D+ G+ A K K+R + E V RE+ +++ L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKEL 55
Query: 113 PKHQNIVCLKDTYEDDTAVHLV-----------MELCEGGELFDRIVARGHYTERAAAAV 161
H NIV L D + ++LV M+ L ++ Y
Sbjct: 56 -NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ------- 107
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVG 220
+++ + CH H V+HRDLKP+N L +++ LK DFGL+ F P ++ V
Sbjct: 108 ---LLQGIAYCHSHRVLHRDLKPQNLLI-DREGA--LKLADFGLARAFGVPVRTYTHEVV 161
Query: 221 SPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------- 271
+ +Y APE+L R Y VD+WS G I ++ P F ++E I R
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDE 221
Query: 272 -------SVLDF-------RRDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVL 310
S+ D+ R KV E+ DL+ KML DP +R++A+ L
Sbjct: 222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-22
Identities = 79/271 (29%), Positives = 123/271 (45%), Gaps = 23/271 (8%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R +E +EL + +G G +G Y + G+ A K I KL D V++E+ +M+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMK 61
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
KH NIV +Y + + ME C GG L D G +E A V++ ++ +
Sbjct: 62 DC-KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEV 229
H G MHRD+K N L + +K DFG+S K +G+PY+MAPEV
Sbjct: 121 YLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 230 L----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
K Y D+W+ G+ L PP + + +S +F+ PK+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NFQP---PKLK 232
Query: 286 ENAK------DLVRKMLDPDPKRRLTAQQVL 310
+ K V+ L +PK+R TA+++L
Sbjct: 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 85/305 (27%), Positives = 126/305 (41%), Gaps = 54/305 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ RY R LG G G+ + D + A K I L ++ RE+ I+R
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV---LTDPQSVKHALREIKIIRR 58
Query: 112 LPKHQNIV----CLKDTYEDDT----------AVHLVMELCEGGELFDRIVARGHYTERA 157
L H NIV L + D T +V++V E E ++ +G +E
Sbjct: 59 L-DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEH 115
Query: 158 AAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--- 214
A ++ ++ H V+HRDLKP N +F N E LK DFGL+ P
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPAN-VFINT-EDLVLKIGDFGLARIVDPHYSHKG 173
Query: 215 -FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271
SE + + +Y +P +L NY +D+W+AG I +L G P F E Q I+
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 272 SVLDFR--------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLT 305
SV R RD P V+ A D + ++L +P RLT
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 306 AQQVL 310
A++ L
Sbjct: 294 AEEAL 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 4e-22
Identities = 86/313 (27%), Positives = 127/313 (40%), Gaps = 58/313 (18%)
Query: 51 REIEERYE-LGRELGRGEFGITYLCTDRENGDAFACK-------SISKKKLRTAVDIEDV 102
I ERY G LG G +G D G A K S K R V + +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 103 R----REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
RE+ IM + KH+NI+ L D Y + ++LVM++ +L + + TE
Sbjct: 64 HFTTLRELKIMNEI-KHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQV 121
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--------- 209
+ I+ + + HK MHRDL P N +F N K K DFGL+ +
Sbjct: 122 KCILLQILNGLNVLHKWYFMHRDLSPAN-IFINSKGIC--KIADFGLARRYGYPPYSDTL 178
Query: 210 ------KPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET 261
+ E+ + V + +Y APE+L Y VD+WS G I LL G P F E
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 262 EQGVAQAIIRSVLDFRRDPWPKV------------------------SENAKDLVRKMLD 297
E I + D WP+ S++A DL++ +L
Sbjct: 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298
Query: 298 PDPKRRLTAQQVL 310
+P R++A++ L
Sbjct: 299 LNPLERISAKEAL 311
|
Length = 335 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-22
Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 39/276 (14%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACK-------SISKKKLRTAVDIEDVRREVDIMRHL 112
G +G+G +G YL + G+ A K + R ++ +R E++ ++ L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
H NIV + + + +E GG + + G + E+ T+ ++E +
Sbjct: 66 -DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV----------GSP 222
H G++HRDLK +N L K DFG+S K S+ + GS
Sbjct: 125 HSKGILHRDLKADNLLV---DADGICKISDFGIS-------KKSDDIYDNDQNMSMQGSV 174
Query: 223 YYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
++MAPEV+ + Y +VD+WS G ++ + G P W++ E A+ +
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEEA--IAAMFKLGNKRSAP 231
Query: 280 PWP-----KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
P P +S A D + +P R TA+++L
Sbjct: 232 PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 6e-22
Identities = 77/290 (26%), Positives = 133/290 (45%), Gaps = 43/290 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
E+YE +G G +G+ C +E G A K K + D + V+ RE+ +++
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLK 55
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
L +H+N+V L + + ++LV E + L D E I+ ++
Sbjct: 56 QL-RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE 114
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEV 229
CH H ++HRD+KPEN L + K DFG + PGE +++ V + +Y APE+
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVV---KLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171
Query: 230 LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------FRRD 279
L + YG VD+W+ G ++ +L G P F +++ II+ + + F+++
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 280 P-------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
P +PK+S DL ++ L DP R ++ Q+L
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 7e-22
Identities = 75/250 (30%), Positives = 121/250 (48%), Gaps = 16/250 (6%)
Query: 63 LGRGEFGITYLC---TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
LG+G FG +L T + G +A K + K L+ D + E DI+ + H IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTKMERDILAEV-NHPFIV 61
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
L ++ + ++L+++ GG+LF R+ +TE + + H G+++
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS-EIVGSPYYMAPEVL-KRNYGPE 237
RDLKPEN L E +K DFGLS EK + G+ YMAPEV+ +R +
Sbjct: 122 RDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKML 296
D WS GV+++ +L G PF + + I+++ L P+ +S A+ L+R +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM-----PQFLSPEAQSLLRALF 233
Query: 297 DPDPKRRLTA 306
+P RL A
Sbjct: 234 KRNPANRLGA 243
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 82/301 (27%), Positives = 127/301 (42%), Gaps = 52/301 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVD 107
++ RY+ +G G +G+ D +G A K I A D+ + RE+
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-----AFDVPTLAKRTLRELK 56
Query: 108 IMRHLPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
I+RH KH NI+ ++D D V++VM+L E +L I + TE
Sbjct: 57 ILRHF-KHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLY 114
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL--SVFFKPGEK---FSEI 218
++ ++ H V+HRDLKP N L E L+ DFG+ + P E +E
Sbjct: 115 QLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 219 VGSPYYMAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVP 255
V + +Y APE+L Y +D+WS G I L + + G P
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP 231
Query: 256 P--FWAETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQV 309
+ I+++ + PW PK S A DL+ +ML DP+ R+T +Q
Sbjct: 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291
Query: 310 L 310
L
Sbjct: 292 L 292
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 69/206 (33%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVV 169
H IV D ++ D + L+ME GG+L +I R + E + IV +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMA 226
H +MHRDLK N T +K DFG S + S G+PYY+A
Sbjct: 183 DEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA 239
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KV 284
PE+ +R Y + D+WS GVILY LL PF ++ + I++ VL + DP+P V
Sbjct: 240 PELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYDPFPCPV 295
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
S K L+ +L +P R T QQ+L
Sbjct: 296 SSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 72/284 (25%), Positives = 117/284 (41%), Gaps = 53/284 (18%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ LG G FG L + +A K++ KK + + V+ E DI+ ++ +V
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWVVK 65
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L +++D ++ VM+ GG++ ++ + E A + ++ HK G +HR
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFK--------------------PGEKFSEI-- 218
D+KP+N L +K DFGL F+ P + + ++
Sbjct: 126 DIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 219 --------------------------VGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILL 251
VG+P Y+APEV L++ Y D WS GVIL+ +L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
G PPF A T +I P K+S A DL+ K+
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-21
Identities = 84/314 (26%), Positives = 121/314 (38%), Gaps = 90/314 (28%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMR 110
E Y+ +LG G + Y + G A K I + TA+ RE +++
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI------REASLLK 58
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLV-----------MELCEGG------ELFDRIVARGHY 153
L KH NIV L D + LV M+ C GG LF + RG
Sbjct: 59 DL-KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRG-- 115
Query: 154 TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL----SVFF 209
+ CH+ V+HRDLKP+N L + + E LK DFGL SV
Sbjct: 116 ---------------LAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSV-- 155
Query: 210 KPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET---EQG 264
P + +S V + +Y P+VL Y +D+W G I Y + G P F T +Q
Sbjct: 156 -PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ- 213
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAK----------------------------DLVRKML 296
I R + + WP VS N + +L K L
Sbjct: 214 -LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFL 272
Query: 297 DPDPKRRLTAQQVL 310
+PK+R++A + +
Sbjct: 273 QYEPKKRISAAEAM 286
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 8e-21
Identities = 69/253 (27%), Positives = 108/253 (42%), Gaps = 38/253 (15%)
Query: 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE-DVRREVDIMRHLPKHQNIVCLKDT 124
G+FG + + F K I K IE V +M+ + N + L +
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVH---QLMKD---NPNFIKLYYS 77
Query: 125 YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184
L+M+ + G+LFD + G +E + + +VE + HKH ++H D+K
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137
Query: 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-------YMAPE-VLKRNYGP 236
EN L+ K+ L D+GL +I+G+P Y +PE + NY
Sbjct: 138 ENVLYDRAKDRIYL--CDYGL----------CKIIGTPSCYDGTLDYFSPEKIKGHNYDV 185
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPK---VSENAKDLV 292
D W+ GV+ Y LL G PF ++ + + L R + P VS+NA D V
Sbjct: 186 SFDWWAVGVLTYELLTGKHPF----KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFV 241
Query: 293 RKMLDPDPKRRLT 305
+ ML + RLT
Sbjct: 242 QSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-20
Identities = 76/257 (29%), Positives = 122/257 (47%), Gaps = 22/257 (8%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG + G +ACK + KK+L+ + E +I+ + IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLA 59
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIV---ARGHYTERA---AAAVTKTIVEVVQMCHKHG 176
+E T + LVM L GG+L I RG ER +A +T I+ + H
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL----HSMD 115
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YG 235
+++RD+KPEN L ++ + D GL+V K G+ ++ G+ YMAPE+LK Y
Sbjct: 116 IVYRDMKPENVLLDDQGNC---RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 236 PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD----FRRDPWPKVSENAKDL 291
VD ++ G +Y ++ G PF E+ + + R L+ F +E +KD+
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESKDI 229
Query: 292 VRKMLDPDPKRRLTAQQ 308
R L P+ RL +++
Sbjct: 230 CRLFLAKKPEDRLGSRE 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 68/245 (27%), Positives = 115/245 (46%), Gaps = 11/245 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L I G + E A I + H+ G+++RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N + ++ +K DFG+ G G+P Y+APE++ + YG VD
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLDPD 299
W+ GV+LY +L G PPF E E + Q+I+ + + PK +S+ A + + ++
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY-----PKSLSKEAVSICKGLMTKH 239
Query: 300 PKRRL 304
P +RL
Sbjct: 240 PSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
++E+ +G G +G+ C +E + A K + V E RE+ ++R L K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVK-ETTLRELKMLRTL-KQ 59
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+NIV LK+ + ++LV E E EL + + G E+ + + + +++ + CH
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCH 117
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPE-VL 230
K+ ++HRD+KPEN L ++ LK DFG + G ++E V + +Y +PE +L
Sbjct: 118 KNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 231 KRNYGPEVDVWSAGVILYILLCGVPPFWAETE 262
YG VD+WS G IL L G P F E+E
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-20
Identities = 73/268 (27%), Positives = 116/268 (43%), Gaps = 34/268 (12%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSI---SKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+LG G G G A K + +K +R + + RE+ IM +
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR-----KQILRELQIMHEC-RSPY 64
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE-VVQMCHKH 175
IV + ++ + + ME + G L DRI + G + +VE + + + H
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPEVLK 231
+MHRD+KP N L ++ + +K DFG+S GE + I VG+ YM+PE ++
Sbjct: 124 RIMHRDIKPSNILVNSRGQ---IKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQ 175
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----DPWPKV-- 284
Y + DVWS G+ + L G PF Q +LD + +P P++
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 285 ---SENAKDLVRKMLDPDPKRRLTAQQV 309
E+ +D V L DP R T QQ+
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-20
Identities = 71/261 (27%), Positives = 125/261 (47%), Gaps = 20/261 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +E+ + +GRG FG + + +A K ++K ++ + R E +++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GD 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCH 173
Q I L ++D+ ++LVM+ GG+L + E A +V + H
Sbjct: 60 CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEI-VGSPYYMAPEVLK 231
+ +HRD+KP+N L ++ DFG + + G S + VG+P Y++PE+L+
Sbjct: 120 QLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 232 R------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-- 283
YGPE D WS GV +Y +L G PF+AE+ I+ F+ +P
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHI 233
Query: 284 --VSENAKDLVRKMLDPDPKR 302
VSE AKDL+++++ +R
Sbjct: 234 TDVSEEAKDLIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-20
Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 40/275 (14%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI--------EDVR--RE 105
RY L + LG+G FG YL D+ K++++++L+ +I E V+ +E
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDK--------KAVAEERLKVLKEIPVGELNPNETVQANQE 52
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTER-AAAAVTKT 164
++ L H IV ++ + A ++ E CEG +L ++ H + + V +
Sbjct: 53 AQLLSKL-DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 165 IVEV---VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVG 220
+++ V H+ ++HRDLK +N N LK DFG+S + + G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL----LKIGDFGVSRLLMGSCDLATTFTG 167
Query: 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+PYYM+PE LK + Y + D+WS G ILY + C F Q + VL
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-------EGQNFLSVVLRIVEG 220
Query: 280 PWPKV----SENAKDLVRKMLDPDPKRRLTAQQVL 310
P P + S +++ ML+ DP R +A ++L
Sbjct: 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-20
Identities = 76/271 (28%), Positives = 126/271 (46%), Gaps = 23/271 (8%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R + YEL + +G G +G Y + G+ A K I KL D +++E+ +++
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVK 61
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
KH NIV +Y + + ME C GG L D G +E A V + ++ +
Sbjct: 62 EC-KHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGSPYYMAPEV 229
H G MHRD+K N L + + +K DFG++ K +G+PY+MAPEV
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGD---VKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 230 --LKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
+++N Y D+W+ G+ L PP + + + S +F+ PK+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMF--DLHPMRALFLMSKSNFQP---PKLK 232
Query: 286 ENAK------DLVRKMLDPDPKRRLTAQQVL 310
+ K + V+ L +PK+R TA+++L
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-20
Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 17/263 (6%)
Query: 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV----RREVDIMRHLPKH 115
G++LG G F Y D + G A K ++ + T+ + E+V R+E+ +M L H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVR-NTSSEQEEVVEALRKEIRLMARL-NH 62
Query: 116 QNIV-CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+I+ L T ED + +L +E GG + + G + E T+ ++ + H+
Sbjct: 63 PHIIRMLGATCED-SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-----FFKPGEKFSEIVGSPYYMAPEV 229
+ ++HRD+K N L + + L+ DFG + GE +++G+ +MAPEV
Sbjct: 122 NQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179
Query: 230 LK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
L+ YG DVWS G ++ + PP+ AE I + P+ +S
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
+D+ + L+ P+ R ++++L
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 7e-20
Identities = 65/283 (22%), Positives = 115/283 (40%), Gaps = 50/283 (17%)
Query: 61 RELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
++LG G FG Y + A K++ K+ + + +D +E +M+ L H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKL-GHPN 57
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----- 172
+V L ++ ++LV+E EGG+L D + + ++ +++
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL-SLKDLLSFAIQIAK 116
Query: 173 -----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY--- 224
+HRDL N L +K DFGLS ++ YY
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSR---------DVYDDDYYRKK 164
Query: 225 ---------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV-AQAIIRS 272
MAPE LK + + DVWS GV+L+ I G P+ G+ + ++
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-----GLSNEEVLEY 219
Query: 273 VLDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ R P P+ + +L+ DP+ R T +++ ++E
Sbjct: 220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 8e-20
Identities = 71/283 (25%), Positives = 114/283 (40%), Gaps = 53/283 (18%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPK 114
ELG++LG G FG Y T + +G+ ++ K L+ + + E+ E IM+ L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGE-GTETKVAVKTLKEGASEEEREEFLEEASIMKKL-S 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-- 172
H NIV L +++V E GG+L D + G T+ +++QM
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---------KLTLKDLLQMALQ 110
Query: 173 --------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
+HRDL N L +K DFGLS +I YY
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLVTENLV---VKISDFGLS---------RDIYEDDYY 158
Query: 225 ------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
MAPE LK + + DVWS GV+L+ I G P+ + + V + +
Sbjct: 159 RKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE 218
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313
+R + +L+ + DP+ R T +++ +
Sbjct: 219 D---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 68/255 (26%), Positives = 120/255 (47%), Gaps = 18/255 (7%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
R +GRG + L ++ +A K I K+ + DI+ V+ E + H +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
L ++ ++ + V+E GG+L + + E A + I + H+ G+++R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 181 DLKPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEV 238
DLK +N L + +K D+G+ +PG+ S G+P Y+APE+L+ +YG V
Sbjct: 121 DLKLDNVLLDAEGH---IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177
Query: 239 DVWSAGVILYILLCGVPPF---------WAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
D W+ GV+++ ++ G PF TE + Q I+ + R +S A
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAS 233
Query: 290 DLVRKMLDPDPKRRL 304
+++ L+ DPK RL
Sbjct: 234 SVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 75/288 (26%), Positives = 122/288 (42%), Gaps = 38/288 (13%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK- 114
+YE E+G G +G Y D +G A KS+ + + + VR EV +++ L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAF 59
Query: 115 -HQNIVCLKDT-----YEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIV 166
H NIV L D + +T V LV E + D++ G E + + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD-LMRQFL 118
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ H + ++HRDLKPEN L + + +K DFGL+ + + +V + +Y A
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 227 PEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW---- 281
PEV L+ Y VD+WS G I + P F +E I + D W
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235
Query: 282 -------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
P++ E+ L+ +ML +P +R++A + L
Sbjct: 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 32/284 (11%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRRE 105
E T +E ++Y + R LG G G T LC R +G+ FA K + + + + D + E
Sbjct: 24 EATAKEQAKKYWISRVLGSGATG-TVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAE 81
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTA-------VHLVMELCEGGELFDRIVARGH----YT 154
V + + + C +D + D + LV++ G+L I +R +
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 155 ERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP--- 211
E A + ++ V H ++HRD+K N L + +K DFG S +
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVS 198
Query: 212 ---GEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
G F G+PYY+APE+ +R Y + D++S GV+LY LL PF E + V
Sbjct: 199 DDVGRTF---CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255
Query: 268 AIIRSVLDFRRDPWP-KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
L R DP P +S +++V +L DPKRR ++ ++L
Sbjct: 256 ----KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 77/316 (24%), Positives = 131/316 (41%), Gaps = 66/316 (20%)
Query: 56 RYELGRELGRGEFGITYLCTDREN--GDAFACKSI-SKKKLRTAVDIEDVRREVDIMRHL 112
+YE+ +GRG +G Y + G +A K K+ T + R E+ ++R L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-EIALLREL 59
Query: 113 PKHQNIVCLKDTYEDDTA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTKT------ 164
KH+N+V L + + + V+L+ + E +L+ I + H + +
Sbjct: 60 -KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII--KFHRQAKRVSIPPSMVKSLLW 115
Query: 165 -IVEVVQMCHKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSE---I 218
I+ V H + V+HRDLKP N + E +K D GL+ +F P + ++ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 219 VGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA---------Q 267
V + +Y APE+L R+Y +D+W+ G I LL P F + +
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235
Query: 268 AII---------------------RSVLDFRRDPWP------------KVSENAKDLVRK 294
I + DF+ +P K DL+RK
Sbjct: 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295
Query: 295 MLDPDPKRRLTAQQVL 310
+L+ DP +R+TA++ L
Sbjct: 296 LLEYDPTKRITAEEAL 311
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-19
Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 28/244 (11%)
Query: 30 YGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSIS 89
YG + L L +PT +E+ +G+G +G Y T++++G A K +
Sbjct: 2 YGLFPYNSSMLGLESLGDPTDT-----WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD 56
Query: 90 KKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT-YEDDTAVH----LVMELCEGG--- 141
VD E++ E +I++ LP H N+V Y+ D V LV+ELC GG
Sbjct: 57 PIS---DVD-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVT 112
Query: 142 ELFDRIVARGHYTERAAAA-VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200
EL ++ G + A + + + +Q H + ++HRD+K N L + +K
Sbjct: 113 ELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKL 169
Query: 201 IDFGLSVFFKPGE-KFSEIVGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCG 253
+DFG+S + + VG+P++MAPEV+ +Y DVWS G+ L G
Sbjct: 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 254 VPPF 257
PP
Sbjct: 230 DPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 4e-19
Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 39/286 (13%)
Query: 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
L++P G +EL +G G +G Y + G A K + T + E++++
Sbjct: 1 LRDPAGI-----FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TGDEEEEIKQ 51
Query: 105 EVDIMRHLPKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYT--ER 156
E+++++ H+NI K+ D + LVME C G + D I T E
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 157 AAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKF 215
A + + I+ + H+H V+HRD+K +N L E A +K +DFG+S + +
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168
Query: 216 SEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVAQAI 269
+ +G+PY+MAPEV+ + P+ D+WS G+ + G PP
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-------CDMHP 221
Query: 270 IRSVLDFRRDPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVL 310
+R++ R+P P++ S+ + + L + +R T +Q++
Sbjct: 222 MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 71/264 (26%), Positives = 122/264 (46%), Gaps = 22/264 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHL 112
EE + +G+G FG + D A K I L A D IED+++E+ ++
Sbjct: 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLSQC 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ +Y T + ++ME GG D + A G + E A + K I++ +
Sbjct: 60 -DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYL 117
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK 231
H +HRD+K N L + E +K DFG++ + K + VG+P++MAPEV++
Sbjct: 118 HSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ 174
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV----SE 286
++ Y + D+WS G+ L G PP +R + ++ P + S+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP-------NSDMHPMRVLFLIPKNNPPTLTGEFSK 227
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVL 310
K+ + L+ DP R TA+++L
Sbjct: 228 PFKEFIDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-19
Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 40/280 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI-EDVRREVDIMRHLP 113
+ +E+ +G+G +G + +++NG A K L DI E++ E +I++ L
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILKALS 72
Query: 114 KHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRI---VARG-HYTERAAAAVTK 163
H N+V KD D + LV+ELC GG + D + + RG E A +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQ-LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSP 222
+ +Q H + +HRD+K N L + +K +DFG+S + + VG+P
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 223 YYMAPEV------LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
++MAPEV L Y DVWS G+ L G PP A+ +R++
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL-ADLHP------MRALFKI 241
Query: 277 RRDPWPKV------SENAKDLVRKMLDPDPKRRLTAQQVL 310
R+P P + S D +RK L D ++R T +L
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 81/295 (27%), Positives = 136/295 (46%), Gaps = 47/295 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY +++G G +G D+ G+ A K +S+ ++ + + RE+ +++H
Sbjct: 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRP-FQSEIFAKRAYRELTLLKH 70
Query: 112 LPKHQNIVCLKDTYEDDTAVH------LVMELCEGGELFDRIVARGH-YTERAAAAVTKT 164
+ +H+N++ L D + + LVM + D GH +E +
Sbjct: 71 M-QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQ 125
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
++ ++ H G++HRDLKP N L N E LK +DFGL+ + + V + +Y
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGN-LAVN--EDCELKILDFGLAR--HADAEMTGYVVTRWY 180
Query: 225 MAPEVLKR--NYGPEVDVWSAGVILYILLCGV-----------------------PPFWA 259
APEV+ +Y VD+WS G I+ +L G P F
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240
Query: 260 ETEQGVAQAIIRSVLDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ E A++ I+S+ + R +PK S A DL+ KML+ D +RLTA + L
Sbjct: 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 72/271 (26%), Positives = 124/271 (45%), Gaps = 36/271 (13%)
Query: 42 LCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED 101
L L++P G +EL +G G +G Y + G A K + T + E+
Sbjct: 8 LSALRDPAGI-----FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV----TEDEEEE 58
Query: 102 VRREVDIMRHLPKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIV-ARGH-Y 153
++ E+++++ H+NI K D + LVME C G + D + +G+
Sbjct: 59 IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNAL 118
Query: 154 TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212
E A + + I+ + H H V+HRD+K +N L E A +K +DFG+S +
Sbjct: 119 KEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTV 175
Query: 213 EKFSEIVGSPYYMAPEVLKRNYGPEV------DVWSAGVILYILLCGVPPFWAETEQGVA 266
+ + +G+PY+MAPEV+ + P+ D+WS G+ + G PP
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL-------CD 228
Query: 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
+R++ R+P PK+ +K +K +D
Sbjct: 229 MHPMRALFLIPRNPPPKL--KSKKWSKKFID 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 67/245 (27%), Positives = 114/245 (46%), Gaps = 11/245 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L +I G + E A I + H G+++RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 183 KPENFLFANKKETAPLKAIDFGL-SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDV 240
K +N + ++ +K DFG+ G G+P Y+APE++ + YG VD
Sbjct: 128 KLDNVMLDSEGH---IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLDPD 299
W+ GV+LY +L G PF E E + Q+I+ + + PK +S+ A + + ++
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY-----PKSMSKEAVAICKGLMTKH 239
Query: 300 PKRRL 304
P +RL
Sbjct: 240 PGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-18
Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 29/200 (14%)
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV ++++L KH NIV L D + + LV E + Y + ++
Sbjct: 52 REVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDSD--------LKQYLDNCGNLMSM 102
Query: 164 TIVEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL----SVFFKP 211
V++ + CHK ++HRDLKP+N L K E LK DFGL SV P
Sbjct: 103 HNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSV---P 156
Query: 212 GEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269
+ +S V + +Y P+VL Y +D+W G ILY + G P F T + I
Sbjct: 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
Query: 270 IRSVLDFRRDPWPKVSENAK 289
R + + WP ++ N +
Sbjct: 217 FRLLGTPTEETWPGITSNEE 236
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 7e-18
Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 46/300 (15%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D + G A K +S+ ++ + + RE+ +++H
Sbjct: 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 72
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ KH+N++ L D + E+ V+LV L G + IV T+ + I
Sbjct: 73 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H ++HRDLKP N E LK +DFGL+ ++ + V + +Y
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR--HTDDEMTGYVATRWYR 184
Query: 226 APEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---------- 273
APE++ +Y VD+WS G I+ LL G F + I+R V
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244
Query: 274 ------------------LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315
++F + + + A DL+ KML D +R+TA Q L F
Sbjct: 245 ISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-18
Identities = 73/264 (27%), Positives = 123/264 (46%), Gaps = 22/264 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-IEDVRREVDIMRHL 112
EE + +G+G FG Y D + A K I L A D IED+++E+ ++
Sbjct: 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQC 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I +Y T + ++ME GG D ++ G E A + + I++ +
Sbjct: 60 -DSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYL 117
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK 231
H +HRD+K N L + E +K DFG++ + K + VG+P++MAPEV+K
Sbjct: 118 HSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 174
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV----SE 286
++ Y + D+WS G+ L G PP +R + ++ P + S+
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPN-------SDLHPMRVLFLIPKNSPPTLEGQYSK 227
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVL 310
K+ V L+ DP+ R TA+++L
Sbjct: 228 PFKEFVEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 9e-18
Identities = 74/300 (24%), Positives = 136/300 (45%), Gaps = 50/300 (16%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T E+ +RY +++G G +G DR G A K + + ++ + + RE+ +
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRP-FQSELFAKRAYRELRL 67
Query: 109 MRHLPKHQNIVCLKDTYEDDTAV------HLVMELCEGGELFDRIVARGHYTERAAAAVT 162
++H+ KH+N++ L D + D ++ +LVM G +++ +E +
Sbjct: 68 LKHM-KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV 124
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG-- 220
+++ ++ H G++HRDLKP N E LK +DFGL+ + SE+ G
Sbjct: 125 YQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLA-----RQTDSEMTGYV 176
Query: 221 -SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVP---------------------- 255
+ +Y APEV+ +Y VD+WS G I+ +L G P
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236
Query: 256 -PFWAETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
F + + A+ ++ + FR+ + P + A +++ KML D + R+TA + L
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 84/302 (27%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
RY++ +G+G +G+ D G+ A K I D + RE+ ++R L +H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLL-RH 58
Query: 116 QNIVCLKD--------TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+IV +K ++D +++V EL E +L I A T ++
Sbjct: 59 PDIVEIKHIMLPPSRREFKD---IYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFK--PGEKF-SEIVGSPY 223
++ H V HRDLKP+N L AN LK DFGL+ V F P F ++ V + +
Sbjct: 115 ALKYIHTANVFHRDLKPKNIL-ANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 224 YMAPEV---LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAET 261
Y APE+ Y P +D+WS G I +L G P F ET
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231
Query: 262 EQGVAQAIIRSVLDFRR--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313
V R L R +P A L+ ++L DPK R TA++ L
Sbjct: 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291
Query: 314 EF 315
F
Sbjct: 292 YF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-17
Identities = 70/263 (26%), Positives = 125/263 (47%), Gaps = 20/263 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE + ++G+G FG + D A K I ++ +IED+++E+ ++
Sbjct: 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQC- 59
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ +Y DT + ++ME GG D ++ G E A + + I++ + H
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR 232
+HRD+K N L + E +K DFG++ + K + VG+P++MAPEV+K+
Sbjct: 119 SEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN---- 287
+ Y + D+WS G+ L G PP +E + + L + +P P + N
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP---HSELHPMKVLF---LIPKNNP-PTLEGNYSKP 228
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
K+ V L+ +P R TA+++L
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 82/291 (28%), Positives = 113/291 (38%), Gaps = 56/291 (19%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMRHLPKHQ 116
+LG G + Y R NG A K IS K TA+ RE +++ L KH
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI------REASLLKGL-KHA 63
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
NIV L D + V E I G ++ + H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVL--KRN 233
++HRDLKP+N L + E LK DFGL+ P + +S V + +Y P+VL +
Sbjct: 124 ILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-----IRSVLDF-RRDPWPKVSE- 286
Y +D+W AG I +L G P F GV+ I +VL D WP VS+
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAF-----PGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 287 ---------------------------NAKDLVRKMLDPDPKRRLTAQQVL 310
A+DL +ML PK R++AQ L
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN---IV 119
+GRG FG Y C + G +A K + KK+++ E + IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
C+ + + +++L GG+L + G ++E I+ ++ H V++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPE 237
RDLKP N L E ++ D GL+ F +K VG+ YMAPEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 238 VDVWSAGVILYILLCGVPPF 257
D +S G +L+ LL G PF
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 58/195 (29%), Positives = 91/195 (46%), Gaps = 23/195 (11%)
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV +++ L KH NIV L D D ++ LV E D+ + + Y + ++
Sbjct: 53 REVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEY------LDKDLKQ--YMDDCGNIMSM 103
Query: 164 TIVEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEK 214
V++ + CH+ V+HRDLKP+N L + E LK DFGL+ P +
Sbjct: 104 HNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKT 160
Query: 215 FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
+S V + +Y P+VL Y ++D+W G I + + G P F T + I R
Sbjct: 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220
Query: 273 VLDFRRDPWPKVSEN 287
+ + WP +S N
Sbjct: 221 LGTPTEETWPGISSN 235
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 11/247 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN---IV 119
+GRG FG Y C + G +A K + KK+++ E + IM L + IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLALNERIMLSLVSTGDCPFIV 60
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
C+ + + +++L GG+L + G ++E+ I+ ++ H V++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPE 237
RDLKP N L E ++ D GL+ F + + VG+ YMAPEVL++ Y
Sbjct: 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSS 176
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D +S G +L+ LL G PF + I R L + S K L+ +L
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235
Query: 298 PDPKRRL 304
D +RL
Sbjct: 236 RDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 6e-17
Identities = 67/265 (25%), Positives = 118/265 (44%), Gaps = 27/265 (10%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLP 113
E +G G G Y R G +A K I + VR RE++I+R +
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------EDTVRRQICREIEILRDV- 129
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H N+V D ++ + + +++E +GG L +A E+ A V + I+ + H
Sbjct: 130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYLH 185
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKR 232
+ ++HRD+KP N L + K +K DFG+S + + + + VG+ YM+PE +
Sbjct: 186 RRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINT 242
Query: 233 NY------GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-LDFRRDPWPKVS 285
+ G D+WS GV + G PF QG +++ ++ + + S
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQPPEAPATAS 301
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVL 310
+ + L +P +R +A Q+L
Sbjct: 302 REFRHFISCCLQREPAKRWSAMQLL 326
|
Length = 353 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-17
Identities = 73/299 (24%), Positives = 128/299 (42%), Gaps = 44/299 (14%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D A K +S+ ++ + RE+ +++H
Sbjct: 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKH 70
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ KH+N++ L D + E+ V+LV L G + IV ++ + +
Sbjct: 71 M-KHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H G++HRDLKP N E L+ +DFGL+ + ++ + V + +Y
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR--QADDEMTGYVATRWYR 182
Query: 226 APEVLKR--NYGPEVDVWSAGVILYILLCG-----------------------VPPFWAE 260
APE++ +Y VD+WS G I+ LL G P +
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAK----DLVRKMLDPDPKRRLTAQQVLGKIEF 315
A+ I+S+ + K+ A DL+ KML D +R++A + L F
Sbjct: 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 9e-17
Identities = 80/272 (29%), Positives = 116/272 (42%), Gaps = 42/272 (15%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSI----SKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
ELG+G +G Y R G A K I + K + E+DI+ H
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII------MELDIL-HKAVSPY 60
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK--- 174
IV + + AV++ ME + G L D++ A G TE V + I V K
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 175 --HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE 228
H ++HRD+KP N L + +K DFG+S G + + +G YMAPE
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVS-----GNLVASLAKTNIGCQSYMAPE 171
Query: 229 VLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV---AQAIIRSVLDFRR 278
+K Y + DVWS G+ + + G P+ ET + AI+ D
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDG--DPPT 229
Query: 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
P S++A+D V K L+ P RR T Q+L
Sbjct: 230 LP-SGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 70/299 (23%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L ++ G +A K++ K ++ + V+ E D++ +V L
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-SDSPWVVSLY 67
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++D ++L+ME GG+L ++ ++E V ++ HK G +HRD+
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM--------APEVLKRN- 233
KP+N L +K DFGLS F + S YY + RN
Sbjct: 128 KPDNILI---DRGGHIKLSDFGLST------GFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 234 ------------------------------------YGPEV----------DVWSAGVIL 247
PE+ D WS G I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 248 YILLCGVPPFWAETEQGVAQAII--RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
+ L G PPF +E + II R L F D +S A+DL+R+++ + + RL
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRL 294
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 77/309 (24%), Positives = 121/309 (39%), Gaps = 63/309 (20%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YE+ +LG G FG Y + G A K I + I +R E+ I++ L K
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKL-K 65
Query: 115 HQNIVCLKD-TYE--DDTA-----VHLVM-----ELCEGGELFDRIVARGHYTERAAAAV 161
H N+V L D E D + V++V +L G L + V TE
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIKCY 120
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-----KPG---- 212
++E + H++ ++HRD+K N L N+ LK DFGL+ + P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQ---GILKIADFGLARPYDGPPPNPKGGGG 177
Query: 213 ---EKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
K++ +V + +Y PE+L +R Y VD+W G + + P +++
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH 237
Query: 268 AIIRSVLDFRRDPWP--------------------------KVSENAKDLVRKMLDPDPK 301
I + + WP K+ DL+ K+L DP
Sbjct: 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297
Query: 302 RRLTAQQVL 310
+RLTA L
Sbjct: 298 KRLTASDAL 306
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
++YE E+G G +G + D +NG F ++ K++R E + REV ++R
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLR 56
Query: 111 HLP--KHQNIV-----CLKDTYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAV 161
HL +H N+V C + +T + LV E + D++ G TE +
Sbjct: 57 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 116
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS 221
+ ++ + H H V+HRDLKP+N L + + +K DFGL+ + + +V +
Sbjct: 117 FQ-LLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALTSVVVT 172
Query: 222 PYYMAPEV-LKRNYGPEVDVWSAGVIL 247
+Y APEV L+ +Y VD+WS G I
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
IEE + + + + RG FG YL + N +A K + K + + V+ E D + L
Sbjct: 3 IEE-FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-L 60
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV--- 169
K IV L + + V+LVME GG++ + G++ E A K I EV
Sbjct: 61 SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA---VKYISEVALAL 117
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
H+HG++HRDLKP+N L +N+ +K DFGLS
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGH---IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 73/264 (27%), Positives = 118/264 (44%), Gaps = 38/264 (14%)
Query: 14 GKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITY- 72
GK + N KK + + + + + + + R + Y+LG +G G FG+ Y
Sbjct: 26 GKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDND-INRSPNKSYKLGNIIGNGSFGVVYE 84
Query: 73 -LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY------ 125
+C D A KK L+ D + RE+ IM++L H NI+ LKD Y
Sbjct: 85 AICIDTSEKVAI------KKVLQ---DPQYKNRELLIMKNL-NHINIIFLKDYYYTECFK 134
Query: 126 --EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV--QMC------HKH 175
E + +++VME + + + R A+ +V++ Q+C H
Sbjct: 135 KNEKNIFLNVVMEF-----IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--KRN 233
+ HRDLKP+N L T LK DFG + G++ + S +Y APE++ N
Sbjct: 190 FICHRDLKPQNLLIDPNTHT--LKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATN 247
Query: 234 YGPEVDVWSAGVILYILLCGVPPF 257
Y +D+WS G I+ ++ G P F
Sbjct: 248 YTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 103 RREVDIMRHLPKHQNIVCLKDTYE-DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
RRE + L H NIV L D+ E + V E G L + + A G +
Sbjct: 26 RRETALCARL-YHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL 84
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG--------- 212
+++ + H G++HRDLKP+N + + K +DFG+ PG
Sbjct: 85 MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL-PGVRDADVATL 143
Query: 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271
+ +E++G+P Y APE L+ P D+++ G+I L G + VA+ + +
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS---VAEILYQ 200
Query: 272 --SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR-LTAQQV 309
S +D PW ++RK L+ DP++R +A +
Sbjct: 201 QLSPVDVSLPPWIA-GHPLGQVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 20/216 (9%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR--REVDIM 109
++ + LG E+G G G Y ++ G A K + RT E+ R ++D++
Sbjct: 13 DLNDLENLG-EIGSGTCGQVYKMRFKKTGHVMAVKQMR----RTGNKEENKRILMDLDVV 67
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVE 167
IV + D+ V + MEL D+++ R G E +T IV+
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 168 VVQ-MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ + KHGV+HRD+KP N L + +K DFG+S + + G YMA
Sbjct: 126 ALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMA 182
Query: 227 PEVL-----KRNYGPEVDVWSAGVILYILLCGVPPF 257
PE + Y DVWS G+ L L G P+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 77/293 (26%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY++ R +G+G G YL D A K I + + + RE I L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-I 60
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFD--------RIVARGHYTERAAAA---VTK 163
H IV + D V+ M EG L +++ + + A +
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK------------- 210
I ++ H GV+HRDLKP+N L E L D+G ++F K
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL---DWGAAIFKKLEEEDLLDIDVDE 177
Query: 211 PGEKFSE------IVGSPYYMAPEVLKRNYGPE-VDVWSAGVILYILLCGVPPFWAETEQ 263
+S IVG+P YMAPE L E D+++ GVILY +L P+ ++
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY--RRKK 235
Query: 264 GVAQAIIRSVLD------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
G + +L +R P P +S+ + K L DP R ++ Q L
Sbjct: 236 GRKISYRDVILSPIEVAPYREIP-PFLSQ----IAMKALAVDPAERYSSVQEL 283
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 10/97 (10%)
Query: 218 IVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
I+G+P Y+APE+L + +GP VD W+ GV L+ L G+PPF ET Q V Q I+
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN----- 594
Query: 277 RRDPWP----KVSENAKDLVRKMLDPDPKRRLTAQQV 309
R PWP K+S NA++ + +L DP +R +++
Sbjct: 595 RDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKEL 631
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 62/249 (24%), Positives = 109/249 (43%), Gaps = 49/249 (19%)
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV +++ L KH NIV L D + ++ LV E D+ + + Y + ++
Sbjct: 53 REVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEY------LDKDLKQ--YLDDCGNSINM 103
Query: 164 TIVEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEK 214
V++ + CH+ V+HRDLKP+N L + E LK DFGL+ P +
Sbjct: 104 HNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKT 160
Query: 215 FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
+S V + +Y P++L +Y ++D+W G I Y + G P F T + I R
Sbjct: 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220
Query: 273 VLDFRRDPWPKVSENAK--------------------------DLVRKMLDPDPKRRLTA 306
+ + WP + N + +L+ K+L + ++R++A
Sbjct: 221 LGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA 280
Query: 307 QQVLGKIEF 315
++ + F
Sbjct: 281 EEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 54 EERY-ELGRELGRGEFGITYLCT-DRENGDAFACKSISKKKLRTA---VDIEDVRREVDI 108
E+R+ + ++LG G FG LC D + ++ K L + D RE++I
Sbjct: 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAV--KSLNHSGEEQHRSDFEREIEI 59
Query: 109 MRHLPKHQNIVCLKDTYEDD--TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
+R L H+NIV K E ++ L+ME G L R + H R + + ++
Sbjct: 60 LRTL-DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRH---RDQINLKRLLL 113
Query: 167 EVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SE 217
Q+C +HRDL N L ++ +K DFGL+ + + E
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLAKVLPEDKDYYYVKE 170
Query: 218 IVGSP-YYMAPEVLK-RNYGPEVDVWSAGVILYILL 251
SP ++ APE L+ + DVWS GV LY L
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-15
Identities = 72/277 (25%), Positives = 104/277 (37%), Gaps = 54/277 (19%)
Query: 63 LGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHLPKHQNI 118
LG G FG Y T G ++ K LR ++ + +E +M + H NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK----TIVEVVQMC-- 172
V L + +++MEL EGG+L Y A T+ E++ +C
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLL-------SYLRDARVERFGPPLLTLKELLDICLD 114
Query: 173 --------HKHGVMHRDLKPENFLFANKKETAP--LKAIDFGLSVFFKPGEKFSEIVGSP 222
+ +HRDL N L + K A +K DFGL+ +I S
Sbjct: 115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---------RDIYKSD 165
Query: 223 YY------------MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA 268
YY MAPE L + + DVWS GV+++ IL G P+ A Q V Q
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH 225
Query: 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
+ R + L+ DP R T
Sbjct: 226 VTA---GGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-15
Identities = 81/305 (26%), Positives = 124/305 (40%), Gaps = 72/305 (23%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMR 110
+ YE +LG G + Y + NG A K I ++ TA+ RE +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI------REASLLK 58
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVME-----LCEGGELFDRIVARGHYTERAAAAVTKTI 165
L KH NIV L D + LV E LC+ Y ++ +
Sbjct: 59 GL-KHANIVLLHDIIHTKETLTLVFEYVHTDLCQ-------------YMDKHPGGLHPEN 104
Query: 166 VEV--------VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFS 216
V++ + H+ ++HRDLKP+N L + +T LK DFGL+ P +S
Sbjct: 105 VKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYS 161
Query: 217 EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAI---- 269
V + +Y P+VL Y +D+W G I ++ GV F + Q + I
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL 221
Query: 270 ----------IRSVLDFR------------RDPWPKVS--ENAKDLVRKMLDPDPKRRLT 305
+ S+ F+ R W K+S +A+DL K+L PK RL+
Sbjct: 222 GTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281
Query: 306 AQQVL 310
AQ L
Sbjct: 282 AQAAL 286
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 80/301 (26%), Positives = 125/301 (41%), Gaps = 65/301 (21%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----VDIEDVRREVDIMRHLP 113
E R +G G FG+ + TD +G K ++ KK+ V + V RE+ ++
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDG-----KRVALKKMPNVFQNLVSCKRVFRELKMLCFF- 56
Query: 114 KHQNIVCLKDT--------YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
KH N++ D +E+ +++V EL + +L IV+ + I
Sbjct: 57 KHDNVLSALDILQPPHIDPFEE---IYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQI 112
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSP 222
+ ++ H G++HRD+KP N L + LK DFGL+ +P E E+V +
Sbjct: 113 LRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEEPDESKHMTQEVV-TQ 168
Query: 223 YYMAPEVL--KRNYGPEVDVWSAGVI---------------------LYILLCGVPPFWA 259
YY APE+L R+Y VD+WS G I L L G P A
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
Query: 260 ETE--QGVAQAIIRSVLDFRRDPWPKV--------SENAKDLVRKMLDPDPKRRLTAQQV 309
+G I+R + P V + A L+ +ML DP +R++A
Sbjct: 229 MRSACEGARAHILRGPH---KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA 285
Query: 310 L 310
L
Sbjct: 286 L 286
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
ELG G G+ R +G A K I +++ A+ + RE+ ++ H IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIR-NQIIRELKVL-HECNSPYIVGF 64
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE-VVQMCHKHGVMH 179
+ D + + ME +GG L D+++ + G E ++ ++ + + KH +MH
Sbjct: 65 YGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMH 123
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPEVLKRN-Y 234
RD+KP N L ++ E +K DFG+S G+ + VG+ YM+PE L+ Y
Sbjct: 124 RDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266
+ D+WS G+ L + G P + +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-14
Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 47/255 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI---EDVRREVD 107
ELG G FG Y + + S++ K L+ + ++ R+E +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT--- 164
+M L +H NIVCL + ++ E G+L + +V +++ A + +T
Sbjct: 61 LMSDL-QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119
Query: 165 -------------IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
I ++ H +HRDL N L +K DFGLS
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISDFGLS----- 171
Query: 212 GEKFSEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+I + YY M PE +L + E D+WS GV+L+ I G+ P+
Sbjct: 172 ----RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY 227
Query: 258 WAETEQGVAQAIIRS 272
+ + Q V + +IRS
Sbjct: 228 YGFSNQEVIE-MIRS 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 83/327 (25%), Positives = 124/327 (37%), Gaps = 100/327 (30%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ +RY+ + +G G GI D G A K +S+ + + RE+ +M+ L
Sbjct: 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP-FQNVTHAKRAYRELVLMK-L 71
Query: 113 PKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
H+NI+ L + + E+ V+LVMEL + +
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-----------------------MDANLC 108
Query: 167 EVVQM---------------C-----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+V+QM C H G++HRDLKP N + K LK +DFGL+
Sbjct: 109 QVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 165
Query: 207 VFFKPGEKF--SEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVIL---------------- 247
G F + V + YY APEV L Y VD+WS G I+
Sbjct: 166 R--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI 223
Query: 248 -----YILLCGVPP--FWAETEQGVA---------QAIIRSVLDFRRDPWPKVSEN---- 287
I G P F + + V L F +P SE+
Sbjct: 224 DQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEEL-FPDVLFPPDSESHNKL 282
Query: 288 ----AKDLVRKMLDPDPKRRLTAQQVL 310
A+DL+ KML DP++R++ L
Sbjct: 283 KASQARDLLSKMLVIDPEKRISVDDAL 309
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 75/301 (24%), Positives = 129/301 (42%), Gaps = 53/301 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY+ + +G G GI D G A K +S+ + + RE+ +++ +
Sbjct: 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCV-N 78
Query: 115 HQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H+NI+ L + + E+ V+LVMEL + +++ ER + + + + +
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHMELDHERMSYLLYQMLCGI 136
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ H G++HRDLKP N + K LK +DFGL+ + V + YY APE
Sbjct: 137 KHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192
Query: 229 V-LKRNYGPEVDVWSAGVILYILLCGVPPF--------WAETEQGVA-------QAIIRS 272
V L Y VD+WS G I+ L+ G F W + + + + +
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252
Query: 273 VLDF--RRDPWPKVS---------------------ENAKDLVRKMLDPDPKRRLTAQQV 309
V ++ R +P +S A+DL+ KML DP +R++ +
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 310 L 310
L
Sbjct: 313 L 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 61 RELGRGEFG-ITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
R LG G FG ++ C D N G+ A K++ K+ + ++E++I++ L H+
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEINILKTL-YHE 66
Query: 117 NIVCLKDTYED--DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-- 172
NIV K + + L+ME G L D Y + + + ++ Q+C
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119
Query: 173 ----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSP-YY 224
H +HRDL N L N + +K DFGL+ G ++ E SP ++
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDR---LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILL 251
A E LK N + DVWS GV LY LL
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 21/240 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ +E ELG G G+ + + + +G A K I +++ A+ + RE+ ++ H
Sbjct: 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 60
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC 172
IV + D + + ME +GG L + G E+ V+ +++ + +
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE 228
KH +MHRD+KP N L ++ E +K DFG+S G+ + VG+ YM+PE
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 172
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCG----VPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
L+ +Y + D+WS G+ L + G PP E E + + P P+
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 15/192 (7%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
E+G G+FG+ +L A K+I + A+ ED E +M L H +V L
Sbjct: 11 EIGSGQFGLVWLGY-WLEKRKVAIKTIREG----AMSEEDFIEEAQVMMKL-SHPKLVQL 64
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180
+ + + LV E E G L D + A RG +++ + + E + V+HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLK-RNYGP 236
DL N L E +K DFG++ F ++++ G+ + + +PEV Y
Sbjct: 125 DLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180
Query: 237 EVDVWSAGVILY 248
+ DVWS GV+++
Sbjct: 181 KSDVWSFGVLMW 192
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 74/301 (24%), Positives = 126/301 (41%), Gaps = 53/301 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY+ + +G G GI D A K +S+ + + RE+ +M+ +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-N 74
Query: 115 HQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H+NI+ L + + E+ V+LVMEL + +++ ER + + + + +
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI 132
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ H G++HRDLKP N + K LK +DFGL+ + V + YY APE
Sbjct: 133 KHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 229 V-LKRNYGPEVDVWSAGVIL---------------------YILLCGVP-PFWAETEQGV 265
V L Y VD+WS G I+ I G P P + + Q
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 266 AQAIIRSVLDFRRDPWPKV----------------SENAKDLVRKMLDPDPKRRLTAQQV 309
+ + + + +PK+ + A+DL+ KML DP +R++ +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 310 L 310
L
Sbjct: 309 L 309
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 56/197 (28%), Positives = 80/197 (40%), Gaps = 17/197 (8%)
Query: 62 ELGRGEFGITYLCT-DRENGDAF--ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
+LG G FG+ G A K + KL +D D +E IM L H+N+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD--DFLKEAAIMHSL-DHENL 58
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+ L + +V EL G L DR+ A GH+ I ++
Sbjct: 59 IRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPY-YMAPEVLK- 231
+HRDL N L A+ + +K DFGL E E + P+ + APE L+
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 232 RNYGPEVDVWSAGVILY 248
R + DVW GV L+
Sbjct: 175 RTFSHASDVWMFGVTLW 191
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 79/319 (24%), Positives = 134/319 (42%), Gaps = 75/319 (23%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YE G ++GRG +G Y ++ D +A K I + + RE+ ++R L K
Sbjct: 4 YE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA-----CREIALLREL-K 56
Query: 115 HQNIVCLKDTY--EDDTAVHLVMELCEGGELFDRIVARGHYTERA-----------AAAV 161
H N++ L+ + D V L+ + E +L+ + + H +A ++
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWH--IIKFHRASKANKKPVQLPRGMVKSL 113
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSVFF----KPGEKFS 216
I++ + H + V+HRDLKP N L + E +K D G + F KP
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 217 EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETE------------ 262
+V + +Y APE+L R+Y +D+W+ G I LL P F E
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233
Query: 263 ----------------QGVAQAIIRSVL--DFRRDPWP-----------KVSENAK--DL 291
+ + + S L DFRR+ + KV ++K L
Sbjct: 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 293
Query: 292 VRKMLDPDPKRRLTAQQVL 310
++K+L DP +R+T++Q +
Sbjct: 294 LQKLLTMDPIKRITSEQAM 312
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 79/290 (27%), Positives = 126/290 (43%), Gaps = 54/290 (18%)
Query: 61 RELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
R+LG G FG LC GD A KS+ K I D+++E++I+R+L H+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNL-YHE 66
Query: 117 NIVCLKDTYEDD--TAVHLVMELCEGGELFDRIVARGHYTERAAAAVT-KTIVE-VVQMC 172
NIV K +D + L+ME G L + Y R + K ++ VQ+C
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-------YLPRNKNKINLKQQLKYAVQIC 119
Query: 173 H------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSP- 222
+HRDL N L ++ + +K DFGL+ + +++ + + SP
Sbjct: 120 KGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 223 YYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETE----------------QGV 265
++ APE L + + DVWS GV LY LL + ++E Q
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCDSESSPMTLFLKMIGPTHGQMT 231
Query: 266 AQAIIRSVLDFRRDPWP-KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
++R + + +R P P E L+RK + P +R T Q ++ E
Sbjct: 232 VTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-12
Identities = 81/316 (25%), Positives = 129/316 (40%), Gaps = 69/316 (21%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
YE G ++GRG +G Y ++ D +A K I + + RE+ ++R L K
Sbjct: 4 YE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA-----CREIALLREL-K 56
Query: 115 HQNIVCLKDTY--EDDTAVHLVMELCEGGEL----FDRIVARGHYTERAAAAVTKT---- 164
H N++ L+ + D V L+ + E F R + ++ K+
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSVFF----KPGEKFSEIV 219
I++ + H + V+HRDLKP N L + E +K D G + F KP +V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 220 GSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------- 269
+ +Y APE+L R+Y +D+W+ G I LL P F E
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236
Query: 270 IRSVL----------------------DFRRDPWP-----------KVSENAKD--LVRK 294
I SV+ DFRR + KV ++K L++K
Sbjct: 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296
Query: 295 MLDPDPKRRLTAQQVL 310
+L DP +R+T++Q L
Sbjct: 297 LLTMDPTKRITSEQAL 312
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 77/317 (24%), Positives = 134/317 (42%), Gaps = 54/317 (17%)
Query: 35 QGNGGHKLCVLKEPTG--REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
Q + + C + + +Y + L G G ++CT GD K I K
Sbjct: 70 QTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKH--GDEQRKKVIVK-- 125
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152
+ RE+DI++ + H+ I+ L Y + V +VM + +LF + G
Sbjct: 126 --AVTGGKTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGP 181
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
A + + ++E + H G++HRD+K EN +F ++ E A L DFG + K
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAAC--KLD 236
Query: 213 E-----KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
+ G+ +PE+L + Y + D+WSAG++L+ + + V F + +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296
Query: 266 AQ--AIIRSV----LDF------------------RRDPW--PKV------SENAKDLVR 293
+Q +IIR + L+F R P+ P V + + L+
Sbjct: 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIA 356
Query: 294 KMLDPDPKRRLTAQQVL 310
KML D + R +AQ +L
Sbjct: 357 KMLTFDQEFRPSAQDIL 373
|
Length = 392 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 72/275 (26%), Positives = 110/275 (40%), Gaps = 32/275 (11%)
Query: 55 ERYELGRELGRGEFGITYLCT-DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E LGR +G G+FG Y + A + K + E +E IMR
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF- 64
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTKTIVEVVQM 171
H +IV L ++ V +VMEL GEL Y + + + I+ Q+
Sbjct: 65 DHPHIVKLIGVITEN-PVWIVMELAPLGEL-------RSYLQVNKYSLDLASLILYSYQL 116
Query: 172 C------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY- 223
+HRD+ N L ++ +K DFGLS + + + G P
Sbjct: 117 STALAYLESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 224 YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQA-IIRSVLDFRRDP 280
+MAPE + R + DVW GV ++ IL+ GV PF QGV +I + + R P
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----QGVKNNDVIGRIENGERLP 228
Query: 281 WPKVSENA-KDLVRKMLDPDPKRRLTAQQVLGKIE 314
P L+ K DP +R ++ ++
Sbjct: 229 MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+RY+ + +G G GI D A K +S+ + + RE+ +M+ +
Sbjct: 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-N 81
Query: 115 HQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H+NI+ L + + E+ V++VMEL + +++ ER + + + + +
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQMELDHERMSYLLYQMLCGI 139
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ H G++HRDLKP N + K LK +DFGL+ + V + YY APE
Sbjct: 140 KHL-HSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 229 V-LKRNYGPEVDVWSAGVILYILLCG 253
V L Y VD+WS G I+ ++ G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 65/262 (24%), Positives = 108/262 (41%), Gaps = 21/262 (8%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+LG +G+GEFG L R G A K + K TA E +M L +H N
Sbjct: 9 KLGATIGKGEFGDVMLGDYR--GQKVAVKCL--KDDSTAAQ--AFLAEASVMTTL-RHPN 61
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKH 175
+V L +++V E G L D + +RG T + E ++ +
Sbjct: 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-YMAPEVLKRN- 233
+HRDL N L + E K DFGL+ K + + P + APE L+
Sbjct: 122 NFVHRDLAARNVLVS---EDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPEALREKK 175
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ + DVWS G++L+ I G P+ + V + + +R + ++
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAPEGCPPEVYKVM 232
Query: 293 RKMLDPDPKRRLTAQQVLGKIE 314
+ + DP +R T +Q+ ++
Sbjct: 233 KDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 59/262 (22%), Positives = 106/262 (40%), Gaps = 21/262 (8%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
+ELG G+FG+ +L R A K I + A+ +D E +M L H N+
Sbjct: 8 FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREG----AMSEDDFIEEAKVMMKL-SHPNL 61
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAA-AVTKTIVEVVQMCHKHGV 177
V L + +V E G L + + R + + E ++ +G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKRN- 233
+HRDL N L E +K DFGL+ + + S G+ + + PEV +
Sbjct: 122 IHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSS-QGTKFPVKWAPPEVFDYSR 177
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-SENAKDL 291
+ + DVWS GV+++ + G P+ + V +++ R PK+ +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY----RLYRPKLAPTEVYTI 233
Query: 292 VRKMLDPDPKRRLTAQQVLGKI 313
+ P+ R +++L ++
Sbjct: 234 MYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ +E ELG G G+ + +G A K I +++ A+ + RE+ ++ H
Sbjct: 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIR-NQIIRELQVL-HEC 60
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE-VVQMC 172
IV + D + + ME +GG L + E V+ ++ + +
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE 228
KH +MHRD+KP N L ++ E +K DFG+S G+ + VG+ YM+PE
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVGTRSYMSPE 172
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCG---VPP 256
L+ +Y + D+WS G+ L L G +PP
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 20/191 (10%)
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR-----EVDIMRHLPKHQNIVCLK 122
F I T G AFAC K V I+ +R E I+R + H +I+ LK
Sbjct: 94 FSILETFTPGAEGFAFAC---IDNKTCEHVVIKAGQRGGTATEAHILRAI-NHPSIIQLK 149
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T+ + L++ + +L+ + A+ + A+ ++++ +Q H++ ++HRD+
Sbjct: 150 GTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDI 208
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFFKP----GEKFSEIVGSPYYMAPEVLKRN-YGPE 237
K EN +F N L DFG + F P K+ G+ APE+L R+ YGP
Sbjct: 209 KAEN-IFINHPGDVCLG--DFGAACF--PVDINANKYYGWAGTIATNAPELLARDPYGPA 263
Query: 238 VDVWSAGVILY 248
VD+WSAG++L+
Sbjct: 264 VDIWSAGIVLF 274
|
Length = 391 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 65/269 (24%), Positives = 102/269 (37%), Gaps = 23/269 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI---EDVRREVDIMRH 111
G+ LG G FG T + A ++ K L+ E + E+ IM H
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTKTIVEVV 169
L H+NIV L + ++ E C G+L + R T + + + + +
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL-------SVFFKPGEKFSEIVGSP 222
+HRDL N L + K K DFGL S + G +
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIV---KICDFGLARDIMNDSNYVVKGNARLPV---- 207
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MAPE + Y E DVWS G++L+ I G P+ +I+ +R
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE--GYRMAQ 265
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQV 309
D+++ D DP +R T +Q+
Sbjct: 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 18/218 (8%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIV 119
+ELG G+FG+ +L G A ++ K + A+ ED E +M L H +V
Sbjct: 10 KELGSGQFGVVHL------GKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLV 62
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVM 178
L +++V E E G L + + R G ++ ++ + + E ++ ++ +
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKRN-Y 234
HRDL N L + T +K DFG++ + E S G+ + + PEV + Y
Sbjct: 123 HRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFPVKWSPPEVFNFSKY 178
Query: 235 GPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
+ DVWS GV+++ + G PF ++ V + I R
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 34/274 (12%)
Query: 63 LGRGEFGITYLC----TDRENGDAF-ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
LGRGEFG +L + E G+ K++ K K + RRE+D+ R L H+N
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKL-SHKN 69
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVV-QMCH- 173
+V L + ++++E + G+L F R + TK V + Q+
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 174 -----KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPYYMA 226
+HRDL N L ++++E +K LS V+ K + ++A
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQRE---VKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 227 PE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE V + ++ + DVWS GV+++ + G PF+ +++ V + L+ P V
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE-----LP-V 240
Query: 285 SENAKDLVRKML----DPDPKRRLTAQQVLGKIE 314
E + K++ +PK R + +++ +
Sbjct: 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 50/243 (20%)
Query: 62 ELGRGEFGITYL-----CTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
ELG FG Y E A A K++ K K + E+ + E +MR +H
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLR-EEFKHEA-MMRSRLQHP 68
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI---VEVVQMCH 173
NIVCL + + ++ C +L + +V R +++ + KT+ +E H
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 174 -------------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
H V+H+DL N L +K +K D GL F E+
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---VKISDLGL---------FREVYA 176
Query: 221 SPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
+ YY M+PE ++ + + D+WS GV+L+ + G+ P+ + Q V
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236
Query: 267 QAI 269
+ I
Sbjct: 237 EMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 68/290 (23%), Positives = 119/290 (41%), Gaps = 53/290 (18%)
Query: 59 LGRELGRGEFGITYL--CTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
L RELG G FG +L C E + A K++ + A +D RE +++ +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNF- 65
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK----TIVEVV 169
+H+NIV + +V E E G+L + + G + + T+ +++
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 170 Q-----------MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
Q + +H V HRDL N L +K DFG+S ++
Sbjct: 126 QIAVQIASGMVYLASQHFV-HRDLATRNCLVGYD---LVVKIGDFGMS---------RDV 172
Query: 219 VGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQG 264
+ YY M PE ++ R + E DVWS GV+L+ I G P++ + +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
V + I + L R P D++ DP++R+ + + +++
Sbjct: 233 VIECITQGRLLQRPRTCPS---EVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 48/239 (20%)
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCH 173
H +++ +KDT +V+ +L+ + R A + K I+E ++ H
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN 233
++HRD+K EN +F N + + D G + F F + G+ APEVL R+
Sbjct: 175 AQRIIHRDVKTEN-IFINDVDQVCIG--DLGAAQFPVVAPAFLGLAGTVETNAPEVLARD 231
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS----VLD-----------FR 277
Y + D+WSAG++L+ +L P E + ++S +L F
Sbjct: 232 KYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290
Query: 278 RDP---------------------WPKVS-----ENAKDLVRKMLDPDPKRRLTAQQVL 310
RDP +P + + LV KML D R +A+++L
Sbjct: 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-10
Identities = 66/265 (24%), Positives = 118/265 (44%), Gaps = 31/265 (11%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
LG +G GEFG G+ + + ++ K ++ V + E +M L H+N+
Sbjct: 10 LGEIIGEGEFGAVL------QGE-YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNL 61
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT------IVEVVQMC 172
V L + +++VMEL G L + + RG RA +V + + E ++
Sbjct: 62 VRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG----RALVSVIQLLQFSLDVAEGMEYL 116
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-YMAPEVLK 231
++HRDL N L + E K DFGL+ + G + P + APE LK
Sbjct: 117 ESKKLVHRDLAARNILVS---EDGVAKVSDFGLA---RVGSMGVDNSKLPVKWTAPEALK 170
Query: 232 RN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ + DVWS GV+L+ + G P+ + + V + + + +R +P +
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVY 227
Query: 290 DLVRKMLDPDPKRRLTAQQVLGKIE 314
L+ + +PK+R + ++ K+E
Sbjct: 228 VLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 51/222 (22%), Positives = 93/222 (41%), Gaps = 34/222 (15%)
Query: 58 ELGRELGRGEFGIT--YLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHL 112
EL +G+ + +L + A K I+ L + ED++ E+ R L
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSK-EDLKLLQQEIITSRQL 56
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYT----ERAAAAVTKTIVEV 168
+H NI+ ++ D+ +++V L G D + + H+ E A A + K ++
Sbjct: 57 -QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNA 113
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV---FFKPGEKFSEIVGSP--- 222
+ H G +HR +K + L + K + GL K G++ + P
Sbjct: 114 LDYIHSKGFIHRSVKASHILL-----SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 223 ----YYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF 257
+++PEVL++N Y + D++S G+ L G PF
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 65/214 (30%), Positives = 97/214 (45%), Gaps = 28/214 (13%)
Query: 54 EERY-ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMR 110
EER+ + ++LG+G FG LC D + ++ KKL+ TA + D RE++I++
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTG-EVVAVKKLQHSTAEHLRDFEREIEILK 60
Query: 111 HLPKHQNIVCLKDT-YE-DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
L +H NIV K Y + LVME G L D + + K ++
Sbjct: 61 SL-QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH-----RKLLLYA 114
Query: 169 VQMCH------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
Q+C +HRDL N L ++ +K DFGL+ P +K V P
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESE---NRVKIGDFGLTKVL-PQDKEYYKVREP 170
Query: 223 -----YYMAPEVLKRN-YGPEVDVWSAGVILYIL 250
++ APE L + + DVWS GV+LY L
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 26/263 (9%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPKHQN 117
+ +G GEFG + G ++ K L+ + D E IM H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKK--EIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPN 66
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
I+ L+ V ++ E E G L F R G +T + + I ++ +
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG--SPY-YMAPEVLK- 231
+HRDL N L N K DFGLS + E G P + APE +
Sbjct: 126 NYVHRDLAARNIL-VNSNLVC--KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 232 RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
R + DVWS G++++ ++ G P+W + Q V I++V D R P P +A
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV----IKAVEDGYRLPPPMDCPSA-- 236
Query: 291 LVRKMLD---PDPKRRLTAQQVL 310
L + MLD D R T Q++
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIV 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 55/215 (25%), Positives = 78/215 (36%), Gaps = 53/215 (24%)
Query: 61 RELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+ELG G FG A K++ ++ + ++ RE +M L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA--GKKEFLREASVMAQL-DHPC 57
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH---- 173
IV L + + + LVMEL G L + R ++ ++ H
Sbjct: 58 IVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPV----------SDLKELAHQVAM 106
Query: 174 -------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
KH V HRDL N L N+ + K DFG+S GS YY A
Sbjct: 107 GMAYLESKHFV-HRDLAARNVLLVNRHQA---KISDFGMSRALGA--------GSDYYRA 154
Query: 227 PEVLK---RNYGPEV----------DVWSAGVILY 248
+ + Y PE DVWS GV L+
Sbjct: 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 66/269 (24%), Positives = 113/269 (42%), Gaps = 35/269 (13%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHLPKHQN 117
ELGRG +G+ G A K ++R V+ ++ +R ++DI
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPY 61
Query: 118 IVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVARG-HYTERAAAAVTKTIVEVVQMCH- 173
V + V + ME+ + + + ++ +G E + +IV+ ++ H
Sbjct: 62 TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--- 230
K V+HRD+KP N L N+ +K DFG+S + + G YMAPE +
Sbjct: 122 KLSVIHRDVKPSNVL-INRN--GQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 231 --KRNYGPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVLDFRRDPWPKV-- 284
++ Y + DVWS G+ + L G P+ W Q + Q + +P P++
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--------EEPSPQLPA 230
Query: 285 ---SENAKDLVRKMLDPDPKRRLTAQQVL 310
S +D V K L + K R ++L
Sbjct: 231 EKFSPEFQDFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 63/236 (26%), Positives = 101/236 (42%), Gaps = 43/236 (18%)
Query: 55 ERYELGRELGRGEFGITYLC----TDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
+R LG+ LG G FG D+ D +++ K L+ T D+ D+ E++
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTV--TVAVKMLKDNATDKDLADLISEME 69
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+M+ + KH+NI+ L + +++++E G L + + AR +TK E
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 168 VVQMCHKHGV------------------MHRDLKPENFLFANKKETAPLKAIDFGLSV-- 207
Q+ K V +HRDL N L E +K DFGL+
Sbjct: 130 --QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGV 184
Query: 208 ----FFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
++K K S +MAPE L R Y + DVWS G++++ I G P+
Sbjct: 185 HDIDYYK---KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 55 ERYELGRELGRGEFGITYL-----CTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+R LG+ LG G FG + A K + K T D+ D+ E+++M
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--KDDATEKDLSDLVSEMEMM 69
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR---GHYTERAAAAVTK--- 163
+ + KH+NI+ L + +++V+E G L D + AR G Y +
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 164 TIVEVVQMCHK----------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
T ++V ++ +HRDL N L E +K DFGL+
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---EDHVMKIADFGLA------- 179
Query: 214 KFSEIVGSPYY------------MAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+I YY MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 180 --RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-09
Identities = 58/251 (23%), Positives = 107/251 (42%), Gaps = 23/251 (9%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121
+LG G++G Y ++ A K++ + + +E+ +E +M+ + KH N+V L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEI-KHPNLVQL 67
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TKTIVEVVQMCHKHGVMH 179
+ +++ E G L D + A + I ++ K +H
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKRN-YG 235
RDL N L E +K DFGLS G+ ++ G+ + + APE L N +
Sbjct: 128 RDLAARNCLVG---ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 236 PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLD--FRRDPWPKVSENAKDLV 292
+ DVW+ GV+L+ I G+ P+ G+ + + +L+ +R + +L+
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238
Query: 293 RKMLDPDPKRR 303
R +P R
Sbjct: 239 RACWQWNPSDR 249
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 60/238 (25%), Positives = 96/238 (40%), Gaps = 29/238 (12%)
Query: 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132
L D F K LR + + R + I +P N+VCL + +V
Sbjct: 11 LVMDTRTQQTFILKG-----LRKSSEYSRERLTI-IPHCVP---NMVCLHKYIVSEDSVF 61
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192
LV++ EGG+L+ I + E +V + H+ G++ RDL P N L ++
Sbjct: 62 LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121
Query: 193 KETAPLKAIDFGLSVFFKP---GEKFSEIVGSPYYMAPEVLKRNYGPEV-DVWSAGVILY 248
++ F + GE + Y APEV + E D WS G IL+
Sbjct: 122 GH---IQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLGAILF 173
Query: 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA 306
LL G G+ ++ ++ VSE A+ L++++L +P RL A
Sbjct: 174 ELLTGKTLVECHP-SGINTHTTLNIPEW-------VSEEARSLLQQLLQFNPTERLGA 223
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 65/251 (25%), Positives = 102/251 (40%), Gaps = 21/251 (8%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-VRREVDIMRHLPKHQNIVC 120
+GRG FG + R + A KS + D++ +E I++ H NIV
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQY-SHPNIVR 57
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMH 179
L +++VMEL +GG+ + G + + + ++ +H
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIH 117
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE--IVGSPY-YMAPEVLKRNYG- 235
RDL N L K LK DFG+S + G S + P + APE L NYG
Sbjct: 118 RDLAARNCLVTEKNV---LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL--NYGR 172
Query: 236 --PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
E DVWS G++L+ G P+ + Q +AI + V R + L+
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---RLPCPELCPDAVYRLM 229
Query: 293 RKMLDPDPKRR 303
+ + DP +R
Sbjct: 230 ERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 76/288 (26%), Positives = 116/288 (40%), Gaps = 55/288 (19%)
Query: 52 EIEER-YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIM 109
EI+ +L R+LG G+FG + N ++ K L+ +D +D E IM
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVW--EGLWNNTT----PVAVKTLKPGTMDPKDFLAEAQIM 55
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ L +H ++ L + +++V EL + G L + Y + A K + +++
Sbjct: 56 KKL-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE-------YLQGGAGRALK-LPQLI 106
Query: 170 QMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------PG 212
M +HRDL N L E K DFGL+ K G
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEAREG 163
Query: 213 EKFSEIVGSPY-YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
KF P + APE N + + DVWS G++L I+ G P+ T V Q +
Sbjct: 164 AKF------PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
Query: 270 IRSVLDFRRDPWPKVSENAKDLVRKMLD---PDPKRRLTAQQVLGKIE 314
+ R P P K+L MLD DP R T + + K+E
Sbjct: 218 DQGY----RMPCPPGCP--KELYDIMLDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 33/231 (14%)
Query: 55 ERYELGRELGRGEFGITYLC----TDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
++ LG+ LG G FG + D++ +++ K L+ T D+ D+ E++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAV--TVAVKMLKDDATEKDLSDLVSEME 72
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR----------------G 151
+M+ + KH+NI+ L D +++++E G L + + AR
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDE 132
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
T + + T + ++ +HRDL N L E +K DFGL+
Sbjct: 133 QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARDVNN 189
Query: 212 GEKFSEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+ + + +MAPE L R Y + DVWS GV+++ I G P+
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 33/218 (15%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---EVDIMRHLPK 114
+LG E+GRG FG + +G A K I R+ VD ++ +R ++D++
Sbjct: 8 DLG-EIGRGAFGTVNKMLHKPSGTIMAVKRI-----RSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 115 HQNIVCLKDTY------EDDTAVHLVMELCEGG-ELFDRIV---ARGHYTERAAAAVTKT 164
IV + E D + MEL + + F + V + E +
Sbjct: 62 CPYIV----KFYGALFREGDCWI--CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA 115
Query: 165 IVEVVQ-MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
V+ + + + ++HRD+KP N L +K DFG+S + G
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRP 172
Query: 224 YMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPF 257
YMAPE + + Y DVWS G+ LY + G P+
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 32/232 (13%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI----------EDVRRE 105
++ + +G GEFG +C+ R K K+++ A+ D E
Sbjct: 5 CIKIEKVIGAGEFG--EVCSGR-------LKLPGKREIPVAIKTLKAGYTEKQRRDFLSE 55
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTK 163
IM H NI+ L+ V +V E E G L D + + G +T + +
Sbjct: 56 ASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLR 113
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--PGEKFSEIVGS 221
I ++ G +HRDL N L K DFGLS + P ++ G
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 222 -PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
P + APE + R + DVWS G++++ ++ G P+W + Q V +AI
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 33/240 (13%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLR---TAVD 98
++P +R LG+ LG G FG + D+E + ++ K L+ T D
Sbjct: 9 EDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVT--KVAVKMLKSDATEKD 66
Query: 99 IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG------H 152
+ D+ E+++M+ + KH+NI+ L D +++++E G L + + AR
Sbjct: 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYC 126
Query: 153 YTERAAAAVTKTIVEVVQMCHK----------HGVMHRDLKPENFLFANKKETAPLKAID 202
Y + ++V ++ +HRDL N L E +K D
Sbjct: 127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIAD 183
Query: 203 FGLSVFFKPGEKFSEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
FGL+ + + + +MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 70/282 (24%), Positives = 108/282 (38%), Gaps = 37/282 (13%)
Query: 58 ELGRELGRGEFGITYLCTDR-ENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
L R LG G FG Y R +GDA + + + D D E IM
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-N 67
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV----EVVQ 170
HQNIV L + +++EL GG+L + ER ++ K ++ +V +
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127
Query: 171 MCH---KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY--- 224
C ++ +HRD+ N L K K DFG++ +I + YY
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYRKG 178
Query: 225 ---------MAPEV-LKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSV 273
M PE L + + DVWS GV+L+ I G P+ T Q V + +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG 238
Query: 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315
R DP ++ P+ R +L +I++
Sbjct: 239 ---RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE- 217
AV + ++ + H G++HRD+K EN + N E L DFG + F + G +
Sbjct: 263 TAVARQLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFAR-GSWSTPF 318
Query: 218 ---IVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY 248
I G+ APEVL + Y P VD+WSAG++++
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 56/217 (25%), Positives = 86/217 (39%), Gaps = 41/217 (18%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
++G+G FG Y + N + A K+ + +E +I++ H NIV
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEV-AVKTC--RSTLPPDLKRKFLQEAEILKQY-DHPNIVK 56
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-------- 172
L +++VMEL GG L + + +T +++QM
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLT-------FLRKKKNRLTVK--KLLQMSLDAAAGME 107
Query: 173 --HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-----VFFKPGEKFSEIVGSPY-Y 224
+HRDL N L E LK DFG+S + + +I P +
Sbjct: 108 YLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSREEEGGIYTVSDGLKQI---PIKW 161
Query: 225 MAPEVLKRNYG---PEVDVWSAGVILY-ILLCGVPPF 257
APE L NYG E DVWS G++L+ G P+
Sbjct: 162 TAPEAL--NYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 56 RYELGRELGRGEFGITYLC------TDRENGDAFACKSISKKKLR---TAVDIEDVRREV 106
R LG+ LG G FG + D+ N +++ K L+ T D+ D+ E+
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPV----TVAVKMLKDDATDKDLSDLVSEM 68
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR---------------- 150
++M+ + KH+NI+ L D +++++E G L + + AR
Sbjct: 69 EMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 151 GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
T + + + ++ +HRDL N L E +K DFGL+
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIADFGLARDVH 185
Query: 211 PGEKFSEIVGSPY---YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPF 257
+ + + +MAPE L R Y + DVWS GV+L+ I G P+
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 59/238 (24%), Positives = 92/238 (38%), Gaps = 45/238 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI---------EDVRRE 105
E + L R+LG G FG + + + K ++R A+ I +D ++E
Sbjct: 6 EEFTLERKLGSGYFGEVW-------------EGLWKNRVRVAIKILKSDDLLKQQDFQKE 52
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY---TERAAAAVT 162
V ++ L +H++++ L V+++ EL E G L + E V
Sbjct: 53 VQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKGSLL-------AFLRSPEGQVLPVA 104
Query: 163 KTIVEVVQ----MCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
I Q M + + +HRDL N L E K DFGL+ K S
Sbjct: 105 SLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVYLS 161
Query: 217 EIVGSPY-YMAPEVL-KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
PY + APE + + DVWS G++LY + G P+ V I
Sbjct: 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 52/197 (26%), Positives = 83/197 (42%), Gaps = 30/197 (15%)
Query: 131 VHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188
+ + E +GG L + +I H R A AV K + + + ++HRD+KP N L
Sbjct: 74 ISICTEFMDGGSLDVYRKIPE--HVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNML 127
Query: 189 FANKKETAPLKAIDFGLSVFFKPGEKFSEI----VGSPYYMAPE-VLKRNYGPEVDVWSA 243
+ + +K DFG+S + + I VG+ YMAPE + YG DVWS
Sbjct: 128 VNTRGQ---VKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSL 179
Query: 244 GVILYILLCGVPPF-WAETEQG------VAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
G+ L G P+ + QG + Q I+ D P + SE + + +
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--DPPVLPVGQFSEKFVHFITQCM 237
Query: 297 DPDPKRRLTAQQVLGKI 313
PK R + ++
Sbjct: 238 RKQPKERPAPENLMDHP 254
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 58/259 (22%), Positives = 102/259 (39%), Gaps = 51/259 (19%)
Query: 62 ELGRGEFGITY----LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
ELG FG Y ++ A K++ K + + ++E +M L H N
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAEL-HHPN 68
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAA----------------- 160
IVCL + V ++ E G+L + ++ R +++ ++
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
+ I ++ H +H+DL N L E +K D GLS EI
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLS---------REIYS 176
Query: 221 SPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
+ YY M PE ++ + + D+WS GV+L+ I G+ P++ + Q V
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236
Query: 267 QAI-IRSVLDFRRDPWPKV 284
+ + R +L D P++
Sbjct: 237 EMVRKRQLLPCSEDCPPRM 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 63/240 (26%), Positives = 97/240 (40%), Gaps = 37/240 (15%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI------EDVRR----EVDIMRHL 112
+G GEFG +C R K K+++ A+ E RR E IM
Sbjct: 12 IGAGEFG--EVCRGR-------LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 62
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVARGHYTERAAAAVTKTIVEVVQ 170
H NI+ L+ V ++ E E G L F R G +T + + I ++
Sbjct: 63 -DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMK 120
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPY---Y 224
+ +HRDL N L K DFGLS F + ++ +G +
Sbjct: 121 YLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 225 MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
APE + R + DVWS G++++ ++ G P+W + Q V AI + D+R P
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ---DYRLPPPM 234
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 57/218 (26%), Positives = 91/218 (41%), Gaps = 18/218 (8%)
Query: 63 LGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
+G GEFG + L A A K++ K T +D E IM H NI+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEASIMGQF-SHHNII 69
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGV 177
L+ ++ E E G L D+ + G ++ + + I ++
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFK--PGEKFSEIVGS-PY-YMAPEVLK-R 232
+HRDL N L + E K DFGLS + P ++ G P + APE + R
Sbjct: 129 VHRDLAARNILVNSNLEC---KVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 233 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
+ DVWS G++++ ++ G P+W + V +AI
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-07
Identities = 63/261 (24%), Positives = 107/261 (40%), Gaps = 21/261 (8%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120
+ELG G+FG+ R D A K I + + ++ E +M L H+ +V
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSE----DEFIEEAKVMMKL-SHEKLVQ 63
Query: 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAA-AVTKTIVEVVQMCHKHGVMH 179
L +++V E G L + + G + + + K + E + +H
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEVLKR-NYG 235
RDL N L + +K DFGLS + E S VGS + + PEVL +
Sbjct: 124 RDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFS 179
Query: 236 PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-SENAKDLVR 293
+ DVW+ GV+++ + G P+ + + + + +R P + SE ++
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR----PHLASEKVYAIMY 235
Query: 294 KMLDPDPKRRLTAQQVLGKIE 314
+ R T QQ+L IE
Sbjct: 236 SCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 21/226 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +L ++LG G+FG ++ N A K++ + +E E ++M+ L +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLE----EANLMKTL-Q 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMC 172
H +V L + ++++ E G L D + + G + I E +
Sbjct: 60 HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEV 229
+ +HRDL+ N L + E+ K DFGL+ + E ++ G+ + + APE
Sbjct: 120 ERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 175
Query: 230 LKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIR 271
+ N+G + DVWS G++LY I+ G P+ + V A+ R
Sbjct: 176 I--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-07
Identities = 62/248 (25%), Positives = 100/248 (40%), Gaps = 54/248 (21%)
Query: 59 LGRELGRGEFGITYL------CTDRENGDAFACKSISKKKLRTAVD--IEDVRREVDIMR 110
L RELG G FG +L C +++ ++ K L+ A D +D RE +++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDK------ILVAVKTLKDASDNARKDFHREAELLT 62
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+L +H++IV + + +V E + G+L + A G A + Q
Sbjct: 63 NL-QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 171 MCH-------------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE 217
M H +HRDL N L E +K DFG+S +
Sbjct: 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---------RD 169
Query: 218 IVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 263
+ + YY M PE ++ R + E DVWS GV+L+ I G P++ +
Sbjct: 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
Query: 264 GVAQAIIR 271
V + I +
Sbjct: 230 EVIECITQ 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 33/218 (15%)
Query: 54 EERYELGRELGRGEFGITY--LCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDI 108
E+ L RELG+G FG+ Y L G+ A K++++ + + + E +
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASV 62
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
M+ H ++V L +VMEL G+L + +R E T+ +
Sbjct: 63 MKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 169 VQMC-----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGL------SVFFKP 211
+QM K V HRDL N + A E +K DFG+ + +++
Sbjct: 122 IQMAAEIADGMAYLAAKKFV-HRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYRK 177
Query: 212 GEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY 248
G K V +MAPE LK + + DVWS GV+L+
Sbjct: 178 GGKGLLPV---RWMAPESLKDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 31/254 (12%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG + T ++ A K+ K+ L + I+ + E I++ H NIV L
Sbjct: 3 LGKGNFGEVFKGTLKDK-TPVAVKT-CKEDLPQELKIKFLS-EARILKQY-DHPNIVKLI 58
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV---VQMCHKHGVMH 179
+++VMEL GG+ + R E + K ++ + +H
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL--RKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLS------VFFKPGEKFSEIVGSPYYMAPEVLKRN 233
RDL N L E LK DFG+S ++ G K I + APE L N
Sbjct: 117 RDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPI----KWTAPEAL--N 167
Query: 234 YG---PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
YG E DVWS G++L+ GV P+ T Q + + + +R K ++
Sbjct: 168 YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---YRMSCPQKCPDDVY 224
Query: 290 DLVRKMLDPDPKRR 303
++++ D P+ R
Sbjct: 225 KVMQRCWDYKPENR 238
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 34/281 (12%)
Query: 57 YELGRELGRGEFGI---TYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ LGR LG+GEFG L ++ + A K + K + ++ DIE+ RE M+
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEF- 58
Query: 114 KHQNI-----VCLKDTYEDDTAVHLV-MELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
H N+ V L+ + + +V + + G+L ++ E + +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 168 VVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS 221
++ + +HRDL N + E + DFGLS G+ + + S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 222 PY---YMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVL-- 274
++A E L N Y DVW+ GV ++ I+ G P+ GV + I + L
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVENSEIYNYLIK 230
Query: 275 -DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ + P P E+ +L+ + P+PK R + Q + ++E
Sbjct: 231 GNRLKQP-PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 50/284 (17%)
Query: 59 LGRELGRGEFGITYL--CTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
L RELG G FG +L C + ++ K T +D +RE +++ +L +H+
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHE 67
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYT-----------------ERAAA 159
+IV D + +V E + G+L + A G +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
++ +V + +H V HRDL N L +K DFG+S ++
Sbjct: 128 IASQIASGMVYLASQHFV-HRDLATRNCLVGA---NLLVKIGDFGMS---------RDVY 174
Query: 220 GSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
+ YY M PE ++ R + E DVWS GVIL+ I G P++ + V
Sbjct: 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309
+ I + + R PK D++ +P++RL +++
Sbjct: 235 IECITQGRVLERPRVCPK---EVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 43/277 (15%)
Query: 61 RELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDIMRHLPK 114
R +G+G FG Y L A KS+++ D+E+V +E IM+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-----ITDLEEVEQFLKEGIIMKDF-S 54
Query: 115 HQNIVCLKD-TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H N++ L + + +V+ + G+L + I +E V I +Q+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAK 109
Query: 174 ------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPY-- 223
+HRDL N + E+ +K DFGL+ ++ K G+
Sbjct: 110 GMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
Query: 224 -YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MA E L+ + + + DVWS GV+L+ L+ G PP+ + I +L RR
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY----PDVDSFDITVYLLQGRRLL 222
Query: 281 WPKVSENAKDLVRKML---DPDPKRRLTAQQVLGKIE 314
P+ + L ML P P+ R T +++ +IE
Sbjct: 223 QPEYCPDP--LYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 68/290 (23%), Positives = 120/290 (41%), Gaps = 49/290 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR---------- 104
E+ + RELG+G FG+ Y G A K + K + T V I+ V
Sbjct: 6 EKITMSRELGQGSFGMVY------EGIA---KGVVKDEPETRVAIKTVNEAASMRERIEF 56
Query: 105 --EVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
E +M+ H ++V L ++MEL G+L + + E
Sbjct: 57 LNEASVMKEFNCH-HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 163 KTIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV----- 207
++ +++QM + + +HRDL N + A E +K DFG++
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYET 172
Query: 208 -FFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQG 264
+++ G K V +M+PE LK + DVWS GV+L+ I P+ + +
Sbjct: 173 DYYRKGGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
V + ++ L + D P + +L+R +PK R + +++ I+
Sbjct: 230 VLRFVMEGGLLDKPDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +L + +G+GEFG L R N A C ++ + E +M L +
Sbjct: 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKC-------IKNDATAQAFLAEASVMTQL-R 57
Query: 115 HQNIV-CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TKTIVEVVQM 171
H N+V L E+ +++V E G L D + +RG + + + E ++
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY-YMAPEVL 230
+ +HRDL N L + E K DFGL+ K + P + APE L
Sbjct: 118 LEANNFVHRDLAARNVLVS---EDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEAL 171
Query: 231 K-RNYGPEVDVWSAGVILY 248
+ + + + DVWS G++L+
Sbjct: 172 REKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 54/238 (22%), Positives = 106/238 (44%), Gaps = 22/238 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +L ++LG G+FG ++ T ++ A K++ + + E ++M+ L +
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA----EANVMKTL-Q 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV--TKTIVEVVQMC 172
H +V L + ++++ E G L D + + + + + I E +
Sbjct: 60 HDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEV 229
+ +HRDL+ N L + + K DFGL+ + E ++ G+ + + APE
Sbjct: 119 EQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEA 174
Query: 230 LKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
+ N+G + DVWS G++L I+ G P+ + V +A+ R R + P+
Sbjct: 175 I--NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 230
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 39/281 (13%)
Query: 55 ERYELGRELGRGEFGITY--LCTDRENGDA---FACKSISKK-KLRTAVDIEDVRREVDI 108
E+ L RELG+G FG+ Y D G+A A K++++ LR ++ + E +
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLN---EASV 62
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
M+ H ++V L +VMEL G+L + + E T+ E+
Sbjct: 63 MKGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 169 VQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV------FFKPG 212
+QM + +HRDL N + A +K DFG++ +++ G
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 213 EKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAII 270
K V +MAPE LK + D+WS GV+L+ + + QG++ + ++
Sbjct: 179 GKGLLPV---RWMAPESLKDGVFTTSSDMWSFGVVLW----EITSLAEQPYQGLSNEQVL 231
Query: 271 RSVLDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ V+D P E DL+R +PK R T +++
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 71/272 (26%), Positives = 103/272 (37%), Gaps = 40/272 (14%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+ RG+ G +Y +NG F K I+ + +I D M L +H NIV L
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-------MGKL-QHPNIVKLI 749
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---GVMH 179
+ +L+ E EG L + V R ER + I + ++ H V+
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSE--VLRNLSWER-RRKIAIGIAKALRFLHCRCSPAVVV 806
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPE-V 238
+L PE + K E ++ L K S Y+APE + E
Sbjct: 807 GNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKC-------FISSAYVAPETRETKDITEKS 859
Query: 239 DVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----SVLDFRRDPW------PKVSENA 288
D++ G+IL LL G P A+ E GV +I+ D D W VS N
Sbjct: 860 DIYGFGLILIELLTGKSP--ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 289 KDLVRKM------LDPDPKRRLTAQQVLGKIE 314
++V M DP R A VL +E
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-06
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 14/120 (11%)
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIV-CLKDTYEDDTAVHLVMELCEGGELFDRIVA 149
K + D REV I++ L + V + + E D +L+ME EG L
Sbjct: 27 KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------ 80
Query: 150 RGHYTERAAAAVTKTIVEVVQMCHKH---GVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+E + + + E++ H+ + H DL P N L + K ID+ +
Sbjct: 81 -DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILG---IIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 80/318 (25%), Positives = 114/318 (35%), Gaps = 93/318 (29%)
Query: 54 EERYELGRELGRGEFGITYLCT-----------DRENGDAFACKSISKKKLRTAVDI--- 99
+ +LG G+FG +LC EN +A A ++ K LR
Sbjct: 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR 63
Query: 100 EDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYT 154
ED +EV I+ L NI VC D + +ME E G+L +
Sbjct: 64 EDFLKEVKILSRL-SDPNIARLLGVCTVD---PPLCM--IMEYMENGDL-------NQFL 110
Query: 155 ERAAAAVTKTIVE---------VVQMC----------HKHGVMHRDLKPENFLFANKKET 195
+ A T + ++ M +HRDL N L K T
Sbjct: 111 -QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL-VGKNYT 168
Query: 196 APLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPE-VLKRNYGPEVDVWS 242
+K DFG+S + S YY MA E VL + + DVW+
Sbjct: 169 --IKIADFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217
Query: 243 AGVILY-IL-LCGVPPFWAETEQGVAQAIIRSVLDFRRD------PWPKVSENAKDLVRK 294
GV L+ IL LC P+ T+Q V + FR D P P KD+
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHF---FRDDGRQIYLPRPPNC--PKDIYEL 272
Query: 295 MLD---PDPKRRLTAQQV 309
ML+ D + R T +++
Sbjct: 273 MLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IEDVRREVDIMR 110
E E + LG G FG Y G+ ++ K LR +++ E +M
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEK-VKIPVAIKVLREETSPKANKEILDEAYVMA 64
Query: 111 HLPKHQNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H ++V CL V L+ +L G L D + R H + +
Sbjct: 65 SV-DHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWC 115
Query: 166 VEVVQ-MCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
V++ + M + + ++HRDL N L K +K DFGL+ EK G
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 223 Y---YMAPE-VLKRNYGPEVDVWSAGVILYILL 251
+MA E +L R Y + DVWS GV ++ L+
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 67/270 (24%), Positives = 106/270 (39%), Gaps = 32/270 (11%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G G FG +++G K+ + D D E++++ L H NI+ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 123 DTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAV--TKTIVEVVQMCH------ 173
E ++L +E G L D + +R T+ A A T + + Q+ H
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 174 -------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS----VFFKPGEKFSEIVGSP 222
+ +HRDL N L E K DFGLS V+ K +
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMGRLPV---- 187
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+MA E L + Y DVWS GV+L+ I+ G P+ T A+ + +R +
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLPQGYRLEK 244
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ DL+R+ P R + Q+L
Sbjct: 245 PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 40/264 (15%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
L R+LG G+FG ++ T A K++ + E +E IM+ L +H +
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTKV-AVKTLKP----GTMSPEAFLQEAQIMKKL-RHDKL 63
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC------ 172
V L ++ +++V E G L D + ++ + ++V M
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFL--------KSGEGKKLRLPQLVDMAAQIAEG 115
Query: 173 ----HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YM 225
+HRDL N L E K DFGL+ + E ++ G+ + +
Sbjct: 116 MAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWT 171
Query: 226 APEVLKRNYGP---EVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
APE NYG + DVWS G++L I+ G P+ T + V + + R +R
Sbjct: 172 APEAA--NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG---YRMPRP 226
Query: 282 PKVSENAKDLVRKMLDPDPKRRLT 305
P E DL+ + D DP+ R T
Sbjct: 227 PNCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 69/275 (25%), Positives = 114/275 (41%), Gaps = 45/275 (16%)
Query: 6 VTPAAAKQGKKKTNKKKQNPFSIDYGTHHQG-NGGHKLCVLKEPTGREIE---ERYELGR 61
TP + KKK + Y +Q GH VL G +I+ +R+++
Sbjct: 85 TTPTTNVEVAPPPKKKK-----VTYALPNQSREEGHFYVVL----GEDIDVSTQRFKILS 135
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISK--KKLRTA-VDIEDVR--REVDIMRHLPKHQ 116
LG G FG DR+ + A K + K R A ++I+ + R+ D P
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFP--- 192
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGE-LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
++ ++ ++++T H+ + + + G L D I+ G ++ R A + + H
Sbjct: 193 -LMKIQRYFQNETG-HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE 250
Query: 176 -GVMHRDLKPENFLF---------ANKKETAP----LKAIDFGLSVFFKPGEKFSE--IV 219
+MH DLKPEN L + P ++ D G E+ S IV
Sbjct: 251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC----DERHSRTAIV 306
Query: 220 GSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCG 253
+ +Y +PEV L + D+WS G I+Y L G
Sbjct: 307 STRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 68/290 (23%), Positives = 111/290 (38%), Gaps = 69/290 (23%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI-----------EDVRREVDIMR 110
ELG G FG +L C ++ ++ + V + +D +RE +++
Sbjct: 12 ELGEGAFGKVFLAE---------CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 62
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--FDR-------------IVARGHYTE 155
L +HQ+IV + + +V E G+L F R VA G T
Sbjct: 63 VL-QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 156 RAAAAVTKTIVE-VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
A+ I +V + H V HRDL N L + +K DFG+S
Sbjct: 122 GQMLAIASQIASGMVYLASLHFV-HRDLATRNCLVG---QGLVVKIGDFGMS-------- 169
Query: 215 FSEIVGSPYY------------MAPE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M PE +L R + E D+WS GV+L+ I G P W +
Sbjct: 170 -RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-WYQ 227
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSEN-AKDLVRKMLDPDPKRRLTAQQV 309
A I + R P+ +++ +P++R+ + +
Sbjct: 228 LSNTEAIECITQGRELER---PRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 67/290 (23%), Positives = 124/290 (42%), Gaps = 43/290 (14%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPKH 115
LG+ LG GEFG T +++ K L+ ++ ++ D+ E ++++ + H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NH 62
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGEL--FDRIVAR------GHYTERAAAAVTKTIVE 167
+++ L D + L++E + G L F R + G R ++ +
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 168 VV----------QMCH------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFF 209
+ Q+ + ++HRDL N L A ++ +K DFGLS V+
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK---MKISDFGLSRDVYE 179
Query: 210 KPGE-KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
+ K S+ +MA E L + Y + DVWS GV+L+ I+ G P+ G+A
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-----PGIA 234
Query: 267 QAIIRSVLD--FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ ++L +R + SE +L+ +P +R T + ++E
Sbjct: 235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +L ++LG G+FG ++ A KS+ + + E E ++M+ L +
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQL-Q 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGH-YTERAAAAVTKTIVEVVQMC 172
H +V L + ++++ E E G L D + G T + I E +
Sbjct: 60 HPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPEV 229
+ +HRDL+ N L + ET K DFGL+ + E ++ G+ + + APE
Sbjct: 119 ERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEA 174
Query: 230 LKRNYGP---EVDVWSAGVIL 247
+ NYG + DVWS G++L
Sbjct: 175 I--NYGTFTIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 6e-05
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 23/199 (11%)
Query: 62 ELGRGEFGIT---YLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMRHLPK 114
ELG G FG + + K+++ K L+ + ++ RE ++M+ L
Sbjct: 2 ELGSGNFGTVKKGMYKMKK------SEKTVAVKILKNDNNDPALKDELLREANVMQQL-D 54
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+ IV + E ++ + LVMEL E G L + H TE+ + + ++ +
Sbjct: 55 NPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS---PY-YMAPEVL 230
+HRDL N L + K DFGLS E + + P + APE +
Sbjct: 114 TNFVHRDLAARNVLLVTQHYA---KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 231 K-RNYGPEVDVWSAGVILY 248
+ + DVWS GV+++
Sbjct: 171 NYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPE-V 229
+H ++HR+L N L K + ++ DFG++ P +K +SE +MA E +
Sbjct: 127 EHRMVHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 230 LKRNYGPEVDVWSAGVILYILLC-GVPPF 257
L Y + DVWS GV ++ ++ G P+
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSE- 217
A+ K ++ V+ H ++HRD+K EN +F N L DFG ++ F K E F
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYG 327
Query: 218 IVGSPYYMAPEVLKRN-YGPEVDVWSAGVIL 247
VG+ +PE+L + Y D+WS G+IL
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLIL 358
|
Length = 501 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 5/73 (6%)
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
V + ++ ++ H+ G++HRD+KPEN L + +K IDFG +V G F+ +
Sbjct: 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLY 369
Query: 220 G--SPYYMAPEVL 230
G P Y PE L
Sbjct: 370 GMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 36/127 (28%), Positives = 52/127 (40%), Gaps = 17/127 (13%)
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCG 253
T G SV FK E PY+MAPEV++ +Y + D++S G+ LY L
Sbjct: 45 TWDGLLKLDG-SVAFKTPE--QSRPD-PYFMAPEVIQGQSYTEKADIYSLGITLYEALDY 100
Query: 254 VPPFWAETEQGVAQAIIRSVLDF-------RRDPWPKVSE--NAKDLVRKMLDPDPKRRL 304
P E+ AI+ +L+ R VS + +D +R P+RR
Sbjct: 101 ELP---YNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRRE 157
Query: 305 TAQQVLG 311
A L
Sbjct: 158 AANHYLA 164
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 63/256 (24%), Positives = 101/256 (39%), Gaps = 40/256 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDR-------ENGDAFACKS--ISKKKLRTAVDI---EDV 102
++ L +LG G+FG +LC E F + ++ K LR V D
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAA-- 160
+E+ IM L K+ NI+ L D + ++ E E G+L + R + A
Sbjct: 65 LKEIKIMSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 161 ----------VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+ I ++ +HRDL N L N +K DFG+S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN---HYTIKIADFGMSRNLY 180
Query: 211 PGEKFSEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQ 263
G+ + I G +MA E +L + DVW+ GV L+ LC P+ +++
Sbjct: 181 SGD-YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239
Query: 264 GVAQAIIRSVLDFRRD 279
V I + +F R+
Sbjct: 240 QV----IENTGEFFRN 251
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G G FG +++G K+ + D D E++++ L H NI+ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 123 DTYEDDTAVHLVMELCEGGELFD-----RIV------ARGH-----YTERAAAAVTKTIV 166
E+ +++ +E G L D R++ A+ H T + +
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGS-PY 223
+Q + +HRDL N L E K DFGLS GE+ + +G P
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS----RGEEVYVKKTMGRLPV 182
Query: 224 -YMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 255
+MA E L + Y + DVWS GV+L+ + L G P
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 14/114 (12%)
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY---YMAPE-VLKR 232
++HRDL N L + +K DFGL+ EK G +MA E +L R
Sbjct: 130 LVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR 186
Query: 233 NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF-RRDPWPKV 284
Y + DVWS GV ++ L+ G P+ G+ + I S+L+ R P P +
Sbjct: 187 IYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASEISSILEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 30/216 (13%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G G FG +++G K+ + D D E++++ L H NI+ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 123 DTYEDDTAVHLVMELCEGGELFD-----RIV------ARGHYT-----ERAAAAVTKTIV 166
E ++L +E G L D R++ A + T + +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGS-PY 223
+ + +HRDL N L E K DFGLS G++ + +G P
Sbjct: 123 RGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYVKKTMGRLPV 175
Query: 224 -YMAPEVLKRN-YGPEVDVWSAGVILY--ILLCGVP 255
+MA E L + Y DVWS GV+L+ + L G P
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 21/70 (30%), Positives = 36/70 (51%), Gaps = 4/70 (5%)
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS--EI 218
+ + I+ + H G++HRD+KP+N +F+ + K ID G + + G + E
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGS--FKIIDLGAAADLRVGINYIPKEF 317
Query: 219 VGSPYYMAPE 228
+ P Y APE
Sbjct: 318 LLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 7e-04
Identities = 32/93 (34%), Positives = 45/93 (48%), Gaps = 8/93 (8%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPY-YMAPE-VLKRN 233
+HRDL N L E +K DFGLS ++ K SE P +M PE +
Sbjct: 152 VHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR 208
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
Y E DVW+ GV+L+ I G+ P++ + V
Sbjct: 209 YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 30/107 (28%), Positives = 45/107 (42%), Gaps = 14/107 (13%)
Query: 103 RREVDIMRHLPKHQNIVCLKDTYEDDT-AVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
RRE I+ + V + Y+ D +VME EG L D E A +
Sbjct: 47 RREARILAKARE--AGVPVPIVYDVDPDNGLIVMEYIEGELLKD-------ALEEARPDL 97
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+ + +V HK G++H DL N + + + + IDFGL F
Sbjct: 98 LREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 3/90 (3%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV---DIEDVRREVDIMRHLPKH 115
LGR LG G FG T + + ++ K L++ + + + E+ IM HL H
Sbjct: 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPH 100
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFD 145
NIV L ++++ E C G+L D
Sbjct: 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVD 130
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 43/209 (20%)
Query: 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI----------EDVRREVDIMRH 111
ELG G FG C + + KK++ A+ + +++ RE +IM
Sbjct: 2 ELGSGNFG----CVKK------GVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQ 51
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV--- 168
L + IV + E + A+ LVME+ GG L + + +VE+
Sbjct: 52 L-DNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGK------KDEITVSNVVELMHQ 103
Query: 169 VQMCHKH----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGS- 221
V M K+ +HRDL N L N+ K DFGLS + + + G
Sbjct: 104 VSMGMKYLEGKNFVHRDLAARNVLLVNQHYA---KISDFGLSKALGADDSYYKARSAGKW 160
Query: 222 PY-YMAPE-VLKRNYGPEVDVWSAGVILY 248
P + APE + R + DVWS G+ ++
Sbjct: 161 PLKWYAPECINFRKFSSRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.002
Identities = 32/121 (26%), Positives = 48/121 (39%), Gaps = 22/121 (18%)
Query: 91 KKLRTAVDIEDVRREVDIMRHLPK---HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI 147
++ RT RRE IM K + V D +VME EG L D +
Sbjct: 42 RRERT-------RREARIMSRARKAGVNVPAVYFVDPENFI----IVMEYIEGEPLKD-L 89
Query: 148 VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
+ +++ I +V H G++H DL N + + K + IDFGL+
Sbjct: 90 INSN---GMEELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGK----IYLIDFGLAE 142
Query: 208 F 208
F
Sbjct: 143 F 143
|
Length = 211 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 29/94 (30%), Positives = 40/94 (42%), Gaps = 26/94 (27%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------M 225
+HRDL N L + +K DFGL+ +I P Y M
Sbjct: 195 IHRDLAARNILLSENN---VVKICDFGLA---------RDIYKDPDYVRKGDARLPLKWM 242
Query: 226 APE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 257
APE + + Y + DVWS GV+L+ I G P+
Sbjct: 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 62/252 (24%), Positives = 104/252 (41%), Gaps = 45/252 (17%)
Query: 62 ELGRGEFGITYLC--------TDRENGDAFACKS---ISKKKLRTAVDI---EDVRREVD 107
+LG G+FG +LC D++ + ++ K LR + D +E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
IM L K NI+ L + ++ E E G+L ++ ++R H + AA +
Sbjct: 72 IMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSR-HEPQEAAEKADVVTIS 128
Query: 168 VVQMCH---------KH----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
+ K+ +HRDL N L K T +K DFG+S G+
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL-VGKNYT--IKIADFGMSRNLYSGD- 184
Query: 215 FSEIVGSPY----YMAPE-VLKRNYGPEVDVWSAGVILY--ILLCGVPPFWAETEQGVAQ 267
+ I G +M+ E +L + DVW+ GV L+ + LC P+ +++ V
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV-- 242
Query: 268 AIIRSVLDFRRD 279
I + +F RD
Sbjct: 243 --IENTGEFFRD 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 12/143 (8%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY----YMAPE-VLKR 232
+HRDL N L + + T K DFGL+ + + + G+ +MAPE +
Sbjct: 236 IHRDLAARNILLTHGRIT---KICDFGLARDIRNDSNYV-VKGNARLPVKWMAPESIFNC 291
Query: 233 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
Y E DVWS G++L+ I G P+ +I+ +R D+
Sbjct: 292 VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE--GYRMLSPECAPSEMYDI 349
Query: 292 VRKMLDPDPKRRLTAQQVLGKIE 314
++ D DP +R T +Q++ IE
Sbjct: 350 MKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 30/94 (31%), Positives = 41/94 (43%), Gaps = 26/94 (27%)
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------M 225
+HRDL N L + E +K DFGL+ +I P Y M
Sbjct: 196 IHRDLAARNILLS---ENNVVKICDFGLA---------RDIYKDPDYVRKGSARLPLKWM 243
Query: 226 APE-VLKRNYGPEVDVWSAGVILY-ILLCGVPPF 257
APE + + Y + DVWS GV+L+ I G P+
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.94 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.73 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.61 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.59 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.57 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.42 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.37 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.35 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.29 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.29 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.15 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.01 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.93 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.83 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.76 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.7 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.69 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.67 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.63 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.62 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.59 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.54 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.5 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.34 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.31 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.28 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.2 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.2 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.2 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 98.1 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.06 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.99 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.94 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.93 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.91 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.87 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.83 | |
| PLN02236 | 344 | choline kinase | 97.83 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.64 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.48 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.36 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.36 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.22 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.17 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.98 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.81 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.78 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.74 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.52 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.42 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.15 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.15 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.12 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-63 Score=422.91 Aligned_cols=264 Identities=36% Similarity=0.649 Sum_probs=243.0
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh----hcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----VDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
..+.+.|.+.+.||+|+||.|-+|..+.+|+.||+|++++...... .......+|+++|++| +|||||++.++|+
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeee
Confidence 3466789999999999999999999999999999999987665432 2334568999999999 9999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
..++.|+||||+.||.|.+.+..++.+.+..-+.++.||+.|+.|||++||+||||||+|||+..+..++.+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 99999999999999999999999999999999999999999999999999999999999999998888888999999999
Q ss_pred cccCCCCcccccccCCCccCchhhcc-c---CCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHhccccCCCCCC
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLKR-N---YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~---~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 281 (315)
+....+..+.+.+|||.|.|||++.. . +..+.|+||+||+||-+++|.+||....... ..+.+.++.+.+.+..|
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 99888888899999999999999862 2 4558999999999999999999998777666 78889999999999999
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..++++..+||+.||..||++|||+.|+|+|+||
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 9999999999999999999999999999999998
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-59 Score=391.78 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=222.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-cEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-AVHL 133 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-~~~l 133 (315)
.+.+.++.||+|..|+||++.++.+++.+|+|++... .+.....++.+|+++++.. +||+||.+++.|.... .+.+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEe
Confidence 4788899999999999999999999999999999544 2445567899999999999 9999999999999988 5999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||++|||.+++...+.+++..+..++.++++||.|||+ .+||||||||+|||++..++ |||||||.|..+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe---VKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE---VKICDFGVSGILVNS 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC---EEeccccccHHhhhh
Confidence 99999999999999988899999999999999999999995 89999999999999998777 999999999987655
Q ss_pred CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCC-----ChHHHHHHHHhccccCCCCCCcc-CC
Q 021233 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE-----TEQGVAQAIIRSVLDFRRDPWPK-VS 285 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-~~ 285 (315)
...+..||..|||||.+.+ .|+.++||||||++++|+++|+.||... ...+....|... .++..+.. ++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---ppP~lP~~~fS 308 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---PPPRLPEGEFS 308 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---CCCCCCcccCC
Confidence 5578899999999999985 5999999999999999999999999764 333444444433 33444444 89
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++++||+.||++||.+|||+.++++|+|+
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 999999999999999999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-58 Score=409.97 Aligned_cols=253 Identities=37% Similarity=0.612 Sum_probs=237.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.+|...+.||+|||+.||.+++..+|+.||+|++.+.........+.+.+|+++.+.| +|||||+++++|++.+.+|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEE
Confidence 5799999999999999999999999999999999998888888889999999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-C
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 213 (315)
+|+|+.++|..+++++..+++.+++.++.||+.||.|||+++|||||||..|++++.+.+ |||+|||+|.....+ +
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~---VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN---VKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc---EEecccceeeeecCccc
Confidence 999999999999999899999999999999999999999999999999999999986666 999999999988744 6
Q ss_pred cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
...+.+|||.|.|||++.+ ..+..+||||+||+||.|+.|++||......+....+.......+. .++.+..+||
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI 249 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLI 249 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHH
Confidence 6788999999999999874 5999999999999999999999999999999999999887666544 5789999999
Q ss_pred HHhcCCCcCCCCCHHHHhcccCC
Q 021233 293 RKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++|++||.+|||+.+||.|.||
T Consensus 250 ~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 250 RKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHHhcCCcccCCCHHHHhcCHhh
Confidence 99999999999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-56 Score=374.63 Aligned_cols=255 Identities=33% Similarity=0.612 Sum_probs=232.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++++.||+|+||.||+++.+++++.+|+|++.+..+......+....|..+|..+ +||.||+++..|.+...+|+
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEE
Confidence 45899999999999999999999999999999999998887777778899999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc-CCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~-~~~ 212 (315)
|+||+.||.|.-+|.+.+.+++..++.++..|+.||.|||+.|||||||||+|||++.+|. ++|+|||+++.. ..+
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH---i~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH---IKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc---EEEeccccchhcccCC
Confidence 9999999999999999999999999999999999999999999999999999999976555 999999999854 334
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
....+.+||+.|||||++. ..|+..+|.||||+++|||++|.+||.........+.+.+...... ...++.+.+++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~---p~~ls~~ardl 256 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP---PGYLSEEARDL 256 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC---CccCCHHHHHH
Confidence 4556689999999999976 5699999999999999999999999999999989898887753332 23478999999
Q ss_pred HHHhcCCCcCCCC----CHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRL----TAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rp----s~~e~l~~l~f 315 (315)
++++|+.||++|. ++.++-+|+||
T Consensus 257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF 284 (357)
T KOG0598|consen 257 LKKLLKRDPRQRLGGPGDAEEIKRHPFF 284 (357)
T ss_pred HHHHhccCHHHhcCCCCChHHhhcCccc
Confidence 9999999999995 78999999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-56 Score=376.42 Aligned_cols=258 Identities=37% Similarity=0.611 Sum_probs=227.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
..+|.+.+.||+|+||+||+|+++.++..||||.+.+... .....+.+..|+.+|+.+ +|||||.+++++...+.+|+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEE
Confidence 4579999999999999999999999999999999987754 444567789999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC---CCEEEEeeccccccC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET---APLKAIDFGLSVFFK 210 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~---~~vkl~Dfg~a~~~~ 210 (315)
|||||+||+|.+++...+.+++..++.++.||+.||++||+++||||||||.|||++..... ..+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999876332 568999999999999
Q ss_pred CCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
++....+.+|+|.|||||++. .+|+.|+|+||+|+++|++++|+.||...+..+....+.+.... .+.....++..+.
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~-~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI-VPVLPAELSNPLR 245 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc-cCchhhhccCchh
Confidence 888889999999999999985 78999999999999999999999999999988888766554332 2333344566777
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+|+...|..+|..|.+..+-+.+++
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~ 270 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPF 270 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhh
Confidence 8999999999999988887666553
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-55 Score=382.46 Aligned_cols=255 Identities=33% Similarity=0.605 Sum_probs=234.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-.+|.+++.||.|+|++|++|++..+++.||||++.+.-+-.....+.+..|-.+|.+|.+||.|++|+..|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 45799999999999999999999999999999999887776666677888999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|+||+++|.|.+++.+.+.|++..++.++.+|+.||+|||++|||||||||+|||++.++. ++|+|||.|..+.+..
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh---ikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH---IKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc---EEEeeccccccCChhh
Confidence 9999999999999999999999999999999999999999999999999999999987766 9999999998764321
Q ss_pred ------------cc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC
Q 021233 214 ------------KF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (315)
Q Consensus 214 ------------~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (315)
.. .+++||-.|.+||++. ...+..+|||+|||++|+|+.|.+||...++-...+.|......+++
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE 308 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence 11 4589999999999987 45889999999999999999999999999999999999988777654
Q ss_pred CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. .++...+||.++|..||.+|+++.+|-+|+||
T Consensus 309 ~----fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF 341 (604)
T KOG0592|consen 309 G----FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFF 341 (604)
T ss_pred C----CCHHHHHHHHHHHccCccccccHHHHhhCccc
Confidence 4 67999999999999999999999999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=379.16 Aligned_cols=258 Identities=33% Similarity=0.531 Sum_probs=227.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-c
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-A 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-~ 130 (315)
.+.++|.+++.||.|.||.||+|+...+|+.||||.+.+.-. ...+.- =.+|+..|++|..||||+++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 456799999999999999999999999999999999876532 332222 3569999999955999999999998887 9
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
+++|||||+. +|+++++.++ .|++..++.|+.||++||+|+|.+|+.|||+||+|||+...+. |||+|||+|+..
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~---iKiaDFGLARev 160 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV---IKIADFGLAREV 160 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce---eEeccccccccc
Confidence 9999999976 9999998664 4999999999999999999999999999999999999975444 999999999999
Q ss_pred CCCCcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC------
Q 021233 210 KPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW------ 281 (315)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 281 (315)
......+..+.|.+|+|||++- +.|+.+.|+||+||+++|+++-++.|.+..+.+.+..|+.-.+......|
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 8888889999999999999864 56999999999999999999999999999999988888776655332222
Q ss_pred --------------------ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 --------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 --------------------~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.++.++.++|.+|+.+||.+||||.++|+|+||
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff 294 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF 294 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence 3467889999999999999999999999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=355.91 Aligned_cols=255 Identities=28% Similarity=0.564 Sum_probs=222.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|+.+..+|+|+||+||+|+++++|+.||||.+..+.. ++.-.+-..+|+++|++| +|+|+|.++.+|.....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEE
Confidence 468899999999999999999999999999999876542 233345577899999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CC
Q 021233 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~ 212 (315)
+||++. ++.+.+.+.. .++...+..++.|++.|+.|+|++++|||||||+|||++.++. +||||||.|+.+. ++
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv---vKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV---VKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc---EEeccchhhHhhcCCc
Confidence 999976 6666676554 4999999999999999999999999999999999999987666 9999999999887 66
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC-----------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----------- 279 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 279 (315)
...+..+-|.+|+|||.+.+ +|+...||||.||++.||++|.+.|++...-+.+..|........+.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 66788899999999999875 59999999999999999999999999999888887776655442211
Q ss_pred ----------------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 ----------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ----------------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+.++.-+.+|+..||+.||++|++.+++|.|.+|
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yF 287 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYF 287 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHH
Confidence 134466778999999999999999999999999987
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-55 Score=349.48 Aligned_cols=263 Identities=41% Similarity=0.770 Sum_probs=245.0
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
..+.+.|++.+.||+|.|++||++.+..+|+.+|+|++....+... +.+.+.+|+.+-+.| +||||+++.+.+.....
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKL-QHPNIVRLHDSIQEESF 84 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhc-CCCcEeehhhhhcccce
Confidence 4567889999999999999999999999999999999987766544 678999999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.|+|+|+|.|+.|..-+..+-.+++..+-..++||++||.|+|.+||||||+||+|+|+-+.....-|||+|||+|..+.
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999999998777766568888999999999999999999999999999999999887777779999999999988
Q ss_pred CCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.+.......|||+|||||++. ..|+..+|||+-|++||-|+.|.+||++.......+.|+.+...++...|+.++++..
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 777778889999999999987 4699999999999999999999999999889999999999999999999999999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+|+++||..||.+|.|+.|+|.|+|.
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi 270 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWI 270 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchh
Confidence 99999999999999999999999995
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-53 Score=370.58 Aligned_cols=251 Identities=28% Similarity=0.421 Sum_probs=216.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCE-EEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-cEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDA-FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-AVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-~~~ 132 (315)
....+.+.||.|+||+||+|.+. |.. ||+|.+......... .+.|.+|+.+|.++ +|||||+++|++.... ..+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRL-RHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCceE
Confidence 34666677999999999999997 666 999999876554444 77899999999999 9999999999999887 799
Q ss_pred EEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 133 LVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHG-VMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~l~~~L~~lH~~~-iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
+||||+++|+|.+++.. ...+++..++.++.+|+.||.|||+++ ||||||||+|||++.+. .++||+|||+++..
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREK 194 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceee
Confidence 99999999999999987 567999999999999999999999999 99999999999998665 34999999999876
Q ss_pred CCC-CcccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPG-EKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
... ...+...||+.|||||++.+ .|+.|+||||||+++|||+||+.||...........+.... .++..+..++
T Consensus 195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~--~Rp~~p~~~~ 272 (362)
T KOG0192|consen 195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG--LRPPIPKECP 272 (362)
T ss_pred ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC--CCCCCCccCC
Confidence 544 34455789999999999984 39999999999999999999999999888766666555432 2333344589
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+..||..||+.||.+||++.+++..|
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~~l 300 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVSRL 300 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence 9999999999999999999999998765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-53 Score=369.86 Aligned_cols=258 Identities=33% Similarity=0.536 Sum_probs=231.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
-.++|++++.||+|+||.||+|+.+.+|..+|+|++.++.+....+.+.++.|-++|... ++|+||+++..|.+.+.+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeE
Confidence 346899999999999999999999999999999999999888888889999999999996 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP- 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~- 211 (315)
|||||++||++..+|...+.|++..++.++.+++.|++.||+.|+|||||||+|+||+..|. +||+|||++.-+..
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH---iKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH---IKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC---Eeeccccccchhhhh
Confidence 99999999999999999999999999999999999999999999999999999999975555 99999999843210
Q ss_pred -----------------------CCc------------------------ccccccCCCccCchhhcc-cCCCcchHHHH
Q 021233 212 -----------------------GEK------------------------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSA 243 (315)
Q Consensus 212 -----------------------~~~------------------------~~~~~gt~~y~aPE~~~~-~~~~~~Di~sl 243 (315)
... ..+.+|||.|+|||++.+ .|+..+|.|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 013579999999999874 59999999999
Q ss_pred HHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCC---CHHHHhcccCC
Q 021233 244 GVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLGKIEF 315 (315)
Q Consensus 244 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp---s~~e~l~~l~f 315 (315)
||++|||+.|.+||...+..+..+.+.+....+..+.-..++++.++||.+||. ||.+|. .+.||-+|+||
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcc
Confidence 999999999999999999999999999887555544445678999999999999 999996 69999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=369.27 Aligned_cols=258 Identities=40% Similarity=0.676 Sum_probs=227.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh--hcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA--VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
...++|.+.+.||+|+||+|+.|.+..++..||+|++........ ...+.+.+|+.+++.+..||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 445689999999999999999999999999999997766532211 234567789999999944999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.+++||||+.||.|.+.+...+++.+..++.+++|++.|++|+|++||+||||||+|||++.+. ..+||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~--~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE--GNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC--CCEEEecccccccc
Confidence 9999999999999999999988999999999999999999999999999999999999998762 33999999999987
Q ss_pred -CCCCcccccccCCCccCchhhcc-c-C-CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccC-
Q 021233 210 -KPGEKFSEIVGSPYYMAPEVLKR-N-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV- 284 (315)
Q Consensus 210 -~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 284 (315)
..+....+.+||+.|+|||++.+ . | +.++||||+|++||.|++|+.||...........+.+....++.. +
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~----~~ 247 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY----LL 247 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC----cC
Confidence 45666788999999999999874 3 4 589999999999999999999999888777777777776555433 4
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++++.+|+.+||..||.+|+|+.+++.|+||
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~ 278 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEILEHPWF 278 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhhChhh
Confidence 9999999999999999999999999999997
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=336.73 Aligned_cols=255 Identities=33% Similarity=0.559 Sum_probs=225.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.+|..++.||+|.||+||+|++..+|+.||+|.+.........+. ...+|++.|+.+ +|+||+.++++|...+.+.+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~-talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINR-TALREIKLLQEL-KHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccH-HHHHHHHHHHHc-cCcchhhhhhhccCCCceEEE
Confidence 478889999999999999999999999999999988766555443 456799999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
+||++. +|...++.+. .++...+..++.+++.||+|||++.|+||||||.|+|+++++. +||+|||+|+......
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~---lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ---LKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc---EEeecccchhccCCCC
Confidence 999975 8988887654 4899999999999999999999999999999999999987776 9999999999876544
Q ss_pred c-ccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCcc-------
Q 021233 214 K-FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK------- 283 (315)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 283 (315)
. ....+-|.+|+|||.+.| .|+...|+||.||++.||+.|.+.|++.+.-+.+..+.+......+..|+.
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 3 344488999999999864 599999999999999999999999999999999988888777665555543
Q ss_pred -----------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 284 -----------------VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 284 -----------------~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++++..+|+.+||..||.+|+|+.|+|+|.+|
T Consensus 236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf 284 (318)
T KOG0659|consen 236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYF 284 (318)
T ss_pred HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence 46778999999999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=349.78 Aligned_cols=249 Identities=28% Similarity=0.515 Sum_probs=215.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEE-EEEcCCc-E
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-TYEDDTA-V 131 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~-~~~~~~~-~ 131 (315)
-.+|++.+.||+|+||+||++.+..+|..+|.|.++-.. .+....+.+..|+.+|++| +|||||++++ .|..++. +
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhh
Confidence 357999999999999999999999999999999998553 3445577899999999999 9999999999 4544444 8
Q ss_pred EEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCceEeecCCCCCCEEEEee
Q 021233 132 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHK--HG--VMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~--~~--iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
+|||||+.+|+|...++. ...+++..+|+++.|++.||..+|+ .. |+||||||.||+++.++. |||+||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv---vKLGDf 172 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV---VKLGDF 172 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc---eeeccc
Confidence 999999999999998863 3459999999999999999999998 44 999999999999986665 999999
Q ss_pred ccccccCCCCcc-cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 204 GLSVFFKPGEKF-SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 204 g~a~~~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
|+++........ .+.+|||.|||||.+. ..|+.+|||||+||++|||..-++||.+.+..+....|.++..+ +-+-
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~--~~p~ 250 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP--PLPD 250 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC--CCcH
Confidence 999988665543 5689999999999987 56999999999999999999999999999888888888887433 2222
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHH
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQV 309 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~ 309 (315)
..+++++..||..|+..||+.||+.-.+
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 4578999999999999999999984333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=363.99 Aligned_cols=255 Identities=32% Similarity=0.538 Sum_probs=225.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--CcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~ 132 (315)
+.|+.++.||+|.||.||+|++..+|+.||+|.+........ ......+||.+|++| +||||+++.+..... ..+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence 469999999999999999999999999999999987654333 334567899999999 999999999988765 7899
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||+|||+. +|..++...+ .|++.++..++.||+.||+|+|++||+|||||.+||||++++. +||+|||+|+.+..
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~---LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV---LKIADFGLARFYTP 270 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC---EEeccccceeeccC
Confidence 99999976 8888877643 5999999999999999999999999999999999999987766 99999999997765
Q ss_pred CC--cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCc-----
Q 021233 212 GE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP----- 282 (315)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 282 (315)
.. ..+..+.|.+|+|||.+.| .|+...|+||.||+|.||++|++.|++.++.+.+..|.+.........|+
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 44 4677889999999999875 49999999999999999999999999999999999998888776666554
Q ss_pred --------------------cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 --------------------KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 --------------------~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++....+|+..+|..||.+|.|+.++|.+-||
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 246778899999999999999999999999988
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-53 Score=358.97 Aligned_cols=252 Identities=32% Similarity=0.517 Sum_probs=211.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC--cEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--AVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--~~~ 132 (315)
.+|...+.||+|+||+||++.+.++|...|+|.+.... ....+.+.+|+.+|.++ +|||||+.++...... .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeE
Confidence 46899999999999999999999999999999987652 11257799999999999 6999999999855444 689
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec-CCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN-KKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~-~~~~~~vkl~Dfg~a~~~~ 210 (315)
+.|||+++|||.+++...+ .+++..++.++.|+++||+|||++|||||||||+|||++. ++. +||+|||++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~---~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD---VKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe---EEeccCccccccc
Confidence 9999999999999999877 7999999999999999999999999999999999999986 344 8999999998765
Q ss_pred C----CCcccccccCCCccCchhhc-cc-CCCcchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHhccccCCCCCCcc
Q 021233 211 P----GEKFSEIVGSPYYMAPEVLK-RN-YGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 211 ~----~~~~~~~~gt~~y~aPE~~~-~~-~~~~~Di~slG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
. ........||+.|||||++. +. ...++|||||||+++||+||..||... ......-.+.... ..+..+..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~~ 247 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPDS 247 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCcc
Confidence 3 12234578999999999987 43 335999999999999999999999763 3222223332222 22345567
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++++..+|+.+|+..||++||||.++|.|+|.
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 89999999999999999999999999999973
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=340.46 Aligned_cols=252 Identities=30% Similarity=0.562 Sum_probs=233.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|++++.||.|+||.|.+++.+.+|..+|+|++.+.......+.+...+|..+|+.+ .||+++++++.|.+.+.+++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCCeEEE
Confidence 35799999999999999999999999999999999988887777888899999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||++||-|..++++.+++++..++.++.+|+.||+|||+++|++||+||+|||++.+|. +||+|||.|......
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~---iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH---IKITDFGFAKRVSGR- 197 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc---EEEEeccceEEecCc-
Confidence 9999999999999999999999999999999999999999999999999999999976665 999999999987544
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
..+.+|||.|+|||++. ..++.++|.|||||++|||+.|.+||...+.....+.|......++. .++.++.+|+
T Consensus 198 -T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~----~fs~~~kdLl 272 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPS----YFSSDAKDLL 272 (355)
T ss_pred -EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCc----ccCHHHHHHH
Confidence 56789999999999986 66999999999999999999999999999999999999988777654 4689999999
Q ss_pred HHhcCCCcCCC-----CCHHHHhcccCC
Q 021233 293 RKMLDPDPKRR-----LTAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~R-----ps~~e~l~~l~f 315 (315)
.++|+.|-.+| .-..+|-.|+||
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF 300 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNHPWF 300 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccCccc
Confidence 99999999999 456789999998
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=363.92 Aligned_cols=265 Identities=59% Similarity=1.023 Sum_probs=247.7
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
...+...|++.+.||+|.||.||+++.+.+|+.+|+|.+.+.........+.+.+|+.+|+++..|||||.+.+.|+...
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 34566789999999999999999999999999999999998877666667899999999999966999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-CCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~-~~~vkl~Dfg~a~~ 208 (315)
.+++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.|++||||||+|+|+..... ...++++|||+|..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999887 5999999999999999999999999999999999999987654 34699999999999
Q ss_pred cCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
...+......+||+.|+|||++. ..|+..+||||+|+++|.|++|.+||+..+.......+......+..+.|+.+++.
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 88776778899999999999998 67999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.++|+.||..||.+|+|+.++|+|+|+
T Consensus 269 akd~i~~ll~~dp~~R~ta~~~L~HpWi 296 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTAAQALQHPWI 296 (382)
T ss_pred HHHHHHHhcccCcccCCCHHHHhcCccc
Confidence 9999999999999999999999999995
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=351.99 Aligned_cols=257 Identities=28% Similarity=0.458 Sum_probs=221.7
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
-.+.|++.+.||.|.-++||+|++...++.||||++..+..++. .+.+.+|+..|..+ +||||++++..|..+..+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhc-CCCCcceEEEEEEecceeE
Confidence 34689999999999999999999999999999999998876554 68899999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+||.||.+||+.+.+... ..+++..+..|++++++||.|||.+|.||||||+.|||++.+|. |||+|||.+..+.
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~---VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT---VKLADFGVSASLF 177 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc---EEEcCceeeeeec
Confidence 999999999999999864 34999999999999999999999999999999999999987777 9999999887654
Q ss_pred CCCc-----ccccccCCCccCchhhc---ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC------
Q 021233 211 PGEK-----FSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------ 276 (315)
Q Consensus 211 ~~~~-----~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------ 276 (315)
.... ..+..||+.|||||++. ..|+.|+||||||++..||.+|..||........+-.-.+...+.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence 3321 14568999999999964 359999999999999999999999998877665555444443321
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+....++..+..+|..||+.||++|||+.++|+|.||
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 111223466789999999999999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-52 Score=371.06 Aligned_cols=252 Identities=37% Similarity=0.641 Sum_probs=235.5
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
-|++++.||.|+-|.|-+|++..+|+.+|||++.+...........+.+|+-+|+.+ .||||+++++++++..++|+|.
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEE
Confidence 499999999999999999999999999999999887555556667899999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 215 (315)
||++||-|.+++...+++++..+++.+.||+.|+.|+|..+|+|||+||+|+|++...+ +||+|||+|..-.++...
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n---IKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN---IKIADFGMASLEVPGKLL 168 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC---EeeeccceeecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999986655 999999999988888888
Q ss_pred cccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 216 SEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 216 ~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.+.||+|.|.+||++.+. .+.++||||-||+||.|+||++||+..+....+.++.++.+..+ ..++.++++||.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLLr 244 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLLR 244 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHHH
Confidence 899999999999998854 57899999999999999999999999999999999999887765 457999999999
Q ss_pred HhcCCCcCCCCCHHHHhcccCC
Q 021233 294 KMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||..||++|.|.+||++|+|+
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred HHhccCccccccHHHHhhCchh
Confidence 9999999999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=366.02 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=214.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+.+++++.||+|.||.||.|.+.. ...||+|.+..... ..+.|.+|+++|++| +|++||++++++..+..++||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceEEE
Confidence 347888999999999999999973 45899998876532 336788999999999 999999999999999899999
Q ss_pred EEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+.|+|.++|.. ...+.....+.++.|||+||+||+++++|||||..+||||+.+. .|||+|||+|+...++
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~---~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL---VVKISDFGLARLIGDD 356 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc---eEEEcccccccccCCC
Confidence 999999999999987 34599999999999999999999999999999999999997554 4999999999955444
Q ss_pred Cccccccc--CCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 213 EKFSEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 213 ~~~~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
.......+ ...|+|||.+. +.++.|||||||||+|||++| |+.||...+..+.++.+.++. +.+.+..||+++
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy---Rlp~P~~CP~~v 433 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY---RLPRPEGCPDEV 433 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC---cCCCCCCCCHHH
Confidence 43322222 34699999987 679999999999999999999 999999999999999998874 455666899999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.++|..||+.+|++|||++.+...+
T Consensus 434 Y~lM~~CW~~~P~~RPtF~~L~~~l 458 (468)
T KOG0197|consen 434 YELMKSCWHEDPEDRPTFETLREVL 458 (468)
T ss_pred HHHHHHHhhCCcccCCCHHHHHHHH
Confidence 9999999999999999999876544
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-53 Score=342.28 Aligned_cols=260 Identities=37% Similarity=0.685 Sum_probs=238.7
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh-----hcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
+-+.|.-.+.||+|..++|-++..+.+|..+|+|++........ .-.+.-.+|+.+|+++..||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34568888999999999999999999999999998865432111 1134566799999999999999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
+...++|+|.|+.|.|.|++...-.++++..+.|++|+++|++|||.++||||||||+|||++++.+ ++|+|||.|+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~---i~isDFGFa~ 171 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN---IKISDFGFAC 171 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc---eEEeccceee
Confidence 9999999999999999999998888999999999999999999999999999999999999987666 9999999999
Q ss_pred ccCCCCcccccccCCCccCchhhcc-------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (315)
.+.++......+|||+|.|||.+.. .|+...|+||.|++||.++.|.+||+....-.+++.+.++...+..+.
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 9999999999999999999998752 388899999999999999999999999999999999999999999999
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+++.+..+||++||+.||.+|.|+.|+|+|+||
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 99999999999999999999999999999999997
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-52 Score=366.14 Aligned_cols=252 Identities=31% Similarity=0.506 Sum_probs=222.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
..|.....||+|+-|.||.|....+++.||+|++.... ....+-+.+|+.+|+.. +|+|||.+++.|...+.+|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEE
Confidence 46888899999999999999999999999999997653 23346789999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
||||+||+|.|.+... .+++.++..|+.+++.||+|||.+||+|||||.+|||++.++. |||+|||++..+....
T Consensus 349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~---vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS---VKLTDFGFCAQISEEQS 424 (550)
T ss_pred EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc---EEEeeeeeeeccccccC
Confidence 9999999999988765 4999999999999999999999999999999999999987777 9999999998876554
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
...+.+|||.|||||+.. ..|+.+.||||||++++||+.|.+||.....-..+..+... .......+..++..+.+|+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcCCccccCHHHHHHH
Confidence 567889999999999987 56999999999999999999999999876655555544433 2333334567999999999
Q ss_pred HHhcCCCcCCCCCHHHHhcccCC
Q 021233 293 RKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++||+.||.+|+|+.|+|+|+||
T Consensus 504 ~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred HHHhhcchhcCCCHHHHhcChhh
Confidence 99999999999999999999997
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=351.58 Aligned_cols=255 Identities=30% Similarity=0.485 Sum_probs=215.3
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.+ +|+|++++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEE
Confidence 78899999999999999999999999999998765444334445678899999999 99999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 137 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|+++++|.+.+... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++. ++|+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~---~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH---IRISDLGLAVQIPEGET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC---EEEeeCCCcEEcCCCCe
Confidence 99999998887643 35899999999999999999999999999999999999976554 89999999987654444
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+..............+++++.+|+.
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 45567999999999986 46899999999999999999999999766543333333322222233344568899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcccCC
Q 021233 294 KMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
+||+.||.+||+ ++++++|+||
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~ 264 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIF 264 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence 999999999997 8999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-52 Score=363.82 Aligned_cols=250 Identities=32% Similarity=0.578 Sum_probs=224.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. ....+...+.+|+++++.+ +||||+.++++|+...++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEE
Confidence 47999999999999999999999999999999998753 3444567799999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
+||+.| +|..++...+.++++.+..++.++..||.|||+++|+|||+||.|||+...+. +|+||||+|+.......
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~---~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT---LKLCDFGLARAMSTNTS 155 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc---eeechhhhhhhcccCce
Confidence 999977 99999999999999999999999999999999999999999999999976555 99999999998765543
Q ss_pred -ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 215 -FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 215 -~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
.+.+.|||.|||||+..+ .|+..+|+||+||++||+++|++||......+....|...... ++...+..+.+|+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~----~p~~~S~~f~nfl 231 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK----PPSTASSSFVNFL 231 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC----CcccccHHHHHHH
Confidence 367789999999999874 5999999999999999999999999887777777777665333 3347899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcccC
Q 021233 293 RKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
..+|.+||.+|.|-.+++.|+|
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred HHHhhcChhhcccHHHHhcChH
Confidence 9999999999999999999987
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=352.88 Aligned_cols=251 Identities=29% Similarity=0.504 Sum_probs=219.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEE
Confidence 3699999999999999999999999999999998755433334456788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~---~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH---IKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEEEecCcchhccCC--
Confidence 999999999999988888999999999999999999999999999999999999976554 999999999865432
Q ss_pred ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+......+ ...+++.+.+||.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~ 230 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF----PRHLDLYAKDLIK 230 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC----CccCCHHHHHHHH
Confidence 234578999999999874 58999999999999999999999998887777777776654333 2346889999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcccCC
Q 021233 294 KMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
+||+.||.+||+ +.+++.|+||
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccc
Confidence 999999999995 9999999997
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=357.62 Aligned_cols=252 Identities=31% Similarity=0.566 Sum_probs=221.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++..+ +||||+++++++...+..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEE
Confidence 35799999999999999999999999999999998765444444557789999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||+++++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH---VKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC---EEEeeccCceEcCCC-
Confidence 9999999999999998888999999999999999999999999999999999999986655 999999999865433
Q ss_pred cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......+ +..+++.+.+||
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~li 246 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF----PNWFDGRARDLV 246 (329)
T ss_pred -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCC----CCCCCHHHHHHH
Confidence 234579999999999874 58899999999999999999999998877766666666543332 234788999999
Q ss_pred HHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 293 RKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
.+||+.||.+||+ +.+++.|+||
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 9999999999997 7999999998
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=357.37 Aligned_cols=255 Identities=31% Similarity=0.515 Sum_probs=220.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999999999765444444456788999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||++|++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++..... .
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH---IKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC---EEEEeCcCCccccc--c
Confidence 999999999999988888999999999999999999999999999999999999976555 99999999976543 2
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC----ccCCHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW----PKVSENAK 289 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 289 (315)
.....||+.|+|||++. ..++.++|||||||++|||++|..||......+....+............ ..+++++.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 34567999999999986 45899999999999999999999999887777666666543322222211 25689999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++|.+||..+|++||++.++++|+||
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~ 260 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFF 260 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCccc
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=342.95 Aligned_cols=259 Identities=32% Similarity=0.513 Sum_probs=222.7
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc---
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--- 127 (315)
-.+..+|..++.||+|+||.|..+.+..+|+.||+|++... +......++..+|+++|+.+ +|+||+.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSR 95 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccc
Confidence 35567788899999999999999999999999999998743 55667778899999999999 89999999999864
Q ss_pred --CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 128 --DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
-+.+|+|+|+| +.+|...++.+..++...+..++.|++.||+|+|+.+++|||+||+|++++.+-. +||+|||+
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~---lKI~DFGL 171 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD---LKICDFGL 171 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC---EEeccccc
Confidence 46789999999 5589999988877999999999999999999999999999999999999975544 89999999
Q ss_pred ccccCC---CCcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC--
Q 021233 206 SVFFKP---GEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-- 278 (315)
Q Consensus 206 a~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 278 (315)
|+.... ....+..+-|.+|+|||++. ..|+...||||.||++.||++|++.|.+...-+.++.+....+...+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998754 44457778899999999864 46999999999999999999999999887766666655544433211
Q ss_pred ---------------------C----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ---------------------D----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ---------------------~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. .++..++...+|+.+||..||.+|+|++|+|+||+|
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 1 135678899999999999999999999999999986
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=364.29 Aligned_cols=256 Identities=29% Similarity=0.497 Sum_probs=232.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.-.++|+++++||+|+||+|+++..+.+++.+|||++.+..+-..++.+....|..|+....+||.++.++.+|...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 33468999999999999999999999999999999999999988889999999999999998899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK- 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~- 210 (315)
|+||||+.||++..+. +.+.+++..++.++..++.||.|||++||||||||.+|||++.+|. +||+|||+++...
T Consensus 445 ~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh---~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH---VKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc---EEecccccccccCC
Confidence 9999999999954433 4457999999999999999999999999999999999999976666 9999999998754
Q ss_pred CCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.+...++.+|||.|||||++.+ .|+...|.|||||+||||+.|..||.+..+++....|......++ ..++.+..
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP----~~ls~ea~ 596 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSKEAI 596 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CcccHHHH
Confidence 5666788999999999999985 599999999999999999999999999999999999998765544 34799999
Q ss_pred HHHHHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
++++++|.++|++|.- +.+|.+|+||
T Consensus 597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFF 627 (694)
T KOG0694|consen 597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFF 627 (694)
T ss_pred HHHHHHhccCcccccCCCCCCchhhhhCCcc
Confidence 9999999999999974 6899999998
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=355.22 Aligned_cols=247 Identities=30% Similarity=0.538 Sum_probs=214.6
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999998765443444456788899999999 999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CCCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 219 (315)
++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.... .........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---EEEeeCCCCcccccCCCccccee
Confidence 999999988888999999999999999999999999999999999999976555 9999999987532 223334567
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
||+.|+|||++. ..++.++|||||||+++||++|..||...........+...... .+..+++++.++|.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----FPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHHHHHHccC
Confidence 999999999986 45899999999999999999999999887766666655544332 2346789999999999999
Q ss_pred CcCCCC-----CHHHHhcccCC
Q 021233 299 DPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rp-----s~~e~l~~l~f 315 (315)
||++|| ++.++++|+||
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f 254 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFF 254 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCc
Confidence 999999 89999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=334.76 Aligned_cols=255 Identities=28% Similarity=0.458 Sum_probs=221.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--CCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 132 (315)
+.|+.+..|++|.||+||+|.+..+++.||+|.+..+.....-.+ .-.+|+.+|.++ +|||||.+-.+... -+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKA-RHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence 469999999999999999999999999999999987653333223 345799999999 89999999888764 46799
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+|||||+. +|..++..-+ +|...+++.++.|++.|++|||++.|+||||||+|+|++..+. +||+|||+|+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~---lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI---LKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc---EEecccchhhhhcC
Confidence 99999976 8888887654 7999999999999999999999999999999999999987666 99999999998865
Q ss_pred C-CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCcc-----
Q 021233 212 G-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK----- 283 (315)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 283 (315)
. ...+..+-|.+|+|||.+-+ .|+.+.|+||+||++.||+++++.|.+..+.+.+..|.+.........|+.
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 4 44677889999999999764 499999999999999999999999999999999999988776654444432
Q ss_pred -----------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 284 -----------------------VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 284 -----------------------~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++...+|++.+|..||.+|.|+.|+|.|-||
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F 364 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF 364 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc
Confidence 34777899999999999999999999999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=356.14 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=215.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +|+||+++++.+......++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEE
Confidence 4799999999999999999999999999999999765443444456788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. ++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~---vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC---EEEeeccCccccccccc
Confidence 999999999999988888999999999999999999999999999999999999976554 9999999987542110
Q ss_pred -----------------------------------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCC
Q 021233 214 -----------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 257 (315)
Q Consensus 214 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~ 257 (315)
.....+||+.|+|||++. ..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 012357999999999986 45899999999999999999999999
Q ss_pred CCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC--CcCCCCCHHHHhcccCC
Q 021233 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP--DPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--~P~~Rps~~e~l~~l~f 315 (315)
......+....+.........+....+++++.++|.+|+.. ++..||++.|+++|+||
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f 296 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFF 296 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCC
Confidence 88877777777765432222222234789999999997752 23356899999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=353.82 Aligned_cols=252 Identities=29% Similarity=0.497 Sum_probs=219.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCC-CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENG-DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+...........+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEE
Confidence 457999999999999999999876554 68999998765444444556788999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++. ++|+|||++......
T Consensus 108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~---ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF---IKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC---EEEecCCCCeecCCC
Confidence 99999999999999998888999999999999999999999999999999999999976554 999999999865432
Q ss_pred CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......+ +..+++++.++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~l 258 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF----PKFLDNNCKHL 258 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHH
Confidence 245679999999999864 58999999999999999999999998887776667766554332 34578899999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
|++||+.||.+|+ ++.++++|+||
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 9999999999995 99999999998
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=357.44 Aligned_cols=256 Identities=30% Similarity=0.524 Sum_probs=218.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..+ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEE
Confidence 4699999999999999999999999999999999765433344456688899999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. ++|+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEeecccceecccccc
Confidence 999999999999988888999999999999999999999999999999999999976555 8999999986542211
Q ss_pred --------------------------------------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCC
Q 021233 214 --------------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV 254 (315)
Q Consensus 214 --------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~ 254 (315)
......||+.|+|||++. ..++.++|||||||++++|++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 001246899999999976 45899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCC---HHHHhcccCC
Q 021233 255 PPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT---AQQVLGKIEF 315 (315)
Q Consensus 255 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~e~l~~l~f 315 (315)
.||......+....+..............+++++.++|.+||. +|.+|++ +.+++.|+||
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~ 299 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence 9998877766666665543332222223578999999999997 8999997 9999999997
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=357.05 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=215.1
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
.|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++++...+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999765544444566789999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC--
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 213 (315)
||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~---~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH---IKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC---EEEeeCcCCccccccccc
Confidence 99999999999988888999999999999999999999999999999999999976544 9999999875321000
Q ss_pred ----------------------------------------------cccccccCCCccCchhhc-ccCCCcchHHHHHHH
Q 021233 214 ----------------------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI 246 (315)
Q Consensus 214 ----------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~ 246 (315)
......||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 012347999999999986 458999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhc--CCCcCCCCCHHHHhcccCC
Q 021233 247 LYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML--DPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 247 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~~P~~Rps~~e~l~~l~f 315 (315)
+|||++|..||......+....+.........+....+++++.+||.+|+ ..+|..||++.++++|+||
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f 308 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCccc
Confidence 99999999999877766555555543323333333467899999999955 5555669999999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=356.63 Aligned_cols=256 Identities=35% Similarity=0.604 Sum_probs=221.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.++..+ +|+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEE
Confidence 4699999999999999999999999999999998765444444556788999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~---~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH---IKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEeecCCCCccCcccCc
Confidence 999999999999988878999999999999999999999999999999999999976655 8999999997654332
Q ss_pred -----------------------------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH
Q 021233 214 -----------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (315)
Q Consensus 214 -----------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 263 (315)
......||+.|+|||++. ..++.++|||||||++|+|++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 223457899999999987 45899999999999999999999999888877
Q ss_pred HHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCC-HHHHhcccCC
Q 021233 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT-AQQVLGKIEF 315 (315)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps-~~e~l~~l~f 315 (315)
.....+.........+....+++++.++|.+||. ||.+||+ +.++++|+||
T Consensus 237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 6666666532233333334479999999999998 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=342.89 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=211.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||.|+||+||+|.+..++..||+|++..... ......+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEE
Confidence 469999999999999999999999999999999865432 22235677899999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||+++ +|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEECcCcceeeccCCC
Confidence 999975 8988887654 4789999999999999999999999999999999999976555 999999999764322
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC-----------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----------- 279 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 279 (315)
.......+++.|+|||.+.+ .++.++||||+|+++++|++|+.||......+....+..........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 22344578999999998753 48999999999999999999999998877666555544322111100
Q ss_pred ---------------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 ---------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ---------------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+.+++++.+||.+||+.||.+|||+.|+++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=347.89 Aligned_cols=245 Identities=31% Similarity=0.533 Sum_probs=213.0
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (315)
||+|+||.||+|.+..+++.||+|++.............+.+|+.+++++ +||||+++++++...+..++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 79999999999999999999999998765444444566788999999999 99999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-CcccccccC
Q 021233 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGS 221 (315)
Q Consensus 143 L~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt 221 (315)
|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++...... .......||
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH---IALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc---EEEEECcccccCccCCCccccccCC
Confidence 9999988888999999999999999999999999999999999999976555 899999998754322 223456799
Q ss_pred CCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCc
Q 021233 222 PYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300 (315)
Q Consensus 222 ~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 300 (315)
+.|+|||++.+ .++.++|||||||++++|++|+.||......+....+...... .+..+++++.++|.+||+.||
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR----FPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCC----CCCcCCHHHHHHHHHHcCCCH
Confidence 99999999874 5899999999999999999999999887777666666554332 334678999999999999999
Q ss_pred CCCC---CHHHHhcccCC
Q 021233 301 KRRL---TAQQVLGKIEF 315 (315)
Q Consensus 301 ~~Rp---s~~e~l~~l~f 315 (315)
.+|| ++.+++.|+||
T Consensus 233 ~~R~~~~~~~e~l~hp~~ 250 (312)
T cd05585 233 TRRLGYNGAQEIKNHPFF 250 (312)
T ss_pred HHcCCCCCHHHHHcCCCc
Confidence 9997 58999999997
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=349.56 Aligned_cols=247 Identities=28% Similarity=0.526 Sum_probs=213.7
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999765444444556788899999999 999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (315)
++|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..... ........
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH---IKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc---EEEecCcCCccCCCccccccccc
Confidence 999999988878999999999999999999999999999999999999976555 89999999875432 22334567
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+...... .+..+++++.++|.+||+.
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK----FPRTLSADAKSLLSGLLIK 232 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc----CCCCCCHHHHHHHHHHcCC
Confidence 999999999986 45899999999999999999999999877766665555443322 3346789999999999999
Q ss_pred CcCCCC-----CHHHHhcccCC
Q 021233 299 DPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rp-----s~~e~l~~l~f 315 (315)
||++|| ++.++++|+||
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCc
Confidence 999997 89999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=356.59 Aligned_cols=256 Identities=28% Similarity=0.496 Sum_probs=213.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+++++.+ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEE
Confidence 3699999999999999999999999999999998765433344456788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||++|++|.+++.....+++..++.++.|++.||+|||+.||+||||||+|||++.++. ++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~---~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH---IKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC---EEEeecccccccccccc
Confidence 999999999999988888999999999999999999999999999999999999976554 9999999986321100
Q ss_pred -----------c------------------------------------ccccccCCCccCchhhc-ccCCCcchHHHHHH
Q 021233 214 -----------K------------------------------------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGV 245 (315)
Q Consensus 214 -----------~------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~ 245 (315)
. .....||+.|+|||++. ..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 01246899999999986 45899999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCC---CCCHHHHhcccCC
Q 021233 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR---RLTAQQVLGKIEF 315 (315)
Q Consensus 246 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~---Rps~~e~l~~l~f 315 (315)
+++||++|..||......+....+.........+....++.++.+||.+||. +|.+ |+++.+++.|+||
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~ 308 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFF 308 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCc
Confidence 9999999999998777666666555432222222223578999999999998 6665 4699999999997
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=342.80 Aligned_cols=255 Identities=36% Similarity=0.652 Sum_probs=237.4
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.-+|++.+.||+|.||.|-+|+....|+.||||.+.+..+.+.++.-.+.+|+++|..| +||||++++.+|++.+.+
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKI 128 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceE
Confidence 3455899999999999999999999999999999999999999998899999999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||||..+|.|+|++...+.+++..++.+++||..|+.|+|+++++|||||.+|||++.+.+ +||+|||++..+..
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N---iKIADFGLSNly~~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN---IKIADFGLSNLYAD 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC---eeeeccchhhhhcc
Confidence 999999999999999999999999999999999999999999999999999999999987666 89999999999988
Q ss_pred CCcccccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.....+++|+|.|.+||+.++. -++..|-||||++||.|+.|..||++.......++|.++.+-.+. -|.+..
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSdA~ 280 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSDAS 280 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCchHH
Confidence 8888999999999999999864 478999999999999999999999999999999999887554332 356788
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
-||+.||-.+|++|.|+.+|..|.|.
T Consensus 281 gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 281 GLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred HHHHHHHhcCcccchhHHHHhhhhee
Confidence 99999999999999999999999883
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-49 Score=347.28 Aligned_cols=253 Identities=27% Similarity=0.452 Sum_probs=218.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++++.||+|+||.||+|.+..+++.||+|++...........+.+..|+.++..+..|++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999876544344455678889999999955567889999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CCCc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEK 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~ 214 (315)
||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++.... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH---IKIADFGMCKENIFGGKT 157 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC---EEEeecCcceecCCCCCc
Confidence 99999999999988888999999999999999999999999999999999999976554 9999999987532 2233
Q ss_pred ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+...... .+..+++++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~ 233 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS----YPKSLSKEAVSICK 233 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHHHH
Confidence 345679999999999874 5899999999999999999999999888777777776654333 33457899999999
Q ss_pred HhcCCCcCCCCCH-----HHHhcccCC
Q 021233 294 KMLDPDPKRRLTA-----QQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps~-----~e~l~~l~f 315 (315)
+||+.||.+|++. .++++|+||
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~ 260 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFF 260 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence 9999999999986 899999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=348.54 Aligned_cols=247 Identities=30% Similarity=0.545 Sum_probs=213.7
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||++.+..+|..||+|++.............+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 4699999999999999999999999998765443344456678899999999 999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (315)
++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... ........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC---EEecccHHhccccCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999976655 99999999875322 22334567
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
||+.|+|||++. ..++.++||||||+++|+|++|+.||...........+...... .+..+++++.++|.+||..
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR----FPRTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCHHHHHHHHHHccC
Confidence 999999999986 45899999999999999999999999877776666665544332 2345789999999999999
Q ss_pred CcCCCC-----CHHHHhcccCC
Q 021233 299 DPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rp-----s~~e~l~~l~f 315 (315)
||++|| ++.++++|+||
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~ 254 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFF 254 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCc
Confidence 999998 99999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=343.60 Aligned_cols=261 Identities=34% Similarity=0.616 Sum_probs=222.4
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC-----------hhcHHHHHHHHHHHHhCCCCC
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----------AVDIEDVRREVDIMRHLPKHQ 116 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~h~ 116 (315)
.++...-+.|++++.||+|.||.|-+|++..+++.||+|++.+..... ....+...+|+.+|+++ .||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~ 168 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHP 168 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCc
Confidence 344555577999999999999999999999999999999997654321 23457899999999999 999
Q ss_pred CcceeEEEEEc--CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC
Q 021233 117 NIVCLKDTYED--DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (315)
Q Consensus 117 ~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~ 194 (315)
|||+++.+..+ .+.+|||+|||..|.+...-.....+++.+++.++++++.||+|||.+|||||||||+|+|++.++.
T Consensus 169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred CeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99999999975 4689999999998877443222223899999999999999999999999999999999999986655
Q ss_pred CCCEEEEeeccccccCCCC------cccccccCCCccCchhhcc-c----CCCcchHHHHHHHHHHHhhCCCCCCCCChH
Q 021233 195 TAPLKAIDFGLSVFFKPGE------KFSEIVGSPYYMAPEVLKR-N----YGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (315)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~----~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 263 (315)
|||+|||.+.....+. .....+|||.|+|||.+.+ . .+.+.||||+||+||.|+.|+.||......
T Consensus 249 ---VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 249 ---VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred ---EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 9999999997653221 2245689999999998764 2 467899999999999999999999999999
Q ss_pred HHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+....|.+..+.++.. +.+.+.+.+||.+||.+||++|.+..+|-.|+|
T Consensus 326 ~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 ELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 9999999887777655 357899999999999999999999999999998
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=341.11 Aligned_cols=256 Identities=28% Similarity=0.459 Sum_probs=211.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||+||+|++..+++.+|+|++..... .....+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEE
Confidence 369999999999999999999999999999999875432 223356788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||++++++..+......+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV---LKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEEeeccCccccccccc
Confidence 999998777655555556999999999999999999999999999999999999976555 8999999998754322
Q ss_pred -cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC--------------
Q 021233 214 -KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-------------- 277 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 277 (315)
......|++.|+|||++. ..++.++|||||||++|+|++|+.||......+....+.......+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 223457899999999976 4589999999999999999999999987665544433322111100
Q ss_pred -----C---------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 -----R---------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 -----~---------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. .....++.++.+||.+||+.||++|||+.++|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 0012367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=321.27 Aligned_cols=255 Identities=32% Similarity=0.558 Sum_probs=233.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
..-++|.+++.||+|-||.||+|+.++++-.||+|++.++++....-..++.+|+++...| +||||++++++|-+....
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSKRI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecccee
Confidence 3346799999999999999999999999999999999988877777778899999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 132 HLVMELCEGGELFDRIV--ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~--~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
|+++||.+.|+|...+. ....+++.....++.|++.||.|+|.+++|||||||+|+|++..+. +|++|||.+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~---lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC---eeccCCCceeec
Confidence 99999999999999998 5566999999999999999999999999999999999999977666 899999999875
Q ss_pred CCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 210 KPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
. .+...+.+||..|.+||...+ .++...|+|++|++.+|++.|.+||......+..+.+.+....++ ..++.+.
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a 249 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGA 249 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhH
Confidence 5 666788999999999999875 589999999999999999999999998888888888887765544 5689999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++|.+||..+|.+|.+..|++.|+|.
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHH
Confidence 999999999999999999999999983
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=356.12 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=216.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++.+...+.+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999999998765433334456788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC--
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-- 212 (315)
|||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||+|......
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~---ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC---EEEEeCCCCcccccccc
Confidence 999999999999988888999999999999999999999999999999999999976554 999999997422100
Q ss_pred ------------------------------------------CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHH
Q 021233 213 ------------------------------------------EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYI 249 (315)
Q Consensus 213 ------------------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~e 249 (315)
.......||+.|+|||++.+ .++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00113479999999999874 58999999999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCC---CHHHHhcccCC
Q 021233 250 LLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLGKIEF 315 (315)
Q Consensus 250 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp---s~~e~l~~l~f 315 (315)
|++|+.||......+....+..............+++++.++|.+|+ .+|.+|+ ++.++++|+||
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~ 304 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFF 304 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCc
Confidence 99999999887766665555544333333334568899999999977 5999999 99999999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=347.11 Aligned_cols=248 Identities=31% Similarity=0.522 Sum_probs=214.6
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||+||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987654333444566778999998876899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (315)
++|.+++.....+++..++.++.|++.||.|||+.|++||||||+|||++.++. ++|+|||++..... ........
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~---~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc---EEEeeCCCCeecCcCCCcccccc
Confidence 999999988888999999999999999999999999999999999999976655 89999999875422 22334567
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
||+.|+|||++. ..++.++||||||+++|+|++|+.||...........+....... +..+++++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY----PTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC----CCCCCHHHHHHHHHHccc
Confidence 999999999987 458999999999999999999999998888777777776543332 235789999999999999
Q ss_pred CcCCCCCH------HHHhcccCC
Q 021233 299 DPKRRLTA------QQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rps~------~e~l~~l~f 315 (315)
||++||++ .+++.|+||
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCc
Confidence 99999998 999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=355.06 Aligned_cols=255 Identities=31% Similarity=0.505 Sum_probs=216.5
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++.+...+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEE
Confidence 689999999999999999999999999999998765433344456788999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC---
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG--- 212 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~--- 212 (315)
||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~---~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEEeECCCCccccccccc
Confidence 99999999999988778999999999999999999999999999999999999976554 999999997532100
Q ss_pred ---------------------------------------------CcccccccCCCccCchhhc-ccCCCcchHHHHHHH
Q 021233 213 ---------------------------------------------EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVI 246 (315)
Q Consensus 213 ---------------------------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~ 246 (315)
.......||+.|+|||++. ..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 0012346899999999986 458999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCC---HHHHhcccCC
Q 021233 247 LYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT---AQQVLGKIEF 315 (315)
Q Consensus 247 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~e~l~~l~f 315 (315)
+|||++|+.||......+....+.........+....+++++.++|.+|+ .+|.+|++ +.+++.|+||
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f 308 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFF 308 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCc
Confidence 99999999999887776666666554333333344568899999999986 59999987 9999999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-49 Score=352.04 Aligned_cols=257 Identities=32% Similarity=0.497 Sum_probs=218.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEE
Confidence 46799999999999999999999999999999998754433344455678899999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||++||+|.+++... .+++..+..++.|++.||+|||+.||+||||||+|||++.++. +||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~---~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC---EEEEeccceeeccCCC
Confidence 99999999999988654 5899999999999999999999999999999999999976555 9999999997654332
Q ss_pred --cccccccCCCccCchhhcc-----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 214 --KFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 214 --~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
......||+.|+|||++.. .++.++|||||||++|||++|+.||...........+.........+....++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK 276 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence 2234579999999998752 378899999999999999999999988877766666665433222223345789
Q ss_pred HHHHHHHHhcCCCcCC--CCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKR--RLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~--Rps~~e~l~~l~f 315 (315)
++.+||.+||..+|.+ |+|+.+++.|+||
T Consensus 277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred HHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 9999999999999988 9999999999997
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=335.86 Aligned_cols=252 Identities=32% Similarity=0.498 Sum_probs=216.3
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--C-
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--T- 129 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~- 129 (315)
..-.|.-.+++|.|+||+||+|...++++.||||.+-.... .-.+|+.+|+.+ +|||||+++.+|... +
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKL-DHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhc-CCcCeeeEEEEEEecCCCc
Confidence 44468889999999999999999999999999998754432 234699999998 999999999998642 2
Q ss_pred --cEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 130 --AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
...+|||||+. +|.+.++. +..++...++-+..||+.||.|||+.||+||||||.|+|++.+ ++.+|||||
T Consensus 94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~--tg~LKicDF 170 (364)
T KOG0658|consen 94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD--TGVLKICDF 170 (364)
T ss_pred hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC--CCeEEeccC
Confidence 45699999976 99998874 4568999999999999999999999999999999999999854 455999999
Q ss_pred ccccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC---
Q 021233 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR--- 278 (315)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--- 278 (315)
|.|+.+..++...+...|..|+|||.+.+ .|+.+.||||.|||+.||+-|++.|.+....+.+..+.+.......
T Consensus 171 GSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 171 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred CcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99999988888888899999999999764 5999999999999999999999999999888888777655443211
Q ss_pred -----------------CC-----CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 -----------------DP-----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 -----------------~~-----~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ....++++.+|+.++|..+|.+|.++.|+|+|+||
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF 309 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF 309 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh
Confidence 11 13468999999999999999999999999999998
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=345.22 Aligned_cols=253 Identities=26% Similarity=0.448 Sum_probs=218.9
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+..|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999876544334445567778888888867899999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEK 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~ 214 (315)
||+++|+|.+.+.....+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++..... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENMWDGVT 157 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc---EEEccCCCceecCCCCCc
Confidence 99999999999988888999999999999999999999999999999999999976655 89999999875432 223
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....||+.|+|||++. ..++.++|||||||++|+|++|+.||...........+......+ +..+++++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~ 233 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY----PKSMSKEAVAICK 233 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CCcCCHHHHHHHH
Confidence 34567999999999987 458999999999999999999999998888777777776654332 3457899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcccCC
Q 021233 294 KMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
+||+.||++|++ ..+++.|+||
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~ 260 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFF 260 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCc
Confidence 999999999998 4899999987
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=345.64 Aligned_cols=248 Identities=27% Similarity=0.498 Sum_probs=215.5
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999987654444445566788999998776899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (315)
++|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++..... ........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH---CKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEeecccceecccCCccccccc
Confidence 999999988888999999999999999999999999999999999999976655 99999999875432 22234567
Q ss_pred cCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 220 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 220 gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+....... +..++.++.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLY----PVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHHhcc
Confidence 8999999999874 58999999999999999999999999888877777776654332 234789999999999999
Q ss_pred CcCCCC-------CHHHHhcccCC
Q 021233 299 DPKRRL-------TAQQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rp-------s~~e~l~~l~f 315 (315)
||++|| ++.++++|+||
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCcc
Confidence 999999 99999999997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=338.47 Aligned_cols=256 Identities=31% Similarity=0.488 Sum_probs=215.8
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEE
Confidence 488999999999999999999989999999998765443333345677899999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++++++. ++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH---IRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC---EEEeeCCCceecCCCC
Confidence 999999999888653 35899999999999999999999999999999999999976544 9999999998765444
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
......|++.|+|||++. ..++.++||||+|+++|++++|..||...........+...........+..+++.+.+||
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 444567899999999986 4589999999999999999999999987655444333333322233334456889999999
Q ss_pred HHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 293 RKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
.+||+.||++|| ++.+++.|+||
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFF 264 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence 999999999999 89999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=353.52 Aligned_cols=258 Identities=30% Similarity=0.429 Sum_probs=217.2
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-----CCcceeEEE
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-----QNIVCLKDT 124 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-----~~iv~~~~~ 124 (315)
.+.+..+|.+++.||+|+||.|.+|++..+++.||||++.... .-..+...|+.+|..|.+| -|+|+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 3455668999999999999999999999999999999997542 3345567799999999533 489999999
Q ss_pred EEcCCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 125 YEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
|...++.|||+|.+ +.+|+++++.+. .++...++.++.||+.||.+||+.||||+||||+|||+..-+.. .|||+|
T Consensus 257 F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVID 334 (586)
T KOG0667|consen 257 FYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVID 334 (586)
T ss_pred cccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEEe
Confidence 99999999999999 559999999775 48999999999999999999999999999999999999765544 699999
Q ss_pred eccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC--
Q 021233 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD-- 279 (315)
Q Consensus 203 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 279 (315)
||+|+.....- -+...+..|+|||++- ..|+.+.||||||||+.||++|.+.|.+..+.+.+..|.+.....+..
T Consensus 335 FGSSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 335 FGSSCFESQRV--YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccccCCcc--eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99998765443 3778899999999976 569999999999999999999999999998888777765443321100
Q ss_pred ---------------C------------------------------Cc------------cCCHHHHHHHHHhcCCCcCC
Q 021233 280 ---------------P------------------------------WP------------KVSENAKDLVRKMLDPDPKR 302 (315)
Q Consensus 280 ---------------~------------------------------~~------------~~~~~l~~li~~~l~~~P~~ 302 (315)
. .+ .-...+.++|.+||.+||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 0 00 11245789999999999999
Q ss_pred CCCHHHHhcccCC
Q 021233 303 RLTAQQVLGKIEF 315 (315)
Q Consensus 303 Rps~~e~l~~l~f 315 (315)
|+|+.++|+|+||
T Consensus 493 R~tp~qal~Hpfl 505 (586)
T KOG0667|consen 493 RITPAQALNHPFL 505 (586)
T ss_pred cCCHHHHhcCccc
Confidence 9999999999997
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=348.89 Aligned_cols=256 Identities=30% Similarity=0.459 Sum_probs=218.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEE
Confidence 3699999999999999999999999999999999765443444556788999999998 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH---IKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC---EEeccCCCCeECCCCC
Confidence 9999999999999876 57999999999999999999999999999999999999976555 9999999998764433
Q ss_pred cc--cccccCCCccCchhhc-------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 214 KF--SEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
.. ....||+.|+|||++. ..++.++||||||+++|+|++|..||...........+.........+..+.+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 22 2347899999999874 24788999999999999999999999887776666666544322222223457
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++++.+||..||. +|.+|||+.+++.|+||
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 8999999999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-49 Score=347.03 Aligned_cols=257 Identities=30% Similarity=0.546 Sum_probs=211.1
Q ss_pred ceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEccccccc-ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 56 RYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
+|++++.||+|+||+||++.+. .+++.||+|++.+.... .....+.+..|+.++..+.+|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999998864 46899999998654322 2233456888999999997799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~---~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH---VVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC---EEEeeCcCCccccc
Confidence 999999999999999988888999999999999999999999999999999999999986654 99999999976533
Q ss_pred CC--cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.. ......||+.|+|||++.+ .++.++||||||+++++|++|..||...........+........+..+..+++.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 22 2234579999999999864 3788999999999999999999999643222111222222222223334567899
Q ss_pred HHHHHHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+.+++.+||+.||++|| ++.++++|+||
T Consensus 238 ~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 270 (332)
T cd05614 238 AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270 (332)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence 99999999999999999 88999999997
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=349.88 Aligned_cols=258 Identities=30% Similarity=0.469 Sum_probs=218.1
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++++...+..+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEE
Confidence 346899999999999999999999999999999998764443444456688899999998 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~---~kL~DFG~a~~~~~~ 195 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH---LKLADFGTCMKMDET 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC---EEEEecccceecccC
Confidence 999999999999988654 5899999999999999999999999999999999999976555 999999999876433
Q ss_pred Cc--ccccccCCCccCchhhcc-----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 213 EK--FSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 213 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.........+....++
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 22 235679999999999753 27889999999999999999999998887777777666543332222223578
Q ss_pred HHHHHHHHHhcCCCcCC--CCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKR--RLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~--Rps~~e~l~~l~f 315 (315)
+.+.+++..||..+|.+ |+++.++++|+||
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 99999999999866654 8999999999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=328.66 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=221.8
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC-cceeEEEEEcCC---
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-IVCLKDTYEDDT--- 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-iv~~~~~~~~~~--- 129 (315)
...|..++.||+|+||+||+|+...+|+.||+|++......+. ......+|+.+|+.| +|+| |+.+.+++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccc
Confidence 3468888999999999999999999999999999987644322 234567899999999 8999 999999998776
Q ss_pred ---cEEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 130 ---AVHLVMELCEGGELFDRIVARG----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 130 ---~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
.+++|+||++. +|.+++.... .++...++.++.||+.||+|||+++|+||||||.|||+++++. +||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~---lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV---LKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc---Eeeec
Confidence 78999999965 9999998754 4788899999999999999999999999999999999987555 99999
Q ss_pred eccccccC-CCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC
Q 021233 203 FGLSVFFK-PGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (315)
Q Consensus 203 fg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (315)
||+|+... +....+..++|.+|+|||++.+ .|+...||||+||++.||++++..|.+..+.+....+.+........
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99999765 4455778899999999999764 49999999999999999999999999999999888888776665444
Q ss_pred CCcc--------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 PWPK--------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ~~~~--------------------------~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.|+. .+++..+++.+||+.+|.+|.|+..+|.|++|
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf 305 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF 305 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence 4432 23478899999999999999999999999987
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=345.71 Aligned_cols=248 Identities=27% Similarity=0.490 Sum_probs=208.9
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|.+..+++.||+|++.............+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999997654444445567889999999987899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc-CCCCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~-~~~~~~~~~~ 219 (315)
++|.+++...+.+++..++.++.|++.||.|||++|++||||||+|||++.++. +||+|||++... ..........
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEECcCccccccccCCCcccccc
Confidence 999999988888999999999999999999999999999999999999976554 999999998753 2233344568
Q ss_pred cCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCC---------hHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 220 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 220 gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
||+.|+|||++.+ .++.++|+||||+++|+|++|+.||.... .....+.+..... ..+..++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~ 233 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----RIPRSLSVKAS 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----CCCCCCCHHHH
Confidence 9999999999874 58999999999999999999999995321 1112223333222 22345789999
Q ss_pred HHHHHhcCCCcCCCCC------HHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLT------AQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps------~~e~l~~l~f 315 (315)
++|.+||+.||.+||+ +.++++|+||
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 9999999999999987 7899999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=342.32 Aligned_cols=248 Identities=31% Similarity=0.488 Sum_probs=210.9
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++...+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987654333344556667778887666899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-Ccccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~ 219 (315)
++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||++...... .......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~---~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH---IKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC---EEEccCcCCeECCCCCCcccccc
Confidence 999999988888999999999999999999999999999999999999976555 999999999764322 2334567
Q ss_pred cCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 220 GSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 220 gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+..... ..+..++.++.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP----HFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----CCCCCCCHHHHHHHHHHccC
Confidence 9999999999874 589999999999999999999999988777666666654322 23345789999999999999
Q ss_pred CcCCCCCH-HHHhcccCC
Q 021233 299 DPKRRLTA-QQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rps~-~e~l~~l~f 315 (315)
||++||++ .+++.|+||
T Consensus 234 ~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFF 251 (316)
T ss_pred CHHHcCCChHHHHcCccc
Confidence 99999986 478899887
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-49 Score=346.23 Aligned_cols=247 Identities=30% Similarity=0.542 Sum_probs=213.1
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|.+..+++.||+|++.............+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999765444444456778899999999 999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CCCccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEI 218 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~ 218 (315)
++|.+++.....+++..++.++.||+.||.|||+ .||+||||||+|||++.++. +||+|||++.... ........
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH---IKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC---EEEecCCCCeecCCCCcccccc
Confidence 9999999888789999999999999999999997 79999999999999986655 9999999987533 22333456
Q ss_pred ccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 219 ~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
.||+.|+|||++. ..++.++||||||+++|+|++|..||...........+...... .+..+++++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~li~~~L~ 232 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----FPRTLSPEAKSLLSGLLK 232 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCHHHHHHHHHHhh
Confidence 7999999999986 45899999999999999999999999887766666655544332 234578999999999999
Q ss_pred CCcCCCC-----CHHHHhcccCC
Q 021233 298 PDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 298 ~~P~~Rp-----s~~e~l~~l~f 315 (315)
.||++|+ ++.++++|+||
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~ 255 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFF 255 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCc
Confidence 9999996 99999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=338.27 Aligned_cols=254 Identities=28% Similarity=0.403 Sum_probs=204.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||+||+|.+..+++.||+|++..... ......+.+|+.+++.+ +||||+++++++......++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEE
Confidence 579999999999999999999998999999999875432 12234577899999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||++ ++|.+++... +.+++..++.++.|++.||+|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSVPS 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECCCCcceeccCCC
Confidence 99996 5787777654 45899999999999999999999999999999999999976555 899999998754322
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhccccC-------------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDF------------- 276 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~------------- 276 (315)
.......+|+.|+|||++.+ .++.++|||||||++++|++|..||...... +....+.......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22344578999999998753 4788999999999999999999999764332 2222221111000
Q ss_pred -CCCC--------------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 -RRDP--------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 -~~~~--------------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.. ....++++.+|+.+||+.||++|||+.++++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 0000 01235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-51 Score=348.87 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=218.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
..|...+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+|..+ +++||.++++.+..+..+|++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHH
Confidence 458888999999999999999999999999999987653 34568899999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||+.||++.+.+.....+.+..+.-++++++.||.|||+.+.+|||||+.|||+..++. |||+|||.+........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~---vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD---VKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc---EEEEecceeeeeechhh
Confidence 999999999999988877799999999999999999999999999999999999987755 99999999987765543
Q ss_pred c-cccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 215 F-SEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 215 ~-~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
. .+++|||.|||||++.+ .|+.|+||||||++.+||++|.+|+........+..|.+. .++..-..+++.+++||
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~---~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS---APPRLDGDFSPPFKEFV 243 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC---CCCccccccCHHHHHHH
Confidence 3 67899999999999985 6999999999999999999999999776653332222222 11122225688899999
Q ss_pred HHhcCCCcCCCCCHHHHhcccC
Q 021233 293 RKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
..||.+||+.||||.++|+|-|
T Consensus 244 ~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 244 EACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred HHHhhcCcccCcCHHHHhhhHH
Confidence 9999999999999999999976
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=341.64 Aligned_cols=248 Identities=29% Similarity=0.471 Sum_probs=210.8
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999987654322334456777888888766899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (315)
++|.+++.....+++..+..++.|++.||+|||++||+||||||+|||++.++. ++|+|||++..... ........
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH---IKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEeCccCCCeecccCCCceeccC
Confidence 999999988878999999999999999999999999999999999999976554 99999999875322 22334567
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
||+.|+|||++. ..++.++||||||+++++|++|..||...........+...... ....++.++.++|.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPH----YPRWITKESKDILEKLFER 233 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCCCCCHHHHHHHHHHccC
Confidence 999999999987 45899999999999999999999999887776666665544322 2234789999999999999
Q ss_pred CcCCCCCH-HHHhcccCC
Q 021233 299 DPKRRLTA-QQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rps~-~e~l~~l~f 315 (315)
||++||++ .+++.|+||
T Consensus 234 dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred CHHHcCCChHHHHcCCCc
Confidence 99999998 588899997
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=335.55 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=207.7
Q ss_pred cceeeeeeeeeecceEEEEEEECC-CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC--CCCCcceeEEEEE-----
Q 021233 55 ERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYE----- 126 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~----- 126 (315)
++|++.+.||+|+||+||+|.+.. ++..||+|.+....... .....+.+|+.+++.+. +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 46789999886543222 22345566777777663 5999999999885
Q ss_pred cCCcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 127 DDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
.....++||||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++. ++|+|||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~---~kl~Dfg 155 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFG 155 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC---EEEcccc
Confidence 3456899999996 5898888753 34899999999999999999999999999999999999976655 8999999
Q ss_pred cccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC----
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD---- 279 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 279 (315)
++.............||+.|+|||.+. ..++.++||||||+++|+|++|++||......+....+........+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 998765444445567899999999976 568999999999999999999999998887776666665432211110
Q ss_pred -------------------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 -------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 -------------------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+.+++.+.+++.+||+.||++|||+.++|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 113467888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=341.19 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=212.7
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++++.||+|+||.||++.+..++..+|+|.+.... .....+.+.+|+++++.+ +||||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999999999999999987542 223356799999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++. ++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc---EEEccCccccccccc
Confidence 999999999999998887899999999999999999999986 6999999999999986655 899999998765432
Q ss_pred CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccc-----------------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----------------- 274 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~----------------- 274 (315)
......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+.....
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2344578999999999874 589999999999999999999999976554433222111000
Q ss_pred -------------------------c--CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 275 -------------------------D--FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 275 -------------------------~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. .+......+++++.+||.+||+.||++|||+.+++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 0 0000112367899999999999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=341.71 Aligned_cols=248 Identities=31% Similarity=0.519 Sum_probs=214.3
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||+||+|.+..+++.||+|++.+...........+..|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654444445567788999999887899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (315)
++|.+.+.....+++..+..++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++..... ........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH---IKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc---EEecccCCCeecCcCCCccccee
Confidence 999999988878999999999999999999999999999999999999976655 89999999875322 22234457
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
||+.|+|||++. ..++.++|||||||++|+|++|..||...........+...... .+..+++++.+||.+||+.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR----YPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC----CCCcCCHHHHHHHHHHccC
Confidence 899999999987 45899999999999999999999999887776666666554332 2345789999999999999
Q ss_pred CcCCCCCH-----HHHhcccCC
Q 021233 299 DPKRRLTA-----QQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rps~-----~e~l~~l~f 315 (315)
||++|||+ .++++|+||
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~ 255 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFF 255 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCc
Confidence 99999999 999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=353.80 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=205.0
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 128 (315)
..++|++++.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.+ +|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNL-NHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhc-CCCCCcceeeeEeeccccc
Confidence 3467999999999999999999999999999999875331 2345799999999 999999999887432
Q ss_pred ----CcEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEE
Q 021233 129 ----TAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (315)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl 200 (315)
..+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++ ..+||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~--~~vkL 212 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT--HTLKL 212 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC--Cceee
Confidence 246799999975 77776642 45699999999999999999999999999999999999997543 23899
Q ss_pred EeeccccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC--
Q 021233 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-- 276 (315)
Q Consensus 201 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 276 (315)
+|||+|+............||+.|+|||++.+ .++.++|||||||++|||++|.+||.+....+....+.+.....
T Consensus 213 ~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 213 CDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred eccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99999987655554455678999999998753 58999999999999999999999998776655555443321110
Q ss_pred ---------------CC--------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ---------------RR--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ---------------~~--------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+. ..+...++++.+||.+||..||.+|||+.|+|+|+||
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f 354 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence 00 0112367899999999999999999999999999997
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=341.76 Aligned_cols=250 Identities=30% Similarity=0.490 Sum_probs=213.1
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHH---hCCCCCCcceeEEEEEcCCcEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR---HLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~---~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++. .+ +||||+++++++...+..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEE
Confidence 788999999999999999999999999999987654333344566777777664 44 79999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-C
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-G 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~ 212 (315)
||||+++++|...+.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||++..... .
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~---~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF---VKIADFGLCKEGMGFG 155 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc---EEeCcccCCccCCCCC
Confidence 9999999999887754 46999999999999999999999999999999999999987655 99999999875332 2
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
.......|++.|+|||.+. ..++.++||||||+++|+|++|+.||......+....+...... .+..+++++.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~l 231 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR----YPRFLSREAISI 231 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCCCCCHHHHHH
Confidence 2334567999999999986 45899999999999999999999999888877777766655333 234578999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
|.+||+.||++|| ++.++++|+||
T Consensus 232 i~~~L~~dP~~R~~~~~~~~~~l~~~~~f 260 (324)
T cd05589 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFF 260 (324)
T ss_pred HHHHhhcCHhHcCCCCCCCHHHHhhCCCc
Confidence 9999999999999 79999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=348.69 Aligned_cols=256 Identities=29% Similarity=0.506 Sum_probs=215.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..+ +|++|+++++.+...+..++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 3699999999999999999999999999999998765443444456788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||++|++|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~---vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC---EEEeeccCCcccccccc
Confidence 999999999999988888999999999999999999999999999999999999976554 9999999986442110
Q ss_pred -----------------------------------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCC
Q 021233 214 -----------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 257 (315)
Q Consensus 214 -----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~ 257 (315)
......||+.|+|||++. ..++.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 011347999999999986 45899999999999999999999999
Q ss_pred CCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCC---CHHHHhcccCC
Q 021233 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLGKIEF 315 (315)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp---s~~e~l~~l~f 315 (315)
...........+.........+....+++++.++|.+|+. ||.+|+ ++.++++|+||
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f 296 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFF 296 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCC
Confidence 8877776666665432222111222478999999999874 999998 58999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=343.47 Aligned_cols=248 Identities=27% Similarity=0.484 Sum_probs=207.8
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++.++.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998665444445567888999998877899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CCCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 219 (315)
++|..++.....+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~---~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC---EEEeeCCccccccCCCCcccccc
Confidence 999999888888999999999999999999999999999999999999976655 9999999987532 222334567
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC---------hHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---------EQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
||+.|+|||++. ..++.++||||||+++|+|++|+.||.... .......+.... ...+..++.++.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----~~~p~~~~~~~~ 233 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----IRIPRSLSVKAA 233 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----CCCCCCCCHHHH
Confidence 999999999987 458999999999999999999999995211 111222232222 223345789999
Q ss_pred HHHHHhcCCCcCCCCC------HHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLT------AQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps------~~e~l~~l~f 315 (315)
++|.+||+.||++||+ +.+++.|+||
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f 265 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence 9999999999999998 5899999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=343.03 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=206.1
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC-----Cc
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-----TA 130 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-----~~ 130 (315)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.+ +||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCce
Confidence 5899999999999999999999999999999886432 2223345688999999999 999999999987543 35
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||+. ++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc---EEEccCccccccc
Confidence 799999995 689999988778999999999999999999999999999999999999976555 8999999997543
Q ss_pred CCC----cccccccCCCccCchhhc---ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccc---------
Q 021233 211 PGE----KFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--------- 274 (315)
Q Consensus 211 ~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------- 274 (315)
... ......||+.|+|||++. ..++.++||||||+++++|++|+.||...........+.....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 123457899999999875 3588999999999999999999999976554332222111100
Q ss_pred --------------cCC----CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 275 --------------DFR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 275 --------------~~~----~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
... ...++.+++++.++|.+||+.||++|||+.++++|+||
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 000 11124567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=339.81 Aligned_cols=253 Identities=26% Similarity=0.453 Sum_probs=217.5
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||+|+||.||+|.+..+++.||+|++...........+.+..|..++..+.+|++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47888999999999999999999999999999876543333445667889999998866788999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-Cc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EK 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~ 214 (315)
||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||++...... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~---ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMVDGVT 157 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEeccccccccCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999986655 899999998754322 22
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....||+.|+|||++. ..++.++||||||+++++|++|..||...........+...... .+..+++++.+++.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~----~p~~~~~~~~~li~ 233 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS----YPKSLSKEAVSICK 233 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCccCCHHHHHHHH
Confidence 34457899999999986 45899999999999999999999999888777777777654433 23457899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcccCC
Q 021233 294 KMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
+||+.+|.+|++ ..++++|+||
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f 260 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFF 260 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCccc
Confidence 999999999997 5789999987
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=331.68 Aligned_cols=256 Identities=32% Similarity=0.539 Sum_probs=228.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-+.|++++.||.|.-|+||+|....++..+|+|++.+..........+...|-+||..+ +||.++.+++.|+.+...|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccceeEE
Confidence 46799999999999999999999999999999999998877777778889999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
|||||+||+|..+++++. .+++..++.++..++.||+|||-.|||+|||||+||||..+|. |.|+||.++.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH---IMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH---IMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc---EEeeeccccccCCC
Confidence 999999999999887653 4999999999999999999999999999999999999976555 99999998743210
Q ss_pred ---------------------------------C-C-----------------------cccccccCCCccCchhhcc-c
Q 021233 212 ---------------------------------G-E-----------------------KFSEIVGSPYYMAPEVLKR-N 233 (315)
Q Consensus 212 ---------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~-~ 233 (315)
. . .....+||..|.|||++.+ .
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 0123578999999999986 4
Q ss_pred CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCC----HHHH
Q 021233 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT----AQQV 309 (315)
Q Consensus 234 ~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~e~ 309 (315)
.+.+.|.|+|||++|||+.|..||-+.+.++....+......++..+ .++..+.+||+++|.+||++|.- +.||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 99999999999999999999999999999999999988877766553 67899999999999999999998 9999
Q ss_pred hcccCC
Q 021233 310 LGKIEF 315 (315)
Q Consensus 310 l~~l~f 315 (315)
-+|+||
T Consensus 390 K~HpFF 395 (459)
T KOG0610|consen 390 KRHPFF 395 (459)
T ss_pred hcCccc
Confidence 999998
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=346.28 Aligned_cols=258 Identities=31% Similarity=0.478 Sum_probs=217.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.+...........+.+|+.+++.+ +||||+++++++...+..+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEE
Confidence 347899999999999999999999999999999998754433334455678899999998 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~---ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC---EEEEeCCceeEcCcC
Confidence 999999999999988654 5899999999999999999999999999999999999976555 999999999866433
Q ss_pred Cc--ccccccCCCccCchhhcc-----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 213 EK--FSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 213 ~~--~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.. .....||+.|+|||++.. .++.++|||||||++|+|++|..||...........+..............++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 22 235679999999999753 27889999999999999999999998887777777766543333323334689
Q ss_pred HHHHHHHHHhcCCCcCC--CCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKR--RLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~--Rps~~e~l~~l~f 315 (315)
+.+.++|..||..+|.+ |+++.++++|+||
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 99999999999855544 7899999999997
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=334.49 Aligned_cols=249 Identities=31% Similarity=0.499 Sum_probs=206.4
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (315)
||+|+||+||++.+..+++.+|+|.+...........+.+..|+.+++.+ +|+||+++.+++......++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 69999999999999999999999998765444444456778899999999 99999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc-ccc
Q 021233 143 LFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSE 217 (315)
Q Consensus 143 L~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~ 217 (315)
|.+.+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++........ ...
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN---VRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeCccceecCCCCccccc
Confidence 9887743 345899999999999999999999999999999999999976544 89999999976544322 234
Q ss_pred cccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhc
Q 021233 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296 (315)
Q Consensus 218 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 296 (315)
..||+.|+|||.+. ..++.++||||||+++|+|++|+.||...........+...........+..+++++.+++.+||
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 236 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence 57899999999986 45899999999999999999999999765433222222222222222334568899999999999
Q ss_pred CCCcCCCC-----CHHHHhcccCC
Q 021233 297 DPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 297 ~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+.||++|| +++++++|+||
T Consensus 237 ~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 237 AKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred cCCHHHhcCCCCCCHHHHhcChhh
Confidence 99999999 88999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=338.14 Aligned_cols=248 Identities=29% Similarity=0.437 Sum_probs=210.3
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||+||+|.+..+++.||+|++................|..++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987654322333456677888888765899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (315)
++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++. ++|+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH---IKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---EEEccCCcceECCCCCCceeeec
Confidence 999999988778999999999999999999999999999999999999976554 99999999875322 22334567
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
||+.|+|||++. ..++.++|||||||++|+|++|..||......+..+.+...... ....++.++.+++.+||+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPC----YPRWLTREAKDILVKLFVR 233 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----CCccCCHHHHHHHHHHhcc
Confidence 899999999986 45899999999999999999999999887776666655443222 2234789999999999999
Q ss_pred CcCCCCCHH-HHhcccCC
Q 021233 299 DPKRRLTAQ-QVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rps~~-e~l~~l~f 315 (315)
||++||++. +++.|+||
T Consensus 234 ~P~~R~~~~~~l~~h~~~ 251 (316)
T cd05619 234 EPERRLGVKGDIRQHPFF 251 (316)
T ss_pred CHhhcCCChHHHHcCccc
Confidence 999999996 89999987
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=339.82 Aligned_cols=248 Identities=32% Similarity=0.528 Sum_probs=211.7
Q ss_pred eeeeeeecceEEEEEEEC---CCCCEEEEEEccccccc-ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 60 GRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
++.||+|+||.||++.+. .+++.||+|++...... .......+.+|+.+++.+ +||||+++++++..++..++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEE
Confidence 367999999999999864 46889999998754321 223345678899999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-Cc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EK 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~ 214 (315)
||+++++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++...... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH---VKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEeeCcCCeecccCCCc
Confidence 99999999999988888999999999999999999999999999999999999976555 999999998754322 22
Q ss_pred ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....||+.|+|||++.+ .++.++||||||+++|||++|+.||...........+...... .++.+++++.++|.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~ 232 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN----LPPYLTPEARDLLK 232 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHHHH
Confidence 344579999999999864 5889999999999999999999999888777777766655433 23457899999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcccCC
Q 021233 294 KMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+||+.||++|| ++.+++.|+||
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~ 259 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQSHPFF 259 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence 99999999999 89999999997
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=332.20 Aligned_cols=256 Identities=31% Similarity=0.504 Sum_probs=212.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
.|++.+.||+|+||.||++.+..+++.+|+|.+.............+.+|+.+++.+ +|++++.+++.+...+..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEE
Confidence 378889999999999999999999999999998765444443345677899999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~---~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH---IRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC---EEEeeccceeecCCCc
Confidence 9999999999886433 4899999999999999999999999999999999999976554 8999999997655444
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
......|+..|+|||.+. ..++.++||||||+++|+|++|+.||..........................+++++.+|+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 444557899999999986 4589999999999999999999999976543221111111111112223456789999999
Q ss_pred HHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 293 RKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
.+||+.||++||| +.|+++|+||
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~ 264 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLF 264 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhh
Confidence 9999999999999 9999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=342.09 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=206.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.+ +|+||+++++++...+..++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEE
Confidence 357899999999999999999999999999999986432 223346788999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTM 222 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC---EEEcccccceeccccc
Confidence 9999999998653 23567888899999999999999999999999999999976554 8999999998654332
Q ss_pred -cccccccCCCccCchhhcc------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 214 -KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
......||..|+|||.+.. ..+.++|||||||++|||++|+.||......+....+..............++.
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASR 302 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCH
Confidence 2244578999999998742 245689999999999999999999974433333222222222223334456889
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||.+||+.||++|||+.|+++|+||
T Consensus 303 ~l~~li~~~l~~~P~~Rpt~~ell~hp~~ 331 (353)
T PLN00034 303 EFRHFISCCLQREPAKRWSAMQLLQHPFI 331 (353)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 99999999999999999999999999997
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=337.23 Aligned_cols=257 Identities=29% Similarity=0.504 Sum_probs=214.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||++.+..+++.||+|++.+.........+.+.+|+.++..+ +|+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEE
Confidence 4799999999999999999999999999999998764433444456688999999998 999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++. ++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH---IRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC---EEEEECCceeecCCCC
Confidence 999999999999976 456999999999999999999999999999999999999976555 8999999987654333
Q ss_pred cc--cccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-CCCCccC
Q 021233 214 KF--SEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKV 284 (315)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 284 (315)
.. ....||+.|+|||++. ..++.++|||||||++|+|++|+.||......+....+........ +.....+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 22 2346899999999975 2378899999999999999999999987776666665554322111 1223457
Q ss_pred CHHHHHHHHHhcCCCcCC--CCCHHHHhcccCC
Q 021233 285 SENAKDLVRKMLDPDPKR--RLTAQQVLGKIEF 315 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~--Rps~~e~l~~l~f 315 (315)
++++.++|.+||..++.+ ||++.+++.|+||
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 899999999998765544 8899999999997
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=339.25 Aligned_cols=247 Identities=28% Similarity=0.535 Sum_probs=209.1
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHH-HHHhCCCCCCcceeEEEEEcCCcEEEEEEecC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
+.||+|+||+||+|.+..+++.||+|++.............+..|.. +++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999999999999999987654333333445555655 45667 99999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCccccc
Q 021233 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (315)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 218 (315)
+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... .......
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~---~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH---VVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc---EEEeccCCCcccccCCCccccc
Confidence 9999999988888999999999999999999999999999999999999976655 89999999875432 2223455
Q ss_pred ccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 219 ~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
.||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+...... ..+.+++++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLR----LKPNISVSARHLLEGLLQ 232 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC----CCCCCCHHHHHHHHHHhh
Confidence 7899999999986 45899999999999999999999999887777666666654333 234578999999999999
Q ss_pred CCcCCCCCH----HHHhcccCC
Q 021233 298 PDPKRRLTA----QQVLGKIEF 315 (315)
Q Consensus 298 ~~P~~Rps~----~e~l~~l~f 315 (315)
.||.+||++ .+++.|+||
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCc
Confidence 999999987 699999997
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=338.82 Aligned_cols=248 Identities=27% Similarity=0.475 Sum_probs=208.6
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|.+..+++.+|+|++...........+.+.+|+.++.++.+||+|+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998664444445567889999999987899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CCCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 219 (315)
++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.... .........
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH---IKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC---EEEeccccceeccCCCCceeccc
Confidence 999999988778999999999999999999999999999999999999976655 9999999987532 233334568
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC-------hHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
||+.|+|||++. ..++.++||||||+++|+|++|..||.... .....+.+... +...+..++..+.++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~p~~~~~~~~~l 233 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----PIRIPRFLSVKASHV 233 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----CCCCCCCCCHHHHHH
Confidence 999999999986 458999999999999999999999995321 11222223222 222334578999999
Q ss_pred HHHhcCCCcCCCCC------HHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLT------AQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps------~~e~l~~l~f 315 (315)
+.+||+.||++|++ +.+++.|+||
T Consensus 234 i~~~L~~dP~~R~~~~~~~~~~~i~~h~~f 263 (327)
T cd05617 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263 (327)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence 99999999999998 5799999997
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=329.03 Aligned_cols=255 Identities=32% Similarity=0.497 Sum_probs=216.3
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
|+..+.||+|+||+||+|.+..+++.+|+|.+.............+.+|+.+++.+ +|+|++.+.+.+..++..+++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEE
Confidence 77889999999999999999999999999998765444444445678899999999 99999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 137 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||++++++. ++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~---~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH---IRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC---EEEecCCcceecCCCCc
Confidence 99999999888653 35999999999999999999999999999999999999976544 99999999976554444
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....|+..|+|||.+. ..++.++|+||||+++++|++|..||...........+..............+++++.+|+.
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 237 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICK 237 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHH
Confidence 44567899999999976 55899999999999999999999999876655444444433333333445568899999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcccCC
Q 021233 294 KMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
.||+.||++||+ +.+++.|.||
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05632 238 MLLTKDPKQRLGCQEEGAGEVKRHPFF 264 (285)
T ss_pred HHccCCHhHcCCCcccChHHHHcChhh
Confidence 999999999999 8899999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=343.45 Aligned_cols=248 Identities=24% Similarity=0.418 Sum_probs=202.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
..+|++++.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.+ +||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEE
Confidence 357999999999999999999999999999999643 23467899999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|+|++. ++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||+|......
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~---vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC---EEEEeCCccccccccc
Confidence 999995 689999888778999999999999999999999999999999999999976655 899999999754322
Q ss_pred -CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC-------hHHHHHHHHhccccCC------
Q 021233 213 -EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVLDFR------ 277 (315)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~-------~~~~~~~~~~~~~~~~------ 277 (315)
.......||+.|+|||++. ..++.++|||||||++|||++|..||.... .......+.......+
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 2233457999999999986 458999999999999999999998875321 1111111111110000
Q ss_pred ----------------------CCCC---ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ----------------------RDPW---PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ----------------------~~~~---~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+ ..++.++.+||.+||+.||.+|||+.|+|+|+||
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence 0001 1346789999999999999999999999999998
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=328.30 Aligned_cols=255 Identities=28% Similarity=0.430 Sum_probs=206.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC--CCCCcceeEEEEEc-----C
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYED-----D 128 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~-----~ 128 (315)
+|++.+.||+|+||+||+|.+..+++.||+|.+........ ....+.+|+.+++.+. +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999998875432221 2234556777777653 69999999998864 3
Q ss_pred CcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
...+++|||+++ +|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++. +||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~---~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECccCcc
Confidence 457999999975 8888887543 4899999999999999999999999999999999999976655 899999999
Q ss_pred cccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC--------
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-------- 277 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------- 277 (315)
.............+|..|+|||++. ..++.++|||||||++++|++|++||......+....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 8765444444567899999999876 4589999999999999999999999987766655555443211100
Q ss_pred ---------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ---------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ---------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+.+++++.++|.+||+.||++|||+.+++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=327.69 Aligned_cols=254 Identities=38% Similarity=0.653 Sum_probs=211.1
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
|++++.||+|+||+||++.+..+++.+|+|.+......... .....+|+.+++++ +||||+++++++......+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccc-ccccccccccccccccccccccc
Confidence 78999999999999999999999999999999766432222 22345599999999 99999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc-CCCCcc
Q 021233 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKF 215 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~-~~~~~~ 215 (315)
|+++++|.+++.....+++..++.++.|++.||++||+.|++|+||||+||+++.++. ++|+|||.+... ......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~---~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE---VKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE---EEESSGTTTEESTSTTSEB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccc
Confidence 9999999999997778999999999999999999999999999999999999986555 899999999763 233344
Q ss_pred cccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcc---ccCCCCCCccCCHHHHH
Q 021233 216 SEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV---LDFRRDPWPKVSENAKD 290 (315)
Q Consensus 216 ~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~ 290 (315)
....++..|+|||++. ..++.++||||||+++++|++|..||......+....+.... ...........++++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 5668899999999987 458999999999999999999999998773333333332221 11111111122489999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+|.+||+.||++|||+.++++|+||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=334.81 Aligned_cols=257 Identities=29% Similarity=0.482 Sum_probs=215.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||+||++.+..+++.+|+|++.+...........+.+|+.++..+ +|++|+++++++...+..++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEE
Confidence 4699999999999999999999999999999998754333333445688899999998 999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~---~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC---EEEeecchheecccCC
Confidence 999999999999976 456899999999999999999999999999999999999976554 8999999987653322
Q ss_pred c--ccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-CCCCccC
Q 021233 214 K--FSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKV 284 (315)
Q Consensus 214 ~--~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 284 (315)
. .....||+.|+|||++. ..++.++|||||||++|||++|+.||......+....+........ +..+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 2 23357999999999874 2478899999999999999999999988877777766655432221 2223467
Q ss_pred CHHHHHHHHHhcCCCcCC--CCCHHHHhcccCC
Q 021233 285 SENAKDLVRKMLDPDPKR--RLTAQQVLGKIEF 315 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~--Rps~~e~l~~l~f 315 (315)
++++.+|+.+||..+|++ |+++.++++|+||
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f 269 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence 999999999999765555 7899999999997
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=337.39 Aligned_cols=252 Identities=22% Similarity=0.343 Sum_probs=201.3
Q ss_pred ccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.++..+.+||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 357999999999999999999752 345689999886432 2233467889999999998899999999988764
Q ss_pred -CcEEEEEEecCCCChHHHHHhc---------------------------------------------------------
Q 021233 129 -TAVHLVMELCEGGELFDRIVAR--------------------------------------------------------- 150 (315)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------- 150 (315)
..++++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999998752
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc---ccccccCC
Q 021233 151 -----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSP 222 (315)
Q Consensus 151 -----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~ 222 (315)
..+++..+..++.|++.||+|||+.||+||||||+|||++.++. +||+|||+++....... .....+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~---~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc---EEEeecccccccccCcchhcccCCCCCc
Confidence 23777888999999999999999999999999999999976554 89999999986533221 12334567
Q ss_pred CccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHH-HHHHhccccCCCCCCccCCHHHHHHHHHhcCCC
Q 021233 223 YYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (315)
Q Consensus 223 ~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 299 (315)
.|+|||++. ..++.++||||||+++|||++ |..||......+.. ..+.... . ...+..+++++.+++.+||+.|
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~li~~cl~~d 317 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT-R--MRAPENATPEIYRIMLACWQGD 317 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC-C--CCCCCCCCHHHHHHHHHHccCC
Confidence 899999876 458999999999999999997 99999765443322 3333221 1 2223467899999999999999
Q ss_pred cCCCCCHHHHhccc
Q 021233 300 PKRRLTAQQVLGKI 313 (315)
Q Consensus 300 P~~Rps~~e~l~~l 313 (315)
|++|||+.++++.|
T Consensus 318 p~~RPs~~el~~~l 331 (338)
T cd05102 318 PKERPTFSALVEIL 331 (338)
T ss_pred hhhCcCHHHHHHHH
Confidence 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=339.67 Aligned_cols=256 Identities=27% Similarity=0.410 Sum_probs=206.2
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC--
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 129 (315)
.+.++|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.+ +||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 95 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSL 95 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCc
Confidence 45678999999999999999999999999999999986542 2333456788999999999 9999999999986443
Q ss_pred ----cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~---~kl~Dfg~ 169 (359)
T cd07876 96 EEFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 169 (359)
T ss_pred cccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEecCCC
Confidence 47999999965 66666543 4889999999999999999999999999999999999976655 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc---------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------- 275 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------- 275 (315)
+.............+|+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.+....
T Consensus 170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 986544444455678999999999864 5899999999999999999999999766544333222211100
Q ss_pred -------------CC----------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 -------------FR----------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 -------------~~----------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+ .......++++.+||.+||..||++|||+.|+|.|+||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 00 00011245788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=347.02 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=201.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC-----CCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-----KHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~~~~~~~ 128 (315)
.++|++++.||+|+||+||+|.+..+++.||+|++.... ........|+.+++.+. +|.+++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 578999999999999999999999999999999985421 12234566777777661 344688899988754
Q ss_pred -CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCC------------
Q 021233 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKE------------ 194 (315)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~------------ 194 (315)
...++|||++ |++|.+++...+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++.
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 77999999888889999999999999999999998 59999999999999976542
Q ss_pred -CCCEEEEeeccccccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhc
Q 021233 195 -TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272 (315)
Q Consensus 195 -~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 272 (315)
...+||+|||.+.... .......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+....+...
T Consensus 283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred CCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 2248999999876432 22345689999999999864 5999999999999999999999999877665544444332
Q ss_pred cccCCC-----------------------CC-------------C--ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 273 VLDFRR-----------------------DP-------------W--PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 273 ~~~~~~-----------------------~~-------------~--~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
....+. .. + ...++.+.+||.+||+.||.+|||+.|+|+|+|
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 211100 00 0 001355779999999999999999999999999
Q ss_pred C
Q 021233 315 F 315 (315)
Q Consensus 315 f 315 (315)
|
T Consensus 441 ~ 441 (467)
T PTZ00284 441 V 441 (467)
T ss_pred c
Confidence 8
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=334.99 Aligned_cols=257 Identities=27% Similarity=0.473 Sum_probs=215.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||++.+..+++.||+|++.+...........+.+|..++..+ +|++|+++++++...+..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999998754333334455688899999998 999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC---EEEEeccceeeccCCC
Confidence 999999999999987 456899999999999999999999999999999999999976555 8999999997654332
Q ss_pred cc--cccccCCCccCchhhcc------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-CCCCccC
Q 021233 214 KF--SEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKV 284 (315)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 284 (315)
.. ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+........ +..+..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 22 33579999999998753 478899999999999999999999988777666666654322221 2223457
Q ss_pred CHHHHHHHHHhcCCCcCC--CCCHHHHhcccCC
Q 021233 285 SENAKDLVRKMLDPDPKR--RLTAQQVLGKIEF 315 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~--Rps~~e~l~~l~f 315 (315)
++++.+++.+||..++++ |++++++++|+||
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f 269 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 269 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence 899999999999876655 5799999999997
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=326.33 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=203.0
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (315)
||+|+||.||++.+..+|+.+|+|.+.............+..|+++++.+ +||||+++++++......++||||++|++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 69999999999999999999999998755443333344566799999999 99999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCccccccc
Q 021233 143 LFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (315)
Q Consensus 143 L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 220 (315)
|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.............|
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~---~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN---CRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC---EEEeeceeeeecCCCceeeccCC
Confidence 998886543 4889999999999999999999999999999999999976555 89999999987655444445678
Q ss_pred CCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc-CCCCCCccCCHHHHHHHHHhcCC
Q 021233 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-FRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 221 t~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
++.|+|||++. ..++.++|||||||++|+|++|..||...........+...... ........+++++.++|.+||+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999976 45899999999999999999999999654332221222111111 11112245789999999999999
Q ss_pred CcCCCCCH----HHHhcccCC
Q 021233 299 DPKRRLTA----QQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rps~----~e~l~~l~f 315 (315)
||++||++ .+++.|+||
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred CHhhCCCCccchhhhhcChhh
Confidence 99999999 667789887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=333.77 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=210.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||.|+||.||++.+..++..+|+|.+.... .....+.+.+|+++++.+ +|+||+++++++...+..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEE
Confidence 468999999999999999999999999999999886542 223346789999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+++++|.+++...+.+++..+..++.+++.||.|||+. +++|+||||+|||++.++. +||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC---EEEeeCCcchhhhhh
Confidence 999999999999998887899999999999999999999975 7999999999999976555 899999998765322
Q ss_pred CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH---------------------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII--------------------- 270 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--------------------- 270 (315)
......|+..|+|||++.+ .++.++|||||||++|+|++|+.||...........+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 2234578999999999874 58899999999999999999999997654433221110
Q ss_pred -------------------hccccCC-CC-CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 271 -------------------RSVLDFR-RD-PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 271 -------------------~~~~~~~-~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....... +. .....+.++.+||.+||+.||++|||+.|++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 0000000 00 011357889999999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=336.90 Aligned_cols=246 Identities=29% Similarity=0.498 Sum_probs=211.1
Q ss_pred eeeeeecceEEEEEEE---CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEe
Q 021233 61 RELGRGEFGITYLCTD---RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~---~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 137 (315)
+.||+|+||.||++.+ ..+++.+|+|++...... ......+..|+.+++++ +||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcC
Confidence 6799999999999886 356899999998764322 22345677899999999 999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-Cccc
Q 021233 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFS 216 (315)
Q Consensus 138 ~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~~ 216 (315)
+++++|.+.+.....+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++...... ....
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kL~Dfg~~~~~~~~~~~~~ 156 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKKAY 156 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc---EEEeeccCCcccCCCCCcee
Confidence 999999999988778999999999999999999999999999999999999976655 899999998765433 2334
Q ss_pred ccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHh
Q 021233 217 EIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (315)
Q Consensus 217 ~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 295 (315)
...||+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+....+....... +..+++++.++|.+|
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~li~~~ 232 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM----PQFLSPEAQSLLRAL 232 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHHHHH
Confidence 5678999999999864 58899999999999999999999998877777766666554332 245789999999999
Q ss_pred cCCCcCCCCC-----HHHHhcccCC
Q 021233 296 LDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 296 l~~~P~~Rps-----~~e~l~~l~f 315 (315)
|+.||++||+ +.+++.|+||
T Consensus 233 l~~~P~~R~~a~~~~~~~~~~~~~~ 257 (318)
T cd05582 233 FKRNPANRLGAGPDGVEEIKRHPFF 257 (318)
T ss_pred hhcCHhHcCCCCCCCHHHHhCCCCc
Confidence 9999999999 7889999987
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=336.52 Aligned_cols=247 Identities=28% Similarity=0.518 Sum_probs=209.0
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHH-HHhCCCCCCcceeEEEEEcCCcEEEEEEecC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-MRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
+.||+|+||+||+|.+..+|+.+|+|++.............+..|..+ ++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999999999999999876543333334555666654 5666 99999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCccccc
Q 021233 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (315)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 218 (315)
+++|...+.....+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~---~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH---VVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEEeecCCcccCCCCCCCcccc
Confidence 9999999988888999999999999999999999999999999999999976655 99999999875422 2233456
Q ss_pred ccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 219 ~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
.||+.|+|||++. ..++.++|||||||++|+|++|..||......+....+....... .+..+..+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVL----RPGASLTAWSILEELLE 232 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccC----CCCCCHHHHHHHHHHhc
Confidence 7999999999987 458999999999999999999999998887777766666543332 23578999999999999
Q ss_pred CCcCCCCCH----HHHhcccCC
Q 021233 298 PDPKRRLTA----QQVLGKIEF 315 (315)
Q Consensus 298 ~~P~~Rps~----~e~l~~l~f 315 (315)
.+|.+||++ .+++.|+||
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f 254 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFF 254 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCc
Confidence 999999977 589999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=335.35 Aligned_cols=247 Identities=28% Similarity=0.527 Sum_probs=207.2
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHH-HHHhCCCCCCcceeEEEEEcCCcEEEEEEecC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
+.||+|+||+||+|.+..+++.||+|++.............+..|.. +++.+ +|+||+++++++...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999987654322223334444544 45667 99999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCccccc
Q 021233 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (315)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 218 (315)
+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++..... .......
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~---~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEEccCCCCcccccCCCCcccc
Confidence 9999999988878999999999999999999999999999999999999976554 89999999875432 2233456
Q ss_pred ccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 219 VGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 219 ~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
.||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+...... ..+.+++.+.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----LKPNITNSARHLLEGLLQ 232 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC----CCCCCCHHHHHHHHHHcc
Confidence 79999999999874 5899999999999999999999999887777766666554332 234678999999999999
Q ss_pred CCcCCCCCHH----HHhcccCC
Q 021233 298 PDPKRRLTAQ----QVLGKIEF 315 (315)
Q Consensus 298 ~~P~~Rps~~----e~l~~l~f 315 (315)
.||.+||++. +++.|+||
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCccc
Confidence 9999999876 88898886
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=339.10 Aligned_cols=247 Identities=30% Similarity=0.523 Sum_probs=208.4
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC--CCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
||+|+||+||+|.+..+++.||+|++................|..++..+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999987654333333444556777776654 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCcccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~ 219 (315)
++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++..... ........
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH---IALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEecCCcCcCCCCCCCCccCcc
Confidence 999999988888999999999999999999999999999999999999976555 89999999875432 22334567
Q ss_pred cCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 220 GSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 220 gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+......++. ..+++++.++|.+||+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~ 234 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLN 234 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcC
Confidence 9999999999763 4789999999999999999999999887777666666554333322 2468999999999999
Q ss_pred CCcCCCC----CHHHHhcccCC
Q 021233 298 PDPKRRL----TAQQVLGKIEF 315 (315)
Q Consensus 298 ~~P~~Rp----s~~e~l~~l~f 315 (315)
.||.+|| ++.+++.|+||
T Consensus 235 ~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 235 RNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred CCHHHCCCCCCCHHHHhcCccc
Confidence 9999998 79999999997
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=330.73 Aligned_cols=254 Identities=27% Similarity=0.449 Sum_probs=209.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++++ +|+||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEE
Confidence 469999999999999999999998999999999865432 22234577899999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||+++ +|.+.+.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECccccceecCCCc
Confidence 999975 8888776543 4899999999999999999999999999999999999976555 899999998764322
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC--------------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-------------- 276 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 276 (315)
.......+++.|+|||.+.+ .++.++||||||+++++|++|+.||......+....+.+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 22334567899999998753 48899999999999999999999998777655554443321110
Q ss_pred -----CC-------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 -----RR-------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 -----~~-------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+. ...+.+++++.++|.+||+.||.+|||+.|++.|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 00 0113468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=338.83 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=209.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-----c
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-----A 130 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-----~ 130 (315)
+|++++.||+|+||.||+|.+..+++.||+|.+... .........+.+|+.+++.+ +|+||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccce
Confidence 478899999999999999999999999999988643 22333456788999999999 9999999999998766 7
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++|+||+. ++|.+.+.....+++..++.++.||+.||.|||+.|++||||||+|||++.++. +||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV---LKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC---EEeccccceeecc
Confidence 899999996 588888877778999999999999999999999999999999999999976554 9999999997653
Q ss_pred CCC--cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc-----------
Q 021233 211 PGE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD----------- 275 (315)
Q Consensus 211 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----------- 275 (315)
... ......+++.|+|||.+.+ .++.++|||||||+++||++|+.||......+....+......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 2234567899999999764 3789999999999999999999999877665544444321110
Q ss_pred -----------CCC------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 -----------FRR------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 -----------~~~------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++ ......++++.+||.+||+.||++|||+.++|.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 291 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence 000 1123457889999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=333.62 Aligned_cols=247 Identities=29% Similarity=0.510 Sum_probs=207.1
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHH-HHHhCCCCCCcceeEEEEEcCCcEEEEEEecC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.+ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999987654333333445555655 56777 99999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCccccc
Q 021233 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEI 218 (315)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~ 218 (315)
+++|...+.....+++..+..++.||+.||.|||+.||+||||||+||+++.++. +||+|||++..... .......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH---VVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEccCCCCccCCCCCCccccc
Confidence 9999999888778999999999999999999999999999999999999976655 99999999875322 2223456
Q ss_pred ccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 219 ~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
.||+.|+|||++. ..++.++|||||||++|+|++|..||...........+..... ..++..+.++.++|.+||+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~~li~~~l~ 232 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL----QLPGGKTVAACDLLVGLLH 232 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC----CCCCCCCHHHHHHHHHHcc
Confidence 7899999999986 4589999999999999999999999988776666666654432 2234568899999999999
Q ss_pred CCcCCCCCH----HHHhcccCC
Q 021233 298 PDPKRRLTA----QQVLGKIEF 315 (315)
Q Consensus 298 ~~P~~Rps~----~e~l~~l~f 315 (315)
.||.+||++ .+++.|+||
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCc
Confidence 999999875 599999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=345.96 Aligned_cols=251 Identities=28% Similarity=0.412 Sum_probs=212.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCC-CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDREN-GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
..|.+.+.||+|++|.||+|.+..+ +..||+|.+... .......+.+|+.+++.+ +||||+++++++...+..++
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEE
Confidence 3599999999999999999998877 788899876433 233345678899999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 134 VMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+|||++.++. +||+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~---~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI---IKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc---EEEEeCcCceec
Confidence 9999999999987753 345899999999999999999999999999999999999976554 999999999876
Q ss_pred CCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
..... .....||+.|+|||++. ..++.++|||||||++++|++|+.||......+....+...... ..+..++
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~s 296 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---PFPCPVS 296 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---CCCccCC
Confidence 43321 24457999999999986 45899999999999999999999999887777766666554332 2234578
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++.++|.+||+.||++||++.+++.+.|+
T Consensus 297 ~~~~~li~~~L~~dP~~Rps~~~~l~~~~~ 326 (478)
T PTZ00267 297 SGMKALLDPLLSKNPALRPTTQQLLHTEFL 326 (478)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHhCHHH
Confidence 999999999999999999999999988653
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=318.98 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=214.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC--hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+.|++.+.||+|++|.||.|.+..++..+|+|.+....... ......+.+|+.+++++ +||||+++++++......+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEE
Confidence 46899999999999999999998899999999886543221 12345688999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+|+||+++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~---~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeecccceecccc
Confidence 99999999999999988878999999999999999999999999999999999999976555 999999998765332
Q ss_pred Ccc----cccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 213 EKF----SEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 213 ~~~----~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
... ....++..|+|||.+.+ .++.++||||||+++|++++|+.||................ ........++++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP--TNPQLPSHVSPD 235 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--CCCCCCccCCHH
Confidence 111 23467889999999864 48899999999999999999999997665544433333221 222334567899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.++|.+||..+|.+|||+.+++.|+||
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=334.91 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=206.7
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccc
Confidence 35678999999999999999999999899999999986542 2233456778899999999 999999999988643
Q ss_pred ---CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~---~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC---EEEeeCcc
Confidence 357999999965 67676643 4889999999999999999999999999999999999976555 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC--------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-------- 276 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------- 276 (315)
++............+|+.|+|||++.+ .++.++||||||+++++|++|+.||......+....+.......
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 987654444455688999999999864 58999999999999999999999997766444333222211000
Q ss_pred ------------------------------CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ------------------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ------------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
........+.++.+||.+||..||++|||+.|+|+|+||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~ 314 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI 314 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence 000111235678999999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=335.31 Aligned_cols=251 Identities=33% Similarity=0.560 Sum_probs=226.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc-EEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA-VHL 133 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~-~~l 133 (315)
+.|..++.+|+|+||.+++++++.++..+++|.+........ ......+|+.+++++ .|||||.+.+.|..++. .+|
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEE
Confidence 469999999999999999999999999999999987754433 344788899999998 99999999999999888 999
Q ss_pred EEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||+|++||+|.+.+.... .++++.+..++.|++.|+.|||+++|+|||||+.||++++++. |+|.|||+|+...+
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~---VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK---VKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc---eeecchhhhhhcCC
Confidence 999999999999998654 4999999999999999999999999999999999999987766 89999999998877
Q ss_pred CC-cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GE-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.. ...+..||+.||+||.+.+ .|+.|+|||||||++|||++-+.+|...+.......+.+.... +.+..++.++.
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~---Plp~~ys~el~ 235 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYS---PLPSMYSSELR 235 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCC---CCCccccHHHH
Confidence 65 5678899999999999874 6999999999999999999999999999988888888887633 23346789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccc
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+|..||..+|..||++.++|.++
T Consensus 236 ~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 236 SLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred HHHHHHhhcCCccCCCHHHHhhCh
Confidence 999999999999999999999886
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=345.94 Aligned_cols=257 Identities=26% Similarity=0.467 Sum_probs=215.5
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~- 129 (315)
....++|++.+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+..+..+ +|+|++++...+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccc
Confidence 3445689999999999999999999999999999999876533 334456788999999999 9999999988775432
Q ss_pred -------cEEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 130 -------AVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 130 -------~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++. +
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~---v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL---V 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC---E
Confidence 368999999999999988643 35899999999999999999999999999999999999986555 9
Q ss_pred EEEeeccccccCCC---CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccc
Q 021233 199 KAIDFGLSVFFKPG---EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274 (315)
Q Consensus 199 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 274 (315)
||+|||+++..... .......||+.|+|||++. ..++.++||||||+++|||++|+.||......+....+.....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999999765322 1224567999999999987 4589999999999999999999999988777666666654432
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. ..++.+++++.+++.+||+.||.+||++.+++.|+++
T Consensus 263 ~---~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~ 300 (496)
T PTZ00283 263 D---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPIC 300 (496)
T ss_pred C---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHH
Confidence 2 2335678999999999999999999999999998764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=336.32 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=208.2
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhc-CCCCccccceeecccccc
Confidence 35578999999999999999999999999999999986542 2233346678899999999 999999999987543
Q ss_pred ---CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc---EEEEeCCC
Confidence 357999999965 77777653 4889999999999999999999999999999999999976555 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------- 277 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 277 (315)
+.............+|+.|+|||++. ..++.++|||||||++|+|++|+.||......+....+........
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 98765444445567899999999986 4589999999999999999999999987766555544433211100
Q ss_pred -------------------------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 -------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 -------------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.......+.++.+||.+||+.||++|||+.++|+|+||
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~ 321 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 321 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 00011134678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=334.44 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=208.9
Q ss_pred eeeecCCCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCccee
Q 021233 42 LCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121 (315)
Q Consensus 42 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~ 121 (315)
...+...+....+++|.-...||+|+||.||+|...+ +..||||.+....... ..+|.+|+.++.++ +|||+|++
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l-~H~Nlv~L 136 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRL-RHPNLVKL 136 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcC-CCcCcccE
Confidence 4445555666777899999999999999999999754 5899999776543221 34599999999999 79999999
Q ss_pred EEEEEcCC-cEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCceEeecCCCC
Q 021233 122 KDTYEDDT-AVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHG---VMHRDLKPENFLFANKKET 195 (315)
Q Consensus 122 ~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~---iiH~dikp~Nill~~~~~~ 195 (315)
+|||.+.+ ..++|+|||++|||.+++.... .++|..+.+|+.++|.||+|||+.. ||||||||+|||++.+..
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~- 215 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN- 215 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC-
Confidence 99999998 5999999999999999998765 7999999999999999999999853 999999999999987666
Q ss_pred CCEEEEeeccccccCC-CCccccc-ccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC------hHHHH
Q 021233 196 APLKAIDFGLSVFFKP-GEKFSEI-VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET------EQGVA 266 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~------~~~~~ 266 (315)
.||+|||+|+.... ....... .||.+|++||+.. +..+.|+||||||++|+|++||+.+.+... ..++.
T Consensus 216 --aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 216 --AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred --EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 79999999976554 3333333 8999999999986 679999999999999999999998876432 11211
Q ss_pred HHHHhc--cccCCCCCC--ccCC-----HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 267 QAIIRS--VLDFRRDPW--PKVS-----ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 267 ~~~~~~--~~~~~~~~~--~~~~-----~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...... ...+..+.+ ...+ ..+..+...|++.+|.+||++.++++.|
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 111111 111111111 1222 2367899999999999999999988765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=323.04 Aligned_cols=243 Identities=18% Similarity=0.211 Sum_probs=205.3
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----CCcEEEEEE
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVHLVME 136 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~~~~~lv~e 136 (315)
..||+|++|.||+|.+ +|+.||+|.+...........+.+.+|+.+|.++ +||||+++++++.. ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5789999999999998 4899999998765433333356788999999999 99999999999876 357899999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc
Q 021233 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 215 (315)
|+++|+|.+++.....+++.....++.+++.||.|||+ .+++||||||+||+++.++. +||+|||++.......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~---~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK---LKIICHGLEKILSSPP-- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc---EEEcccchHhhhcccc--
Confidence 99999999999888789999999999999999999998 49999999999999986554 8999999988654322
Q ss_pred cccccCCCccCchhhc---ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 216 SEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 216 ~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
....++..|+|||.+. ..++.++||||||+++|||++|..||......+....+....... .....+++++.+++
T Consensus 178 ~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~l~~li 255 (283)
T PHA02988 178 FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--KLPLDCPLEIKCIV 255 (283)
T ss_pred ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--CCCCcCcHHHHHHH
Confidence 2346889999999986 358999999999999999999999998887777666665443222 22236789999999
Q ss_pred HHhcCCCcCCCCCHHHHhccc
Q 021233 293 RKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+||+.||++|||+.+++..|
T Consensus 256 ~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred HHHhcCCcccCcCHHHHHHHH
Confidence 999999999999999999765
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=322.73 Aligned_cols=251 Identities=31% Similarity=0.573 Sum_probs=218.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|++|.||++.+..+++.+|+|++...........+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEE
Confidence 4699999999999999999999999999999998765444444567789999999999 799999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~---~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY---IKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC---EEEeeCCCccccCCC--
Confidence 999999999999988888999999999999999999999999999999999999976655 899999999876443
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....+++.|+|||.+. ...+.++||||||+++++|++|..||...........+...... .+..++..+.++|.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~ 230 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVR----FPSFFSPDAKDLIR 230 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcc----CCccCCHHHHHHHH
Confidence 34457889999999876 45788999999999999999999999877755555555543322 23456899999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcccCC
Q 021233 294 KMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+||..||.+|+ ++.|++.|+||
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~ 257 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWF 257 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCccc
Confidence 99999999999 99999999997
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=315.98 Aligned_cols=260 Identities=37% Similarity=0.614 Sum_probs=228.8
Q ss_pred cccceee-eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 53 IEERYEL-GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 53 ~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
+.+-|++ .+.||+|+|+.|-.+....++..+|||++.+. ....+.++.+|++++.....|+||++++++|+++..+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 4455666 46799999999999999999999999999876 3445678999999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
|+|||-|.||+|..++.++..+++.++.++.++|+.||.|||.+||.|||+||+|||......-.-||||||.+......
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999998776666699999988754322
Q ss_pred C--------CcccccccCCCccCchhhc---c---cCCCcchHHHHHHHHHHHhhCCCCCCCCC---------------h
Q 021233 212 G--------EKFSEIVGSPYYMAPEVLK---R---NYGPEVDVWSAGVILYILLCGVPPFWAET---------------E 262 (315)
Q Consensus 212 ~--------~~~~~~~gt~~y~aPE~~~---~---~~~~~~Di~slG~~l~el~tg~~p~~~~~---------------~ 262 (315)
. ....+.+|+..|||||+.. + .|+.++|.||||+++|-|+.|.+||.+.. .
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 2 1224557888899999753 2 38999999999999999999999996543 2
Q ss_pred HHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.....|.++.+.++...|..++.+..++|+.+|..||.+|.++..++.|||+
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 44667788888999999999999999999999999999999999999999996
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=324.38 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=208.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEE
Confidence 469999999999999999999998999999999865432 22234677899999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc---EEECcCcchhccCCCC
Confidence 99997 4898888754 45899999999999999999999999999999999999976655 8999999987643222
Q ss_pred -cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC------------
Q 021233 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------ 278 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 278 (315)
......+++.|+|||.+.+ .++.++||||||+++++|++|+.||......+....+.........
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 2234467889999998753 4788999999999999999999999877665544433322111000
Q ss_pred --------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 --------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 --------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+.+++++.+||.+||+.||.+|||+.|++.|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0113468889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=314.99 Aligned_cols=257 Identities=39% Similarity=0.679 Sum_probs=231.0
Q ss_pred cccccceee-eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--
Q 021233 51 REIEERYEL-GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-- 127 (315)
Q Consensus 51 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-- 127 (315)
..+.++|++ -++||-|-.|.|-.+.++.+++.+|+|++... +..++|++..-..+.|||||+++++|++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 346678887 45799999999999999999999999988543 5577888887777789999999999864
Q ss_pred --CCcEEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 128 --DTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
...+.+|||.|+||.|...+..++. +++.++..|+.||+.|+.|||+.+|.||||||+|+|+.....+..+||+||
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence 4678899999999999999988765 999999999999999999999999999999999999998888888999999
Q ss_pred ccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHhccccCCC
Q 021233 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVLDFRR 278 (315)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~ 278 (315)
|.|+.........+.+.||.|.|||++. ..|+..+|+||+||++|-|+.|.+||.... .......|..+.+.++.
T Consensus 209 GFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 209 GFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred ccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 9999877667778889999999999997 569999999999999999999999997543 34567788899999999
Q ss_pred CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.|..+++...++|+.+|..+|.+|.|+.+++.|+|.
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 9999999999999999999999999999999999984
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=319.85 Aligned_cols=256 Identities=29% Similarity=0.560 Sum_probs=211.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+ +|+|++++++++......++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEE
Confidence 469999999999999999999998999999998865432 222335678899999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||+++++|..+......+++..++.++.|++.||.|||+.|++|+||||+||++++++. ++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc---EEECccccceecCCCcc
Confidence 999999888877766667999999999999999999999999999999999999976654 9999999998764433
Q ss_pred cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc----------------
Q 021233 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD---------------- 275 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------- 275 (315)
......++..|+|||.+.+ .++.++||||||+++++|++|..||......+....+......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2334567889999998753 4788999999999999999999999876655444333221100
Q ss_pred ---CCC--------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 ---FRR--------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ---~~~--------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+. ...+.++..+.+|+.+||+.+|++||++.+++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 0123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=354.98 Aligned_cols=262 Identities=30% Similarity=0.517 Sum_probs=214.2
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~- 127 (315)
.+....++|++++.||+|+||+||+|.+..++..+|+|++..... .......+..|+.+++.| +||||++++++|..
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNK 84 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEec
Confidence 445566789999999999999999999999999999999875533 223356788999999999 99999999998854
Q ss_pred -CCcEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCceEeecCC--
Q 021233 128 -DTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKH-------GVMHRDLKPENFLFANKK-- 193 (315)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~-------~iiH~dikp~Nill~~~~-- 193 (315)
...+|+||||+++++|.+++.. ...+++..++.|+.||+.||.|||+. +||||||||+|||++.+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4568999999999999998865 24699999999999999999999985 499999999999996532
Q ss_pred ------------CCCCEEEEeeccccccCCCCcccccccCCCccCchhhc---ccCCCcchHHHHHHHHHHHhhCCCCCC
Q 021233 194 ------------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFW 258 (315)
Q Consensus 194 ------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~~l~el~tg~~p~~ 258 (315)
....+||+|||++.............||+.|+|||++. ..++.++|||||||+||+|++|..||.
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 12348999999998765444445568999999999874 348899999999999999999999997
Q ss_pred CCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 259 AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
............... +..+....+.++.+||..||+.+|.+||++.++|.++||
T Consensus 245 ~~~~~~qli~~lk~~---p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i 298 (1021)
T PTZ00266 245 KANNFSQLISELKRG---PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298 (1021)
T ss_pred cCCcHHHHHHHHhcC---CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence 655433333332222 222334578999999999999999999999999998775
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=349.69 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=215.3
Q ss_pred cceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.+.++.+.||+|+||+||+|.... +...||||.++... +.....+|++|++++..+ +|||||+++|+|..++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l-~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAEL-QHPNIVRLLGVCREGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhc-cCCCeEEEEEEEccCC
Confidence 457778999999999999998643 34569999887553 444678999999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 021233 130 AVHLVMELCEGGELFDRIVARG--------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~ 195 (315)
..++|+|||..|+|.++|.... +++..+.+.|+.|||.||.||-++.+|||||-.+|+||.. .
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge---~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE---N 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc---c
Confidence 9999999999999999997432 2788999999999999999999999999999999999954 4
Q ss_pred CCEEEEeeccccccCCCCccc---ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 021233 196 APLKAIDFGLSVFFKPGEKFS---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 270 (315)
..|||+|||+++..-...... ...-..+||+||.+. +.||.+||||||||||||+++ |+.||.+..+++.++.+.
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 459999999998654333322 234456899999865 889999999999999999998 999999999999999998
Q ss_pred hccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+.. .+.+..+|.++.+||..||+.+|++|||+.||-..|
T Consensus 720 ~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L 759 (774)
T KOG1026|consen 720 AGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRL 759 (774)
T ss_pred cCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 8766 334567999999999999999999999999986554
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=312.22 Aligned_cols=252 Identities=25% Similarity=0.450 Sum_probs=215.6
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|.+.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.+ +|||++++++++...+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEE
Confidence 488899999999999999999999999999998654332 34467788999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||+++++|.+++... ..+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~---~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC---EEEcccccceeccCcc
Confidence 999999999998764 45899999999999999999999999999999999999986655 8999999988654432
Q ss_pred c-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
. .....+++.|+|||++. ..++.++|+||||+++++|++|+.||...........+...... .....++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP---PVSQMYSQQLAQL 232 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---CCccccCHHHHHH
Confidence 2 23456888999999876 45889999999999999999999999877766666655544322 2223578999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||+.+|++||++.+++.++|+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999999999999999999999885
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=334.06 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=204.7
Q ss_pred ccceeeeeeeeeecceEEEEEEE-----CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++.+.||+|+||+||+|.+ ..++..||+|++.... .....+.+.+|+.++..+.+||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34799999999999999999974 3456789999986432 2233467889999999997899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcC---------------------------------------------------------
Q 021233 129 TAVHLVMELCEGGELFDRIVARG--------------------------------------------------------- 151 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~--------------------------------------------------------- 151 (315)
+..++||||+++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886421
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 152 ------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 152 ------------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
.+++..++.++.|++.||.|||+.||+||||||+|||++.++. ++|+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~---~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI---TKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc---EEEecCccceeccCcc
Confidence 3678889999999999999999999999999999999976544 8999999998654332
Q ss_pred cc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 214 KF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 214 ~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
.. ....++..|+|||.+. ..++.++||||||+++|+|++ |..||................. ....+...+.++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 346 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--RMLSPECAPSEM 346 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc--cCCCCCCCCHHH
Confidence 21 2233456799999976 468999999999999999998 8999976654443333333221 222233467899
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.+|+..||+.||++|||+.++++.|+
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=337.59 Aligned_cols=251 Identities=22% Similarity=0.403 Sum_probs=209.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.+...+...||+|.||+||+|.|.. .||||.+...... ....+.|+.|+.++++- +|.||+-+.|++..... .|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL-AI 464 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCC-HHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce-ee
Confidence 3567888999999999999999964 5999999877554 44788999999999998 99999999999999887 99
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC--
Q 021233 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-- 210 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-- 210 (315)
|+.+|+|.||+.++.-. ..|.....+.|++|+++|+.|||.++|||||||..||++.++.. |||+|||++....
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k---VkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK---VKIGDFGLATVKTRW 541 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc---EEEecccceeeeeee
Confidence 99999999999999743 45999999999999999999999999999999999999976544 9999999986432
Q ss_pred -CCCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC-CCccC
Q 021233 211 -PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD-PWPKV 284 (315)
Q Consensus 211 -~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 284 (315)
...-....-|...|||||+++ ..|+..+||||||+|+|||++|..||......+++-.+-++.+..+.. ....+
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~ 621 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNC 621 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccC
Confidence 222233445677899999986 249999999999999999999999998666655555555554433322 23467
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++++.+|+..||.+++++||.+.+||..|
T Consensus 622 pk~mk~Ll~~C~~~~~~eRP~F~~il~~l 650 (678)
T KOG0193|consen 622 PKAMKRLLSDCWKFDREERPLFPQLLSKL 650 (678)
T ss_pred HHHHHHHHHHHHhcCcccCccHHHHHHHH
Confidence 88999999999999999999999999854
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=317.76 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=209.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.++..+ +||||+++++++...+..++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEE
Confidence 457999999999999999999999899999999886432 22345688899999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~---~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD---VKLADFGVAAKITATI 160 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC---EEECcCccceeecccc
Confidence 9999999999999987778999999999999999999999999999999999999976555 8999999998654322
Q ss_pred -cccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-CCCCccCCHH
Q 021233 214 -KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKVSEN 287 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 287 (315)
......+++.|+|||.+. ..++.++|+||||+++++|++|..||...........+........ ......++..
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 223456888999999873 3378899999999999999999999865543322222222111111 1112346789
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+.++|.+||+.+|++|||+.+++++||
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=314.68 Aligned_cols=253 Identities=26% Similarity=0.462 Sum_probs=212.8
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh------hcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA------VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~------~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
+|.+...||.|++|.||+|.+..+++.+|+|.+........ ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Confidence 47888999999999999999988899999998865433221 1235688999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
..++++||+++++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||++++++. ++|+|||.+...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~---~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG---IKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC---EEecccCCCccc
Confidence 99999999999999999988878999999999999999999999999999999999999976554 899999998765
Q ss_pred CCCC-------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 210 KPGE-------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 210 ~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
.... ......++..|+|||.+. ..++.++|+||||+++++|++|..||...........+... ..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~ 233 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN---ASPEIP 233 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---CCCcCC
Confidence 4211 112345788999999876 45888999999999999999999999876554444433332 223334
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+++++.++|.+||+.||.+||++.++++++||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 234 SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 4678999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=320.41 Aligned_cols=256 Identities=30% Similarity=0.505 Sum_probs=216.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||++.+..+++.|++|.+.............+.+|+.+++.+ +||||+++++.+...+..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEE
Confidence 3689999999999999999999999999999998765433334456788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~---~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC---EEEeeCCCccccCcCcc
Confidence 999999999999988888999999999999999999999999999999999999976554 8999999886421100
Q ss_pred ---------------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC
Q 021233 214 ---------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (315)
Q Consensus 214 ---------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (315)
......++..|+|||.+. ..++.++|+||||++++++++|..||.+....+............+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 236 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence 011235788899999875 4589999999999999999999999988777766666655443333
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCC---HHHHhcccCC
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLT---AQQVLGKIEF 315 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~e~l~~l~f 315 (315)
... ..+++++.++|.+||+.||++||+ +.++|+++||
T Consensus 237 ~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 237 EGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred Ccc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 222 257899999999999999999998 7999999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=317.00 Aligned_cols=253 Identities=29% Similarity=0.477 Sum_probs=217.7
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||.|+||.||+|.+..+++.+|+|.+...........+.+.+|+++++++ +||||+++++.+......++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEE
Confidence 489999999999999999999989999999999866544444567899999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 215 (315)
||+.|++|.+++.....+++..+..++.|+++||.|||++|++|+||+|+||++++++. ++|+|||.+.........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH---VHITDFNIATKVTPDTLT 156 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC---EEEeecccccccCCCccc
Confidence 99999999999988778999999999999999999999999999999999999987655 899999999876554444
Q ss_pred cccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 216 SEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 216 ~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
....++..|+|||.+.. .++.++|+||||+++++|++|..||..... .......... .....+...+.++.++|
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---ADVLYPATWSTEAIDAI 233 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---ccccCcccCcHHHHHHH
Confidence 55678889999999764 479999999999999999999999986663 2222222221 22334456789999999
Q ss_pred HHhcCCCcCCCCCH--HHHhcccCC
Q 021233 293 RKMLDPDPKRRLTA--QQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps~--~e~l~~l~f 315 (315)
.+||..||.+||++ .|++.|+||
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHccCChhHcCCccHHHHhcCCCC
Confidence 99999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=321.18 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=203.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECC----------------CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRE----------------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 117 (315)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++.++ +|||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~n 80 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRL-KDPN 80 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhc-CCCC
Confidence 4679999999999999999998642 23469999886542 233456789999999999 9999
Q ss_pred cceeEEEEEcCCcEEEEEEecCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 021233 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-------------------HYTERAAAAVTKTIVEVVQMCHKHGVM 178 (315)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~l~~~~~~~i~~~l~~~L~~lH~~~ii 178 (315)
|+++++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886431 367788999999999999999999999
Q ss_pred ecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh--
Q 021233 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-- 252 (315)
Q Consensus 179 H~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-- 252 (315)
||||||+|||++.++. +||+|||++........ .....++..|+|||++. +.++.++||||||+++++|++
T Consensus 161 H~dlkp~Nill~~~~~---~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 161 HRDLATRNCLVGENLT---IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccCcchhheEEcCCcc---EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999986554 89999999976543322 12334577899999875 568999999999999999986
Q ss_pred CCCCCCCCChHHHHHHHHhcc----ccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 253 GVPPFWAETEQGVAQAIIRSV----LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 253 g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+..||................ .......++.+++.+.+|+.+||+.||++|||+.+|.+.|
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 567887666555444332211 1111222346789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=317.56 Aligned_cols=254 Identities=29% Similarity=0.472 Sum_probs=207.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++++.||+|++|.||+|.+..++..||+|.+..... .......+.+|+.+++.+ +|||++++++++..++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEE
Confidence 48899999999999999999998999999999865432 222346688899999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 136 ELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 136 e~~~~~sL~~~l~~~---~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV---IKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc---EEECcccceeecCCC
Confidence 9997 5888887643 45899999999999999999999999999999999999987665 899999998754322
Q ss_pred C-cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC------------
Q 021233 213 E-KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------ 277 (315)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------ 277 (315)
. ......+++.|+|||.+.+ .++.++||||||+++++|++|+.||...........+........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 2 2233467889999998753 378899999999999999999999987655443333222111000
Q ss_pred -------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 -------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 -------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
......+++++.++|.+||+.||++|||+.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=315.25 Aligned_cols=251 Identities=17% Similarity=0.259 Sum_probs=208.1
Q ss_pred ccceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 54 EERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.++|++.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.++..+ +||||+++++++...+.
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCC
Confidence 357999999999999999999865 346689999887542 223346788999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++. ++++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~---~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV---CKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc---EEECCCcccccc
Confidence 99999999999999998764 46899999999999999999999999999999999999976554 899999987654
Q ss_pred CCCCccc--ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPGEKFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
....... ...++..|+|||.+. ..++.++||||||++++|+++ |..||+.....+....+.+.. ..+.+..++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF---RLPAPRNCP 234 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC---CCCCCCCCC
Confidence 3222111 223457899999876 568999999999999999775 999998887777666665442 223345688
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..+.+++.+||+.+|++|||+.++++.+
T Consensus 235 ~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 235 NLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 9999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=331.12 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=206.7
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
.+.++|++++.||+|+||+||+|.+..+++.||+|.+.... ........+.+|+.+++.+ +|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccc
Confidence 35678999999999999999999999999999999986542 2223345677899999999 999999999987533
Q ss_pred ---CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~---~kl~Dfg~ 164 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE---LRILDFGL 164 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC---EEEcCCcc
Confidence 4578999998 7799877754 46999999999999999999999999999999999999986655 89999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC-------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------- 276 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 276 (315)
+..... ......+|+.|+|||++.+ .++.++||||||+++++|++|..||......+....+.......
T Consensus 165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 165 ARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 986543 2344578999999999764 48899999999999999999999997765544443332211110
Q ss_pred ----------------CC----CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ----------------RR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ----------------~~----~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+. ..+...++.+.+||.+||+.||.+|||+.++|.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 00 0112356778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=320.69 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=209.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|++++.++ +||||+++++++..++..++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEE
Confidence 36999999999999999999999999999999886432 223345688999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||++++++. ++|+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDS- 153 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc---EEEccCCCccccccc-
Confidence 9999999999999888889999999999999999999997 59999999999999986655 899999998765332
Q ss_pred cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC----------------
Q 021233 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF---------------- 276 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------------- 276 (315)
......+++.|+|||.+.+ .++.++|+||||+++++|++|+.||...........+.......
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 2244578899999998764 48899999999999999999999986544332222111100000
Q ss_pred ------------------CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+..+...++.++.+++.+||..+|++|||+.+++.|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 000111367889999999999999999999999999997
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=332.37 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=204.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCC-----CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++.+.||+|+||.||+|++... +..||+|.+.... .....+.+.+|+.+++.+.+|+||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 45799999999999999999986433 3579999987543 2233567889999999987899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhc----------------------------------------------------------
Q 021233 129 TAVHLVMELCEGGELFDRIVAR---------------------------------------------------------- 150 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------- 150 (315)
+..++||||+++|+|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc---
Q 021233 151 ------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--- 215 (315)
Q Consensus 151 ------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~--- 215 (315)
..+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||++.........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~---~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV---AKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe---EEEeeceeeeeccCCcceeec
Confidence 13678889999999999999999999999999999999976544 899999999765433221
Q ss_pred cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 216 SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 216 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
....+++.|+|||++. ..++.++||||||+++|+|++ |+.||................. .......+++++.+++.
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~ 349 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY--QMSRPDFAPPEIYSIMK 349 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc--CccCCCCCCHHHHHHHH
Confidence 1223456799999876 568999999999999999997 9999976654443333333322 22223346899999999
Q ss_pred HhcCCCcCCCCCHHHHhccc
Q 021233 294 KMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 294 ~~l~~~P~~Rps~~e~l~~l 313 (315)
+||+.||++|||+.++++.|
T Consensus 350 ~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 350 MCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHcCCChhhCcCHHHHHHHH
Confidence 99999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=330.30 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=203.4
Q ss_pred cccccceeeeeeeeeecceEEEEEEEC--CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
..+..+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+++.+ +||||+++++++...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l-~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTI-SHRAIINLIHAYRWK 158 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhc-CCCCccceeeeEeeC
Confidence 344567999999999999999999764 34678999987543 2356799999999 999999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
...+++||++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++..
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~---~~l~DfG~a~~ 234 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN---AVLGDFGAACK 234 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC---EEEccCccccc
Confidence 99999999995 589898877778999999999999999999999999999999999999976555 89999999976
Q ss_pred cCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH---HHHHHHHhcccc------
Q 021233 209 FKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVLD------ 275 (315)
Q Consensus 209 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~------ 275 (315)
...... .....||+.|+|||++. ..++.++|||||||++|||++|+.||...... .....+.+....
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 543322 23457899999999987 45899999999999999999999999664322 112222111100
Q ss_pred -----------------CCCCC-C------ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 -----------------FRRDP-W------PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 -----------------~~~~~-~------~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++.. + ..++.++.++|.+||..||++|||+.|+|.|+||
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f 378 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLF 378 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchh
Confidence 00000 0 1346788999999999999999999999999998
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=335.29 Aligned_cols=236 Identities=25% Similarity=0.421 Sum_probs=203.4
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+-||.|+.|.||+|+.. ++.||||++.. .=..+|+-|++| +|+||+.+.++|.....+|||||||..
T Consensus 130 eWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkL-kH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKL-KHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhc-cCcceeeEeeeecCCceeEEeeecccc
Confidence 34899999999999976 89999998742 223578899999 999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCccccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 220 (315)
|.|...|+....++......|..+||.|+.|||.+.|||||||.-||||.-++. |||+|||.++..........++|
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~---VKIsDFGTS~e~~~~STkMSFaG 273 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV---VKISDFGTSKELSDKSTKMSFAG 273 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce---EEeccccchHhhhhhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999987666 99999999998776666677899
Q ss_pred CCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCC
Q 021233 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (315)
Q Consensus 221 t~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 299 (315)
|..|||||++. ...+.|.||||||||||||+||..||.......++--+ +........+..+|+.+.=||++||+-.
T Consensus 274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV--GsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV--GSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec--cCCcccccCcccCchHHHHHHHHHHhcC
Confidence 99999999997 56899999999999999999999999543322111111 1111223345678999999999999999
Q ss_pred cCCCCCHHHHhcccC
Q 021233 300 PKRRLTAQQVLGKIE 314 (315)
Q Consensus 300 P~~Rps~~e~l~~l~ 314 (315)
|.+|||+.++|.||.
T Consensus 352 pRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 352 PRNRPSFRQILLHLD 366 (904)
T ss_pred CCCCccHHHHHHHHh
Confidence 999999999999985
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=315.06 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=210.0
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 128 (315)
..+.|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.++..+.+|+|++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4567999999999999999999999999999999986432 23467889999999987799999999998753
Q ss_pred --CcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 129 --TAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 129 --~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
...+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++. ++|+|||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~---~~l~Dfg 156 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDFG 156 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC---EEEccCC
Confidence 4589999999999999998863 35899999999999999999999999999999999999986655 8999999
Q ss_pred cccccCCC-CcccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC
Q 021233 205 LSVFFKPG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (315)
Q Consensus 205 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (315)
++...... .......|++.|+|||++. ..++.++||||||+++|+|++|..||............... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~ 234 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PAP 234 (272)
T ss_pred CceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC--CCC
Confidence 98765432 2234467899999999874 24788999999999999999999999765544433333322 122
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
......++.++.+|+.+||..+|.+|||+.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 22234578899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=321.23 Aligned_cols=255 Identities=31% Similarity=0.523 Sum_probs=215.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|++|.||+|.+..+++.+|+|.+.............+..|+++++.+ +|+||+++++.+......++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEE
Confidence 3699999999999999999999988999999999876544434556789999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH---IMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC---EEEeecchhhccccc
Confidence 9999999999998754 45899999999999999999999999999999999999986554 899999998754321
Q ss_pred Cc------------------------------ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC
Q 021233 213 EK------------------------------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET 261 (315)
Q Consensus 213 ~~------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 261 (315)
.. .....||..|+|||.+. ..++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 11346788999999976 458899999999999999999999998777
Q ss_pred hHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCC----HHHHhcccCC
Q 021233 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT----AQQVLGKIEF 315 (315)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~e~l~~l~f 315 (315)
.......+......... ...+++++.++|.+||+.||++||| +.+++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 237 RDETFSNILKKEVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred hHHHHHHHhcCCccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 66666555543332222 1236899999999999999999999 9999999987
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=309.27 Aligned_cols=252 Identities=25% Similarity=0.486 Sum_probs=211.5
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-CCcEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTAVHLV 134 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv 134 (315)
+|++++.||+|++|.||++.+..+++.+|+|.+..... .....+.+.+|+.+++.+ +|+|++++.+.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEE
Confidence 48999999999999999999998899999999865432 223356788999999999 89999999998864 4468999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||+++++|.+++... ..+++.+++.++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~---~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI---IKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc---EEEecccceEEeccc
Confidence 9999999999998763 34899999999999999999999999999999999999976554 999999998765432
Q ss_pred C-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 213 E-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
. ......+++.|+|||.+. ..++.++||||||++++++++|+.||...........+..... +......++++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 232 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL---PPMPKDYSPELGE 232 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---CCCccccCHHHHH
Confidence 2 223456889999999976 4588999999999999999999999987766555555544332 2233457899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||+.+|++||++.++++|+||
T Consensus 233 li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 233 LIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=312.46 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=214.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||.|++|+||+|.+..++..+++|++....... ....+.+|+..++.+ +|+|++++++.+...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEE
Confidence 46999999999999999999998889999999986543322 457789999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 135 MELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~---~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+|++++++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++. ++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~---~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS---VKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC---EEEcccchHHHhcc
Confidence 9999999999999764 35899999999999999999999999999999999999986554 89999999876544
Q ss_pred CCcc-----cccccCCCccCchhhc-c-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC--Cc
Q 021233 212 GEKF-----SEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--WP 282 (315)
Q Consensus 212 ~~~~-----~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 282 (315)
.... ....++..|+|||.+. . .++.++|+||||+++++|++|..||....................... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence 3221 3446888999999876 3 589999999999999999999999977665544444443322111111 23
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+++++.+++.+||..||++|||+.+++.|+||
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=328.16 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=197.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
..+|++++.||+|+||.||+|.+..++..||+|..... ....|+.+++.+ +|+||+++++++...+..++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEE
Confidence 34699999999999999999999988999999975432 234699999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|+|++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++......
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ---VCIGDLGAAQFPVVA 210 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEecCccccccccC
Confidence 999995 588888765 346999999999999999999999999999999999999976555 899999999764433
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh-H---------HHHHHHHhccccCCCCC-
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-Q---------GVAQAIIRSVLDFRRDP- 280 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~-~---------~~~~~~~~~~~~~~~~~- 280 (315)
.......||+.|+|||++. ..++.++|||||||++|||+++..++..... . .....+.......+...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 3344567899999999976 4589999999999999999986554422211 0 11111111110000000
Q ss_pred -----------------------------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 -----------------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 -----------------------------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...++.++.+||.+||+.||.+|||+.|+|+|+||
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 01346677889999999999999999999999998
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=314.92 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=210.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.+ +||||+++++.+...+..++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEE
Confidence 457999999999999999999999999999999886442 22345678899999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~---~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH---VKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECcceeeeEccCcc
Confidence 9999999999999988888999999999999999999999999999999999999976555 8999999987553222
Q ss_pred -cccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC-CCCccCCHH
Q 021233 214 -KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-DPWPKVSEN 287 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 287 (315)
......|++.|+|||.+. ..++.++|+||||+++++|++|..||..................... .....++..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNS 240 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHH
Confidence 223457899999999863 34888999999999999999999998655443333222222111111 111246788
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+.++|.+||+.+|++|||+.++++|+|
T Consensus 241 ~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 241 FHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=313.60 Aligned_cols=253 Identities=28% Similarity=0.504 Sum_probs=208.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||+|++..+++.||+|.+.............+.+|+.+++.+ +|||++++++++...+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEE
Confidence 4799999999999999999999989999999988654444444456788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~---~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC---EEECccccceecc
Confidence 999999999988853 234889999999999999999999999999999999999976555 8999999987654
Q ss_pred CCCc-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.... .....+++.|+|||.+. ..++.++|+||||+++|+|++|..||..... ......+... ..++......+.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--DYPPLPTEHYSE 235 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--CCCCCChhhcCH
Confidence 3221 23456888999999876 4588999999999999999999999865432 2333333222 222222345778
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+.++|.+||+.+|++|||+.++++.+
T Consensus 236 ~~~~li~~cl~~~p~~Rp~~~~vl~~~ 262 (267)
T cd08228 236 KLRELVSMCIYPDPDQRPDIGYVHQIA 262 (267)
T ss_pred HHHHHHHHHCCCCcccCcCHHHHHHHH
Confidence 999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=317.89 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=210.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||+|.+..+++.+|+|.+....... ...+.+.+|+++++.+ +||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEE
Confidence 36999999999999999999998889999999886543322 3346688899999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
+||+++++|.++......+++..++.++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~---~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc---EEEEeeeeeeeccCCcc
Confidence 999999888887766667999999999999999999999999999999999999976554 8999999987654332
Q ss_pred cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC---------------
Q 021233 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--------------- 276 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------------- 276 (315)
......++..|+|||.+.+ .++.++||||||+++++|++|++||......+....+.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2234567889999998763 47889999999999999999999997655443333322111100
Q ss_pred ----C--------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ----R--------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ----~--------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+ ...++.++..+.+++.+||+.+|++||++.++++|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 00134568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=309.14 Aligned_cols=253 Identities=27% Similarity=0.468 Sum_probs=216.1
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||+|++|.||+|.+..++..+|+|.+...... ......+.+|+.+++.+ +|||++++++.+...+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEE
Confidence 589999999999999999999999999999998765432 23457789999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||+++++|.+++... ..+++..+..++.+++.+|.|||++|++|+||+|+||+++.++. .++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM--VVKIGDFGISKILSSKS 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEccCCCceecCCCc
Confidence 999999999999764 34899999999999999999999999999999999999975433 37999999998765544
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
......++..|+|||.+. ..++.++||||||+++++|++|..||...........+..... ......+++++.+++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li 233 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF---APISDRYSPDLRQLI 233 (256)
T ss_pred cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC---CCCCCCcCHHHHHHH
Confidence 444567889999999986 4578999999999999999999999987766655555544322 222345789999999
Q ss_pred HHhcCCCcCCCCCHHHHhcccCC
Q 021233 293 RKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+||+.+|++|||+.++++|++|
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=308.15 Aligned_cols=252 Identities=30% Similarity=0.479 Sum_probs=216.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++++.||.|+||.||.+.+..++..+++|.+...... ......+.+|+++++++ +|+||+++++++...+..+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEE
Confidence 589999999999999999999999999999988654332 23456788999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||+++++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++. +||+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~---~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL---IKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC---EEECcCcceEEccccc
Confidence 999999999999765 35899999999999999999999999999999999999986655 8999999987654333
Q ss_pred -cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......+++.|+|||.+.+ .++.++|+||||+++++|++|..||......+....+....... ....++.++.++
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---VVSVYSSELISL 232 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence 2344578999999998764 47889999999999999999999998777666666665443221 224578999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||..+|++|||+.++++++|+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=316.78 Aligned_cols=254 Identities=30% Similarity=0.494 Sum_probs=212.0
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
...+|++.+.||+|++|.||+|.+..++..+++|.+..... ...+.+.+|+.+++.+ .|+|++++++.+......+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~ 93 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 93 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEE
Confidence 34689999999999999999999998999999998865432 2346788999999998 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+++... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~---~kl~dfg~~~~~~~~ 169 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPE 169 (296)
T ss_pred EeecccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC---EEECccccchhcccc
Confidence 999999999999988653 5899999999999999999999999999999999999976554 899999998765433
Q ss_pred C-cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 213 E-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
. ......+++.|+|||.+.+ .++.++||||||+++++|++|+.||................ .........+++.+.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 248 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRD 248 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC-CCCCCCccccCHHHHH
Confidence 2 2234578899999998764 48899999999999999999999997766544333332221 1111223457889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||..+|++||++.+++.++||
T Consensus 249 li~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 249 FLNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred HHHHHCcCCcccCcCHHHHhhChhh
Confidence 9999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=321.91 Aligned_cols=249 Identities=27% Similarity=0.457 Sum_probs=191.8
Q ss_pred eeeeeeecceEEEEEEEC--CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--CCcEEEEE
Q 021233 60 GRELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVHLVM 135 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~ 135 (315)
...||+|+||+||+|.+. .+++.+|+|.+.... ....+.+|+.+++++ +||||+++++++.. ....+++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEE
Confidence 467999999999999965 467889999886432 124577899999999 99999999999864 45689999
Q ss_pred EecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CCCCCEEEEeecc
Q 021233 136 ELCEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGL 205 (315)
Q Consensus 136 e~~~~~sL~~~l~~~---------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~-~~~~~vkl~Dfg~ 205 (315)
||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+..+ .....+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9995 4888877532 248899999999999999999999999999999999999643 2344599999999
Q ss_pred ccccCCCC----cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH---------HHHHHHH
Q 021233 206 SVFFKPGE----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAII 270 (315)
Q Consensus 206 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---------~~~~~~~ 270 (315)
+....... ......+|+.|+|||++.+ .++.++||||+||++++|++|++||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98654321 2245678999999998763 4899999999999999999999999643321 1111111
Q ss_pred hccccCC---------------------C-------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 271 RSVLDFR---------------------R-------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 271 ~~~~~~~---------------------~-------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....... . ......+.++.+||.+||+.||.+|||++|+|+|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1100000 0 0001234678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=318.33 Aligned_cols=254 Identities=29% Similarity=0.496 Sum_probs=204.9
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||+|+||.||+|.+..+|+.+|+|.+..... .......+.+|+.+++.+ +|+|++++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEE
Confidence 58899999999999999999999999999999865432 222235677899999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-C
Q 021233 136 ELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 213 (315)
||+++ +|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++...... .
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~---~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc---EEECccchhhccCCCCC
Confidence 99965 88887765 456999999999999999999999999999999999999986655 899999998765432 2
Q ss_pred cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHhcccc--------------C
Q 021233 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLD--------------F 276 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~-~~~~~~~~~~~~~~~~--------------~ 276 (315)
......+++.|+|||.+.+ .++.++||||||+++++|++|..|+.. .........+.+.... .
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234567889999998764 378999999999999999999888643 3333333322221100 0
Q ss_pred ---C--------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ---R--------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ---~--------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. ....+.+++++.++|.+||+.||.+|||+.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 01123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=316.20 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=210.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCC-----CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENG-----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
++|++.+.||+|+||.||+|.+...+ ..+++|.+.... .......+.+|+.++..+ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCC
Confidence 47999999999999999999876544 679999886432 233356789999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 021233 130 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~ 193 (315)
..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||++++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 999999999999999999764 3478899999999999999999999999999999999997655
Q ss_pred CCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 021233 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (315)
. ++|+|||++........ .....+++.|+|||.+. +.++.++||||||++++||++ |..||......+....
T Consensus 162 ~---~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 162 T---VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred c---EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4 89999999876533221 22345678899999875 568999999999999999998 9999988777776666
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+...... .....+++++.+|+.+||+.||.+||++.+++++|
T Consensus 239 i~~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 239 IRSRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HHcCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 6544322 23356899999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=315.50 Aligned_cols=249 Identities=33% Similarity=0.534 Sum_probs=208.8
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (315)
||+|+||+||+|.+..+++.||+|.+.............+..|+.+++.+ +|||++++++.+...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 68999999999999999999999998765443344455677899999999 89999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCccccccc
Q 021233 143 LFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (315)
Q Consensus 143 L~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 220 (315)
|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||.+.............+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN---VRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEccCcchhhhccCCccccccC
Confidence 999987755 6899999999999999999999999999999999999976554 89999999876544433445567
Q ss_pred CCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCC
Q 021233 221 SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (315)
Q Consensus 221 t~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 299 (315)
+..|+|||.+. ..++.++||||||+++++|++|+.||...........+...........+..+++++.++|.+||+.|
T Consensus 157 ~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 88999999976 45889999999999999999999999765542223333333333333444567899999999999999
Q ss_pred cCCCC-----CHHHHhcccCC
Q 021233 300 PKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 300 P~~Rp-----s~~e~l~~l~f 315 (315)
|++|| ++.+++.|+||
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred hhHccCCCcccHHHHHhChhh
Confidence 99999 88889999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=333.93 Aligned_cols=251 Identities=29% Similarity=0.459 Sum_probs=220.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.+.|.=++.||.|+||.||-|++..+.+.||||.+.-+-..+.....++..|+..|.++ .|||.+.+-++|..+...|+
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHHH
Confidence 34588888999999999999999999999999999876666666677899999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~-~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||||-| |-.|++. ...++.+..+..|..+.+.||+|||+.+.||||||..|||++..+. |||+|||.|....+
T Consensus 104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~---VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL---VKLADFGSASIMAP- 178 (948)
T ss_pred HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe---eeeccccchhhcCc-
Confidence 9999955 8888886 3457999999999999999999999999999999999999976555 99999999976543
Q ss_pred CcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
..+++|||.|||||++. |.|+-+.||||||++.+||...++|+.+.+....+..|.....+. -..+..++.+
T Consensus 179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPt--Lqs~eWS~~F 254 (948)
T KOG0577|consen 179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--LQSNEWSDYF 254 (948)
T ss_pred --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCC--CCCchhHHHH
Confidence 35679999999999863 679999999999999999999999999999888888887653322 1223457889
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.+|+..||++-|.+|||++++|.|.|
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhhcch
Confidence 99999999999999999999999987
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=314.23 Aligned_cols=253 Identities=31% Similarity=0.478 Sum_probs=211.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+.|++.+.||.|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.+ +|+|++++++.+...+..++|
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEE
Confidence 3478999999999999999999988999999988643 233456788899999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
+||+++++|...+.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~---~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC---EEEccccccccccccc
Confidence 999999999888765 456899999999999999999999999999999999999976655 999999998754322
Q ss_pred CcccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 213 EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.......+++.|+|||.+. ..++.++||||||+++|+|++|..||......+....+....... ......++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCH
Confidence 2223457889999999873 237789999999999999999999997766555555544332211 122345788
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.++|.+||+.||.+||++.++++|+||
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 265 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFV 265 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCE
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=319.70 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=203.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCE--EEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
++|++.+.||+|+||.||+|.+..++.. +++|.+... ........+.+|+.++.++.+|+||+++++++...+..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 4799999999999999999998877765 466665432 223345678899999999978999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 133 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
+||||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||++.++.
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~-- 162 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 162 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--
Confidence 9999999999999987542 4789999999999999999999999999999999999976554
Q ss_pred CEEEEeeccccccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccc
Q 021233 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 274 (315)
++|+|||++.............++..|+|||.+.+ .++.++||||||+++++|+| |..||......+....+...
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-- 239 (303)
T cd05088 163 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 239 (303)
T ss_pred -EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC--
Confidence 89999999864321111122234567999998764 48899999999999999998 99999877666555544332
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.....+..+++++.+|+.+||+.+|++||++.+++.++
T Consensus 240 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 240 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 12223345788999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=313.60 Aligned_cols=251 Identities=27% Similarity=0.470 Sum_probs=213.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|+.+++.+ +|+|++++.+++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEE
Confidence 36899999999999999999999999999999986542 233346788999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-C
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 213 (315)
+||+++++|.+++... .+++..++.++.|++.||.|||+.+++|+||+|+||++++++. ++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD---VKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEcccccceeeccccc
Confidence 9999999999998765 7899999999999999999999999999999999999987655 899999999876543 2
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCcc-CCHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSENAKDL 291 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l 291 (315)
......+++.|+|||.+. ..++.++||||||+++|+|++|..||...........+..... +..... +++++.++
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 230 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP---PSLEGNKFSKPFKDF 230 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC---CCCcccccCHHHHHH
Confidence 234457888999999876 4589999999999999999999999976655444444433321 111122 78899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||..+|++|||+.+++.|+||
T Consensus 231 l~~~l~~~p~~Rpt~~~il~~~~~ 254 (274)
T cd06609 231 VSLCLNKDPKERPSAKELLKHKFI 254 (274)
T ss_pred HHHHhhCChhhCcCHHHHhhChhh
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=314.84 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=204.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++++ +||||+++++++...+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEE
Confidence 36889999999999999999999999999999886542 223346788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++...... .
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~---~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC---EEEeeCCcceecccc-c
Confidence 999999988654 25788999999999999999999999999999999999987655 999999999765432 2
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH-------HHHHHHHhccccCCCCCCccCCH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.....++..|+|||.+. ..++.++|+||||+++|+|++|..||...... .....+... ..........++
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 227 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE--DPPVLPVGQFSE 227 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--CCCCCCCCcCCH
Confidence 34457899999999876 45899999999999999999999999643211 111111111 111112234678
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+++.+||+.+|++||++.+++.|+||
T Consensus 228 ~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 228 KFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred HHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 99999999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=310.39 Aligned_cols=247 Identities=32% Similarity=0.554 Sum_probs=211.6
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (315)
||.|++|.||+|.+..+++.+++|++...........+.+.+|+.+++.+ +||||+++++.+......++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 68999999999999988999999999766544444557799999999999 99999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCC
Q 021233 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222 (315)
Q Consensus 143 L~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~ 222 (315)
|.+++.....+++..+..++.|++.||+|||+++++|+||+|+||+++.++. ++|+|||.+.............+++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY---VKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC---EEEeeCCcccccCcccccccccCCc
Confidence 9999988777999999999999999999999999999999999999976554 8999999998765544344457889
Q ss_pred CccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC--hHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCC
Q 021233 223 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (315)
Q Consensus 223 ~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 299 (315)
.|++||.+. ..++.++|+||||+++|++++|..||.... .......+... ......+...++++.++|.+||+.+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG--NGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc--CCCCCCCcccCHHHHHHHHHHccCC
Confidence 999999876 458899999999999999999999997766 44444444421 1122233345899999999999999
Q ss_pred cCCCCC-----HHHHhcccCC
Q 021233 300 PKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 300 P~~Rps-----~~e~l~~l~f 315 (315)
|++||+ +.|+++|+||
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred hhhCcCCcccCHHHHhcChhh
Confidence 999999 9999999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=315.50 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=210.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||.||+|.+..++..+|+|.+.... .......+.+|+.+++++ +|+||+++++.+...+..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEE
Confidence 36899999999999999999999899999999886431 233346788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 135 MELCEGGELFDRIVAR---GHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~---~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
|||+++++|..++... ..+++..+..++.+++.||.|||+ .+++|+||||+||+++.++. ++|+|||.+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC---EEEeecCCccccc
Confidence 9999999998888763 368999999999999999999997 59999999999999986544 8999999987653
Q ss_pred CCCcccccccCCCccCchhhcc-------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
.. ......+++.|+|||.+.+ .++.++|+||||+++++|++|..||...........+.......+...++.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 155 AS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred CC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 22 2234467889999998742 257899999999999999999999976554443333322222223334456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++++.++|.+||+.+|++||++.+++.++||
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~ 265 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence 88999999999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=309.85 Aligned_cols=249 Identities=31% Similarity=0.486 Sum_probs=208.3
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||.|+||.||+|.+..+++.||+|.+.............+..|..++....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56899999999999998899999999986543322222334555666555544899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCccccccc
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 220 (315)
++|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH---LKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc---EEEeecccceeccc---cccCCC
Confidence 999999988778999999999999999999999999999999999999976544 89999999875432 233467
Q ss_pred CCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCC
Q 021233 221 SPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPD 299 (315)
Q Consensus 221 t~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 299 (315)
++.|+|||.+.+ .++.++||||||+++++|++|..||...........+..............+++++.+++.+||+.+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 235 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCC
Confidence 889999999764 4789999999999999999999999887776666666555444444444568999999999999999
Q ss_pred cCCCC---CHHHHhcccCC
Q 021233 300 PKRRL---TAQQVLGKIEF 315 (315)
Q Consensus 300 P~~Rp---s~~e~l~~l~f 315 (315)
|++|| ++.|++.|+||
T Consensus 236 p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 236 PAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHccCCCcHHHHHcChHh
Confidence 99999 55799999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=320.90 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=200.5
Q ss_pred eeeeeeee--cceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 59 LGRELGRG--EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 59 ~~~~lg~G--~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
++++||+| +|++||++.+..+|+.||+|.+...... ....+.+.+|+.+++.+ +||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEe
Confidence 56789999 7889999999999999999998754322 22345678899999999 99999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 137 LCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 137 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|+++++|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++. ++++||+.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~---~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc---EEEcccchhhccccccc
Confidence 99999999998653 35899999999999999999999999999999999999986654 8999998654332111
Q ss_pred -------cccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC------
Q 021233 214 -------KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------ 277 (315)
Q Consensus 214 -------~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------ 277 (315)
......++..|+|||++.+ .++.++|||||||++++|++|..||....................
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 0112346677999999863 488999999999999999999999976554433322222111000
Q ss_pred ------------------------------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ------------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ------------------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
......+++++.+||.+||+.||++|||+.++++|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 00112346789999999999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=313.99 Aligned_cols=253 Identities=32% Similarity=0.488 Sum_probs=212.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+.+++++ +|+|++++++.+......++|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEE
Confidence 5699999999999999999999888999999998643 334456788999999999 799999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~---~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNKSTL 157 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC---EEEccCccchhhcccc
Confidence 9999999999998764 46999999999999999999999999999999999999976555 8999999887553322
Q ss_pred -cccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 214 -KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
......+++.|+|||.+. ..++.++|+||||+++|+|++|+.||...........+...... .......++.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 236 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP-TLDQPSKWSS 236 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC-CcCCcccCCH
Confidence 223456889999999864 23678999999999999999999999876655544444433211 1122345788
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.++|.+||+.+|++||++.++++|+||
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 99999999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=307.03 Aligned_cols=254 Identities=29% Similarity=0.446 Sum_probs=214.5
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc--ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
+|+..+.||+|++|.||+|.+..++..|++|.+...... .....+.+.+|+.+++.+ +|+|++++++++......++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEE
Confidence 478889999999999999999888999999988654321 123456789999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
++||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~---~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV---VKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEccCccceeccccc
Confidence 9999999999999988777999999999999999999999999999999999999976554 8999999988664444
Q ss_pred cccccccCCCccCchhhc-cc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......++..|++||.+. .. ++.++|+||||++++++++|..||...........+... ...+..+..+++++.++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS--KELPPIPDHLSDEAKDF 234 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc--ccCCCcCCCcCHHHHHH
Confidence 344567889999999875 34 789999999999999999999999766544444333321 12223345678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||+.+|++||++.+++.++||
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=313.78 Aligned_cols=253 Identities=29% Similarity=0.497 Sum_probs=213.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
..+|++.+.||.|++|.||+|.+..+++.|++|.+.... ....+.+.+|+.+++.+ +|+|++++++++...+..++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEE
Confidence 357999999999999999999999999999999886542 23346788999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|+||+++++|.+++... .+++..+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~---~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS---VKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEccCccchhccccc
Confidence 99999999999988654 5899999999999999999999999999999999999976554 8999999987654332
Q ss_pred c-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
. .....++..|+|||.+. ..++.++||||||+++|++++|..||...........+.... ......+..+++.+.++
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CcccCCcccCCHHHHHH
Confidence 2 23456888999999876 458899999999999999999999998766554444333221 11122334678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||..||++||++.+++.|+||
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHh
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=313.79 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=211.4
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..+.|++++.||.|+||.||+|.+..++..+++|.+... .....+.+.+|+.+++.+ +|+|++++++.+..++..+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEE
Confidence 446799999999999999999999999999999998643 334456788899999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||+++++|...+.. ...+++..+..++.|++.+|.|||+.|++||||||+||+++.++. ++|+|||.+.....
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~dfg~~~~~~~ 162 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKNVK 162 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC---EEEccCccceeccc
Confidence 99999999999887764 346899999999999999999999999999999999999976555 89999998875432
Q ss_pred C-CcccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 212 G-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
. .......+++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+...... .......+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 241 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKW 241 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCc-cCCCCccc
Confidence 2 2224456888999999873 23678999999999999999999999766554444444332211 11123456
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.++.++|.+||+.+|++||++.++++|+||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 272 (292)
T cd06644 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272 (292)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 7899999999999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=309.12 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=210.5
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc---ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+...... .......+.+|+.+++.+ +|+||+++.+++...+..+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEE
Confidence 488899999999999999986 46889999988644221 122345688999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+++||+++++|.+++.....+++..+..++.|++.||+|||+.+++|+||+|+||++++++. ++|+|||.+......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI---IKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe---EEeccchhhHhhhhc
Confidence 99999999999999988778999999999999999999999999999999999999976554 899999998754211
Q ss_pred -------CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 213 -------EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 213 -------~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
.......++..|+|||.+.+ .++.++|+||||++++++++|..||...........+.... ...+.....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR-GLMPRLPDSF 234 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc-CCCCCCCCCC
Confidence 11234568889999999864 58899999999999999999999997665544433333221 1222334567
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++++.++|.+||+.+|++||++.+++.|+||
T Consensus 235 ~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=308.26 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=211.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||.|+||.||+|.+..++..+++|.+.... ..+.+.+|+.+++.+ +|+|++++++++......+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEE
Confidence 57999999999999999999998889999999886442 157899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+.+++|+||+|+||++++++. ++|+|||++.......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~---~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDTM 153 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc---EEEcccccchhcccCc
Confidence 999999999999875 345899999999999999999999999999999999999986655 8999999998765443
Q ss_pred -cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......++..|+|||.+.+ .++.++||||||+++++|++|+.||...........+...... .......++.++.++
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 232 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-TLSDPEKWSPEFNDF 232 (256)
T ss_pred cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCC-CCCchhhcCHHHHHH
Confidence 2344567889999999764 5889999999999999999999999765554433332221111 111223467899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||+.||++|||+.+++.|+||
T Consensus 233 i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=311.09 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=211.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++.+.||+|++|.||+|.+.. .+..|++|.+.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC
Confidence 4579999999999999999999876 67889999875432 223345688899999999 999999999999998
Q ss_pred CcEEEEEEecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEE
Q 021233 129 TAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+++|+||||+||+++.++....++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999987643 48899999999999999999999999999999999999876655568999
Q ss_pred eeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccC
Q 021233 202 DFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (315)
Q Consensus 202 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (315)
|||++......... .....+..|+|||++. ..++.++|||||||++++|++ |..||...........+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--- 238 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG--- 238 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---
Confidence 99999865322211 1223346799999976 569999999999999999997 999998777666555444321
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+...+..++..+.+++.+||+.+|++|||+.++++++.
T Consensus 239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 22334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=312.91 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=210.5
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++++ +|+|++++++++......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEe
Confidence 589999999999999999999989999999998765322 22346788999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 136 ELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
||+ +++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||.+.......
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~---~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV---LKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc---EEEeeeeecccccCCCC
Confidence 999 99999988653 45899999999999999999999999999999999999986554 8999999988664432
Q ss_pred -cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-------------
Q 021233 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------- 277 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (315)
......++..|+|||.+.+ .++.++||||||+++++|++|.+||...........+........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2344578899999998753 368999999999999999999888876665544444333211100
Q ss_pred ------C-------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ------R-------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ------~-------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. ...+..++++.++|.+||..+|++|||+.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~ 285 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence 0 0123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=309.58 Aligned_cols=256 Identities=24% Similarity=0.403 Sum_probs=210.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC-------hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-------AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+....... ....+.+.+|+.+++.+ +|+|++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccC
Confidence 5888999999999999999998889999999875432111 11234678899999999 899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~---~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI---CKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe---EEEeecccccc
Confidence 999999999999999999988778999999999999999999999999999999999999976554 89999999875
Q ss_pred cCCCC---cccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcc--ccCCCCC
Q 021233 209 FKPGE---KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV--LDFRRDP 280 (315)
Q Consensus 209 ~~~~~---~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~ 280 (315)
..... ......++..|+|||.+.. .++.++|+||||++++++++|..||...........+.... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 43221 1233467889999998753 37899999999999999999999996554443333322221 1122223
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.++.++.++|.+||..+|++|||+.++++|+||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 34578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=306.41 Aligned_cols=252 Identities=27% Similarity=0.540 Sum_probs=215.0
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||+|+||.||.+.+..+++.||+|.+...... ......+.+|+.+++.+ +|+||+++.+++...+..++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEE
Confidence 589999999999999999999999999999998654332 23346789999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||+++++|.+.+.... .+++..++.++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~---~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT---IKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEEeeccceeecCcch
Confidence 9999999999887643 4789999999999999999999999999999999999976555 8999999997654332
Q ss_pred c-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
. .....+++.|+|||.+. ..++.++|+||||++++++++|..||......+....+..... +.....++.++.++
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l 232 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY---PPVSSHYSYDLRNL 232 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC---CCCcccCCHHHHHH
Confidence 2 23346788999999976 4588899999999999999999999987776666665554432 22234578999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||+.+|++||++.++++|+||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.51 Aligned_cols=254 Identities=29% Similarity=0.484 Sum_probs=211.1
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++++.||+|++|.||+|.+..++..||+|.+.... ....+.+.+|+.+++.+ +|+|++++++++...+..+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~ 92 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 92 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEE
Confidence 4468999999999999999999998899999999886543 22346688999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~---~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPE 168 (297)
T ss_pred EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEECcCccceEccCC
Confidence 99999999999998865 35899999999999999999999999999999999999976554 899999998765433
Q ss_pred Cc-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 213 EK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 213 ~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
.. .....+++.|+|||.+. ..++.++|+||||++++++++|..||...........+.... .........+++.+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHHH
Confidence 22 23457888999999876 458899999999999999999999997654432222222111 1111223457888999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||..+|++||++.+++.|+||
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~ 272 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFL 272 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchh
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=335.07 Aligned_cols=253 Identities=28% Similarity=0.444 Sum_probs=216.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+.|.|+..||.|+||.||+|.++.++-..|.|++.. .+....+++.-|++||..+ +||+||++++.|..++.+|++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEE
Confidence 469999999999999999999998888888888853 3556678888999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CC
Q 021233 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~ 212 (315)
.|||.||-....+..-+ .|++.++..++.|++.||.|||+++|||||||..|||++-+|. |+|+|||.+.... ..
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn~~t~ 184 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKNKSTR 184 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---EeeecccccccchhHH
Confidence 99999999988877654 5999999999999999999999999999999999999998888 9999999886432 23
Q ss_pred CcccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 213 EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
....++.|||+|||||+.. ..|+.++||||||++|+||..+.+|-...+....+-.+.+...+-- ..+...+.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTL-lqPS~Ws~ 263 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-LQPSHWSR 263 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcc-cCcchhhh
Confidence 4456789999999999864 3489999999999999999999999876666555555555432211 11234578
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.+|+.+||.+||..||++.++|+|+||
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 89999999999999999999999999997
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.26 Aligned_cols=255 Identities=31% Similarity=0.505 Sum_probs=209.1
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC--hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
+|++++.||.|++|.||+|.+..+++.|++|.+....... ......+..|+.+++.+ +|+||+++++++...+..++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEE
Confidence 4889999999999999999999889999999987654331 12234577899999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+ +++|.+++.... .+++..++.++.||++||.|||++|++|+||+|+||+++.++. ++|+|||++......
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~---~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC---EEEccceeeeeccCC
Confidence 99999 889999998765 6999999999999999999999999999999999999987655 899999999866443
Q ss_pred C-cccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC------------
Q 021233 213 E-KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------ 277 (315)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------ 277 (315)
. ......+++.|+|||.+. ..++.++|+||||+++++|++|.+||......+....+........
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 2 223345678899999875 3478999999999999999999888876655444443332211000
Q ss_pred ------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.......+.++.++|.+||+++|++|||+.+++.|.||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~ 285 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence 00123457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=306.82 Aligned_cols=253 Identities=30% Similarity=0.478 Sum_probs=212.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||.|+||.||+|.+..+++.+++|.+.... ....+.+.+|+.+++.+ +|||++++++.+......+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEE
Confidence 57999999999999999999998889999999986543 22457889999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD---VKLADFGVSAQLTATI 155 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC---EEECccccchhhhhhh
Confidence 9999999999998776 67999999999999999999999999999999999999986555 8999999987654322
Q ss_pred -cccccccCCCccCchhhc-c---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC-CCCCCccCCHH
Q 021233 214 -KFSEIVGSPYYMAPEVLK-R---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-RRDPWPKVSEN 287 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~-~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 287 (315)
......++..|+|||.+. . .++.++|+||||+++++|++|..||...........+....... ........+.+
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 234457888999999875 3 58889999999999999999999997766554444443331111 11112345788
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+.+++.+||..+|.+|||+.+++.|.|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=308.31 Aligned_cols=253 Identities=27% Similarity=0.471 Sum_probs=207.7
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc--ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--CCcE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAV 131 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~ 131 (315)
+|++.+.||+|+||.||+|.+..++..+++|.+...... .......+.+|+.+++.+ +||||+++++++.. ....
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEE
Confidence 689999999999999999999999999999988654322 122345688999999999 89999999998875 3678
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++++||+++++|.+.+.....+++...+.++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~---~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEccCCCcccccc
Confidence 899999999999999988778999999999999999999999999999999999999976554 89999999875432
Q ss_pred C----CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 212 G----EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 212 ~----~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
. .......++..|+|||.+.+ .++.++||||||++++++++|+.||...........+.... ..+.....+++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP--TNPQLPSHISE 236 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC--CCCCCchhcCH
Confidence 1 11233467889999999864 48899999999999999999999997665444443332221 12233345678
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.+++ .||..+|++||++.|++.|+||
T Consensus 237 ~~~~li-~~~~~~p~~Rp~~~eil~hp~~ 264 (266)
T cd06651 237 HARDFL-GCIFVEARHRPSAEELLRHPFA 264 (266)
T ss_pred HHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence 889998 6777899999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=311.78 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=207.1
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE----
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE---- 126 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~---- 126 (315)
....++|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.++..+.+|+||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 345678999999999999999999999999999999875421 123567889999999867999999999874
Q ss_pred -cCCcEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEE
Q 021233 127 -DDTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 127 -~~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
..+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~---~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---VKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC---EEEc
Confidence 34578999999999999988753 245889999999999999999999999999999999999986655 8999
Q ss_pred eeccccccCCCC-cccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccc
Q 021233 202 DFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274 (315)
Q Consensus 202 Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 274 (315)
|||++....... ......|++.|+|||++. ..++.++||||||+++|+|++|..||................
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~- 245 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP- 245 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-
Confidence 999987654322 223456899999999874 237889999999999999999999997665433332222211
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.........++.++.++|.+||+.||++|||+.|+++|+||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 11111123357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=329.48 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=199.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
...|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+++++++ +|+||+++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEE
Confidence 4479999999999999999999999999999996421 2356899999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||++. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||+++.....
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~---vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC---EEEcccCCceecccc
Confidence 999995 5888888654 45999999999999999999999999999999999999976555 899999999765332
Q ss_pred Cc---ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCC--------hHHHHHHHHhcccc---C-
Q 021233 213 EK---FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET--------EQGVAQAIIRSVLD---F- 276 (315)
Q Consensus 213 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~--------~~~~~~~~~~~~~~---~- 276 (315)
.. .....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .....+.+...... +
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 21 224579999999999864 58999999999999999999876553221 12222222221110 0
Q ss_pred -----------------------CCCCCc---cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 -----------------------RRDPWP---KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 -----------------------~~~~~~---~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....|. .++.++.+||.+||+.||.+|||+.|+|+|+||
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 001111 345688999999999999999999999999998
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=314.72 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=205.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCC--EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
++|++.+.||+|+||.||+|.+..++. .+++|.+... ......+.+.+|+.++.++.+||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 479999999999999999999877664 4688776532 223335678899999999977999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 133 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
+++||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||++.++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~-- 157 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA-- 157 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--
Confidence 9999999999999997532 4788999999999999999999999999999999999976544
Q ss_pred CEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccc
Q 021233 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 274 (315)
+||+|||++..............+..|+|||.+. ..++.++||||||+++++|++ |..||......+....+....
T Consensus 158 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~- 235 (297)
T cd05089 158 -SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 235 (297)
T ss_pred -EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-
Confidence 8999999986433221112223345799999876 458999999999999999997 999998877776666655432
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.......+++++.+|+.+||..+|.+|||+.+++..|
T Consensus 236 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 236 --RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2223345789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=311.78 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=206.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc----
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA---- 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~---- 130 (315)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+.+|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 369999999999999999999999999999998765432 222345688899999999667999999999887655
Q ss_pred -EEEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 131 -VHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 131 -~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
.++||||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++||||+|+||+++.+ ...++|+|||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~--~~~~kl~dfg 156 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ--KGLLKIADLG 156 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC--CCeEEEeecc
Confidence 8999999976 888887642 347999999999999999999999999999999999999762 2338999999
Q ss_pred cccccCCC-CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC----
Q 021233 205 LSVFFKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR---- 277 (315)
Q Consensus 205 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---- 277 (315)
.+...... .......+++.|+|||.+.+ .++.++||||||+++++|++|..||...........+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98754322 22233456888999998753 478999999999999999999999987665554444433211000
Q ss_pred --------------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 --------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 --------------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+.+++++.++|.+||..||.+||++.+++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~ 294 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCc
Confidence 00113578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=310.76 Aligned_cols=252 Identities=27% Similarity=0.513 Sum_probs=207.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.+|++.+.||+|++|.||+|.+..+++.+++|.+.............+.+|+.+++.+ +|+||+++++++...+..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEE
Confidence 3689999999999999999999889999999988765444444556788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
|||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEECcchhhhccc
Confidence 999999999998863 345899999999999999999999999999999999999976554 9999999987654
Q ss_pred CCCc-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH--HHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.... .....++..|+|||.+. ..++.++|+||||+++++|++|..||...... .....+... ..++.....+++
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 235 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDHYSE 235 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCCCCCcccccH
Confidence 3322 23456888999999986 45889999999999999999999999654332 222222221 222223345788
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
++.+++.+||+.||++|||+.+|+..
T Consensus 236 ~~~~li~~~l~~~p~~Rpt~~~i~~~ 261 (267)
T cd08229 236 ELRQLVNMCINPDPEKRPDITYVYDV 261 (267)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHHHH
Confidence 99999999999999999999977654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=328.00 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=214.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCC---E-EEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGD---A-FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~-~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
++-.+.+.||+|+||.||+|.....+. . ||+|....+.........++.+|+++++.+ +|||||+++|+......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCc
Confidence 456667899999999999999765422 3 899988765445667788999999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
+++|||+|+||+|.++|...+. ++..+...++.+.+.||+|||++++|||||-.+|+|++.++. +||+|||+|+..
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~---vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV---VKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe---EEeCccccccCC
Confidence 9999999999999999998874 999999999999999999999999999999999999975444 899999999865
Q ss_pred CCCCccc-ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 210 KPGEKFS-EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 210 ~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
....... ...-...|+|||.+. +-|+.++|||||||++||+++ |..||.+....+....+..... +...+...|+
T Consensus 313 ~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~--r~~~~~~~p~ 390 (474)
T KOG0194|consen 313 SQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY--RMPIPSKTPK 390 (474)
T ss_pred cceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc--cCCCCCCCHH
Confidence 4111111 112346799999987 569999999999999999998 8899999999988888855433 3334457789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++..++.+||..+|++|||+.++.+.+
T Consensus 391 ~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 391 ELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred HHHHHHHHhccCChhhccCHHHHHHHH
Confidence 999999999999999999999987654
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=330.40 Aligned_cols=252 Identities=23% Similarity=0.425 Sum_probs=215.4
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccc-cChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC--cEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--AVHL 133 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--~~~l 133 (315)
.++...||+|+|-+||+|.|..+|..||.-.+..... +.+...++|..|+.+|+.| +||||+++++++.+.. .+.+
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeee
Confidence 4667899999999999999999999999876654433 3455568999999999999 9999999999998654 5889
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
|+|.+.+|+|..++++.+..+...++.|++||+.||.|||++. |||||||.+||+|+ |..+.|||+|+|+|+....
T Consensus 121 iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhc
Confidence 9999999999999999999999999999999999999999985 99999999999997 5566699999999998755
Q ss_pred CCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHhccccCCCCCCccCCHHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
... ....|||.|||||.+...|+...||||||++++||+|+..||..+.... +..++..+..+-. ...--+++.++
T Consensus 199 s~a-ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s--l~kV~dPevr~ 275 (632)
T KOG0584|consen 199 SHA-KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA--LSKVKDPEVRE 275 (632)
T ss_pred ccc-ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH--hhccCCHHHHH
Confidence 443 3489999999999999999999999999999999999999997765543 3344444432211 11223689999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
||.+||.. .++|||+.|+|.++||
T Consensus 276 fIekCl~~-~~~R~sa~eLL~d~Ff 299 (632)
T KOG0584|consen 276 FIEKCLAT-KSERLSAKELLKDPFF 299 (632)
T ss_pred HHHHHhcC-chhccCHHHHhhChhh
Confidence 99999999 8999999999999998
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=309.98 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=209.5
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
...++|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.++.++.+|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 45678999999999999999999999999999999886432 12356788999999987899999999998643
Q ss_pred --CcEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 129 --TAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 129 --~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
+..++||||+++++|.+++.. ...+++..++.++.|++.||++||+.+++|+||||+||+++.++. ++|+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~---~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG---VKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC---EEEee
Confidence 358999999999999998763 346899999999999999999999999999999999999976555 89999
Q ss_pred eccccccCCCC-cccccccCCCccCchhhcc------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc
Q 021233 203 FGLSVFFKPGE-KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (315)
Q Consensus 203 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (315)
||++....... ......++..|+|||.+.. .++.++||||||+++++|++|+.||...........+.+....
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~ 251 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPP 251 (291)
T ss_pred cccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCC
Confidence 99987654322 2234568889999998742 2688999999999999999999999776654444444333221
Q ss_pred CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. .......+..+.++|.+||+.+|++||++.++++|+||
T Consensus 252 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 252 T-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred C-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 1 11123466789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=312.43 Aligned_cols=256 Identities=30% Similarity=0.503 Sum_probs=210.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+.+|+++++.+ +|+||+++++++...+..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEE
Confidence 369999999999999999999998999999998865432 233456789999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||++++.+.........+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~---~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV---LKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEEeeecccccCCCcc
Confidence 999988767666666566999999999999999999999999999999999999986555 9999999988765443
Q ss_pred -cccccccCCCccCchhhc-c-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-------------
Q 021233 214 -KFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------- 277 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (315)
......++..|+|||.+. . .++.++||||||+++++|++|+.||......+....+........
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 234457788999999875 4 578999999999999999999999977655544333322111000
Q ss_pred ------C---------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ------R---------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ------~---------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. .....+++++.+||.+||..+|++|||+.+++.++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 0112348889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=311.01 Aligned_cols=247 Identities=28% Similarity=0.455 Sum_probs=201.7
Q ss_pred eeeeeeeeecceEEEEEEEC----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 58 ELGRELGRGEFGITYLCTDR----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.+.+.||.|+||.||+|.+. ..+..|+||.+... ......+.+.+|++.++++ +||||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccc-cccccccccccccccccccc
Confidence 46789999999999999987 34677999998542 2333467899999999999 99999999999998888999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
|+||+++|+|.+++... ..+++..+..++.|++.||.|||+++++|+||+++||+++.++. +||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~---~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ---VKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE---EEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc
Confidence 99999999999999987 66999999999999999999999999999999999999987665 99999999987632
Q ss_pred CCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 212 GEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 212 ~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
... .........|+|||.+. ..++.++||||||+++||+++ |+.||......+....+.+... ......++.
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 232 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR---LPIPDNCPK 232 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE---TTSBTTSBH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ceeccchhH
Confidence 221 12335667899999986 458999999999999999999 7899988887777777754432 223346789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+.++|..||+.||++|||+.++++.|
T Consensus 233 ~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 233 DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 999999999999999999999998754
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=306.10 Aligned_cols=254 Identities=28% Similarity=0.493 Sum_probs=208.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccc--cChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--Cc
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~ 130 (315)
.+|++.+.||+|+||.||.|.+..++..||+|.+..... ......+.+.+|+.+++++ .||||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 469999999999999999999999999999998764321 1223356788999999999 999999999988763 56
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++++|||+++++|.+++.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+....
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~l~Dfg~~~~~~ 157 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC---EEECcCccccccc
Confidence 8899999999999999988777899999999999999999999999999999999999976555 8999999987543
Q ss_pred CC----CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 211 PG----EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 211 ~~----~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.. .......++..|+|||.+. ..++.++||||||+++|+|++|+.||............... ...+..+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVLPPHVS 235 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcC--CCCCCCchhhC
Confidence 21 1223356888999999876 45889999999999999999999999765544443333221 11222334567
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+.+++++||. +|++||++.+++.|+|+
T Consensus 236 ~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 236 DHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 889999999995 89999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=305.48 Aligned_cols=254 Identities=27% Similarity=0.457 Sum_probs=211.0
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||+|+||.||+|.+..++..|++|.+...... ......+.+|+.+++.+ +|+||+++++.+...+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEE
Confidence 589999999999999999999888999999998765432 34567899999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc-
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~- 214 (315)
||+++++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||++++++. ++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV---IKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEcccccccccCCCCCc
Confidence 99999999999988777899999999999999999999999999999999999986554 89999999876543322
Q ss_pred ----ccccccCCCccCchhhcc-c---CCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHhccccCCCCCCccCC
Q 021233 215 ----FSEIVGSPYYMAPEVLKR-N---YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 215 ----~~~~~gt~~y~aPE~~~~-~---~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.....+++.|+|||.+.+ . .+.++||||||++++++++|..||....... ....+.. ......+....++
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLS 234 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCcccccC
Confidence 123467889999998763 3 7889999999999999999999996553222 2222222 1111112223458
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+.++|.+||+.+|++|||+.+++.|+|+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 899999999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=309.21 Aligned_cols=257 Identities=24% Similarity=0.441 Sum_probs=211.3
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC---hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+|+..+.||+|++|.||+|.+..+++.+|+|++....... ....+.+.+|+.+++.+ +|+|++++++++...+..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEE
Confidence 4788899999999999999999999999999986543211 12346789999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+|+||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++. .++|+|||.+......
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~--~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ--RLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEcccccccccccc
Confidence 99999999999999988778999999999999999999999999999999999999975433 3899999998765432
Q ss_pred C-----cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcc-ccCCCCCCccCC
Q 021233 213 E-----KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-LDFRRDPWPKVS 285 (315)
Q Consensus 213 ~-----~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 285 (315)
. ......++..|+|||.+. ..++.++|+||||++++++++|..||...........+.... ....+.....++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 112346788999999876 458899999999999999999999996544322222222111 112233334578
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++.+++.+||..+|++||++.+++.|+||
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~ 267 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVF 267 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCccc
Confidence 999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=306.95 Aligned_cols=248 Identities=21% Similarity=0.350 Sum_probs=209.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.+|++.+.||+|++|.||+|.+..+++.+|+|.+... ......+.+|+.+++.+ +|+|++++++++...+..+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEE
Confidence 4689999999999999999999989999999987643 22346788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||++++++. ++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc---EEeCCCccccccccc
Confidence 99999999999987543 4899999999999999999999999999999999999976554 899999999876443
Q ss_pred Ccc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 213 EKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 213 ~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
... ....++..|+|||.+. ..++.++||||||+++++|++ |..||......+....+... ........++.++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 234 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG---YRMERPEGCPPKV 234 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC---CCCCCCCCCCHHH
Confidence 221 1223456799999876 458899999999999999998 99999877766665555443 2233445688999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+++.+||..+|++|||+.++++.|
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l 259 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAF 259 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHH
Confidence 9999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=309.94 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=204.9
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--CcEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVHLV 134 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv 134 (315)
|++.+.||+|+||.||+|.+..+++.+|+|.+..... ... .....+|+..+.++.+|+|++++++++... +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999998999999998865421 222 223457899999986699999999999887 889999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
+||+++ +|.+.+... ..+++..++.++.|++.||+|||+.|++||||+|+||+++. ..++|+|||++.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~----~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD----DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC----CCeEEEecccccccccCC
Confidence 999975 888887653 46899999999999999999999999999999999999976 449999999998765444
Q ss_pred cccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC--------------
Q 021233 214 KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-------------- 277 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 277 (315)
......+++.|+|||.+. +.++.++||||||+++++|++|..||...+..+....+........
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 444556889999999764 3478899999999999999999999977665544443322111100
Q ss_pred ----CC-------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ----RD-------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ----~~-------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ..+.+++++.++|.+||+++|++||++.+++.|+||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 013467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=310.56 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=203.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|++|.||+|.+..+++.||+|.+...... .....+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEE
Confidence 5799999999999999999999888999999998654321 1224467899999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||+++ +|.+++... ..+++..++.++.|+++||.|||+.+++||||||+||+++.++. ++|+|||++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC---EEECccccccccCCCC
Confidence 999975 899888764 35899999999999999999999999999999999999987655 899999998754322
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHhccccCC------------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFR------------ 277 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~------------ 277 (315)
.......++..|+|||.+.+ .++.++||||+|+++++|++|..||.... ..+....+.+......
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 12223356788999998753 47899999999999999999999996554 2222222211100000
Q ss_pred --------------CCCCccCC--HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 --------------RDPWPKVS--ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 --------------~~~~~~~~--~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+.++ .++.+++.+||+.+|++|||+.+++.++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00012234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=311.08 Aligned_cols=249 Identities=28% Similarity=0.456 Sum_probs=199.1
Q ss_pred eeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhC--CCCCCcceeEEEEEcCCcEEEEEEecC
Q 021233 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL--PKHQNIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l--~~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
.||+|+||.||++.+..+++.+|+|.+.............+.+|..++..+ .+|+|++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999989999999988765433222223344454443332 279999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccc
Q 021233 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219 (315)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 219 (315)
+++|.+++...+.+++..+..++.|++.||.|||+.+++|+||||+|||++.++. ++|+|||++....... .....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~---~~l~dfg~~~~~~~~~-~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKK-PHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC---EEEccCCcceeccccC-ccCcC
Confidence 9999999988888999999999999999999999999999999999999976554 8999999987554322 23346
Q ss_pred cCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 220 GSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 220 gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
|++.|+|||.+. ..++.++||||+|+++++|++|..||........ ..+...........+..+++++.++|.+||.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPDSFSPELKSLLEGLLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCccccCHHHHHHHHHHhc
Confidence 899999999875 3478999999999999999999999965432211 1111112222333445678999999999999
Q ss_pred CCcCCCC-----CHHHHhcccCC
Q 021233 298 PDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 298 ~~P~~Rp-----s~~e~l~~l~f 315 (315)
.||++|| |+.++++|+||
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccc
Confidence 9999999 69999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=311.18 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=208.0
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++++.||.|++|.||+|.+..++..||+|.+..... .......+.+|+++++++ +||||+++++++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEe
Confidence 48899999999999999999998999999998865432 222345788999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||+. ++|.+++... ..+++..++.++.|++.||+|||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~---~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEeeccchhhcccCc
Confidence 9996 5888888653 45899999999999999999999999999999999999987655 8999999987654322
Q ss_pred -cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-------------
Q 021233 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------- 277 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (315)
......+++.|+|||.+.+ .++.++||||||+++++|+||+.||......+....+.+......
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 2233457889999998753 368899999999999999999999977665544443332211100
Q ss_pred ------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+.+++++.++|.+||+.||++|||+.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=312.11 Aligned_cols=251 Identities=26% Similarity=0.371 Sum_probs=209.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||++.+..+++.+|+|++.... .......+.+|+++++.+ +||||+++++++...+.+++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEE
Confidence 57999999999999999999999899999999876442 233356789999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+++|+||+|+||++++++. ++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~---~~l~d~gl~~~~~~~- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELINS- 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc---EEEccCCcccchhhh-
Confidence 9999999999999887789999999999999999999997 58999999999999976554 899999998654322
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH-----------HHHHHHHhccccCCCCC-
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-----------GVAQAIIRSVLDFRRDP- 280 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~- 280 (315)
......++..|+|||++. +.++.++||||||++++++++|..||...... +....+.... .+..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 234 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---PPRLP 234 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---CCCCC
Confidence 223457899999999875 56889999999999999999999999754432 1222222211 1111
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...++.++.+|+.+||+.||++|||+.|+++++||
T Consensus 235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 12367899999999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=331.84 Aligned_cols=261 Identities=28% Similarity=0.463 Sum_probs=216.4
Q ss_pred CCccccccceeeee-----eeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeE
Q 021233 48 PTGREIEERYELGR-----ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122 (315)
Q Consensus 48 ~~~~~~~~~y~~~~-----~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~ 122 (315)
+.++.++-+|+..+ +||+|.||+||.|++..+...+|||.+... .....+-+.+|+.+.+.| +|.|||+++
T Consensus 563 ~ane~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~L-rHkNIVrYL 638 (1226)
T KOG4279|consen 563 PANEKIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTL-RHKNIVRYL 638 (1226)
T ss_pred CcccceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHH-hhHhHHHHh
Confidence 33444444554433 699999999999999999999999998654 233456688999999999 999999999
Q ss_pred EEEEcCCcEEEEEEecCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEE
Q 021233 123 DTYEDDTAVHLVMELCEGGELFDRIVAR-GHY--TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (315)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l--~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vk 199 (315)
|.+..++.+-|.||-++||||.+++... +++ ++.+...+.+||++||.|||++.|||||||-+|||++ .-.+.+|
T Consensus 639 Gs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlK 716 (1226)
T KOG4279|consen 639 GSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLK 716 (1226)
T ss_pred hccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEE
Confidence 9999999999999999999999999865 456 7889999999999999999999999999999999996 3445699
Q ss_pred EEeeccccccCCCCc-ccccccCCCccCchhhc---ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc
Q 021233 200 AIDFGLSVFFKPGEK-FSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (315)
Q Consensus 200 l~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (315)
|+|||.++.+..-+. ..++.||..|||||++. +.|+.++|||||||++.||.||++||......... ...-+...
T Consensus 717 ISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-MFkVGmyK 795 (1226)
T KOG4279|consen 717 ISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-MFKVGMYK 795 (1226)
T ss_pred ecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-hhhhccee
Confidence 999999987644333 35678999999999986 35999999999999999999999999765443322 22233334
Q ss_pred CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..++.+..++.+.+++|.+|+.+||.+|||+.++|..+|+
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFl 835 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFL 835 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCccc
Confidence 4556667788999999999999999999999999999885
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=310.47 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=207.8
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----- 127 (315)
..+.|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....+..|+.+++++.+|+|++++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3467999999999999999999999999999999875432 2345688899999998789999999999853
Q ss_pred -CCcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 128 -DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
....+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~---~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE---VKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeCc
Confidence 46789999999999999988753 34888999999999999999999999999999999999976554 8999999
Q ss_pred cccccCCC-CcccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC
Q 021233 205 LSVFFKPG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (315)
Q Consensus 205 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (315)
++...... .......+++.|+|||.+. ..++.++|+||||+++|+|++|..||...........+.+.. ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~ 244 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--PP 244 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCC--CC
Confidence 98754322 2234457889999999864 247889999999999999999999997655443333332221 11
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
......++.++.++|.+||+.||.+||++.+++.|+||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 11223578999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=319.49 Aligned_cols=256 Identities=38% Similarity=0.646 Sum_probs=230.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+..-|.+.+.||+|.|++|-+|++.-+|+.||||++.+....... ...+.+|+.-|+.+ +|||||++|.+......+
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHh-cCcCeeeeeehhcccceE
Confidence 4566799999999999999999999999999999999988765543 34577899999998 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
|+|+|+-++|+|+|++.++. .+.++.+.+++.||+.|+.|+|+..+|||||||+||++... -+.|||+|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK--lGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK--LGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee--cCceEeeeccccccCC
Confidence 99999999999999998654 49999999999999999999999999999999999998643 2349999999999999
Q ss_pred CCCcccccccCCCccCchhhccc-CC-CcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKRN-YG-PEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~-~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
++....+.+|+..|-|||++.+. |+ ++.||||||++||-|+.|++||+..+..+.+-.|+...+..+ ..++.++
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS~eC 246 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVSKEC 246 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhhHHH
Confidence 99999999999999999998754 54 678999999999999999999999998888888887766543 4578999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+||..||..||.+|.|.++|..+.|+
T Consensus 247 rdLI~sMLvRdPkkRAslEeI~s~~Wl 273 (864)
T KOG4717|consen 247 RDLIQSMLVRDPKKRASLEEIVSTSWL 273 (864)
T ss_pred HHHHHHHHhcCchhhccHHHHhccccc
Confidence 999999999999999999999999885
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=304.24 Aligned_cols=249 Identities=29% Similarity=0.518 Sum_probs=211.1
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||.|+||.||++.+..++..+|+|.+.... .....+.+.+|+.+++.+ +|+|++++++.+...+..+++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEE
Confidence 5889999999999999999999999999999886432 223456788999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||||+||+++.++. ++|+|||.+.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK---VKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc---EEEcccCcceeecccc
Confidence 999999999988653 34899999999999999999999999999999999999976554 8999999997654332
Q ss_pred -cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......+++.|+|||++.+ .++.++|+||||+++++|++|..||...........+...... .....++..+.++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 231 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK---PLPSHYSYELRSL 231 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC---CCCcccCHHHHHH
Confidence 2234578889999999864 5889999999999999999999999877766665555543322 2234578899999
Q ss_pred HHHhcCCCcCCCCCHHHHhccc
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l 313 (315)
|.+||+.||++|||+.+++...
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhcc
Confidence 9999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=342.09 Aligned_cols=251 Identities=28% Similarity=0.396 Sum_probs=201.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||.||+|.+..+++.||+|++...........+++.+|+.+++.+ +||||+++++++...+..+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEE
Confidence 4799999999999999999999999999999998765433344456789999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 135 MELCEGGELFDRIVAR-----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-----------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
|||++|++|.+++... ..++...++.++.|++.||.|||+.||+||||||+||+++.++. ++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~---vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE---VVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC---EEEEec
Confidence 9999999999988641 23556778899999999999999999999999999999976655 899999
Q ss_pred ccccccCCCC-------------------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH
Q 021233 204 GLSVFFKPGE-------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (315)
Q Consensus 204 g~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 263 (315)
|++....... ......||+.|+|||++. ..++.++|||||||+++||+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997652110 112346899999999976 45899999999999999999999999764433
Q ss_pred HHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHh
Q 021233 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310 (315)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l 310 (315)
...... ....+........+++.+.+++.+||+.||++||+..+.+
T Consensus 238 ki~~~~-~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 238 KISYRD-VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred hhhhhh-hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 222211 1101111122346789999999999999999997655443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=308.75 Aligned_cols=253 Identities=21% Similarity=0.337 Sum_probs=206.2
Q ss_pred cccceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence 45789999999999999999998642 35679999875432 223345688999999999 99999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCC
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~ 197 (315)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--- 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--- 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC---
Confidence 999999999999999999986532 2567889999999999999999999999999999999986554
Q ss_pred EEEEeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhc
Q 021233 198 LKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS 272 (315)
Q Consensus 198 vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 272 (315)
++|+|||++......... ....+++.|+|||++. +.++.++||||||++++||++ |..||...........+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 899999998754332211 1234567899999976 458999999999999999999 78999877766655555443
Q ss_pred cccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.. ......+++.+.+++.+||+.+|++|||+.|++++++
T Consensus 238 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 238 GL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred Cc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 22 2223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=344.90 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=215.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCC-----EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGD-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
...++...||+|+||.||.|....... .||+|.+... .+......|.+|+.+|+.+ +|||||+++|++....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCC
Confidence 467888999999999999999765433 3888887654 4566788999999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 130 AVHLVMELCEGGELFDRIVAR-------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
..+|++|||.||+|..+++.. ..++...++.++.++|.|++||+++++|||||..+|+|++.. .+|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~---r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER---RVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc---CcEEEcc
Confidence 999999999999999999875 248999999999999999999999999999999999999755 5599999
Q ss_pred eccccccCCCCccc---ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCC
Q 021233 203 FGLSVFFKPGEKFS---EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFR 277 (315)
Q Consensus 203 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (315)
||+|+......... .-.....|||||.+. +.++.|+|||||||++||++| |..||....+.+......++. +
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg---R 922 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG---R 922 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC---c
Confidence 99999443222221 112345799999987 779999999999999999998 999999999988888777664 5
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+.++.||+.+.++|..||+.+|++||++..|++.+
T Consensus 923 L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 923 LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhh
Confidence 666678999999999999999999999999998754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=303.95 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=206.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||++.+. ++..+|+|.+.... .....+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA----MSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC----ccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEE
Confidence 46899999999999999999875 46689999876432 2246788999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV---VKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe---EEECCCCCccccCCCc
Confidence 9999999999998753 45899999999999999999999999999999999999976554 8999999987653322
Q ss_pred ccc--ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 214 KFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 214 ~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
... ...++..|+|||.+. ..++.++|+||||+++++|++ |+.||......+....+.+.... ..+...+.++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~ 231 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---YRPKLASMTVY 231 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHHH
Confidence 221 223456799999976 458899999999999999999 89999887777777766654322 22334678899
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccc
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++.+||+.+|++|||+.++++.|
T Consensus 232 ~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 232 EVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHccCCcccCcCHHHHHHhh
Confidence 999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=310.39 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=209.3
Q ss_pred cceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .....+.+.+|+++++.+ +|+||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNF-QHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCC
Confidence 469999999999999999998743 35789999886542 222356899999999999 8999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 021233 130 AVHLVMELCEGGELFDRIVARG--------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~ 195 (315)
..++||||+++++|.+++...+ .+++..+..++.|++.||.+||++|++||||||+||+++.++.
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~- 160 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV- 160 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe-
Confidence 9999999999999999997542 3788899999999999999999999999999999999986655
Q ss_pred CCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 021233 196 APLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 270 (315)
++|+|||++........ .....+++.|+|||.+. +.++.++||||||+++++|++ |..||......+....+.
T Consensus 161 --~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05049 161 --VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT 238 (280)
T ss_pred --EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 89999999875432221 12334577899999876 568999999999999999998 999998877777666666
Q ss_pred hccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...... ....++..+.+++.+||+.||++||++.|++..+
T Consensus 239 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 239 QGRLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred cCCcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 443322 2345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=314.87 Aligned_cols=250 Identities=20% Similarity=0.272 Sum_probs=203.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCE----EEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
..+|++.+.||+|+||.||+|.+..++.. ||+|.+.... .....+++.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-
Confidence 35799999999999999999998666554 8999886432 233456788999999999 999999999998765
Q ss_pred cEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++++||+++|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++. +||+|||++..
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~---~kl~DfG~a~~ 158 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKL 158 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc---EEEcccccccc
Confidence 5679999999999999998754 5889999999999999999999999999999999999976554 89999999987
Q ss_pred cCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 209 FKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 209 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
....... ....++..|+|||.+. ..++.++||||||+++|||++ |..||......+....+ ..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~--~~~~~~ 235 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGER--LPQPPI 235 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hCCCC--CCCCCC
Confidence 6543322 1223456799999876 568999999999999999998 99999776655543333 22221 222345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.++.+++.+||..+|.+||++.+++.++
T Consensus 236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l 265 (316)
T cd05108 236 CTIDVYMIMVKCWMIDADSRPKFRELIIEF 265 (316)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=313.10 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=211.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++.+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.+ +|||++++.+++...+..
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeE
Confidence 4456799999999999999999999888999999998654434444456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++|+||++| +|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~---~kL~dfg~~~~~~ 166 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT---VKLADFGSASLVS 166 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC---EEEeecCcceecC
Confidence 999999974 77777654 446899999999999999999999999999999999999976655 8999999987654
Q ss_pred CCCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.. ....+++.|+|||++. +.++.++||||||+++|+|++|..||...........+..... +......+++
T Consensus 167 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 241 (307)
T cd06607 167 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLSSNDWSD 241 (307)
T ss_pred CC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC--CCCCchhhCH
Confidence 32 3346788999999863 4488899999999999999999999977665554444433211 1111234678
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.++|.+||+.+|++||++.+++.|+||
T Consensus 242 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 270 (307)
T cd06607 242 YFRNFVDSCLQKIPQDRPSSEELLKHRFV 270 (307)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 99999999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=313.09 Aligned_cols=255 Identities=30% Similarity=0.455 Sum_probs=207.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--CcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~ 132 (315)
++|++.+.||+|+||.||+|.+..+|+.||+|.+....... .....+.+|+.+++++ +|+|++++++++... +..+
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEE
Confidence 57999999999999999999999999999999986543222 1223456799999999 999999999998755 5689
Q ss_pred EEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||.+.....
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~kL~dfg~~~~~~~ 160 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGL 160 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECccceeeecCC
Confidence 99999965 888888753 56899999999999999999999999999999999999976554 99999999986643
Q ss_pred C-CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC----------
Q 021233 212 G-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR---------- 278 (315)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 278 (315)
. .......+++.|+|||.+.+ .++.++||||||+++|+|++|..||......+....+.........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 161 PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 3 22233355788999998753 4789999999999999999999999887777666655442211100
Q ss_pred ---------CC-------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ---------DP-------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ---------~~-------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ....++++.++|.+||+.||++|||+.+++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f 293 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence 00 12257889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=305.03 Aligned_cols=253 Identities=26% Similarity=0.515 Sum_probs=209.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|++|.||+|.+..+++.||+|.+...........+.+.+|+.+++++ +|+|++++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEE
Confidence 4799999999999999999999989999999988755444444567899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
|||+++++|.+++.. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~---~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV---VKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc---EEEeccceeeecc
Confidence 999999999998864 234899999999999999999999999999999999999986655 8999999987654
Q ss_pred CCC-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
... ......+++.|+|||.+. ..++.++|+||||+++++|++|..||..... ......+.... ..+.+....+.
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD--YPPLPADHYSE 235 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--CCCCChhhcCH
Confidence 322 223456888999999876 4588999999999999999999999854432 22223332221 12222235788
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.++|.+||..+|++|||+.+++..+
T Consensus 236 ~~~~~i~~cl~~~p~~Rp~~~~il~~~ 262 (267)
T cd08224 236 ELRDLVSRCINPDPEKRPDISYVLQVA 262 (267)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=312.84 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=208.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--CcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~ 132 (315)
++|++.+.||.|+||.||+|.+..+++.+++|.+...... ......+.+|+.+++++ +||||+++++++... +..+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEE
Confidence 4699999999999999999999989999999998754332 22234567899999999 899999999998877 8999
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+|+||+++ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~---~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc---EEEeecCceeeccC
Confidence 99999975 9999887644 4899999999999999999999999999999999999986655 89999999986654
Q ss_pred C-CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-----------
Q 021233 212 G-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR----------- 277 (315)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 277 (315)
. .......+++.|+|||.+.+ .++.++|+||||+++++|++|..||...........+........
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 3 23344567889999998763 368899999999999999999999987665554444432211000
Q ss_pred ---------------CCCCcc--CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ---------------RDPWPK--VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ---------------~~~~~~--~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+. +++.+.++|.+||+.+|++|||+.|++.|.||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 001112 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=296.61 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=205.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
.-+++|++.+.||+|||+-||++....++..+|+|.+... +..+.+...+|++..+++ +|||+++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhcc
Confidence 3457899999999999999999999999999999999755 355678899999999999 999999999886433
Q ss_pred --CcEEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEE
Q 021233 129 --TAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKA 200 (315)
Q Consensus 129 --~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl 200 (315)
...|++++|...|||.+.+... ..+++.+++.|+.+++.||++||+.. ++||||||.|||+.+++. .+|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~---~vl 170 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL---PVL 170 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc---eEE
Confidence 4589999999999999988743 35899999999999999999999998 999999999999987555 799
Q ss_pred EeeccccccCCC----------CcccccccCCCccCchhhcc----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH--
Q 021233 201 IDFGLSVFFKPG----------EKFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-- 264 (315)
Q Consensus 201 ~Dfg~a~~~~~~----------~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-- 264 (315)
.|||.++...-. ........|..|+|||.+.. ..+.++|||||||+||+|+.|..||.......
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 999998754211 12234567889999999862 37889999999999999999999994322211
Q ss_pred HHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..-++......++.. ..+++.+.++|..||+.||.+||++.+++.++
T Consensus 251 laLAv~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~ 297 (302)
T KOG2345|consen 251 LALAVQNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSKL 297 (302)
T ss_pred EEEeeeccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 111122222333333 23899999999999999999999999999865
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=303.83 Aligned_cols=252 Identities=31% Similarity=0.538 Sum_probs=213.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--CCcEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVHL 133 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~~l 133 (315)
+|++.+.||.|+||.||+|.+..++..+|+|.+..... .....+.+..|+.+++.+ +|+|++++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEE
Confidence 48899999999999999999999999999998865433 334456788999999999 99999999998764 456899
Q ss_pred EEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 134 VMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCH-----KHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH-----~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
+|||+++++|.+++.. ...+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++. ++|+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~---~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN---VKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC---EEEeccc
Confidence 9999999999999875 356899999999999999999999 899999999999999986554 9999999
Q ss_pred cccccCCCCc-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 205 LSVFFKPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 205 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
++........ .....+++.|+|||.+. ..++.++|+||||+++++|++|..||...........+..... +....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 232 (265)
T cd08217 156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF---RRIPY 232 (265)
T ss_pred ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC---CCCcc
Confidence 9987654433 34457899999999976 4588999999999999999999999988776665555554432 22334
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+.++.+++.+||+.+|++||++.++++|+|+
T Consensus 233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 678999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=322.90 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=203.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCC-----CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++++.||+|+||.||+|.+... +..||+|++.... .....+.+.+|+.+++++..||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45799999999999999999987433 3469999986542 2333567899999999995599999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhc----------------------------------------------------------
Q 021233 129 TAVHLVMELCEGGELFDRIVAR---------------------------------------------------------- 150 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~---------------------------------------------------------- 150 (315)
+..++||||+++|+|.+++..+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999887642
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC
Q 021233 151 --------------------------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (315)
Q Consensus 151 --------------------------------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~ 192 (315)
..+++..+..++.|++.||.|||+.+|+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999765
Q ss_pred CCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 021233 193 KETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 267 (315)
Q Consensus 193 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~ 267 (315)
+. ++|+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ |..||..........
T Consensus 274 ~~---~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 274 KI---VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CE---EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 54 89999999986543222 12335677899999876 458999999999999999997 999997654433333
Q ss_pred HHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...... .+......+++++.+++.+||+.||++|||+.++.+.+
T Consensus 351 ~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 351 NKIKSG--YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HHHhcC--CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 222222 12223346789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=309.34 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=209.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||.|++|.||+|.+..+++.+++|.+..... ......+.+|+++++.+ +||||+++++.+...+..+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEE
Confidence 368889999999999999999999999999998876532 23456788999999999 799999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~---~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC---EEEeecccchhhHHH
Confidence 9999999999999876 679999999999999999999999 99999999999999987554 999999998765332
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC-----hHHHHHHHHhccccCCCCCCcc-CC
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVLDFRRDPWPK-VS 285 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-~~ 285 (315)
... ...++..|+|||.+. ..++.++||||||+++++|++|..||.... ..+..+.+... ..+..... ++
T Consensus 155 ~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (265)
T cd06605 155 LAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PPPRLPSGKFS 230 (265)
T ss_pred Hhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CCCCCChhhcC
Confidence 222 267888999999876 458899999999999999999999996542 22222222222 11122222 78
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++.++|.+||..||++|||+.+++.|+||
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 899999999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=319.26 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=206.7
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.+ +|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCc
Confidence 35678999999999999999999999999999999886432 2233345677899999999 999999999988643
Q ss_pred ---CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||+
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~---~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEccCcc
Confidence 357999999964 888877654 899999999999999999999999999999999999987655 89999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------- 277 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 277 (315)
+.............+++.|+|||.+. ..++.++||||||+++++|++|+.||...........+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 98765444334456889999999876 4589999999999999999999999976654443333322111100
Q ss_pred ---------------C-----------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ---------------R-----------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ---------------~-----------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. ......++++.++|.+||+.||++|||+.|+|.|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 0 0011245678999999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=304.99 Aligned_cols=248 Identities=22% Similarity=0.372 Sum_probs=207.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|++|.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.+ +|+||+++++.+...+..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEE
Confidence 57999999999999999999964 56789999876432 2356789999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+++|+||||+||+++.++. ++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM---CKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc---EEECCCccceecCCC
Confidence 9999999999998753 45889999999999999999999999999999999999976554 899999999865432
Q ss_pred Ccc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 213 EKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 213 ~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
... ....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+.... +.+....++.++
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 233 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY---RMPRMENCPDEL 233 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHHH
Confidence 211 2234566799999876 558899999999999999998 999998777666666655432 223334678999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.+++.+||+.+|++|||+.++++.|+
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHh
Confidence 99999999999999999999987663
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=313.52 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=190.2
Q ss_pred eeeeeeecceEEEEEEECC--CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--CCcEEEEE
Q 021233 60 GRELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVHLVM 135 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~ 135 (315)
...||+|+||+||+|.+.. ++..+|+|.+.... ....+.+|+.+++.+ +||||+++++++.. ....++|+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEE
Confidence 3679999999999999653 56789999886432 124577899999999 99999999999853 56789999
Q ss_pred EecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC-CCCCEEEEeecc
Q 021233 136 ELCEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGL 205 (315)
Q Consensus 136 e~~~~~sL~~~l~~~---------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~-~~~~vkl~Dfg~ 205 (315)
||+.+ +|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||+..++ ....+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99965 887777521 2478899999999999999999999999999999999996442 344599999999
Q ss_pred ccccCCCC----cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH---------HHHHHHH
Q 021233 206 SVFFKPGE----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---------GVAQAII 270 (315)
Q Consensus 206 a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---------~~~~~~~ 270 (315)
++...... ......+|+.|+|||.+.+ .++.++||||||++++||+||.+||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 98654322 2234578999999998763 4789999999999999999999999643321 1111111
Q ss_pred hccccCCC----------------------------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 271 RSVLDFRR----------------------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 271 ~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
........ ......+..+.+|+.+||+.||.+|||+.|+|+|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 10000000 0001234568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=320.14 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=202.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
+..|++++.||+||.+.||++... +...+|+|.+.... .+......+..|+..|.+|.+|.+|+++++|-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 346999999999999999999864 45667777665443 3445577899999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||-+ .+|..+|.+... .+.-.++.+..||+.|+.++|.+||||.||||.|+|+.+ +.+||+|||.|.....+
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk----G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK----GRLKLIDFGIANAIQPD 512 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe----eeEEeeeechhcccCcc
Confidence 999974 489999987755 444588899999999999999999999999999999963 33899999999887665
Q ss_pred Ccc---cccccCCCccCchhhcc------------cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhccccC
Q 021233 213 EKF---SEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDF 276 (315)
Q Consensus 213 ~~~---~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~ 276 (315)
... .+.+||+.|||||.+.. ..++++|||||||+||+|+.|+.||...... .-+..+......+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~I 592 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEI 592 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccc
Confidence 432 56799999999998731 1578999999999999999999999654321 1222232221111
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+..+ -..++++++..||+.||.+|||+.++|+|+|+
T Consensus 593 efp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl 630 (677)
T KOG0596|consen 593 EFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQHPFL 630 (677)
T ss_pred cccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhcCccc
Confidence 111111 12348999999999999999999999999985
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=308.48 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=202.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||+|.+..+|+.||+|.+...... .....+..|+.++.+..+|||++++++++...+..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 3699999999999999999999999999999988654321 22345666777644444899999999999999999999
Q ss_pred EEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 135 MELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
|||++ ++|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++. +||+|||++...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~---~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ---VKLCDFGISGYL 154 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC---EEEeeccccccc
Confidence 99996 588877754 23589999999999999999999997 9999999999999976555 899999999865
Q ss_pred CCCCcccccccCCCccCchhhcc-----cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHhccccCCCCCCcc
Q 021233 210 KPGEKFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
..........++..|+|||.+.+ .++.++|+||||+++++|++|+.||.... ..+.......... .......
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~ 232 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS--PQLPAEK 232 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--CCCCccc
Confidence 44333344578889999998742 36889999999999999999999996432 2222222222211 1111234
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++++.++|.+||..+|++||++.+++.|+||
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 264 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 78999999999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=310.90 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=208.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCC----------------CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENG----------------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 117 (315)
.++|++++.||+|+||.||+|.+...+ ..||+|.+.... .....+.+.+|+++++.+ +|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRL-SDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhc-CCCC
Confidence 357999999999999999999876543 457999876543 223456789999999999 9999
Q ss_pred cceeEEEEEcCCcEEEEEEecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 021233 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (315)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~N 186 (315)
|+++++++..++..+++|||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997755 58999999999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh--CCCCCCCC
Q 021233 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAE 260 (315)
Q Consensus 187 ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t--g~~p~~~~ 260 (315)
|++++++. ++|+|||++........ .....+++.|+|||.+. ..++.++||||||+++|+|++ +..||...
T Consensus 161 ili~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 161 CLVGKNYT---IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eeecCCCc---eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99986644 89999999876543321 22345677899999876 468999999999999999998 77888766
Q ss_pred ChHHHHHHHHhcc----ccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 261 TEQGVAQAIIRSV----LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 261 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
...+......... ..........+++++.+++.+||+.||++|||+.+++..|.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 6655555443321 11111223456789999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=311.66 Aligned_cols=255 Identities=21% Similarity=0.280 Sum_probs=204.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|...+.||+|+||.||++.+..+++.+|+|.+...... .....+.+|+.++.++.+|+||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3577788999999999999999999999999998754322 34567889999999995699999999999999999999
Q ss_pred EEecCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 135 MELCEGGELFDRIV-----ARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 135 ~e~~~~~sL~~~l~-----~~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
|||+.. ++.++.. ....+++..+..++.+++.||+|||+. +++||||||+||+++.++. ++|+|||++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN---IKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc---EEEeecchhHH
Confidence 999854 6655432 235699999999999999999999975 9999999999999976554 89999999976
Q ss_pred cCCCCcccccccCCCccCchhhcc----cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhcc-ccCCCCCCc
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-LDFRRDPWP 282 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~ 282 (315)
...........+++.|+|||.+.. .++.++||||||+++++|++|+.||...... +....+.... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred hccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 544433344578899999999763 4889999999999999999999999654321 1112221111 111122223
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++.++.+||.+||+.+|++|||+.+++.|+||
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 578999999999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=302.71 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=207.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||+||.|.+.. +..+|+|.+..... ..+.+.+|+.+++.+ +||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEE
Confidence 469999999999999999998753 55699998764322 246789999999999 899999999999998899999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++. +||+|||.+.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~---~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC---VKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC---EEECCCccceecCCCc
Confidence 9999999999998764 35899999999999999999999999999999999999976554 8999999987654332
Q ss_pred ccc--ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 214 KFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 214 ~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
... ...++..|++||.+. ..++.++||||||+++|+|++ |..||...........+....... .....++.+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY---RPHLASEKVY 231 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence 211 123456799999986 458899999999999999998 999998777666666665543322 2234688999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+++.+||+.+|.+||++.+++..++
T Consensus 232 ~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 232 AIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHHHhhC
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=309.27 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=206.6
Q ss_pred cceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.+|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.+++++ +|||++++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCC
Confidence 47999999999999999999852 34566899987643 223356789999999999 8999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 130 AVHLVMELCEGGELFDRIVARG-------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
..++||||+++++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~-- 158 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-- 158 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--
Confidence 9999999999999999987543 3899999999999999999999999999999999999976554
Q ss_pred CEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHh
Q 021233 197 PLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 271 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 271 (315)
++|+|||++........ .....+++.|+|||.+. ..++.++||||||+++++|++ |..||...........+..
T Consensus 159 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 159 -VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred -EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 89999999976533221 12334567899999887 458999999999999999998 9999988777666666655
Q ss_pred ccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..... ....++.++.+|+.+||+.||.+|||+.++++.+
T Consensus 238 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l 276 (288)
T cd05093 238 GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276 (288)
T ss_pred CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 43221 2235788999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=305.95 Aligned_cols=248 Identities=26% Similarity=0.429 Sum_probs=201.4
Q ss_pred ccceeeeeee--eeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 54 EERYELGREL--GRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 54 ~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.++|++.+.+ |+|+||.||++.+..++..+|+|.+....... .|+.....+.+|+|++++++.+...+..
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3467776666 99999999999999999999999986542211 1333333333799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||||+++++|.+++.....+++..++.++.|++.||.+||+.|++||||+|+||+++.++. .++|+|||.+.....
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD--RIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC--eEEEecCccceecCC
Confidence 999999999999999988778999999999999999999999999999999999999987652 389999999876543
Q ss_pred CCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHH-HHHHhccccCCCCCCccCCHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. ....++..|+|||++. ..++.++|+||||+++++|++|..||......... ..+.... ......++.+++.+.
T Consensus 163 ~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (267)
T PHA03390 163 P---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNAN 238 (267)
T ss_pred C---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHH
Confidence 2 2346788999999986 45889999999999999999999999755433221 2222221 223344456899999
Q ss_pred HHHHHhcCCCcCCCCC-HHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLT-AQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps-~~e~l~~l~f 315 (315)
++|.+||+.+|.+||+ ++++|+|+||
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhcCCcc
Confidence 9999999999999996 6999999998
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=306.03 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=208.7
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC----
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT---- 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~---- 129 (315)
.++|++.+.||.|++|.||+|.+..+++.+++|.+.... ...+.+.+|+.+++++.+|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 468999999999999999999998889999999886542 234678999999999977999999999997644
Q ss_pred --cEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 130 --AVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~---~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE---VKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe---EEECCC
Confidence 48999999999999998865 346899999999999999999999999999999999999986555 899999
Q ss_pred ccccccCCCC-cccccccCCCccCchhhcc------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC
Q 021233 204 GLSVFFKPGE-KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (315)
Q Consensus 204 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 276 (315)
|.+....... ......++..|+|||.+.. .++.++||||||+++++|++|..||...........+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 9987643322 2234568889999998642 36789999999999999999999997655444444444332111
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
......+++++.++|.+||..||++|||+.++++|+|+
T Consensus 238 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 -LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 11112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=317.39 Aligned_cols=253 Identities=21% Similarity=0.340 Sum_probs=201.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-
Q 021233 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~- 127 (315)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+.... .....+.+.+|+.++.++.+|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3579999999999999999997543 35789999886432 223345678899999999789999999998864
Q ss_pred CCcEEEEEEecCCCChHHHHHhc---------------------------------------------------------
Q 021233 128 DTAVHLVMELCEGGELFDRIVAR--------------------------------------------------------- 150 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------- 150 (315)
...+++++||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45788999999999999988542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc---ccccccCCC
Q 021233 151 ----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPY 223 (315)
Q Consensus 151 ----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~ 223 (315)
..+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++........ .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~---vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc---EEEeccccchhcccCcchhhccCCCCCcc
Confidence 25788999999999999999999999999999999999986544 89999999986543221 123345678
Q ss_pred ccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcC
Q 021233 224 YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPK 301 (315)
Q Consensus 224 y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 301 (315)
|+|||++. ..++.++|||||||++++|++ |..||......+.......... ........++++.+++.+||+.+|+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--RMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--CCCCCccCCHHHHHHHHHHccCChh
Confidence 99999876 569999999999999999998 9999976544333322222211 1122345688999999999999999
Q ss_pred CCCCHHHHhccc
Q 021233 302 RRLTAQQVLGKI 313 (315)
Q Consensus 302 ~Rps~~e~l~~l 313 (315)
+||++.+++++|
T Consensus 319 ~RPs~~ell~~l 330 (337)
T cd05054 319 DRPTFSELVEIL 330 (337)
T ss_pred hCcCHHHHHHHH
Confidence 999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=311.61 Aligned_cols=261 Identities=30% Similarity=0.466 Sum_probs=214.9
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-C----CcceeE
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-Q----NIVCLK 122 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~----~iv~~~ 122 (315)
..++.+..+|.+...+|+|.||.|-.+++.+++..||+|++..= ....+...-|+++|.++..+ | -+|++.
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 34567788999999999999999999999999999999988531 22345667799999999433 2 378999
Q ss_pred EEEEcCCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC-------
Q 021233 123 DTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK------- 193 (315)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~------- 193 (315)
+||...++.++|+|.+ |.|+.+++..+. +++...++.++.|+++++++||+.+++|.||||+|||+.+..
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence 9999999999999999 779999998765 489999999999999999999999999999999999996432
Q ss_pred ----------CCCCEEEEeeccccccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh
Q 021233 194 ----------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE 262 (315)
Q Consensus 194 ----------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 262 (315)
....|+|+|||.|+.. ...++..+.|..|+|||++.+ .++.++||||+||+|+|++||...|+...+
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred CCccceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 1344899999999854 344578899999999999764 699999999999999999999999998887
Q ss_pred HHHHHHHHhccccCCCC----------------CCcc--------------------------CCHHHHHHHHHhcCCCc
Q 021233 263 QGVAQAIIRSVLDFRRD----------------PWPK--------------------------VSENAKDLVRKMLDPDP 300 (315)
Q Consensus 263 ~~~~~~~~~~~~~~~~~----------------~~~~--------------------------~~~~l~~li~~~l~~~P 300 (315)
.+.+..+.+...+++.. .|+. ...+|.+||.+||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 77654443333332210 0100 12357899999999999
Q ss_pred CCCCCHHHHhcccCC
Q 021233 301 KRRLTAQQVLGKIEF 315 (315)
Q Consensus 301 ~~Rps~~e~l~~l~f 315 (315)
.+|+|+.|+|.|+||
T Consensus 395 ~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 395 ARRITLREALSHPFF 409 (415)
T ss_pred cccccHHHHhcCHHh
Confidence 999999999999998
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=304.02 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=213.6
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||.|++|.||+|.+..+++.|++|.+...... .....+.+|+..+.++ +|+|++++++++...+..++|+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEE
Confidence 689999999999999999999999999999998765321 3457799999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
||+++++|.+++.....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~---~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLD 155 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC---EEEccCccceecccCCC
Confidence 999999999999887789999999999999999999999 99999999999999976555 89999999886644333
Q ss_pred c-cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHhccccCCCCCCcc-CCHHH
Q 021233 215 F-SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVLDFRRDPWPK-VSENA 288 (315)
Q Consensus 215 ~-~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~l 288 (315)
. ....++..|+|||.+. ..++.++|+||||+++++|++|..||.... ..+....+.... ....... ++..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l 232 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP---PPSLPAEEFSPEF 232 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC---CCCCCcccCCHHH
Confidence 2 2456788999999876 458899999999999999999999997663 333333333221 1222233 78999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++|.+||+.+|++|||+.++++++||
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~ 259 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFI 259 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHH
Confidence 999999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=307.29 Aligned_cols=251 Identities=21% Similarity=0.370 Sum_probs=205.9
Q ss_pred cceeeeeeeeeecceEEEEEEEC----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 55 ERYELGRELGRGEFGITYLCTDR----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.+|++.+.||+|+||+||+|.+. .++..+++|.+.... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCc
Confidence 46899999999999999999853 356789999886432 233346788999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 021233 131 VHLVMELCEGGELFDRIVAR-----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~ 193 (315)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999998532 2378888999999999999999999999999999999997654
Q ss_pred CCCCEEEEeeccccccCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 021233 194 ETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (315)
. ++|+|||++....... ......++..|+|||.+. ..++.++||||||++++||++ |..||...........
T Consensus 162 ~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 162 H---VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred c---EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4 8999999997653322 123344567799999876 558999999999999999998 9999977666555554
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+..... ...+..+++.+.+++.+||+.||.+||++.++++++.
T Consensus 239 ~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 239 VRKRQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHcCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 443321 2233467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=303.53 Aligned_cols=252 Identities=27% Similarity=0.438 Sum_probs=203.5
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
......||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+.+++.+ +|+||+++++++...+..++++|
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEe
Confidence 334468999999999999999889999999876542 33456789999999999 99999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 137 LCEGGELFDRIVAR-GHY--TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 137 ~~~~~sL~~~l~~~-~~l--~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|+++++|.+++... ..+ ++..+..++.|++.||.|||+.||+||||||+||+++.+. ..++|+|||.+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~--~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGIN 163 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CeEEEecchhheecccCC
Confidence 99999999998764 345 8888999999999999999999999999999999996532 238999999987653322
Q ss_pred c-ccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 214 K-FSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. .....+++.|+|||.+.. .++.++|+||||+++++|++|..||........... ........+..+..+++++.
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 242 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEIPESLSAEAK 242 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhccCCCCCcccCHHHH
Confidence 2 233467889999998753 378899999999999999999999965432211111 11111122223346789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++.+||+.+|++|||+.+++.|+||
T Consensus 243 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 243 NFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=307.68 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=207.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|++|+||+|.+..+++.||+|.+...... ....+.+.+|+++++.+ +|+|++++++++......++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEE
Confidence 4699999999999999999999989999999988654322 22345688899999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||++ ++|.+++..... +++..++.++.||+.||+|||+++++|+||+|+||+++.++. .+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~--~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC--EEEEcccccccccCCC
Confidence 99996 488888765443 578889999999999999999999999999999999975432 3899999999765332
Q ss_pred C-cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC-----------
Q 021233 213 E-KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR----------- 278 (315)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 278 (315)
. ......+++.|+|||.+.+ .++.++||||||+++++|+||..||......+....+.........
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 2 2234467889999998753 4788999999999999999999999776655554443321111000
Q ss_pred ----------C----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ----------D----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ----------~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. ..+.+++++.+++.+||+.+|++||++.+++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~ 287 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence 0 123567889999999999999999999999999997
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=303.20 Aligned_cols=243 Identities=24% Similarity=0.335 Sum_probs=200.8
Q ss_pred eeeeecceEEEEEEE--CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecC
Q 021233 62 ELGRGEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~--~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
.||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.+ +||||+++++++.. +..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQL-DNPYIVRMIGICEA-ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCcEEEEecCC
Confidence 589999999999965 4567889999876442 2333456789999999999 99999999998864 46789999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc----
Q 021233 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---- 215 (315)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~---- 215 (315)
+++|.+++.....+++..+..++.|++.||.+||++|++||||||.||+++.++. ++|+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~---~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY---AKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe---EEECCCccccccCCCCCeeeec
Confidence 9999999988778999999999999999999999999999999999999976544 899999999865433221
Q ss_pred cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 216 SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 216 ~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
....+++.|+|||.+. ..++.++|+||||+++|||++ |..||......+....+.+.. ....+..+++++.++|.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE---RMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC---CCCCCCCCCHHHHHHHH
Confidence 1223357899999876 458889999999999999998 999998776666666555432 22334568999999999
Q ss_pred HhcCCCcCCCCCHHHHhccc
Q 021233 294 KMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 294 ~~l~~~P~~Rps~~e~l~~l 313 (315)
+||+.||++||++.+|...|
T Consensus 233 ~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 233 LCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred HHhccCchhCcCHHHHHHHH
Confidence 99999999999999998776
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=302.31 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=201.7
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|.+..+++.+|+|.+.... .......+.+|+++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 36899999999999999899999999876432 233346789999999999 999999999999999999999999999
Q ss_pred CChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc---c
Q 021233 141 GELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---S 216 (315)
Q Consensus 141 ~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~---~ 216 (315)
++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++......... .
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV---LKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc---EEECccccCcccccccccccCC
Confidence 99999987644 5899999999999999999999999999999999999976554 899999998764432111 1
Q ss_pred ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHH
Q 021233 217 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (315)
Q Consensus 217 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (315)
....+..|+|||.+. +.++.++||||||+++++|++ |..||...........+... .+...+..++..+.+++.+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~ 231 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG---VRLPCPELCPDAVYRLMER 231 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC---CCCCCcccCCHHHHHHHHH
Confidence 112245699999876 558999999999999999998 89999766665554444432 1223344678999999999
Q ss_pred hcCCCcCCCCCHHHHhcccC
Q 021233 295 MLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 295 ~l~~~P~~Rps~~e~l~~l~ 314 (315)
||+.+|++|||+.++++.|.
T Consensus 232 ~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 232 CWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HcCCChhhCcCHHHHHHHHh
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=302.26 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=209.7
Q ss_pred eeeeeecceEEEEEEECCC---CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEe
Q 021233 61 RELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 137 (315)
+.||+|+||.||+|.+... +..+++|.+....... ..+.+.+|+..+..+ +|+|++++++++......+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEe
Confidence 4689999999999999866 8899999987653322 467899999999999 799999999999999999999999
Q ss_pred cCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 138 CEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 138 ~~~~sL~~~l~~~---------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~---~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc---EEEcccccccc
Confidence 9999999999875 67999999999999999999999999999999999999987655 89999999987
Q ss_pred cCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 209 FKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 209 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
..... ......++..|+|||.+. ..++.++||||||+++++|++ |..||......+....+... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---YRLPKPEY 231 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCcc
Confidence 65432 223446788899999876 468999999999999999999 69999888777666666653 22333456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
++.++.+++.+||..+|++|||+.++++++.
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 7899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=309.88 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=201.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-----
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT----- 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~----- 129 (315)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 4699999999999999999999999999999988654321 12233566799999999 9999999999886543
Q ss_pred ---cEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 130 ---AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 130 ---~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
..++||||+.+ +|.+.+.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++|+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI---LKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc---EEECcCCC
Confidence 45999999964 8888776543 5899999999999999999999999999999999999976554 89999999
Q ss_pred ccccCCCCc-----ccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC
Q 021233 206 SVFFKPGEK-----FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (315)
Q Consensus 206 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (315)
+........ .....++..|+|||.+.+ .++.++||||||+++++|++|+.||...........+.......++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 976533221 123457788999998754 3788999999999999999999999776654443333322111111
Q ss_pred CCC----------------------------ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 DPW----------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ~~~----------------------------~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+ ...+..+.++|.+||..||.+|||+.++++|+||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 100 0124677899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=316.66 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=208.6
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 128 (315)
+.++|++.+.||+|+||+||+|.+..+++.||+|.+.... ........+.+|+.+++.+ +|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~ 80 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREA 80 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhc-CCCCccchHHheecccccc
Confidence 4568999999999999999999999999999999986542 2233345677899999999 999999999987643
Q ss_pred -CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
...++++||+. ++|.+++.....+++..+..++.|++.||.|||+.+++|+||||+||+++.++. ++|+|||++.
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~---~kL~Dfg~~~ 156 (337)
T cd07858 81 FNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLAR 156 (337)
T ss_pred cCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEECcCcccc
Confidence 35899999995 689999988778999999999999999999999999999999999999976555 8999999998
Q ss_pred ccCCC-CcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc---------
Q 021233 208 FFKPG-EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD--------- 275 (315)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------- 275 (315)
..... .......++..|+|||.+. ..++.++||||||+++++|++|+.||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 65433 2233456788999999875 35889999999999999999999999765433322222111000
Q ss_pred --------------CC----CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 --------------FR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 --------------~~----~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ....+.+++++.++|.+||+.+|++|||+.++++|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~ 294 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence 00 01134578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.51 Aligned_cols=255 Identities=32% Similarity=0.500 Sum_probs=226.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|.+++.||+|+||.|..++.+.+++.||+|++++..+....+-.-|..|-.+|..- +.+-|++++..|.++.++|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEE
Confidence 46899999999999999999999999999999999987666566667799999999887 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||++||+|..++....++++++++.++..|..||..||+.|+|||||||+|||++..|. +||+|||.+-.+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH---ikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH---IKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc---EeeccchhHHhcCCCC
Confidence 9999999999999998889999999999999999999999999999999999999976555 9999999988776443
Q ss_pred cc--cccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhc--cccCCCCCCcc
Q 021233 214 KF--SEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS--VLDFRRDPWPK 283 (315)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 283 (315)
.. ..-+|||.|.|||++. +.|+..+|.||+||++|||+.|..||......+....|++- .+.++ .-..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~ 307 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETD 307 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccc
Confidence 32 4569999999999874 34899999999999999999999999998888888888765 45555 2245
Q ss_pred CCHHHHHHHHHhcCCCcCCCCC---HHHHhcccCC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLT---AQQVLGKIEF 315 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps---~~e~l~~l~f 315 (315)
+|+++.+||.+.+.. |+.|.. +.++-.|+||
T Consensus 308 VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF 341 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFF 341 (1317)
T ss_pred cCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccc
Confidence 999999999999875 677777 9999999998
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=308.11 Aligned_cols=254 Identities=30% Similarity=0.571 Sum_probs=217.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|++|.||+|.+..++..|++|++.............+.+|+.++.++.+|+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46999999999999999999999899999999987654444444567889999999994499999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||+++++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~---~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSS 157 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEecCCccccccCCccc
Confidence 999999999999998878999999999999999999999999999999999999976555 8999999987653322
Q ss_pred --------------------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhc
Q 021233 214 --------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272 (315)
Q Consensus 214 --------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 272 (315)
......++..|+|||... ..++.++|+||||++++++++|..||.........+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 112345788999999876 45888999999999999999999999877665555555443
Q ss_pred cccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCH----HHHhcccCC
Q 021233 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA----QQVLGKIEF 315 (315)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~----~e~l~~l~f 315 (315)
... ....+++.+.++|.+||+.+|++|||+ .++++|+||
T Consensus 238 ~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EYS----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCC----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 322 234568999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=307.41 Aligned_cols=252 Identities=26% Similarity=0.428 Sum_probs=211.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
...|+.++.||.|+||.||+|.+..++..+|+|.+..... ......+.+|+.+++.+ +|+|++++++.+......++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEE
Confidence 3568889999999999999999988899999998865422 23356789999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||+++++|.+++.. ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~---~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 80 IMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC---EEEcccccceeccCCc
Confidence 9999999999998865 46899999999999999999999999999999999999986555 8999999997654332
Q ss_pred c-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 K-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 ~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
. .....++..|+|||.+. ..++.++|+||||+++++|++|..||...........+... ..+.....++..+.++
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l 232 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN---NPPTLTGEFSKPFKEF 232 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC---CCCCCchhhhHHHHHH
Confidence 1 23346788899999876 45899999999999999999999999766554443333222 1223334578889999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||+.+|++||++.+++.|+||
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06640 233 IDACLNKDPSFRPTAKELLKHKFI 256 (277)
T ss_pred HHHHcccCcccCcCHHHHHhChHh
Confidence 999999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=304.72 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=208.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCC-----CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCC
Confidence 46899999999999999999997643 3789999976442 223345688999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 129 TAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+||+++.++. +
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~---~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT---V 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC---E
Confidence 99999999999999999986432 3678899999999999999999999999999999999987655 8
Q ss_pred EEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhcc
Q 021233 199 KAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (315)
Q Consensus 199 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 273 (315)
+|+|||+++....... .....++..|+|||.+. +.++.++||||||++++++++ |..||......+....+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 9999999876543321 22345678899999876 568999999999999999998 999998777666666555322
Q ss_pred ccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
....+..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus 239 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 ---HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 22233456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=304.91 Aligned_cols=250 Identities=22% Similarity=0.356 Sum_probs=210.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
..+|++.+.||.|+||.||+|.+.. +..+++|.+.... ......+..|+.+++.+ +|+||+++++++...+..++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEE
Confidence 3579999999999999999999877 8999999986543 22346788999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~---~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV---CKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce---EEEccccchhhcCC
Confidence 99999999999999753 35899999999999999999999999999999999999986655 89999999976543
Q ss_pred CCcc-cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 212 GEKF-SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 212 ~~~~-~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
.... ....++..|++||.+. ..++.++||||||+++++|++ |+.||......+....+... .+......+++.+
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG---YRMPCPAKCPQEI 233 (261)
T ss_pred ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC---CcCCCCCCCCHHH
Confidence 3211 2234566799999876 458899999999999999998 89999877766666666543 2223345688999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.++|.+||+.||++|||+.++++.|+
T Consensus 234 ~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 234 YKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred HHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=301.58 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=207.4
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|++|.||+|.+. +++.||+|.+.... ...+.+.+|+.+++++ +|+||+++++++...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeee
Confidence 357999999999999999999975 45789999986542 2346688999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+|||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI---CKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC---EEECCcceEEEccC
Confidence 999999999999997654 5899999999999999999999999999999999999986655 89999999987643
Q ss_pred CCccc--ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEKFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
..... ....+..|+|||.+. ..++.++||||||+++++|++ |+.||...........+.+.. .......+++.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY---RMPCPPGCPKE 232 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCcCCHH
Confidence 22111 112235799999876 458999999999999999999 999998777666665554432 22233467899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+.+++.+||+.+|++||++.+++..|+
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=302.14 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=207.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCC---CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
++|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.+++.+ +||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCce
Confidence 5799999999999999999998644 4579999886542 233346788999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+++|||+++++|.+++... +.+++..++.++.|++.||.|||+++|+|+||||+||+++.++. ++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~---~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC---EEECccchhhccc
Confidence 9999999999999998764 46899999999999999999999999999999999999976554 8999999998764
Q ss_pred CCC-ccc--ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 211 PGE-KFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 211 ~~~-~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
... ... ...+++.|+|||.+. ..++.++||||||++++++++ |..||...........+.... ..+....++
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDCP 234 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 211 111 123456799999876 458999999999999999998 999998777666666555432 222334678
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+.+++.+||+.+|++||++.+++++|
T Consensus 235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 235 SALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=301.71 Aligned_cols=253 Identities=26% Similarity=0.517 Sum_probs=213.3
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+.+|+.+++.+ +|+|++++++.+...+..++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEE
Confidence 58899999999999999999999999999999876432 223456788999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||++++++. .++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM--VAKLGDFGIARQLNDSM 156 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC--eEEecccccchhccCCc
Confidence 9999999999987643 3799999999999999999999999999999999999976543 36999999987654332
Q ss_pred cc-cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 KF-SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 ~~-~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
.. ....|++.|+|||.+. ..++.++|+||||++++++++|..||...........+..... ....+.++.++.++
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 233 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF---APISPNFSRDLRSL 233 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC---CCCCCCCCHHHHHH
Confidence 22 3346888999999876 4588999999999999999999999977665555544443322 22334578899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||..+|++|||+.++++++||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=305.79 Aligned_cols=253 Identities=29% Similarity=0.506 Sum_probs=207.5
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||.|++|.||+|.+..++..||+|++..... ....+.+.+|+.+++.+ +|+|++++++++...+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEE
Confidence 48999999999999999999999999999999875432 22345677899999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 136 ELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||+++ +|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~---~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc---EEEeecchhhhhcCC
Confidence 99975 8888886543 5899999999999999999999999999999999999976655 899999999755332
Q ss_pred C-cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc--------------
Q 021233 213 E-KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-------------- 275 (315)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------- 275 (315)
. ......++..|++||.+.+ .++.++||||||++++++++|..||......+....+.+....
T Consensus 154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 2 2234567889999998753 4788999999999999999999999776655444433322100
Q ss_pred CCCC-----------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 FRRD-----------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~~~-----------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+... ..+.+++++.+++.+||+.||.+||++.++++++||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0000 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=308.03 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=207.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCC-----CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.+|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.++..+ +||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCC
Confidence 3688999999999999999987543 5789999987442 222346688999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 021233 130 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~ 193 (315)
..++++||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998532 2478888999999999999999999999999999999997654
Q ss_pred CCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 021233 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (315)
. +||+|||+++....... .....+++.|+|||.+. +.++.++||||||++++||++ |..||......+....
T Consensus 162 ~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 162 N---VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred c---eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 4 89999999876533221 12335577899999875 568999999999999999998 8889987777666666
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+...... .....+++++.+++.+||+.+|.+||++.++++.|
T Consensus 239 i~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 239 IRNRQVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred HHcCCcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 6554322 22346889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=305.87 Aligned_cols=254 Identities=29% Similarity=0.427 Sum_probs=201.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.+ +|+||+++.+++......++|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEE
Confidence 5799999999999999999999989999999998654322 2234577899999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
+||+. ++|.+.+... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc---EEEeccccccccCCCC
Confidence 99996 5777766543 45788999999999999999999999999999999999976655 999999998754322
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhccc--------------c
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVL--------------D 275 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~--------------~ 275 (315)
.......+++.|+|||.+.+ .++.++||||||+++++|++|..||...... +....+..... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 22234467889999998753 4788999999999999999999999654432 11111111000 0
Q ss_pred CCCC------------CCc--cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 FRRD------------PWP--KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~~~------------~~~--~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+... .+. ..+.++.+++.+||..||++|||+.+++.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0000 000 125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=309.56 Aligned_cols=245 Identities=27% Similarity=0.481 Sum_probs=211.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+-|.+++.||+|+||.||+|.++++|..+|+|.+... .+.+++..|+.++.++ +.+++|++++.|.....+|+|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEee
Confidence 4589999999999999999999999999999998654 3567899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
||||..|+..|.++. +.++++..+..+++..+.||+|||...=||||||..|||++-++. .||+|||.|..+.+.
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~---AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI---AKLADFGVAGQLTDTM 183 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch---hhhhhccccchhhhhH
Confidence 999999999999874 456999999999999999999999999999999999999986666 799999999876543
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC------ccCC
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW------PKVS 285 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 285 (315)
.+..++.|||.|||||++. -.|+.++||||||++..||..|++||...... +.....+..++ ...+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-------RAIFMIPT~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-------RAIFMIPTKPPPTFKKPEEWS 256 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-------ceeEeccCCCCCCCCChHhhh
Confidence 3456789999999999987 46999999999999999999999999654332 11222222222 2346
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++.+++++||.++|++|-|+.++++|+|.
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fi 286 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEHTFI 286 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhhhhh
Confidence 778999999999999999999999999873
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=321.84 Aligned_cols=252 Identities=37% Similarity=0.597 Sum_probs=228.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
..|.+...||+|.|++|.+|++..++..||+|.+.+..... .....+.+|+++|+.+ +|||||+++.+......+|+|
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEE
Confidence 46999999999999999999999999999999998876544 3445589999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||+.+|.+++++..++...+..++.++.|+..|++|||+++|+|||||++|||++.+.+ +||+|||++..+..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn---ikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN---IKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc---eeeeccccceeeccccc
Confidence 999999999999999999989999999999999999999999999999999999986665 89999999999988888
Q ss_pred ccccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
..+.+|++.|.|||++.+. .++.+|+||+|+++|.|+.|.+||.+.+..+.......+....+ ..++.++.++|
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp----~~ms~dce~lL 286 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP----FYMSCDCEDLL 286 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc----ceeechhHHHH
Confidence 8999999999999998853 67899999999999999999999998888777766666554433 23688999999
Q ss_pred HHhcCCCcCCCCCHHHHhcccCC
Q 021233 293 RKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++|..+|.+|++.+++..+.|.
T Consensus 287 rk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 287 RKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred HHhhccCccccCCHHHhhhhccc
Confidence 99999999999999999998873
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=306.73 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=207.4
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.+ +|+|++++++++...+..+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEe
Confidence 67889999999999999999989999999998755322 22335678899999999 89999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-C
Q 021233 137 LCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 213 (315)
|++ ++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+...... .
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA---LKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc---EEEeecccccccCCCcc
Confidence 995 58999887765 6899999999999999999999999999999999999987554 899999998765322 1
Q ss_pred cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc----------------
Q 021233 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD---------------- 275 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------------- 275 (315)
......++..|+|||++.+ .++.++|+||||+++|+|++|..||...........+.+....
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 2233456889999998753 4688999999999999999999999776654443333221110
Q ss_pred ---------CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 ---------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ---------~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
......+.+++++.++|.+||+.+|++|||+.+++.++||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0011134567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=310.16 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=209.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.+.|+..+.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.+ +|+||+++++++...+..++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEE
Confidence 3468888999999999999999988899999998864432 22346789999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~---~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 80 IMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC---EEEccccccccccCcc
Confidence 9999999999988864 46899999999999999999999999999999999999976555 8999999987654332
Q ss_pred -cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......++..|+|||++.+ .++.++|+||||+++++|++|+.||...........+.... .+.....++.++.++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l 232 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS---PPTLEGQYSKPFKEF 232 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC---CCCCCcccCHHHHHH
Confidence 2233467889999999864 58899999999999999999999986554443333332221 122223567899999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||+.+|++||++.++++|+||
T Consensus 233 i~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 233 VEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred HHHHccCCcccCcCHHHHHHhHHH
Confidence 999999999999999999999875
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=306.98 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=206.3
Q ss_pred cceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
++|.+.+.||+|+||.||+|.+.. ++..+++|.+.... ....+.+.+|+.+++++ +|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNL-QHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCC
Confidence 469999999999999999998542 34568888875432 23346788999999999 8999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 021233 130 AVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~ 193 (315)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997542 378999999999999999999999999999999999998655
Q ss_pred CCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 021233 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (315)
. ++|+|||++........ .....++..|+|||.+. ..++.++||||||+++++|++ |..||......+....
T Consensus 161 ~---~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 161 L---VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred c---EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 4 89999999976543221 12345678899999876 458899999999999999999 9999987777666665
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+...... .....++..+.+++.+||+.+|++|||+.++++.+
T Consensus 238 ~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l 279 (291)
T cd05094 238 ITQGRVL---ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279 (291)
T ss_pred HhCCCCC---CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 5544322 22345688999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=314.57 Aligned_cols=255 Identities=29% Similarity=0.495 Sum_probs=203.1
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 128 (315)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFES 79 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccc
Confidence 4578999999999999999999999999999999886421 223345678899999999 899999999887543
Q ss_pred -CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
...++++||+.+ +|.+.+.. ..+++..++.++.|++.||.+||+.||+||||||+||+++.++. ++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~---~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLAR 154 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC---EEECccccee
Confidence 357999999964 88777744 46999999999999999999999999999999999999976555 8999999987
Q ss_pred ccCCCCc----ccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc------
Q 021233 208 FFKPGEK----FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD------ 275 (315)
Q Consensus 208 ~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------ 275 (315)
....... .....+++.|+|||.+. ..++.++||||||+++++|++|+.||...........+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 6543221 12356789999999864 35889999999999999999999999765443322222111100
Q ss_pred ----------------CC-C----CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 ----------------FR-R----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ----------------~~-~----~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. . ...+..++++.++|.+||+.+|++|||+.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~ 295 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 00 0 0123457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=305.28 Aligned_cols=252 Identities=29% Similarity=0.500 Sum_probs=208.6
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC--CCCCcceeEEEEEcCCcEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~~~~~~l 133 (315)
.|++.+.||.|+||.||+|.+..+++.+|+|.+.... .....+.+.+|+.+++.+. .|||++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888899999999999999999999999999886542 2334567889999999984 39999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC---EEEccCCceeecCCCc
Confidence 99999999999988654 7899999999999999999999999999999999999986544 8999999998764432
Q ss_pred -cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 214 -KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
......|+..|+|||.+.. .++.++|+||||+++|+|++|..||...........+... ..+.......+.++.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 233 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPPRLEDNGYSKLLRE 233 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCCCCCcccCCHHHHH
Confidence 2334578889999998753 3688999999999999999999999766554333322221 1111111237889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||+.||++||++.+++.++||
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhhChHh
Confidence 9999999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=303.90 Aligned_cols=252 Identities=31% Similarity=0.523 Sum_probs=210.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
..|...+.||+|++|.||++.+..+++.+++|.+... .....+.+.+|+.+++.+ +|+|++++++++...+..+++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEE
Confidence 3566678999999999999999888999999987533 223345688999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
+||+++++|.+++.. ..++...+..++.|++.||++||++|++||||+|+||+++.++. ++|+|||.+.......
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 95 MEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR---VKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc---EEEcccccchhhccCCc
Confidence 999999999998877 56899999999999999999999999999999999999976554 8999999886543222
Q ss_pred cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
......|++.|+|||.+.+ .++.++||||||+++++|++|..||...........+...... .......++..+.+++
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 249 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP-KLKNLHKVSPRLRSFL 249 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCC-CCcccccCCHHHHHHH
Confidence 2233568899999999764 5889999999999999999999999776665555555443211 1112234788999999
Q ss_pred HHhcCCCcCCCCCHHHHhcccCC
Q 021233 293 RKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+||+.+|++|||+.++++|+||
T Consensus 250 ~~~l~~~p~~Rpt~~~il~~~~~ 272 (285)
T cd06648 250 DRMLVRDPAQRATAAELLNHPFL 272 (285)
T ss_pred HHHcccChhhCcCHHHHccCccc
Confidence 99999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=307.31 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=207.5
Q ss_pred cccccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
....++|++.+.||+|+||.||++.+. .++..+|+|.+.... .....+.+.+|+.+++++.+|+||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 344568999999999999999999852 345679999876542 2233467899999999997799999999999
Q ss_pred EcCCcEEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 126 EDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
...+..+++|||+++++|.+++..... +++.++..++.+++.||.|||+++++|+||||+|||++.++ .++|+||
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~---~~~l~df 185 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDF 185 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC---eEEECCC
Confidence 999999999999999999999876432 89999999999999999999999999999999999997544 3899999
Q ss_pred ccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCC
Q 021233 204 GLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRR 278 (315)
Q Consensus 204 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (315)
|++........ .....++..|+|||.+. ..++.++||||||+++++|++ |..||................. +.
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~ 263 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY--RM 263 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC--cC
Confidence 99976543221 12234567899999876 558999999999999999998 9999977665544444433221 22
Q ss_pred CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 279 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
......++++.+++.+||+.+|++|||+.++++.+
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 22345689999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=328.87 Aligned_cols=262 Identities=21% Similarity=0.289 Sum_probs=192.7
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCC-EEEEE--------------EcccccccChhcHHHHHHHHHHHHhCC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGD-AFACK--------------SISKKKLRTAVDIEDVRREVDIMRHLP 113 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~a~K--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~ 113 (315)
.+..+.++|++++.||+|+||+||+|..+.... ..+.| .+.+...........+.+|+.+|+++
T Consensus 142 ~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l- 220 (501)
T PHA03210 142 HDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL- 220 (501)
T ss_pred cchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-
Confidence 345566789999999999999999987643221 12222 11111111222345688999999999
Q ss_pred CCCCcceeEEEEEcCCcEEEEEEecCCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceE
Q 021233 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (315)
Q Consensus 114 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nil 188 (315)
+|+||+++++++...+..++|++++. ++|.+++.... ......++.++.||+.||.|||++||+||||||+|||
T Consensus 221 ~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NIL 299 (501)
T PHA03210 221 NHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIF 299 (501)
T ss_pred CCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 99999999999999999999999995 47777765421 2345678889999999999999999999999999999
Q ss_pred eecCCCCCCEEEEeeccccccCCCCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC---h
Q 021233 189 FANKKETAPLKAIDFGLSVFFKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET---E 262 (315)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~---~ 262 (315)
++.++. +||+|||++........ .....||+.|+|||++. ..++.++|||||||++|||++|..++.... .
T Consensus 300 l~~~~~---vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 300 LNCDGK---IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred ECCCCC---EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 976555 99999999986643322 23457999999999986 458999999999999999999875443221 1
Q ss_pred HHHHHHHHhcccc----CC------------------CCC------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 263 QGVAQAIIRSVLD----FR------------------RDP------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 263 ~~~~~~~~~~~~~----~~------------------~~~------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
......+...... ++ ... ...++.++.++|.+||+.||.+|||+.|+|+|+|
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 1222222111100 00 000 0124667888999999999999999999999999
Q ss_pred C
Q 021233 315 F 315 (315)
Q Consensus 315 f 315 (315)
|
T Consensus 457 f 457 (501)
T PHA03210 457 F 457 (501)
T ss_pred h
Confidence 8
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=305.39 Aligned_cols=253 Identities=31% Similarity=0.500 Sum_probs=208.3
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--CcEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVHLV 134 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~lv 134 (315)
|++.+.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.+ +|+|++++++++... +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEE
Confidence 678899999999999999999889999999997653 2233345688899999999 899999999999887 899999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
+||+++ +|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||++++++. ++|+|||.+.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~---~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC---EEEccccceeeccCCC
Confidence 999975 898888765 46999999999999999999999999999999999999987655 8999999998664433
Q ss_pred --cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC---------
Q 021233 214 --KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--------- 280 (315)
Q Consensus 214 --~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 280 (315)
......++..|+|||.+.+ .++.++||||||+++++|++|+.||...........+...........
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 2334466888999997653 478999999999999999999999987765554444433211111110
Q ss_pred -----------------Ccc-CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 -----------------WPK-VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 -----------------~~~-~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
... +++++.+++.+||+.+|++||++.+++.++||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 111 37889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=313.73 Aligned_cols=257 Identities=32% Similarity=0.503 Sum_probs=229.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+.|+.-++||+|+||.||.+..+.+|+-+|+|.+.+..+...........|-.+|.++ +.+.||.+-..|+..+.+++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEE
Confidence 4688889999999999999999999999999999887776666666788899999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+..|+||+|.-++.+.+ .+++..++.++.+|+.||++||+.+||+||+||+|||+++.+. |+|+|+|+|..+..+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh---vRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH---VRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC---eEeeccceEEecCCC
Confidence 99999999988887665 5999999999999999999999999999999999999976655 999999999999888
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......+||.+|||||++. +.|+...|.|||||++|||+.|+.||....+..-...+.+.............++++.+|
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 8888889999999999987 459999999999999999999999998776665555565555555566667889999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
...+|++||.+|. .+.++-+|++|
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfF 449 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFF 449 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCccc
Confidence 9999999999985 56799999988
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=309.70 Aligned_cols=254 Identities=30% Similarity=0.506 Sum_probs=210.7
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..+.|.....||.|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.+ +|+|++++++.+...+..+
T Consensus 20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELW 95 (292)
T ss_pred hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEE
Confidence 345567678899999999999999888999999987543 223356688999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||++++++. ++|+|||++......
T Consensus 96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kL~dfg~~~~~~~~ 171 (292)
T cd06658 96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR---IKLSDFGFCAQVSKE 171 (292)
T ss_pred EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC---EEEccCcchhhcccc
Confidence 99999999999988754 46899999999999999999999999999999999999976554 899999998754322
Q ss_pred C-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 213 E-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
. ......++..|+|||.+. ..++.++||||||++++||++|..||...........+...... .......+++.+.+
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 250 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP-RVKDSHKVSSVLRG 250 (292)
T ss_pred cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-ccccccccCHHHHH
Confidence 2 223456889999999976 45889999999999999999999999876655544444332211 11222356889999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||..||.+|||+.++++++||
T Consensus 251 li~~~l~~~P~~Rpt~~~il~~~~~ 275 (292)
T cd06658 251 FLDLMLVREPSQRATAQELLQHPFL 275 (292)
T ss_pred HHHHHccCChhHCcCHHHHhhChhh
Confidence 9999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=297.98 Aligned_cols=252 Identities=28% Similarity=0.526 Sum_probs=216.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||.|+||.||++.+..++..+++|.+..... .......+.+|+++++.+ +|+|++++.+.+......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEE
Confidence 58899999999999999999998999999999875432 234456788999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 136 ELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 136 e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||+++++|.+.+... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~---~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc---EEECCccceeeccc
Confidence 999999999998764 56999999999999999999999999999999999999986554 89999999976544
Q ss_pred CC-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.. ......+++.|+|||... ..++.++|+||+|+++++|++|..||.................. .....++.++.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (258)
T cd08215 156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP---PIPSQYSSELR 232 (258)
T ss_pred CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC---CCCCCCCHHHH
Confidence 33 223457888999999876 45889999999999999999999999877766666655544322 22336789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++.+||..+|++|||+.++|.++||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=303.67 Aligned_cols=245 Identities=23% Similarity=0.311 Sum_probs=198.8
Q ss_pred eeeeeecceEEEEEEECCCCCE--EEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 61 RELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~--~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
+.||+|+||.||+|.+..++.. +++|.+... ......+.+.+|+.++.++.+||||+++++++...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3689999999999999877754 677877532 223344678899999999988999999999999999999999999
Q ss_pred CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 139 EGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 139 ~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
++++|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||+++.++. ++|+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~---~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe---EEECC
Confidence 9999999987532 3788999999999999999999999999999999999976555 89999
Q ss_pred eccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCC
Q 021233 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 203 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (315)
||++..............+..|+|||++. ..++.++||||||+++++|++ |..||......+....+.... ....
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~ 232 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEK 232 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---CCCC
Confidence 99986432211111223356799999876 458899999999999999997 999998777666655554331 2223
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...++.++.+++.+||+.+|.+|||+.+++..|
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=307.39 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=208.7
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCC-----CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
.-.++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++.+|+||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3456899999999999999999987643 3679999886542 22334568899999999977999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 021233 127 DDTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~ 190 (315)
..+..+++|||+++++|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+||+++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999999999998642 3488999999999999999999999999999999999997
Q ss_pred cCCCCCCEEEEeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHH
Q 021233 191 NKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (315)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 265 (315)
.++. ++|+|||.+......... ....++..|+|||.+. ..++.++||||||+++|++++ |..||......+.
T Consensus 167 ~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 167 EDHV---MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred CCCe---EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 6554 899999999865433211 1223456799999876 568999999999999999997 9999987776666
Q ss_pred HHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...+.... ....+..++.++.+|+.+||..||++|||+.++++.|
T Consensus 244 ~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 244 FKLLKEGY---RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHHHHcCC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 65554432 2223346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=297.28 Aligned_cols=253 Identities=31% Similarity=0.512 Sum_probs=214.0
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--CcEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAVHL 133 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~~l 133 (315)
+|++.+.||+|++|.||+|.+..++..+++|++...... ....+.+.+|+.+++++ +|+||+++++.+... ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEE
Confidence 488899999999999999999989999999998755322 34467899999999999 899999999999988 88999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
++||+++++|.+++.....+++..++.++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC---EEEcccccEEeccccc
Confidence 9999999999999988778999999999999999999999999999999999999987554 8999999998765544
Q ss_pred c---ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHhccccCCCCCCccCCHHH
Q 021233 214 K---FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 214 ~---~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
. .....++..|++||.+.. ..+.++||||||+++++|++|..||..... ......+.. .......+..+++.+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 233 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--SGEPPEIPEHLSEEA 233 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--cCCCcCCCcccCHHH
Confidence 3 345578889999998864 489999999999999999999999976651 111122211 112223344568999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++|.+||+.+|++||++.+++.|+||
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 234 KDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=300.59 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=205.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+..... ....+.+|+.+++.+ +|+||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEE
Confidence 36899999999999999999875 467899998764322 235688899999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV---VKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc---EEECCcccceeccccc
Confidence 9999999999998764 35899999999999999999999999999999999999976554 8999999987654322
Q ss_pred ccc--ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 214 KFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 214 ~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
... ...++..|+|||.+. ..++.++|+||||+++|++++ |..||......+....+.... +......+++++.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 231 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY---RLYRPKLAPTEVY 231 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC---cCCCCCCCCHHHH
Confidence 211 112345799999876 568999999999999999999 899998776666655554432 2223345789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccc
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++.+||+.+|++|||+.++++.+
T Consensus 232 ~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 232 TIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHh
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=299.12 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=208.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ..+++.+|+.+++.+ +|+|++++++++...+..++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEE
Confidence 357999999999999999999875 88999999865422 457789999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~---~~l~d~g~~~~~~~ 154 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV---AKVSDFGLAKEASQ 154 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC---EEEccccccccccc
Confidence 999999999999998765 6899999999999999999999999999999999999976555 89999999986633
Q ss_pred CCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
... ....+..|+|||.+. +.++.++||||||++++++++ |..||......+....+... .+......+++++.
T Consensus 155 ~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (256)
T cd05039 155 GQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG---YRMEAPEGCPPEVY 229 (256)
T ss_pred ccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---CCCCCccCCCHHHH
Confidence 222 233456799999876 568899999999999999997 99999877766655555443 22233346789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
++|.+||..+|++|||+.++++.|.
T Consensus 230 ~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 230 KVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred HHHHHHhccChhhCcCHHHHHHHHh
Confidence 9999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=302.59 Aligned_cols=249 Identities=20% Similarity=0.289 Sum_probs=200.5
Q ss_pred eeeeeeeeeecceEEEEEEECCCCC--EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC------
Q 021233 57 YELGRELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD------ 128 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~--~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~------ 128 (315)
|.+.+.||+|+||.||+|.+..++. .+|+|.+.... ......+.+.+|+.+++.+ +|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCC
Confidence 3567899999999999999877665 58999876542 2334457788999999999 999999999986432
Q ss_pred CcEEEEEEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 129 TAVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
...+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++. ++|+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN---VCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC---EEECC
Confidence 3578999999999999887421 23789999999999999999999999999999999999976554 89999
Q ss_pred eccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCC
Q 021233 203 FGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFR 277 (315)
Q Consensus 203 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 277 (315)
||++........ .....+++.|++||... ..++.++||||||+++|+|++ |..||...........+.....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 232 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--- 232 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 999986543321 12234567899999976 458999999999999999999 8999987766655555544322
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
......+++.+.++|.+||+.||++|||+.++++.+
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=303.32 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=203.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCC----EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.++|++++.||+|+||+||+|.+..++. .||+|.+.... .......+.+|+.++..+ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGV-GSPYVCRLLGICLTS- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcCC-
Confidence 4579999999999999999999877666 47999876432 233356788999999999 899999999998754
Q ss_pred cEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++++||+++|+|.+++... +.+++..++.++.|++.||.|||+++++||||||+|||+++++. +||+|||++..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~---~kL~dfG~~~~ 158 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARL 158 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc---EEECCCCceee
Confidence 578999999999999999764 45899999999999999999999999999999999999976554 89999999987
Q ss_pred cCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 209 FKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 209 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
....... ....+++.|+|||... ..++.++||||||+++|||++ |..||...........+.... .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~ 235 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE---RLPQPPI 235 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC---cCCCCcc
Confidence 6433221 1123456799999876 558999999999999999998 899997766655544443322 1222346
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.++.+++.+||+.||++||++.+++..+
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l 265 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVDEF 265 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 789999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=307.70 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=206.4
Q ss_pred cccceeeeeeeeeecceEEEEEEECC-------CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
..++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... .......+..|+.+++.+.+|+||+++++++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34689999999999999999998643 23569999886542 2233467888999999997899999999999
Q ss_pred EcCCcEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEe
Q 021233 126 EDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (315)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill 189 (315)
...+..++||||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 99999999999999999999997542 37889999999999999999999999999999999999
Q ss_pred ecCCCCCCEEEEeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHH
Q 021233 190 ANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (315)
Q Consensus 190 ~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~ 264 (315)
+.++. ++|+|||.+......... ....+++.|+|||.+. ..++.++||||||+++|+|++ |..||......+
T Consensus 174 ~~~~~---~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 174 TEDNV---MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred cCCCc---EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 76554 899999998765332211 1123456899999876 458999999999999999998 889997776655
Q ss_pred HHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
....+.... ....+..++.++.+++.+||+.+|++|||+.++++++
T Consensus 251 ~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 251 LFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HHHHHHcCC---CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 555544332 2233456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=306.56 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=203.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCC--------------CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcce
Q 021233 55 ERYELGRELGRGEFGITYLCTDREN--------------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~ 120 (315)
++|++.+.||+|+||.||+|++... ...||+|.+.... .....+.+.+|+++++++ +|+|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRL-KNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCcCe
Confidence 5799999999999999999987543 2358999886532 233456789999999999 9999999
Q ss_pred eEEEEEcCCcEEEEEEecCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceE
Q 021233 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARG------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (315)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nil 188 (315)
+++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886532 3678899999999999999999999999999999999
Q ss_pred eecCCCCCCEEEEeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh--CCCCCCCCCh
Q 021233 189 FANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAETE 262 (315)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t--g~~p~~~~~~ 262 (315)
++.++. +||+|||++......... ....++..|+|||.+. +.++.++||||||+++++|++ +..||.....
T Consensus 162 l~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 162 VGNHYT---IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred EcCCCc---EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 976554 899999999765333211 2234467899999876 568999999999999999988 6778876665
Q ss_pred HHHHHHHHhcc----ccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 263 QGVAQAIIRSV----LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 263 ~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
........... ........+.+++.+.+|+.+||+.||++|||+.++++.|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 55444432211 11112223457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=302.10 Aligned_cols=254 Identities=30% Similarity=0.583 Sum_probs=228.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|..+++||+|.||.|-+++.+.+++.+|+|++.+..+-.......-..|-.+|+.. +||.+..+-..|...+.+|+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEE
Confidence 36799999999999999999999999999999999888776666666677899999998 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc-cCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF-FKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~-~~~~ 212 (315)
||||+.||.|.-++.+...+++...+.+...|..||.|||+.+||+||+|.+|.|+++++. +||+|||+++. ...+
T Consensus 246 VMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH---IKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH---IKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc---eEeeecccchhccccc
Confidence 9999999999999988888999999999999999999999999999999999999987666 99999999985 3456
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
....+.+|||.|.|||++. ..|+...|.|.+|+|+|||++|+.||.+........-|.-....++ ..++++...|
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----r~ls~eAktL 398 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----RTLSPEAKTL 398 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC----ccCCHHHHHH
Confidence 6678899999999999997 5699999999999999999999999998888777777766655544 4579999999
Q ss_pred HHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
++.+|.+||.+|. .+.||.+|.||
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF 427 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFF 427 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhh
Confidence 9999999999994 68899999887
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=298.45 Aligned_cols=253 Identities=28% Similarity=0.477 Sum_probs=209.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccc--cChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--Cc
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~ 130 (315)
.+|++.+.||+|+||.||+|.+..++..+|+|.+..... ........+.+|+.+++++ +|+||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 479999999999999999999999999999998753221 1233456788999999999 999999999998764 46
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++++||+++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEECccccccccc
Confidence 8899999999999999987777999999999999999999999999999999999999976554 8999999997653
Q ss_pred CC----CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 211 PG----EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 211 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.. .......++..|+|||.+.+ .++.++|+||||++++++++|+.||...........+... ..++..+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~p~~~~ 235 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTKPMLPDGVS 235 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC--CCCCCCCcccC
Confidence 21 11234568889999999864 4889999999999999999999999776555444433321 22333456688
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+++.+++.+||. +|.+||++.+++.|+|
T Consensus 236 ~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 236 DACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred HHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 999999999999 5799999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=306.48 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=208.5
Q ss_pred cccccceeeeeeeeeecceEEEEEEEC-------CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD 123 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 123 (315)
....++|++.+.||+|+||.||+|.+. .++..+|+|.+.... .......+.+|+.+++.+.+||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 344568999999999999999999753 234579999876432 23345678999999999978999999999
Q ss_pred EEEcCCcEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q 021233 124 TYEDDTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187 (315)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Ni 187 (315)
++......+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999998753 2367888999999999999999999999999999999
Q ss_pred EeecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCCh
Q 021233 188 LFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETE 262 (315)
Q Consensus 188 ll~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~ 262 (315)
+++.++. ++|+|||.+........ .....+++.|+|||++. ..++.++||||||++++++++ |..||.....
T Consensus 169 li~~~~~---~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 169 LVTENNV---MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred EEcCCCc---EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9976554 89999999986543221 12234567899999876 458999999999999999998 8899987777
Q ss_pred HHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+....+.... +......++.++.+++.+||+.+|++|||+.++++.|
T Consensus 246 ~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 246 EELFKLLKEGH---RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHHHHHHcCC---cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 66666654432 2223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=299.09 Aligned_cols=243 Identities=22% Similarity=0.334 Sum_probs=200.6
Q ss_pred eeeeeecceEEEEEEECCCC---CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEe
Q 021233 61 RELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 137 (315)
+.||+|+||.||+|.+...+ ..+|+|.+...... ...+.+.+|+.+++.+ +|+|++++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEe
Confidence 46999999999999876554 78999998765432 3456788999999999 8999999999876 4468999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc--
Q 021233 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF-- 215 (315)
Q Consensus 138 ~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~-- 215 (315)
+++++|.+++.....+++..++.++.|++.||.|||+.+++|+||||+||+++.++. ++|+|||.+.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~---~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ---AKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc---EEeccccccceeecCCcccc
Confidence 999999999988778999999999999999999999999999999999999986655 899999999866433321
Q ss_pred --cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 216 --SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 216 --~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
....++..|+|||.+. ..++.++||||||++++++++ |..||......+....+.... +...+..++..+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~l 230 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE---RLPRPEECPQEIYSI 230 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC---cCCCCCCCCHHHHHH
Confidence 1112345799999876 458999999999999999998 999997776655555544332 223345678999999
Q ss_pred HHHhcCCCcCCCCCHHHHhccc
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l 313 (315)
|.+||..+|++|||+.++++.+
T Consensus 231 i~~cl~~~p~~Rp~~~~l~~~l 252 (257)
T cd05060 231 MLSCWKYRPEDRPTFSELESTF 252 (257)
T ss_pred HHHHhcCChhhCcCHHHHHHHH
Confidence 9999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=318.72 Aligned_cols=258 Identities=31% Similarity=0.581 Sum_probs=230.8
Q ss_pred cccceee--eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 53 IEERYEL--GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 53 ~~~~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
+..-|++ .+.||+|.||+||-|.++++|+.||||++.+..+... ....+++|++||..+ .||.||.+--.|+..+.
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l-~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNL-HHPGIVNLECMFETPER 637 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhc-CCCCeeEEEEeecCCce
Confidence 3444665 4689999999999999999999999999998776544 347899999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 131 VHLVMELCEGGELFDRIV--ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~--~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+++|||-+.| +..+.+. ..+++++.....+..||+.||+|||.++|+|+||||+|||+.+...--.+||||||.|+.
T Consensus 638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999965 6666554 346799999999999999999999999999999999999998776555699999999999
Q ss_pred cCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
........+.+|||.|.|||++. ..|...-|+||.|+++|.-++|..||.. .+++..+|.+....+++.+|..++++
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHH
Confidence 98877778899999999999987 5699999999999999999999999954 45677788888889999999999999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+||..+|+..=.+|.|....|.|+|+
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 9999999999999999999999999985
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=294.87 Aligned_cols=251 Identities=31% Similarity=0.510 Sum_probs=211.8
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|.+.+.||+|++|.||++.+..++..+++|.+..... .....+.+|+.+++.+ +|+|++++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEE
Confidence 48889999999999999999988899999999875432 3457789999999999 7999999999999999999999
Q ss_pred EecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 136 ELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe---EEEeecccccccccccc
Confidence 999999999998776 57999999999999999999999999999999999999986555 89999999987655432
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....++..|++||.+. ..++.++|+||||+++++|++|..||................... ......++..+.++|.
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~ 232 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG-LRNPEKWSDEFKDFLK 232 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCC-cCcccccCHHHHHHHH
Confidence 34567888999999876 447899999999999999999999997765444444333321111 1111224789999999
Q ss_pred HhcCCCcCCCCCHHHHhcccC
Q 021233 294 KMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 294 ~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+||+.||++|||+.+++.|+|
T Consensus 233 ~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 233 KCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHccCChhhCCCHHHHhcCCC
Confidence 999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=304.87 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=203.4
Q ss_pred ceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 56 RYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... .......+.+|+.+++.+ +||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCC
Confidence 48889999999999999998753 23568888876542 223346788999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 021233 131 VHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~N 186 (315)
.++++||+++++|.+++... ..+++..++.++.|++.||.|||+.+++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 99999999999999988642 237888999999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 021233 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 261 (315)
Q Consensus 187 ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~ 261 (315)
|++++++. ++|+|||++........ .....++..|+|||.+. ..++.++||||||+++++|++ |..||....
T Consensus 158 ill~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGRK---MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCCc---EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99976554 89999999976533221 12234567899999875 458999999999999999998 999998776
Q ss_pred hHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.......+.... .......+++++.+++..||+.+|++||++.++++.|
T Consensus 235 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 235 PERLFNLLKTGY---RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred HHHHHHHHhCCC---CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 665555444332 2233456789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=314.47 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=207.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----C
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----D 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~ 128 (315)
+.++|++.+.||.|++|.||+|.+..++..||+|.+..... .......+.+|+.+++.+ +||||+++++++.. .
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 80 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADF 80 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCC
Confidence 45789999999999999999999999999999999875422 223356678899999999 89999999998763 3
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
...++||||+. ++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~dfg~~~~ 156 (334)
T cd07855 81 KDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE---LRIGDFGMARG 156 (334)
T ss_pred ceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEeccccccee
Confidence 56899999995 589999887777999999999999999999999999999999999999986655 89999999876
Q ss_pred cCCCCc-----ccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcc--------
Q 021233 209 FKPGEK-----FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV-------- 273 (315)
Q Consensus 209 ~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-------- 273 (315)
...... .....++..|+|||.+.. .++.++||||||+++++|++|+.||...........+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 533221 134578889999998753 48899999999999999999999997654433222211110
Q ss_pred ---------------ccCCCCC----CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 274 ---------------LDFRRDP----WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 274 ---------------~~~~~~~----~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....... .+..++++.++|.+||+.+|++|||+.+++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 0001111 23468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=301.85 Aligned_cols=247 Identities=34% Similarity=0.588 Sum_probs=210.9
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (315)
||.|+||.||++.+..+++.+++|.+...........+.+.+|+++++++ +|+|++++++.+......++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 68999999999999988999999998765444445567789999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC---------
Q 021233 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--------- 213 (315)
Q Consensus 143 L~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~--------- 213 (315)
|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||++++++. ++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH---LKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC---EEEEecccchhcccCcccccccccc
Confidence 9999988778999999999999999999999999999999999999987655 8999999987543321
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
......++..|++||... ...+.++|+||||++++++++|..||......+....+.......+.. ..++..+.+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHH
Confidence 223456788999999876 448889999999999999999999998877776666665533322211 12489999999
Q ss_pred HHhcCCCcCCCCCH---HHHhcccCC
Q 021233 293 RKMLDPDPKRRLTA---QQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps~---~e~l~~l~f 315 (315)
.+||+.+|++|||+ .+++.++||
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccc
Confidence 99999999999999 999999997
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=303.52 Aligned_cols=251 Identities=21% Similarity=0.356 Sum_probs=206.5
Q ss_pred ccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++.++||+|+||.||++... .++..+++|.+... .....+.+.+|+++++.+ +|+||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 79 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVL-QHQHIVRFYGVCTEG 79 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecC
Confidence 357899999999999999999743 34668899987643 233456799999999999 999999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 021233 129 TAVHLVMELCEGGELFDRIVARG---------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~---------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~ 193 (315)
...+++|||+++++|.+++.... .+++..++.++.|++.||+|||+.|++||||||+||++++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999987642 378899999999999999999999999999999999997644
Q ss_pred CCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 021233 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (315)
. ++|+|||++........ .....+++.|+|||.+. ..++.++||||||+++++|++ |..||......+....
T Consensus 160 ~---~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 160 V---VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred C---EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 4 89999999875533221 12234467899999876 458999999999999999998 9999977766666555
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+..... ...+..+++.+.+++.+||+.||.+||++.++++.|.
T Consensus 237 ~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCcc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 544322 2233467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=301.87 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=204.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--CCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 132 (315)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|+++++.+ +||||+++++++.. .+.++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEE
Confidence 368999999999999999999998999999998865422 23456789999999999 89999999998864 34689
Q ss_pred EEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 133 LVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~---~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe---EEEeecccccc
Confidence 99999999999887653 334899999999999999999999999999999999999976554 89999999875
Q ss_pred cCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC-----hHHHHHHHHhccccCCCCCC-
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-----EQGVAQAIIRSVLDFRRDPW- 281 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~- 281 (315)
..... .....++..|+|||.+. ..++.++||||||+++|+|++|..||.... ..+....+............
T Consensus 155 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 155 LVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 43322 22346788899999876 468999999999999999999999997552 12222222221111111111
Q ss_pred --ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 --PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 --~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...++.+.++|.+||..+|++|||+.|++.|+||
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 1245789999999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=304.96 Aligned_cols=257 Identities=31% Similarity=0.547 Sum_probs=208.7
Q ss_pred ceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEccccccc-ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 56 RYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.|++.+.||.|+||.||.|.+. .+|..||+|.+...... .....+.+.+|+.++..+.+|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 46899999998654322 2223466888999999997799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++. ++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC---EEEeeCccceeccc
Confidence 999999999999999988878999999999999999999999999999999999999976544 99999999976543
Q ss_pred CC--cccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 212 GE--KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.. ......++..|+|||.+.. .++.++||||||+++++|++|..||...........+..............+++
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCH
Confidence 22 2234568899999998753 367899999999999999999999964332222222222221122223345789
Q ss_pred HHHHHHHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
.+.+++.+||+.||++|| ++.+++.|+||
T Consensus 238 ~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 271 (290)
T cd05613 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271 (290)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence 999999999999999997 89999999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=307.28 Aligned_cols=251 Identities=29% Similarity=0.514 Sum_probs=209.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
.|.....||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++..+ +|||++++++.+...+..++++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEE
Confidence 3555668999999999999998889999999986432 23346688999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-c
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (315)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~---~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVPK 173 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc---EEEeechhHhhccccccc
Confidence 99999999887754 46899999999999999999999999999999999999976655 8999999987543322 2
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....++..|+|||.+. ..++.++||||||+++++|++|..||......+....+.... ......+..+++.+.++|.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHHH
Confidence 23457889999999986 458999999999999999999999998766555554443322 1112223457889999999
Q ss_pred HhcCCCcCCCCCHHHHhcccCC
Q 021233 294 KMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||+.+|++||++.++++|+||
T Consensus 253 ~~l~~~P~~Rps~~~ll~~~~~ 274 (297)
T cd06659 253 RMLTREPQERATAQELLDHPFL 274 (297)
T ss_pred HHhcCCcccCcCHHHHhhChhh
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=301.43 Aligned_cols=249 Identities=21% Similarity=0.304 Sum_probs=202.8
Q ss_pred eeeeeeeeeecceEEEEEEECCC---CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc---
Q 021233 57 YELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA--- 130 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~--- 130 (315)
|++.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+.+|+..++.+ +|+||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCcccc
Confidence 57889999999999999987643 47899998865422 233456789999999999 99999999998865543
Q ss_pred ---EEEEEEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEE
Q 021233 131 ---VHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 131 ---~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
.++++||+++++|..++... ..+++..++.++.|++.||.|||+.+++||||||+||++++++. ++|+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT---VCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe---EEEC
Confidence 79999999999999888532 24899999999999999999999999999999999999976544 8999
Q ss_pred eeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccC
Q 021233 202 DFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (315)
Q Consensus 202 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (315)
|||+++........ ....++..|+|||.+. ..++.++||||||++++||++ |..||......+....+....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--- 232 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--- 232 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence 99999865433221 1223466899999876 458999999999999999999 899998777666665555432
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.......+++++.+++.+||+.||++|||+.+++++|
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2223346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=300.63 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=206.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCC---EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+..|+.+++.+ +||||+++.+++......
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCce
Confidence 468999999999999999999876654 59999886532 233456799999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+++++|.+++... +.+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~---~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc---EEECCCccccccc
Confidence 9999999999999998764 45899999999999999999999999999999999999975544 8999999987654
Q ss_pred CCCcc----ccccc--CCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 211 PGEKF----SEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 211 ~~~~~----~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
..... ....+ +..|+|||.+. ..++.++||||||++++|+++ |..||......+....+... .....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~ 234 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD---YRLPPPM 234 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---CcCCCcc
Confidence 32211 11111 34799999976 568999999999999999886 99999887776666655432 2223345
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.++..+.+++.+||..+|++||++.+++..|
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=308.71 Aligned_cols=258 Identities=29% Similarity=0.488 Sum_probs=202.2
Q ss_pred ceeeeeeeeeecceEEEEEEECC--CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--CcE
Q 021233 56 RYELGRELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~ 131 (315)
+|++.+.||+|++|.||+|.+.. ++..||+|.+...........+.+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 48899999999999999999987 7899999998764322233346678899999999 999999999999987 889
Q ss_pred EEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC-CCCCEEEEeecc
Q 021233 132 HLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGL 205 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~-~~~~vkl~Dfg~ 205 (315)
++||||+++ +|.+.+... ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++ ....+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999999965 777766432 2589999999999999999999999999999999999998622 134499999999
Q ss_pred ccccCCCCc----ccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH---------HHHHHH
Q 021233 206 SVFFKPGEK----FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQG---------VAQAII 270 (315)
Q Consensus 206 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---------~~~~~~ 270 (315)
+........ .....+++.|+|||.+.+ .++.++||||||+++++|++|+.||....... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 886533221 233467889999998753 47899999999999999999999996544321 111111
Q ss_pred hccc---------------------cCCCCCC------------ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 271 RSVL---------------------DFRRDPW------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 271 ~~~~---------------------~~~~~~~------------~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.... ....... ...+.++.+++.+||+.||++|||+.+++.|+||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 1000 0000001 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.23 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=211.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.....|...+.||+|+||.||+|.+..++..+|+|.+.............+.+|+++++.+ +|+|++++++++......
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTA 100 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeE
Confidence 3445589999999999999999999889999999998755333334456788999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||++| +|.+.+.. ...+++..+..++.+++.||.|||+.+++|+||+|+||+++.++. ++|+|||++....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~---~kl~dfg~~~~~~ 176 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ---VKLADFGSASIAS 176 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC---EEEecCCCccccC
Confidence 999999975 77777754 456899999999999999999999999999999999999976554 8999999887543
Q ss_pred CCCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.. ....+++.|+|||.+. +.++.++||||||+++++|++|..||...........+...... .......++
T Consensus 177 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (317)
T cd06635 177 PA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--TLQSNEWSD 251 (317)
T ss_pred Cc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC--CCCCccccH
Confidence 22 3346888999999863 45889999999999999999999999877665555555443322 222335678
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.++|.+||+.+|.+||++.++++++||
T Consensus 252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 252 YFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 99999999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=301.54 Aligned_cols=249 Identities=21% Similarity=0.298 Sum_probs=200.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCE----EEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
++|++++.||+|+||+||+|.+..++.. +++|.+.... ......++..|+..++++ +||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcC-CCCCcceEEEEECC-Cc
Confidence 4799999999999999999998777764 6677664321 122345678888899999 99999999998764 45
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++++||+++|+|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++. +||+|||.++..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~---~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI---VQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc---EEEcCCccceec
Confidence 78999999999999999764 46899999999999999999999999999999999999976544 899999999765
Q ss_pred CCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 210 KPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 210 ~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
..... .....++..|++||.+. +.++.++||||||+++||+++ |..||...........+..... ......+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 236 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER---LAQPQIC 236 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc---CCCCCCC
Confidence 33221 22345677899999876 568999999999999999998 9999977665544444433221 1222346
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.++.+++.+||..||++|||+.|++..+
T Consensus 237 ~~~~~~li~~c~~~~p~~Rps~~el~~~l 265 (279)
T cd05111 237 TIDVYMVMVKCWMIDENVRPTFKELANEF 265 (279)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 78899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=298.23 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=206.0
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++++.||+|+||.||+|... +++.+|+|.+.... ...+.+.+|+.+++++ +|+|++++++++. .+..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQL-QHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhc-CCcCeeeEEEEEc-cCCcE
Confidence 4568999999999999999999864 57889999886543 2346789999999999 8999999999874 45689
Q ss_pred EEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++|||+++++|.+++... ..+++.++..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC---CKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC---EEEccCcceeecC
Confidence 999999999999988753 35899999999999999999999999999999999999976554 8999999997654
Q ss_pred CCCcc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
..... ....++..|+|||.+. ..++.++||||||++++++++ |+.||...........+.... +.......+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---RMPRPDNCPE 230 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC---CCCCCCCCCH
Confidence 22211 2234567899999886 558899999999999999999 999998777666655554432 2233455789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
++.+++.+||+.+|++||++.+++..|+
T Consensus 231 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 231 ELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 9999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=303.02 Aligned_cols=248 Identities=28% Similarity=0.443 Sum_probs=198.1
Q ss_pred eeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHH---HHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI---MRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~---l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
.||+|+||.||+|.+..+++.||+|.+.............+..|..+ +... .||+|+++.+++...+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecCCEEEEEEecC
Confidence 48999999999999988899999999876543322222233344333 3344 7999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCccccc
Q 021233 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218 (315)
Q Consensus 139 ~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 218 (315)
+|++|.+++...+.+++..++.++.|++.||.|||+.+++||||||+||+++.++. ++|+|||++....... ....
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~---~kl~dfg~~~~~~~~~-~~~~ 155 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKK-PHAS 155 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC---EEEccCcCccccCccC-CcCc
Confidence 99999999988778999999999999999999999999999999999999976554 8999999987543322 2345
Q ss_pred ccCCCccCchhhc-c-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhc
Q 021233 219 VGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296 (315)
Q Consensus 219 ~gt~~y~aPE~~~-~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 296 (315)
.|+..|+|||.+. + .++.++||||+|+++++|++|+.||.......... ............+..+++++.+++.+||
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence 7899999999986 3 48899999999999999999999997652211111 1111111222333456899999999999
Q ss_pred CCCcCCCC-----CHHHHhcccCC
Q 021233 297 DPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 297 ~~~P~~Rp-----s~~e~l~~l~f 315 (315)
..+|.+|| ++.++++|+||
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhCccc
Confidence 99999999 99999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=294.71 Aligned_cols=252 Identities=31% Similarity=0.525 Sum_probs=215.0
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||+|++|.||++.+..+++.+++|.+...... ....+.+.+|++++.++ +|+|++++++++...+..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEE
Confidence 588999999999999999999888999999998765432 23457799999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc-
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~- 214 (315)
||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV---VKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC---EEEeccccceecCCCccc
Confidence 99999999999988788999999999999999999999999999999999999986544 89999999987654332
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....++..|+|||... ..++.++||||||+++++|++|..||.............. .........+++.+.+++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ---DDHPPLPEGISPELKDFLM 232 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc---cCCCCCCCCCCHHHHHHHH
Confidence 23456788999999876 3478999999999999999999999976654433333332 2222334567899999999
Q ss_pred HhcCCCcCCCCCHHHHhcccCC
Q 021233 294 KMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||+.+|++|||+.+++.++||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=306.07 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=205.5
Q ss_pred ccceeeeeeeeeecceEEEEEEEC-------CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
.++|.+.+.||+|+||.||+|.+. .....+|+|.+.... .......+.+|+.+++.+.+||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 357999999999999999999753 234578999876432 23335678899999999967999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 021233 127 DDTAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~ 190 (315)
..+..+++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 999999999999999999999753 2378899999999999999999999999999999999997
Q ss_pred cCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHH
Q 021233 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (315)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 265 (315)
.++. +||+|||.++....... .....++..|+|||.+. +.++.++||||||+++|+|++ |..||......+.
T Consensus 169 ~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 169 EDNV---MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred CCCc---EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 6554 89999999976543221 11223446799999876 458999999999999999999 8999987776666
Q ss_pred HHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...+.... .......++.++.+++.+||+.+|++|||+.++++.+
T Consensus 246 ~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 246 FKLLREGH---RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HHHHHcCC---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 65554432 2223456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=299.71 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=206.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCC---CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
++|++.+.||+|+||.||+|.+..++ ..+|+|.+.... .....+.+..|+.+++.+ +||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCcc
Confidence 57999999999999999999876444 379999886532 223356789999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+++++|.+++... ..+++..+..++.|++.||.+||+.+++||||||+||+++.++. ++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~---~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV---CKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe---EEeCCCCcccccc
Confidence 9999999999999999765 35899999999999999999999999999999999999976554 8999999998654
Q ss_pred CCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
..... ....++..|++||.+. ..++.++|+||||++++++++ |..||......+....+.+.. +.+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 234 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY---RLPAPMDC 234 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC---cCCCCCCC
Confidence 33211 1112346799999987 468999999999999999886 999998777666666555432 22233467
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.+.+++.+||+.+|.+||++.++++.|
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 263 (267)
T cd05066 235 PAALHQLMLDCWQKDRNERPKFEQIVSIL 263 (267)
T ss_pred CHHHHHHHHHHcccCchhCCCHHHHHHHH
Confidence 89999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=298.99 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=202.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+++++.+ +|+||+++++.+.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhC-CCCCcceEEEEECC-CCcEE
Confidence 35799999999999999999988654 5699998865322 245789999999999 89999999998754 56799
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||++++++. ++|+|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~---~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc---EEeccCCceeeccc
Confidence 99999999999999753 34889999999999999999999999999999999999976554 89999999976543
Q ss_pred CCcc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.... ....++..|+|||... ..++.++||||||++++++++ |..||......+....+.... .......+++.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPES 231 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC---CCCCccccCHH
Confidence 3221 2234567899999875 568999999999999999999 888998776666555554322 22223467899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+++.+||+.+|++||++.++++.|
T Consensus 232 l~~li~~~l~~~p~~Rp~~~~~~~~l 257 (262)
T cd05071 232 LHDLMCQCWRKEPEERPTFEYLQAFL 257 (262)
T ss_pred HHHHHHHHccCCcccCCCHHHHHHHH
Confidence 99999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=316.38 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=203.9
Q ss_pred ccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|.+.+.||+|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.++.++..||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 457999999999999999999864 3456899999975422 222456889999999994599999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcC---------------------------------------------------------
Q 021233 129 TAVHLVMELCEGGELFDRIVARG--------------------------------------------------------- 151 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~--------------------------------------------------------- 151 (315)
+..++||||+++|+|.+++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986532
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 021233 152 -----------------------------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (315)
Q Consensus 152 -----------------------------------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~ 190 (315)
.+++..++.++.|++.||.|||+.+++||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 256677888999999999999999999999999999997
Q ss_pred cCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHH
Q 021233 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (315)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 265 (315)
.++. ++|+|||++........ .....+++.|+|||.+. ..++.++||||||++++||++ |..||......+.
T Consensus 274 ~~~~---~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 274 EGKL---VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred CCCE---EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 6444 89999999976532221 12345678899999876 458999999999999999998 8999976655444
Q ss_pred HHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
........ .+...+..++.++.+++.+||+.+|.+||++.+++..|
T Consensus 351 ~~~~~~~~--~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 351 FYNAIKRG--YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HHHHHHcC--CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 43333222 22233445789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=301.06 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=210.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+-|++.+.||.|+||.||+|.+..++..+|+|.+..... ......+.+|+.++..+ +||||+++++++..+...++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEE
Confidence 458889999999999999999988899999998764432 23346788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||+++++|.+++.. ..+++..+..++.+++.+|.+||+.|++|+||+|+||++++++. ++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~---~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC---EEEeecccceecccchh
Confidence 999999999988864 46899999999999999999999999999999999999976655 8999999987654322
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
......++..|+|||.+. ..++.++|+||||+++++|++|..||...........+.... .+.....++.++.+++
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i 233 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFV 233 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC---CCCCCcccCHHHHHHH
Confidence 223456788999999876 457889999999999999999999997665544444433221 2223345789999999
Q ss_pred HHhcCCCcCCCCCHHHHhcccCC
Q 021233 293 RKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+||+.+|++||++.+++.|+||
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~~~~~ 256 (277)
T cd06641 234 EACLNKEPSFRPTAKELLKHKFI 256 (277)
T ss_pred HHHccCChhhCcCHHHHHhCHHH
Confidence 99999999999999999999886
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=305.78 Aligned_cols=259 Identities=31% Similarity=0.512 Sum_probs=209.5
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~- 129 (315)
....++|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.+ +|||++++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQD 80 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhC-CCCCeeeeeheecCcch
Confidence 44567899999999999999999999989999999998654321 22335677899999999 8999999999987654
Q ss_pred ---------cEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEE
Q 021233 130 ---------AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (315)
Q Consensus 130 ---------~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vk 199 (315)
..++|+||+++ ++.+.+... ..+++..++.++.|++.||.|||+.||+|+||+|+||++++++. +|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~---~k 156 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IK 156 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc---EE
Confidence 78999999976 777777654 35899999999999999999999999999999999999976555 89
Q ss_pred EEeeccccccCCCC--cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc
Q 021233 200 AIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (315)
Q Consensus 200 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (315)
|+|||.+....... ......++..|+|||.+.+ .++.++||||||+++++|++|+.||...........+......
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999998654332 1223356778999998753 4788999999999999999999999876665555444432211
Q ss_pred CCC--------------------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 FRR--------------------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~~--------------------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+ ..+..++..+.+++..||+.+|++|||+.+++.++||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 110 0123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=306.02 Aligned_cols=253 Identities=30% Similarity=0.500 Sum_probs=208.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||+||++.+..++..|++|.+.... ....+.+.+|+.+++.+ +|||++++++.+...+..++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEE
Confidence 367999999999999999999998889999999885432 22346788999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|+||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~---~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC---EEEccCcceecccccc
Confidence 99999999999988654 5889999999999999999999999999999999999976554 8999999887554332
Q ss_pred -cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 -KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......+++.|++||.+. ..++.++|+||||+++|++++|..||...........+.... ......+..++..+.++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC-CCCCCCccccCHHHHHH
Confidence 223456888999999876 458899999999999999999999997655433322222111 11111233467889999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||..+|++||++.+++.|.||
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHH
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=298.59 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=207.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCC---EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.++|+..+.||+|+||.||+|.+..++. .+++|.+.... .....+.+.+|+.+++.+ +|+|++++.+++...+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCC
Confidence 3578899999999999999999876554 69999886442 223356788999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~---~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE---CKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc---EEECCCccceec
Confidence 99999999999999998764 46899999999999999999999999999999999999976554 899999998765
Q ss_pred CCCCcc--c--ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 210 KPGEKF--S--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 210 ~~~~~~--~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
...... . ....++.|+|||.+. ..++.++||||||+++|++++ |..||......+....+.... ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~ 234 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMD 234 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---CCCCCCC
Confidence 432211 1 112345799999876 558999999999999999997 999998777766666665432 2223345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.++.+++.+||+.+|++||++.++++.|
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=329.95 Aligned_cols=247 Identities=33% Similarity=0.514 Sum_probs=205.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEE-EEc---C--
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT-YED---D-- 128 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~-~~~---~-- 128 (315)
-++++.+.|.+|||+.||+|.+...+..||+|++... +....+.+.+|+.+|+.|..|+|||.+++. ... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4689999999999999999999887799999998754 456678899999999999889999999993 321 1
Q ss_pred -CcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEEEee
Q 021233 129 -TAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
-.++|+||||.||+|-|++..+ ..|++.++++|+.++++|+.+||... |||||||-+|||+..++. +|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~---~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN---YKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC---EEeCcc
Confidence 2578999999999999999853 34999999999999999999999987 999999999999987665 899999
Q ss_pred ccccccCCCCcc----------cccccCCCccCchhhc---c-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH
Q 021233 204 GLSVFFKPGEKF----------SEIVGSPYYMAPEVLK---R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269 (315)
Q Consensus 204 g~a~~~~~~~~~----------~~~~gt~~y~aPE~~~---~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 269 (315)
|.+......... -...-|+.|+|||.+. + ..+.|+|||+|||+||-|+....||..... -.|
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI 266 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI 266 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence 998754322211 0124588999999864 3 489999999999999999999999965422 345
Q ss_pred HhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+..+.+++. +.++..+.+||..||+.||++||++.+++.++
T Consensus 267 lng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 267 LNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred EeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 5665555543 57899999999999999999999999998764
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=296.96 Aligned_cols=244 Identities=23% Similarity=0.376 Sum_probs=203.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE-cCCcEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDTAVHL 133 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-~~~~~~l 133 (315)
++|++.+.||+|+||.||++... +..+++|.+... ...+.+.+|+.+++.+ +|+|++++++++. ..+..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEE
Confidence 47999999999999999999865 788999987533 2346788999999999 9999999999764 5567899
Q ss_pred EEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||+++++|.+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc---EEecCCccceeccc
Confidence 999999999999987654 3789999999999999999999999999999999999976655 89999999876533
Q ss_pred CCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.. ....++..|+|||++. ..++.++||||||+++++|++ |+.||......+....+... ........+++.+.
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPVVY 229 (256)
T ss_pred cC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCCHHHH
Confidence 22 2234456799999876 458899999999999999997 99999877666665555443 22333456789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+++.+||+.+|++|||+.++++.|.
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHHh
Confidence 9999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=291.04 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=214.8
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+.+++..||.|..|.|++++.+.+|...|||.+..+. +..+.+++...++++....+.|+||+.+|+|..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4677788999999999999999999999999987653 44556788888888887756899999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|.| +..+..++.+ .+++++..+-++...+..||.||-+ ++|||||+||+|||++..++ +||||||.|..+.+..
T Consensus 171 elM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn---iKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 171 ELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSK 246 (391)
T ss_pred HHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC---EEeecccccceeeccc
Confidence 999 4466666664 3469999999999999999999975 58999999999999987666 9999999999888888
Q ss_pred cccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
.++...|-+.|||||.+. ..|+.++||||||++++||.||+.||.+. .+.+.+..+.+...+. ...-...++++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~-L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL-LPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC-CCcccCcCHHH
Confidence 888889999999999885 34899999999999999999999999875 4455666666643321 11223489999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++|+..||.+|+.+||...++|+|+|.
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi 352 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFI 352 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcce
Confidence 999999999999999999999999973
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=300.96 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=202.1
Q ss_pred cccceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC
Confidence 34689999999999999999997542 34579999876432 222345678899999999 89999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCC
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~ 197 (315)
.+..++||||+++|+|.+++.... .++...+..++.|++.||.|||+++++||||||+||+++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--- 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--- 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc---
Confidence 999999999999999999997532 2466788999999999999999999999999999999976554
Q ss_pred EEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhc
Q 021233 198 LKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS 272 (315)
Q Consensus 198 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 272 (315)
++|+|||+++....... .....++..|+|||.+. +.++.++|+||||++++||++ |..||......+....+...
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 89999999875533221 12224467799999876 568999999999999999998 78899877766655554433
Q ss_pred cccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 273 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
... .....+++.+.+++.+||+.||++|||+.++++.
T Consensus 238 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 274 (288)
T cd05061 238 GYL---DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL 274 (288)
T ss_pred CCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 221 1223567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=297.25 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=204.6
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+.+++++ +|+|++++++++. ....+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcE
Confidence 3468999999999999999999875 567799998865432 246789999999999 9999999999875 45689
Q ss_pred EEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++|||+++++|.+++... ..+++..++.++.+++.||.|||+.+++|+||||+||++++++. ++|+|||.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~---~~l~dfg~~~~~~ 153 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV---CKIADFGLARLIE 153 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce---EEeCCceeeeecc
Confidence 999999999999998753 34899999999999999999999999999999999999976544 8999999997654
Q ss_pred CCCcc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
..... ....++..|+|||.+. ..++.++||||||+++++|++ |..||......+....+... ...+.....+.
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (260)
T cd05070 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG---YRMPCPQDCPI 230 (260)
T ss_pred CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---CCCCCCCcCCH
Confidence 33211 1223456799999876 458899999999999999999 89999877766666655443 12223346789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.+.+++.+||..+|++|||+.++++.|+
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 9999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=302.74 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=196.6
Q ss_pred cce-eeeeeeeeecceEEEEEEE----CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC-
Q 021233 55 ERY-ELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD- 128 (315)
Q Consensus 55 ~~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~- 128 (315)
++| ++.+.||+|+||+||++.. ..++..||+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQG 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCC
Confidence 345 9999999999999988653 3567889999886542 223356788999999999 999999999987653
Q ss_pred -CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
...+++|||+++++|.+++... .+++..++.++.|++.||.|||++|++||||||+||++++++. ++|+|||++.
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~~ 155 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL---VKIGDFGLAK 155 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc---EEEeeccccc
Confidence 4689999999999999998764 5999999999999999999999999999999999999976544 8999999998
Q ss_pred ccCCCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHH--H------------HHH
Q 021233 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--V------------AQA 268 (315)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~------------~~~ 268 (315)
........ ....++..|+|||.+. ..++.++||||||+++++|++|..||....... . ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence 65433221 1224556799999876 558999999999999999999999985433210 0 000
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.... .........++.++.+++.+||+.+|++|||+.+++..+
T Consensus 236 ~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 236 LLER--GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hhhc--CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 0000 011122345789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=295.96 Aligned_cols=245 Identities=34% Similarity=0.611 Sum_probs=212.1
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (315)
||.|+||.||++.+..+++.+++|.+.............+..|+.+++.+ +|+|++++++.+...+..+++|||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 68999999999999888999999998876555555667899999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-CcccccccC
Q 021233 143 LFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-EKFSEIVGS 221 (315)
Q Consensus 143 L~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt 221 (315)
|.+++.....+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||.+...... .......++
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH---IKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc---EEEeecCcceecccCCCcccCCcCC
Confidence 9999988878999999999999999999999999999999999999986554 899999998765443 223445778
Q ss_pred CCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCc
Q 021233 222 PYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300 (315)
Q Consensus 222 ~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P 300 (315)
..|++||...+ ..+.++|+||||++++++++|..||...........+... .......++..+.+++.+||..||
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD----PLRFPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC----CCCCCCCCCHHHHHHHHHHhcCCH
Confidence 89999998764 4788999999999999999999999777665555555442 223334568999999999999999
Q ss_pred CCCCCH---HHHhcccCC
Q 021233 301 KRRLTA---QQVLGKIEF 315 (315)
Q Consensus 301 ~~Rps~---~e~l~~l~f 315 (315)
++||++ .+++.|+||
T Consensus 233 ~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 233 TKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhCCCcccHHHHHhCCCC
Confidence 999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=309.35 Aligned_cols=259 Identities=31% Similarity=0.458 Sum_probs=209.0
Q ss_pred ccccceee-eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChh-----------cHHHHHHHHHHHHhCCCCCCcc
Q 021233 52 EIEERYEL-GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----------DIEDVRREVDIMRHLPKHQNIV 119 (315)
Q Consensus 52 ~~~~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~h~~iv 119 (315)
.+.++|.. .+.||.|+||+||+|.+..+++.||+|.+......... ....+.+|+.+++.+ +|+||+
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 83 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIM 83 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCccee
Confidence 34567764 57799999999999999989999999988654322100 112477899999999 999999
Q ss_pred eeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEE
Q 021233 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (315)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vk 199 (315)
++++++...+..++||||++ ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~---~k 159 (335)
T PTZ00024 84 GLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CK 159 (335)
T ss_pred eeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC---EE
Confidence 99999999999999999996 599999988778999999999999999999999999999999999999976554 89
Q ss_pred EEeeccccccCCC---------------CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCCh
Q 021233 200 AIDFGLSVFFKPG---------------EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE 262 (315)
Q Consensus 200 l~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 262 (315)
|+|||.+...... .......+++.|+|||.+.+ .++.++|+||||+++++|++|..||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999998765411 11123356788999998764 378999999999999999999999987776
Q ss_pred HHHHHHHHhccccCCCC------------------------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 263 QGVAQAIIRSVLDFRRD------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 263 ~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+....+.......... ..+..++++.++|.+||+.+|++|||+.+++.|+||
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 65554443322111100 012457889999999999999999999999999998
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=295.83 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=197.0
Q ss_pred eeeeecceEEEEEEEC--CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecC
Q 021233 62 ELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
.||+|+||.||+|.+. ..+..||+|.+.... .....+.+.+|+.+++++ +|+||+++++++.. ...++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~-~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA-EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC-CCeEEEEEeCC
Confidence 3899999999999875 345679999886542 233346789999999999 99999999998864 57899999999
Q ss_pred CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc---
Q 021233 140 GGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--- 215 (315)
Q Consensus 140 ~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~--- 215 (315)
+++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||++.........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY---AKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc---EEeccCCccccccCCccceec
Confidence 9999999875 346899999999999999999999999999999999999976544 899999999765433221
Q ss_pred -cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 216 -SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 216 -~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
....++..|+|||.+. ..++.++||||||+++|++++ |..||......+....+.... +......+++++.++|
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li 231 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK---RLDCPAECPPEMYALM 231 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC---CCCCCCCCCHHHHHHH
Confidence 1112356899999876 458999999999999999996 999998777666655554432 2233456789999999
Q ss_pred HHhcCCCcCCCCCHHHHhccc
Q 021233 293 RKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+||..+|++||++.++++.+
T Consensus 232 ~~c~~~~~~~Rp~~~~i~~~l 252 (257)
T cd05115 232 KDCWIYKWEDRPNFAKVEERM 252 (257)
T ss_pred HHHcCCChhhCcCHHHHHHHH
Confidence 999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.66 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=210.3
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+.+.|...+.||+|+||+||+|.+..++..+++|.+.............+.+|+.+++.+ +|||++++++++......+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEE
Confidence 345588888999999999999999889999999998765444444456788999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||+.+ +|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~---~kL~dfg~~~~~~~ 173 (313)
T cd06633 98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ---VKLADFGSASKSSP 173 (313)
T ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC---EEEeecCCCcccCC
Confidence 99999964 77777765 446899999999999999999999999999999999999976554 89999998864322
Q ss_pred CCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.....++..|+|||.+. +.++.++||||||+++++|++|..||...........+..... +......++..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 248 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS--PTLQSNEWTDS 248 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CCCCccccCHH
Confidence 23457888999999873 4588899999999999999999999977665555554443322 12222346788
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+++.+||+.+|.+||++.+++.|+||
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~ 276 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFV 276 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 9999999999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=301.28 Aligned_cols=254 Identities=32% Similarity=0.512 Sum_probs=213.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..+.|++.+.||.|++|.||+|.+..++..+++|++..... ..+.+.+|+..++.+ +|+|++++++.+...+..+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDC-KHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEE
Confidence 45679999999999999999999988899999999865422 456788999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+++||+++++|.+++.... .+++..+..++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~ 168 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQLTK 168 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC---EEECccchhhhhcc
Confidence 9999999999999998876 7999999999999999999999999999999999999986555 89999998875543
Q ss_pred CC-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.. ......++..|++||.+. ..++.++|+||||+++++|++|..||...........+...... .......++.++.
T Consensus 169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 247 (286)
T cd06614 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-PLKNPEKWSPEFK 247 (286)
T ss_pred chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-CCcchhhCCHHHH
Confidence 22 223346788999999876 45899999999999999999999999766555444444332221 1112234789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++|.+||+.+|.+|||+.+++.++||
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~ 273 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFL 273 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHh
Confidence 99999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=295.43 Aligned_cols=251 Identities=28% Similarity=0.473 Sum_probs=213.5
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|+.+++.+ +|+||+++.+++......++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEe
Confidence 588999999999999999999989999999998765332 23456778899999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 136 ELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 136 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||+++++|.+++.. ...+++..++.++.+++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~---~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc---EEEeeccchhhhcc
Confidence 99999999998866 345899999999999999999999999999999999999987544 89999999987654
Q ss_pred CCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
. ......+++.|++||.+. ..++.++|+||||++++++++|+.||...........+...... .....++.++.+
T Consensus 156 ~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 231 (256)
T cd08530 156 N-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP---PIPPIYSQDLQN 231 (256)
T ss_pred C-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---CCchhhCHHHHH
Confidence 4 233456888999999976 45888999999999999999999999877766555555443222 222367899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||+.+|++|||+.++++||+.
T Consensus 232 li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 232 FIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=310.58 Aligned_cols=254 Identities=21% Similarity=0.322 Sum_probs=199.2
Q ss_pred ccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-
Q 021233 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED- 127 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~- 127 (315)
.++|++++.||+|+||+||+|.+. .+++.||+|.+.... .......+.+|+.++.++.+|+||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 357999999999999999999853 457889999986542 222345688899999999778999999998765
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC--------------------------------------------------------
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG-------------------------------------------------------- 151 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~-------------------------------------------------------- 151 (315)
....+++|||+++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 456789999999999999886421
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc---ccc
Q 021233 152 -----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSE 217 (315)
Q Consensus 152 -----------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~ 217 (315)
.+++..+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||++........ ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc---EEEEecccccccccCcchhhcCC
Confidence 2677888999999999999999999999999999999976554 89999999876532221 122
Q ss_pred cccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHh
Q 021233 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (315)
Q Consensus 218 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 295 (315)
..++..|+|||.+. ..++.++||||||++++++++ |..||.................. ...+...++++.+++..|
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~c 318 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--MRAPDYTTPEMYQTMLDC 318 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC--CCCCCCCCHHHHHHHHHH
Confidence 34566799999875 458999999999999999997 99999765433222222222111 112234678999999999
Q ss_pred cCCCcCCCCCHHHHhcccC
Q 021233 296 LDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 296 l~~~P~~Rps~~e~l~~l~ 314 (315)
|+.||++|||+.+++++|.
T Consensus 319 l~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 319 WHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred ccCChhhCcCHHHHHHHHH
Confidence 9999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=299.26 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=206.5
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC--CCCCcceeEEEEEcCCc----
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTA---- 130 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~~~~---- 130 (315)
|++.+.||+|+||.||+|.+..++..+|+|.+....... .....+.+|+.+++++. +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 678899999999999999998889999999987543222 22345667888877763 59999999999987766
Q ss_pred -EEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 131 -VHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 131 -~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
.+++|||+++ +|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~---~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC---EEEeccCcce
Confidence 9999999975 8988887643 4899999999999999999999999999999999999987644 9999999998
Q ss_pred ccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC---------
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--------- 277 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 277 (315)
............++..|+|||.+. ..++.++|+||||+++++|++|.+||......+....+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 765544444556788999999876 4588999999999999999999999987776665555543211100
Q ss_pred --------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 --------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 --------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+.+++.+.++|.+||+.||++||++.+++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00112356788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=307.28 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=206.7
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCC-------CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDREN-------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 124 (315)
....+|++++.||+|+||.||+|.+... ...+|+|.+.... .....+.+.+|+++++++.+||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3445799999999999999999986432 2368999876432 223356788999999999779999999999
Q ss_pred EEcCCcEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceE
Q 021233 125 YEDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (315)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nil 188 (315)
+...+..++++||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999999999999999999999987532 3778889999999999999999999999999999999
Q ss_pred eecCCCCCCEEEEeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChH
Q 021233 189 FANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 263 (315)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~ 263 (315)
++.++. ++|+|||+++........ ....++..|+|||++. ..++.++||||||++++||++ |..||......
T Consensus 167 l~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 167 VTEDNV---MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred EcCCCc---EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 976554 899999999765432211 1123356799999876 458999999999999999998 89999887776
Q ss_pred HHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+....+.... .......++.++.+++.+||+.+|.+|||+.+++.+|
T Consensus 244 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 244 ELFKLLKEGH---RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHHHHHcCC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 6666554432 2223346788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=310.72 Aligned_cols=254 Identities=33% Similarity=0.505 Sum_probs=212.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-----c
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-----A 130 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-----~ 130 (315)
+|++.+.||.|++|.||+|.+..+++.+|+|.+.... ......+.+.+|+.+++.+ +|+||+++.+++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccc
Confidence 5899999999999999999998889999999887542 2234456788999999999 8999999999987765 7
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.+++|||++ ++|.+.+.....+++..++.++.+++.||++||+.||+|+||||+||+++.++. ++|+|||.+....
T Consensus 79 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~---~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD---LKICDFGLARGVD 154 (330)
T ss_pred eEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEcccCceEeec
Confidence 899999997 489998887778999999999999999999999999999999999999986644 9999999998765
Q ss_pred CCC----cccccccCCCccCchhhc-c-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC-----
Q 021233 211 PGE----KFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----- 279 (315)
Q Consensus 211 ~~~----~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 279 (315)
... ......++..|+|||.+. . .++.++|+||||+++++|++|..||......+....+..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 443 234456788999999876 3 58899999999999999999999998777665555544432211110
Q ss_pred ----------------------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 ----------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ----------------------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+.+++++.++|.+||+.+|++||++.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=302.06 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=204.8
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|++|.||+|.+..+++.+|+|.+..... ......+..|+.++....+|+||+++++++......++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 3579999999999999999999998899999999865432 22345566788777777579999999999999999999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+|||+. ++|.+++.. ...+++..+..++.|++.||.|||+ .||+||||+|+||++++++. ++|+|||++.....
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~---~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN---VKLCDFGISGRLVD 167 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC---EEECccccchhccC
Confidence 999985 477777765 3468999999999999999999997 59999999999999976554 89999999976654
Q ss_pred CCcccccccCCCccCchhhcc-----cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHhccccCCCCCCccCC
Q 021233 212 GEKFSEIVGSPYYMAPEVLKR-----NYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~Di~slG~~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
........++..|+|||.+.+ .++.++||||||+++++|++|+.||..... .+....+........ .....++
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 246 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFS 246 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCCC
Confidence 443344467889999998753 278899999999999999999999965322 233333333221111 1112478
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++.+|+.+||+.||++||++.+++.++||
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 899999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=295.71 Aligned_cols=245 Identities=23% Similarity=0.351 Sum_probs=203.5
Q ss_pred eeeeeecceEEEEEEECC-CCC--EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEe
Q 021233 61 RELGRGEFGITYLCTDRE-NGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL 137 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~-~~~--~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 137 (315)
+.||+|++|.||+|.+.. +++ .+|+|.+...... ...+.+.+|+.+++++ +|+||+++++.+.. ...++|+||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEe
Confidence 368999999999999865 333 5899998765433 4457899999999999 99999999999988 889999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc-
Q 021233 138 CEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (315)
Q Consensus 138 ~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~- 214 (315)
+++++|.+.+.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~---~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE---EEeccccccccccccccc
Confidence 99999999998764 5899999999999999999999999999999999999987654 89999999987643221
Q ss_pred ---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 215 ---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 215 ---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.....++..|+|||.+. ..++.++||||||+++++|++ |..||......+....+...... ......++..+.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 231 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER--LERPEACPQDIY 231 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc--CCCCccCCHHHH
Confidence 12345677899999876 458999999999999999998 99999877776666655542211 222345789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+++.+||+.+|++|||+.++++.|.
T Consensus 232 ~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 232 NVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHCCCCcccCCCHHHHHHHhc
Confidence 9999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=309.96 Aligned_cols=255 Identities=31% Similarity=0.452 Sum_probs=204.5
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 128 (315)
+..+|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhc-CCCcchhhHhhhccccccc
Confidence 45789999999999999999999999999999998865432 3456788899999999 999999999776543
Q ss_pred ----------CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 129 ----------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 129 ----------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
...++||||++ ++|.+.+.. ..+++..++.++.|+++||.|||+.|++||||||+||+++.++. .+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~--~~ 154 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL--VL 154 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc--eE
Confidence 35789999996 488887754 46899999999999999999999999999999999999975432 38
Q ss_pred EEEeeccccccCCCC----cccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhc
Q 021233 199 KAIDFGLSVFFKPGE----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272 (315)
Q Consensus 199 kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 272 (315)
+|+|||.+....... ......++..|+|||.+. ..++.++||||||+++++|++|+.||...........+...
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999987653221 112345788899999864 34788999999999999999999999776654444433322
Q ss_pred cccC----------------------CC----CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 273 VLDF----------------------RR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 273 ~~~~----------------------~~----~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.... .. ...+.++.++.+||.+||..||.+|||+.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~ 303 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence 1000 00 0123577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=294.93 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=203.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|++|.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.+ +|+|++++++++.. +..+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT----MMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE-EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC----ccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC-CCcEEE
Confidence 5799999999999999999987654 569999876432 2346788999999999 99999999998754 568899
Q ss_pred EEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||++++++. ++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~---~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV---CKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe---EEECCCccceEccCC
Confidence 99999999999997643 3789999999999999999999999999999999999976555 899999999765332
Q ss_pred Cc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 213 EK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 213 ~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
.. .....++..|+|||... ..++.++||||||+++++|++ |..||......+....+.... ....+...+..+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY---RMPCPQGCPESL 232 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCcccCHHH
Confidence 21 12234567899999876 558999999999999999999 999998777666655554432 222334678999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.+++.+||+.||++||++.++++.|.
T Consensus 233 ~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 233 HELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHh
Confidence 99999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=301.36 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=201.8
Q ss_pred ccceeeeeeeeeecceEEEEEEECC----------------CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRE----------------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 117 (315)
.++|++.+.||+|+||+||++.+.. ++..+|+|.+.... .......+.+|+.+++.+ +|+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l-~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRL-KDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCC
Confidence 4579999999999999999986432 34468999886442 233356789999999999 9999
Q ss_pred cceeEEEEEcCCcEEEEEEecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 021233 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-----------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (315)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~N 186 (315)
|+++++++...+..+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999999999999999999999999999987542 26678899999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh--CCCCCCCC
Q 021233 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC--GVPPFWAE 260 (315)
Q Consensus 187 ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t--g~~p~~~~ 260 (315)
|+++.++. ++|+|||++........ .....+++.|++||... +.++.++||||||+++|||++ |..||...
T Consensus 161 ili~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 161 CLVGKNYT---IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEEcCCCC---EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99976554 89999999976543321 12233457899999755 568999999999999999998 77888766
Q ss_pred ChHHHHHHHHhc----cccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 261 TEQGVAQAIIRS----VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 261 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
...+........ ......+....+++.+.+|+..||+.||.+|||+.++++.|.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 555544333211 001111223457899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=294.19 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=208.7
Q ss_pred eeeeeeeeeecceEEEEEEECCCC----CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+++++.||.|+||.||++.+...+ ..+|+|.+..... ......+.+|+..+..+ +|+||+++++++...+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeE
Confidence 357789999999999999998766 8899999865422 22457899999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++|||+++++|.+++..... +++..+..++.|++.||.+||+.+++|+||+|+||++++++. ++|+|||.+....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~---~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe---EEEcccCCceecc
Confidence 99999999999999976544 899999999999999999999999999999999999986654 8999999998665
Q ss_pred CCCccc--ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEKFS--EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
...... ...+++.|+|||.+. ..++.++|+||||+++++|++ |..||.........+.+...... .....++.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 231 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL---PKPENCPP 231 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---CCCCcCCH
Confidence 442222 123678899999875 458999999999999999998 88999877776666666554322 23345789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.+++.+||..+|++|||+.++++.+
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 999999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=300.26 Aligned_cols=253 Identities=33% Similarity=0.527 Sum_probs=207.4
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
|++.+.||.|++|+||+|.+..+++.|++|.+...... .......+|+..++++.+|+|++++++++...+..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999888999999988654221 2223456799999999339999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 137 LCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|+ +++|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~---~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV---VKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC---EEEeecccceeccCCCC
Confidence 99 779999887764 6899999999999999999999999999999999999986555 89999999987655444
Q ss_pred ccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC--------------
Q 021233 215 FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-------------- 278 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 278 (315)
.....++..|+|||.+. ..++.++|+||||+++++|++|+.||......+....+.........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 45567888999999874 34789999999999999999999999776655444433321111000
Q ss_pred ------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+..+.++.++|.+||+.+|++|||+.|++.++||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0112236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=300.50 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=206.8
Q ss_pred ccceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++++.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +|||++++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC
Confidence 4579999999999999999998743 57889999886432 223346788999999999 999999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 021233 129 TAVHLVMELCEGGELFDRIVARG----------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~----------------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~N 186 (315)
...++++||+++++|.+++.... .+++..++.++.|++.||.|||+.+++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999987432 36788899999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 021233 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 261 (315)
Q Consensus 187 ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~ 261 (315)
|+++.++. ++|+|||.+........ ......+..|+|||.+. ..++.++||||||+++++|++ |..||....
T Consensus 161 il~~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 161 CLVGENMV---VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred eEecCCCc---eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99976554 89999999875432221 12233466799999876 568999999999999999997 888998777
Q ss_pred hHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
..+....+...... .....++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 238 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 238 HEEVIYYVRDGNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 76666655544321 122457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=298.25 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=205.4
Q ss_pred ccceeeeeeeeeecceEEEEEEECC----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-C
Q 021233 54 EERYELGRELGRGEFGITYLCTDRE----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-D 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~ 128 (315)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+... ......+.+.+|+.+++.+ +|+|++++++++.. .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDG 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 4679999999999999999999875 2578899987533 2334467788999999999 99999999998765 5
Q ss_pred CcEEEEEEecCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEE
Q 021233 129 TAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl 200 (315)
...++++||+++++|.+++... ..+++..++.++.|++.||.|||+.+++|+||||+||+++.++. +||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~---~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ---VKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc---EEE
Confidence 6789999999999999998653 34889999999999999999999999999999999999976544 899
Q ss_pred EeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhcccc
Q 021233 201 IDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLD 275 (315)
Q Consensus 201 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 275 (315)
+|||+++........ ....++..|+|||++. ..++.++||||||+++|++++ |+.||......+....+....
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-- 236 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-- 236 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC--
Confidence 999999865433221 2234567799999876 458999999999999999999 999998766655544444331
Q ss_pred CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.......+++++.+++.+||..||++|||+.++++.|
T Consensus 237 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 237 -RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 2222345789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=294.07 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=208.5
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++.+.||.|+||.||+|.+. ++..+|+|.+.... ...+.+.+|+.+++.+ +|+|++++++++......+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceE
Confidence 3468999999999999999999975 46789999886543 2346789999999999 8999999999999989999
Q ss_pred EEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++|||+++++|.+++.... .+++..+..++.+++.||.|||++|++|+||||+||++++++. ++|+|||.+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~---~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV---CKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC---EEECccccceecc
Confidence 9999999999999997643 5899999999999999999999999999999999999976655 8999999987654
Q ss_pred CCCcc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
..... ....++..|+|||.+. ..++.++|+||||++++++++ |+.||...........+.... ........++
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 231 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---RMPRPPNCPE 231 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCH
Confidence 32111 1223456799999876 458899999999999999998 999998777766666665432 2223345689
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
++.+++.+||..+|++||++.++++.++
T Consensus 232 ~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 232 ELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred HHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 9999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=302.97 Aligned_cols=253 Identities=29% Similarity=0.448 Sum_probs=209.3
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..+.|...+.||+|+||.||+|.+..++..+++|.+............++.+|+.+++.+ +|+|++++.+++......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeE
Confidence 345688899999999999999999989999999988654333333456688899999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++. ++|+|||++.....
T Consensus 92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~ 167 (308)
T cd06634 92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAP 167 (308)
T ss_pred EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc---EEECCcccceeecC
Confidence 9999996 588777754 445899999999999999999999999999999999999976554 89999999876543
Q ss_pred CCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
. ....+++.|+|||.+. +.++.++||||||+++++|++|..||...........+...... ......++..
T Consensus 168 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 242 (308)
T cd06634 168 A---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEY 242 (308)
T ss_pred c---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC--CcCcccccHH
Confidence 2 2346788999999863 34788999999999999999999999776655544444443221 1122357889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.++|.+||+.+|++||++.+++.++||
T Consensus 243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred HHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 9999999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=297.20 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=207.8
Q ss_pred cceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
++|++++.||+|+||.||+|.... +...+++|.+.... .....+.+.+|+.+++++ +|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCC
Confidence 579999999999999999999753 34678999875432 222356789999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEE
Q 021233 130 AVHLVMELCEGGELFDRIVARG---------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~---------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl 200 (315)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.++. +++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~---~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE---VKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc---EEE
Confidence 9999999999999999998655 6899999999999999999999999999999999999977655 899
Q ss_pred EeeccccccCCCC--cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccC
Q 021233 201 IDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (315)
Q Consensus 201 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (315)
+|||.+....... ......++..|+|||.+. ..++.++||||||++++++++ |..||...........+......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL 238 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence 9999986543221 223345567799999875 458889999999999999998 888997766666655555433322
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
. ....+++.+.+++.+||+.+|++|||+.++++.+.
T Consensus 239 ~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 239 P--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 2 23457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=306.37 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=207.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC--
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 129 (315)
.+.++|++++.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.+ +|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSL 89 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccc
Confidence 35678999999999999999999999999999999886432 2223345688999999999 9999999999987543
Q ss_pred ----cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
..++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~---~kl~dfg~ 164 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE---LKILDFGL 164 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeeccc
Confidence 358999999 7789887764 46999999999999999999999999999999999999986555 89999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc--------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-------- 275 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------- 275 (315)
+...... .....+++.|+|||.+.+ .++.++|+||||++++++++|..||...........+......
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 165 ARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 9765332 233467889999998763 4889999999999999999999999776554443333221111
Q ss_pred ---------------CC----CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 ---------------FR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ---------------~~----~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ...++.+++++.++|.+||+.||++|||+.+++.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~ 301 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence 00 01124567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=303.66 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=203.8
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC-----
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD----- 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~----- 128 (315)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+........ ....+.+|+++++.+ +|+||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence 4689999999999999999999999999999998865432221 234567899999999 999999999987543
Q ss_pred ---CcEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 129 ---TAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
...++|+||+.+ +|...+.. ...+++..+..++.|+++||.|||+.|++|+||||+||++++++. ++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECcCc
Confidence 346999999965 67776654 346999999999999999999999999999999999999986655 8999999
Q ss_pred cccccCCCCc------------ccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 021233 205 LSVFFKPGEK------------FSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270 (315)
Q Consensus 205 ~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 270 (315)
++........ .....+++.|+|||.+.+ .++.++||||||+++++|++|++||...........+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9975532211 123456788999998753 47899999999999999999999998766655544443
Q ss_pred hccccCCCC--------------------------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 271 RSVLDFRRD--------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 271 ~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.......+. ....+++++.++|.+||+.||++|||+.+++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 321111000 012345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=296.84 Aligned_cols=250 Identities=22% Similarity=0.290 Sum_probs=206.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCC----EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
..+|++.+.||+|+||.||+|.+..++. .+|+|....... ......+.+|+.+++.+ +|+|++++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASV-DHPHVVRLLGICLS-S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-C
Confidence 3579999999999999999999876654 588998765432 33456788999999999 99999999999887 7
Q ss_pred cEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||.+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~---~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH---VKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe---EEECCCccccc
Confidence 889999999999999999864 45899999999999999999999999999999999999976554 89999999986
Q ss_pred cCCCCcccc---cccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 209 FKPGEKFSE---IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 209 ~~~~~~~~~---~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
......... ..++..|+|||.+. ..++.++|+||||++++|+++ |..||......+....+..... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 235 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER---LPQPPI 235 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC---CCCCCC
Confidence 653332211 12356799999876 568999999999999999998 9999988777666666654321 122334
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.++.+++.+||..+|++||++.+++..+
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l 265 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELINEF 265 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 678999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=291.81 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=205.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.+|++.+.||.|+||.||+|.+. ++..+|+|.+..... ....+.+|+++++.+ +|||++++++++......+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEE
Confidence 36899999999999999999875 477899998864432 245688999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++++|.+++... ..+++..++.++.+++.+|.+||+.+++|+||||+||+++.++. ++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV---VKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe---EEECCCcceeecccCc
Confidence 9999999999998764 45899999999999999999999999999999999999975554 8999999987653322
Q ss_pred cc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 214 KF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 214 ~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.. ....++..|+|||.+. +.++.++||||||+++|+|++ |..||...........+...... ......++.+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 231 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---YKPRLASQSVY 231 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC---CCCCCCCHHHH
Confidence 11 1223456899999876 568899999999999999998 99999877776666666543222 22234689999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccc
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+|+.+||+.+|++|||+.++++++
T Consensus 232 ~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 232 ELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHHcccChhhCCCHHHHHHhh
Confidence 999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=300.15 Aligned_cols=253 Identities=32% Similarity=0.557 Sum_probs=205.5
Q ss_pred ceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEccccccc-ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 56 RYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
+|++.+.||+|++|.||++.+. .+++.+|+|.+...... .....+.+.+|+.++.++.+||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 45788999988654322 2223456888999999997799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||||+++++|.+++.....+++..++.++.|++.+|.|||+.+++|+||+|+||+++.++. ++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH---VVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEEECcccccccc
Confidence 999999999999999987777999999999999999999999999999999999999976544 89999999876543
Q ss_pred CCc--ccccccCCCccCchhhccc---CCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHhccccCCCCCCc
Q 021233 212 GEK--FSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~~~~~---~~~~~Di~slG~~l~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~ 282 (315)
... .....++..|++||.+.+. .+.++|+||||+++++|++|..||..... .+....+... ......
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 233 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS----KPPFPK 233 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc----CCCCCc
Confidence 322 1234678899999987532 68899999999999999999999954322 2222222222 223334
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCC---HHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLT---AQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps---~~e~l~~l~f 315 (315)
.++..+.+++.+||+.||++||| +.++|.|+||
T Consensus 234 ~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 234 TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 57889999999999999999998 5677999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=308.17 Aligned_cols=259 Identities=31% Similarity=0.491 Sum_probs=208.4
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-- 128 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-- 128 (315)
..+.++|++.+.||+|+||.||+|.+..+++.+|+|.+... .........+.+|+.+++++.+|+||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-FRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc-cCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 34677899999999999999999999888999999988643 222333456778999999997899999999998653
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
...++||||+++ +|..++... .+++..++.++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||.+..
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~---~kl~d~g~~~~ 156 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR---VKLADFGLARS 156 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEEeeccchhc
Confidence 468999999974 998888765 7889999999999999999999999999999999999986655 89999999976
Q ss_pred cCCCC------cccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc-----
Q 021233 209 FKPGE------KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD----- 275 (315)
Q Consensus 209 ~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----- 275 (315)
..... ......+++.|+|||.+. ..++.++||||||+++++|++|+.||......+....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 54322 223456888999999864 34788999999999999999999999766544433332221100
Q ss_pred ----------------------CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 ----------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ----------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
......+.++.++.++|.+||+.||++|||+.+++.++||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~ 298 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhh
Confidence 0011123468899999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=298.76 Aligned_cols=250 Identities=24% Similarity=0.410 Sum_probs=197.1
Q ss_pred cceeeeeeeeeecceEEEEEEE----CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--C
Q 021233 55 ERYELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--D 128 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~ 128 (315)
++|++++.||+|+||.||+|.. ..++..||+|.+... .....+.+.+|++++..+ +||||+++.+++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCC
Confidence 5799999999999999999974 456889999998643 233456789999999999 99999999998753 3
Q ss_pred CcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~---~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR---VKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe---EEECCCcccc
Confidence 5689999999999999999764 45899999999999999999999999999999999999976554 8999999998
Q ss_pred ccCCCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH---------------
Q 021233 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ--------------- 267 (315)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~--------------- 267 (315)
........ ....++..|+|||.+. ..++.++||||||++++||++|..++...... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchHHH
Confidence 65433221 1112334599999876 45899999999999999999987765332211 111
Q ss_pred -HHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 268 -AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 268 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
...... ........++.++.+|+.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 236 IELLKNN--GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred HHHHhcC--CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 111111 111223457899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=290.93 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=200.4
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||+|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCC
Confidence 36899999999999864 68899999886542 222345688999999999 999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc--cc
Q 021233 141 GELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SE 217 (315)
Q Consensus 141 ~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~--~~ 217 (315)
++|.+++... ..+++..+..++.+++.+|.|+|+.|++|+||+|+||+++.++. ++|+|||++......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~---~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV---LKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe---EEECCCccceeccccccccCCC
Confidence 9999988754 35899999999999999999999999999999999999976554 899999998754332211 12
Q ss_pred cccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHh
Q 021233 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (315)
Q Consensus 218 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 295 (315)
..++..|+|||++. +.++.++||||||++++++++ |..||...........+... .+......++.++.+++.+|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~ 230 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---YRMSCPQKCPDDVYKVMQRC 230 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHH
Confidence 23456799999876 558899999999999999998 99999877666555555433 22233446789999999999
Q ss_pred cCCCcCCCCCHHHHhccc
Q 021233 296 LDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 296 l~~~P~~Rps~~e~l~~l 313 (315)
|+.+|++|||+.++++.+
T Consensus 231 l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 231 WDYKPENRPKFSELQKEL 248 (250)
T ss_pred cccCcccCCCHHHHHHHh
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=294.92 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=204.7
Q ss_pred ccceeeeeeeeeecceEEEEEEECCC---CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 54 EERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.++|.+.+.||+|+||.||+|.+... ...+++|...... .....+.+.+|+.+++.+ +||||+++++++.. +.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CC
Confidence 35699999999999999999987543 3468999876442 233456789999999999 89999999998875 45
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++++|.+++.... .+++..++.++.+++.||.|||+.|++|+||||+||+++.++. ++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~---~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC---VKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC---eEEccCceeeec
Confidence 789999999999999997654 4899999999999999999999999999999999999986554 899999998765
Q ss_pred CCCCcc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
...... ....++..|+|||.+. ..++.++||||||++++++++ |..||......+....+.... +...+..++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~ 234 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE---RLPMPPNCP 234 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC---cCCCCCCCC
Confidence 433221 1223346799999876 458999999999999999886 999998877766665554432 223345678
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.++.++|.+||..+|++|||+.+++..|
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~l 262 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQL 262 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=294.85 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=193.7
Q ss_pred eeeeeecceEEEEEEECC--CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 61 RELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
+.||+|+||.||+|.+.. ++..+|+|.+..... ......+.+|+.+++.+ +||||+++++++......++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECC
Confidence 368999999999998643 456799998765432 22335688899999999 9999999999999999999999999
Q ss_pred CCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 139 EGGELFDRIVARG-----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 139 ~~~sL~~~l~~~~-----~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
++++|.+++.... ..++..+..++.|++.||.|||+.+++|+||||+||+++.++. ++|+|||.+.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~---~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT---VKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc---EEECCccccccccCcc
Confidence 9999999987532 3567788899999999999999999999999999999976544 9999999987543222
Q ss_pred c---ccccccCCCccCchhhcc--------cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhc-cccCCCCC
Q 021233 214 K---FSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRS-VLDFRRDP 280 (315)
Q Consensus 214 ~---~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 280 (315)
. .....++..|+|||++.+ .++.++|+||||++++||++ |..||......+........ ........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 1 123456788999998752 25789999999999999996 99999776655443332222 11122111
Q ss_pred -CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 -WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 -~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....++.+.+++..|| .+|++|||+.+|+..|.|
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~~ 269 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLSY 269 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhcC
Confidence 2246788999999999 689999999999988865
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=309.01 Aligned_cols=255 Identities=28% Similarity=0.484 Sum_probs=208.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc-
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA- 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~- 130 (315)
.+.++|++...||+|++|.||+|.+..++..||+|++.... ........+.+|+.+++.+ +|+|++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSL 89 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccc
Confidence 45678999999999999999999999999999999886542 2223345677899999999 99999999988866554
Q ss_pred -----EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 131 -----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 131 -----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~---~kL~dfg~ 164 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---LKILDFGL 164 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEccccc
Confidence 89999999 6699888865 46999999999999999999999999999999999999986555 89999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------ 277 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------ 277 (315)
+...... .....++..|+|||.+.+ .++.++||||||++++++++|+.||...........+........
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 9865432 334467889999998753 578999999999999999999999987666555444433211100
Q ss_pred -----------------C----CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 -----------------R----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 -----------------~----~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. .....+++++.++|.+||+.+|++|||+.+++.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~ 301 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence 0 0112358899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=327.84 Aligned_cols=149 Identities=31% Similarity=0.504 Sum_probs=135.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.+ +|+||+++++++......++|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999998765544444457788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
|||+.|++|.+++...+.+++..++.++.||+.||.|||+++|+||||||+|||++.++. ++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~---vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH---IKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC---EEEEeCCCCc
Confidence 999999999999988778999999999999999999999999999999999999976554 9999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=297.55 Aligned_cols=242 Identities=19% Similarity=0.260 Sum_probs=193.0
Q ss_pred eeeeeecceEEEEEEECCCCC-------EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 61 RELGRGEFGITYLCTDRENGD-------AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~-------~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
+.||+|+||.||+|.+...+. .+++|.+.... ....+.+.+|+.+++.+ +|||++++++++......++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEE
Confidence 368999999999999865443 37888765332 23345788899999999 89999999999999889999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC-----CCEEEEeecccc
Q 021233 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET-----APLKAIDFGLSV 207 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~-----~~vkl~Dfg~a~ 207 (315)
||||+++++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+||+++.++.. ..++++|||.+.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999997654 48999999999999999999999999999999999999865432 237999999987
Q ss_pred ccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCC-CCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
..... ....+++.|+|||.+.. .++.++||||||+++|+|++|. .||........ ........ ..+...
T Consensus 157 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~----~~~~~~ 228 (258)
T cd05078 157 TVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRH----QLPAPK 228 (258)
T ss_pred ccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccc----cCCCCC
Confidence 54322 23467889999999864 4789999999999999999985 56544443332 22222222 222345
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+.++.+++.+||+.||++|||+.++++.|.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=291.49 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=201.4
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
+.||.|+||.||+|.+.. ++.|++|.+...... .....+.+|+++++++ +|+||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 468999999999999877 999999988754322 3456789999999999 999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc---c
Q 021233 141 GELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---S 216 (315)
Q Consensus 141 ~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~---~ 216 (315)
++|.+++... ..+++..+..++.+++.+|.|||+++++||||+|+||+++.++. ++|+|||.+......... .
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~---~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV---LKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc---EEEeeccccccccCCcceeccc
Confidence 9999998654 45899999999999999999999999999999999999976554 999999998765422211 1
Q ss_pred ccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHH
Q 021233 217 EIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294 (315)
Q Consensus 217 ~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (315)
....+..|+|||.+. +.++.++|+||||+++++|++ |..||...........+... .....+..++.++.+++.+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~ 230 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG---YRMPAPQLCPEEIYRLMLQ 230 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC---CCCCCCccCCHHHHHHHHH
Confidence 123356799999876 558999999999999999999 88999777665555554432 1222334678999999999
Q ss_pred hcCCCcCCCCCHHHHhccc
Q 021233 295 MLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 295 ~l~~~P~~Rps~~e~l~~l 313 (315)
||..+|++|||+.|++..|
T Consensus 231 ~l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 231 CWAYDPENRPSFSEIYNEL 249 (251)
T ss_pred HhccChhhCcCHHHHHHHh
Confidence 9999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=303.60 Aligned_cols=255 Identities=31% Similarity=0.464 Sum_probs=203.8
Q ss_pred ceeeeeeeeeecceEEEEEEECCC--CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----CC
Q 021233 56 RYELGRELGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DT 129 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~~ 129 (315)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ......+.+.+|+.+++++.+|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999877 8899999886432 2222345678899999999679999999987543 24
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
..+++++|+. ++|.+.+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~---~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC---EEeCcCCCceec
Confidence 5789999985 589999987778999999999999999999999999999999999999976554 899999999765
Q ss_pred CCCC-----cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc-------
Q 021233 210 KPGE-----KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD------- 275 (315)
Q Consensus 210 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------- 275 (315)
.... ......|++.|+|||.+.+ .++.++||||||++++++++|..||...........+......
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 4321 1233578899999998653 4789999999999999999999999765544333322221110
Q ss_pred ----------------CC----CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 ----------------FR----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ----------------~~----~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+ ...++..+..+.+++.+||+.||++|||+.+++.++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 00 11123467889999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=312.79 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=211.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCC--C--CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 55 ERYELGRELGRGEFGITYLCTDREN--G--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~--~--~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
+...+.+.||.|.||.||.|++..- | -.||||.+..+. +.++.+.|.+|+-+|+.+ +||||++++|++.+. .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-c
Confidence 3455667899999999999986532 3 358899887653 345578899999999999 999999999999876 5
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.|+|||.++-|-|..++..+. .++...+..++.||+.||.|||+.++|||||..+|||+.+..- |||+|||+|+..
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C---VKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC---VKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce---eeecccchhhhc
Confidence 899999999999999998765 4999999999999999999999999999999999999975433 999999999988
Q ss_pred CCCCccccccc--CCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPGEKFSEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~~~~~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.+........| ...|||||.++ +.++.++|||-||+++||+++ |..||++..+.+.+..+.++ .+.+.++.||
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG---eRlP~P~nCP 618 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG---ERLPCPPNCP 618 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC---CCCCCCCCCC
Confidence 77665433333 45699999987 789999999999999999876 99999999888877777665 3555667899
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+..|+++||+.+|.+||.+.++...|
T Consensus 619 p~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 9999999999999999999999886543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=297.95 Aligned_cols=253 Identities=32% Similarity=0.526 Sum_probs=208.5
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++.+ +|+|++++++++...+..++|+|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEe
Confidence 67789999999999999999889999999988655332 23346788899999999 89999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-c
Q 021233 137 LCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (315)
Q Consensus 137 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (315)
|+++ +|.+.+... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. ++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc---EEEeeeeeeEecCCCccc
Confidence 9975 888887663 56899999999999999999999999999999999999986555 8999999997665433 2
Q ss_pred ccccccCCCccCchhhc-c-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC--------------
Q 021233 215 FSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-------------- 278 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 278 (315)
.....++..|+|||.+. . .++.++|+||||+++++|++|+.||......+....+........+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 33456788899999875 3 5889999999999999999999999776655544443322111000
Q ss_pred ------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+.+++++.++|.+||++||.+||++.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 1123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=299.23 Aligned_cols=251 Identities=30% Similarity=0.512 Sum_probs=208.6
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
.|.....||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.+ +|+|++++++.+...+..+++|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEE
Confidence 344457899999999999999989999999987543 223356788999999999 8999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-c
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (315)
||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+....... .
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~---~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 97 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEcccccceeccccccc
Confidence 99999999887754 46899999999999999999999999999999999999976554 8999999887653322 2
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....+++.|++||.+. ..++.++|+||+|+++++|++|..||...........+..... ........++..+.+++.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 251 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PKLKNLHKVSPSLKGFLD 251 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC-cccCCcccCCHHHHHHHH
Confidence 23456889999999876 4588999999999999999999999977665555444433322 222223457899999999
Q ss_pred HhcCCCcCCCCCHHHHhcccCC
Q 021233 294 KMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||+.+|.+||++.+++.|+||
T Consensus 252 ~~l~~~P~~R~~~~~ll~~~~~ 273 (292)
T cd06657 252 RLLVRDPAQRATAAELLKHPFL 273 (292)
T ss_pred HHHhCCcccCcCHHHHhcChHH
Confidence 9999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=305.95 Aligned_cols=250 Identities=17% Similarity=0.263 Sum_probs=197.0
Q ss_pred eeeeee--cceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 61 RELGRG--EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 61 ~~lg~G--~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
..||+| +||+||++.+..+++.||+|.+..... .....+.+.+|+.+++.+ +||||++++++|...+..++|+||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEecc
Confidence 456666 999999999999999999999865432 223357789999999998 8999999999999999999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc-
Q 021233 139 EGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF- 215 (315)
Q Consensus 139 ~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~- 215 (315)
.+++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++++||+.+.........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~---~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL---VSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc---EEEechHHHhhhhccCccc
Confidence 9999999887643 4899999999999999999999999999999999999986654 899999865432211100
Q ss_pred -------cccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc----------
Q 021233 216 -------SEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD---------- 275 (315)
Q Consensus 216 -------~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------- 275 (315)
....++..|+|||++.+ .++.++||||||+++++|++|..||..................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 11234567999999863 3789999999999999999999999766544433332221100
Q ss_pred ---------------------------------CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 ---------------------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ---------------------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
........+++++.+|+++||+.||++|||+.++++|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~ 311 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence 0001112356789999999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=294.44 Aligned_cols=254 Identities=30% Similarity=0.518 Sum_probs=208.7
Q ss_pred ceeeeeeeeeecceEEEEEEECC-CCCEEEEEEcccccc-------cChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 56 RYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKL-------RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
.|++.+.||+|+||.||+|.+.. .++.+|+|.+..... .......++.+|+.++.+..+|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999887 678899998764321 1222345577888888764489999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 128 DTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
.+..+++|||+++++|.+.+.. ...+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++. ++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~---~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc---EEEec
Confidence 9999999999999999988743 3458999999999999999999996 68999999999999976555 89999
Q ss_pred eccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 203 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
||.+.............++..|++||.+. +.++.++|+||||+++|+|++|..||...........+...... +...
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--PLPE 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC--cCCc
Confidence 99998765544445567889999999976 45899999999999999999999999777666555555444322 2122
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
..+++++.++|.+||+.||++||++.|+.+++.
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 356899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=293.49 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=193.3
Q ss_pred eeeeeecceEEEEEEECC--CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 61 RELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.+ +|+||+++++.+......++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeC
Confidence 368999999999996432 34568888765432 223345688899999999 9999999999999999999999999
Q ss_pred CCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 139 EGGELFDRIVARG-----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 139 ~~~sL~~~l~~~~-----~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
++++|.+++.... ..++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS---VKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc---EEEeccccccccccch
Confidence 9999999997643 2467888999999999999999999999999999999986555 8999999987543222
Q ss_pred c---ccccccCCCccCchhhc--------ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccc-cCC-CC
Q 021233 214 K---FSEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL-DFR-RD 279 (315)
Q Consensus 214 ~---~~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~-~~~-~~ 279 (315)
. .....+++.|+|||++. ..++.++||||||+++|||++ |..||......+.......... ..+ +.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 1 12234567799999863 236789999999999999999 7889877766555554433322 111 11
Q ss_pred CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 280 ~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
....+++.+.+++..|| .||++|||+.+|++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 23357888999999999 59999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=298.24 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=198.2
Q ss_pred ceeeeeeeeeecceEEEEEEE----CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--C
Q 021233 56 RYELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--T 129 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~ 129 (315)
-|++++.||+|+||.||+|.+ ..++..||+|.+.... .......+.+|+.+++.+ +|||++++.+++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCC
Confidence 479999999999999999974 3467889999986442 233456799999999999 999999999998765 5
Q ss_pred cEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++||||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~---~~l~dfg~~~~ 158 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKA 158 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC---EEECCCccccc
Confidence 6899999999999999987653 5899999999999999999999999999999999999976554 89999999986
Q ss_pred cCCCCc----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh---------------HHHHHH
Q 021233 209 FKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE---------------QGVAQA 268 (315)
Q Consensus 209 ~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~---------------~~~~~~ 268 (315)
...... .....++..|+|||.+. ..++.++||||||+++++|+++..|...... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 543322 12345667799999876 4588999999999999999998766432110 001111
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+ .. ....+.+..+++.+.+|+.+||+.+|++|||+.+++..+
T Consensus 239 ~-~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 239 L-EE--GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred H-Hc--CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 1 11 112223456889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=297.19 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=208.8
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
|++.+.||+|++|.||+|.+..+++.+++|.+.... ......+.+..|+.+++.+ +|+|++++++++...+..++|+|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEec
Confidence 677889999999999999999999999999987653 2223346678899999999 89999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-c
Q 021233 137 LCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (315)
Q Consensus 137 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (315)
|++ ++|.+++... ..+++..+..++.+++.||.+||+.||+|+||+|+||++++++. ++|+|||.+....... .
T Consensus 79 ~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~---~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC---EEEecCCcccccCCCccc
Confidence 997 4999999876 57999999999999999999999999999999999999976554 8999999987654332 2
Q ss_pred ccccccCCCccCchhhc-c-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC----------------
Q 021233 215 FSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF---------------- 276 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---------------- 276 (315)
.....++..|+|||.+. . .++.++||||||++++++++|..||......+....+.......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 33445677899999875 3 58899999999999999999999997776555444433211100
Q ss_pred --C-------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 --R-------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 --~-------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+ ....+..+..+.++|.+||..+|++||++.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 01123457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=290.70 Aligned_cols=248 Identities=22% Similarity=0.358 Sum_probs=204.1
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++.+.||+|+||.||++.+. .+..+++|.+.... ...+.+.+|+.+++.+ +|+|++++.+.+.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeE
Confidence 3568999999999999999999864 46679999876432 2346788999999999 89999999999887 7789
Q ss_pred EEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~---~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV---CKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc---EEECCCcceeecc
Confidence 999999999999999763 34788899999999999999999999999999999999976554 8999999987653
Q ss_pred CCCcc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
..... ....++..|+|||.+. +.++.++|+||||++++++++ |..||...........+.... ........+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 230 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPENCPE 230 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC---CCCCcccCCH
Confidence 32211 2224456799999976 458889999999999999999 999998776665555554432 2233356789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.+++.+||+.+|++||++.++++.|
T Consensus 231 ~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 231 ELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred HHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=304.77 Aligned_cols=253 Identities=29% Similarity=0.494 Sum_probs=202.8
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 128 (315)
+.++|.+.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhc-CCCCccchhheecccccCC
Confidence 45689999999999999999999988999999998865422 222345678899999999 999999999998754
Q ss_pred --CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 129 --TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 129 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
...++|+||+.. +|.... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+|||++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~---~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE---LKILDFGLA 164 (342)
T ss_pred CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeCCCC
Confidence 346899999964 776654 235899999999999999999999999999999999999986655 999999998
Q ss_pred cccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccc----------
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL---------- 274 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 274 (315)
..... ......+++.|+|||.+.+ .++.++||||||+++++|++|+.||...........+.....
T Consensus 165 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 165 RHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred cCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 76432 2234467889999998753 488999999999999999999999987654443333322110
Q ss_pred -------------cCCCC----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 275 -------------DFRRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 275 -------------~~~~~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+.. .++..++++.++|.+||+.||++||++.+++.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f 300 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence 00000 123467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=295.70 Aligned_cols=240 Identities=17% Similarity=0.193 Sum_probs=190.7
Q ss_pred eeeeecceEEEEEEECCC------------------------CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC
Q 021233 62 ELGRGEFGITYLCTDREN------------------------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~------------------------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~ 117 (315)
.||+|+||.||+|....+ ...|++|.+.... ......+.+|+.+++.+ +|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l-~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQV-SHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcC-CCCC
Confidence 589999999999975321 2358888875432 22345688899999999 9999
Q ss_pred cceeEEEEEcCCcEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC--
Q 021233 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-- 194 (315)
Q Consensus 118 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~-- 194 (315)
|+++++++......++||||+++++|..++.. .+.+++..+..++.|++.||+|||+.+|+||||||+|||++..+.
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999998875 456899999999999999999999999999999999999976432
Q ss_pred --CCCEEEEeeccccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHH
Q 021233 195 --TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAI 269 (315)
Q Consensus 195 --~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~-tg~~p~~~~~~~~~~~~~ 269 (315)
...++++|||.+...... ....++..|+|||.+.+ .++.++||||||+++||++ +|..||......+.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 234 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY 234 (274)
T ss_pred CccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence 234799999988643222 22356788999998753 4899999999999999984 799999766554433322
Q ss_pred HhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...... ....++++.++|.+||+.+|++|||+.+++++|
T Consensus 235 -~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 235 -EKKHRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HhccCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 221111 123457899999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=291.00 Aligned_cols=243 Identities=26% Similarity=0.423 Sum_probs=202.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||++.. +++.+|+|.+... ...+.+.+|+.+++.+ +|||++++++++... ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-----VTAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-----chHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEE
Confidence 5699999999999999999874 5888999987543 1236788999999999 999999999998765 47999
Q ss_pred EEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||.+......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~---~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV---AKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc---EEECCCccceecccc
Confidence 99999999999997653 4789999999999999999999999999999999999976554 899999998764322
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
. .....+..|+|||.+. +.++.++|+||||+++++|++ |+.||......+....+... ........+++++.+
T Consensus 154 ~--~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 228 (254)
T cd05083 154 V--DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYV 228 (254)
T ss_pred C--CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC---CCCCCCCcCCHHHHH
Confidence 1 2223456799999876 568999999999999999997 99999887776665555443 223334567899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
++.+||+.+|++||++.+++..+.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHc
Confidence 999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=292.04 Aligned_cols=240 Identities=18% Similarity=0.206 Sum_probs=191.9
Q ss_pred eeeeeecceEEEEEEECCCC----------CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 61 RELGRGEFGITYLCTDRENG----------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~----------~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
+.||+|+||.||+|.+..++ ..+++|.+..... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQL-SHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcC-CCcchhheeeEEec-CC
Confidence 46899999999999988766 3477776654321 157788999999999 89999999999988 77
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC----CCCCEEEEeecc
Q 021233 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK----ETAPLKAIDFGL 205 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~----~~~~vkl~Dfg~ 205 (315)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++ ....++|+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 899999999999999998765 689999999999999999999999999999999999998665 222489999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
+..... .....++..|+|||++.+ .++.++||||||++++++++ |..||............. ..... .
T Consensus 155 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~----~ 226 (259)
T cd05037 155 PITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRL----P 226 (259)
T ss_pred cccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCC----C
Confidence 986543 223456678999999763 48899999999999999999 578886654333222222 11111 1
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
......+.++|.+||..+|++|||+.++++.|.
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 227 MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 112378999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=303.66 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=204.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++.++ +|+||+++.+++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~ 91 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSL 91 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccc
Confidence 35678999999999999999999998899999999886532 1223345688899999999 999999999988532
Q ss_pred ---CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...+++++++ +++|.+++... .+++..++.++.|++.||.|||+.|++||||||+||++++++. ++|+|||+
T Consensus 92 ~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kl~dfg~ 166 (345)
T cd07877 92 EEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGL 166 (345)
T ss_pred cccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC---EEEecccc
Confidence 3478888887 77998877544 6999999999999999999999999999999999999986654 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc--------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-------- 275 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------- 275 (315)
+..... ......++..|+|||.+.+ .++.++||||||+++++|++|+.||...........+......
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 167 ARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 244 (345)
T ss_pred cccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 876432 2234577889999998754 4788999999999999999999999765544433332221110
Q ss_pred ---------------CCC----CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 ---------------FRR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ---------------~~~----~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+. ......++++.++|.+||+.||.+||++.+++.|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f 303 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence 000 0112357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=289.46 Aligned_cols=259 Identities=29% Similarity=0.478 Sum_probs=208.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCC----CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-C
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-D 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~ 128 (315)
-..|+++..||+|.||.||+|...+++ +.+|+|.+..+...+... ...-+|+.+++.+ +|+|++.+..+|.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLREL-KHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHh-cCCcchhHHHHHhccC
Confidence 356999999999999999999765543 368999887664433333 3456799999999 99999999999876 8
Q ss_pred CcEEEEEEecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-CCCEEEEe
Q 021233 129 TAVHLVMELCEGGELFDRIVAR-----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAID 202 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~-~~~vkl~D 202 (315)
..+++++||.+. +|+..++.. ..++...++.|+.||+.|+.|||++-|+||||||.|||+..++. .+.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999976 899988743 24899999999999999999999999999999999999987643 35599999
Q ss_pred eccccccCCC----CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---------HHHHH
Q 021233 203 FGLSVFFKPG----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE---------QGVAQ 267 (315)
Q Consensus 203 fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~---------~~~~~ 267 (315)
||+++.+... .....++.|.+|+|||.+-+ .|+.+.||||.||++.||+|-.+.|.+... .+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999976433 23355678999999999764 599999999999999999999888854332 23444
Q ss_pred HHHhccccCCCCCCccC---------------------------------CHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 268 AIIRSVLDFRRDPWPKV---------------------------------SENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 268 ~~~~~~~~~~~~~~~~~---------------------------------~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.|.+.........|+.+ ++...+|+.+||+.||.+|.|+.++|+|.+
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 55554444333334321 344678999999999999999999999999
Q ss_pred C
Q 021233 315 F 315 (315)
Q Consensus 315 f 315 (315)
|
T Consensus 340 F 340 (438)
T KOG0666|consen 340 F 340 (438)
T ss_pred c
Confidence 8
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.45 Aligned_cols=241 Identities=20% Similarity=0.218 Sum_probs=190.9
Q ss_pred eeeeeecceEEEEEEECCC------------CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 61 RELGRGEFGITYLCTDREN------------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~------------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
+.||+|+||.||+|+.... ...+++|.+.... ......+.+|+.++..+ +||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQV-SHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC
Confidence 3689999999999985422 2358888865432 22345688899999999 999999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC----CCEEEEee
Q 021233 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET----APLKAIDF 203 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~----~~vkl~Df 203 (315)
...+++|||+++++|..++... ..+++..++.++.|++.||+|||+.+|+||||||+|||++.++.. ..++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999998888754 458999999999999999999999999999999999999765421 23799999
Q ss_pred ccccccCCCCcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHHHhccccCCCCC
Q 021233 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (315)
|++...... ....++..|+|||.+. ..++.++||||||+++|+|+ +|..||......+.. ........ .
T Consensus 157 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~----~ 228 (262)
T cd05077 157 GIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCM----L 228 (262)
T ss_pred CCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCcc----C
Confidence 988654322 2345788899999875 45899999999999999997 588888665443322 22222111 1
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
....++++.+||.+||+.||.+||++.+|+.++
T Consensus 229 ~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 229 VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 223467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=293.87 Aligned_cols=246 Identities=26% Similarity=0.335 Sum_probs=200.0
Q ss_pred eeeeecceEEEEEEECCCC------CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 62 ELGRGEFGITYLCTDRENG------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~------~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
.||+|+||.||+|.+.... ..+++|.+.... .......+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEE
Confidence 6899999999999976433 679999876432 123356788999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCEEEEeeccc
Q 021233 136 ELCEGGELFDRIVAR-------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLS 206 (315)
Q Consensus 136 e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~--~~~~vkl~Dfg~a 206 (315)
||+++++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++ ....++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 2378899999999999999999999999999999999998765 2335899999998
Q ss_pred cccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 207 VFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 207 ~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
........ .....++..|+|||.+. +.++.++||||||+++++|++ |..||......+....+.... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~~ 235 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---RLQKP 235 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC---ccCCc
Confidence 76533221 12334567899999876 568999999999999999998 999998766655555443321 22233
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..+++.+.++|.+||..+|++||++.++++.|
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 46789999999999999999999999998876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=300.16 Aligned_cols=255 Identities=31% Similarity=0.493 Sum_probs=204.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-CCc
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTA 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~~~ 130 (315)
.+.++|++.+.||.|+||.||+|.+..+++.+|+|.+.... ......+.+.+|+.+++.+ +|||++++.+++.. ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCc
Confidence 46778999999999999999999999999999999886542 2223346688899999999 99999999999875 567
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++++||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+++|+||+|+||+++.++. ++|+|||.+....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~---~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD---LKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC---EEeCccccccccC
Confidence 89999999 5688887754 45888999999999999999999999999999999999976544 8999999987543
Q ss_pred CCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccc--------------
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL-------------- 274 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------------- 274 (315)
. ......++..|+|||.+.+ .++.++||||||+++++|++|+.||...........+.+...
T Consensus 160 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 160 P--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred C--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 2 2234467888999998653 589999999999999999999999976654322221111100
Q ss_pred --------cC-C----CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 275 --------DF-R----RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 275 --------~~-~----~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. . ....+.+++++.++|.+||+.+|++||++.+++.++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 00 0 01123567899999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=295.40 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=201.8
Q ss_pred cceeeeeeeeeecceEEEEEEECC----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--C
Q 021233 55 ERYELGRELGRGEFGITYLCTDRE----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--D 128 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~ 128 (315)
++|++.+.||+|+||.||+|.+.. +++.+|+|.+...... ...+.+.+|+++++.+ +|+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTL-DHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhC-CCCChheEEeeeecCCC
Confidence 468889999999999999998653 4788999998754322 2456799999999999 99999999999877 5
Q ss_pred CcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
...+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC---EEEccccccc
Confidence 67899999999999999997654 5899999999999999999999999999999999999986644 8999999998
Q ss_pred ccCCCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHH--------------HHHH
Q 021233 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------VAQA 268 (315)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--------------~~~~ 268 (315)
........ ....++..|++||.+. ..++.++||||||+++++|++|..|+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 76532211 1123455699999876 568899999999999999999999986543221 1111
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
..... .+......++.++.+++.+||+.+|++|||+.++++.|.
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 238 LLKEG--ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred HHHcC--CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 11111 122223457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=296.03 Aligned_cols=258 Identities=13% Similarity=0.135 Sum_probs=189.5
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCC---CCEEEEEEcccccccChhc--------HHHHHHHHHHHHhCCCCCCc
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVD--------IEDVRREVDIMRHLPKHQNI 118 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~h~~i 118 (315)
.+...++|++.+.||+|+||+||+|.+..+ +..+|+|............ ......+...+..+ +|+++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i 85 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGI 85 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCC
Confidence 345567899999999999999999998876 6677777643322110000 01122333445556 79999
Q ss_pred ceeEEEEEcCC----cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC
Q 021233 119 VCLKDTYEDDT----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (315)
Q Consensus 119 v~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~ 194 (315)
+++++++.... ..+++++++. .++.+.+......++..++.++.|++.||.|||+.+|+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 99998765443 3478888874 477777766555788999999999999999999999999999999999975544
Q ss_pred CCCEEEEeeccccccCCCC--------cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-
Q 021233 195 TAPLKAIDFGLSVFFKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG- 264 (315)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~- 264 (315)
++|+|||+|+...... ......||+.|+|||++.+ .++.++|||||||+++||++|..||.......
T Consensus 165 ---~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 165 ---GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred ---EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 8999999997653221 1123469999999999774 58999999999999999999999997663221
Q ss_pred HHHHHH----hccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 265 VAQAII----RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 265 ~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...... .... ......+.+++++.+++..||..+|++||++.++++.+
T Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLH-EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhh-hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111111 1111 11112345689999999999999999999999998754
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=321.16 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=219.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCC---CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
....+.+.||.|.||.|++|+.+..+ ..||||.+.... ...++.+|..|+.||.++ +||||++|.|+.......
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCcee
Confidence 35688899999999999999987655 469999987542 445567899999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.||+|||++|+|+.+|+.+ +.|+..++..+++.|+.|++||.+.|+|||||..+|||++.+-- +|++|||+++.+.
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv---CKVsDFGLSRvle 782 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLE 782 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE---EEeccccceeecc
Confidence 9999999999999999876 45999999999999999999999999999999999999976544 8999999999775
Q ss_pred CCC--ccccccc--CCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 211 PGE--KFSEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 211 ~~~--~~~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
++. ..++..| ..+|+|||.+. +.++.+|||||+|+||||.++ |..||+...+++.+..+.++ ++.+++.+|
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g---yRLPpPmDC 859 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG---YRLPPPMDC 859 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc---cCCCCCCCC
Confidence 544 2233444 35799999986 889999999999999999776 99999999999999999886 455566789
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
|..|.+||..||++|-.+||.+.+|+..|
T Consensus 860 P~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 860 PAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred cHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 99999999999999999999999998765
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=295.62 Aligned_cols=255 Identities=27% Similarity=0.469 Sum_probs=227.8
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
..+|.++.+||+|+||.|.+|..+.+.+.+|||++.+..+-...+.+--..|-.+|+...+.|.++++..+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 45799999999999999999999999999999999888766666666666788888887788999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc-CCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~-~~~ 212 (315)
||||+.||+|--.+.+-+.+.+..+..++..|+.||-+||++|||+||||.+|||++.++. +||+|||++... ..+
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH---iKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIFDG 504 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc---eEeeecccccccccCC
Confidence 9999999999999999999999999999999999999999999999999999999987666 999999999753 445
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
....+.+|||.|+|||++. ..|+.+.|.||+|++||||+.|.+||.+..+.+..+.|..-...++ ..++.+..++
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----KslSkEAv~i 580 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----KSLSKEAVAI 580 (683)
T ss_pred cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----ccccHHHHHH
Confidence 5567889999999999976 6799999999999999999999999999999999999988766654 4579999999
Q ss_pred HHHhcCCCcCCCCCH-----HHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTA-----QQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~-----~e~l~~l~f 315 (315)
....|.+.|.+|.-. .+|-.|+||
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FF 609 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFF 609 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcch
Confidence 999999999999543 567778776
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=308.59 Aligned_cols=245 Identities=22% Similarity=0.370 Sum_probs=212.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+..+..+||-|.||.||.|+|++-.-.||||.+... ....++|..|+.+|+.+ +|||+|+++++|..+..+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEE
Confidence 345567899999999999999998899999998644 45578999999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 136 ELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||..|+|.++|.+... ++.-.++.++.||..|++||..+++|||||...|+|+. +...||++|||+++.+..+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCc
Confidence 99999999999986543 77888899999999999999999999999999999994 55669999999999886554
Q ss_pred ccccccc---CCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 214 KFSEIVG---SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 214 ~~~~~~g---t~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
. +.-.| ...|+|||.+. ..++.|+|||+||++|||+.| |-.||.+....+...-+.++ ++...+..||+..
T Consensus 420 Y-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg---yRM~~PeGCPpkV 495 (1157)
T KOG4278|consen 420 Y-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG---YRMDGPEGCPPKV 495 (1157)
T ss_pred e-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc---ccccCCCCCCHHH
Confidence 3 32333 35699999876 669999999999999999998 88999888777666666554 5566677899999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
.+||..||+++|.+||++.|+-+.
T Consensus 496 YeLMraCW~WsPsDRPsFaeiHqa 519 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEIHQA 519 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHHHHH
Confidence 999999999999999999998554
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=290.60 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=205.3
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc--ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
+|.+.+.||+|+||.||++.+...+..+++|++...... .......+..|+.+++.+ +||||+++++++......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEE
Confidence 589999999999999999998877666666665432221 122234567799999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 134 VMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
|+||+++++|.+.+.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. ..++|+|||.+...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~----~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN----NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec----CCEeecccCceeec
Confidence 9999999999988753 345899999999999999999999999999999999999963 23899999998765
Q ss_pred CCCCc-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 210 KPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 210 ~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
..... .....+++.|+|||.+. ..++.++|+||||+++++|++|..||...........+.... .+.....++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP---TPSLPETYSRQ 232 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC---CCCCcchhcHH
Confidence 43322 23456788999999876 457889999999999999999999997665554444443322 22223457889
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.++|.+||..+|++||++.++++|+||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=295.67 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=200.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCC----EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-
Confidence 3578999999999999999999877775 46888775432 222234688899999999 999999999998754
Q ss_pred cEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++. +||+|||++..
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~---~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc---eEEcccccccc
Confidence 4679999999999999987654 5899999999999999999999999999999999999976544 89999999986
Q ss_pred cCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 209 FKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 209 ~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
....... ....++..|++||.+. ..++.++||||||+++||+++ |..||...........+... .. ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~ 235 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKG-ER--LPQPPI 235 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CC--CCCCCC
Confidence 5433221 2234567899999876 458999999999999999997 89999766554444333322 11 222345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.++.+++..||..+|++||++.++++.+
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l 265 (303)
T cd05110 236 CTIDVYMVMVKCWMIDADSRPKFKELAAEF 265 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.72 Aligned_cols=244 Identities=22% Similarity=0.331 Sum_probs=192.5
Q ss_pred eeeeeecceEEEEEEECC---CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE-cCCcEEEEEE
Q 021233 61 RELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDTAVHLVME 136 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-~~~~~~lv~e 136 (315)
+.||+|+||.||+|.+.. ++..+|+|.+... ......+.+.+|+.+++.+ +|||++++++++. .++..++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEe
Confidence 368999999999998653 3457999987532 2233456788999999999 9999999999765 4566899999
Q ss_pred ecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc-
Q 021233 137 LCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK- 214 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~- 214 (315)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+|||++.++. +||+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~---~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT---VKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc---EEECCccccccccCCcce
Confidence 999999999997643 4678888999999999999999999999999999999976554 89999999875432211
Q ss_pred ----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 215 ----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 215 ----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
.....++..|+|||.+. ..++.++||||||++++||++ |.+||......+....+.... .......+++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 231 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR---RLLQPEYCPDPL 231 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC---CCCCCCcCCHHH
Confidence 12234567899999875 568999999999999999999 566776655555544443332 111223468899
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+++.+||+.+|++||++.+++..+
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHHH
Confidence 9999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=339.59 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=217.4
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+.-+|+-...||.|.||.||.|.+.++|+..|+|.+...... ....+.+.+|..++..+ +|||+|+++++-.+.+..+
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhc-cCccccccCceeecHHHHH
Confidence 445788889999999999999999999999999988765433 44567789999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|-||||++|+|.+.+...+..++.....+..|++.|+.|||++|||||||||+||+++.++. +|++|||.|......
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~---iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL---IKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc---EEeecccceeEecCc
Confidence 99999999999999988877888899999999999999999999999999999999986664 999999999876543
Q ss_pred C-----cccccccCCCccCchhhcc----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 213 E-----KFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 213 ~-----~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
. .....+||+-|||||++.+ ....++||||||||++||+||+.||.....+-. -+.+-.....+..+..
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a--IMy~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA--IMYHVAAGHKPQIPER 1465 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH--HHhHHhccCCCCCchh
Confidence 2 3356789999999999864 356799999999999999999999976654422 2222222334455566
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
++.+-.+||..||..||++|.++.|+|+|-|
T Consensus 1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred hhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 8999999999999999999999999998754
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=288.50 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=192.6
Q ss_pred eeeeeecceEEEEEEECCC--CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 61 RELGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
+.||+|+||+||++..... ...+++|.+.... .....+.+.+|+.+++.+ +||||+++++.+......++||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecC
Confidence 3699999999999975432 2346677655432 223356789999999999 9999999999999999999999999
Q ss_pred CCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 139 EGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 139 ~~~sL~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
++++|.+++... ..++...++.++.|++.||+|||+.+++||||||+|||++.++. ++|+|||++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~---~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT---VKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc---EEecccccccccCcchh
Confidence 999999998754 23667788899999999999999999999999999999976554 9999999986432211
Q ss_pred --cccccccCCCccCchhhcc--------cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccc-c-CCCCC
Q 021233 214 --KFSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL-D-FRRDP 280 (315)
Q Consensus 214 --~~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~ 280 (315)
......++..|+|||++.. .++.++||||||+++|||++ |..||......+....+..... . .++..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 1234567889999998642 25789999999999999997 5778877666655555443321 1 12222
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+++.+.+++..|| .+|++||++.++++.|.+
T Consensus 235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~~ 268 (268)
T cd05086 235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLTY 268 (268)
T ss_pred CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhcC
Confidence 3457889999999999 679999999999987753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=289.82 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=198.8
Q ss_pred eeeeeeeeeecceEEEEEEECC---CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC----
Q 021233 57 YELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT---- 129 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~---- 129 (315)
|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ......+.+.+|+.+++.+ +||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCc
Confidence 6778899999999999998643 56889999986543 2333456788999999999 8999999999886532
Q ss_pred --cEEEEEEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEE
Q 021233 130 --AVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
..++++||+++++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~---~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT---VCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC---EEEC
Confidence 347899999999998887532 13788999999999999999999999999999999999976554 8999
Q ss_pred eeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccC
Q 021233 202 DFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDF 276 (315)
Q Consensus 202 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 276 (315)
|||.++....... .....+++.|++||.+. ..++.++||||||+++|+|++ |..||......+....+.....
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-- 233 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR-- 233 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc--
Confidence 9999886543321 12234456799999876 458899999999999999999 8999977766555554443321
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
....+..++.+.+++.+||+.+|++|||+.+++..|
T Consensus 234 -~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 234 -LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 112245788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=296.37 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=191.9
Q ss_pred cceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCChHHH
Q 021233 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDR 146 (315)
Q Consensus 67 ~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 146 (315)
++|.||.+....+++.||+|++.... ........+.+|+.+++.+ +|+||+++++++...+..+++|||+++++|.++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCCCCHHHH
Confidence 44556666666789999999987642 2334567899999999999 899999999999999999999999999999999
Q ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc--------cc
Q 021233 147 IVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK--------FS 216 (315)
Q Consensus 147 l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~--------~~ 216 (315)
+... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++. ++|+|||.+........ ..
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~---~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK---VVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc---eEEecCccceeeccccccccccccccc
Confidence 8753 35899999999999999999999999999999999999986655 89999998865432211 12
Q ss_pred ccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC-----------------
Q 021233 217 EIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF----------------- 276 (315)
Q Consensus 217 ~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------------- 276 (315)
...++..|+|||.+.. .++.++|+||||+++++|++|..||...................
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQS 246 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcc
Confidence 3456778999999753 37889999999999999999999997655433322211111000
Q ss_pred -------------CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 -------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 -------------~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.......++.++.+++..||..||++|||+.++|+|+||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 000011234678899999999999999999999999997
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=262.31 Aligned_cols=254 Identities=30% Similarity=0.539 Sum_probs=217.1
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+|.-.+.||+|.||+||+|++.++++.||+|.+.......... ....+|+-+|+.+ +|.|||++++..-.++.+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp-ssalreicllkel-khknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP-SSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc-HHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeH
Confidence 4666788999999999999999999999999998765444433 4567799999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 136 ELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 136 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||+. .|..+... ++.+....++.++.|++.||.++|++++.|||+||.|.|++.+++ +||+|||+++...-.-
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge---lkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE---LKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc---EEecccchhhhcCCceE
Confidence 99965 78777764 556999999999999999999999999999999999999998877 8999999998765433
Q ss_pred cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc-------
Q 021233 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK------- 283 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 283 (315)
-.+..+.|.+|++|.++.+ -|+...|+||.||++.|+.. |++.|++..-.+....+.........+.|+.
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 3456678999999999764 39999999999999999986 8899999988888888877766554444432
Q ss_pred ------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 284 ------------------VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 284 ------------------~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+...-+++++++|.-+|..|.+++++++|++|
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 22334689999999999999999999999998
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=313.95 Aligned_cols=202 Identities=32% Similarity=0.532 Sum_probs=180.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC------
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD------ 128 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~------ 128 (315)
.-|...+.||+|+||.||+++++.+|+.||||.+.... .....+++-+|+++|+++ +|+|||++.++-+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccc
Confidence 34777899999999999999999999999999987654 455678899999999999 799999999987644
Q ss_pred CcEEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC-CCCCEEEEeec
Q 021233 129 TAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFG 204 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~-~~~~vkl~Dfg 204 (315)
....+|||||.||+|+..+.... .|++.+.+.+..++..||.|||++||+||||||.||++-... .....||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 36789999999999999997543 499999999999999999999999999999999999996544 33447999999
Q ss_pred cccccCCCCcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCC
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWA 259 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~ 259 (315)
.|+.+.++....+..||+.|.+||.+. +.|+...|.|||||++|+++||..||-.
T Consensus 170 ~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 170 AARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 999999999899999999999999987 5699999999999999999999999943
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=306.50 Aligned_cols=247 Identities=34% Similarity=0.490 Sum_probs=207.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.+.|.+...+|.|+|+.|-.+.+..+++..++|++.+... .-.+|+.++....+|||++++.+.+.+....
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 345679999999999999999999999999999999976622 2335777777777999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
|+|||.+.|+-+.+.+.....+. ..+..|+.+|+.|+.|||++|+|||||||+|||+. +...+++|+|||.+.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCch
Confidence 99999999998888887665555 78888999999999999999999999999999996 3444499999999987654
Q ss_pred CCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
. ..+.+-|..|.|||++.. .|+.++|+||||++||+|++|+.||........+..... ... ....+|++.++
T Consensus 469 ~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~---~~~--~s~~vS~~AKd 541 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ---MPK--FSECVSDEAKD 541 (612)
T ss_pred h--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc---CCc--cccccCHHHHH
Confidence 4 344567889999999874 599999999999999999999999987776622222221 111 11568999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
||++||+.||.+||++.+++.|+||
T Consensus 542 Ll~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 542 LLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHhccCChhhCcChhhhccCcch
Confidence 9999999999999999999999997
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=323.06 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=198.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
....+|+.++.||+||||.||+++++-+|..||||++.... +......+.+|+..|.+| +|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCc
Confidence 35567999999999999999999999999999999998664 334456789999999999 999999987433100
Q ss_pred --------------------------------------------------------------------------------
Q 021233 129 -------------------------------------------------------------------------------- 128 (315)
Q Consensus 129 -------------------------------------------------------------------------------- 128 (315)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ------------------------------------CcEEEEEEecCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHH
Q 021233 129 ------------------------------------TAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQM 171 (315)
Q Consensus 129 ------------------------------------~~~~lv~e~~~~~sL~~~l~~~~~l-~~~~~~~i~~~l~~~L~~ 171 (315)
..+||-||||+..+|.+++..+... .....++++++|++||.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 0168899999886676666665433 478899999999999999
Q ss_pred HHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-------------------CCCcccccccCCCccCchhhc-
Q 021233 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------------------PGEKFSEIVGSPYYMAPEVLK- 231 (315)
Q Consensus 172 lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~- 231 (315)
+|+.|||||||||.||+++.++. |||+|||+|+... .....+..+||..|+|||++.
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~---VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNS---VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCC---eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999999999999999986555 9999999998621 111345678999999999986
Q ss_pred -c--cCCCcchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHH
Q 021233 232 -R--NYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307 (315)
Q Consensus 232 -~--~~~~~~Di~slG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~ 307 (315)
. .|+.|+|+||||+||+||+. ||... .....+..+.....+.+...+..--+.-..+|..||+.||.+||||.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 2 59999999999999999995 45433 33334445554444444222323334557899999999999999999
Q ss_pred HHhcccCC
Q 021233 308 QVLGKIEF 315 (315)
Q Consensus 308 e~l~~l~f 315 (315)
|+|..=+|
T Consensus 867 eLL~s~ll 874 (1351)
T KOG1035|consen 867 ELLNSELL 874 (1351)
T ss_pred HHhhccCC
Confidence 99987543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=282.87 Aligned_cols=255 Identities=29% Similarity=0.527 Sum_probs=215.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-------
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------- 127 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------- 127 (315)
+.|.-...||+|.||.||+|+...+|+.||+|++..+.....-. ....+|+++|..| +|+|++.++..|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp-italreikiL~~l-kHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP-ITALREIKILQLL-KHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc-HHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence 45888889999999999999999999999999876543333322 3456799999999 99999999887642
Q ss_pred -CCcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 128 -DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...+++||.+|+. +|..++... ..++..++..++.++.+||.|+|...|+|||+||.|+|++.++. +||+|||+
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi---lklADFGl 170 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI---LKLADFGL 170 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce---EEeecccc
Confidence 3458999999965 888877654 46999999999999999999999999999999999999987665 99999999
Q ss_pred ccccCCC-----CcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC
Q 021233 206 SVFFKPG-----EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (315)
Q Consensus 206 a~~~~~~-----~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (315)
++..... +..+..+.|.+|++||.+- ..|+++.|||..||++.||+|+.+.+++.++...+..|......+.+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9755332 2234556799999999876 45999999999999999999999999999999999888887777777
Q ss_pred CCCccC-------------------------------CHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 DPWPKV-------------------------------SENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ~~~~~~-------------------------------~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.|+.+ +++..+|+.++|..||.+|+++.++|.|.||
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 776653 3467799999999999999999999999988
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=282.53 Aligned_cols=228 Identities=25% Similarity=0.337 Sum_probs=187.4
Q ss_pred ecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCChHH
Q 021233 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD 145 (315)
Q Consensus 66 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~ 145 (315)
|.+|.||++.+..+++.+|+|.+.... ...+|...+... .|||++++++++...+..+++|||+++++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 899999999999999999999986542 123344444555 69999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCcc
Q 021233 146 RIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225 (315)
Q Consensus 146 ~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~ 225 (315)
++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++++|||.+...... .....++..|+
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH---IQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC---EEEecccchhccccc--cccCCcCcccc
Confidence 9988778999999999999999999999999999999999999986655 899999987654332 23345677899
Q ss_pred Cchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCC
Q 021233 226 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304 (315)
Q Consensus 226 aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 304 (315)
|||... ..++.++|+||+|+++++|++|..|+....... .. ......+..+++.+.++|.+||+.||++||
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 221 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NT--HTTLNIPEWVSEEARSLLQQLLQFNPTERL 221 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------cc--ccccCCcccCCHHHHHHHHHHccCCHHHhc
Confidence 999876 458899999999999999999998875432110 00 001112245788999999999999999999
Q ss_pred CH-----HHHhcccCC
Q 021233 305 TA-----QQVLGKIEF 315 (315)
Q Consensus 305 s~-----~e~l~~l~f 315 (315)
++ .+++.|+||
T Consensus 222 ~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 222 GAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCCccchHHHHcCCCC
Confidence 86 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=298.11 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=211.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.+...+.+.||+|.||.|.+|.-. .+..||+|.+...... ....+|.+|+++|.+| +||||+.++++|..++.+++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK--NARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccch--hHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHH
Confidence 356889999999999999999854 3689999998765433 3357899999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++|||+.|+|..++..+.. +.......|+.||+.||+||.+.++|||||.+.|+|++.++. +||+|||+++.+-.
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~---iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT---IKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc---EEecCccccccccc
Confidence 9999999999999987732 455667789999999999999999999999999999976555 99999999998766
Q ss_pred CCccc---ccccCCCccCchhh-cccCCCcchHHHHHHHHHHHhh--CCCCCCCCChHHHHHHHHhccccCC----CCCC
Q 021233 212 GEKFS---EIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLC--GVPPFWAETEQGVAQAIIRSVLDFR----RDPW 281 (315)
Q Consensus 212 ~~~~~---~~~gt~~y~aPE~~-~~~~~~~~Di~slG~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 281 (315)
+.... ..+...+|||+|.+ .++++.++|+|+||+++||+++ ...||...+.++..+.......... ...+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 65442 23456789999975 5889999999999999999775 6899988887776665544333222 2235
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.++..+.++|..||..|-++|||++++-.+|
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 67899999999999999999999999986554
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=303.99 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=211.7
Q ss_pred ccceeeeeeeeeecceEEEEEEECCC-C--CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 54 EERYELGRELGRGEFGITYLCTDREN-G--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
+++.++.++||+|.||+|++|.|..- | ..||||++....... ...+|.+|+.+|.+| +|+|+++++|+..+ ..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L-~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKL-QHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhc-cCcceeEEeeeecc-ch
Confidence 35678889999999999999998753 3 358999998765433 467899999999999 99999999999887 66
Q ss_pred EEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 131 VHLVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
.-+|+|++++|||.+.|.. ...|....+..++.||+.||.||.++++|||||...|+|+-. ...|||+|||+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas---prtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS---PRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc---cceeeeecccceec
Confidence 7899999999999999986 345888899999999999999999999999999999999965 44499999999998
Q ss_pred cCCCCcccc----cccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 209 FKPGEKFSE----IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 209 ~~~~~~~~~----~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
+.....+-. ..-...|+|||.++ +.++.++|||+|||++|||+| |..||.+....++++.+..+. +...++
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e---rLpRPk 338 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE---RLPRPK 338 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc---cCCCCC
Confidence 876554422 12234699999987 789999999999999999998 899999999888888876443 344556
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
.|++++.+++..||..+|.+|||+..|.+.
T Consensus 339 ~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 339 YCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 799999999999999999999999998644
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=301.03 Aligned_cols=255 Identities=30% Similarity=0.508 Sum_probs=232.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++++++..||-|+||.|=++........+|+|++.+..+....+.+.+..|-.+|..+ ..|.||+++-.|.++.++|++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccchhhhhh
Confidence 4678889999999999999988766667999999998888888888999999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
||-|-||.|+..+..++.|...+++.++..+++|++|||++|||+|||||+|.+++.++- +||.|||.|+....+.+
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy---~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY---LKLVDFGFAKKIGSGRK 575 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc---eEEeehhhHHHhccCCc
Confidence 999999999999999999999999999999999999999999999999999999975554 89999999999999988
Q ss_pred ccccccCCCccCchhh-cccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~-~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
..+++|||.|.|||++ ....+.+.|.||||++++||++|.+||.+.......+.|.++.-.+. .+..++....+||.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--~Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--FPRRITKTATDLIK 653 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--cccccchhHHHHHH
Confidence 8999999999999985 46799999999999999999999999999988888888887754433 22567889999999
Q ss_pred HhcCCCcCCCCC-----HHHHhcccCC
Q 021233 294 KMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
++...+|.+|.- +.+|-+|-||
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhh
Confidence 999999999975 7899999887
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=278.19 Aligned_cols=254 Identities=26% Similarity=0.501 Sum_probs=220.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|.++..||+|+|+.|.+++...+.+.+|+|++.++-.+...+++=...|-.+..+.++||.+|.+..+|..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 57999999999999999999999999999999999988888777887888999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc-cCCCC
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF-FKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~-~~~~~ 213 (315)
.||++||+|--++.+...++++.++.+...|+.||.|||+.|||+||+|.+|+|++.++. +||+|+|+++. +.++.
T Consensus 330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh---ikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKEGLGPGD 406 (593)
T ss_pred EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc---eeecccchhhcCCCCCc
Confidence 999999999888888888999999999999999999999999999999999999986666 99999999975 45666
Q ss_pred cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCC-------CCChHHH-HHHHHhccccCCCCCCccC
Q 021233 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFW-------AETEQGV-AQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~-------~~~~~~~-~~~~~~~~~~~~~~~~~~~ 284 (315)
..++.+|||.|.|||++.+ .|+...|.|+||++++||+.|+.||+ ..+.++. .+.+.+.....+ ..+
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip----rsl 482 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP----RSL 482 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc----cee
Confidence 6788999999999999986 49999999999999999999999994 1222333 333444333222 346
Q ss_pred CHHHHHHHHHhcCCCcCCCC------CHHHHhcccCC
Q 021233 285 SENAKDLVRKMLDPDPKRRL------TAQQVLGKIEF 315 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rp------s~~e~l~~l~f 315 (315)
+-....++...|++||.+|. -+.++-.|.||
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ff 519 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFF 519 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhh
Confidence 77788999999999999984 35677777776
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=278.22 Aligned_cols=254 Identities=20% Similarity=0.245 Sum_probs=206.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.+.+-+..||.|+||+|++-.++.+|+..|||.+..... .....++..|.+...+-++.||||+++|....++..|+.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 346667789999999999999999999999999986644 344578889999888888999999999999999999999
Q ss_pred EEecCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 135 MELCEGGELFDRIV-----ARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 135 ~e~~~~~sL~~~l~-----~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
||.|+ .||..+.+ +...+++..+..|...+..||.||-. ..|||||+||+|||++..+. |||||||.+..
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~---vKLCDFGIcGq 217 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD---VKLCDFGICGQ 217 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC---EeeecccchHh
Confidence 99995 47766543 34569999999999999999999975 58999999999999987666 99999999987
Q ss_pred cCCCCcccccccCCCccCchhhc--c-cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHhccccCCCCC--Cc
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLK--R-NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRRDP--WP 282 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~--~-~~~~~~Di~slG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~--~~ 282 (315)
+..+-..+...|-..|||||.+. + .|+.+|||||||++|+|+.||+.||..-. ..+.+..+..+..+.-... .-
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~ 297 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV 297 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence 76554555667888999999875 3 49999999999999999999999985432 2223333333322211111 12
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.++..+..+|..||.+|-+.||...++++++|
T Consensus 298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred ccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 36788999999999999999999999999886
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=281.48 Aligned_cols=260 Identities=26% Similarity=0.455 Sum_probs=204.2
Q ss_pred Cccccc-cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-------CCcce
Q 021233 49 TGREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-------QNIVC 120 (315)
Q Consensus 49 ~~~~~~-~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-------~~iv~ 120 (315)
.|+.+. .+|.++++||.|.|++||+|+|..+.+.||+|++.... ...+....||++|+++..+ .+||+
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 466676 89999999999999999999999999999999986432 2345677899999998533 36999
Q ss_pred eEEEEEc----CCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCC
Q 021233 121 LKDTYED----DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKK 193 (315)
Q Consensus 121 ~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~ 193 (315)
+++.|.. +.++++|+|++ |-+|..++.... .++...++.|+.|++.||.|||. +||||.||||+|||+....
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e 225 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTE 225 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccc
Confidence 9999974 56899999999 779999998653 49999999999999999999995 6999999999999996210
Q ss_pred --------------------------------------------------------------------------------
Q 021233 194 -------------------------------------------------------------------------------- 193 (315)
Q Consensus 194 -------------------------------------------------------------------------------- 193 (315)
T Consensus 226 ~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~ 305 (590)
T KOG1290|consen 226 IDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNN 305 (590)
T ss_pred cchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 021233 194 -------------------------------------------------------------------------------- 193 (315)
Q Consensus 194 -------------------------------------------------------------------------------- 193 (315)
T Consensus 306 ~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~ 385 (590)
T KOG1290|consen 306 EPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIP 385 (590)
T ss_pred ccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCC
Confidence
Q ss_pred ---CCCCEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCC------ChH
Q 021233 194 ---ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE------TEQ 263 (315)
Q Consensus 194 ---~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~------~~~ 263 (315)
....|||+|||-|+... ..++....|..|+|||++- ..|+..+||||++|++|||+||...|... ..+
T Consensus 386 ~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 386 LPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred CCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 01236777888777642 2234456788999999976 46999999999999999999999998533 234
Q ss_pred HHHHHHHhccccCCCC-------------------------CCc-------------cCCHHHHHHHHHhcCCCcCCCCC
Q 021233 264 GVAQAIIRSVLDFRRD-------------------------PWP-------------KVSENAKDLVRKMLDPDPKRRLT 305 (315)
Q Consensus 264 ~~~~~~~~~~~~~~~~-------------------------~~~-------------~~~~~l~~li~~~l~~~P~~Rps 305 (315)
+.+..|.+.....+.. +|+ ....++.+|+.-||+.+|++|||
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 4444444443332211 121 11345789999999999999999
Q ss_pred HHHHhcccCC
Q 021233 306 AQQVLGKIEF 315 (315)
Q Consensus 306 ~~e~l~~l~f 315 (315)
|.++|.|+|+
T Consensus 544 A~~cl~hPwL 553 (590)
T KOG1290|consen 544 AAQCLKHPWL 553 (590)
T ss_pred HHHHhcCccc
Confidence 9999999996
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.43 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=211.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE-----cCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-----DDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-----~~~ 129 (315)
..|++++.||.|.+|.||++....+++..|+|+..... ...++++.|.++|+.+..|||++.++++|. .++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 45999999999999999999999999999999886542 334678899999999999999999999985 457
Q ss_pred cEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 130 AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
++|||||||.|||..|+++.. ..+.+..+..|+..++.||.+||.+.++|||||-.|||++.++. |||+|||.+.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~---VKLvDFGvSa 171 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE---VKLVDFGVSA 171 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc---EEEeeeeeee
Confidence 899999999999999999753 45899999999999999999999999999999999999998777 9999999998
Q ss_pred ccCCCC-cccccccCCCccCchhhcc------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC
Q 021233 208 FFKPGE-KFSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 208 ~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (315)
.++... ...+..|||.|||||++.+ .|+..+|+||||++.+||..|.+|+...-....+..+.+. .+.....
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkr 250 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKR 250 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccc
Confidence 775442 3467799999999999852 3778999999999999999999999665543333222211 0001111
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+..-++++.++|+.||.+|-.+||+..++|.|+|.
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI 285 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence 33457889999999999999999999999999984
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=268.98 Aligned_cols=242 Identities=43% Similarity=0.725 Sum_probs=204.1
Q ss_pred cceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCChHHH
Q 021233 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDR 146 (315)
Q Consensus 67 ~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~ 146 (315)
+||.||+|.+..+++.+++|++........ .+.+.+|+..++++ +|+|++++++++......++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 589999999998899999999876543221 57899999999999 999999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCccC
Q 021233 147 IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226 (315)
Q Consensus 147 l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~a 226 (315)
+.....++...++.++.+++.+|.+||+.+++|+||+|+||++++++. ++|+|||.+.............++..|++
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH---VKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc---EEEccccceeeeccccccccccCCcCCCC
Confidence 987666899999999999999999999999999999999999987644 89999999987765544556678889999
Q ss_pred chhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCC
Q 021233 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304 (315)
Q Consensus 227 PE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 304 (315)
||... ..++.++||||||++++++++|..||.. .........+...... .......++.++.+++.+||..+|++||
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-FPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-CccccccCCHHHHHHHHHHccCCchhcc
Confidence 99876 5588899999999999999999999977 3443333333332222 1111122789999999999999999999
Q ss_pred CHHHHhcccCC
Q 021233 305 TAQQVLGKIEF 315 (315)
Q Consensus 305 s~~e~l~~l~f 315 (315)
++.++++++||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=293.97 Aligned_cols=260 Identities=25% Similarity=0.410 Sum_probs=218.9
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCC-----CCCcceeE
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK-----HQNIVCLK 122 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-----h~~iv~~~ 122 (315)
..|..+..+|.+....|+|-|++|..|.+...|..||||+|..+.... ..-..|+++|++|.. -.|+++++
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 346777889999999999999999999999999999999998765432 445679999999942 34899999
Q ss_pred EEEEcCCcEEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEE
Q 021233 123 DTYEDDTAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (315)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vk 199 (315)
.+|...+++|||+|.+ ..+|.+.|+..+ .|....++.++.||..||..|-.+||+|.||||+||||+.... .+|
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~--iLK 577 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN--ILK 577 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc--eee
Confidence 9999999999999999 569999998755 3889999999999999999999999999999999999985444 489
Q ss_pred EEeeccccccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC
Q 021233 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (315)
Q Consensus 200 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (315)
|||||.|..... +..+.+..+..|.|||++.| .|+...|+||.||+||||+||+..|++.++..++.-.+.....++.
T Consensus 578 LCDfGSA~~~~e-neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 578 LCDFGSASFASE-NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred eccCcccccccc-ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 999999987653 34566677788999999765 6999999999999999999999999999998888776655554432
Q ss_pred CCC-------------------------------------------------ccC-------CHHHHHHHHHhcCCCcCC
Q 021233 279 DPW-------------------------------------------------PKV-------SENAKDLVRKMLDPDPKR 302 (315)
Q Consensus 279 ~~~-------------------------------------------------~~~-------~~~l~~li~~~l~~~P~~ 302 (315)
..+ +.+ -.++.+|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 110 011 135789999999999999
Q ss_pred CCCHHHHhcccCC
Q 021233 303 RLTAQQVLGKIEF 315 (315)
Q Consensus 303 Rps~~e~l~~l~f 315 (315)
|.|..++|+|+||
T Consensus 737 Rit~nqAL~HpFi 749 (752)
T KOG0670|consen 737 RITVNQALKHPFI 749 (752)
T ss_pred cCCHHHHhcCCcc
Confidence 9999999999997
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=284.25 Aligned_cols=263 Identities=30% Similarity=0.426 Sum_probs=216.5
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh----hcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----VDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
-..++++|-++.+||+|+|+.||+|.+....+.||+|+-..+..... ...+..-+|..|.+.| +||.||+++++|
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyf 536 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYF 536 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeee
Confidence 34567899999999999999999999999999999998765433221 1233456799999999 999999999999
Q ss_pred Ec-CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCceEeecCCCCCCEEEEe
Q 021233 126 ED-DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--GVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 126 ~~-~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~--~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
.- .+.+|-|+|||+|.+|.-+++.+..+++..++.|+.||+.||.||... .|||-||||.|||+.+....+.+||+|
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 74 467899999999999999999998899999999999999999999976 599999999999998877777799999
Q ss_pred eccccccCCCCcc--------cccccCCCccCchhhc-c----cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHH-
Q 021233 203 FGLSVFFKPGEKF--------SEIVGSPYYMAPEVLK-R----NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQ- 267 (315)
Q Consensus 203 fg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~-~----~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~- 267 (315)
||++..+..+... +...||.+|.+||.+. + ..+.|.||||.||++|.++.|+.||....... +++
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999987654322 4568999999999864 3 37889999999999999999999997654322 222
Q ss_pred -HHH-hccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 268 -AII-RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 268 -~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.|. .....+++. +.++.+..+||++||+..-++|....++..+++|
T Consensus 697 NTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 697 NTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred hchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 111 222233332 5689999999999999999999999999998876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=301.66 Aligned_cols=252 Identities=20% Similarity=0.304 Sum_probs=172.4
Q ss_pred cccceeeeeeeeeecceEEEEEEECCC----CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEE----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDREN----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT---- 124 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~---- 124 (315)
..++|++.+.||+|+||.||+|++..+ +..||+|.+.... ..+.+..| .+... .+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e--~l~~~-~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNE--RVRRA-CPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHH--HHHhh-chhhHHHHHHhhhcc
Confidence 346899999999999999999999888 8999999875321 11111111 11111 22222222221
Q ss_pred --EEcCCcEEEEEEecCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 021233 125 --YEDDTAVHLVMELCEGGELFDRIVARGH--------------------YTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182 (315)
Q Consensus 125 --~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------l~~~~~~~i~~~l~~~L~~lH~~~iiH~di 182 (315)
.......++|+||+++++|.+++..... .....+..++.|++.||.|||+.+|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456679999999999999998865421 123446689999999999999999999999
Q ss_pred CCCceEeecCCCCCCEEEEeeccccccCCCC--cccccccCCCccCchhhc-c----------------------cCCCc
Q 021233 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK-R----------------------NYGPE 237 (315)
Q Consensus 183 kp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~----------------------~~~~~ 237 (315)
||+|||++.+. ..+||+|||+|....... ......+|+.|+|||.+. . .++.+
T Consensus 282 KP~NILl~~~~--~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 282 KPQNIIFSEGS--GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CHHHEEEeCCC--CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999997532 238999999998653322 224567899999999653 1 13346
Q ss_pred chHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc-------CCCCC----------CccCCHHHHHHHHHhcCCCc
Q 021233 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-------FRRDP----------WPKVSENAKDLVRKMLDPDP 300 (315)
Q Consensus 238 ~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~----------~~~~~~~l~~li~~~l~~~P 300 (315)
+|||||||+||||+++..++... .......+...... ..... +.......++||.+||+.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 79999999999999977665321 11111111111000 00000 01123345689999999999
Q ss_pred CCCCCHHHHhcccCC
Q 021233 301 KRRLTAQQVLGKIEF 315 (315)
Q Consensus 301 ~~Rps~~e~l~~l~f 315 (315)
++|||+.++|+|+||
T Consensus 439 ~kR~ta~e~L~Hpff 453 (566)
T PLN03225 439 RQRISAKAALAHPYF 453 (566)
T ss_pred ccCCCHHHHhCCcCc
Confidence 999999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=259.04 Aligned_cols=251 Identities=28% Similarity=0.533 Sum_probs=206.4
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--CcE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~ 131 (315)
.++|++++.+|+|-|+.||.|.+..+++.+++|++. +...+.+.+|+.+|..|..+|||+++++...+. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 357999999999999999999999999999999875 344577999999999998899999999998754 567
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
.+++||+++.+...+. ..++...++..+.+++.||.|+|+.||+|||+||.|++++.... .++|+|+|+|..+-+
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r--kLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR--KLRLIDWGLAEFYHP 185 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc--eeeeeecchHhhcCC
Confidence 8999999875443333 34888899999999999999999999999999999999975443 489999999999988
Q ss_pred CCcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHhcccc-------------
Q 021233 212 GEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLD------------- 275 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~------------- 275 (315)
+...+-.+-+..|-.||.+. ..|+.+-|+|||||++..|+..+.||... .+.+.+..+.+-...
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 88887778888999999876 45899999999999999999999888533 333433333221111
Q ss_pred -----------CCCCCCc---------cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 -----------FRRDPWP---------KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 -----------~~~~~~~---------~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+|. -.+++..+|+.++|..|.++|||+.|+++|++|
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF 325 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF 325 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence 0111111 146899999999999999999999999999998
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=288.88 Aligned_cols=255 Identities=30% Similarity=0.489 Sum_probs=217.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
-|..++.||-|+||.|.++...++...+|.|.+.+............+.|-+||+.. +.+-||+|+..|.+.+.+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEE
Confidence 488899999999999999998888899999999887766666677889999999998 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc------
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF------ 209 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~------ 209 (315)
+|++||++-.+|.+-+-|++..++.++..+..|+++.|+.|+|||||||+||||+.++. +||+|||+++-.
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH---IKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc---eeeeeccccccceecccc
Confidence 99999999999999999999999999999999999999999999999999999976666 999999998532
Q ss_pred ---CCCC----------------------------------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHh
Q 021233 210 ---KPGE----------------------------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILL 251 (315)
Q Consensus 210 ---~~~~----------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~ 251 (315)
..+. .....+||+.|+|||++. ..++..+|.||.||+|+||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 1100 002357999999999986 56999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCC---CHHHHhcccCC
Q 021233 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL---TAQQVLGKIEF 315 (315)
Q Consensus 252 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp---s~~e~l~~l~f 315 (315)
.|+.||-..+..+....+.++.......+...++.++.++|.++.. +++.|. -+++|-+|+||
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfF 931 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFF 931 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccc
Confidence 9999998877776666666555444455556789999999988654 355664 45679999998
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=295.74 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=207.4
Q ss_pred cceeeeeeeeeecceEEEEEEEC---C----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 55 ERYELGRELGRGEFGITYLCTDR---E----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~---~----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
++..+.+.||+|+||.|++|... . ....||||........ .+.+.+..|+++|+.+..|+||+.+++++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 44567779999999999999743 1 1456999988765432 5678899999999999999999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~ 191 (315)
.+..++|.||+..|+|.+++...+ .++...+..++.||+.|++||++..+|||||-.+|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 999999999999999999998765 3888999999999999999999999999999999999975
Q ss_pred CCCCCCEEEEeeccccccCCCCcccc--ccc--CCCccCchhhcc-cCCCcchHHHHHHHHHHHhh-CCCCCCCCC-hHH
Q 021233 192 KKETAPLKAIDFGLSVFFKPGEKFSE--IVG--SPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAET-EQG 264 (315)
Q Consensus 192 ~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~-~~~~~~Di~slG~~l~el~t-g~~p~~~~~-~~~ 264 (315)
+ ..+||+|||+|+.......... ..+ ...|||||.+.. .|+.++||||||++|||++| |..||.+.. ..+
T Consensus 454 ~---~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 454 N---KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred C---CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 5 4499999999996544443321 122 345999999874 69999999999999999998 899998754 555
Q ss_pred HHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
....+..+ .+...+..+++++.++|..||+.+|++||++.++...+
T Consensus 531 l~~~l~~G---~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 531 LLEFLKEG---NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred HHHHHhcC---CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 55544443 34445567899999999999999999999999987653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=270.99 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=195.1
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHh-CCCCCCcceeEEEEEc
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH-LPKHQNIVCLKDTYED 127 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~h~~iv~~~~~~~~ 127 (315)
..+.+.++.++.+.||+|.||.||+|.|+ |+.||||++... +...+.+|.++... +-+|+||+.+++.-..
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 34567888999999999999999999998 999999998533 34678888888765 2389999999987654
Q ss_pred C----CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCceEeecCCCC
Q 021233 128 D----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--------GVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 128 ~----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~--------~iiH~dikp~Nill~~~~~~ 195 (315)
+ .++|||++|.+.|||+|+|.+ ..++....++++..++.||++||-. .|.|||||..||||.+++.
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~- 354 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT- 354 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc-
Confidence 3 368999999999999999988 4699999999999999999999953 4999999999999987666
Q ss_pred CCEEEEeeccccccCCCC-----cccccccCCCccCchhhcccC-------CCcchHHHHHHHHHHHhhC----------
Q 021233 196 APLKAIDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLKRNY-------GPEVDVWSAGVILYILLCG---------- 253 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-------~~~~Di~slG~~l~el~tg---------- 253 (315)
+.|+|+|+|....... .....+||.+|||||++.... -..+||||||.|+||++..
T Consensus 355 --C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey 432 (513)
T KOG2052|consen 355 --CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY 432 (513)
T ss_pred --EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence 8999999998765442 235679999999999986432 2368999999999998732
Q ss_pred CCCCCCCCh----HHHHHHH--HhccccCCCCCCccCC--HHHHHHHHHhcCCCcCCCCCHHHHhc
Q 021233 254 VPPFWAETE----QGVAQAI--IRSVLDFRRDPWPKVS--ENAKDLVRKMLDPDPKRRLTAQQVLG 311 (315)
Q Consensus 254 ~~p~~~~~~----~~~~~~~--~~~~~~~~~~~~~~~~--~~l~~li~~~l~~~P~~Rps~~e~l~ 311 (315)
.+||..... .+..+.+ .+...+..+..|...+ ..+..+|+.||..+|.-|.|+..+-+
T Consensus 433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 567743322 2222222 1222333344554432 34678999999999999999976643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.26 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=184.1
Q ss_pred cccceeeeeeeeeecceEEEEEEEC----------------CCCCEEEEEEcccccccCh-----------hcHHHHHHH
Q 021233 53 IEERYELGRELGRGEFGITYLCTDR----------------ENGDAFACKSISKKKLRTA-----------VDIEDVRRE 105 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~~a~K~~~~~~~~~~-----------~~~~~~~~e 105 (315)
-.++|++.++||+|+||+||+|.+. ..++.||+|.+........ ...+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 2356799999864321100 011223447
Q ss_pred HHHHHhCCCCCC-----cceeEEEEEc--------CCcEEEEEEecCCCChHHHHHhcC---------------------
Q 021233 106 VDIMRHLPKHQN-----IVCLKDTYED--------DTAVHLVMELCEGGELFDRIVARG--------------------- 151 (315)
Q Consensus 106 ~~~l~~l~~h~~-----iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~--------------------- 151 (315)
+.++.++ +|.+ +++++++|.. .+..++||||+++++|.+++....
T Consensus 223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777 4443 4667777653 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccc--cccCCCccC
Q 021233 152 ---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE--IVGSPYYMA 226 (315)
Q Consensus 152 ---~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~gt~~y~a 226 (315)
.+++..++.++.|++.+|.|||+.+|+||||||+|||++.++. ++|+|||++........... ..+|+.|+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGINFNPLYGMLDPRYSP 378 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc---EEEEeCcCccccccCCccCccccCCCcceeC
Confidence 2356778899999999999999999999999999999976554 89999999976543332222 234789999
Q ss_pred chhhccc---------------------C--CCcchHHHHHHHHHHHhhCCC-CCCCCChHHH-----------HHHHHh
Q 021233 227 PEVLKRN---------------------Y--GPEVDVWSAGVILYILLCGVP-PFWAETEQGV-----------AQAIIR 271 (315)
Q Consensus 227 PE~~~~~---------------------~--~~~~Di~slG~~l~el~tg~~-p~~~~~~~~~-----------~~~~~~ 271 (315)
||.+... + ..+.|+||+||++++|++|.. ||........ .+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 9986421 1 124799999999999999875 6643211110 111111
Q ss_pred ccccCCCCCCccCCHHHHHHHHHhcCCCc---CCCCCHHHHhcccCC
Q 021233 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDP---KRRLTAQQVLGKIEF 315 (315)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P---~~Rps~~e~l~~l~f 315 (315)
. .+....+...++..++|+.+||..+| .+|+|+.|+|+|+||
T Consensus 459 ~--~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 459 Q--KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred c--CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 1 12223456678999999999999866 689999999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=315.34 Aligned_cols=243 Identities=23% Similarity=0.287 Sum_probs=186.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
...+.....||+|+||.||+|.+..++..||+|.+..... ....|++.++++ +||||+++++++...+..++
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKL-QHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhC-CCCCcceEEEEEEcCCCCEE
Confidence 3457778899999999999999988999999998864321 123468889999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH---KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH---~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
||||+++|+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++. .++. ||.+....
T Consensus 761 v~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~---~~~~-~~~~~~~~ 833 (968)
T PLN00113 761 IHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE---PHLR-LSLPGLLC 833 (968)
T ss_pred EEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc---eEEE-eccccccc
Confidence 999999999999985 3889999999999999999999 669999999999999976555 4443 66554332
Q ss_pred CCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh-----HHHHHHHHhcc-----cc--C-
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-----QGVAQAIIRSV-----LD--F- 276 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~-----~~~~~~~~~~~-----~~--~- 276 (315)
.. ....+|+.|+|||++. ..++.++|||||||++|||+||+.||..... .+..+...... .+ .
T Consensus 834 ~~---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 834 TD---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred cC---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence 11 2236789999999976 4599999999999999999999999853211 11111110000 00 0
Q ss_pred -CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 277 -RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 277 -~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
..........++.+++.+||+.||++|||+.|+++.|+
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 00000112235678999999999999999999998763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=291.41 Aligned_cols=246 Identities=29% Similarity=0.457 Sum_probs=194.6
Q ss_pred eeeeeeeeeecce-EEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 57 YELGRELGRGEFG-ITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 57 y~~~~~lg~G~~g-~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
|.-.+.+|.|+.| .||+|... |+.||||.+-.+. .....+|+..|..-.+||||+++++.-.+....||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 4445678999988 58999986 8899999885442 3457889999999889999999999999999999999
Q ss_pred EecCCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCEEEEeecccccc
Q 021233 136 ELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVFF 209 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~----l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~--~~~~vkl~Dfg~a~~~ 209 (315)
|.|.. ||.+++..... ......+.+..|++.||++||+.+||||||||.||||.... ....++|+|||+++.+
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 99966 99999987411 12245678899999999999999999999999999998642 2345899999999987
Q ss_pred CCCCc----ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHhccccCC-CCCCc
Q 021233 210 KPGEK----FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFR-RDPWP 282 (315)
Q Consensus 210 ~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 282 (315)
..+.. .....||-+|+|||++.. .-+.+.|||||||++|+.++| ..||......+ ..|..+..... .....
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLP 739 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCc
Confidence 65432 355689999999999874 466789999999999998885 99996554432 23333322211 11111
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+..+||.+|++++|..||++.++|.||+|
T Consensus 740 --d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF 770 (903)
T KOG1027|consen 740 --DCEAKDLISRMLNPDPQLRPSATDVLNHPLF 770 (903)
T ss_pred --hHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence 1278999999999999999999999999998
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=241.79 Aligned_cols=216 Identities=23% Similarity=0.332 Sum_probs=180.2
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
-+.-.++..-+..||+|++|.|=+-++..+|...|+|.+.... +.....++..|+++..+....|.+|.+++......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3344566777889999999999999999999999999987653 23445778889999988889999999999999999
Q ss_pred cEEEEEEecCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 130 AVHLVMELCEGGELFDRI----VARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l----~~~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
..|+.||.|+ .||..+- ...+.+++..+-+|+..+..||.|||++ .+||||+||+|||++.++. ||+||||
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq---VKiCDFG 194 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ---VKICDFG 194 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc---EEEcccc
Confidence 9999999995 4886654 3456799999999999999999999976 8999999999999987777 9999999
Q ss_pred cccccCCCCcccccccCCCccCchhhc-----ccCCCcchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHh
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIR 271 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Di~slG~~l~el~tg~~p~~~-~~~~~~~~~~~~ 271 (315)
.+..+.++-..+...|-..|||||.+. ..|+.++||||||++++||.+++.||.. .+..+.+.++.+
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 998876655555567888899999875 2489999999999999999999999953 344444444443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=261.17 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=210.0
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-- 128 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-- 128 (315)
..+..+|.-++.+|.|+- .|-.|.|.-.++.||+|.+... +.......+..+|...+..+ +|+|+++++.+|.-.
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhh-cccceeeeeeccCcccc
Confidence 345678999999999998 8888999999999999998877 55566678899999999999 999999999999643
Q ss_pred ----CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
...|+|||+|.. +|...+.. .+.-..+..+..|++.|++|||+.||+||||||+||++.. .+.+||.|||
T Consensus 90 l~~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~---~~~lKi~dfg 163 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS---DCTLKILDFG 163 (369)
T ss_pred HHHHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc---hhheeeccch
Confidence 457999999954 88887763 4788899999999999999999999999999999999964 4459999999
Q ss_pred cccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC----
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD---- 279 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 279 (315)
+|+.....-..+..+.|..|.|||++- -.+....||||+||++.||++|+..|.+...-+....+.+......+.
T Consensus 164 ~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 164 LARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 999776664567788999999999865 349999999999999999999999997766555444443332221110
Q ss_pred ---------------------------CCc-------cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 ---------------------------PWP-------KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ---------------------------~~~-------~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++ .-...+.+++.+||..||++|.|++++|+||+|
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 011 112346899999999999999999999999986
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.49 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=205.9
Q ss_pred eeeeeeeeeecceEEEEEEECCCCC----EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
.+..++||+|+||+||+|.+-..|+ +||+|++.... ......++.+|+-+|.++ +|||++++++++.... +-
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HH
Confidence 5567889999999999999876655 57888876543 333457899999999999 9999999999998776 77
Q ss_pred EEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||++|+++|+|.|+++.+ .++.....+.|..||++||.|||+++++||||-.+||||.. ..+||+.|||+|+....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks---P~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS---PNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC---CCeEEEEecchhhccCc
Confidence 999999999999999864 45899999999999999999999999999999999999964 44499999999998765
Q ss_pred CCcc-ccccc--CCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 212 GEKF-SEIVG--SPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 212 ~~~~-~~~~g--t~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
+... ....| .+.|||-|.+. ..|+.++|||||||++||++| |..|+++...+++-..+..+. +.+.++.++.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge---RLsqPpiCti 927 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE---RLSQPPICTI 927 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc---cCCCCCCccH
Confidence 5432 22222 35689999876 679999999999999999998 999999988887777666543 2444567899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhc
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLG 311 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~ 311 (315)
+++-++.+||..|+..||++.++..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 9999999999999999999998864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=259.88 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=207.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC-----C
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-----T 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-----~ 129 (315)
.+.+-.+.||.|+||+||.++|..+|+.||+|++.. .+.+....+++.+|+++|..+ +|.|++..++...-. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHH
Confidence 356667899999999999999999999999998753 244555567889999999999 999999988876532 3
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.+|+++|.|.. +|...+.....++.+.+.-+..||+.||+|||+.+|.||||||.|.|++ .++.+||||||+++..
T Consensus 131 EiYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN---SNCvLKICDFGLARve 206 (449)
T KOG0664|consen 131 ELYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN---SNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec---cCceEEeccccccccc
Confidence 57899999954 8888888888899999999999999999999999999999999999996 4566999999999976
Q ss_pred CCCC--cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC-------
Q 021233 210 KPGE--KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------- 278 (315)
Q Consensus 210 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 278 (315)
..+. .++..+.|..|+|||++.+ .|+...||||.||++.|++..+..|+....-+.++.+.........
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 5443 3455678899999999874 5999999999999999999999999877776666666544333110
Q ss_pred --------------CCC---------ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 279 --------------DPW---------PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 279 --------------~~~---------~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+.. ....-+...++..+|.+||++|.+..+++.|++
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000 112345678999999999999999999999886
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=264.01 Aligned_cols=244 Identities=25% Similarity=0.353 Sum_probs=186.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC-CCCCcceeEEEEEcCC----c
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-KHQNIVCLKDTYEDDT----A 130 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~iv~~~~~~~~~~----~ 130 (315)
..++.++||+|.||.||+|... ++.||||++.. .+.+.|..|-+|..... +|+||+++++.-.... .
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 4778889999999999999875 79999999853 34567888887776532 7999999999876554 8
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCceEeecCCCCCCEEEE
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---------GVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~---------~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
++||++|.+.|||.++|..+ .++|....+|+..++.||+|||+. .|+|||||..||||.+|.. ..|+
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT---ccIa 358 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT---CCIA 358 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc---EEee
Confidence 99999999999999999876 599999999999999999999963 5999999999999976665 7999
Q ss_pred eeccccccCCCCc---ccccccCCCccCchhhcccCC-------CcchHHHHHHHHHHHhhCCCCC------------C-
Q 021233 202 DFGLSVFFKPGEK---FSEIVGSPYYMAPEVLKRNYG-------PEVDVWSAGVILYILLCGVPPF------------W- 258 (315)
Q Consensus 202 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-------~~~Di~slG~~l~el~tg~~p~------------~- 258 (315)
|||+|..+..+.. .-..+||.+|||||++.+... .+.||||+|.||||+++...-+ .
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA 438 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence 9999988765432 234799999999999976422 3589999999999999753322 1
Q ss_pred ----CCChHHHHHHHH-hccccCCCCCCcc--CCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 021233 259 ----AETEQGVAQAII-RSVLDFRRDPWPK--VSENAKDLVRKMLDPDPKRRLTAQQVLG 311 (315)
Q Consensus 259 ----~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~l~~li~~~l~~~P~~Rps~~e~l~ 311 (315)
..+.++....+. +...+..++.|.. -..-+.+.+..||..||+.|.|+.=+.+
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 111122222221 2212222222322 2345789999999999999999976544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=263.57 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=201.0
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECC---CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
...+.+.|+.+.+||.|.|++||++.+.. ..+.||+|.+.... ...++..|++.|..+..+.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 34566789999999999999999999887 67899999886542 34679999999999999999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
.+++..+|+||++...-.++.. .++...++.++..++.||.++|.+|||||||||+|+|.+..-. ...|+|||+|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~--rg~LvDFgLA 180 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ--RGVLVDFGLA 180 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC--CceEEechhH
Confidence 9999999999999877777664 3678999999999999999999999999999999999986444 3689999998
Q ss_pred cccC-----------------C--C--------------------------CcccccccCCCccCchhhc--ccCCCcch
Q 021233 207 VFFK-----------------P--G--------------------------EKFSEIVGSPYYMAPEVLK--RNYGPEVD 239 (315)
Q Consensus 207 ~~~~-----------------~--~--------------------------~~~~~~~gt~~y~aPE~~~--~~~~~~~D 239 (315)
...+ + + .......||++|+|||++. ...+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 6210 0 0 0012356999999999976 45889999
Q ss_pred HHHHHHHHHHHhhCCCCCCCCChH-HHHHHH--------------Hhcc--c-----------------cC---------
Q 021233 240 VWSAGVILYILLCGVPPFWAETEQ-GVAQAI--------------IRSV--L-----------------DF--------- 276 (315)
Q Consensus 240 i~slG~~l~el~tg~~p~~~~~~~-~~~~~~--------------~~~~--~-----------------~~--------- 276 (315)
|||.|++++.+++++.||...... +.+.++ ..+. + ..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999998433211 000000 0000 0 00
Q ss_pred ----CCCCC-ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ----RRDPW-PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ----~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+ ...+..+.+|+.+||..||.+|.|++++|.|+||
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF 384 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF 384 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence 00011 1234478899999999999999999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=275.41 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=218.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|.++..+|+|.||.||++++..+++..|+|++... ...+...+.+|+-+++.. +||||+.+++.+......|+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecC-CCcChHHHHhhhhhhcCcEE
Confidence 45799999999999999999999999999999999755 455667788999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
+||||.||+|.+...-.+++++.++..+.+..+.+|+|||+.|=+|||||-.|||+++.+. ||+.|||.+..+...
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---vklaDfgvsaqitati 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---VKLADFGVSAQITATI 166 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc---eeecccCchhhhhhhh
Confidence 9999999999998888889999999999999999999999999999999999999998777 899999998765432
Q ss_pred CcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-CCCCccCCHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKVSEN 287 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 287 (315)
.+...+.||+.|||||+.. +.|...+|||++|++..|+..-++|....-.......+.+.....+ ......-++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 3445679999999999852 5699999999999999999998888765555555555544433322 1222345788
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+-+|++.+|.++|++||+++-+|.|+|
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~f 273 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPF 273 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheecee
Confidence 999999999999999999999999876
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=265.76 Aligned_cols=199 Identities=33% Similarity=0.554 Sum_probs=175.0
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhc-----HHHHHHHHHHHHhCCC---CCCcceeEEEEEc
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-----IEDVRREVDIMRHLPK---HQNIVCLKDTYED 127 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~-----~~~~~~e~~~l~~l~~---h~~iv~~~~~~~~ 127 (315)
+|..++.+|.|+||.|++|+++.++..|++|.+.++...-... .-.+-.|++||..+ + |+||++++++|++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l-~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL-NKHSHENILKLLDFFED 640 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh-hhcCccchhhhhheeec
Confidence 5999999999999999999999999999999998765432111 11255699999999 5 8999999999999
Q ss_pred CCcEEEEEEec-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 DTAVHLVMELC-EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~-~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
++.+|++||.- +|.+|.+++.....+++.++..|+.|++.|+++||+.||||||||-+||.++.++- +||+|||.|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~---~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF---VKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe---EEEeeccch
Confidence 99999999986 57889999999999999999999999999999999999999999999999987666 899999999
Q ss_pred cccCCCCcccccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCC
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWA 259 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~ 259 (315)
.....+ ....+.||..|.|||++.+. .+..-|||++|++||.++....||.+
T Consensus 718 a~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 776544 46778999999999999864 57889999999999999999999854
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=229.88 Aligned_cols=210 Identities=42% Similarity=0.746 Sum_probs=183.6
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (315)
||.|++|.||++.+..+++.+++|.+....... ..+.+.+|+..++.+ .|++++++++++......++++|++++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 689999999999998889999999987553221 346799999999999 89999999999999999999999999899
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec-CCCCCCEEEEeeccccccCCCC-cccccc
Q 021233 143 LFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN-KKETAPLKAIDFGLSVFFKPGE-KFSEIV 219 (315)
Q Consensus 143 L~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~-~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~ 219 (315)
|.+++... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++. ++|+|||.+....... ......
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK---VKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc---EEEecCCceEEccCCcchhhccc
Confidence 99998875 46899999999999999999999999999999999999986 343 8999999998654432 123356
Q ss_pred cCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 220 GSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 220 gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
+...|++||.... ..+.++|+|++|++++++ +.+.+++..|++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence 7788999999864 688999999999999998 678899999999
Q ss_pred CCcCCCCCHHHHhccc
Q 021233 298 PDPKRRLTAQQVLGKI 313 (315)
Q Consensus 298 ~~P~~Rps~~e~l~~l 313 (315)
.+|++||++.+++++|
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 9999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=241.64 Aligned_cols=248 Identities=19% Similarity=0.258 Sum_probs=203.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCCC-----CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE-cC
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENG-----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DD 128 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-~~ 128 (315)
.++++...+-+|.||.||.|.+.+.. +.|.+|.+... .+..+...+.+|...+..+ .|||+.++.++.. +.
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDY 360 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeecc
Confidence 46888888999999999999887543 33555655432 2445567789999999999 7999999999864 55
Q ss_pred CcEEEEEEecCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEE
Q 021233 129 TAVHLVMELCEGGELFDRIVAR--------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl 200 (315)
...++++.++.-|+|..++... ..++..++..++.|++.|++|||+.|+||.||..+|+++++. ..|||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~---LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ---LQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh---eeEEe
Confidence 7789999999999999999721 237778889999999999999999999999999999999754 44999
Q ss_pred EeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhcccc
Q 021233 201 IDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLD 275 (315)
Q Consensus 201 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 275 (315)
+|=.+++.+.+...+ ........|||||.+. ..|+..+|+||||++||||+| |+.|+......+...-++.+.
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy-- 515 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY-- 515 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc--
Confidence 999999987665443 2223345799999986 569999999999999999998 999999888888777776653
Q ss_pred CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 021233 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLG 311 (315)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~ 311 (315)
+..-+.+||+++..+|..||..+|++||++.++..
T Consensus 516 -RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 -RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 34445679999999999999999999999999865
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=232.77 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=195.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEE-EEcCCc
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT-YEDDTA 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~-~~~~~~ 130 (315)
.+.+.|.+.+.||+|.||.+-+|.++.+++.+++|.+... .....+|.+|...--.|+.|.||+.-++. |+..+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 4667899999999999999999999999999999998654 34567899999988888889999977764 777888
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+++++||++-|+|..-+... .+.+.....++.|+++||.|+|++++||||||.+|||+...+-. .|||||||.++...
T Consensus 97 YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~-rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFY-RVKLCDFGLTRKVG 174 (378)
T ss_pred EEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCcc-EEEeeecccccccC
Confidence 99999999999998887664 48889999999999999999999999999999999999654332 59999999987543
Q ss_pred CCCcccccccCCCccCchhhc----c--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH----HHHHHHhccccCCCCC
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK----R--NYGPEVDVWSAGVILYILLCGVPPFWAETEQG----VAQAIIRSVLDFRRDP 280 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~----~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 280 (315)
.. ....--+..|.+||... + ...+.+|+|.||++++.++||.+||+.....+ ..........+--+..
T Consensus 175 ~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 175 TT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred ce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 22 22223345689999763 2 25788999999999999999999996332111 1112222222222333
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHH
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQ 308 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e 308 (315)
...+++.+..+.++-|.++|++|--..+
T Consensus 253 F~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 253 FNPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred hcccCHHHHHHHHHhcCCcccccchhHH
Confidence 4457899999999999999999944433
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=226.77 Aligned_cols=210 Identities=41% Similarity=0.728 Sum_probs=178.7
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
|++.+.||.|++|.||++....+++.+++|.+...... ...+.+.+|+..++.+ +|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEe
Confidence 56789999999999999999888999999998765432 2457899999999999 99999999999999999999999
Q ss_pred ecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC--
Q 021233 137 LCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~~-l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-- 213 (315)
++++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++. ++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~---~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL---VKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeeCceeeEecCcccc
Confidence 9999999999987766 899999999999999999999999999999999999986644 8999999998765442
Q ss_pred cccccccCCCccCchhh-c-ccCCCcchHHHHHHHHHHHhhCCCCCCC-CC-hHHHHHHHHhc
Q 021233 214 KFSEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLCGVPPFWA-ET-EQGVAQAIIRS 272 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~-~-~~~~~~~Di~slG~~l~el~tg~~p~~~-~~-~~~~~~~~~~~ 272 (315)
......++..|++||.+ . ..++.++|+|+||+++++|++|+.||.. .. .....+.+..+
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 33445778889999987 3 3477799999999999999999999976 33 33454555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=224.90 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=196.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCC-CEEEEEEcccccccChhcHHHHHHHHHHHHhCCC---CCCcceeEEEE-EcCCc
Q 021233 56 RYELGRELGRGEFGITYLCTDRENG-DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK---HQNIVCLKDTY-EDDTA 130 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~---h~~iv~~~~~~-~~~~~ 130 (315)
+|++.+.||+|+||.||.|.+..++ ..+|+|......... ...+..|+.++..+.. .+++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 578888776542211 1267889999999852 46899999999 57788
Q ss_pred EEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC--CCCEEEEeeccc
Q 021233 131 VHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE--TAPLKAIDFGLS 206 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~--~~~vkl~Dfg~a 206 (315)
.++||+.+ |.+|.++.... +.++..++..|+.|++.+|++||+.|++||||||+|+++..... ...++|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 88999988654 46999999999999999999999999999999999999976542 255999999999
Q ss_pred c--ccC-CCC-------c-ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccc
Q 021233 207 V--FFK-PGE-------K-FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274 (315)
Q Consensus 207 ~--~~~-~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 274 (315)
+ ... ... . .....||..|++++...+ ..+++.|+|||++++.+++.|..||...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 321 111 1 123459999999998774 589999999999999999999999976654333333332222
Q ss_pred cCCCC-CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 275 DFRRD-PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 275 ~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
..... .....+.++..+...+-..+...+|....+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22222 223356788888888888899999998776543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=264.37 Aligned_cols=194 Identities=20% Similarity=0.233 Sum_probs=143.8
Q ss_pred CCcceeEEEE-------EcCCcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q 021233 116 QNIVCLKDTY-------EDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187 (315)
Q Consensus 116 ~~iv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Ni 187 (315)
+||++++++| .....+++++|++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777778877 2334678889988 56999999753 4599999999999999999999999999999999999
Q ss_pred EeecCC----------------CCCCEEEEeeccccccCCCC-----------------cccccccCCCccCchhhc-cc
Q 021233 188 LFANKK----------------ETAPLKAIDFGLSVFFKPGE-----------------KFSEIVGSPYYMAPEVLK-RN 233 (315)
Q Consensus 188 ll~~~~----------------~~~~vkl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~~~-~~ 233 (315)
|++..+ ....+|++|||+++...... ......||+.|||||++. ..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 996422 23347788888876421100 001246788999999976 56
Q ss_pred CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 234 ~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.++|||||||+||||++|..|+.... .....+..... ++.. ........+++..||+++|.+||++.|+++|+
T Consensus 192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQI-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chhh-hhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence 8999999999999999999988864321 12222222211 1111 11245567899999999999999999999999
Q ss_pred CC
Q 021233 314 EF 315 (315)
Q Consensus 314 ~f 315 (315)
||
T Consensus 267 ~~ 268 (793)
T PLN00181 267 FI 268 (793)
T ss_pred hh
Confidence 86
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=207.71 Aligned_cols=249 Identities=20% Similarity=0.255 Sum_probs=200.1
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+...|++++.||+|+||.+|.|....+|+.||+|+-.... ....+..|..+.+.|+.-..|+.+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45678999999999999999999999999999999865432 2345778999999996678888888899999999
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.+||+.+ |.||.+++.- ...++..+++.++.|++.-++|+|.+++|||||||+|+|+.-+.....+.|+|||+|+.+.
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 8899998874 3459999999999999999999999999999999999999776666779999999998764
Q ss_pred CCC--------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHH---HHhccccCC-
Q 021233 211 PGE--------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA---IIRSVLDFR- 277 (315)
Q Consensus 211 ~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~- 277 (315)
+.. ......||.+|.|-...- ...+.+.|+-|+|++|+.+-.|..||++.....-.+. |.+.....+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 322 124567999999988765 3578899999999999999999999987765544333 332222221
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCH
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTA 306 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~ 306 (315)
.......|.++.-.+..|=..--++-|..
T Consensus 246 e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy 274 (341)
T KOG1163|consen 246 EVLCKGFPAEFAMYLNYCRGLGFEEKPDY 274 (341)
T ss_pred HHHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence 12245678888888888866555566654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=209.43 Aligned_cols=249 Identities=19% Similarity=0.293 Sum_probs=196.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.-.|+++++||+|+||+.+.|.+.-+++.||||.-... ....++..|....+.|...++|+.++.+.....+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4556799999999999999999999999999999965432 22367889999999998899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC--CCCEEEEeeccccc
Q 021233 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE--TAPLKAIDFGLSVF 208 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~--~~~vkl~Dfg~a~~ 208 (315)
.+|+|++ |.||.|++.-. ..|+.+++..++.|++.-++++|++++|.|||||+|+||...+. ...|.++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 88999998754 45999999999999999999999999999999999999975433 34489999999998
Q ss_pred cCCCC--------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC
Q 021233 209 FKPGE--------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (315)
Q Consensus 209 ~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (315)
+.+.. ...+..||.+||+-.... ...+.+.|+-|||.+++.++-|.+||++......-+...+..-.-+..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 75443 235678999999998755 568999999999999999999999998765433322222211111111
Q ss_pred ----CCccCCHHHHHHHHHhcCCCcCCCCCH
Q 021233 280 ----PWPKVSENAKDLVRKMLDPDPKRRLTA 306 (315)
Q Consensus 280 ----~~~~~~~~l~~li~~~l~~~P~~Rps~ 306 (315)
....+|+++...+...=..+-.+-|..
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 123466777666665555555555554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=202.77 Aligned_cols=160 Identities=26% Similarity=0.342 Sum_probs=123.7
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccc
Q 021233 141 GELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219 (315)
Q Consensus 141 ~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 219 (315)
|||.+++..+ ..+++..++.++.|++.||.|||+.+ ||+|||++.++. +++ ||.+....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~---~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL---LKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc---eee--ccceEeecccc----CC
Confidence 6899999864 45999999999999999999999998 999999976554 777 99987654322 26
Q ss_pred cCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHhccccCCC---CCCccCCH--HHHHHH
Q 021233 220 GSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE-QGVAQAIIRSVLDFRR---DPWPKVSE--NAKDLV 292 (315)
Q Consensus 220 gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~--~l~~li 292 (315)
||+.|+|||++. ..++.++||||||+++|||++|+.||..... ......+......... ......++ ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 889999999986 4589999999999999999999999965433 2223333322221111 11122333 699999
Q ss_pred HHhcCCCcCCCCCHHHHhcccCC
Q 021233 293 RKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+||+.+|.+||++.+++.|+++
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHH
Confidence 99999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=214.42 Aligned_cols=169 Identities=21% Similarity=0.233 Sum_probs=130.0
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECC-CCCEEEEEEcccccc--cChhcHHHHHHHHHHHHhCCCCCCcce-eEE
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKL--RTAVDIEDVRREVDIMRHLPKHQNIVC-LKD 123 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~-~~~ 123 (315)
...+.+..+|++.+.||+|+||+||+|++.. +++.+|+|.+..... ........+.+|+.+|+.+ +|+|+++ +++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~ 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE
Confidence 3445677889999999999999999999876 677789998653211 1223356799999999999 8999885 443
Q ss_pred EEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCceEeecCCCCCCEEEEe
Q 021233 124 TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL-KPENFLFANKKETAPLKAID 202 (315)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~di-kp~Nill~~~~~~~~vkl~D 202 (315)
+ +..++||||++|++|.. +. ... ...++.+++++|.|||+.||+|||| ||+|||++.++. ++|+|
T Consensus 90 ~----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~---ikLiD 155 (365)
T PRK09188 90 T----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE---AAVID 155 (365)
T ss_pred c----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC---EEEEE
Confidence 2 45799999999999963 21 111 1467889999999999999999999 999999975544 89999
Q ss_pred eccccccCCCCc---------ccccccCCCccCchhhc
Q 021233 203 FGLSVFFKPGEK---------FSEIVGSPYYMAPEVLK 231 (315)
Q Consensus 203 fg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~ 231 (315)
||+|+....... .....+++.|++||.+.
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999986543321 23457788899999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-26 Score=200.90 Aligned_cols=250 Identities=37% Similarity=0.597 Sum_probs=201.3
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeEEEEEcCCcEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~~~~~~~~lv~ 135 (315)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.++..+ .|+ +++++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCEEEEEE
Confidence 788899999999999999986 78899988776544433467899999999999 665 8999999998777789999
Q ss_pred EecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 136 ELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+++.++++.+++.... .++......++.|++.++.++|+.+++|||+||+||+++..+. .++++|||.+......
T Consensus 78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDP 155 (384)
T ss_pred ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCC
Confidence 9999999997777664 6999999999999999999999999999999999999976552 3799999998755433
Q ss_pred C-------cccccccCCCccCchhhcc----cCCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHhcccc-C
Q 021233 213 E-------KFSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVLD-F 276 (315)
Q Consensus 213 ~-------~~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~~l~el~tg~~p~~~~~~----~~~~~~~~~~~~~-~ 276 (315)
. ......||..|++||.+.+ ..+...|+||+|++++++++|..||..... ......+...... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 2 2356789999999998764 588899999999999999999999866653 3444444443322 1
Q ss_pred CCCCCccC----CHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 277 RRDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 277 ~~~~~~~~----~~~l~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
........ ...+.+++..++..+|..|.+..+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11211111 2578999999999999999999876654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-28 Score=226.68 Aligned_cols=253 Identities=29% Similarity=0.435 Sum_probs=191.7
Q ss_pred eeeeeeeeecceEEEEEEECCCCCEEEEEEcccc---cccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKK---KLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.....+|.|++|.|+.+......+.++.|..... ..........+..|+-+-..+ .|+|++..+..+.+.......
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhh
Confidence 5678899999999998888777777777755421 111111111255677777777 899998777776666555556
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||+++ +|..++...+.+....+-.++.|++.|++|+|+.||.|||+||+|+++..++. +||+|||.+......-
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~---lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI---LKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc---eEEeecCcceeeccCcc
Confidence 999999 99999988878999999999999999999999999999999999999987664 9999999987543322
Q ss_pred ----cccccccCCCccCchhhcc-cCC-CcchHHHHHHHHHHHhhCCCCCCCCChHHHHH--HHH---hccccCCCCCCc
Q 021233 214 ----KFSEIVGSPYYMAPEVLKR-NYG-PEVDVWSAGVILYILLCGVPPFWAETEQGVAQ--AII---RSVLDFRRDPWP 282 (315)
Q Consensus 214 ----~~~~~~gt~~y~aPE~~~~-~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~--~~~---~~~~~~~~~~~~ 282 (315)
.....+|+..|+|||++.+ .|. ...||||.|++++.|.+|+.||......+... ..- ..........+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 2245688999999999874 454 46899999999999999999996544332211 000 000011112244
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++.+.+.+|.+||+.||.+|.|+.+|++..||
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 578889999999999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=188.12 Aligned_cols=176 Identities=19% Similarity=0.205 Sum_probs=135.2
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHH------HHHHHHHHHhCCCCCCcceeEEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED------VRREVDIMRHLPKHQNIVCLKDT 124 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~------~~~e~~~l~~l~~h~~iv~~~~~ 124 (315)
+.+.++|++++.||.|+||.||++.+ ++..+|+|++...........+. +.+|+..+.++ .|++|..+.++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEe
Confidence 45678999999999999999999755 47789999997654444333333 68999999999 99999999988
Q ss_pred EEcC--------CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 125 YEDD--------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 125 ~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
+... +..+++|||++|.+|.+.. .+++ ....+++.+|..+|+.|++|||++|+||++++++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--- 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--- 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---
Confidence 6533 3589999999999997763 2333 3456999999999999999999999999997543
Q ss_pred CEEEEeeccccccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHh
Q 021233 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILL 251 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~ 251 (315)
++|+|||.+........... =++...+..++|+||||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence 89999998865532222111 012245678999999999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=190.40 Aligned_cols=234 Identities=27% Similarity=0.415 Sum_probs=154.0
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCC---------CCCcceeEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK---------HQNIVCLKDTYE 126 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~---------h~~iv~~~~~~~ 126 (315)
.+...+.||.|+++.||.+++.++|+.+|+|+............+.+++|.-....+.. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 57778999999999999999999999999999887664445556777777655544322 212222222221
Q ss_pred ---------cC---C-----cEEEEEEecCCCChHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 021233 127 ---------DD---T-----AVHLVMELCEGGELFDRIVA---RGH----YTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182 (315)
Q Consensus 127 ---------~~---~-----~~~lv~e~~~~~sL~~~l~~---~~~----l~~~~~~~i~~~l~~~L~~lH~~~iiH~di 182 (315)
.. + ..+++|+-+. ++|.+++.. ... +.......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 2367888884 488877542 221 223344566789999999999999999999
Q ss_pred CCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCccCchhhcc---------cCCCcchHHHHHHHHHHHhhC
Q 021233 183 KPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR---------NYGPEVDVWSAGVILYILLCG 253 (315)
Q Consensus 183 kp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~Di~slG~~l~el~tg 253 (315)
+|+|++++.++. ++|+||+....... .......+..|.+||.... .++.+.|.|+||+++|.++++
T Consensus 172 ~~~nfll~~~G~---v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGG---VFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS----EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCC---EEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999987766 99999987765432 2222345577999997532 378899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCC
Q 021233 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR 303 (315)
Q Consensus 254 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 303 (315)
+.||........... .+. ....+|+..+.||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~------~f~--~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------DFS--RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------GGT--TSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------cch--hcCCcCHHHHHHHHHHccCCcccC
Confidence 999975543211111 121 223689999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=182.25 Aligned_cols=143 Identities=20% Similarity=0.221 Sum_probs=110.2
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhc-----------------------HHHHHHHHHHHHhCCCCC
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD-----------------------IEDVRREVDIMRHLPKHQ 116 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~-----------------------~~~~~~e~~~l~~l~~h~ 116 (315)
...||+|++|.||+|.+. +|+.||+|++.......... ......|+.++.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 468999999999999986 89999999987543211110 11234599999999 777
Q ss_pred CcceeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCceEeecCCCC
Q 021233 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-HKHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~l-H~~~iiH~dikp~Nill~~~~~~ 195 (315)
++.......... .++||||++|+++.........++...+..++.|++.+|.++ |+.||+||||||+|||++. +
T Consensus 80 ~v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~-- 154 (190)
T cd05147 80 GIPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G-- 154 (190)
T ss_pred CCCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--
Confidence 764433332222 389999999877766544556799999999999999999999 7999999999999999973 2
Q ss_pred CCEEEEeeccccccC
Q 021233 196 APLKAIDFGLSVFFK 210 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~ 210 (315)
.++|+|||+|....
T Consensus 155 -~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 -KLYIIDVSQSVEHD 168 (190)
T ss_pred -cEEEEEccccccCC
Confidence 38999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-27 Score=210.87 Aligned_cols=238 Identities=27% Similarity=0.457 Sum_probs=197.9
Q ss_pred eeeeecceEEEEEEE---CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 62 ELGRGEFGITYLCTD---RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~---~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
.+|.|+||.|+++.. .+.+.-+|+|+..+......... .-..|..++....+||.++++...+..+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 378999999998652 34467789998877655443332 55668888888867999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCccccc
Q 021233 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218 (315)
Q Consensus 139 ~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~ 218 (315)
.||.|...+.....+...........++-+++++|+.+++|||+|++||+++.+|. +++.|||+++..-..+..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh---i~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH---IKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc---cccCCchhhhHhHhhhhc---
Confidence 99999988888777888888999999999999999999999999999999987666 899999999875433332
Q ss_pred ccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCC
Q 021233 219 VGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDP 298 (315)
Q Consensus 219 ~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 298 (315)
+||..|||||+++ ......|.||||++++||+||..||.. +....|.+.....+. .++..+.+++..++..
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~----~l~~~a~~~~~~l~~r 224 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR----ELSAEARSLFRQLFKR 224 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch----hhhHHHHHHHHHHHhh
Confidence 8999999999998 567789999999999999999999976 566666665554443 4678889999999999
Q ss_pred CcCCCCCH-----HHHhcccCC
Q 021233 299 DPKRRLTA-----QQVLGKIEF 315 (315)
Q Consensus 299 ~P~~Rps~-----~e~l~~l~f 315 (315)
+|.+|.-. .++.+|.+|
T Consensus 225 ~p~nrLg~~~~~~~eik~h~f~ 246 (612)
T KOG0603|consen 225 NPENRLGAGPDGVDEIKQHEFF 246 (612)
T ss_pred CHHHHhccCcchhHHHhccchh
Confidence 99999644 677777765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=172.74 Aligned_cols=188 Identities=21% Similarity=0.271 Sum_probs=141.2
Q ss_pred eeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc-ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
-+...|++|+||+||.+.. .+..++.+.+...... .......+.+|+++|++|.+++++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3467899999999998765 4778887766543321 111123578999999999767899999986 34799999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCceEeecCCCCCCEEEEeeccccccCCCCcc
Q 021233 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL-KPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~di-kp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 215 (315)
|+.|.+|...... ....++.|++.+|.++|++||+|||| ||+|||++.++. ++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~---i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS---PAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC---EEEEECCCceecCCcchH
Confidence 9999888654321 12357789999999999999999999 799999976554 899999999855433321
Q ss_pred --------------cccccCCCccCchhhc--ccCC-CcchHHHHHHHHHHHhhCCCCCCCCC
Q 021233 216 --------------SEIVGSPYYMAPEVLK--RNYG-PEVDVWSAGVILYILLCGVPPFWAET 261 (315)
Q Consensus 216 --------------~~~~gt~~y~aPE~~~--~~~~-~~~Di~slG~~l~el~tg~~p~~~~~ 261 (315)
.-...++.|++|+... ...+ ...+.++.|.-+|.++|+..+.+...
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 1123577888888643 2334 67899999999999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-24 Score=173.10 Aligned_cols=144 Identities=17% Similarity=0.175 Sum_probs=111.7
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChh-----------------------cHHHHHHHHHHHHhCCCCC
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----------------------DIEDVRREVDIMRHLPKHQ 116 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~~h~ 116 (315)
...||+|++|.||+|.+. +|+.||+|++......... ....+..|...+.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 578999999999999987 8999999998765321000 012346789999999 788
Q ss_pred CcceeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCC
Q 021233 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~ 195 (315)
++.....+.... .++||||++|+++.........++...+..++.+++.++.++|+ .||+||||||+||+++ ++.
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~- 155 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK- 155 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC-
Confidence 875444443332 48999999987654443344568889999999999999999999 9999999999999997 333
Q ss_pred CCEEEEeeccccccCC
Q 021233 196 APLKAIDFGLSVFFKP 211 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~ 211 (315)
++|+|||++.....
T Consensus 156 --~~liDFG~a~~~~~ 169 (190)
T cd05145 156 --PYIIDVSQAVELDH 169 (190)
T ss_pred --EEEEEcccceecCC
Confidence 89999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=179.93 Aligned_cols=245 Identities=17% Similarity=0.230 Sum_probs=190.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
...++.+|.....|..|+|+++ |..+++|++....... .-..+|..|.-.|+-+ .||||+.+++.|.....+.++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrif-shpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeee-cCCchhhhhhhccCCCCceEee
Confidence 3566778999999999999998 5667778776654432 2245688999999988 8999999999999999999999
Q ss_pred EecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 136 ELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
.||+.|||+..+..... .+..++.+++.+++.|++|||+.. |.--.+....++++.+-.. .+-.+|--.+..-
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta-rismad~kfsfqe-- 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA-RISMADTKFSFQE-- 343 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh-heecccceeeeec--
Confidence 99999999999987654 678899999999999999999875 4445678888888754432 1333333332211
Q ss_pred CCcccccccCCCccCchhhccc----CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
....-+|.||+||.+... --..+|+|||++++||+.|...||......+...++.-. ..+...++.++..
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale--glrv~ippgis~h 417 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE--GLRVHIPPGISRH 417 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc--cccccCCCCccHH
Confidence 112346789999998643 235789999999999999999999887776666655433 2345566789999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+..|++-|++.||.+||.+..++--|
T Consensus 418 m~klm~icmnedpgkrpkfdmivpil 443 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIVPIL 443 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceehhhH
Confidence 99999999999999999998876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=184.40 Aligned_cols=192 Identities=28% Similarity=0.415 Sum_probs=141.9
Q ss_pred CCCCCcceeEEEEEc---------------------------CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 021233 113 PKHQNIVCLKDTYED---------------------------DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165 (315)
Q Consensus 113 ~~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l 165 (315)
.+|||||++...|.+ ....|+||..++. ||..++..+ ..+....+.++.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHH
Confidence 479999999887642 2357999999866 999988765 46777888899999
Q ss_pred HHHHHHHHHCCceecCCCCCceEeecCCCC-CCEEEEeeccccccCC-------CCcccccccCCCccCchhhcc---c-
Q 021233 166 VEVVQMCHKHGVMHRDLKPENFLFANKKET-APLKAIDFGLSVFFKP-------GEKFSEIVGSPYYMAPEVLKR---N- 233 (315)
Q Consensus 166 ~~~L~~lH~~~iiH~dikp~Nill~~~~~~-~~vkl~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~---~- 233 (315)
++|..|||++|+.|||+|.+|||+.-++.. -.++|+|||.+-.-+. ....-...|.-..||||+... .
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 999999999999999999999999755443 3478999997743221 111123456667899999752 2
Q ss_pred ---CCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHH
Q 021233 234 ---YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309 (315)
Q Consensus 234 ---~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~ 309 (315)
--.|+|.|+.|.+.||+++...||....+.- ..+...+. .-+..+..+++.+++++..+|+.||++|+|..=+
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~---qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES---QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh---hCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 2348999999999999999999997632211 11111111 1123345688999999999999999999987543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=210.31 Aligned_cols=245 Identities=24% Similarity=0.310 Sum_probs=177.1
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccc-cChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+|...+.||++.|=.|.+|.++ ...|++|++.+... -+-....+...|++ .. +.++||++++.-+.+.+..-|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~--eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~-l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR--EGLVVVKVFVKQDPTISLRPFKQRLEEIK-FA-LMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC--CceEEEEEEeccCCCCCchHHHHHHHHHH-HH-hhcCCcccchHHHHHhhHHHHHH
Confidence 5788899999999999999876 34499999876531 12222333334455 33 34899999999988888888999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc--CCC
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF--KPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~--~~~ 212 (315)
-+|+.. +|+|.+..+..+..-+.+-|+.||+.||..+|..||.|||||.+|||++ ....+.|+||...+.. ..+
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence 999955 9999999888889999999999999999999999999999999999996 4555899999876432 111
Q ss_pred C--ccc----ccccCCCccCchhhcc-----------c-CCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhcc
Q 021233 213 E--KFS----EIVGSPYYMAPEVLKR-----------N-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (315)
Q Consensus 213 ~--~~~----~~~gt~~y~aPE~~~~-----------~-~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 273 (315)
+ +.. +.....-|.|||.+.. . .+++.||||+||++.|+++ |++||.-.. +-+.....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhccC
Confidence 1 111 1122234999997631 1 4678999999999999987 788883211 11111111
Q ss_pred ccCCCCCCcc-CCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 274 LDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 274 ~~~~~~~~~~-~~~~l~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
...+...+.. -+..++++|..|++.||++|.|+++.|+.
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000000000 13468999999999999999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=201.73 Aligned_cols=218 Identities=30% Similarity=0.524 Sum_probs=171.3
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
...+|..++.|..|+||.||.++++.+.+.+|+| ++++.. +.+- ++... ..|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--------ilRn--ilt~a-~npfvv------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--------ILRN--ILTFA-GNPFVV------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch--------hhhc--ccccc-CCccee-------------
Confidence 3568999999999999999999999999999994 443321 1111 33333 566555
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|+-...++.-+.++... +.+++|+|+-||+|||+||+|.+|+.-+. +|++|||++......
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh---iKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKKGLMS 196 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc---ccccchhhhhhhhhh
Confidence 33334444444555443 78899999999999999999999986555 899999998643211
Q ss_pred C----------------cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc
Q 021233 213 E----------------KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (315)
Q Consensus 213 ~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (315)
. .....+|||.|.|||++. ..|+...|.|++|+++||++-|..||.+.+.++....+......
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 0 013458999999999975 56999999999999999999999999999999999999999888
Q ss_pred CCCCCCccCCHHHHHHHHHhcCCCcCCC---CCHHHHhcccCC
Q 021233 276 FRRDPWPKVSENAKDLVRKMLDPDPKRR---LTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~~P~~R---ps~~e~l~~l~f 315 (315)
++... ..++++.++++.++|..+|..| +.+.++-+|-||
T Consensus 277 wpE~d-ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff 318 (1205)
T KOG0606|consen 277 WPEED-EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFF 318 (1205)
T ss_pred ccccC-cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccce
Confidence 88774 4578999999999999999999 466777777665
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-23 Score=195.15 Aligned_cols=194 Identities=24% Similarity=0.381 Sum_probs=158.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCC---CCCcceeEEEEEcCCc
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK---HQNIVCLKDTYEDDTA 130 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~---h~~iv~~~~~~~~~~~ 130 (315)
++.|.|.+.||+|+||.||.|...+ |+.||+|+-....... |.--.+++.+| + -+.|..+...+...+.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RL-k~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERL-KPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhh-chhhhcchHHHHHHHccCCc
Confidence 4579999999999999999999776 9999999876543322 23334445555 3 2445566666667778
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC----CCCCCEEEEeeccc
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK----KETAPLKAIDFGLS 206 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~----~~~~~vkl~Dfg~a 206 (315)
-++|+||.+.|||.+++...+.+++.....++.|++..+++||..+|||+||||+|+|+... .....++|+|||.|
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 89999999999999999988889999999999999999999999999999999999999643 22344899999998
Q ss_pred ccc---CCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCC
Q 021233 207 VFF---KPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVP 255 (315)
Q Consensus 207 ~~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~ 255 (315)
.-+ .++......++|-.+-.+|...+ .++..+|.|.++.+++.|+.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 644 34446677788999999998874 69999999999999999998864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-22 Score=161.66 Aligned_cols=140 Identities=18% Similarity=0.200 Sum_probs=108.3
Q ss_pred eeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC----CCCCcceeEEEEEcCC---c-
Q 021233 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----KHQNIVCLKDTYEDDT---A- 130 (315)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~iv~~~~~~~~~~---~- 130 (315)
-.+.||+|+||.||. +..++.. ++|++.... ....+.+.+|+.+++.+. +||||++++++++.+. .
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 6666655 689886542 223467899999999994 4799999999998763 3
Q ss_pred EEEEEEe--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCceEeecCC-CCCCEEEEeeccc
Q 021233 131 VHLVMEL--CEGGELFDRIVARGHYTERAAAAVTKTIVEVV-QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLS 206 (315)
Q Consensus 131 ~~lv~e~--~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L-~~lH~~~iiH~dikp~Nill~~~~-~~~~vkl~Dfg~a 206 (315)
+.+|+|| +++++|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||+|||++..+ ....++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 3378999 5579999999764 46655 35677888777 999999999999999999998644 2335999995544
Q ss_pred c
Q 021233 207 V 207 (315)
Q Consensus 207 ~ 207 (315)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=164.01 Aligned_cols=146 Identities=20% Similarity=0.131 Sum_probs=112.8
Q ss_pred ceeeeeeeeeecceEEEEEE-ECCCCCEEEEEEcccccccCh-----------------h----cHHHHHHHHHHHHhCC
Q 021233 56 RYELGRELGRGEFGITYLCT-DRENGDAFACKSISKKKLRTA-----------------V----DIEDVRREVDIMRHLP 113 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~a~K~~~~~~~~~~-----------------~----~~~~~~~e~~~l~~l~ 113 (315)
-|++.+.||+|++|.||+|. +..+|+.||+|.+........ . ....+..|+.++.++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L- 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL- 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 48899999999999999998 667899999999875431100 0 112367899999999
Q ss_pred CCC--CcceeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCceEee
Q 021233 114 KHQ--NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG-VMHRDLKPENFLFA 190 (315)
Q Consensus 114 ~h~--~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~-iiH~dikp~Nill~ 190 (315)
.+. .+++++++ ...++||||++|.+|.........+....+..++.|++.+|.+||+.| ++||||||+||+++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 443 34444443 235899999999888766544445667778899999999999999999 99999999999997
Q ss_pred cCCCCCCEEEEeeccccccC
Q 021233 191 NKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++ .++|+|||.+....
T Consensus 184 -~~---~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -DG---KVVIIDVSQSVELD 199 (237)
T ss_pred -CC---CEEEEEChhhhccC
Confidence 33 38999999987543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=173.84 Aligned_cols=199 Identities=23% Similarity=0.327 Sum_probs=156.4
Q ss_pred HhCCCCCCcceeEEEEEcCCcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCce
Q 021233 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGV-MHRDLKPENF 187 (315)
Q Consensus 110 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~i-iH~dikp~Ni 187 (315)
+.+ .|.|+.++++.+.+....++|.+|+..|+|.|.+... -.+++.....+.++++.||.|||+..| .|+.+++.|+
T Consensus 2 ~~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred ccc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 456 8999999999999999999999999999999999873 348888888999999999999998876 9999999999
Q ss_pred EeecCCCCCCEEEEeeccccccCC---CCcccccccCCCccCchhhccc--------CCCcchHHHHHHHHHHHhhCCCC
Q 021233 188 LFANKKETAPLKAIDFGLSVFFKP---GEKFSEIVGSPYYMAPEVLKRN--------YGPEVDVWSAGVILYILLCGVPP 256 (315)
Q Consensus 188 ll~~~~~~~~vkl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~--------~~~~~Di~slG~~l~el~tg~~p 256 (315)
+++..-. +||+|||+...... ........-...|+|||.+... .+.+.||||||++++|+++...|
T Consensus 81 lvd~~w~---lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LVDSRWV---LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeeeEE---EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9975444 99999999876632 1112222344569999998642 46789999999999999999999
Q ss_pred CCCCCh----HHHHHHHHh-ccccCCCCCCc--cCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 257 FWAETE----QGVAQAIIR-SVLDFRRDPWP--KVSENAKDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 257 ~~~~~~----~~~~~~~~~-~~~~~~~~~~~--~~~~~l~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
|..... .+....+.+ ....+++..+. ..++++..++..||..+|..||++..+-..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 975322 234444444 33334444331 456689999999999999999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-22 Score=176.59 Aligned_cols=174 Identities=29% Similarity=0.438 Sum_probs=134.3
Q ss_pred CcEEEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
.++++.|+++...+|.+++.++.. .++...+.++.|++.|++| ++.+|+|+||.||....++. +||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q---~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ---LKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh---hhhhhhhh
Confidence 368899999999999999975543 6788899999999999999 99999999999999976665 89999999
Q ss_pred ccccCCCC-------cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHhccccC
Q 021233 206 SVFFKPGE-------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDF 276 (315)
Q Consensus 206 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~ 276 (315)
........ .++...||..||+||++.+ .|+.++||||||++|+|++.- ..++ ........+..+ .+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g--~i 477 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDG--II 477 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcC--CC
Confidence 98765554 5677899999999999985 599999999999999999972 2222 111122222222 23
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
++..+...|+ -..|+.+++.+.|.+||++.+..-+.|
T Consensus 478 p~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~~~~~ 514 (516)
T KOG1033|consen 478 PPEFLQDYPE-EYTLLQQLLSPSPEERPSAIEVALHEF 514 (516)
T ss_pred ChHHhhcCcH-HHHHHHHhcCCCcccCchHHHHhhhhh
Confidence 3333334443 468999999999999998777655443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=154.65 Aligned_cols=137 Identities=28% Similarity=0.369 Sum_probs=112.6
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccCh-----hcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+.||+|++|.||+|.+ ++..+++|.......... .....+.+|+.++..+ .+++++....++...+..+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEE
Confidence 5799999999999987 577899997654322211 1234578899999999 8888887777777777889999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
||++|++|.+.+.... . ....++.+++.+|.++|+.|++|+|++|.|||++ ++ .++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~---~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG---KIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC---CEEEEECCcccC
Confidence 9999999999886543 2 7889999999999999999999999999999997 33 389999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=150.67 Aligned_cols=134 Identities=26% Similarity=0.327 Sum_probs=105.6
Q ss_pred eeeeecceEEEEEEECCCCCEEEEEEcccccccCh-----hcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
.||+|++|.||+|.+ ++..+++|.......... ....++.+|++++..+ .++++.....++...+..++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999985 478899998654322211 1235678899999999 77766555555556666789999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
|++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++. ++++|||++...
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~---~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK---LYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc---EEEEECCCCcCC
Confidence 9999999988755321 7899999999999999999999999999997 333 899999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=170.55 Aligned_cols=141 Identities=23% Similarity=0.283 Sum_probs=111.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc-----ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
...|...+.||+|+||+||++.+... .+++|+....... .....+++.+|+.++..+ +|++++....++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC
Confidence 34567789999999999999987643 3444432221111 112245688999999999 899998887777777
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
...++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||++ ++. ++|+|||+++.
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~---~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR---LYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc---EEEEeCccccc
Confidence 77899999999999998875 3567899999999999999999999999999993 333 89999999976
Q ss_pred c
Q 021233 209 F 209 (315)
Q Consensus 209 ~ 209 (315)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-20 Score=149.68 Aligned_cols=139 Identities=24% Similarity=0.310 Sum_probs=106.3
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh-------------------hcHHHHHHHHHHHHhCCCCC-
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-------------------VDIEDVRREVDIMRHLPKHQ- 116 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~~h~- 116 (315)
|.+.+.||+|+||.||++... +|+.+|+|++........ ........|+.++..+ .++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence 888899999999999999874 799999998764321000 0112367788889888 665
Q ss_pred -CcceeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 021233 117 -NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 117 -~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~ 195 (315)
.++..++. ...++||||++|++|.+... ......++.+++.++.++|+.|++|+||+|+||+++.++.
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 44455442 34589999999998866432 1345678899999999999999999999999999976444
Q ss_pred CCEEEEeeccccccC
Q 021233 196 APLKAIDFGLSVFFK 210 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~ 210 (315)
++|+|||.+....
T Consensus 164 --~~liDfg~~~~~~ 176 (198)
T cd05144 164 --IYIIDWPQMVSTD 176 (198)
T ss_pred --EEEEECCccccCC
Confidence 8999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-21 Score=181.88 Aligned_cols=258 Identities=29% Similarity=0.496 Sum_probs=204.7
Q ss_pred cceeeeeeeeeecceEEEEEEECCC-CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDREN-GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
..|.+.+.||+|+|+.|-.+....+ ...+|.|.+.... ......+....|..+-+.+.+|.|++.+++........++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4588888999999999998876443 3456666665443 2334455667788888888669999999999999999999
Q ss_pred EEEecCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 134 VMELCEGGELFDRI-VARG-HYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 134 v~e~~~~~sL~~~l-~~~~-~l~~~~~~~i~~~l~~~L~~lH-~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++|..|+++.+.+ .... ..+...+-..+.|+..++.|+| ..++.|+||||+|.+++..+. ..+++|||+|....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYR 176 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC--cccCCCchhhcccc
Confidence 99999999999888 5544 5778888899999999999999 999999999999999987663 37999999998765
Q ss_pred C-CC---ccccccc-CCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH-HHHhccccCCCCCCc
Q 021233 211 P-GE---KFSEIVG-SPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVLDFRRDPWP 282 (315)
Q Consensus 211 ~-~~---~~~~~~g-t~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 282 (315)
. .. .....+| ++.|+|||...+ ......|+||.|+++.-+++|..|+.......... ............+|.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 4 22 2234577 999999999765 46788999999999999999999986554443221 111111222355677
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.++....+++.+++..+|..|.+.+++-.+.|+
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~ 289 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWL 289 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccc
Confidence 889999999999999999999999999888764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.4e-19 Score=142.47 Aligned_cols=140 Identities=20% Similarity=0.241 Sum_probs=98.1
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHH---------------------HHHHHHHHHHhCCCCC--
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE---------------------DVRREVDIMRHLPKHQ-- 116 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~~h~-- 116 (315)
.+.||+|+||+||+|.+. +++.||+|++............ ....|...+..+ .+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL-YEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH-HHcCC
Confidence 568999999999999976 7999999988654321111111 113566666666 332
Q ss_pred CcceeEEEEEcCCcEEEEEEecCCCChHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCC
Q 021233 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDR-IVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKE 194 (315)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~-l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~ 194 (315)
.+++.++. ...++||||++++++... +... .. ...+..++.+++.++.++|. .||+|+||||+||+++ ++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 24444443 235899999998543221 1111 11 16778999999999999999 9999999999999998 333
Q ss_pred CCCEEEEeeccccccCC
Q 021233 195 TAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~ 211 (315)
++|+|||.+.....
T Consensus 153 ---~~liDfg~a~~~~~ 166 (187)
T cd05119 153 ---VYIIDVPQAVEIDH 166 (187)
T ss_pred ---EEEEECcccccccC
Confidence 89999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-17 Score=139.39 Aligned_cols=138 Identities=19% Similarity=0.259 Sum_probs=103.8
Q ss_pred eeee-eecceEEEEEEECCCCCEEEEEEcccccc----------cChhcHHHHHHHHHHHHhCCCCCCc--ceeEEEEEc
Q 021233 61 RELG-RGEFGITYLCTDRENGDAFACKSISKKKL----------RTAVDIEDVRREVDIMRHLPKHQNI--VCLKDTYED 127 (315)
Q Consensus 61 ~~lg-~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----------~~~~~~~~~~~e~~~l~~l~~h~~i--v~~~~~~~~ 127 (315)
..|| .|+.|+||.+... +..+++|.+..... .......++.+|+.++..| .++++ +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4677 8889999998764 78899998753211 0122345688899999999 77774 667776443
Q ss_pred C-Cc---EEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 128 D-TA---VHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 128 ~-~~---~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
. .. .++|||+++| .+|.+++.. ..++... +.+++.+|.+||+.||+|+||||.|||++.++. ++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~---v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK---FWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC---EEEEE
Confidence 2 22 3599999997 688888754 3455543 568999999999999999999999999976553 99999
Q ss_pred ecccccc
Q 021233 203 FGLSVFF 209 (315)
Q Consensus 203 fg~a~~~ 209 (315)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-17 Score=128.71 Aligned_cols=133 Identities=24% Similarity=0.304 Sum_probs=110.4
Q ss_pred eeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-CCcceeEEEEEcCCcEEEEEEe
Q 021233 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDDTAVHLVMEL 137 (315)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~~~~~lv~e~ 137 (315)
+++.||+|.++.||++... +..+++|....... ...+.+|+.+++.+.++ .++++++.++...+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999975 47899998754421 45788999999999444 6899999998888899999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 138 CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 138 ~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~---~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
++|+++... +......++.+++.+|..+|.. +++|+|++|+||++++.+. ++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~---~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI---LGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE---EEEEecccccC
Confidence 998777543 5567778899999999999985 6999999999999986433 89999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.3e-18 Score=152.77 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=198.7
Q ss_pred ccccceeeeeeeee--ecceEEEEEEE--CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 52 EIEERYELGRELGR--GEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 52 ~~~~~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
...+.+.+...+|. |.+|.||.+.. ..++..+|+|.-... ...+....+=.+|+...+.+..|++.++....++.
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCccccc
Confidence 34567888999999 99999999998 788899999874322 23333334445678888888789999998999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVE----VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~~l~~----~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
.+..++-+|++ +.+|..+...... ++...++....+... ||.++|+.+++|-|+||.||+...+. ..++++|
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~--~s~~~~d 266 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW--TSCKLTD 266 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc--ceeecCC
Confidence 99999999999 5688888876555 889999999999999 99999999999999999999998663 3379999
Q ss_pred eccccccCCCCccc------ccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC
Q 021233 203 FGLSVFFKPGEKFS------EIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (315)
Q Consensus 203 fg~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 276 (315)
||+......+.... ...|...|++||...+-++..+|+||+|.++++..++..+........ ...+.+.. .
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-W~~~r~~~--i 343 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-WSQLRQGY--I 343 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-cccccccc--C
Confidence 99988776554221 125677899999999999999999999999999888866553332211 11121211 2
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+.+.....+.++...+..|+..+|-.|++++.++++.+
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~ 381 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNV 381 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccc
Confidence 33344455667778999999999999999999987653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.8e-17 Score=136.34 Aligned_cols=233 Identities=17% Similarity=0.190 Sum_probs=151.1
Q ss_pred EEEEEEECCCCCEEEEEEcccccccChh-cHHHHHHHHHHHHhCCCCCCcceeEEEEEcC-----CcEEEEEEecCCCCh
Q 021233 70 ITYLCTDRENGDAFACKSISKKKLRTAV-DIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-----TAVHLVMELCEGGEL 143 (315)
Q Consensus 70 ~Vy~~~~~~~~~~~a~K~~~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~sL 143 (315)
.||++.+...|..|+...++.....+.. ..+....=...|-.+ .|.|+|+++.++.+. ....++.|||..|++
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 4677766666666654443322222211 122233334445556 799999999998654 347899999999999
Q ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEEEeecccccc-----CCC
Q 021233 144 FDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-----KPG 212 (315)
Q Consensus 144 ~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~-----~~~ 212 (315)
..+|++- ..+......+|+.||+.||.|||+.. |+|+++..+.|++..++- +|+.--...... ...
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL---Ikig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL---IKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce---EEecccCccccchhhhhhhH
Confidence 9999753 34888999999999999999999885 999999999999974433 454311111000 000
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
.......+-++|.+||.-. .+.+..+|||+||+..++|.-+..--...... .....+.+-..... ..--..
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~ 309 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG 309 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence 0112234567899999744 45778899999999999998876543222111 11111111111110 111247
Q ss_pred HHHHhcCCCcCCCCCHHHHhccc
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.+|++..|..||++++++.|+
T Consensus 310 ~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred cCcccccCCCCCCcchhhhhcCc
Confidence 89999999999999999999986
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.7e-16 Score=139.31 Aligned_cols=252 Identities=22% Similarity=0.233 Sum_probs=186.5
Q ss_pred ccccceeeeeeeeeecceEEEEEEEC-CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
....+|..+..||.|.|+.|+.+..+ .++..|++|...........++. -..|+.+...+..|.+++.....+.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34457999999999999999998766 67889999988766544443333 33477777777789999988777777777
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++-.||+.++++.....-...+.+...+.+..|++.++.++|+..++|+|++|+||++.+++ ...++.|||......
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLA 418 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccc
Confidence 789999999999877765555688889999999999999999999999999999999998764 336899999886421
Q ss_pred CCCcccccccCCCcc-Cchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 211 PGEKFSEIVGSPYYM-APEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~-aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
- ........-++. ..|.+.. .+..+.|++|||..+.+..++...-.... ....+..+... ..+....+
T Consensus 419 ~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~~~p----~~~~~~~~ 489 (524)
T KOG0601|consen 419 F--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSGDTP----NLPGLKLQ 489 (524)
T ss_pred e--ecccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeeccccc----CCCchHHh
Confidence 1 111222233444 3555543 47789999999999999999876543222 12222222211 22334478
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+..+...++.+++..||++.++..+..|
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchh
Confidence 8899999999999999999999888765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-14 Score=111.21 Aligned_cols=148 Identities=20% Similarity=0.248 Sum_probs=114.3
Q ss_pred eeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC-----hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.+..|-+|+-+.|+++.+. |+.++||.=....... .....+..+|+.+|.++ ..-.|....-++.+...-.+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeE
Confidence 5678899999999999876 8888887543333332 23456788899999998 55566655666666666789
Q ss_pred EEEecCC-CChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 134 VMELCEG-GELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 134 v~e~~~~-~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
+|||++| .++.+++..... ........++..+-+.+.-||.++|+|+||..+||++.+++....+.++|||++...
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999987 467787765422 333344788999999999999999999999999999999888877899999998643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-14 Score=131.52 Aligned_cols=144 Identities=19% Similarity=0.255 Sum_probs=98.5
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChh-----------------------c--------------HHHHH
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----------------------D--------------IEDVR 103 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~-----------------------~--------------~~~~~ 103 (315)
+.||.|++|.||+|+.. +|+.||||+.......... + .-++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999974 6999999998654211000 0 01244
Q ss_pred HHHHHHHhCC----CCCCcceeEEEEEcCCcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 021233 104 REVDIMRHLP----KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE-VVQMCHKHGV 177 (315)
Q Consensus 104 ~e~~~l~~l~----~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~-~L~~lH~~~i 177 (315)
+|+..+.++. +++++.-..-+....+..++||||++|++|.+..... .... ...++..++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 5666555552 2344332222233345679999999999998876532 1222 3456666665 4788999999
Q ss_pred eecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 178 iH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+|+|++|.||++..++. ++++|||++.....
T Consensus 279 ~H~D~hPgNilv~~~g~---i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK---IIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCc---EEEEeCCCeeECCH
Confidence 99999999999976554 89999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.3e-14 Score=114.61 Aligned_cols=143 Identities=13% Similarity=0.112 Sum_probs=101.7
Q ss_pred eeeeeeecceEEEEEEECC------CCCEEEEEEcccccc--cC-----------------hhcHHHHH----HHHHHHH
Q 021233 60 GRELGRGEFGITYLCTDRE------NGDAFACKSISKKKL--RT-----------------AVDIEDVR----REVDIMR 110 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~--~~-----------------~~~~~~~~----~e~~~l~ 110 (315)
...||.|--+.||.|.... ++..+|+|+...... .. ......+. +|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 357899998753321 00 01122333 7999999
Q ss_pred hCCCC-CCcceeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCceE
Q 021233 111 HLPKH-QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC-HKHGVMHRDLKPENFL 188 (315)
Q Consensus 111 ~l~~h-~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~l-H~~~iiH~dikp~Nil 188 (315)
++... -++++++++ ...++||||+.+..+.........++...+..+..+++.+|..+ |+.|++|+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 98433 356677765 45689999997643422222223456667778889999999998 8999999999999999
Q ss_pred eecCCCCCCEEEEeeccccccC
Q 021233 189 FANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+.. + .++|+|||.+....
T Consensus 158 ~~~-~---~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WHD-G---KVWFIDVSQSVEPT 175 (197)
T ss_pred EEC-C---cEEEEECCCceeCC
Confidence 963 2 38999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=114.91 Aligned_cols=129 Identities=18% Similarity=0.171 Sum_probs=95.3
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecC
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
++.|+.|..+.||++... +..+++|....... ....+..|+.+++.+.+...+++++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999865 78899998754321 12346789999998843333455655543 23579999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 140 GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV-----MHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 140 ~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~i-----iH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
|.++.+. ......++.+++.+|..||+.++ +|+|++|.||+++ ++. ++++|||.+..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~---~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR---LWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe---EEEEecccccC
Confidence 9887543 01123456789999999999885 9999999999997 333 89999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.4e-15 Score=141.86 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=194.1
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
-.+.+.+.+.+-+|+++.++.+.-..+|...+.|+......-...+.+....+-.++-.- .+|.++.....+......+
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcc
Confidence 445688888999999999999887767766666655433222222233344444443322 4566666555566777889
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP- 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~- 211 (315)
++++|+.+++|...+...+..+...++.....+..++++||...+.|+|++|.|++...++. .++.|||.......
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh---~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH---RPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC---cccCccccccccccc
Confidence 99999999999999888777888888888889999999999999999999999999976555 68999983321100
Q ss_pred -----------------------------C--CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCC
Q 021233 212 -----------------------------G--EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWA 259 (315)
Q Consensus 212 -----------------------------~--~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~ 259 (315)
+ .......+|+.|.+||... ......+|.|++|++++|.++|.+||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0012346899999999865 4578889999999999999999999999
Q ss_pred CChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHH---HHhcccCC
Q 021233 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ---QVLGKIEF 315 (315)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~---e~l~~l~f 315 (315)
.......+.+.+....++.. ....+.+.++++...+..+|.+|..+. ++-.|.+|
T Consensus 1038 ~tpq~~f~ni~~~~~~~p~g-~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~ 1095 (1205)
T KOG0606|consen 1038 ETPQQIFENILNRDIPWPEG-PEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFF 1095 (1205)
T ss_pred cchhhhhhccccCCCCCCCC-ccccChhhhhhhhhhhccCchhccCcccccccccCCcc
Confidence 99888888887776655433 235678899999999999999998876 66666665
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-14 Score=134.02 Aligned_cols=151 Identities=19% Similarity=0.292 Sum_probs=94.0
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC--------------------------h-----hcHH----
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT--------------------------A-----VDIE---- 100 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~--------------------------~-----~~~~---- 100 (315)
.|.. +.||+|++|.||+|+.+.+|+.||||++....... . .-.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 78999999999999998779999999997542100 0 0011
Q ss_pred --HHHHHHHHHHhCC---CCCCcceeEEEE-EcCCcEEEEEEecCCCChHHHH--HhcCCCCHHHHHHHHHHHH-HHHHH
Q 021233 101 --DVRREVDIMRHLP---KHQNIVCLKDTY-EDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIV-EVVQM 171 (315)
Q Consensus 101 --~~~~e~~~l~~l~---~h~~iv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l--~~~~~l~~~~~~~i~~~l~-~~L~~ 171 (315)
++.+|+..+.++. .+.+.+.+-.++ ......++||||++|+++.+.- ...+ .+... ++...+ .-+..
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~---la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKL---LAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHH---HHHHHHHHHHHH
Confidence 2334444444442 122222222222 2245678999999999997743 2222 22221 111111 22344
Q ss_pred HHHCCceecCCCCCceEeecCC-CCCCEEEEeeccccccCC
Q 021233 172 CHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 172 lH~~~iiH~dikp~Nill~~~~-~~~~vkl~Dfg~a~~~~~ 211 (315)
+...|++|+|+||.||+++.++ ....++++|||++.....
T Consensus 276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5568999999999999998765 122489999999877643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.6e-13 Score=105.17 Aligned_cols=135 Identities=26% Similarity=0.332 Sum_probs=101.8
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccCh-----hcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
..+++|+-+.+|.+.+. |..+++|.=.......+ ...++-.+|+.++.++ ..-.|...+-+..+.+...|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEE
Confidence 35789999999999764 55677775433333332 2244567899999998 5666666666677777778999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
||++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++.+++ +.++|||++...
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~----i~~IDfGLg~~s 141 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEFS 141 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc----EEEEECCccccc
Confidence 999998888888765 245566666677889999999999999999996433 799999999753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.8e-12 Score=117.45 Aligned_cols=168 Identities=17% Similarity=0.206 Sum_probs=127.8
Q ss_pred EEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCChHHHHHhcCC
Q 021233 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152 (315)
Q Consensus 73 ~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~ 152 (315)
.|..+.++.+|.|.....+.- ...+...+.++.|+.+ +||||+++++.++.++..|+|+|.+. .|...+++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-
Confidence 466667788888887764432 3345678889999999 99999999999999999999999985 6777776643
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc-ccccccCCCccCchhh
Q 021233 153 YTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK-FSEIVGSPYYMAPEVL 230 (315)
Q Consensus 153 l~~~~~~~i~~~l~~~L~~lH-~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~ 230 (315)
.......+.||+.||.||| +.+++|++|..+.|+++..|+ .||.+|.++........ ......-..|..|+.+
T Consensus 103 --~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge---WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 103 --KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE---WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEI 177 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc---EEEeeeEEEeccccCCcccccchhhhcccChhhc
Confidence 5666777899999999997 678999999999999988777 89999998865433221 1111122235666654
Q ss_pred cccCCCcchHHHHHHHHHHHhhC
Q 021233 231 KRNYGPEVDVWSAGVILYILLCG 253 (315)
Q Consensus 231 ~~~~~~~~Di~slG~~l~el~tg 253 (315)
... +-..|.|-||+++++++.|
T Consensus 178 ~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Ccc-ccchhhhhHHHHHHHHhCc
Confidence 321 1346999999999999999
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.1e-11 Score=106.27 Aligned_cols=243 Identities=16% Similarity=0.186 Sum_probs=162.4
Q ss_pred eeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEE------EEcCCc-
Q 021233 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT------YEDDTA- 130 (315)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~------~~~~~~- 130 (315)
.....||+|+.+.+|..-.- ...+.|++..... ..-.+.+..|.....||-+-.-+.| ....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Ppp------a~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPP------AAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCc------hHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 34577999999999975422 2235577765422 1222345556666567644332322 122233
Q ss_pred EEEEEEecCCCC-hHHHHH---hc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 131 VHLVMELCEGGE-LFDRIV---AR---GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 131 ~~lv~e~~~~~s-L~~~l~---~~---~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
.-+.|+.++|.. ...+.. ++ ....|..++++++.|+.+...||..|.+-+|+.++|+|+.++.. |.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~---V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK---VVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce---EEEEcc
Confidence 668888887642 222221 11 23789999999999999999999999999999999999976555 889887
Q ss_pred ccccccCCCCcccccccCCCccCchhhc-c-----cCCCcchHHHHHHHHHHHhhC-CCCCCCCChHH-----HHHHHHh
Q 021233 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK-R-----NYGPEVDVWSAGVILYILLCG-VPPFWAETEQG-----VAQAIIR 271 (315)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~Di~slG~~l~el~tg-~~p~~~~~~~~-----~~~~~~~ 271 (315)
........+..+...+|...|++||... + .-+...|.|.||+++++++.| +.||.+..... ....|..
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 6555545555666678899999999754 2 256789999999999998886 99995432110 0112211
Q ss_pred cccc------------CCCCCCccCCHHHHHHHHHhcCC--CcCCCCCHHHHhcc
Q 021233 272 SVLD------------FRRDPWPKVSENAKDLVRKMLDP--DPKRRLTAQQVLGK 312 (315)
Q Consensus 272 ~~~~------------~~~~~~~~~~~~l~~li~~~l~~--~P~~Rps~~e~l~~ 312 (315)
+.+. ....+|..++++++.+..+|+.. ++.-|||++..++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 1111 12234567899999999999865 46789999876643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.9e-11 Score=106.40 Aligned_cols=212 Identities=17% Similarity=0.241 Sum_probs=154.0
Q ss_pred cceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE----cCCcEEEEEEecCC-C
Q 021233 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE----DDTAVHLVMELCEG-G 141 (315)
Q Consensus 67 ~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----~~~~~~lv~e~~~~-~ 141 (315)
.-.+.|+++...+|..|++|+++....... .....-+++++++ .|+|+|++.++|. .+..+++|++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 346899999999999999999954433222 1233467888999 9999999999886 45678999999984 6
Q ss_pred ChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 142 ELFDRIVAR---------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 142 sL~~~l~~~---------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
+|.+..... ...++..+|.++.||..||.++|+.|+..+-|.|.+||++.+. +++|+.-|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~---RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM---RIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc---eEEEecccce
Confidence 677765321 2367899999999999999999999999999999999997543 3788877766
Q ss_pred cccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHH-HHHHHhccccCCCCCCccC
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGV-AQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~ 284 (315)
.....+.. +| + .--.+-|.--||.+++.|.||..--+... ..+. ...+. ..+
T Consensus 441 Dvl~~d~~-----------~~--l--e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~y 494 (655)
T KOG3741|consen 441 DVLQEDPT-----------EP--L--ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTY 494 (655)
T ss_pred eeecCCCC-----------cc--h--hHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhh
Confidence 65543331 11 0 01235688899999999999965422111 1111 22221 346
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
+.+++++|......++++ -++.+++.+
T Consensus 495 S~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 495 STDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 789999999999999887 677777754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-11 Score=103.30 Aligned_cols=144 Identities=24% Similarity=0.368 Sum_probs=104.0
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-CCcceeEEEEEcC---CcEEEEEE
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDD---TAVHLVME 136 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~---~~~~lv~e 136 (315)
+.|+.|..+.||++... +|..+++|........ .....+..|+.+++.+..+ ..+++++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 57899999999999864 3688999987654321 1245688999999999432 3467777777654 36689999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 021233 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK------------------------------------------ 174 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~------------------------------------------ 174 (315)
|++|.++.+.+.. ..++......++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 346666666777777777777763
Q ss_pred --------------CCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 175 --------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 175 --------------~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
..++|+|++|.||+++.+ ....+.|+||+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccccC
Confidence 236999999999999763 1223689999988643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-10 Score=98.70 Aligned_cols=136 Identities=18% Similarity=0.140 Sum_probs=94.2
Q ss_pred EEEEEEECCCCCEEEEEEccccccc----C----hhcHHHHHHHHHHHHhCCCCCCc--ceeEEEEEc-----CCcEEEE
Q 021233 70 ITYLCTDRENGDAFACKSISKKKLR----T----AVDIEDVRREVDIMRHLPKHQNI--VCLKDTYED-----DTAVHLV 134 (315)
Q Consensus 70 ~Vy~~~~~~~~~~~a~K~~~~~~~~----~----~~~~~~~~~e~~~l~~l~~h~~i--v~~~~~~~~-----~~~~~lv 134 (315)
.|+++.. +|+.+.+|........ . ......+.+|...+.+| ..-+| +.++++++. ...-++|
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3556554 3677888866332210 0 01112477888888887 33333 345556543 2346899
Q ss_pred EEecCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC----CCCCCEEEEeecccc
Q 021233 135 MELCEGG-ELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK----KETAPLKAIDFGLSV 207 (315)
Q Consensus 135 ~e~~~~~-sL~~~l~~--~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~----~~~~~vkl~Dfg~a~ 207 (315)
+|++++. +|.+++.. ....+......++.+++..+.-||..||+|+|+++.|||++.+ .....+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999875 78888753 2345667788999999999999999999999999999999752 233458999999885
Q ss_pred c
Q 021233 208 F 208 (315)
Q Consensus 208 ~ 208 (315)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.4e-11 Score=96.15 Aligned_cols=130 Identities=22% Similarity=0.219 Sum_probs=82.4
Q ss_pred EEEEEEECCCCCEEEEEEcccccccC-----------------------hhcHHHHHHHHHHHHhCCCCC-CcceeEEEE
Q 021233 70 ITYLCTDRENGDAFACKSISKKKLRT-----------------------AVDIEDVRREVDIMRHLPKHQ-NIVCLKDTY 125 (315)
Q Consensus 70 ~Vy~~~~~~~~~~~a~K~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~ 125 (315)
.||.|... +|..+|+|........- ........+|...|.++.... ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999874 57899999875432110 011345778999999994332 567777553
Q ss_pred EcCCcEEEEEEecC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 126 EDDTAVHLVMELCE--GGELFDRIVARGHYTERAAAAVTKTIVEVVQM-CHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 126 ~~~~~~~lv~e~~~--~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~-lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
..++||||++ |..+..+.... ++......++.+++..+.. +|..||+|+|+++.||+++.+ .+.++|
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~----~~~iID 149 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG----KVYIID 149 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT----CEEE--
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc----eEEEEe
Confidence 3479999998 65554433322 2244566777788875544 689999999999999999754 389999
Q ss_pred eccccccC
Q 021233 203 FGLSVFFK 210 (315)
Q Consensus 203 fg~a~~~~ 210 (315)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.8e-10 Score=91.04 Aligned_cols=111 Identities=18% Similarity=0.223 Sum_probs=86.8
Q ss_pred cHHHHHHHHHHHHhCCCCCC--cceeEEEEEcCC----cEEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 021233 98 DIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDT----AVHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQ 170 (315)
Q Consensus 98 ~~~~~~~e~~~l~~l~~h~~--iv~~~~~~~~~~----~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~ 170 (315)
...+..+|...+..| ..-. +++.+++.+... ..++|+|++++ .+|.+++......+......++.+++..+.
T Consensus 54 ~~~ra~~E~~~~~~L-~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRL-REAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHH-HHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHH
Confidence 345677788877777 3222 456666665432 35899999987 478888877545777888899999999999
Q ss_pred HHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 171 ~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
-||..||+|+|+++.|||+..++....+.|+||+.+...
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999988775555899999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.8e-11 Score=111.34 Aligned_cols=148 Identities=20% Similarity=0.328 Sum_probs=106.2
Q ss_pred HHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc-----c-----ccccCCCccCchhhcc
Q 021233 164 TIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF-----S-----EIVGSPYYMAPEVLKR 232 (315)
Q Consensus 164 ~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~-----~-----~~~gt~~y~aPE~~~~ 232 (315)
+.+.||.++|.. ++||++|.|++|.++..+. +||+.|+.+......... . -..-...|.|||++..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~---wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD---WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc---eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 444899999955 8999999999999987666 899999988765442211 1 1123456999999764
Q ss_pred -cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCC-CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHH
Q 021233 233 -NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFR-RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309 (315)
Q Consensus 233 -~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~ 309 (315)
..+.++|+||+|++++.++. |+..+...... ............. ......+|.++.+=+.+++..++.-||++.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 47889999999999999884 55554333221 2222222211111 11235789999999999999999999999999
Q ss_pred hcccCC
Q 021233 310 LGKIEF 315 (315)
Q Consensus 310 l~~l~f 315 (315)
+..+||
T Consensus 263 ~~~~ff 268 (700)
T KOG2137|consen 263 LSIPFF 268 (700)
T ss_pred hccccc
Confidence 988887
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.9e-10 Score=92.48 Aligned_cols=140 Identities=23% Similarity=0.302 Sum_probs=102.5
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEccccc--cc---------------C--hhcHHHHHHHHHHHHhCCCC-C
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKK--LR---------------T--AVDIEDVRREVDIMRHLPKH-Q 116 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~---------------~--~~~~~~~~~e~~~l~~l~~h-~ 116 (315)
+.+...||-|--|.||.|.+. .|.++|+|.-.... +. + .......++|.++|.+|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 567789999999999999976 68999999532211 10 0 11244577899999999433 3
Q ss_pred CcceeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
.|++.+++- ...+|||+++|..|...- +.......++..|+.-+..+-..||||+|+++-||+++.++.
T Consensus 172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAWN----RHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCccccc----cceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 567776653 467999999987665432 234555566677777777667899999999999999988766
Q ss_pred CEEEEeecccccc
Q 021233 197 PLKAIDFGLSVFF 209 (315)
Q Consensus 197 ~vkl~Dfg~a~~~ 209 (315)
+.++||-.+...
T Consensus 241 -~~vIDwPQ~v~~ 252 (304)
T COG0478 241 -IVVIDWPQAVPI 252 (304)
T ss_pred -EEEEeCcccccC
Confidence 899999877643
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=1e-08 Score=83.05 Aligned_cols=142 Identities=14% Similarity=0.113 Sum_probs=101.6
Q ss_pred eeecceEEEEEEECCCCCEEEEEEcccccccC---hhcHHHHHHHHHHHHhCCCC-CCcceeEEEEEcC----CcEEEEE
Q 021233 64 GRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDD----TAVHLVM 135 (315)
Q Consensus 64 g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~----~~~~lv~ 135 (315)
|+||-+-|+..... |..+-+|........+ +.....|.+|...+..|... -.++++....... -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56888889887654 4578888765222222 44678899999999988321 1244555222221 2357999
Q ss_pred EecCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 136 ELCEG-GELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 136 e~~~~-~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
|-++| .+|.+++... .+.+......+..+++..+.-||+.|+.|+|+.+.||+++.++ ...|.++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence 97753 5788887653 2357777889999999999999999999999999999997544 23489999997764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.6e-08 Score=82.28 Aligned_cols=144 Identities=22% Similarity=0.289 Sum_probs=93.7
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcH------HHHHHHHHHHHhCC--CCCCcceeE
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI------EDVRREVDIMRHLP--KHQNIVCLK 122 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~------~~~~~e~~~l~~l~--~h~~iv~~~ 122 (315)
..+.++|++.+.+-......|.+... +|+.+++|............. +...+++..+.++. .......++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 34567899999998888887877764 489999998765432111111 11233444444441 122222222
Q ss_pred EE-----EEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCC
Q 021233 123 DT-----YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197 (315)
Q Consensus 123 ~~-----~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~ 197 (315)
.+ +......+++|||++|..|.+... +++ .++..+.+++.-||+.|+.|+|..|.|++++++ .
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~--- 172 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-G--- 172 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-c---
Confidence 22 223345679999999988866542 222 355677888999999999999999999999743 2
Q ss_pred EEEEeeccccc
Q 021233 198 LKAIDFGLSVF 208 (315)
Q Consensus 198 vkl~Dfg~a~~ 208 (315)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 79999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.9e-08 Score=91.61 Aligned_cols=146 Identities=18% Similarity=0.233 Sum_probs=96.5
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccCh-----------------------hc--------------HHHHH
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----------------------VD--------------IEDVR 103 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----------------------~~--------------~~~~~ 103 (315)
..|+.++-|.||+|+.. +|+.||||+....-.... .. .-++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999976 499999999865432100 00 01234
Q ss_pred HHHHHHHhC----CCCCCcceeEEEEEcCCcEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 021233 104 REVDIMRHL----PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVM 178 (315)
Q Consensus 104 ~e~~~l~~l----~~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~ii 178 (315)
+|+..+.++ .+.+++.-..-+++..+...++|||++|..+.+...- ...++.+.+.....++. +..+=..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 455555544 2345554444455556678999999999999887432 23355333333222221 3344457999
Q ss_pred ecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 179 H~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|.|.+|.||++..++. +.+.|||+.....+.
T Consensus 288 HaDpHpGNi~v~~~g~---i~~lDfGi~g~l~~~ 318 (517)
T COG0661 288 HADPHPGNILVRSDGR---IVLLDFGIVGRLDPK 318 (517)
T ss_pred ccCCCccceEEecCCc---EEEEcCcceecCCHH
Confidence 9999999999987755 899999998776543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.4e-07 Score=79.03 Aligned_cols=79 Identities=24% Similarity=0.227 Sum_probs=56.5
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeEEEEE---cCCcEEEEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYE---DDTAVHLVM 135 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~~---~~~~~~lv~ 135 (315)
++.|+.|..+.||++.... ..+++|..... .....+..|..++..+..+. .+++++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4789999999999999763 58999986432 33467888999988884332 3566776443 234579999
Q ss_pred EecCCCChHH
Q 021233 136 ELCEGGELFD 145 (315)
Q Consensus 136 e~~~~~sL~~ 145 (315)
++++|.++..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.6e-07 Score=77.10 Aligned_cols=73 Identities=25% Similarity=0.277 Sum_probs=54.1
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeEEEEEcCCcEEEEEEecC
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
..||+|..+.||+.. +..+++|..... .......+|.++++.+.... .+++.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~-----~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPG-----FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCC-----CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 578999999999842 456788877532 12356788999999884332 25678888887777889999999
Q ss_pred CCC
Q 021233 140 GGE 142 (315)
Q Consensus 140 ~~s 142 (315)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.7e-08 Score=74.75 Aligned_cols=133 Identities=21% Similarity=0.264 Sum_probs=92.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
..+..+.|++|.+|.||++.+. |..+|+|+-.. ......+..|+++|..+....--.+++.+..+. +.|
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-----ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~m 91 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR-----DSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRM 91 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc--CceEEEEEecC-----CcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhh
Confidence 3456788999999999999987 77999997643 334577999999999984333344666665543 459
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-CCceEeecCCCCCCEEEEeecccccc
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLK-PENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dik-p~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
||+.|.+|.+..... .. +-...++++-.-|-..||-|+.|. |...++.++.. +.|+||..|+..
T Consensus 92 e~i~G~~L~~~~~~~---~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~---~~iIDFd~At~k 156 (201)
T COG2112 92 EYIDGRPLGKLEIGG---DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRD---VYIIDFDSATFK 156 (201)
T ss_pred hhhcCcchhhhhhcc---cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCc---EEEEEccchhhc
Confidence 999998887655421 22 333445555555667899999996 44444433333 799999998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.9e-07 Score=71.11 Aligned_cols=129 Identities=19% Similarity=0.243 Sum_probs=92.3
Q ss_pred cceeeeeeeeeecc-eEEEEEEECCCCCEEEEEEcccccccCh------------------hcHHHHHHHHHHHHhCCC-
Q 021233 55 ERYELGRELGRGEF-GITYLCTDRENGDAFACKSISKKKLRTA------------------VDIEDVRREVDIMRHLPK- 114 (315)
Q Consensus 55 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~a~K~~~~~~~~~~------------------~~~~~~~~e~~~l~~l~~- 114 (315)
.+++.++.||.|.. |.||++... |+.+|+|.+..-..... .....|..|.....+|..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 999999875 88999999322111000 123357888888887732
Q ss_pred -CCCc--ceeEEEEEcC------------------CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 021233 115 -HQNI--VCLKDTYEDD------------------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173 (315)
Q Consensus 115 -h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH 173 (315)
+.++ |+.+||..-. ..+.||.||++... .++. .-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 3344 8888887322 12468999887643 1222 23456777788999
Q ss_pred HCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 174 ~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
..||+-+|+++.|.. +. +|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~----~G----~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR----GG----KLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc----CC----EEEecccC
Confidence 999999999999997 33 89999965
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.9e-07 Score=77.92 Aligned_cols=77 Identities=16% Similarity=0.151 Sum_probs=56.0
Q ss_pred eeeeecc-eEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 62 ELGRGEF-GITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 62 ~lg~G~~-g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
.|-.|.. +.||++... +..+++|...... ...+.+|+.+++.+.++--+++++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3555665 789998753 4678888764332 245778999999986565566888888777778999999999
Q ss_pred CChHHH
Q 021233 141 GELFDR 146 (315)
Q Consensus 141 ~sL~~~ 146 (315)
.+|...
T Consensus 77 ~~l~~~ 82 (244)
T cd05150 77 VPAAAL 82 (244)
T ss_pred ccHhHh
Confidence 877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.2e-07 Score=75.64 Aligned_cols=140 Identities=20% Similarity=0.183 Sum_probs=91.6
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChh----------------cHHH-----HHHHHHHHHhCCC-CCCc
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV----------------DIED-----VRREVDIMRHLPK-HQNI 118 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~----------------~~~~-----~~~e~~~l~~l~~-h~~i 118 (315)
..|..|--+.||+|.. .++..+|+|++......... +... ..+|...|+++.+ +=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3566777889999985 56899999988654321110 1111 2457777777622 2234
Q ss_pred ceeEEEEEcCCcEEEEEEecCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCC
Q 021233 119 VCLKDTYEDDTAVHLVMELCEGGEL-FDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 119 v~~~~~~~~~~~~~lv~e~~~~~sL-~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~ 196 (315)
++.+++.. ..+||||+..... .-.|. .-.+....+..+..++++.+.-|-. .++||+||+.-|||+. ++.
T Consensus 133 P~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~-- 204 (268)
T COG1718 133 PEPIAFRN----NVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE-- 204 (268)
T ss_pred CCceeecC----CeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--
Confidence 45555543 4699999954211 00111 1123444678888899999888876 8999999999999997 334
Q ss_pred CEEEEeeccccccC
Q 021233 197 PLKAIDFGLSVFFK 210 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~ 210 (315)
+.++|||.|....
T Consensus 205 -p~iID~~QaV~~~ 217 (268)
T COG1718 205 -PYIIDVSQAVTID 217 (268)
T ss_pred -EEEEECccccccC
Confidence 7999999987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.2e-09 Score=99.98 Aligned_cols=195 Identities=18% Similarity=0.232 Sum_probs=139.6
Q ss_pred ecCCCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC-cceeEE
Q 021233 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-IVCLKD 123 (315)
Q Consensus 45 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-iv~~~~ 123 (315)
++.+..+.-.+.+......++|+++.+++.+...+...+ .+.+... ....-++++|.++ +||| .+..++
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~-n~P~~~v~~~~ 301 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKV-NNPNPVVRYLE 301 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHc-cCCCCcccccc
Confidence 333444444455777778999999999998765544333 5544322 3455688999999 9999 667777
Q ss_pred EEEcCCcEEEEEEecCCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEE
Q 021233 124 TYEDDTAVHLVMELCEGG-ELFDRI-VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~-sL~~~l-~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
-+..+...+++++++.++ +-.... .....+..-+...+.+.-+.+|+++|+.-=+|+| ||+..++ .++..
T Consensus 302 d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~----~~~~~ 373 (829)
T KOG0576|consen 302 DYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE----EVKLL 373 (829)
T ss_pred cCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc----ccccc
Confidence 777888999999999876 222211 1111244445555666667889999987668888 8887542 25899
Q ss_pred eeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCC
Q 021233 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPF 257 (315)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~ 257 (315)
||+....+.......+..+++.++|||+.. ..+...-|.|++|.--.++.-|.+|-
T Consensus 374 ~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 374 DFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 999988776665567778999999999866 55888999999998777777777664
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.3e-06 Score=69.51 Aligned_cols=136 Identities=21% Similarity=0.260 Sum_probs=97.0
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccc-------------cChhcHHHHHHHHHHHHhCC-----CCCCccee
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL-------------RTAVDIEDVRREVDIMRHLP-----KHQNIVCL 121 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~ 121 (315)
...||+|+.=.||. ..++...+||+...... .......+..+|+.....+. .+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~---HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ---HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE---CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999996 34466678898876540 11122456677777777662 26789999
Q ss_pred EEEEEcCCcEEEEEEecC------CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 021233 122 KDTYEDDTAVHLVMELCE------GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~------~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~ 195 (315)
+|+.+.+-..-+|+|.+. ..||.+++... .++. . +...+-+-..+|-+.+|+.+|++|.||++......
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 999999988999999873 35677777444 4555 3 33344445567788899999999999999877665
Q ss_pred C-CEEEEee
Q 021233 196 A-PLKAIDF 203 (315)
Q Consensus 196 ~-~vkl~Df 203 (315)
. .+.|+|-
T Consensus 158 ~~~lvlIDG 166 (199)
T PF10707_consen 158 EFRLVLIDG 166 (199)
T ss_pred ceEEEEEeC
Confidence 5 5777774
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.2e-07 Score=88.29 Aligned_cols=82 Identities=22% Similarity=0.329 Sum_probs=57.7
Q ss_pred eeeeeeecceEEEEEEECCCC--CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCc--ceeEEEEEcC---CcEE
Q 021233 60 GRELGRGEFGITYLCTDRENG--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI--VCLKDTYEDD---TAVH 132 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~--~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i--v~~~~~~~~~---~~~~ 132 (315)
++.++.|.++.+|+......+ ..+++|+...... ......+.+|+.+++.+..|.++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~--~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL--LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc--CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998765432 4677776543221 11235688999999999546654 6777777654 4678
Q ss_pred EEEEecCCCCh
Q 021233 133 LVMELCEGGEL 143 (315)
Q Consensus 133 lv~e~~~~~sL 143 (315)
+||||++|..+
T Consensus 121 lVME~v~G~~~ 131 (822)
T PLN02876 121 YIMEYLEGRIF 131 (822)
T ss_pred EEEEecCCccc
Confidence 99999988653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.5e-07 Score=89.46 Aligned_cols=200 Identities=19% Similarity=0.167 Sum_probs=139.7
Q ss_pred HHHHHHHHHHHhCCCCCCcceeEEEEEcCCc----EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 021233 100 EDVRREVDIMRHLPKHQNIVCLKDTYEDDTA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175 (315)
Q Consensus 100 ~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~ 175 (315)
....-|+..+.++ .|+|++.++.|...... ..+..+++...++...+..-+..+..+.+.+..++.+||.++|+.
T Consensus 227 ~~~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 227 QTTEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3445567777777 89999999988765432 235567888888888888888899999999999999999999998
Q ss_pred CceecCCCCCceEeecCCCCCCEEEE--eeccccccCCCCcccccccCCCccCchhhccc---CCCcchHHHHHHHHHHH
Q 021233 176 GVMHRDLKPENFLFANKKETAPLKAI--DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYIL 250 (315)
Q Consensus 176 ~iiH~dikp~Nill~~~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~Di~slG~~l~el 250 (315)
...|.-+..+-..-...+....+..+ ||+.+..............+..+-++|....+ .....|+|.+|..+..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 66555554442221111233335555 88888776555444445556668888876533 34457999999999998
Q ss_pred hhCCCCCCCCChHHHHHHHHhccccCCCCCCccC-CHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 251 LCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV-SENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 251 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
..|..+-.... ... ...... ...+.+...+|+..++++|+++.+++.+++
T Consensus 386 ~~~~~i~~~~~---~~~-----------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 386 SQGEDISEKSA---VPV-----------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPF 436 (1351)
T ss_pred hhcCccccccc---chh-----------hhhccccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence 88765531110 000 011111 126788999999999999999999999986
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.2e-06 Score=75.16 Aligned_cols=81 Identities=17% Similarity=0.232 Sum_probs=56.4
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccc---c-ChhcHHHHHHHHHHHHhCCCC--CCcceeEEEEEcCCcEEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL---R-TAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~-~~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~~~~~~l 133 (315)
.+.||.|.+..||++.+...++.++||....... . .+...++...|.+.|..+... .++++++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 3679999999999999864335899998542111 1 123456788888888887443 4567777773 355789
Q ss_pred EEEecCCCC
Q 021233 134 VMELCEGGE 142 (315)
Q Consensus 134 v~e~~~~~s 142 (315)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998644
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.5e-06 Score=80.15 Aligned_cols=146 Identities=16% Similarity=0.187 Sum_probs=90.9
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccCh-hc---------------------------HH------HHHHHH
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-VD---------------------------IE------DVRREV 106 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~---------------------------~~------~~~~e~ 106 (315)
+.||.-+.|.||+|+.+. |+.||||+.+..-.... .+ .+ +|.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999999765 99999998765421100 00 11 244454
Q ss_pred HHHHhCC---CCCC------cceeEEEEEcCCcEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 021233 107 DIMRHLP---KHQN------IVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHG 176 (315)
Q Consensus 107 ~~l~~l~---~h~~------iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~ 176 (315)
+...+.. .|-+ |++++ +.......++|||++|..+.|.-.- ...++...+..-+.+.. ++.|=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 4444331 1223 22222 2233567899999999888775432 22355554333333322 23334568
Q ss_pred ceecCCCCCceEeecCC-CCCCEEEEeeccccccCC
Q 021233 177 VMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 177 iiH~dikp~Nill~~~~-~~~~vkl~Dfg~a~~~~~ 211 (315)
++|+|-+|.||++..+. ....+.+-|||+.....+
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999998542 344488999999876643
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.1e-05 Score=67.70 Aligned_cols=76 Identities=26% Similarity=0.290 Sum_probs=49.7
Q ss_pred eeeeeeecceEEEEEEECC-CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 60 GRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
++.|..|-...+|++.... .++.+++|....... . .-...+|+.+++.+..+.-.++++..+. + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-L---IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-c---eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567778888999987543 357888997653311 1 1123468888888854444556655443 2 3899999
Q ss_pred CCCCh
Q 021233 139 EGGEL 143 (315)
Q Consensus 139 ~~~sL 143 (315)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98776
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.1e-06 Score=69.42 Aligned_cols=75 Identities=19% Similarity=0.104 Sum_probs=47.4
Q ss_pred eeeeeeecce-EEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC--CcceeEEEEEcC---CcEEE
Q 021233 60 GRELGRGEFG-ITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ--NIVCLKDTYEDD---TAVHL 133 (315)
Q Consensus 60 ~~~lg~G~~g-~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~iv~~~~~~~~~---~~~~l 133 (315)
++.|+.|+.. .||+. +..+++|..... .....+.+|+.++..+..+- .++++++..... ...++
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777766 59975 235777764321 12357889999999884431 344555544332 24589
Q ss_pred EEEecCCCChH
Q 021233 134 VMELCEGGELF 144 (315)
Q Consensus 134 v~e~~~~~sL~ 144 (315)
+|++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.3e-05 Score=68.22 Aligned_cols=81 Identities=9% Similarity=0.019 Sum_probs=58.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC--CCcceeEEEEEc---CCc
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYED---DTA 130 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~---~~~ 130 (315)
.-.-.+.||.|..+.||..... ++ .+++|... . ......+..|+..|+.+.+. -.++++++++.. .+.
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMAR-S----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hhheeeecCCccceeEEEEEcC-CC-CEEEEEec-c----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 3444678999999999998643 23 46667632 1 11235788999999999554 357889988754 366
Q ss_pred EEEEEEecCCCCh
Q 021233 131 VHLVMELCEGGEL 143 (315)
Q Consensus 131 ~~lv~e~~~~~sL 143 (315)
.++|||+++|.++
T Consensus 88 ~~LVmE~i~G~~~ 100 (297)
T PRK10593 88 DVLLLERLRGVSV 100 (297)
T ss_pred eEEEEeccCCEec
Confidence 8999999998765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.4e-05 Score=69.72 Aligned_cols=138 Identities=17% Similarity=0.184 Sum_probs=81.6
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeEEE------EEcCCcEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDT------YEDDTAVH 132 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~------~~~~~~~~ 132 (315)
++.|..|....+|++... +..+++|.... ...+.+..|+.++..+.++. .+++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 566777888899998643 45788898653 12355777888888873321 24454432 23345678
Q ss_pred EEEEecCCCChHH----HH----------Hh-cCCC----------CHHHH--H--------HHHHHHHHHHHHHHH---
Q 021233 133 LVMELCEGGELFD----RI----------VA-RGHY----------TERAA--A--------AVTKTIVEVVQMCHK--- 174 (315)
Q Consensus 133 lv~e~~~~~sL~~----~l----------~~-~~~l----------~~~~~--~--------~i~~~l~~~L~~lH~--- 174 (315)
+|+++++|.++.. .. .. ...+ .+... . .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866522 11 00 0000 10000 0 011112334444443
Q ss_pred ----CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 175 ----HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 175 ----~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
.+++|+|+.|.||+++++.. +.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~---~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDEL---SGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCce---EEEeehhhhcC
Confidence 36999999999999975432 57999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.6e-05 Score=67.77 Aligned_cols=135 Identities=18% Similarity=0.129 Sum_probs=76.8
Q ss_pred eeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCC
Q 021233 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGE 142 (315)
Q Consensus 63 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~s 142 (315)
+..|-.+.+|+... ++..+++|........-. -...+|..+++.+..+.-.++++.... -++|+||++|.+
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALG---VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCccccccc---CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 45577788998873 467888887543311110 124678899998854433445555432 368999999866
Q ss_pred hHHH-------H-------H---hcC----CCCHH-HHHHHHHHH---------HHHHHHHHH--------CCceecCCC
Q 021233 143 LFDR-------I-------V---ARG----HYTER-AAAAVTKTI---------VEVVQMCHK--------HGVMHRDLK 183 (315)
Q Consensus 143 L~~~-------l-------~---~~~----~l~~~-~~~~i~~~l---------~~~L~~lH~--------~~iiH~dik 183 (315)
+... . . ... +++.. .+.....++ ...++.+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5321 1 1 000 11111 111111111 111222221 248999999
Q ss_pred CCceEeecCCCCCCEEEEeeccccccC
Q 021233 184 PENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 184 p~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
|.||+++.++ +.|+||+.|....
T Consensus 155 ~~Nil~~~~~----~~lIDwE~a~~gd 177 (256)
T TIGR02721 155 AYNLVVTPQG----LKLIDWEYASDGD 177 (256)
T ss_pred cCcEEEeCCC----CEEEeccccCcCC
Confidence 9999997543 5899999887543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.20 E-value=9.4e-06 Score=65.59 Aligned_cols=99 Identities=17% Similarity=0.187 Sum_probs=78.3
Q ss_pred HHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 021233 103 RREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDR---IVARGHYTERAAAAVTKTIVEVVQMCHK---HG 176 (315)
Q Consensus 103 ~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~l~~~~~~~i~~~l~~~L~~lH~---~~ 176 (315)
..|.-++..+...+++++++|+|- .+++.||...+++... +.+-...+|..+..|+.++++.++++++ ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888866679999999994 3689999987666431 1122246899999999999999999997 34
Q ss_pred ceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 177 iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+.-.|++|+|+.+++++. +|++|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~---lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR---LKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCc---EEEEechhcch
Confidence 778999999999986655 99999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.7e-05 Score=66.20 Aligned_cols=84 Identities=17% Similarity=0.156 Sum_probs=53.4
Q ss_pred eeeeecceEEEEEEECCCCCEEEEEEcccccc----cChhcHHHHHHHHHHHHhCCCC-C-CcceeEEEEEcCCcEEEEE
Q 021233 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKL----RTAVDIEDVRREVDIMRHLPKH-Q-NIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~~~~e~~~l~~l~~h-~-~iv~~~~~~~~~~~~~lv~ 135 (315)
.||.|....||++.+...++.++||.-..... ..+...++..-|...|+..... | .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999754346899997642211 1244566777788888876432 3 34444433 444567999
Q ss_pred EecCCCC-hHHHH
Q 021233 136 ELCEGGE-LFDRI 147 (315)
Q Consensus 136 e~~~~~s-L~~~l 147 (315)
|+++... |.+.+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 9996433 43444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=4e-06 Score=71.83 Aligned_cols=139 Identities=19% Similarity=0.275 Sum_probs=96.0
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEccccc--ccC---------------hh--cHHHHHHHHHHHHhCCCCCC
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKK--LRT---------------AV--DIEDVRREVDIMRHLPKHQN 117 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~---------------~~--~~~~~~~e~~~l~~l~~h~~ 117 (315)
+.+++.||-|--+.||.+.+. .|++.++|.-.... +.+ .. .+-...+|.+.|+.|..|..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 678889999999999999864 58888888432211 110 00 12235678889998854432
Q ss_pred -cceeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 118 -IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 118 -iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
|++.+++. ..++|||++.|-.|.....- ..+..+...+..-+.-|..+|+||+|+.--||++..++.
T Consensus 173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~-- 240 (465)
T KOG2268|consen 173 PVPKPIDHN----RHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK-- 240 (465)
T ss_pred CCCCccccc----ceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--
Confidence 45555543 46899999998877554321 123345556666677888999999999999999975444
Q ss_pred CEEEEeecccccc
Q 021233 197 PLKAIDFGLSVFF 209 (315)
Q Consensus 197 ~vkl~Dfg~a~~~ 209 (315)
++++||-.....
T Consensus 241 -i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 241 -IVVIDFPQMVST 252 (465)
T ss_pred -EEEeechHhhcc
Confidence 899999865443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00016 Score=64.97 Aligned_cols=84 Identities=14% Similarity=0.125 Sum_probs=56.1
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccC----hhcHHHHHHHHHHHHhCCC--CCCcceeEEEEEcCCcEEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT----AVDIEDVRREVDIMRHLPK--HQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~----~~~~~~~~~e~~~l~~l~~--h~~iv~~~~~~~~~~~~~l 133 (315)
.+.||.|....||++.+. +..++||.-....... +...++...|+..|+.+.+ ..++++++.++.+ ..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence 577899999999998863 4568999765222111 1244556667788877633 2467888888773 4578
Q ss_pred EEEecCC--CChHHHH
Q 021233 134 VMELCEG--GELFDRI 147 (315)
Q Consensus 134 v~e~~~~--~sL~~~l 147 (315)
+||++++ ..+.+.+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 8999976 3454443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00015 Score=63.32 Aligned_cols=77 Identities=12% Similarity=0.081 Sum_probs=49.7
Q ss_pred eeeeeeecceEEEEEEECC------CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 60 GRELGRGEFGITYLCTDRE------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
++.|..|--..||++.... .++.+++|...... .......+|..++..+....-.+++++.+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456666677899887543 25789999865432 1123456788888888544444566666642 36
Q ss_pred EEEecCCCChH
Q 021233 134 VMELCEGGELF 144 (315)
Q Consensus 134 v~e~~~~~sL~ 144 (315)
|+||++|.++.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00014 Score=63.35 Aligned_cols=146 Identities=16% Similarity=0.243 Sum_probs=85.6
Q ss_pred eeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-CCcceeEEEEEcCC--cEEEE
Q 021233 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDDT--AVHLV 134 (315)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~~--~~~lv 134 (315)
.+++.+..|....+|..... ++.+++. ... ............+|..+++.+..- --+...++.+..+. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 33444444444456665544 7778877 221 112223345677888888887332 12345566665554 77999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHH-HHHHHHHHHHHH---------------------------------------
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVT-KTIVEVVQMCHK--------------------------------------- 174 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~-~~l~~~L~~lH~--------------------------------------- 174 (315)
|+|++|..+.+.+.. .....+.+ ..++..|..||+
T Consensus 104 ~~~veGe~~~~~~~~-----~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 104 MEWVEGEVVWSALPP-----ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred EEEecceeccCcCCc-----ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 999988433222111 00001112 244444444443
Q ss_pred -------------------CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc
Q 021233 175 -------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215 (315)
Q Consensus 175 -------------------~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~ 215 (315)
..++|+|+.+.||++++++. +-|+||+++...++..+.
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~---~gVlDwe~~~lGDP~~Dl 235 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP---TGVLDWELATLGDPLEDL 235 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe---eEEEeccccccCCcHHHH
Confidence 24899999999999987666 789999999876554443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00021 Score=62.95 Aligned_cols=76 Identities=13% Similarity=0.131 Sum_probs=44.7
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-CCcceeEEE------EEcCCcEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDT------YEDDTAVH 132 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~------~~~~~~~~ 132 (315)
++.|+.|....+|++... +..+++|+.. . ...+.+..|+.++..|..+ -.+++++.. ....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~-----~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-R-----LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEec-c-----CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 355677777899998753 3468889764 1 1123344555666555211 113444431 23355679
Q ss_pred EEEEecCCCCh
Q 021233 133 LVMELCEGGEL 143 (315)
Q Consensus 133 lv~e~~~~~sL 143 (315)
++++|++|..+
T Consensus 99 ~l~~~l~G~~~ 109 (319)
T PRK05231 99 AIVTFLEGKWP 109 (319)
T ss_pred EEEEecCCCCC
Confidence 99999998654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00016 Score=63.40 Aligned_cols=140 Identities=19% Similarity=0.206 Sum_probs=79.4
Q ss_pred eeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeEEEE------EcCCcE
Q 021233 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTY------EDDTAV 131 (315)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~------~~~~~~ 131 (315)
.++.++.|....+|++... +..+++|..... ...+.+..|++++..|.++. .+++++... ...+..
T Consensus 26 ~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~-----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD--VGRYILTLYEKR-----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eccccCCccccceEEEEeC--CCcEEEEEecCC-----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 3566777877899998643 446778876432 11244556777777763221 244444421 234567
Q ss_pred EEEEEecCCCChH----HHH----------Hh-cCCC--------CHHH-----HH----------HHHHHHHHHHHHHH
Q 021233 132 HLVMELCEGGELF----DRI----------VA-RGHY--------TERA-----AA----------AVTKTIVEVVQMCH 173 (315)
Q Consensus 132 ~lv~e~~~~~sL~----~~l----------~~-~~~l--------~~~~-----~~----------~i~~~l~~~L~~lH 173 (315)
+++++|++|.++. +.. .. ...+ .... .. .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999885532 111 10 0001 0010 00 00112233455554
Q ss_pred H-------CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 174 K-------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 174 ~-------~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
. .+++|+|+.+.||+++.++. +.|+||+.+..
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~---~~vIDfd~~~~ 217 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSV---KGVIDFYFACT 217 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCce---EEEeecccccC
Confidence 2 57999999999999976532 57999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00014 Score=64.90 Aligned_cols=86 Identities=15% Similarity=0.143 Sum_probs=56.0
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccc---cChhcHHHHHHHHHHHHhCCC-CC-CcceeEEEEEcCCcEEEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIMRHLPK-HQ-NIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~~~e~~~l~~l~~-h~-~iv~~~~~~~~~~~~~lv 134 (315)
.+.||.|.-..||++.+...++.++||.-..... ..+...++..-|...|+.+.+ .| ++++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5789999999999999744356799996542211 224556778888888887643 23 44555543 44456789
Q ss_pred EEecCCC-ChHHHH
Q 021233 135 MELCEGG-ELFDRI 147 (315)
Q Consensus 135 ~e~~~~~-sL~~~l 147 (315)
||+++.. .|++.+
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9998542 244443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00031 Score=62.51 Aligned_cols=140 Identities=11% Similarity=0.095 Sum_probs=81.6
Q ss_pred eeeeeeecceEEEEEEECC----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 60 GRELGRGEFGITYLCTDRE----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+..|-.|-...+|++.... .++.+++|...... ..-.+ -.+|..+++.+..+.--+++++.+... .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3455557778899987532 24688999876542 11122 267888888885555555777776443 589
Q ss_pred EecCCCChHHH-------H----------HhcC------CCCHHHHHHHHHHH-----------------HHHHHHH---
Q 021233 136 ELCEGGELFDR-------I----------VARG------HYTERAAAAVTKTI-----------------VEVVQMC--- 172 (315)
Q Consensus 136 e~~~~~sL~~~-------l----------~~~~------~l~~~~~~~i~~~l-----------------~~~L~~l--- 172 (315)
+|+++.+|... . +... ......+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99988776421 0 0000 01122222222111 1112222
Q ss_pred -H----HCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 173 -H----KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 173 -H----~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
. ...++|+|+++.|||+++++ ..+.++||..+...
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~--~~~~lID~Eya~~~ 232 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEET--RAITIIDYEYASYN 232 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCC--CcEEEEeehhcccc
Confidence 1 22589999999999997532 23899999988654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00027 Score=61.89 Aligned_cols=143 Identities=21% Similarity=0.273 Sum_probs=94.4
Q ss_pred eeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC-------------------hhcHH---H-HHHHHHHHHhCCCC
Q 021233 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-------------------AVDIE---D-VRREVDIMRHLPKH 115 (315)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-------------------~~~~~---~-~~~e~~~l~~l~~h 115 (315)
+-..|.-|--+.||.|.. .+|..+|||++.-+-... ...+. . ...|+..|+++ ..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~~ 225 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-NN 225 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-Hh
Confidence 345577788899999984 568889999875332110 00011 1 34688888888 44
Q ss_pred CCcceeEEEEEcCCcEEEEEEecCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCceEeecCC
Q 021233 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKTIVEVVQMC-HKHGVMHRDLKPENFLFANKK 193 (315)
Q Consensus 116 ~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~i~~~l~~~L~~l-H~~~iiH~dikp~Nill~~~~ 193 (315)
..|+..--.... ...|||+++.. +=+- -......++...+..+-.+++.-+.-| |.+++||.||+--|+|+.
T Consensus 226 aGIP~PePIlLk--~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh--- 299 (520)
T KOG2270|consen 226 AGIPCPEPILLK--NHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH--- 299 (520)
T ss_pred cCCCCCCceeee--cceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE---
Confidence 444432222221 34799999942 2211 111233577788888888888888776 577999999999999995
Q ss_pred CCCCEEEEeeccccccC
Q 021233 194 ETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~ 210 (315)
.+.++++|.+.|....
T Consensus 300 -dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEHD 315 (520)
T ss_pred -CCEEEEEEccccccCC
Confidence 3348999999886544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00069 Score=58.35 Aligned_cols=32 Identities=22% Similarity=0.270 Sum_probs=25.0
Q ss_pred CceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 176 ~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++|+|++|.||++++++ ...-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~--~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDA--RVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCC--CEEEEECcHhcccC
Confidence 389999999999997532 22469999988754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0017 Score=57.58 Aligned_cols=78 Identities=10% Similarity=0.152 Sum_probs=47.2
Q ss_pred eeeeeeeeeecceEEEEEEECCC---CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 57 YELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++ +.|..|=-..+|++..... +..|++++...... .. -.-.+|..+++.+..+.--+++++++. .+ +
T Consensus 17 i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~---IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~ 87 (330)
T PLN02421 17 FSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YV---IDRERELQAIKYLSAAGFGAKLLGVFG-NG---M 87 (330)
T ss_pred eEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eE---echHHHHHHHHHHHhcCCCCceeEEeC-Cc---E
Confidence 443 4444466677888865432 34788887764321 11 123568888888844444456776663 22 5
Q ss_pred EEEecCCCCh
Q 021233 134 VMELCEGGEL 143 (315)
Q Consensus 134 v~e~~~~~sL 143 (315)
|.+|++|.+|
T Consensus 88 i~~fi~g~~l 97 (330)
T PLN02421 88 IQSFINARTL 97 (330)
T ss_pred eehhhcCCCC
Confidence 8999987665
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.36 E-value=5.8e-05 Score=76.47 Aligned_cols=203 Identities=17% Similarity=0.069 Sum_probs=128.6
Q ss_pred HHHHHHHHHhCCCCCCcceeEEEEE--cCCcEEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC
Q 021233 102 VRREVDIMRHLPKHQNIVCLKDTYE--DDTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKH 175 (315)
Q Consensus 102 ~~~e~~~l~~l~~h~~iv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~ 175 (315)
...|.+-++.+ .|+++.....-.. .....+..++|+.+|.+.+.+.+. ..+....+.....+......-+|+.
T Consensus 1276 ll~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 33444445555 6887766555443 334568999999999999988654 2244444445555556666776654
Q ss_pred -----CceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHH
Q 021233 176 -----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILY 248 (315)
Q Consensus 176 -----~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~ 248 (315)
--+|+++|+.|.++..+.. |++.++|+.+...+ ........+++.|+++++... .++.++|+|..|+.++
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~---v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYN---VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCc---ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 2789999999999976665 89999999984333 333456678888999998764 5788899999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhccccCCCCC-Cc-cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP-WP-KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 249 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.-.|..+|- ...+...++........ .+ ..|.+.......+|-..-..||.-...+...
T Consensus 1432 ~rs~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d 1493 (2724)
T KOG1826|consen 1432 LRSDGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRD 1493 (2724)
T ss_pred HHhcccHHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccc
Confidence 9888877762 23333333333222111 11 1233333344444444445666666555443
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00067 Score=61.93 Aligned_cols=160 Identities=21% Similarity=0.234 Sum_probs=99.2
Q ss_pred HHHHHHHHHHHhCCCCCCcceeEEEEEcC-CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 021233 100 EDVRREVDIMRHLPKHQNIVCLKDTYEDD-TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178 (315)
Q Consensus 100 ~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~ii 178 (315)
..+.--..+++.+ .|+|..+.+++.... ...++|+|++ +.||.+.+..+. +-..... .+++.
T Consensus 27 ~~ilgr~~~lktl-~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~ 89 (725)
T KOG1093|consen 27 IQILGRFQYLKSL-QHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVL 89 (725)
T ss_pred HHHhhhhHHHHhh-cCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccc
Confidence 3455567788888 899999999887643 4478999999 669999887653 2111100 11111
Q ss_pred ecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCC
Q 021233 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFW 258 (315)
Q Consensus 179 H~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 258 (315)
| -|+ ++.+| -++.. . .. . ..+|+||||+|.++.++..|...+.
T Consensus 90 ~-----~~~----------~~~td-~~~t~---~---~~-----------~----~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 90 H-----LNI----------IYITD-HFLTK---Y---PS-----------P----IGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred e-----ehh----------hhccc-ccccc---C---CC-----------C----CCcchhhhhHHHHHHHHHHhhHHHH
Confidence 1 122 23334 01100 0 00 0 1249999999999999999988876
Q ss_pred CCChHHHHHHHHhccccCCCC--------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 259 AETEQGVAQAIIRSVLDFRRD--------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.....+....+..-....... ..-.+++....+..+|+-..|..||...++.++.
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC 195 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence 655555544443322111100 0113567778999999999999999888877764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0033 Score=54.35 Aligned_cols=76 Identities=17% Similarity=0.188 Sum_probs=49.2
Q ss_pred eeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC--CCCCcceeEEEEEcCCcEEEEE
Q 021233 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
+-.+.++.|....+|+.. .+++.+.+|.-.. .....+..|+.-|+.|. ..-.+++++++....+..++|+
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 345678889999999987 5688899997642 22345888988888883 3446789999998887889999
Q ss_pred EecCCC
Q 021233 136 ELCEGG 141 (315)
Q Consensus 136 e~~~~~ 141 (315)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0012 Score=54.51 Aligned_cols=56 Identities=16% Similarity=0.166 Sum_probs=33.8
Q ss_pred CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCCCCh
Q 021233 80 GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL 143 (315)
Q Consensus 80 ~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~sL 143 (315)
++.|++++..... ...-.-..|..+++.++.+..-+++++.+... .|++|++|.+|
T Consensus 2 ~~~~~~Ri~g~~t----~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGT----ENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCG----CSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE-
T ss_pred CCEEEEEeCCCCc----ccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEeccccc
Confidence 4677888765442 22345567888888885555566777776443 57799977664
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.021 Score=49.99 Aligned_cols=30 Identities=30% Similarity=0.547 Sum_probs=24.6
Q ss_pred CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 175 ~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
.+++|+|+.+.||+++. +. +.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~---i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE---VYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc---EEEEECccccc
Confidence 47899999999999975 22 78999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.03 Score=49.14 Aligned_cols=30 Identities=23% Similarity=0.402 Sum_probs=25.7
Q ss_pred CceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 176 ~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+++|+|+.+.|||++.++. +.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~---~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG---GYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC---EEEEEhhhccc
Confidence 6999999999999976554 78999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.01 Score=53.49 Aligned_cols=77 Identities=18% Similarity=0.170 Sum_probs=48.1
Q ss_pred eeeeeeecceEEEEEEECCC-CCE-----EEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 60 GRELGRGEFGITYLCTDREN-GDA-----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~-~~~-----~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
++.|..|--..+|++..... +.. |.+...... ..... .-.+|+.+++.++.+..-+++++.+.. ++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~ 126 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FT 126 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence 44565577789999875432 122 444432211 11111 235689999999666667788888864 59
Q ss_pred EEEecCCCChH
Q 021233 134 VMELCEGGELF 144 (315)
Q Consensus 134 v~e~~~~~sL~ 144 (315)
+.||++|.+|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 99999987764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.0065 Score=54.22 Aligned_cols=61 Identities=21% Similarity=0.189 Sum_probs=45.6
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCceEeecC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM-CHKHGVMHRDLKPENFLFANK 192 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~-lH~~~iiH~dikp~Nill~~~ 192 (315)
..++-+|..|.++..++... ..++.....++.-...||-- +--.+++|.|+.|.||++.-.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 45777888999998888754 35566677777777777543 445689999999999999643
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.025 Score=49.86 Aligned_cols=107 Identities=16% Similarity=0.156 Sum_probs=69.4
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
..+.|++|++- |+++.- + ..-...++..++.+.+..++-+... .+-|||+.-.|||++ +|+ |.|+||-++
T Consensus 298 ~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn---vtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN---VTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc---eEEEEeeee
Confidence 34567777775 555522 2 1245788888888888887777754 689999999999997 566 899999999
Q ss_pred cccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHH
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVIL 247 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l 247 (315)
+....+..... ...-.|-.+.|.-+..-+||-+--.+
T Consensus 369 Rl~~~q~~isy----~rldhp~lF~G~dd~QFeIYrlMr~l 405 (488)
T COG5072 369 RLSYSQGIISY----NRLDHPDLFNGVDDYQFEIYRLMRRL 405 (488)
T ss_pred ecccCCceeec----cccCchhhhcCccceeeeHHHHHHHH
Confidence 85433332211 11233444445456666776654433
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.099 Score=46.23 Aligned_cols=72 Identities=14% Similarity=0.086 Sum_probs=43.3
Q ss_pred ecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeE---E--EEEcCCcEEEEEEecC
Q 021233 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLK---D--TYEDDTAVHLVMELCE 139 (315)
Q Consensus 66 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~---~--~~~~~~~~~lv~e~~~ 139 (315)
+.-..||++.. .++..+++|+..... .....+..|+..+..|..+. .++... + ....++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 44567999874 456789999875321 13456777888887763321 122211 1 2233567889999998
Q ss_pred CCC
Q 021233 140 GGE 142 (315)
Q Consensus 140 ~~s 142 (315)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 754
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.06 Score=54.93 Aligned_cols=141 Identities=17% Similarity=0.222 Sum_probs=76.4
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-CC--cceeEEE--------EEc-C
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QN--IVCLKDT--------YED-D 128 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~--iv~~~~~--------~~~-~ 128 (315)
+.|+ |..-.+|++.. .++..+++|+..... ....+..|.++|..|..+ +. +.+++-. ... .
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 4564 45677888874 457789999986531 223444556666655322 22 2233221 111 2
Q ss_pred C--cEEEEEEecCCCChHHH-------H----------Hh------c----CCCCHH-----------------HHHHHH
Q 021233 129 T--AVHLVMELCEGGELFDR-------I----------VA------R----GHYTER-----------------AAAAVT 162 (315)
Q Consensus 129 ~--~~~lv~e~~~~~sL~~~-------l----------~~------~----~~l~~~-----------------~~~~i~ 162 (315)
+ ..+.+++|++|..+.+. + .. . ..+.|. ..+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 46788999999777541 1 00 0 011111 111222
Q ss_pred HHHHHHHH-----HHH--HCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 163 KTIVEVVQ-----MCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 163 ~~l~~~L~-----~lH--~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
.++++... .+. ..++||+|+.+.|||++.+......-|+|||.+..
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 23322222 121 14699999999999998665322234999997754
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.053 Score=44.84 Aligned_cols=76 Identities=18% Similarity=0.184 Sum_probs=52.2
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCC--CCCcceeEEEEEcCCcEEEEEEec
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--HQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
+.+.-|.-...|...+. ..++.+|+-. ......|..|+.-|..+.+ .-.+.+++.+....++.|+|+||+
T Consensus 22 ~~v~gG~inea~~v~dg--~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRDG--TDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeecC--CcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 34444555555555442 4567888643 2234568888888887733 345789999999999999999999
Q ss_pred CCCChH
Q 021233 139 EGGELF 144 (315)
Q Consensus 139 ~~~sL~ 144 (315)
+-+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876664
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.048 Score=47.35 Aligned_cols=32 Identities=28% Similarity=0.503 Sum_probs=25.7
Q ss_pred ceecCCCCCceEeecCCC--CCCEEEEeeccccc
Q 021233 177 VMHRDLKPENFLFANKKE--TAPLKAIDFGLSVF 208 (315)
Q Consensus 177 iiH~dikp~Nill~~~~~--~~~vkl~Dfg~a~~ 208 (315)
++|||+++.|||+..++. ...++++||-.++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 899999999999976533 24488999987764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.099 Score=46.15 Aligned_cols=136 Identities=17% Similarity=0.246 Sum_probs=77.9
Q ss_pred eeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC-----cceeEEEE--EcCC--cEE
Q 021233 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-----IVCLKDTY--EDDT--AVH 132 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-----iv~~~~~~--~~~~--~~~ 132 (315)
.|.+ .-..||+.... +|+ +++|+.... .....+..|+..+..|..+.- +...-|-. .... ..+
T Consensus 33 ~l~s-~eN~~f~~~~~-~g~-~iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 33 GLNS-EENSNFRVQTE-DGR-YILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred cccc-ccCceEEEEec-CCC-eEEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 3444 56678998754 344 488887543 234567778888887743321 12222211 1233 788
Q ss_pred EEEEecCCCChHH-----HH----------Hh--------cC----CCCHHH-------------HHHHHHHHHHHHHHH
Q 021233 133 LVMELCEGGELFD-----RI----------VA--------RG----HYTERA-------------AAAVTKTIVEVVQMC 172 (315)
Q Consensus 133 lv~e~~~~~sL~~-----~l----------~~--------~~----~l~~~~-------------~~~i~~~l~~~L~~l 172 (315)
.+++|++|..+.. .+ .. +. ...+.. ......++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 9999999977762 11 00 00 011210 001222333444444
Q ss_pred HH--------CC--ceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 173 HK--------HG--VMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 173 H~--------~~--iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
.+ .+ +||+|+.|.||+++.+.. .+.++||+-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~--~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTD--VSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCC--eeeEEEccccc
Confidence 43 24 999999999999986543 36799999775
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 315 | ||||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-55 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-55 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-52 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-52 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-52 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-52 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-52 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-52 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-51 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-51 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-51 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-51 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-51 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-51 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-51 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-50 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-50 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-50 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-50 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-49 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-49 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-49 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-49 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-49 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-48 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-48 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-48 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-48 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-48 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-47 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-47 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-46 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-45 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-45 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-44 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-44 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-44 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-43 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-43 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-43 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-43 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-43 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-43 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-43 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-42 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-42 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-42 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-41 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-41 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-41 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-41 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-41 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-41 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-41 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-41 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-41 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-41 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-41 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-41 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-41 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-41 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-41 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-40 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-40 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-38 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-38 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-37 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-37 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-36 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-36 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-36 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-36 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-36 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-36 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-36 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-36 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-36 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-36 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-36 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-36 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-36 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-35 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-35 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-35 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-35 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-35 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-35 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-35 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-35 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-35 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-35 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-35 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-35 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-35 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-35 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-34 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-33 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-33 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-33 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-33 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-33 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-33 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-32 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-32 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-32 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-32 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-32 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-32 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-32 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-32 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-32 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-32 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-32 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-32 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-31 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-31 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-31 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-31 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-31 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-31 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-31 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-31 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-31 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-31 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-31 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-30 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-30 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-30 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-30 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-30 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-30 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-30 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-30 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-30 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-30 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-30 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-30 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-30 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-30 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-30 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-30 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-30 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-30 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-30 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-30 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-30 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-30 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-30 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-29 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-29 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-28 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-28 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-28 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-28 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-28 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-28 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-28 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-27 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-27 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-27 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-27 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-27 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-27 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-27 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-27 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-27 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-27 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-27 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-27 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-27 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-27 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-27 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-27 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-27 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-27 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-27 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-27 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-27 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-26 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-26 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-26 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-26 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-26 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-26 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-26 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-26 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-26 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-25 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-25 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-25 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-25 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-25 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-25 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-25 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-25 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-25 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-25 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-25 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-25 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-25 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-25 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-25 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-25 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-25 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-25 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-25 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-25 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-25 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-25 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-25 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-24 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-24 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-24 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-24 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-24 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-24 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-24 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-24 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-24 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-24 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-23 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-23 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-23 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-23 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-23 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-23 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-23 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-23 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-23 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-23 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-23 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-23 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-23 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-23 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-23 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-23 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-23 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-23 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-22 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-22 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-22 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-22 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-22 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-19 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-19 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-19 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-18 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-18 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-18 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-18 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-18 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-18 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-18 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-18 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-18 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-18 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-18 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-18 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-18 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-18 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-18 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-18 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-18 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-17 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-17 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-17 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-16 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-16 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-16 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-16 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-16 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-16 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 6e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-16 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-16 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-16 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-16 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-15 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-15 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-15 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-13 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-13 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-13 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-13 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-13 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-13 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-13 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-13 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-13 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-13 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-13 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-12 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-12 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-12 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-12 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-12 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-12 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-12 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-12 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-12 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-12 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-12 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-12 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-11 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-11 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-11 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-11 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-09 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-09 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-09 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-05 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 4e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 4e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-04 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-04 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-04 |
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 476 bits (1227), Expect = e-171
Identities = 110/278 (39%), Positives = 158/278 (56%), Gaps = 6/278 (2%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
HH + G + + ERY + LG+G FG C DR +A K I+K
Sbjct: 4 HHHHSSGRENLYFQG----TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152
+ D + REV++++ L H NI+ L + ED ++ ++V EL GGELFD I+ R
Sbjct: 60 AKNK-DTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
++E AA + K + + HKH ++HRDLKPEN L +K++ +K IDFGLS F+
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 213 EKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
K + +G+ YY+APEVL+ Y + DVWSAGVILYILL G PPF+ + E + + +
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237
Query: 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
F W +S++AKDL+RKML P R+TA Q L
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 472 bits (1217), Expect = e-170
Identities = 107/260 (41%), Positives = 157/260 (60%), Gaps = 3/260 (1%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ + Y++ ELG+G F + C + G FA K I+ KKL +A D + + RE I R
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRK 61
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
L +H NIV L D+ ++++ +LV +L GGELF+ IVAR Y+E A+ + I+E +
Sbjct: 62 L-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231
CH +G++HR+LKPEN L A+K + A +K DFGL++ E + G+P Y++PEVLK
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
++ Y VD+W+ GVILYILL G PPFW E + + I D+ W V+ AK
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 291 LVRKMLDPDPKRRLTAQQVL 310
L+ ML +PK+R+TA Q L
Sbjct: 241 LIDSMLTVNPKKRITADQAL 260
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 473 bits (1220), Expect = e-169
Identities = 108/281 (38%), Positives = 160/281 (56%), Gaps = 3/281 (1%)
Query: 31 GTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISK 90
+ G + + + Y++ ELG+G F + C + G FA K I+
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR 150
KKL +A D + + RE I R L +H NIV L D+ ++++ +LV +L GGELF+ IVAR
Sbjct: 65 KKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 151 GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
Y+E A+ + I+E + CH +G++HR+LKPEN L A+K + A +K DFGL++
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 211 PGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269
E + G+P Y++PEVLK++ Y VD+W+ GVILYILL G PPFW E + + I
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
Query: 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
D+ W V+ AK L+ ML +PK+R+TA Q L
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 476 bits (1226), Expect = e-168
Identities = 110/278 (39%), Positives = 158/278 (56%), Gaps = 6/278 (2%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
HH + G + + ERY + LG+G FG C DR +A K I+K
Sbjct: 4 HHHHSSGRENLYFQGT----FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH 152
+ D + REV++++ L H NI+ L + ED ++ ++V EL GGELFD I+ R
Sbjct: 60 AKNK-DTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
++E AA + K + + HKH ++HRDLKPEN L +K++ +K IDFGLS F+
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 213 EKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
K + +G+ YY+APEVL+ Y + DVWSAGVILYILL G PPF+ + E + + +
Sbjct: 178 TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237
Query: 273 VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
F W +S++AKDL+RKML P R+TA Q L
Sbjct: 238 KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 467 bits (1204), Expect = e-168
Identities = 114/262 (43%), Positives = 160/262 (61%), Gaps = 4/262 (1%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T +I + Y L +GRG +G + + A K I K + D++ ++E++I
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEI 59
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
M+ L H NI+ L +T+ED+T ++LVMELC GGELF+R+V + + E AA + K ++
Sbjct: 60 MKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
V CHK V HRDLKPENFLF +PLK IDFGL+ FKPG+ VG+PYY++P+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178
Query: 229 VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
VL+ YGPE D WSAGV++Y+LLCG PPF A T+ V I F W VS A
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
+ L+R++L PK+R+T+ Q L
Sbjct: 239 ESLIRRLLTKSPKQRITSLQAL 260
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 470 bits (1212), Expect = e-167
Identities = 111/264 (42%), Positives = 158/264 (59%), Gaps = 4/264 (1%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T E Y+L ELG+G F + C G +A I+ KKL +A D + + RE I
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARI 63
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
R L KH NIV L D+ ++ +L+ +L GGELF+ IVAR +Y+E A+ + I+E
Sbjct: 64 CRLL-KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAP 227
V CH+ GV+HR+LKPEN L A+K + A +K DFGL++ + + + G+P Y++P
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286
EVL+++ YG VD+W+ GVILYILL G PPFW E + + Q I DF W V+
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVL 310
AKDL+ KML +P +R+TA + L
Sbjct: 243 EAKDLINKMLTINPSKRITAAEAL 266
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 466 bits (1202), Expect = e-166
Identities = 99/316 (31%), Positives = 152/316 (48%), Gaps = 16/316 (5%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRG 66
P+ + + K + Q G E ++Y+ +GRG
Sbjct: 47 DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAK-EFYQKYDPKDVIGRG 105
Query: 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVD-----IEDVRREVDIMRHLPKHQNIVCL 121
+ C R G FA K + R + + E RRE I+R + H +I+ L
Sbjct: 106 VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165
Query: 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181
D+YE + + LV +L GELFD + + +E+ ++ ++++E V H + ++HRD
Sbjct: 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRD 225
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-------RNY 234
LKPEN L + ++ DFG S +PGEK E+ G+P Y+APE+LK Y
Sbjct: 226 LKPENILLDDN---MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
G EVD+W+ GVIL+ LL G PPFW + + + I+ F W S KDL+ +
Sbjct: 283 GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISR 342
Query: 295 MLDPDPKRRLTAQQVL 310
+L DP+ RLTA+Q L
Sbjct: 343 LLQVDPEARLTAEQAL 358
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 469 bits (1210), Expect = e-166
Identities = 109/267 (40%), Positives = 160/267 (59%), Gaps = 2/267 (0%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
++ T +RY+ R LG+G FG LC D+ G A K ISK++++ D E +
Sbjct: 16 FVQHSTAI-FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
REV +++ L H NI+ L + +ED +LV E+ GGELFD I++R ++E AA + +
Sbjct: 75 REVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR 133
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
++ + HK+ ++HRDLKPEN L +K + A ++ IDFGLS F+ +K + +G+ Y
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY 193
Query: 224 YMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
Y+APEVL Y + DVWS GVILYILL G PPF E + + + + F W K
Sbjct: 194 YIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVL 310
VSE+AKDL+RKML P R++A+ L
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDAL 280
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 460 bits (1187), Expect = e-165
Identities = 98/282 (34%), Positives = 158/282 (56%), Gaps = 12/282 (4%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKK 92
HH + G + + I++ + R+LG G FG +L +R +G K+I+K +
Sbjct: 4 HHHHSSGRENLYFQG----TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR 59
Query: 93 LRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-- 150
+ V +E + E+++++ L H NI+ + + +ED +++VME CEGGEL +RIV+
Sbjct: 60 SQ--VPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 151 --GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+E A + K ++ + H V+H+DLKPEN LF + +P+K IDFGL+
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 209 FKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQA 268
FK E + G+ YMAPEV KR+ + D+WSAGV++Y LL G PF + + V Q
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
++ + P ++ A DL+++ML DP+RR +A QVL
Sbjct: 237 ATYKEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAAQVL 277
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 467 bits (1204), Expect = e-165
Identities = 106/306 (34%), Positives = 163/306 (53%), Gaps = 19/306 (6%)
Query: 15 KKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLC 74
+ ++N + QG + +++ G+ I E Y R+LG G +G LC
Sbjct: 4 HHHHSSGRENLY-------FQGIAINPGMYVRKKEGK-IGESYFKVRKLGSGAYGEVLLC 55
Query: 75 TDRENGDAFACKSISKKKLRTAV----------DIEDVRREVDIMRHLPKHQNIVCLKDT 124
++ A K I K + E++ E+ +++ L H NI+ L D
Sbjct: 56 KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDV 114
Query: 125 YEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184
+ED +LV E EGGELF++I+ R + E AA + K I+ + HKH ++HRD+KP
Sbjct: 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKP 174
Query: 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAG 244
EN L NK +K +DFGLS FF K + +G+ YY+APEVLK+ Y + DVWS G
Sbjct: 175 ENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCG 234
Query: 245 VILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
VI+YILLCG PPF + +Q + + + + F + W +S+ AK+L++ ML D +R
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294
Query: 305 TAQQVL 310
TA++ L
Sbjct: 295 TAEEAL 300
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-164
Identities = 106/263 (40%), Positives = 150/263 (57%), Gaps = 6/263 (2%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIM 109
+E+ YE+G ELG G+F I C + G +A K I K++L R V E++ REV+I+
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
R + +H NI+ L D +E+ T V L++EL GGELFD + + TE A K I++ V
Sbjct: 63 REI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 170 QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
H + H DLKPEN + +K +K IDFG++ + G +F I G+P ++APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
++ G E D+WS GVI YILL G PF ET+Q I DF + + SE
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
AKD +R++L DPKRR+T Q L
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSL 264
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 463 bits (1193), Expect = e-163
Identities = 111/298 (37%), Positives = 165/298 (55%), Gaps = 9/298 (3%)
Query: 13 QGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITY 72
+ ++N + G + G + E Y+ ++LG G +G
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGM------FITSKKGH-LSEMYQRVKKLGSGAYGEVL 54
Query: 73 LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132
LC D+ A K I K + T+ + EV +++ L H NI+ L D +ED +
Sbjct: 55 LCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYY 112
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192
LVME +GGELFD I+ R + E AA + K ++ V HKH ++HRDLKPEN L +K
Sbjct: 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 193 KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLC 252
++ A +K +DFGLS F+ +K E +G+ YY+APEVL++ Y + DVWS GVIL+ILL
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLA 232
Query: 253 GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
G PPF +T+Q + + + + F W VSE AKDL+++ML D +RR++AQQ L
Sbjct: 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 455 bits (1174), Expect = e-163
Identities = 96/263 (36%), Positives = 145/263 (55%), Gaps = 6/263 (2%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIM 109
+++ Y+ G ELG G+F + C ++ G +A K I K++ R V ED+ REV I+
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ + +H N++ L + YE+ T V L++EL GGELFD + + TE A K I+ V
Sbjct: 69 KEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 170 QMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
H + H DLKPEN + ++ +K IDFGL+ G +F I G+P ++APE
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
++ G E D+WS GVI YILL G PF +T+Q + +F + + S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
AKD +R++L DPK+R+T Q L
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSL 270
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 456 bits (1175), Expect = e-163
Identities = 102/267 (38%), Positives = 152/267 (56%), Gaps = 10/267 (3%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RTAVDIEDVRREVDIM 109
E+ YEL +G+G F + C +RE G FA K + K + ED++RE I
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTI 165
L KH +IV L +TY D +++V E +G +L IV R Y+E A+ + I
Sbjct: 81 HML-KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYY 224
+E ++ CH + ++HRD+KP L A+K+ +AP+K FG+++ + G VG+P++
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
MAPEV+KR YG VDVW GVIL+ILL G PF+ T++ + + II+ W
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSH 258
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVL 310
+SE+AKDLVR+ML DP R+T + L
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEAL 285
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 456 bits (1175), Expect = e-163
Identities = 116/269 (43%), Positives = 158/269 (58%), Gaps = 9/269 (3%)
Query: 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
+ + + +E+ ELGRG I Y C + +A K + K D + VR
Sbjct: 43 IDGSNRD-ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVR 96
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
E+ ++ L H NI+ LK+ +E T + LV+EL GGELFDRIV +G+Y+ER AA K
Sbjct: 97 TEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK 155
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
I+E V H++G++HRDLKPEN L+A APLK DFGLS + + G+P
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215
Query: 224 YMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRRDPW 281
Y APE+L+ YGPEVD+WS G+I YILLCG PF+ E +Q + + I+ F W
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+VS NAKDLVRK++ DPK+RLT Q L
Sbjct: 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQAL 304
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 452 bits (1164), Expect = e-162
Identities = 98/272 (36%), Positives = 145/272 (53%), Gaps = 16/272 (5%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVR----RE 105
E YE LGRG + C + +A K I +A +++++R +E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
VDI+R + H NI+ LKDTYE +T LV +L + GELFD + + +E+ + + +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+EV+ HK ++HRDLKPEN L + +K DFG S PGEK E+ G+P Y+
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD---DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 190
Query: 226 APEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
APE+++ YG EVD+WS GVI+Y LL G PPFW + + + I+ F
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
Query: 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
W S+ KDLV + L P++R TA++ L
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 451 bits (1163), Expect = e-161
Identities = 76/286 (26%), Positives = 139/286 (48%), Gaps = 9/286 (3%)
Query: 33 HHQGNGGHKLCVLKEP----TGREIEERYEL-GRELGRGEFGITYLCTDRENGDAFACKS 87
HH + + + E + Y L +ELGRG+F + C + G +A K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF 61
Query: 88 ISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI 147
+ K++ ++ E+ ++ ++ L + YE+ + + L++E GGE+F
Sbjct: 62 LKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 148 VAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205
+ +E + K I+E V H++ ++H DLKP+N L ++ +K +DFG+
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180
Query: 206 SVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQG 264
S + EI+G+P Y+APE+L + D+W+ G+I Y+LL PF E Q
Sbjct: 181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE 240
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
I + +D+ + + VS+ A D ++ +L +P++R TA+ L
Sbjct: 241 TYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-160
Identities = 105/260 (40%), Positives = 148/260 (56%), Gaps = 6/260 (2%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
I + + LG G F +L R G FA K I K + E+ +++
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKK 62
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
+ KH+NIV L+D YE T +LVM+L GGELFDRI+ RG YTE+ A+ V + ++ V+
Sbjct: 63 I-KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231
H++G++HRDLKPEN L+ +E + + DFGLS + G S G+P Y+APEVL
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLA 180
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
+ Y VD WS GVI YILLCG PPF+ ETE + + I +F W +SE+AKD
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKD 240
Query: 291 LVRKMLDPDPKRRLTAQQVL 310
+ +L+ DP R T ++ L
Sbjct: 241 FICHLLEKDPNERYTCEKAL 260
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 448 bits (1155), Expect = e-160
Identities = 79/262 (30%), Positives = 142/262 (54%), Gaps = 8/262 (3%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+E+ E+Y + +LGRGEFGI + C + + + K + K D V++E+ I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVV 169
+H+NI+ L +++E + ++ E G ++F+RI ER + + E +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
Q H H + H D++PEN ++ + ++ +K I+FG + KPG+ F + +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 230 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
+ + D+WS G ++Y+LL G+ PF AET Q + + I+ + F + + ++S A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
D V ++L + K R+TA + L
Sbjct: 235 MDFVDRLLVKERKSRMTASEAL 256
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 448 bits (1154), Expect = e-160
Identities = 102/265 (38%), Positives = 152/265 (57%), Gaps = 6/265 (2%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVD 107
+++E+ Y++G ELG G+F I C ++ G +A K I K++ R V E++ REV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
I+R + H N++ L D YE+ T V L++EL GGELFD + + +E A + K I++
Sbjct: 68 ILRQV-LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
V H + H DLKPEN + +K P +K IDFGL+ + G +F I G+P ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PE++ G E D+WS GVI YILL G PF +T+Q I DF + + S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVL 310
E AKD +RK+L + ++RLT Q+ L
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEAL 271
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 445 bits (1147), Expect = e-158
Identities = 103/264 (39%), Positives = 152/264 (57%), Gaps = 6/264 (2%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDI 108
++E+ Y++G ELG G+F I C ++ G +A K I K++ R V E++ REV I
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
+R + H NI+ L D YE+ T V L++EL GGELFD + + +E A + K I++
Sbjct: 69 LRQV-LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
V H + H DLKPEN + +K P +K IDFGL+ + G +F I G+P ++AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 228 EVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286
E++ G E D+WS GVI YILL G PF +T+Q I DF + + + SE
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSE 247
Query: 287 NAKDLVRKMLDPDPKRRLTAQQVL 310
AKD +RK+L + ++RLT Q+ L
Sbjct: 248 LAKDFIRKLLVKETRKRLTIQEAL 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 440 bits (1134), Expect = e-157
Identities = 91/270 (33%), Positives = 138/270 (51%), Gaps = 18/270 (6%)
Query: 53 IEERYELG---RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+ Y+L + LG G F I C +++ AFA K ISK+ + ++E+ +
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITAL 59
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ H NIV L + + D LVMEL GGELF+RI + H++E A+ + + +V V
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIVGSPYYMAPE 228
H GV+HRDLKPEN LF ++ + +K IDFG + P + + +Y APE
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQ-------GVAQAIIRSVLDFRRDP 280
+L +N Y D+WS GVILY +L G PF + + + I + F +
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
W VS+ AKDL++ +L DP +RL +
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 440 bits (1134), Expect = e-156
Identities = 95/279 (34%), Positives = 141/279 (50%), Gaps = 13/279 (4%)
Query: 38 GGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV 97
G H + + + YE+ ++G G + + C + FA K I K K
Sbjct: 5 GVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----- 59
Query: 98 DIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERA 157
D E++I+ +H NI+ LKD Y+D V++V EL +GGEL D+I+ + ++ER
Sbjct: 60 --RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE 117
Query: 158 AAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA-PLKAIDFGLSVFFKPGEK-F 215
A+AV TI + V+ H GV+HRDLKP N L+ ++ ++ DFG + +
Sbjct: 118 ASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 216 SEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIR 271
+ ++APEVL+R Y D+WS GV+LY +L G PF +T + + I
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237
Query: 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
W VS+ AKDLV KML DP +RLTA VL
Sbjct: 238 GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 438 bits (1128), Expect = e-156
Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 33/288 (11%)
Query: 53 IEERYELGRE-LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ Y+L + LG G C + +A K I K+ V REV+++
Sbjct: 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQ 66
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
H+N++ L + +E++ +LV E GG + I R H+ E A+ V + + +
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI--------VGSPY 223
H G+ HRDLKPEN L + + +P+K DF L K S I GS
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 224 YMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE---------------TE 262
YMAPEV++ Y D+WS GVILYILL G PPF +
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ ++I +F W +S AKDL+ K+L D K+RL+A QVL
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 435 bits (1121), Expect = e-155
Identities = 106/291 (36%), Positives = 146/291 (50%), Gaps = 21/291 (7%)
Query: 32 THHQGNGGHKLCVLKEPTGREIEERYELGRE-LGRGEFGITYLCTDRENGDAFACKSISK 90
HH +G L EP + + Y+L ++ LG G G C R G A K +
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD 64
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDR 146
R+EVD +IVC+ D YE+ + ++ME EGGELF R
Sbjct: 65 SP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116
Query: 147 IVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
I RG +TER AA + + I +Q H H + HRD+KPEN L+ +K++ A LK DFG
Sbjct: 117 IQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176
Query: 205 LSVFFKPGEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
+ +PYY+APEVL Y D+WS GVI+YILLCG PPF++ T Q
Sbjct: 177 FAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235
Query: 264 GVAQAIIRSVL----DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
++ + R + F W +VSE+AK L+R +L DP RLT Q +
Sbjct: 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 435 bits (1120), Expect = e-153
Identities = 99/315 (31%), Positives = 145/315 (46%), Gaps = 19/315 (6%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRG 66
PA A + T P Q H L+ I++ + LG G
Sbjct: 14 FPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLG 73
Query: 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126
G ++ + FA K + RREV++ + +IV + D YE
Sbjct: 74 INGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYE 125
Query: 127 D----DTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHR 180
+ + +VME +GGELF RI RG +TER A+ + K+I E +Q H + HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVD 239
D+KPEN L+ +K+ A LK DFG + + +PYY+APEVL Y D
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 240 VWSAGVILYILLCGVPPFWAE----TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295
+WS GVI+YILLCG PPF++ G+ I +F W +VSE K L+R +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305
Query: 296 LDPDPKRRLTAQQVL 310
L +P +R+T + +
Sbjct: 306 LKTEPTQRMTITEFM 320
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 432 bits (1112), Expect = e-153
Identities = 95/270 (35%), Positives = 143/270 (52%), Gaps = 12/270 (4%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-----RTAVDIEDVRRE 105
+ + + Y + + LG G G L +R+ A K ISK+K R A +V E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
++I++ L H I+ +K+ ++ + ++V+EL EGGELFD++V E +
Sbjct: 66 IEILKKL-NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ VQ H++G++HRDLKPEN L ++++E +K DFG S + G+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 226 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDP 280
APEVL Y VD WS GVIL+I L G PPF T+ + I +F +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
W +VSE A DLV+K+L DPK R T ++ L
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEAL 273
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 431 bits (1109), Expect = e-152
Identities = 90/297 (30%), Positives = 144/297 (48%), Gaps = 7/297 (2%)
Query: 16 KKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCT 75
K K P DY ++ + E + + Y++ ELG G FG+ + C
Sbjct: 12 SKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCV 71
Query: 76 DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135
++ G F K I+ +D V+ E+ IM L H ++ L D +ED + L++
Sbjct: 72 EKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLIL 127
Query: 136 ELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194
E GGELFDRI A + +E + E ++ H+H ++H D+KPEN + K +
Sbjct: 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-K 186
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCG 253
+ +K IDFGL+ P E + + APE++ R G D+W+ GV+ Y+LL G
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ PF E + Q + R +F D + VS AKD ++ +L +P++RLT L
Sbjct: 247 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-152
Identities = 88/305 (28%), Positives = 143/305 (46%), Gaps = 7/305 (2%)
Query: 8 PAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE 67
++ + + S +Y + E + + Y++ ELG G
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG+ + T+R G+ FA K + D E VR+E+ M L +H +V L D +ED
Sbjct: 170 FGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVL-RHPTLVNLHDAFED 225
Query: 128 DTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186
D + ++ E GGELF+++ +E A + + + + H++ +H DLKPEN
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285
Query: 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGV 245
+F K+ LK IDFGL+ P + G+ + APEV + + G D+WS GV
Sbjct: 286 IMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
Query: 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
+ YILL G+ PF E + + + + + +SE+ KD +RK+L DP R+T
Sbjct: 345 LSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 404
Query: 306 AQQVL 310
Q L
Sbjct: 405 IHQAL 409
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 421 bits (1083), Expect = e-148
Identities = 88/263 (33%), Positives = 138/263 (52%), Gaps = 9/263 (3%)
Query: 52 EIEERYELGR--ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
+ Y + + LG G FG + C + G A K I + ++ D E+V+ E+ +M
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVM 140
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEV 168
L H N++ L D +E + LVME +GGELFDRI+ + TE K I E
Sbjct: 141 NQL-DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
++ H+ ++H DLKPEN L N+ + +K IDFGL+ +KP EK G+P ++APE
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNR-DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258
Query: 229 VLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
V+ + D+WS GVI Y+LL G+ PF + + I+ D + + +SE
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
AK+ + K+L + R++A + L
Sbjct: 319 AKEFISKLLIKEKSWRISASEAL 341
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 419 bits (1078), Expect = e-148
Identities = 91/329 (27%), Positives = 151/329 (45%), Gaps = 52/329 (15%)
Query: 32 THHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKK 91
HH + G + + + E++++Y L +G+G +G+ + + + A K ++K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 92 KLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA 149
K+R D+E ++ EV +M+ L H NI L + YED+ + LVMELC GG L D++
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121
Query: 150 RGH----------------------------------------YTERAAAAVTKTIVEVV 169
E+ + + + I +
Sbjct: 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-----GEKFSEIVGSPYY 224
H G+ HRD+KPENFLF+ ++ +K +DFGLS F + G+PY+
Sbjct: 182 HYLHNQGICHRDIKPENFLFSTN-KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 225 MAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
+APEVL +YGP+ D WSAGV+L++LL G PF + ++ L F +
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNY 300
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+S A+DL+ +L+ + R A + L
Sbjct: 301 NVLSPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 421 bits (1084), Expect = e-148
Identities = 94/270 (34%), Positives = 143/270 (52%), Gaps = 12/270 (4%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-----RTAVDIEDVRRE 105
+ + + Y + + LG G G L +R+ A + ISK+K R A +V E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
++I++ L H I+ +K+ ++ + ++V+EL EGGELFD++V E +
Sbjct: 191 IEILKKL-NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ VQ H++G++HRDLKPEN L ++++E +K DFG S + G+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 226 APEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDP 280
APEVL Y VD WS GVIL+I L G PPF T+ + I +F +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
W +VSE A DLV+K+L DPK R T ++ L
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEAL 398
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-141
Identities = 88/283 (31%), Positives = 129/283 (45%), Gaps = 38/283 (13%)
Query: 38 GGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV 97
G H L+ I++ + LG G G ++ + FA K +
Sbjct: 1 GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------ 54
Query: 98 DIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDRIVARGH- 152
RREV++ + +IV + D YE+ + +VME +GGELF RI RG
Sbjct: 55 --PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 153 -YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+TER A+ + K+I E +Q H + HRD+KPEN L+ +K+ A LK DFG
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------ 166
Query: 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQ 267
A E Y D+WS GVI+YILLCG PPF++ G+
Sbjct: 167 --------------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
I +F W +VSE K L+R +L +P +R+T + +
Sbjct: 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 255
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-105
Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 21/269 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ + LG G G T + + A K I + REV ++R
Sbjct: 23 KISFCPKDVLGHGAEG-TIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESD 75
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
+H N++ T +D ++ +ELC L + + + + + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAI--DFGLSVFFKPGE----KFSEIVGSPYYMA 226
H ++HRDLKP N L + +KA+ DFGL G + S + G+ ++A
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 227 PEVL----KRNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
PE+L K N VD++SAG + Y ++ G PF ++ + LD P
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC-LHPE 253
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
A++L+ KM+ DP++R +A+ VL
Sbjct: 254 KHEDVIARELIEKMIAMDPQKRPSAKHVL 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-103
Identities = 64/294 (21%), Positives = 111/294 (37%), Gaps = 44/294 (14%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+ ++ + LG G G G A K + + E+ ++
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALMEIKLLT 63
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-------TERAAAAVTK 163
H N++ + D +++ +ELC L D + ++ E ++ +
Sbjct: 64 ESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKK----------ETAPLKAIDFGLSVFFKPGE 213
I V H ++HRDLKP+N L + E + DFGL G+
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 214 -----KFSEIVGSPYYMAPEVL--------KRNYGPEVDVWSAGVILYILLC-GVPPFWA 259
+ G+ + APE+L KR +D++S G + Y +L G PF
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 260 ETEQGVAQAIIRSVLDF---RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ + IIR + + + A DL+ +M+D DP +R TA +VL
Sbjct: 243 KYSR--ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 3e-96
Identities = 62/298 (20%), Positives = 114/298 (38%), Gaps = 43/298 (14%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ L LG+G + ++ GD FA K + ++ RE ++++ L
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL 64
Query: 113 PKHQNIVCLKDTYEDDTAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVE 167
H+NIV L E+ T H L+ME C G L+ + + E V + +V
Sbjct: 65 -NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 168 VVQMCHKHGVMHRDLKPENFL-FANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ ++G++HR++KP N + + + K DFG + + E+F + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 227 PEVLKR---------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--- 274
P++ +R YG VD+WS GV Y G PF + ++ ++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 275 ------------------DFRRDPWPKVSENAKDLV----RKMLDPDPKRRLTAQQVL 310
+S + L+ +L+ D ++ Q
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 3e-94
Identities = 62/302 (20%), Positives = 115/302 (38%), Gaps = 43/302 (14%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ L LG+G + ++ GD FA K + ++ RE ++++ L
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKL 64
Query: 113 PKHQNIVCLKDTYEDDTAVH--LVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVE 167
H+NIV L E+ T H L+ME C G L+ + + E V + +V
Sbjct: 65 -NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 168 VVQMCHKHGVMHRDLKPENFL-FANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
+ ++G++HR++KP N + + + K DFG + + E+F + G+ Y+
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 227 PEVLKRN---------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--- 274
P++ +R YG VD+WS GV Y G PF + ++ ++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 275 ------------------DFRRDPWPKVSENAKDLV----RKMLDPDPKRRLTAQQVLGK 312
+S + L+ +L+ D ++ Q +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
Query: 313 IE 314
Sbjct: 304 TS 305
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 5e-91
Identities = 87/258 (33%), Positives = 127/258 (49%), Gaps = 10/258 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
RY GR LG+G F + +D + + FA K + K L E + E+ I R L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 73
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
HQ++V +ED+ V +V+ELC L + R TE A + IV Q H+
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKRN 233
+ V+HRDLK N E +K DFGL+ + GE+ + G+P Y+APEVL +
Sbjct: 134 NRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ EVDVWS G I+Y LL G PPF + I ++ ++ ++ A L+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLI 246
Query: 293 RKMLDPDPKRRLTAQQVL 310
+KML DP R T ++L
Sbjct: 247 QKMLQTDPTARPTINELL 264
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 1e-90
Identities = 87/258 (33%), Positives = 127/258 (49%), Gaps = 10/258 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
RY GR LG+G F + +D + + FA K + K L E + E+ I R L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-A 99
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
HQ++V +ED+ V +V+ELC L + R TE A + IV Q H+
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKRN 233
+ V+HRDLK N E +K DFGL+ + GE+ + G+P Y+APEVL +
Sbjct: 160 NRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ EVDVWS G I+Y LL G PPF + I ++ ++ ++ A L+
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKH--INPVAASLI 272
Query: 293 RKMLDPDPKRRLTAQQVL 310
+KML DP R T ++L
Sbjct: 273 QKMLQTDPTARPTINELL 290
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 2e-89
Identities = 72/300 (24%), Positives = 127/300 (42%), Gaps = 32/300 (10%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE----ERYELGRELGRGEFGITYLCTDRENGDAFACKSI 88
HH + + + E + Y + +++G G + + E +A K +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 60
Query: 89 SKKKLRTAVDIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDTAVHLVMELCEGGELFDR 146
+ ++ ++ R E+ + L + + I+ L D D +++VME C +L
Sbjct: 61 NLEEADNQ-TLDSYRNEIAYLNKL-QQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSW 117
Query: 147 IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+ + + K ++E V H+HG++H DLKP NFL + LK IDFG++
Sbjct: 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIA 173
Query: 207 VFFKPGEKFSE---IVGSPYYMAPEVLKRN------------YGPEVDVWSAGVILYILL 251
+P VG+ YM PE +K P+ DVWS G ILY +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 252 CGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
G PF Q AII + + ++ +D+++ L DPK+R++ ++L
Sbjct: 234 YGKTPFQQIINQISKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 1e-88
Identities = 87/259 (33%), Positives = 132/259 (50%), Gaps = 11/259 (4%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +++G LG+G F Y G A K I KK + A ++ V+ EV I L K
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-K 69
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCH 173
H +I+ L + +ED V+LV+E+C GE+ + R ++E A I+ + H
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVLKR 232
HG++HRDL N L +K DFGL+ K P EK + G+P Y++PE+ R
Sbjct: 130 SHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR 186
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
+ +G E DVWS G + Y LL G PPF +T + ++ + + P +S AKDL
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM---P-SFLSIEAKDL 242
Query: 292 VRKMLDPDPKRRLTAQQVL 310
+ ++L +P RL+ VL
Sbjct: 243 IHQLLRRNPADRLSLSSVL 261
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 1e-87
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 28/274 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
Y + +++G G + + E +A K ++ ++ ++ R E+ + L +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-Q 65
Query: 115 HQN--IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ I+ L D D +++VME C +L + + + K ++E V
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---IVGSPYYMAPEV 229
H+HG++H DLKP NFL + LK IDFG++ +P VG+ YM PE
Sbjct: 125 HQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 230 LKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDF 276
+K P+ DVWS G ILY + G PF Q AII +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NH 238
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ ++ +D+++ L DPK+R++ ++L
Sbjct: 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 1e-87
Identities = 62/289 (21%), Positives = 117/289 (40%), Gaps = 41/289 (14%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+E LG+G FG + + +A K I + + + EV ++ L
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASL 59
Query: 113 PKHQNIVCLKDTYEDD-------------TAVHLVMELCEGGELFDRIVARGHYTERAAA 159
HQ +V + + + + + ME CE G L+D I + +R
Sbjct: 60 -NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 160 A-VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------- 210
+ + I+E + H G++HRDLKP N + +K DFGL+
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---VKIGDFGLAKNVHRSLDILKL 175
Query: 211 -------PGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET 261
+ + +G+ Y+A EVL +Y ++D++S G+I + ++ P
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGME 233
Query: 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ + + ++F D + K ++R ++D DP +R A+ +L
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 4e-86
Identities = 87/257 (33%), Positives = 140/257 (54%), Gaps = 10/257 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+GR LG+G+FG YL ++++ A K + K +L A +RREV+I HL +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 67
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NI+ L + D T V+L++E G ++ + + E+ A + + CH
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN- 233
V+HRD+KPEN L + E LK DFG SV P + +++ G+ Y+ PE+++
Sbjct: 128 KRVIHRDIKPENLLLGSAGE---LKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
+ +VD+WS GV+ Y L G PPF A T Q + I R +F + V+E A+DL+
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDF--VTEGARDLIS 239
Query: 294 KMLDPDPKRRLTAQQVL 310
++L +P +R ++VL
Sbjct: 240 RLLKHNPSQRPMLREVL 256
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 262 bits (670), Expect = 5e-86
Identities = 48/294 (16%), Positives = 86/294 (29%), Gaps = 44/294 (14%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL--- 112
+ +L L G+ + +L D E + FA K + + ++E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 113 --------------------PKHQNIVCLKDTYEDDTAVH--LVMELCEG------GELF 144
L +D + L+M L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 145 DRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
V RG A +T ++ + G++H P+N L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVS 239
Query: 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAET 261
K G + Y E L + + ++ W G+ +Y + C PF T
Sbjct: 240 ALW--KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 262 EQGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
S+ D + + K L+ + L+ D +RRL + +
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 5e-86
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 28/274 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
Y + +++G G + + E +A K ++ ++ ++ R E+ + L +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKL-Q 112
Query: 115 HQN--IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
+ I+ L D D +++VME C +L + + + K ++E V
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---IVGSPYYMAPEV 229
H+HG++H DLKP NFL + LK IDFG++ +P VG+ YM PE
Sbjct: 172 HQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 230 LKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDF 276
+K P+ DVWS G ILY + G PF Q AII +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NH 285
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ ++ +D+++ L DPK+R++ ++L
Sbjct: 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 9e-85
Identities = 92/257 (35%), Positives = 139/257 (54%), Gaps = 11/257 (4%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y L + +G+G F L G A K I K +L ++ + REV IM+ L H
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKIL-NH 73
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
NIV L + E + ++L+ME GGE+FD +VA G E+ A + + IV VQ CH+
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNY 234
++HRDLK EN L +K DFG S F G K G+P Y APE+ + + Y
Sbjct: 134 RIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVDVWS GVILY L+ G PF + + + + ++R +R + +S + ++L++
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG--KYRIPFY--MSTDCENLLK 246
Query: 294 KMLDPDPKRRLTAQQVL 310
+ L +P +R T +Q++
Sbjct: 247 RFLVLNPIKRGTLEQIM 263
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 267 bits (683), Expect = 1e-84
Identities = 65/285 (22%), Positives = 114/285 (40%), Gaps = 33/285 (11%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
+E+ LG G FG ++ G+ A K ++ + + E E+ IM+ L H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKL-NH 71
Query: 116 QNIVCLKDTYEDDTAVH------LVMELCEGGELFDRIVARGH---YTERAAAAVTKTIV 166
N+V ++ + + L ME CEGG+L + + E + I
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
++ H++ ++HRDLKPEN + + K ID G + GE +E VG+ Y+A
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PE+L+ + Y VD WS G + + + G PF + +R + + ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 286 EN--------------------AKDLVRKMLDPDPKRRLTAQQVL 310
+ ++ ML ++R T Q
Sbjct: 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 2e-84
Identities = 82/257 (31%), Positives = 143/257 (55%), Gaps = 10/257 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +++GR LG+G+FG YL +++N A K + K +L +RRE++I HL +
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-R 72
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NI+ + + + D ++L++E GEL+ + G + E+ +A + + + + CH+
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL-KRN 233
V+HRD+KPEN L K E LK DFG SV P + + G+ Y+ PE++ +
Sbjct: 133 RKVIHRDIKPENLLMGYKGE---LKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKT 188
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
+ +VD+W AGV+ Y L G+PPF + + + I+ D + P+ +S+ +KDL+
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--DLKFPPF--LSDGSKDLIS 244
Query: 294 KMLDPDPKRRLTAQQVL 310
K+L P +RL + V+
Sbjct: 245 KLLRYHPPQRLPLKGVM 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 2e-83
Identities = 93/257 (36%), Positives = 128/257 (49%), Gaps = 10/257 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y LG LG G FG + + G A K ++++K+R+ + ++RE+ ++ +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RH 70
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
+I+ L T +VME GGELFD I G E A + + I+ V CH+H
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL-KRNY 234
V+HRDLKPEN L K DFGLS GE GSP Y APEV+ R Y
Sbjct: 131 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVD+WS GVILY LLCG PF E + + I F + ++ + L+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEY--LNRSVATLLM 243
Query: 294 KMLDPDPKRRLTAQQVL 310
ML DP +R T + +
Sbjct: 244 HMLQVDPLKRATIKDIR 260
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 9e-83
Identities = 76/262 (29%), Positives = 122/262 (46%), Gaps = 14/262 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++L + LG G +G L +R +A A K + K+ E++++E+ I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-N 63
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+N+V + +L +E C GGELFDRI E A ++ V H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSPYYMAPEVL- 230
G+ HRD+KPEN L + LK DFGL+ F+ + + G+ Y+APE+L
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 231 KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENA 288
+R + VDVWS G++L +L G P+ ++ +PW K+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
L+ K+L +P R+T +
Sbjct: 239 LALLHKILVENPSARITIPDIK 260
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 1e-82
Identities = 83/269 (30%), Positives = 130/269 (48%), Gaps = 11/269 (4%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE 105
P + + RY+ +++G G FG+ L D+ + A K I + E+V+RE
Sbjct: 12 DMPIMHDSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQRE 66
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ R L +H NIV K+ T + ++ME GGEL++RI G ++E A + +
Sbjct: 67 IINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ V CH + HRDLK EN L + LK DFG S + VG+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184
Query: 226 APEVL-KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--DFRRDPW 281
APEVL ++ Y G DVWS GV LY++L G PF E + I+ +L +
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
++S L+ ++ DP R++ ++
Sbjct: 245 IRISPECCHLISRIFVADPATRISIPEIK 273
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 2e-82
Identities = 76/262 (29%), Positives = 122/262 (46%), Gaps = 14/262 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++L + LG G +G L +R +A A K + K+ E++++E+ I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-N 63
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+N+V + +L +E C GGELFDRI E A ++ V H
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---VGSPYYMAPEVL- 230
G+ HRD+KPEN L + LK DFGL+ F+ + + G+ Y+APE+L
Sbjct: 124 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 231 KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENA 288
+R + VDVWS G++L +L G P+ ++ +PW K+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAP 238
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
L+ K+L +P R+T +
Sbjct: 239 LALLHKILVENPSARITIPDIK 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 251 bits (641), Expect = 1e-81
Identities = 47/308 (15%), Positives = 96/308 (31%), Gaps = 58/308 (18%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
E E G LG+ + TD+E G++F + + I+ ++ EV
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 107 DIMRHL------------------------PKHQNIVCLKDTYEDDTA--VHLVMELCE- 139
+R L P+ + ++ ++ D + +
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 140 -----GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194
G L A +T ++ ++ H +G++H L+P + + +
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQ 241
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN------------YGPEVDVWS 242
+ F V S + PE+ R D W+
Sbjct: 242 RGGVFLTGFEHLV---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 243 AGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR 302
G+++Y + C P + G ++ I RS + + + + L+ L +
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKED 350
Query: 303 RLTAQQVL 310
RL Q +
Sbjct: 351 RLLPLQAM 358
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 5e-81
Identities = 91/257 (35%), Positives = 131/257 (50%), Gaps = 10/257 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y LG LG G FG + G A K ++++K+R+ + +RRE+ ++ +H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RH 75
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
+I+ L + + +VME GGELFD I G E+ + + + I+ V CH+H
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL-KRNY 234
V+HRDLKPEN L K DFGLS GE GSP Y APEV+ R Y
Sbjct: 136 MVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 192
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVD+WS+GVILY LLCG PF + + + I F + ++ + L++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQY--LNPSVISLLK 248
Query: 294 KMLDPDPKRRLTAQQVL 310
ML DP +R T + +
Sbjct: 249 HMLQVDPMKRATIKDIR 265
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 7e-81
Identities = 83/274 (30%), Positives = 124/274 (45%), Gaps = 26/274 (9%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED----- 101
E ++Y LG G FG + D+E K I K+K+ IED
Sbjct: 16 AACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 102 VRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMEL-CEGGELFDRIVARGHYTERAAAA 160
V E+ I+ + +H NI+ + D +E+ LVME G +LF I E A+
Sbjct: 76 VTLEIAILSRV-EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
+ + +V V ++HRD+K EN + A +K IDFG + + + G+ F G
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFYTFCG 191
Query: 221 SPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPF--WAETEQGVAQAIIRSVLDF 276
+ Y APEVL N Y GPE+++WS GV LY L+ PF ET +
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA----------AI 241
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
VS+ LV +L P P+RR T ++++
Sbjct: 242 HPPYL--VSKELMSLVSGLLQPVPERRTTLEKLV 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-80
Identities = 74/269 (27%), Positives = 114/269 (42%), Gaps = 22/269 (8%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED---VRREVD 107
E Y LG LG+G FG + + A K I + ++ + D EV
Sbjct: 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 108 IMRHL---PKHQNIVCLKDTYEDDTAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTK 163
++ + H ++ L D +E LV+E +LFD I +G E +
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+V +Q CH GV+HRD+K EN L K IDFG +++ G+
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILI--DLRRGCAKLIDFGSGALLHDE-PYTDFDGTRV 203
Query: 224 YMAPEVLK-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
Y PE + Y VWS G++LY ++CG PF + E I+ + L F
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFP---- 253
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
VS + L+R+ L P P R + +++L
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 3e-80
Identities = 89/257 (34%), Positives = 134/257 (52%), Gaps = 11/257 (4%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y + LG G FG L T + A K IS++ L+ + V RE+ ++ L +H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RH 68
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
+I+ L D T + +V+E GGELFD IV + TE + I+ ++ CH+H
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNY 234
++HRDLKPEN L + +K DFGLS G GSP Y APEV+ + Y
Sbjct: 128 KIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184
Query: 235 -GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
GPEVDVWS G++LY++L G PF E + + + + + +S A+ L+R
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC--VYVMPDF--LSPGAQSLIR 240
Query: 294 KMLDPDPKRRLTAQQVL 310
+M+ DP +R+T Q++
Sbjct: 241 RMIVADPMQRITIQEIR 257
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-79
Identities = 69/259 (26%), Positives = 109/259 (42%), Gaps = 13/259 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ ++ LG G +G + +E+G +A K S R D EV +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMC 172
+H V L+ +E+ ++L ELC G L A G E + + +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232
H G++H D+KP N + K DFGL V G P YMAPE+L+
Sbjct: 174 HSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 233 NYGPEVDVWSAGVILYILLCGVP-PFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
+YG DV+S G+ + + C + P E Q + Q + +S + +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSV 284
Query: 292 VRKMLDPDPKRRLTAQQVL 310
+ ML+PDPK R TA+ +L
Sbjct: 285 LVMMLEPDPKLRATAEALL 303
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 3e-79
Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 37/285 (12%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD----------------- 98
+Y L E+G+G +G+ L + + +A K +SKKKL
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 99 ------IEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL--VMELCEGGELFDRIVAR 150
IE V +E+ I++ L H N+V L + +D HL V EL G + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131
Query: 151 GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+E A + +++ ++ H ++HRD+KP N L +K DFG+S FK
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH---IKIADFGVSNEFK 188
Query: 211 PGEKF-SEIVGSPYYMAPEVL---KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGV 265
+ S VG+P +MAPE L ++ + G +DVW+ GV LY + G PF E +
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
I L+F P ++E+ KDL+ +MLD +P+ R+ ++
Sbjct: 249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIK 291
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 4e-79
Identities = 81/285 (28%), Positives = 128/285 (44%), Gaps = 22/285 (7%)
Query: 34 HQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL 93
N H + +E +Y++G LG G FG Y + A K + K ++
Sbjct: 22 APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 81
Query: 94 RTAVDIED---VRREVDIMRHLPKHQ--NIVCLKDTYEDDTAVHLVMELCEG-GELFDRI 147
++ + V EV +++ + ++ L D +E + L++E E +LFD I
Sbjct: 82 SDWGELPNGTRVPMEVVLLKKV-SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI 140
Query: 148 VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
RG E A + ++E V+ CH GV+HRD+K EN L LK IDFG
Sbjct: 141 TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGA 198
Query: 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGV 265
K +++ G+ Y PE ++ Y G VWS G++LY ++CG PF + E
Sbjct: 199 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--- 254
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
IIR + FR +VS + L+R L P R T +++
Sbjct: 255 ---IIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQ 292
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 1e-76
Identities = 56/307 (18%), Positives = 103/307 (33%), Gaps = 49/307 (15%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDI------ 99
+ Y + R L +G+F LC ++ +A K K L D
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 100 --------EDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG 151
+D + E+ I+ + K++ + + + V+++ E E +
Sbjct: 80 KISIKSKYDDFKNELQIITDI-KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 152 H--------YTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAID 202
+ + K+++ H + HRD+KP N L +K D
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKLSD 195
Query: 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWA 259
FG S + +K G+ +M PE G +VD+WS G+ LY++ V PF
Sbjct: 196 FGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254
Query: 260 ETEQ----------------GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRR 303
+ + +S D ++ L +P R
Sbjct: 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314
Query: 304 LTAQQVL 310
+T++ L
Sbjct: 315 ITSEDAL 321
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 3e-76
Identities = 80/271 (29%), Positives = 132/271 (48%), Gaps = 25/271 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E YE+ +G G +G + +G K + + T + + + EV+++R L K
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 63
Query: 115 HQNIVCLKDTYED--DTAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEV 168
H NIV D D +T +++VME CEGG+L I R + E V +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 169 VQMCHK-----HGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGS 221
++ CH+ H V+HRDLKP N FL + +K DFGL+ F++ VG+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN----VKLGDFGLARILNHDTSFAKTFVGT 179
Query: 222 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
PYYM+PE + +Y + D+WS G +LY L +PPF A +++ +A I +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----KFRR 235
Query: 281 WPKV-SENAKDLVRKMLDPDPKRRLTAQQVL 310
P S+ +++ +ML+ R + +++L
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEIL 266
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-74
Identities = 70/262 (26%), Positives = 135/262 (51%), Gaps = 16/262 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E+Y +++G G FG L E+G + K I+ ++ ++ + E+ RREV ++ ++ K
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-K 81
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMC 172
H NIV ++++E++ ++++VM+ CEGG+LF RI A+ + E I ++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 173 HKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLSVFFKPGEKFSE-IVGSPYYMAPEVL 230
H ++HRD+K +N FL + ++ DFG++ + + +G+PYY++PE+
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP-KVSENA 288
+ Y + D+W+ G +LY L F A + + + II P S +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----SFPPVSLHYSYDL 253
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
+ LV ++ +P+ R + +L
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSIL 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 5e-73
Identities = 71/266 (26%), Positives = 124/266 (46%), Gaps = 20/266 (7%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-VRREVDIMRHLPK 114
+Y +G LG G +G D E A K + KKKLR + E V++E+ ++R L +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 115 HQNIVCLKD--TYEDDTAVHLVMELCEGG--ELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H+N++ L D E+ +++VME C G E+ D + + A +++ ++
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDGLE 123
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF---FKPGEKFSEIVGSPYYMAP 227
H G++H+D+KP N L LK G++ F + GSP + P
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 228 EVL--KRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
E+ + G +VD+WSAGV LY + G+ PF + + + I + +
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGD--C 236
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
DL++ ML+ +P +R + +Q+
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIR 262
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 1e-72
Identities = 68/308 (22%), Positives = 114/308 (37%), Gaps = 37/308 (12%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE---ERYELGRELGRGEFGITYLCTDRENGDAFACKSIS 89
HH +G L G + + Y ++LG G F L +G +A K I
Sbjct: 8 HHHSSGRENL----YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL 63
Query: 90 KKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA----VHLVMELCEGGELFD 145
+ + D E+ +RE D+ R H NI+ L + L++ + G L++
Sbjct: 64 CHEQQ---DREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWN 119
Query: 146 RIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201
I TE + I ++ H G HRDLKP N L ++ + +
Sbjct: 120 EIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLM 176
Query: 202 DFGLSVFFKPG----------EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVIL 247
D G + ++ + Y APE+ DVWS G +L
Sbjct: 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236
Query: 248 YILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307
Y ++ G P+ ++G + A+ P+ S L+ M+ DP +R
Sbjct: 237 YAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295
Query: 308 QVLGKIEF 315
+L ++E
Sbjct: 296 LLLSQLEA 303
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-69
Identities = 73/275 (26%), Positives = 123/275 (44%), Gaps = 16/275 (5%)
Query: 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
L+ G + + +++GRG+F Y +G A K + L A D +
Sbjct: 22 LRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK 81
Query: 105 EVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG----HYTERAAAA 160
E+D+++ L H N++ ++ +D +++V+EL + G+L I ER
Sbjct: 82 EIDLLKQL-NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPEN-FLFANKKETAPLKAIDFGLS-VFFKPGEKFSEI 218
+ ++ H VMHRD+KP N F+ A +K D GL F +
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGV----VKLGDLGLGRFFSSKTTAAHSL 196
Query: 219 VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQAIIRSVLD 275
VG+PYYM+PE + N Y + D+WS G +LY + PF+ + + + I + D
Sbjct: 197 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--D 254
Query: 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ P SE + LV ++PDP++R V
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVY 289
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 4e-69
Identities = 64/283 (22%), Positives = 108/283 (38%), Gaps = 38/283 (13%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
+ ++ +G G FG + R +G + K + E REV
Sbjct: 3 HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREV 55
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTA----------------VHLVMELCEGGELFDRIVAR 150
+ L H NIV ++ + + ME C+ G L I R
Sbjct: 56 KALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 151 --GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+ A + + I + V H +++RDLKP N + K+ +K DFGL
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIGDFGLVTS 171
Query: 209 FKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267
K K + G+ YM+PE + ++YG EVD+++ G+IL LL A
Sbjct: 172 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETSKFFT 229
Query: 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ ++ + K L++K+L P+ R ++L
Sbjct: 230 DLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEIL 266
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 9e-66
Identities = 76/290 (26%), Positives = 121/290 (41%), Gaps = 41/290 (14%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
GR + + +E + LGRG FG+ + ++ + +A K I + E V REV +
Sbjct: 1 GRYLTD-FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKAL 57
Query: 110 RHLPKHQNIVCLKDTYEDDTA------------VHLVMELCEGGELFDRIVARGHYTERA 157
L +H IV + + + +++ M+LC L D + R ER
Sbjct: 58 AKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 158 AAAVTKT---IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-------- 206
+ I E V+ H G+MHRDLKP N F +K DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEE 173
Query: 207 -----VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE 260
+ + VG+ YM+PE + +Y +VD++S G+IL+ LL PF +
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
E+ +R+ L F + +V+ ML P P R A ++
Sbjct: 231 MERVRTLTDVRN-LKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINII 278
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-65
Identities = 70/290 (24%), Positives = 111/290 (38%), Gaps = 41/290 (14%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E R + R L G F Y D +G +A K + + + +EV M+ L
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE---KNRAIIQEVCFMKKLS 83
Query: 114 KHQNIVCLKDTYEDDTA--------VHLVMELCEGG--ELFDRIVARGHYTERAAAAVTK 163
H NIV L+ ELC+G E ++ +RG + +
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 164 TIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS----- 216
VQ H+ ++HRDLK EN L +N+ +K DFG + +S
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFGSATTISHYPDYSWSAQR 200
Query: 217 --------EIVGSPYYMAPEVL----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG 264
+P Y PE++ G + D+W+ G ILY+L PF E G
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF----EDG 256
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
I+ + P L+R ML +P+ RL+ +V+ +++
Sbjct: 257 AKLRIVNG--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 207 bits (527), Expect = 3e-64
Identities = 48/310 (15%), Positives = 98/310 (31%), Gaps = 58/310 (18%)
Query: 51 REIEERYEL---GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
E+ ER G LG+ + TD+E G++F + + I+ ++ EV
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 108 IMRHL------------------------PKHQNIVCLKDTYEDDTAVH--LVMELCEG- 140
+R L P+ + ++ ++ D + + +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 141 -----GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195
L A +T ++ ++ H +G++H L+P + + +
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QR 247
Query: 196 APLKAIDFGLSVFFKPGEKF----SEIVGSPYYMAPEVL------KRNYGPEVDVWSAGV 245
+ F V + G P A +L D W+ G+
Sbjct: 248 GGVFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT 305
+Y + C P + G ++ I RS + + + L+ L + RL
Sbjct: 306 AIYWIWCADLPNTDDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLL 357
Query: 306 AQQVLGKIEF 315
Q + E+
Sbjct: 358 PLQAMETPEY 367
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-62
Identities = 47/280 (16%), Positives = 89/280 (31%), Gaps = 34/280 (12%)
Query: 53 IEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
+ + LG G F Y T D +N F K + + ++
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLME 119
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERA-----AAAVT 162
++ + + LV EL G L + I + E+ +
Sbjct: 120 RLKPS-MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP--------LKAIDFGLSV---FFKP 211
++ +++ H ++H D+KP+NF+ N L ID G S+ F
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 212 GEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
G F+ + + E+L + + ++D + +Y +L G +
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
L D W + ML+ L + +L
Sbjct: 299 FRRL-PHLDMW-------NEFFHVMLNIPDCHHLPSLDLL 330
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-60
Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 40/284 (14%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ ++G GEFG + C R +G +A K SKK L +VD ++ REV L
Sbjct: 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK-RSKKPLAGSVDEQNALREVYAHAVL 67
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEV 168
+H ++V + +D + + E C GG L D I ++ E + +
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAI----------------DFGLSVFFKPG 212
++ H ++H D+KP N + D G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRI 184
Query: 213 EKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
G ++A EVL+ N + P+ D+++ + + P G I
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP----RNGDQWHEI 240
Query: 271 RSVLDFRRDPWPKV----SENAKDLVRKMLDPDPKRRLTAQQVL 310
R+ P++ S+ +L++ M+ PDP+RR +A ++
Sbjct: 241 ------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-57
Identities = 79/259 (30%), Positives = 122/259 (47%), Gaps = 12/259 (4%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
++ G+ LG G F L + +A K + K+ + + V RE D+M L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP 90
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
V L T++DD ++ + + GEL I G + E T IV ++ H G
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS---VFFKPGEKFSEIVGSPYYMAPEVLKRN 233
++HRDLKPEN L ++ DFG + + + VG+ Y++PE+L
Sbjct: 151 IIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
D+W+ G I+Y L+ G+PPF A E + Q II+ DF P K A+DLV
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---P-EKFFPKARDLV 263
Query: 293 RKMLDPDPKRRLTAQQVLG 311
K+L D +RL +++ G
Sbjct: 264 EKLLVLDATKRLGCEEMEG 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 76/299 (25%), Positives = 143/299 (47%), Gaps = 21/299 (7%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRG 66
AA K ++++ K+ D+ + + + ++++ + LG G
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQL----------DQFDRIKTLGTG 52
Query: 67 EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126
FG L +E+G+ +A K + K+K+ IE E I++ + +V L+ +++
Sbjct: 53 SFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFK 111
Query: 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186
D++ +++VME GGE+F + G ++E A IV + H +++RDLKPEN
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171
Query: 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGV 245
L + ++ DFG + + + + G+P +APE++ Y VD W+ GV
Sbjct: 172 LLIDQQGY---IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGV 226
Query: 246 ILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL 304
++Y + G PPF+A+ + + I+ + F P S + KDL+R +L D +R
Sbjct: 227 LIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---P-SHFSSDLKDLLRNLLQVDLTKRF 281
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-52
Identities = 79/255 (30%), Positives = 119/255 (46%), Gaps = 13/255 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
YE+ + +GRG FG L + +A K +SK ++ D E DIM
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSP 129
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L ++DD +++VME GG+L +++ E+ A T +V + H G
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGSPYYMAPEVLKR-- 232
+HRD+KP+N L ++ LK DFG + VG+P Y++PEVLK
Sbjct: 189 FIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 233 ---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
YG E D WS GV LY +L G PF+A++ G I+ +S+ AK
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305
Query: 290 DLVRKMLDPDPKRRL 304
+L+ L D + RL
Sbjct: 306 NLICAFLT-DREVRL 319
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-51
Identities = 64/268 (23%), Positives = 103/268 (38%), Gaps = 21/268 (7%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR-REVDIM 109
RE +GRG FG + D++ G A K + +E R E+
Sbjct: 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV---------RLEVFRVEELVAC 104
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
L IV L + V++ MEL EGG L I G E A +E +
Sbjct: 105 AGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGL 163
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS------VFFKPGEKFSEIVGSPY 223
+ H ++H D+K +N L ++ A DFG + K I G+
Sbjct: 164 EYLHTRRILHGDVKADNVLLSSDGSRA--ALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 224 YMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
+MAPEV+ +VD+WS+ ++ +L G P+ + I R P P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIP-P 280
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ +++ L +P R +A ++
Sbjct: 281 SCAPLTAQAIQEGLRKEPVHRASAMELR 308
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-50
Identities = 65/275 (23%), Positives = 115/275 (41%), Gaps = 18/275 (6%)
Query: 43 CVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV 102
V GR + E+GRG F Y D E A + +KL T + +
Sbjct: 18 AVGMSNDGR----FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRF 72
Query: 103 RREVDIMRHLPKHQNIV----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
+ E ++++ L +H NIV + T + + LV EL G L + +
Sbjct: 73 KEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL 131
Query: 159 AAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
+ + I++ +Q H ++HRDLK +N T +K D GL+ K
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATL-KRASFAK 188
Query: 217 EIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
++G+P +MAPE+ + Y VDV++ G+ + + P ++E Q AQ R
Sbjct: 189 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYP-YSE-CQNAAQIYRRVTSGV 246
Query: 277 RRDPWPKV-SENAKDLVRKMLDPDPKRRLTAQQVL 310
+ + KV K+++ + + R + + +L
Sbjct: 247 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-50
Identities = 63/254 (24%), Positives = 120/254 (47%), Gaps = 15/254 (5%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
E+ R +G+G FG + + +A K ++K+K ++ +V +E+ IM+ L +H
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPF 76
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGV 177
+V L +++D+ + +V++L GG+L + H+ E +V + +
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 178 MHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN---- 233
+HRD+KP+N L E + DF ++ + + + G+ YMAPE+
Sbjct: 137 IHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 234 YGPEVDVWSAGVILYILLCGVPPFW---AETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y VD WS GV Y LL G P+ + + + + +V+ + S+
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEMVS 249
Query: 291 LVRKMLDPDPKRRL 304
L++K+L+P+P +R
Sbjct: 250 LLKKLLEPNPDQRF 263
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 1e-49
Identities = 73/251 (29%), Positives = 117/251 (46%), Gaps = 7/251 (2%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ R LG+G FG C R G +ACK + KK+++ E I+ + +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSR 244
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRI--VARGHYTERAAAAVTKTIVEVVQMCHK 174
+V L YE A+ LV+ L GG+L I + + + E A I ++ H+
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN- 233
+++RDLKPEN L + ++ D GL+V G+ VG+ YMAPEV+K
Sbjct: 305 ERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
Y D W+ G +LY ++ G PF ++ + + R V + + + S A+ L
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 294 KMLDPDPKRRL 304
++L DP RL
Sbjct: 422 QLLCKDPAERL 432
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 1e-49
Identities = 71/252 (28%), Positives = 123/252 (48%), Gaps = 17/252 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+++ R LG G FG +L R NG +A K + K+ + +E E ++ + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP 66
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA---AAVTKTIVEVVQMCH 173
I+ + T++D + ++M+ EGGELF + + A AA + ++ H
Sbjct: 67 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA---EVCLALEYLH 123
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN 233
+++RDLKPEN L + +K DFG + + + G+P Y+APEV+
Sbjct: 124 SKDIIYRDLKPENILLD---KNGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTK 178
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y +D WS G+++Y +L G PF+ + I+ + L F P P +E+ KDL+
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF---P-PFFNEDVKDLL 234
Query: 293 RKMLDPDPKRRL 304
+++ D +RL
Sbjct: 235 SRLITRDLSQRL 246
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 74/256 (28%), Positives = 119/256 (46%), Gaps = 14/256 (5%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ + +GRG FG + + FA K ++K ++ + R E D++ + +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSK 134
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKH 175
I L ++DD ++LVM+ GG+L + E A +V + H+
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGSPYYMAPEVL--- 230
+HRD+KP+N L ++ DFG + S VG+P Y++PE+L
Sbjct: 195 HYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW-PKVSE 286
K YGPE D WS GV +Y +L G PF+AE+ I+ F+ VSE
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 287 NAKDLVRKMLDPDPKR 302
NAKDL+R+++ R
Sbjct: 312 NAKDLIRRLICSREHR 327
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 1e-48
Identities = 64/254 (25%), Positives = 108/254 (42%), Gaps = 15/254 (5%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR--HLPKH 115
+ R +GRG FG Y C + G +A K + KK+++ E ++
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
IVC+ + + +++L GG+L + G ++E I+ ++ H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN-- 233
V++RDLKP N L E ++ D GL+ F + + VG+ YMAPEVL++
Sbjct: 312 FVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQKGVA 367
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D +S G +L+ LL G PF + + + ++ S +
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRS 423
Query: 291 LVRKMLDPDPKRRL 304
L+ +L D RRL
Sbjct: 424 LLEGLLQRDVNRRL 437
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-48
Identities = 73/244 (29%), Positives = 113/244 (46%), Gaps = 9/244 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L +E GD +A K + K + D+E E I+ H + L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GG+L I + E A I+ + H G+++RDL
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L K DFG+ G + G+P Y+APE+L+ YGP VD
Sbjct: 151 KLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDW 207
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W+ GV+LY +LCG PF AE E + +AI+ + + + E+A +++ + +P
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----LHEDATGILKSFMTKNP 263
Query: 301 KRRL 304
RL
Sbjct: 264 TMRL 267
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-48
Identities = 84/294 (28%), Positives = 134/294 (45%), Gaps = 51/294 (17%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
E+YE ++G G +G+ + C +R+ G A K K + D ++ RE+ +++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLK 57
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEV 168
L KH N+V L + + +HLV E C+ DR + E ++T ++
Sbjct: 58 QL-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQA 114
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
V CHKH +HRD+KPEN L +K DFG + + P + + + V + +Y +P
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVL---------- 274
E+L YGP VDVW+ G + LL GVP + +++ V Q +IR L
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD--VDQLYLIRKTLGDLIPRHQQV 229
Query: 275 -----DFR-------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
F +P +S A L++ L DP RLT +Q+L
Sbjct: 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-48
Identities = 70/328 (21%), Positives = 112/328 (34%), Gaps = 79/328 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSI-------SKKKLRTAVDIEDVRREV 106
+E + +GRG FG+ + ++ + +A K I +++K+ V
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 107 DIMRHLP-----------------------------------------------KHQNIV 119
I+R+ +N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK---TIVEVVQMCHKHG 176
+++ M+LC L D + R +R I E V+ H G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-------------VFFKPGEKFSEIVGSPY 223
+MHRDLKP N F +K DFGL + VG+
Sbjct: 185 LMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 224 YMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
YM+PE + NY +VD++S G+IL+ LL F + E+ +R+ L F
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN-LKFPLLFTQ 297
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
K +V+ ML P P R A ++
Sbjct: 298 K-YPQEHMMVQDMLSPSPTERPEATDII 324
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 67/260 (25%), Positives = 119/260 (45%), Gaps = 17/260 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+ + +GRG F + ++ G +A K ++K + ++ R E D++ + +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRR 121
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKH 175
I L ++D+ ++LVME GG+L + G A IV + H+
Sbjct: 122 WITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--SEIVGSPYYMAPEVLKR- 232
G +HRD+KP+N L ++ DFG + + VG+P Y++PE+L+
Sbjct: 182 GYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 233 -------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-V 284
+YGPE D W+ GV Y + G PF+A++ I+ + V
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGV 298
Query: 285 SENAKDLVRKMLDPDPKRRL 304
E A+D ++++L P+ RL
Sbjct: 299 PEEARDFIQRLLC-PPETRL 317
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-48
Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 21/277 (7%)
Query: 47 EPTGREIEERYELGRE-----LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED 101
+ +E YE LG+G +GI Y D N A K I R + +
Sbjct: 9 DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQP 65
Query: 102 VRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG---HYTERAA 158
+ E+ + +HL KH+NIV ++ ++ + + ME GG L + ++ E+
Sbjct: 66 LHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSE 217
TK I+E ++ H + ++HRD+K +N L LK DFG S
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPCTET 182
Query: 218 IVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274
G+ YMAPE++ + YG D+WS G + + G PP + E + A A+ + +
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP-FYELGEPQA-AMFKVGM 240
Query: 275 DFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVL 310
P+ +S AK + K +PDP +R A +L
Sbjct: 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLL 277
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-47
Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 9/244 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L + + +A K + K + D+E E ++ K + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ VME GG+L I G + E A I + G+++RDL
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N + +K DFG+ G G+P Y+APE++ YG VD
Sbjct: 148 KLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW 204
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W+ GV+LY +L G PF E E + Q+I+ + + + +S+ A + + ++ P
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKGLMTKHP 260
Query: 301 KRRL 304
+RL
Sbjct: 261 GKRL 264
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-47
Identities = 69/244 (28%), Positives = 115/244 (47%), Gaps = 9/244 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG +L ++ FA K++ K + D+E E ++ +H + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
T++ + VME GG+L I + + A I+ +Q H G+++RDL
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L + +K DFG+ K + G+P Y+APE+L Y VD
Sbjct: 145 KLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDW 201
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
WS GV+LY +L G PF + E+ + +I + R + + AKDL+ K+ +P
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLVKLFVREP 257
Query: 301 KRRL 304
++RL
Sbjct: 258 EKRL 261
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-47
Identities = 81/265 (30%), Positives = 133/265 (50%), Gaps = 23/265 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ ++G G GI L ++ +G A K + LR E + EV IMR
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDY- 99
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H N+V + +Y + ++ME +GG L D IV++ E A V + +++ + H
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLH 158
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR 232
GV+HRD+K ++ L +K DFG K K +VG+PY+MAPEV+ R
Sbjct: 159 AQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 215
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVS 285
+ Y EVD+WS G+++ ++ G PP+++++ + + R P P KVS
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-------RDSPPPKLKNSHKVS 268
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVL 310
+D + +ML DP+ R TAQ++L
Sbjct: 269 PVLRDFLERMLVRDPQERATAQELL 293
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-47
Identities = 79/318 (24%), Positives = 132/318 (41%), Gaps = 53/318 (16%)
Query: 31 GTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISK 90
HH + G L E + E+YE +G G +G+ C +++ G A K
Sbjct: 3 HHHHHHSSGVDLGT--ENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---- 56
Query: 91 KKLRTAVDIEDVR----REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELF 144
K + D + V+ RE+ +++ L +H+N+V L + + +LV E + +
Sbjct: 57 -KFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL 114
Query: 145 DRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
+ + I+ + CH H ++HRD+KPEN L + +K DFG
Sbjct: 115 ELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFG 169
Query: 205 LS-VFFKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAET 261
+ PGE + + V + +Y APE+L YG VDVW+ G ++ + G P F ++
Sbjct: 170 FARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229
Query: 262 EQGVAQ-AIIRSVL---------------DFR-------------RDPWPKVSENAKDLV 292
+ + Q I L F +PK+SE DL
Sbjct: 230 D--IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLA 287
Query: 293 RKMLDPDPKRRLTAQQVL 310
+K L DP +R ++L
Sbjct: 288 KKCLHIDPDKRPFCAELL 305
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-46
Identities = 86/353 (24%), Positives = 134/353 (37%), Gaps = 61/353 (17%)
Query: 1 MGNCCVTPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEP---TGREIEERY 57
M T + A+ K + +G V+ P R E Y
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVS----RDKDGSKVTTVVATPGQGPDRPQEVSY 56
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+ +G G FG+ Y ++G+ A K + + K RE+ IMR L H N
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKL-DHCN 108
Query: 118 IVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
IV L+ + +D+ ++LV++ ++ + K + Q+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYM--YQL 165
Query: 172 ------CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
H G+ HRD+KP+N L + +TA LK DFG + GE + S YY
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLL-LD-PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 226 APEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL--------- 274
APE++ +Y +DVWSAG +L LL G P F ++ II+ VL
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK-VLGTPTREQIR 282
Query: 275 ------------DFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ PW P+ A L ++L+ P RLT +
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 77/265 (29%), Positives = 127/265 (47%), Gaps = 23/265 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+++Y ++G+G G Y D G A + + L+ E + E+ +MR
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMREN- 74
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
K+ NIV D+Y + +VME GG L D +V E AAV + ++ ++ H
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR 232
+ V+HRD+K +N L +K DFG K S +VG+PY+MAPEV+ R
Sbjct: 134 SNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP------KVS 285
YGP+VD+WS G++ ++ G PP+ E I + P K+S
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGTPELQNPEKLS 243
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVL 310
+D + + L+ D ++R +A+++L
Sbjct: 244 AIFRDFLNRCLEMDVEKRGSAKELL 268
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-46
Identities = 82/317 (25%), Positives = 131/317 (41%), Gaps = 55/317 (17%)
Query: 34 HQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL 93
N K+ TG + E Y + +G G FG+ + E+ + A K + + K
Sbjct: 19 DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR 77
Query: 94 RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRI 147
RE+ IMR + KH N+V LK + +D+ ++LV+E ++
Sbjct: 78 FKN-------RELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS 128
Query: 148 VARGHYTERAAAAVTKTIVEVVQM------CHKHGVMHRDLKPENFLFANKKETAPLKAI 201
+ + K + Q+ H G+ HRD+KP+N L + + LK I
Sbjct: 129 RHYAKLKQTMPMLLIKLYM--YQLLRSLAYIHSIGICHRDIKPQNLL-LD-PPSGVLKLI 184
Query: 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWA 259
DFG + GE + S YY APE++ NY +D+WS G ++ L+ G P F
Sbjct: 185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 260 ETEQGVAQAIIRSVL---------------------DFRRDPW-----PKVSENAKDLVR 293
E+ II+ VL R P+ P+ +A DL+
Sbjct: 245 ESGIDQLVEIIK-VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303
Query: 294 KMLDPDPKRRLTAQQVL 310
++L+ P RLTA + L
Sbjct: 304 RLLEYTPSARLTAIEAL 320
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 1e-45
Identities = 74/244 (30%), Positives = 120/244 (49%), Gaps = 10/244 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LG+G FG L ++ G +A K + K+ + ++ E ++++ +H + LK
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK 71
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ + VME GGELF + +TE A IV ++ H V++RD+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K EN + + +K DFGL G G+P Y+APEVL+ N YG VD
Sbjct: 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 188
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W GV++Y ++CG PF+ + + + + I+ + F R +S AK L+ +L DP
Sbjct: 189 WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT----LSPEAKSLLAGLLKKDP 244
Query: 301 KRRL 304
K+RL
Sbjct: 245 KQRL 248
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 75/248 (30%), Positives = 119/248 (47%), Gaps = 14/248 (5%)
Query: 63 LGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNI 118
LG+G +G + T G FA K + K + R A D + E +I+ + KH I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFI 83
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V L ++ ++L++E GGELF ++ G + E A I + H+ G++
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGP 236
+RDLKPEN + +K DFGL G G+ YMAPE+L R+ +
Sbjct: 144 YRDLKPENIMLN---HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
VD WS G ++Y +L G PPF E + I++ L+ +++ A+DL++K+L
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY----LTQEARDLLKKLL 256
Query: 297 DPDPKRRL 304
+ RL
Sbjct: 257 KRNAASRL 264
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 64/250 (25%), Positives = 109/250 (43%), Gaps = 9/250 (3%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ LG+G FG L + + +A K + K + D+E E ++ K
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+ L ++ ++ VME GG+L I G + E A I + G
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-Y 234
+++RDLK +N + +K DFG+ G G+P Y+APE++ Y
Sbjct: 463 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 235 GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
G VD W+ GV+LY +L G PF E E + Q+I+ + + + +S+ A + +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS----MSKEAVAICKG 575
Query: 295 MLDPDPKRRL 304
++ P +RL
Sbjct: 576 LMTKHPGKRL 585
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 75/248 (30%), Positives = 118/248 (47%), Gaps = 10/248 (4%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
LGRG FG + C + G +ACK ++KK+L+ + E I+ + + IV L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLA 251
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGH----YTERAAAAVTKTIVEVVQMCHKHGVM 178
+E T + LVM + GG++ I + E A T IV ++ H+ ++
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKRN-YGP 236
+RDLKPEN L + ++ D GL+V K G+P +MAPE+L Y
Sbjct: 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
VD ++ GV LY ++ PF A E+ + + + VL+ K S +KD +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 297 DPDPKRRL 304
DP++RL
Sbjct: 429 QKDPEKRL 436
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-45
Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 18/253 (7%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+GRG + L ++ +A K + K+ + DI+ V+ E + H +V L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
++ ++ + V+E GG+L + + E A + I + H+ G+++RDL
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
K +N L +K D+G+ +PG+ S G+P Y+APE+L+ YG VD
Sbjct: 137 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 193
Query: 241 WSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
W+ GV+++ ++ G PF TE + Q I+ + R +S A +
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAASV 249
Query: 292 VRKMLDPDPKRRL 304
++ L+ DPK RL
Sbjct: 250 LKSFLNKDPKERL 262
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-45
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 9/244 (3%)
Query: 63 LGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLK 122
+G+G FG L + +A K + KK + + + + E +++ KH +V L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDL 182
+++ ++ V++ GGELF + + E A I + H +++RDL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 183 KPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDV 240
KPEN L + DFGL + S G+P Y+APEVL + Y VD
Sbjct: 166 KPENILLD---SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 241 WSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
W G +LY +L G+PPF++ + I+ L + + ++ +A+ L+ +L D
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLLQKDR 278
Query: 301 KRRL 304
+RL
Sbjct: 279 TKRL 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-44
Identities = 69/262 (26%), Positives = 122/262 (46%), Gaps = 18/262 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE + ++G+G FG + D A K I ++ +IED+++E+ ++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQC- 77
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ +Y DT + ++ME GG D ++ G E A + + I++ + H
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 136
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLKR 232
+HRD+K N L + E +K DFG++ K + VG+P++MAPEV+K+
Sbjct: 137 SEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 233 N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPWPKVSENA 288
+ Y + D+WS G+ L G PP V I ++ L+ + S+
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE---GNY---SKPL 247
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
K+ V L+ +P R TA+++L
Sbjct: 248 KEFVEACLNKEPSFRPTAKELL 269
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-44
Identities = 67/259 (25%), Positives = 121/259 (46%), Gaps = 18/259 (6%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
++L R +GRG + L ++ +A + + K+ + DI+ V+ E + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+V L ++ ++ + V+E GG+L + + E A + I + H+ G
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 177 VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-Y 234
+++RDLK +N L +K D+G+ +PG+ S G+P Y+APE+L+ Y
Sbjct: 174 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 235 GPEVDVWSAGVILYILLCGVPPFW---------AETEQGVAQAIIRSVLDFRRDPWPKVS 285
G VD W+ GV+++ ++ G PF TE + Q I+ + R +S
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS 286
Query: 286 ENAKDLVRKMLDPDPKRRL 304
A +++ L+ DPK RL
Sbjct: 287 VKAASVLKSFLNKDPKERL 305
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-44
Identities = 70/247 (28%), Positives = 115/247 (46%), Gaps = 14/247 (5%)
Query: 63 LGRGEFGITYLC---TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119
LG+G FG +L + + +A K + K L D + E DI+ + H IV
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL-KVRDRVRTKMERDILVEV-NHPFIV 89
Query: 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMH 179
L ++ + ++L+++ GG+LF R+ +TE + + H G+++
Sbjct: 90 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 149
Query: 180 RDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPE 237
RDLKPEN L E +K DFGLS +K G+ YMAPEV+ R +
Sbjct: 150 RDLKPENILLD---EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 238 VDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
D WS GV+++ +L G PF + + I+++ L + +S A+ L+R +
Sbjct: 207 ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF----LSPEAQSLLRMLFK 262
Query: 298 PDPKRRL 304
+P RL
Sbjct: 263 RNPANRL 269
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-44
Identities = 80/302 (26%), Positives = 136/302 (45%), Gaps = 12/302 (3%)
Query: 7 TPAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIE-ERYELGRELGR 65
A + K+ G+ +G ++ V + +E + LG+
Sbjct: 99 WTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGK 158
Query: 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125
G FG L ++ G +A K + K+ + ++ E ++++ +H + LK ++
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSF 217
Query: 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKP 184
+ + VME GGELF + ++E A IV + H + V++RDLK
Sbjct: 218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKL 277
Query: 185 ENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWS 242
EN + + +K DFGL K G G+P Y+APEVL+ N YG VD W
Sbjct: 278 ENLMLD---KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 334
Query: 243 AGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKR 302
GV++Y ++CG PF+ + + + + I+ + F R + AK L+ +L DPK+
Sbjct: 335 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT----LGPEAKSLLSGLLKKDPKQ 390
Query: 303 RL 304
RL
Sbjct: 391 RL 392
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-43
Identities = 75/268 (27%), Positives = 119/268 (44%), Gaps = 22/268 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E +E+ ELG G FG Y ++E G A K I ++ ++ED E++I+
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEILATC- 73
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMC 172
H IV L Y D + +++E C GG + ++ TE V + ++E +
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GEKFSEIVGSPYYMAPEVL- 230
H ++HRDLK N L ++ DFG+S +K +G+PY+MAPEV+
Sbjct: 134 HSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDFRRDPWP 282
Y + D+WS G+ L + PP V I +S L W
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-TPSKW- 248
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
S +D ++ LD +P+ R +A Q+L
Sbjct: 249 --SVEFRDFLKIALDKNPETRPSAAQLL 274
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 73/301 (24%), Positives = 120/301 (39%), Gaps = 58/301 (19%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-------RTAVDIEDVRREVD 107
+++ +LG G + Y ++ G A K + KL TA+ RE+
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAI------REIS 55
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGG-----ELFDRIVARGHYTERAAAAVT 162
+M+ L KH+NIV L D + + LV E + +
Sbjct: 56 LMKEL-KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGS 221
+++ + CH++ ++HRDLKP+N L + + LK DFGL+ F P FS V +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 222 PYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------- 271
+Y AP+VL R Y +D+WS G IL ++ G P F ++ + I
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231
Query: 272 -----SVL-----------------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQV 309
+ L + + N D + +L +P RL+A+Q
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 310 L 310
L
Sbjct: 292 L 292
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-43
Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 44/292 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIM 109
+RY +LG G +G Y D + A K I + TA+ REV ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAI------REVSLL 87
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ L +H+NI+ LK + +HL+ E E +L + + R + ++ V
Sbjct: 88 KEL-QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 170 QMCHKHGVMHRDLKPENFLF--ANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMA 226
CH +HRDLKP+N L ++ ET LK DFGL+ F P +F+ + + +Y
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRP 205
Query: 227 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 271
PE+L R+Y VD+WS I +L P F ++E I
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265
Query: 272 -------------SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+R + + DL+ ML+ DP +R++A+ L
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-43
Identities = 70/260 (26%), Positives = 122/260 (46%), Gaps = 13/260 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
EE +++ +LG G +G Y +E G A K + + D++++ +E+ IM+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQC- 81
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-TERAAAAVTKTIVEVVQMC 172
++V +Y +T + +VME C G + D I R TE A + ++ ++ ++
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYYMAPEVLK 231
H +HRD+K N L K DFG++ K + ++G+P++MAPEV++
Sbjct: 142 HFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ 198
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D+WS G+ + G PP+ I + R P S+N D
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP-ELWSDNFTD 257
Query: 291 LVRKMLDPDPKRRLTAQQVL 310
V++ L P++R TA Q+L
Sbjct: 258 FVKQCLVKSPEQRATATQLL 277
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-43
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 56/296 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL--------RTAVDIEDVRREV 106
++YE ++G G +G + +RE + A K + +L +A+ RE+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSAL------REI 52
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKT 164
+++ L KH+NIV L D D + LV E C+ + FD G +
Sbjct: 53 CLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQ 109
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPY 223
+++ + CH V+HRDLKP+N L E LK +FGL+ F P +S V + +
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVRCYSAEVVTLW 166
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVL------ 274
Y P+VL + Y +D+WSAG I + G P F + I R +L
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR-LLGTPTEE 225
Query: 275 ---------DFRRDP-----------WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
D++ P PK++ +DL++ +L +P +R++A++ L
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 70/294 (23%), Positives = 117/294 (39%), Gaps = 53/294 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-------RTAVDIEDVRREVD 107
E Y +LG G + Y + + A K I +L TA+ REV
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAI------REVS 52
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTI 165
+++ L KH NIV L D + ++ LV E + + D +
Sbjct: 53 LLKDL-KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC--GNIINMHNVKLFLFQL 109
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYY 224
+ + CH+ V+HRDLKP+N L + E LK DFGL+ P + + V + +Y
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYDNEVVTLWY 166
Query: 225 MAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR----------- 271
P++L +Y ++D+W G I Y + G P F T + I R
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 272 --SVL-DFR------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+F+ P++ + DL+ K+L + + R++A+ +
Sbjct: 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-43
Identities = 80/290 (27%), Positives = 126/290 (43%), Gaps = 46/290 (15%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV----RREVDIMR 110
E+Y ++G G +G+ Y + ++ + KK+R + E + RE+ I++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG------ETFALKKIRLEKEDEGIPSTTIREISILK 55
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEV 168
L KH NIV L D + LV E + +L D G A + ++
Sbjct: 56 EL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNG 112
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
+ CH V+HRDLKP+N L + E LK DFGL+ F P K++ + + +Y AP
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------S 272
+VL + Y +D+WS G I ++ G P F +E I R +
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 273 VL-DFR-----------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
L + + E+ DL+ KML DP +R+TA+Q L
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-43
Identities = 80/257 (31%), Positives = 131/257 (50%), Gaps = 14/257 (5%)
Query: 58 ELGRELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLP 113
EL + LG G +G +L + + G +A K + K + + A E R E ++ H+
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+ +V L ++ +T +HL+++ GGELF + R +TE IV ++ H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS--VFFKPGEKFSEIVGSPYYMAPEVLK 231
K G+++RD+K EN L + DFGLS E+ + G+ YMAP++++
Sbjct: 177 KLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 232 RN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK-VSEN 287
+ VD WS GV++Y LL G PF + E+ I R +L P+P+ +S
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEMSAL 292
Query: 288 AKDLVRKMLDPDPKRRL 304
AKDL++++L DPK+RL
Sbjct: 293 AKDLIQRLLMKDPKKRL 309
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 66/279 (23%), Positives = 120/279 (43%), Gaps = 28/279 (10%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+ YEL +G G + + A K I+ +K +T ++++ +E+ M
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQC- 70
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--------RIVARGHYTERAAAAVTKTI 165
H NIV ++ + LVM+L GG + D G E A + + +
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS------VFFKPGEKFSEIV 219
+E ++ HK+G +HRD+K N L E ++ DFG+S + V
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 220 GSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS----- 272
G+P +MAPEV+++ Y + D+WS G+ L G P+ V +++
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 273 -VLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
++ K ++ + ++ L DP++R TA ++L
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-42
Identities = 75/265 (28%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E+ + RE+G G FG Y D N + A K +S ++ +D+ +EV ++ L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL- 111
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
+H N + + Y + LVME C G V + E AAVT ++ + H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--- 230
H ++HRD+K N L + E +K DFG + P F VG+PY+MAPEV+
Sbjct: 172 SHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAM 225
Query: 231 -KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP----WPKVS 285
+ Y +VDVWS G+ L PP + I ++ + S
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------ESPALQSGHWS 279
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVL 310
E ++ V L P+ R T++ +L
Sbjct: 280 EYFRNFVDSCLQKIPQDRPTSEVLL 304
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-42
Identities = 76/290 (26%), Positives = 117/290 (40%), Gaps = 43/290 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED-----VRREVDIM 109
+RYE LG G+F Y D+ A K I KL + +D RE+ ++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLL 66
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVE 167
+ L H NI+ L D + + + LV + E + T A ++
Sbjct: 67 QEL-SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 123
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMA 226
++ H+H ++HRDLKP N L LK DFGL+ F P ++ V + +Y A
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRA 180
Query: 227 PEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 271
PE+L R YG VD+W+ G IL LL VP +++ I
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 272 -------SVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ F P ++ DL++ + +P R+TA Q L
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-42
Identities = 72/291 (24%), Positives = 123/291 (42%), Gaps = 47/291 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV----RREVDIMR 110
E+Y+ ++G G +G+ Y D + + ++ K++R + E + RE+ +++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQG------RIVALKRIRLDAEDEGIPSTAIREISLLK 74
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAAVTKTIVEV 168
L H NIV L D + + LV E E ++ D + + ++
Sbjct: 75 EL-HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIYLYQLLRG 131
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAP 227
V CH+H ++HRDLKP+N L + LK DFGL+ F P ++ V + +Y AP
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR-------------S 272
+VL + Y VD+WS G I ++ G P F T+ I
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248
Query: 273 VL-DFR------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
L ++ P + DL+ ML DP +R++A+ +
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 49/297 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ Y+L R+LGRG++ + + N + K + V + ++RE+ I+ +
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILEN 86
Query: 112 LPKHQNIVCLKDTYEDDTAVH--LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
L NI+ L D +D + LV E + T+ I++ +
Sbjct: 87 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 143
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
CH G+MHRD+KP N + E L+ ID+GL+ F+ PG++++ V S Y+ PE+
Sbjct: 144 DYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 201
Query: 230 L--KRNYGPEVDVWSAGVILYILLCGVPPFWA-----------------ETEQGVAQAI- 269
L + Y +D+WS G +L ++ PF+ E
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 270 -------IRSVLDFRRDPW---------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ R W VS A D + K+L D + RLTA++ +
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-41
Identities = 65/277 (23%), Positives = 120/277 (43%), Gaps = 34/277 (12%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
+EL +G G +G Y + G A K + + + E++++E+++++
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGD-EEEEIKQEINMLKKYS 78
Query: 114 KHQNIVCLKDTY------EDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTKTI 165
H+NI + D + LVME C G + D + E A + + I
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV-FFKPGEKFSEIVGSPYY 224
+ + H+H V+HRD+K +N L E A +K +DFG+S + + + +G+PY+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 195
Query: 225 MAPEVLKRN------YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
MAPEV+ + Y + D+WS G+ + G PP I R+
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN------ 249
Query: 279 DPWPKV-----SENAKDLVRKMLDPDPKRRLTAQQVL 310
P P++ S+ + + L + +R +Q++
Sbjct: 250 -PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 64/263 (24%), Positives = 103/263 (39%), Gaps = 34/263 (12%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDV---RRE 105
G + +YE+ + G G YL DR NG K L + D E E
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKG-----LVHSGDAEAQAMAMAE 129
Query: 106 VDIMRHLPKHQNIVCLKDTYED-----DTAVHLVMELCEGGELFDRIVARGHYTERAAAA 160
+ + H +IV + + E D ++VME G L A A
Sbjct: 130 RQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIA 186
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
I+ + H G+++ DLKPEN + ++ LK ID G F + G
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV---SRINSFGYLYG 239
Query: 221 SPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+P + APE+++ D+++ G L L +P G+ + DP
Sbjct: 240 TPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----------DDP 289
Query: 281 WPKVSENAKDLVRKMLDPDPKRR 303
K ++ L+R+ +DPDP++R
Sbjct: 290 VLKTYDSYGRLLRRAIDPDPRQR 312
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-40
Identities = 74/303 (24%), Positives = 116/303 (38%), Gaps = 49/303 (16%)
Query: 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---- 103
P G RYE E+G G +G Y D +G A K +R
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPI 56
Query: 104 ---REVDIMRHL--PKHQNIVCLKD-----TYEDDTAVHLVMELCEG--GELFDRIVARG 151
REV ++R L +H N+V L D + + V LV E + D+ G
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + + + H + ++HRDLKPEN L + +K DFGL+ +
Sbjct: 117 -LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLARIYSY 172
Query: 212 GEKFSEIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
+ +V + +Y APEVL + Y VD+WS G I + P F +E I
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232
Query: 271 R-------------------SVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQ 307
+ P P++ E+ L+ +ML +P +R++A
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292
Query: 308 QVL 310
+ L
Sbjct: 293 RAL 295
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-39
Identities = 77/262 (29%), Positives = 123/262 (46%), Gaps = 14/262 (5%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV---RRE 105
G+ I ERY++ +LG G YL D A K+I + E + RE
Sbjct: 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFERE 61
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
V L HQNIV + D E+D +LVME EG L + I + G + A T I
Sbjct: 62 VHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI 120
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPY 223
++ ++ H ++HRD+KP+N L + K LK DFG++ + + ++G+
Sbjct: 121 LDGIKHAHDMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 224 YMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPW 281
Y +PE K D++S G++LY +L G PPF ET +A + I SV + D
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237
Query: 282 PKVSENAKDLVRKMLDPDPKRR 303
+ ++ +++ + + D R
Sbjct: 238 KDIPQSLSNVILRATEKDKANR 259
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-39
Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 35/277 (12%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
I+ + E+ +GRG FG+ R K ++ K++ + + + E+ +
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESESERKAFIVELRQLS 56
Query: 111 HLPKHQNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H NIV CL LVME EGG L++ + AA
Sbjct: 57 RV-NHPNIVKLYGACLNPVC-------LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 166 VEVVQ-MCHKH-----GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
++ Q + + H ++HRDLKP N L LK DFG + + +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV--LKICDFGTACDIQ--THMTNNK 164
Query: 220 GSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
GS +MAPEV + + Y + DV+S G+IL+ ++ PF + G A I+ +V + R
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTR 222
Query: 279 DPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
P K + + + L+ + DP +R + ++++ +
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-38
Identities = 70/298 (23%), Positives = 121/298 (40%), Gaps = 55/298 (18%)
Query: 55 ERYELGRELGRGEFGITYLCTD-RENGDAFACKSISKKKLR--------TAVDIEDVRRE 105
++YE E+G G +G + D + G A K + +++ + + RE
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTI------RE 61
Query: 106 VDIMRHL--PKHQNIVCLKD-----TYEDDTAVHLVMELCEG--GELFDRIVARGHYTER 156
V ++RHL +H N+V L D + +T + LV E + D++
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGVPTE 120
Query: 157 AAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
+ ++ + H H V+HRDLKP+N L + + +K DFGL+ + +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLARIYSFQMALT 177
Query: 217 EIVGSPYYMAPEVL-KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR---- 271
+V + +Y APEVL + +Y VD+WS G I + P F ++ I+
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 272 ---------------SVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ P + E KDL+ K L +P +R++A L
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 63/277 (22%), Positives = 118/277 (42%), Gaps = 33/277 (11%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR----TAVDIEDVRREVDIMRHLP 113
E +++G+G FG+ + ++ A KS+ ++ +REV IM +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL- 80
Query: 114 KHQNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
H NIV +VME G+L+ R++ + H + + ++++
Sbjct: 81 NHPNIVKLYGLMHN-------PPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDI 131
Query: 169 VQ-MCHKHG----VMHRDLKPENFLFANKKETAP--LKAIDFGLSVFFKPGEKFSEIVGS 221
+ + ++HRDL+ N + E AP K DFGLS S ++G+
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGN 189
Query: 222 PYYMAPEVL---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278
+MAPE + + +Y + D +S +ILY +L G P + E G + I + R
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGKIKFINMIREEGLR 248
Query: 279 DPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
P+ ++++ DPK+R ++ ++
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 75/307 (24%), Positives = 119/307 (38%), Gaps = 59/307 (19%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
R+ +R+++ R G+G FG L ++ G + A K + + R RE+ IM+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFR------NRELQIMQ 71
Query: 111 HLP--KHQNIVCLKDTY-------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
L H NIV L+ + D +++VME L +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 162 TKTIVEVVQM------CHK--HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
K + Q+ H V HRD+KP N L N+ LK DFG + P E
Sbjct: 131 IKVFL--FQLIRSIGCLHLPSVNVCHRDIKPHNVL-VNE-ADGTLKLCDFGSAKKLSPSE 186
Query: 214 KFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271
+ S YY APE++ ++Y VD+WS G I ++ G P F + G I+R
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246
Query: 272 --------------------SVLDFRRDPWPKV--------SENAKDLVRKMLDPDPKRR 303
+ + + PW V ++ A DL+ +L P+ R
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306
Query: 304 LTAQQVL 310
+ + L
Sbjct: 307 MKPYEAL 313
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-37
Identities = 75/333 (22%), Positives = 122/333 (36%), Gaps = 92/333 (27%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
++Y LG+ LG G FGI D E+G FA K + + RE+DIM+ L
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMKVL 57
Query: 113 PKHQNIVCLKD--------------------------------------TYEDDTAVHLV 134
H NI+ L D + ++++
Sbjct: 58 -DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVE--VVQM------CHKHGVMHRDLKPEN 186
ME L + R+ ++ ++ + Q+ H G+ HRD+KP+N
Sbjct: 117 MEYVPD-TLHKVL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 187 FLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAG 244
L N + LK DFG + P E + S +Y APE++ Y P +D+WS G
Sbjct: 172 LL-VN-SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
Query: 245 VILYILLCGVPPFWAETEQGVAQ-AIIRSVL---------------------DFRRDPWP 282
+ L+ G P F ET + Q I ++ + W
Sbjct: 230 CVFGELILGKPLFSGET--SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287
Query: 283 KV-----SENAKDLVRKMLDPDPKRRLTAQQVL 310
K+ A DL+ ++L +P R+ + +
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-37
Identities = 73/267 (27%), Positives = 117/267 (43%), Gaps = 19/267 (7%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDV---RRE 105
T + +RYELG LG G +L D + A K + + A D RRE
Sbjct: 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRRE 62
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVH----LVMELCEGGELFDRIVARGHYTERAAAAV 161
L H IV + DT E +T +VME +G L D + G T + A V
Sbjct: 63 AQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----SE 217
+ + H++G++HRD+KP N + + T +K +DFG++ +
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 218 IVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276
++G+ Y++PE + + DV+S G +LY +L G PPF ++ VA +R
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRR 303
+S + +V K L +P+ R
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 55/335 (16%), Positives = 107/335 (31%), Gaps = 62/335 (18%)
Query: 33 HHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE--FGITYLCTDRENGDAFACKSISK 90
HH + L + YEL +G+G L + G+ + I+
Sbjct: 3 HHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL 62
Query: 91 KKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--RIV 148
+ + ++ E+ + + H NIV + T+ D + +V G D
Sbjct: 63 EACSNE-MVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH 120
Query: 149 ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV- 207
E A A + + +++ + H G +HR +K + L + + ++
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV---YLSGLRSNLS 177
Query: 208 FFKPGEK-------FSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPF 257
G++ V +++PEVL++N Y + D++S G+ L G PF
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 258 -----------------------------------------WAETEQGVAQAIIRSVLDF 276
++ S D
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 277 RRDPWPKV-SENAKDLVRKMLDPDPKRRLTAQQVL 310
P+ + S + V + L +P R +A +L
Sbjct: 298 PSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 75/296 (25%), Positives = 133/296 (44%), Gaps = 49/296 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ + Y +G G +G D+ +G+ A K +S+ ++ + + RE+ +++H
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKH 79
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTK 163
+ +H+N++ L D + + +LVM + D +I+ ++E +
Sbjct: 80 M-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT----DLQKIM-GLKFSEEKIQYLVY 133
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+++ ++ H GV+HRDLKP N E LK +DFGL+ + + V + +
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRW 188
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-----------------------W 258
Y APEV+ +Y VD+WS G I+ +L G F
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 248
Query: 259 AETEQGVAQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ A++ I+S+ R + P+ S A DL+ KML+ D +RLTA Q L
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-36
Identities = 71/308 (23%), Positives = 118/308 (38%), Gaps = 66/308 (21%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR----REVDIMR 110
+YE ++G+G FG + R+ G A K K+ + E RE+ I++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITALREIKILQ 71
Query: 111 HLPKHQNIVCLKD--------TYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAAAA 160
L KH+N+V L + +++LV + CE L + +T
Sbjct: 72 LL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKR 128
Query: 161 VTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
V + ++ + H++ ++HRD+K N L LK DFGL+ F +
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQP--- 182
Query: 221 SPY--------YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270
+ Y Y PE+L +R+YGP +D+W AG I+ + P TEQ I
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 271 R-------------------SVLDFRRD---------PWPKVSENAKDLVRKMLDPDPKR 302
+ L+ + A DL+ K+L DP +
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 303 RLTAQQVL 310
R+ + L
Sbjct: 303 RIDSDDAL 310
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-36
Identities = 78/296 (26%), Positives = 129/296 (43%), Gaps = 48/296 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D + G A K +S+ ++ + + RE+ +++H
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKH 84
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTK 163
+ KH+N++ L D + E+ V+LV L D IV T+ +
Sbjct: 85 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQKLTDDHVQFLIY 139
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
I+ ++ H ++HRDLKP N E LK +DFGL+ + + V + +
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTAD--EMTGYVATRW 194
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETE 262
Y APE++ +Y VD+WS G I+ LL G F AE
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254
Query: 263 QGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ + A+ I+S+ + + + A DL+ KML D +R+TA Q L
Sbjct: 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-36
Identities = 80/310 (25%), Positives = 120/310 (38%), Gaps = 72/310 (23%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ RY +G G +G+ D N A K IS + RE+ I+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLR 81
Query: 112 LPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFD--RIVARGHYTE--------- 155
+H+NI+ + D T E V++V +L E D +++ H +
Sbjct: 82 F-RHENIIGINDIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQ 136
Query: 156 --RAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
R K I H V+HRDLKP N L N T LK DFGL+ P
Sbjct: 137 ILRG----LKYI-------HSANVLHRDLKPSN-LLLN--TTCDLKICDFGLARVADPDH 182
Query: 214 KFS----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF---------- 257
+ E V + +Y APE++ + Y +D+WS G IL +L P F
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 258 ---------WAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDP 300
E + A+ + S+ + PW P A DL+ KML +P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 301 KRRLTAQQVL 310
+R+ +Q L
Sbjct: 303 HKRIEVEQAL 312
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 58/310 (18%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
G ++ RY + LG G G+ + D + A K I L ++ RE+ I
Sbjct: 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKI 61
Query: 109 MRHLPKHQNIVCLKD--------------TYEDDTAVHLVMELCEGGELFD--RIVARGH 152
+R L H NIV + + + + +V++V E E D ++ +G
Sbjct: 62 IRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGP 116
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
E A ++ ++ H V+HRDLKP N LF N E LK DFGL+ P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPAN-LFINT-EDLVLKIGDFGLARIMDPH 174
Query: 213 EKFS----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF--------- 257
E + + +Y +P +L NY +D+W+AG I +L G F
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM 234
Query: 258 ----------WAETEQGV---AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDP 300
E Q + IR+ + P P +S A D + ++L P
Sbjct: 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 301 KRRLTAQQVL 310
RLTA++ L
Sbjct: 295 MDRLTAEEAL 304
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 71/305 (23%), Positives = 123/305 (40%), Gaps = 55/305 (18%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +RY+ + +G G GI D A K +S+ + + RE+ +M+
Sbjct: 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 117
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKT 164
+ H+NI+ L + T E+ V+LVMEL + + V + + +
Sbjct: 118 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQ 172
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
++ ++ H G++HRDLKP N + K LK +DFGL+ + V + YY
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 229
Query: 225 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 264
APEV L Y VD+WS G I+ ++ F E +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 265 V---AQAIIRSVLDFRRDPWPKV----------------SENAKDLVRKMLDPDPKRRLT 305
+ + + + + +PK+ + A+DL+ KML DP +R++
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 306 AQQVL 310
L
Sbjct: 350 VDDAL 354
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-35
Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 48/296 (16%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ Y + +G G +G D G A K + + ++ + + RE+ +++H
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKH 80
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD--RIVARGHYTERAAAAVTK 163
+ +H+N++ L D T +D T +LVM D +++ E +
Sbjct: 81 M-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVY 135
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPY 223
+++ ++ H G++HRDLKP N E LK +DFGL+ + + V + +
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYVVTRW 190
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETE 262
Y APEV+ Y VD+WS G I+ ++ G F AE
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250
Query: 263 QGV----AQAIIRSVLDFRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
Q + A+ ++ + + + + S A +L+ KML D ++R+TA + L
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 37/265 (13%), Positives = 67/265 (25%), Gaps = 34/265 (12%)
Query: 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
P R RY L G + D A + + + +++
Sbjct: 24 PGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+ + + + D +V E GG L + VA + A +++
Sbjct: 84 RLSRI-DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAA 140
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
H+ GV P + G V + P M
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVS-----------IDGDVV-----------LAYPATMPD 178
Query: 228 EVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW---PKV 284
P+ D+ G LY LL P + R +P +
Sbjct: 179 A------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI 232
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQV 309
+ + + D R + +
Sbjct: 233 PFQISAVAARSVQGDGGIRSASTLL 257
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 78/321 (24%), Positives = 126/321 (39%), Gaps = 86/321 (26%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVDI 108
I ++L LG G +G+ T + G+ A I KK+ RE+ I
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVA---I--KKIEPFDKPLFALRTLREIKI 62
Query: 109 MRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFD--RIVARGHYTE------ 155
++H KH+NI+ + + ++E+ V+++ EL + D R+++ ++
Sbjct: 63 LKHF-KHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYF 117
Query: 156 -----RAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
RA K + H V+HRDLKP N L N LK DFGL+
Sbjct: 118 IYQTLRA----VKVL-------HGSNVIHRDLKPSN-LLIN--SNCDLKVCDFGLARIID 163
Query: 211 PGEKFSEIVGSP-----------YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVP-- 255
+ +Y APEV+ Y +DVWS G IL L P
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
Query: 256 ------------------PFWAETEQGV----AQAIIRSVLDFRRDPW----PKVSENAK 289
P + + A+ I+S+ + P P+V+
Sbjct: 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGI 283
Query: 290 DLVRKMLDPDPKRRLTAQQVL 310
DL+++ML DP +R+TA++ L
Sbjct: 284 DLLQRMLVFDPAKRITAKEAL 304
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 66/275 (24%), Positives = 110/275 (40%), Gaps = 36/275 (13%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E E+G G G + R+ G A K + + + + + ++D++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHD 82
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH- 173
IV T+ +T V + MEL + +G ER +T IV+ +
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-----VGSPYYMAPE 228
KHGV+HRD+KP N L + + +K DFG+S G + G YMAPE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQ---IKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPE 194
Query: 229 VLKRN------YGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLDFRRDPW 281
+ Y DVWS G+ L L G P+ +T+ V ++ ++
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-------QEEP 247
Query: 282 PKV------SENAKDLVRKMLDPDPKRRLTAQQVL 310
P + S + + V+ L D ++R ++L
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 59/282 (20%), Positives = 117/282 (41%), Gaps = 44/282 (15%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
E+G +G+G FG Y +G+ A + I ++ ++ +REV R +H+N
Sbjct: 36 EIGELIGKGRFGQVYHGR--WHGEV-AIRLIDIERD-NEDQLKAFKREVMAYRQT-RHEN 90
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVVQM 171
+V C+ + + ++ LC+G L+ + A+ + + IV+ +
Sbjct: 91 VVLFMGACMSPPH-----LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP------GEKFSEIVGSPYYM 225
H G++H+DLK +N + N K + DFGL +K G ++
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 226 APEVLKRN----------YGPEVDVWSAGVILYILLCGVPPFWAETEQGV-AQAIIRSVL 274
APE++++ + DV++ G I Y L PF + A+AII +
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-----KTQPAEAIIWQMG 256
Query: 275 DFRRDPWPKVS--ENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ ++ + D++ + + R T +++ +E
Sbjct: 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 74/327 (22%), Positives = 127/327 (38%), Gaps = 67/327 (20%)
Query: 46 KEPTGREIEERYE-LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRR 104
+E+ +E G ++GRG +G Y ++ D K + K++ R
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDD---KDYALKQIEGTGISMSACR 67
Query: 105 EVDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEG--GELFDRIVARGHYTERAA-- 158
E+ ++R L KH N++ L+ D V L+ + E + A +
Sbjct: 68 EIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 159 AAVTKT----IVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLS-VFFKPG 212
+ K+ I++ + H + V+HRDLKP N L + E +K D G + +F P
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 213 EKFS----EIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266
+ + +V + +Y APE+L R+Y +D+W+ G I LL P F E
Sbjct: 187 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245
Query: 267 QA---------IIR---------------------SVLDFRRDPW-------------PK 283
I + DFRR+ + K
Sbjct: 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVL 310
A L++K+L DP +R+T++Q +
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAM 332
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 58/275 (21%), Positives = 97/275 (35%), Gaps = 31/275 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E + E+GRG +G + +G A K I + + + ++D++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSD 79
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEV 168
IV + + MEL FD+ E +T V+
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 169 VQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-----VGSP 222
+ ++HRD+KP N L +K DFG+S G+ I G
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGIS-----GQLVDSIAKTRDAGCR 189
Query: 223 YYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRS-VLD 275
YMAPE + + Y DVWS G+ LY L G P+ + +++
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ 249
Query: 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ S + + V L D +R +++L
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-34
Identities = 62/265 (23%), Positives = 110/265 (41%), Gaps = 17/265 (6%)
Query: 46 KEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE 105
K+ G ++ +E ELG G G+ + + + +G A K I + + RE
Sbjct: 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRE 81
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ ++ IV + D + + ME +GG L + G E+ V+ +
Sbjct: 82 LQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 166 VEVVQMCH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI----VG 220
++ + KH +MHRD+KP N L ++ E +K DFG+S G+ + VG
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVS-----GQLIDSMANSFVG 192
Query: 221 SPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+ YM+PE L+ Y + D+WS G+ L + G P + + V +
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRL 304
P+ + L + +D P +
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAI 277
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 64/312 (20%), Positives = 112/312 (35%), Gaps = 68/312 (21%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----DIEDVR--- 103
++ Y + R + G +G D E G A K + D +
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 104 REVDIMRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFD--RIVARGHYTER 156
RE+ ++ H H NI+ L+D ++LV EL D +++
Sbjct: 78 REIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIV-- 130
Query: 157 AAAAVTKTIVE--VVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
++ ++ + + H+ GV+HRDL P N L + + DF L+
Sbjct: 131 ----ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLARE 183
Query: 209 FKPGEKFSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPF--------- 257
+ V +Y APE++ + + VD+WSAG ++ + F
Sbjct: 184 DTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243
Query: 258 --------------WAETEQGVAQAIIRSVLDFR-RDPW----PKVSENAKDLVRKMLDP 298
A+ +R+ L W P A DL+ KML+
Sbjct: 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303
Query: 299 DPKRRLTAQQVL 310
+P+RR++ +Q L
Sbjct: 304 NPQRRISTEQAL 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 62/267 (23%), Positives = 107/267 (40%), Gaps = 22/267 (8%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+ ++G G FG + G A K + ++ A + + REV IM+ L +H N
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPN 95
Query: 118 IVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-MCHKHG 176
IV + +V E G L+ + G + +V + M + H
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 177 ----VMHRDLKPENFLFANKKETAPLKAIDFGLS-VFFKPGEKFSEIVGSPYYMAPEVLK 231
++HR+LK N L K +K DFGLS + G+P +MAPEVL+
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 232 RN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVLDFRRDPWPK-VSEN 287
+ DV+S GVIL+ L P+ + AQ + +R P+ ++
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPW-----GNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267
Query: 288 AKDLVRKMLDPDPKRRLTAQQVLGKIE 314
++ +P +R + ++ +
Sbjct: 268 VAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-33
Identities = 67/305 (21%), Positives = 121/305 (39%), Gaps = 55/305 (18%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +RY+ + +G G GI D A K +S+ + + RE+ +M+
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKC 80
Query: 112 LPKHQNIVCLKD------TYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKT 164
+ H+NI+ L + + E+ V++VMEL + + V + + +
Sbjct: 81 V-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQ 135
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
++ ++ H G++HRDLKP N + K LK +DFGL+ + V + YY
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192
Query: 225 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPF-------------------WAETEQG 264
APEV L Y VD+WS G I+ ++ G F E +
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252
Query: 265 V---AQAIIRSVLDFRRDPW----------------PKVSENAKDLVRKMLDPDPKRRLT 305
+ + + + + + + A+DL+ KML D +R++
Sbjct: 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312
Query: 306 AQQVL 310
+ L
Sbjct: 313 VDEAL 317
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 62/251 (24%), Positives = 104/251 (41%), Gaps = 8/251 (3%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH 115
Y L R +GRG G Y D A K +S+ V ++RE L +
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QE 93
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
++V + D E D +++ M L G +L + +G A A+ + I + H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLKRN 233
G HRD+KPEN L + +DFG++ + + VG+ YYMAPE +
Sbjct: 154 GATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 234 Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ D+++ +LY L G PP+ + V A I + P + ++
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVI 269
Query: 293 RKMLDPDPKRR 303
+ + +P+ R
Sbjct: 270 ARGMAKNPEDR 280
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 70/350 (20%), Positives = 119/350 (34%), Gaps = 86/350 (24%)
Query: 29 DY--GTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACK 86
DY G +H G + RY L R+LG G F +L D N A K
Sbjct: 1 DYRPGGYHPAFKGEPY----------KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK 50
Query: 87 SI-SKKKLRTAVDIEDVRREVDIMRHL----------PKHQNIVCLKD--TYEDDTAVH- 132
+ K A + E + +++ + +I+ L D ++ VH
Sbjct: 51 IVRGDKVYTEAAEDE-----IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHV 105
Query: 133 -LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFL 188
+V E+ G L I H ++K ++ + H+ G++H D+KPEN L
Sbjct: 106 VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 189 FANKK---ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAG 244
+K D G + + E ++ + + Y +PEV L +G D+WS
Sbjct: 165 MEIVDSPENLIQIKIADLGNACW--YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA 222
Query: 245 VILYILLCGVPPFWAETEQGVAQ-----AIIRSVLD----------------FRRDPWPK 283
+++ L+ G F + + A I +L F +
Sbjct: 223 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 282
Query: 284 VSENAK-----------------------DLVRKMLDPDPKRRLTAQQVL 310
K D + ML DP++R A ++
Sbjct: 283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 59/271 (21%), Positives = 107/271 (39%), Gaps = 27/271 (9%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ E ELGRG +G+ +G A K I + + + + ++DI
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVD 64
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGG--ELFDRIVAR-GHYTERAAAAVTKTIVEVVQM 171
V + V + MEL + + + +++ + E + +IV+ ++
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 172 CH-KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI-----VGSPYYM 225
H K V+HRD+KP N L + +K DFG+S G ++ G YM
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGIS-----GYLVDDVAKDIDAGCKPYM 176
Query: 226 APEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWA-ETEQGVAQAIIRSVLDFRRD 279
APE + + Y + D+WS G+ + L P+ + T + ++ +
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE--PSPQL 234
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
P K S D + L + K R T +++
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELM 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 76/273 (27%), Positives = 114/273 (41%), Gaps = 29/273 (10%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQ 116
L +G G FG Y GD A K+ + IE+VR+E + L KH
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-MCHKH 175
NI+ L+ + + LVME GG L + + V++ + M + H
Sbjct: 67 NIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLH 122
Query: 176 G-----VMHRDLKPENFLFANKKETAP-----LKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
++HRDLK N L K E LK DFGL+ + K S G+ +M
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWM 181
Query: 226 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVLDFRRDPWP 282
APEV++ + + DVWS GV+L+ LL G PF +G+ ++ P P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGIDGLAVAYGVAMNKLALPIP 236
Query: 283 K-VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
E L+ +PDP R + +L ++
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 63/292 (21%), Positives = 107/292 (36%), Gaps = 46/292 (15%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
R G LG+G FG T RE G+ K + + +EV +M
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVM 61
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
R L +H N++ D ++ + E +GG L I + + V
Sbjct: 62 RCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY---------PWSQRV 111
Query: 170 QMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS------------- 206
H ++HRDL N L + + DFGL+
Sbjct: 112 SFAKDIASGMAYLHSMNIIHRDLNSHNCLV-RENKNV--VVADFGLARLMVDEKTQPEGL 168
Query: 207 --VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
+ +K +VG+PY+MAPE++ R+Y +VDV+S G++L ++ V
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYL 226
Query: 264 GVAQAIIRSVLDFRRDPWPK-VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+V F P + + + D DP++R + ++ +E
Sbjct: 227 PRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 67/286 (23%), Positives = 114/286 (39%), Gaps = 57/286 (19%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+G+ +G G FG Y +GD A K ++ T ++ + EV ++R +H N
Sbjct: 27 TVGQRIGSGSFGTVYKGK--WHGDV-AVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVN 81
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I+ +V + CEG L+ + A E + +++ +
Sbjct: 82 ILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASETKFE---------MKKLIDIA 126
Query: 173 ----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI---V 219
H ++HRDLK N +F ++ T +K DFGL+ +
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNN-IFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLS 183
Query: 220 GSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSV 273
GS +MAPEV++ Y + DV++ G++LY L+ G P+ + II V
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMV 238
Query: 274 L-DFRRDPWPKVSENA----KDLVRKMLDPDPKRRLTAQQVLGKIE 314
KV N K L+ + L R + ++L +IE
Sbjct: 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-31
Identities = 42/272 (15%), Positives = 95/272 (34%), Gaps = 33/272 (12%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+L G + + G+ K + + + D E +R H N
Sbjct: 13 NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIF-SHPN 68
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ-M 171
++ C L+ G L++ + ++ + AV K +++ + M
Sbjct: 69 VLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV-KFALDMARGM 124
Query: 172 CHKHG----VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
H + L + + + + F+ + + +P ++AP
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDM---TARISMADVKFSFQSPGR----MYAPAWVAP 177
Query: 228 EVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
E L++ D+WS V+L+ L+ PF + + ++ L+ R P
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPF---ADLSNMEIGMKVALEGLRPTIPP 234
Query: 284 -VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+S + L++ ++ DP +R ++ +E
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 69/322 (21%), Positives = 116/322 (36%), Gaps = 73/322 (22%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSI-SKKKLRTAVDIEDVRREVDIMRH 111
+ RYE+ + +G+G FG D + A K + ++K+ E + I+ H
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-----IRILEH 149
Query: 112 LPKHQ-----NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKT 164
L K N++ + + + + + EL L++ I ++ +
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY 224
I++ + HK+ ++H DLKPEN L + + +K IDFG S + ++ + S +Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSSCY--EHQRVYTYIQSRFY 265
Query: 225 MAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII------------- 270
APEV L YG +D+WS G IL LL G P E E +I
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325
Query: 271 --------------RSVLDFRRDPWPKVSENAKDL------------------------- 291
R V +
Sbjct: 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLF 385
Query: 292 ---VRKMLDPDPKRRLTAQQVL 310
+++ L+ DP R+T Q L
Sbjct: 386 LDFLKQCLEWDPAVRMTPGQAL 407
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 20/225 (8%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSI-SKKKLRTAVDIEDVRREVDI 108
G + +RYE+ +G+G FG DR + A K I +KK + EV +
Sbjct: 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQ-----AQIEVRL 103
Query: 109 MRHLPKH-----QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAV 161
+ + KH IV LK + + LV E+ L+D + +
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKF 162
Query: 162 TKTIVEVVQMCH--KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
+ + + + ++H DLKPEN L N K +A +K +DFG S G++ + +
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL--GQRIYQYI 219
Query: 220 GSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263
S +Y +PEV L Y +D+WS G IL + G P F E
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 68/333 (20%), Positives = 115/333 (34%), Gaps = 80/333 (24%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSI-SKKKLRTAVDIEDVRREVDI 108
G + + + R++G G FG LC +N +A K + + KK + IE DI
Sbjct: 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-----ADI 84
Query: 109 MRHL----PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVT 162
++ + + NIV + + L+ E G L++ I + +
Sbjct: 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYC 143
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP----------------------LKA 200
I++ + K + H DLKPEN L + +K
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWA 259
IDFG + F + I+ + Y APEV L + D+WS G +L L G F
Sbjct: 204 IDFGCATF--KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261
Query: 260 ETEQ-------GVAQAIIRSVLD----------FRRDP----WPKVSENAK--------- 289
+ Q I +++L +D WP+ + +
Sbjct: 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL 321
Query: 290 ------------DLVRKMLDPDPKRRLTAQQVL 310
D + +L DP R + ++L
Sbjct: 322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-29
Identities = 72/324 (22%), Positives = 122/324 (37%), Gaps = 74/324 (22%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAF-ACKSI-SKKKLRTAVDIEDVRREVDIMR 110
++ERYE+ LG G FG C D G + A K I + K R A R E+++++
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLK 71
Query: 111 HLPKH-----QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTK 163
+ + V + D + + + EL G F+ + Y +
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP----------------LKAIDFGLSV 207
+ ++ H++ + H DLKPEN LF N + ++ DFG +
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 208 FFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA 266
F E + IV + +Y PEV L+ + DVWS G IL+ G F +
Sbjct: 191 F--DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
Query: 267 QAIIR-------SVLD-------FRRD--PWPKVSENAK--------------------- 289
+ + ++ F + W + S + +
Sbjct: 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308
Query: 290 ---DLVRKMLDPDPKRRLTAQQVL 310
DL+R+ML+ DP +R+T + L
Sbjct: 309 QLFDLMRRMLEFDPAQRITLAEAL 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 63/308 (20%), Positives = 115/308 (37%), Gaps = 57/308 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-- 108
R + L +G+G +G + + + G+ A K S + D + RE ++
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR------DEKSWFRETELYN 55
Query: 109 MRHLPKHQNIVCL----KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
L +H+NI+ + T + L+ E G L+D + + + +
Sbjct: 56 TVML-RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLS 113
Query: 165 IV--------EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
I E+ K + HRDLK +N L + D GL+V
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ---CCIADLGLAVMHSQSTNQL 170
Query: 217 EI-----VGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGV---------- 254
++ VG+ YMAPEVL + VD+W+ G++L+ + +
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
Query: 255 PPFWAETEQGVAQAIIRS--VLDFRRDPWPKVSENA------KDLVRKMLDPDPKRRLTA 306
PPF+ + +R +D +R P + L+++ +P RLTA
Sbjct: 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290
Query: 307 QQVLGKIE 314
++ +
Sbjct: 291 LRIKKTLT 298
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 80/342 (23%), Positives = 128/342 (37%), Gaps = 103/342 (30%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +YEL ++LG+G +GI + DR G+ A K I + + D + RE+ I+
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTE 64
Query: 112 LPKHQNIVCLKD--TYEDDTAVHLVMELCE--------GGELFDRIVARGHYTERAAAAV 161
L H+NIV L + ++D V+LV + E L H
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-----HK-------- 111
Query: 162 TKTIVEVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
+ + V Q+ H G++HRD+KP N + N +K DFGLS F +
Sbjct: 112 -QYV--VYQLIKVIKYLHSGGLLHRDMKPSN-ILLN--AECHVKVADFGLSRSFVNIRRV 165
Query: 216 SEIVGSP----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYILL 251
+ + +Y APE+L Y +D+WS G IL +L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 252 CGVPPF-------------------WAETEQGV----AQAIIRSVLDFRRDPW------- 281
CG P F E + + A+ +I S+ +
Sbjct: 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF 285
Query: 282 -------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+E A DL+ K+L +P +R++A L
Sbjct: 286 TKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDAL 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 66/308 (21%), Positives = 111/308 (36%), Gaps = 57/308 (18%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI-- 108
R I L +G+G FG + R G+ A K S + + RE +I
Sbjct: 38 RTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQ 89
Query: 109 MRHLPKHQNIVCLK--DTYEDDTAVH--LVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
L +H+NI+ D ++ T LV + E G LFD + R T + +
Sbjct: 90 TVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALS 147
Query: 165 IV--------EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
E+V K + HRDLK +N L K+ D GL+V
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTI 204
Query: 217 EI-----VGSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV---------- 254
+I VG+ YMAPEVL + + D+++ G++ + +
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264
Query: 255 PPFWAETEQGVAQAIIRS--VLDFRRDPWPKVSENA------KDLVRKMLDPDPKRRLTA 306
P++ + +R R P ++ ++R+ + RLTA
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 307 QQVLGKIE 314
++ +
Sbjct: 325 LRIKKTLS 332
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 75/324 (23%), Positives = 115/324 (35%), Gaps = 74/324 (22%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAF-ACKSI-SKKKLRTAVDIEDVRREVDIMR 110
+ RYE+ LG G FG C D + G A K + + + A E + ++
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-----IQVLE 66
Query: 111 HLPKH-----QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTK 163
HL V + + +E + +V EL G +D I G + +
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAY 125
Query: 164 TIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP----------------LKAIDFGLSV 207
I + V H + + H DLKPEN LF T +K +DFG +
Sbjct: 126 QICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 208 FFKPGEKFSEIVGSPYYMAPEV-LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-- 264
+ E S +V + +Y APEV L + DVWS G IL G F +
Sbjct: 186 Y--DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
Query: 265 --------------VAQAIIRSVLDFRRDPWPKVSENAK--------------------- 289
+ + R R W + S +
Sbjct: 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303
Query: 290 ---DLVRKMLDPDPKRRLTAQQVL 310
DL++KML+ DP +R+T ++ L
Sbjct: 304 RLFDLIQKMLEYDPAKRITLREAL 327
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 70/350 (20%), Positives = 122/350 (34%), Gaps = 103/350 (29%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ + Y + +GRG +G YL D+ A K ++ + +D + + RE+ I+
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNR 81
Query: 112 LPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
L K I+ L D +++V+E+ + +L TE KTI
Sbjct: 82 L-KSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTE----EHIKTI- 134
Query: 167 EVVQMC------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVG 220
+ + H+ G++HRDLKP N L N + +K DFGL+ + + +
Sbjct: 135 -LYNLLLGENFIHESGIIHRDLKPANCL-LN--QDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 221 SP-----------------------YYMAPEVL--KRNYGPEVDVWSAGVILYILLC--- 252
+Y APE++ + NY +D+WS G I LL
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 253 --------------GVPPFWAETEQGVAQAIIRSVLD----------------------- 275
G F ++ + +S D
Sbjct: 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKP 310
Query: 276 -----------FRRDPW----PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ P +S++ +L+ ML +P +R+T Q L
Sbjct: 311 EVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQAL 360
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 61/313 (19%), Positives = 107/313 (34%), Gaps = 81/313 (25%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI--MRHLPKH 115
++ +++G+G +G ++ R G+ A K + RE +I + +H
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLM-RH 90
Query: 116 QNIVCL----KDTYEDDTAVHLVMELCEGGELFDRI----------------VARG---- 151
+NI+ T ++L+ + E G L+D + G
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
H E+ K + HRDLK +N L K+ D GL+V F
Sbjct: 151 H-------------TEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFIS 194
Query: 212 GEKFSEI-----VGSPYYMAPEVLKRNYGPE-------VDVWSAGVILYILLCGV----- 254
+I VG+ YM PEVL + D++S G+IL+ +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGI 254
Query: 255 -----PPFWAETEQGVAQAIIRS--VLDFRRDPWPKVSENA------KDLVRKMLDPDPK 301
P+ + +R + R +P + L+ + +P
Sbjct: 255 VEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314
Query: 302 RRLTAQQVLGKIE 314
RLTA +V +
Sbjct: 315 SRLTALRVKKTLA 327
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-26
Identities = 69/310 (22%), Positives = 115/310 (37%), Gaps = 75/310 (24%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN 117
+L RG FG + + A K EV + + KH+N
Sbjct: 27 QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPI----QDKQSWQNEYEVYSLPGM-KHEN 79
Query: 118 IV-----CLKDTYEDDTAVHLVMELCEGGELFD-------------RI---VARG----H 152
I+ + T D + L+ E G L D I +ARG H
Sbjct: 80 ILQFIGAEKRGT-SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH 138
Query: 153 YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
+ ++ HK + HRD+K +N L N DFGL++ F+ G
Sbjct: 139 -----------EDIPGLKDGHKPAISHRDIKSKNVLLKNNLT---ACIADFGLALKFEAG 184
Query: 213 EKFSEI---VGSPYYMAPEVL------KRNYGPEVDVWSAGVILYILLCG---------- 253
+ + VG+ YMAPEVL +R+ +D+++ G++L+ L
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 254 -VPPFWAET-EQGVAQAIIRSVLDFRRDP-----WPKVSENAK--DLVRKMLDPDPKRRL 304
+ PF E + + + V+ ++ P W K + A + + + D D + RL
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 305 TAQQVLGKIE 314
+A V +I
Sbjct: 305 SAGCVGERIT 314
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 74/372 (19%), Positives = 124/372 (33%), Gaps = 101/372 (27%)
Query: 32 THHQGNGGHKLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKK 91
HH + + +I +RYE+ +G G +G D+ A K I +
Sbjct: 32 QHHSSKPTASMPRPH--SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-R 88
Query: 92 KLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD-----TYEDDTAVHLVMELCEGGELFDR 146
+D + + RE+ I+ L H ++V + D E +++V+E+ + +
Sbjct: 89 VFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKL 146
Query: 147 IVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206
+ TE + ++ V+ H G++HRDLKP N L N + +K DFGL+
Sbjct: 147 FRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL-VN--QDCSVKVCDFGLA 203
Query: 207 -VFFKPGEKFSEIVGSP---------------------------YYMAPEVL--KRNYGP 236
P S++ SP +Y APE++ + NY
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE 263
Query: 237 EVDVWSAGVILYILLCGVPPFWAETEQG-------------VAQAIIRSVLDFRRDP--- 280
+DVWS G I LL + A Q R
Sbjct: 264 AIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ 323
Query: 281 ---------------WPKV-SENAKDLVR--------------------------KMLDP 298
+ E+AK +R +ML
Sbjct: 324 LNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVF 383
Query: 299 DPKRRLTAQQVL 310
+P +R+T + L
Sbjct: 384 NPNKRITINECL 395
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 64/314 (20%), Positives = 103/314 (32%), Gaps = 59/314 (18%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE--------ERYELGRELGRGEFGITYLCTDRENGDAFA 84
H R + E LG ++GRG FG + R + A
Sbjct: 84 HLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVA 143
Query: 85 CKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELF 144
KS ++ +E I++ H NIV L +++VMEL +GG+
Sbjct: 144 VKSC--RETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 145 DRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRDLKPENFLFANKKE 194
+ G + ++QM +HRDL N L K
Sbjct: 201 TFLRTEGARL---------RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV 251
Query: 195 TAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLKRN-YGPEVDVW 241
LK DFG+S E Y APE L Y E DVW
Sbjct: 252 ---LKISDFGMS---------REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVW 299
Query: 242 SAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDP 300
S G++L+ G P+ + Q + + + R + L+ + +P
Sbjct: 300 SFGILLWETFSLGASPYPNLSNQQTREFVEK---GGRLPCPELCPDAVFRLMEQCWAYEP 356
Query: 301 KRRLTAQQVLGKIE 314
+R + + +++
Sbjct: 357 GQRPSFSTIYQELQ 370
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 4e-22
Identities = 61/312 (19%), Positives = 104/312 (33%), Gaps = 68/312 (21%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--H 115
+L +GRG +G Y + A K S + ++ E +I R +P H
Sbjct: 16 KLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFA------NRQNFINEKNIYR-VPLMEH 66
Query: 116 QNIV-----CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV---- 166
NI + T + LVME G L ++ ++ + ++
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 167 -----EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE---- 217
+K + HRDL N L K DFGLS+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 218 -----IVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLCGV---------- 254
VG+ YMAPEVL+ + +VD+++ G+I + +
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 255 ---PPFWAETEQGVAQAIIRSVLDFRR------DPWPKVSENAKDLVRKML---DPDPKR 302
F E ++ ++ + + W + S + L + D D +
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 303 RLTAQQVLGKIE 314
RLTAQ ++
Sbjct: 303 RLTAQXAEERMA 314
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-21
Identities = 67/367 (18%), Positives = 115/367 (31%), Gaps = 114/367 (31%)
Query: 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
G RY + R+LG G F +L D + A K + K E E+ ++
Sbjct: 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVK---SAEHYTETALDEIRLL 87
Query: 110 RHL-------PKHQNIVCLKDTYEDD--TAVH--LVMELCEGGELFDRIVARGH--YTER 156
+ + P + +V L D ++ H +V E+ G L I+ +
Sbjct: 88 KSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLP 146
Query: 157 AAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFA------------------------- 190
+ + +++ + H ++H D+KPEN L +
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 191 ---------------------NKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
E +K D G + + + F+E + + Y + EV
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTEDIQTRQYRSLEV 264
Query: 230 -LKRNYGPEVDVWSAGVILYILLCGVPPF-------WAETEQGVAQAII----------- 270
+ Y D+WS + + L G F + E +A II
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL-IIELLGKVPRKLI 323
Query: 271 ----RSVLDFRRD----------PWPKVS----------ENAK---DLVRKMLDPDPKRR 303
S F + PW E A D + ML+ P++R
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 304 LTAQQVL 310
TA + L
Sbjct: 384 ATAAECL 390
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 5e-20
Identities = 64/313 (20%), Positives = 116/313 (37%), Gaps = 50/313 (15%)
Query: 33 HHQGNGGHKLCVLKEPTGR----------------EIE-ERYELGRELGRGEFGITYLCT 75
HH + L P + E+E + +LG G++G Y
Sbjct: 181 HHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGV 240
Query: 76 DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135
++ A K++ + +++E+ +E +M+ + KH N+V L + +++
Sbjct: 241 WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIIT 295
Query: 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRDLKPE 185
E G L D + R + V ++ M K +HR+L
Sbjct: 296 EFMTYGNLLDYL--------RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 186 NFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY-YMAPEVLK-RNYGPEVDVWS 242
N L E +K DFGLS + P + APE L + + DVW+
Sbjct: 348 NCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWA 404
Query: 243 AGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPK 301
GV+L+ I G+ P+ V + + + D+R + E +L+R +P
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRACWQWNPS 461
Query: 302 RRLTAQQVLGKIE 314
R + ++ E
Sbjct: 462 DRPSFAEIHQAFE 474
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-20
Identities = 62/301 (20%), Positives = 105/301 (34%), Gaps = 63/301 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVD 107
I +++ LGR LG+GEFG ++ +F A K + K + + DIE+ RE
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAA 77
Query: 108 IMRHLPKHQNIVCL------KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
M+ H ++ L +++ + G+L ++A
Sbjct: 78 CMKEF-DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL-- 134
Query: 162 TKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ +V+ +HRDL N + A E + DFGLS
Sbjct: 135 --PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLS----- 184
Query: 212 GEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPF 257
+I YY +A E L Y DVW+ GV ++ I+ G P+
Sbjct: 185 ----RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY 240
Query: 258 WAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKI 313
+ ++ R P + V M DPK+R + + ++
Sbjct: 241 AGIENAEI----YNYLIGGNRLKQP---PECMEEVYDLMYQCWSADPKQRPSFTCLRMEL 293
Query: 314 E 314
E
Sbjct: 294 E 294
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 63/324 (19%), Positives = 112/324 (34%), Gaps = 67/324 (20%)
Query: 33 HHQGNGGHKLCVLKEPTGREIE------ERYELGRELGRGEFGITYLCTDRENGDAF--- 83
HH + + E ++E LG+ LG GEFG ++
Sbjct: 6 HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 84 ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELC 138
A K++ K + +IE+ E M+ H N+ VC++ + + +++
Sbjct: 66 AVKTM-KLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPMVILPFM 123
Query: 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFL 188
+ G+L ++ T + +++ +HRDL N +
Sbjct: 124 KYGDLHTYLLYSRLETGPKHI----PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCM 179
Query: 189 FANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYG 235
+ + DFGLS +I YY +A E L R Y
Sbjct: 180 LR---DDMTVCVADFGLS---------KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227
Query: 236 PEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK 294
+ DVW+ GV ++ I G+ P+ + +L R P E+ D + +
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----YDYLLHGHRLKQP---EDCLDELYE 280
Query: 295 -MLD---PDPKRRLTAQQVLGKIE 314
M DP R T + ++E
Sbjct: 281 IMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 67/244 (27%), Positives = 95/244 (38%), Gaps = 49/244 (20%)
Query: 33 HHQGNGGHKLCVLKEPTG--REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----AC 85
HH + L VL + G +RY + R+LG G FG L D A
Sbjct: 6 HHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAV 65
Query: 86 KSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGEL 143
K++ K ++E+DI+R L H++I+ K ++ LVME G L
Sbjct: 66 KAL--KADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 144 FDRIVARGHYTERAAAAVTKTIVEVVQMC------HKHGVMHRDLKPENFLFANKKETAP 197
D Y R + + + ++ Q+C H +HRDL N L N +
Sbjct: 123 RD-------YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--- 172
Query: 198 LKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAG 244
+K DFGL+ G + YY APE LK + DVWS G
Sbjct: 173 VKIGDFGLAKAVPEGHE--------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFG 224
Query: 245 VILY 248
V LY
Sbjct: 225 VTLY 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 62/298 (20%), Positives = 114/298 (38%), Gaps = 58/298 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT--DRENGDAF---ACKSISKKKLRTAVDIEDVRRE 105
E+ E+ + RELG+G FG+ Y + A K++ + + + + E
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNE 78
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+M+ ++V L ++MEL G+L + + ++
Sbjct: 79 ASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
+++QM V HRDL N + A +K DFG++
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFV-HRDLAARNCMVAEDFT---VKIGDFGMT-------- 185
Query: 215 FSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M+PE LK + DVWS GV+L+ I P+
Sbjct: 186 -RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKIE 314
+ + V +R V++ P +N D++ + M +PK R + +++ I+
Sbjct: 245 SNEQV----LRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 49/248 (19%), Positives = 86/248 (34%), Gaps = 61/248 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIM 109
E ++ + LG G FG Y G+ A K + ++ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 110 RHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
+ + ++ +CL T V L+ +L G L D +
Sbjct: 72 ASV-DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKD---------NIG 115
Query: 165 IVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++ C ++HRDL N L + +K DFGL+ EK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEK 172
Query: 215 FSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
Y MA E + R Y + DVWS GV ++ ++ G P+
Sbjct: 173 --------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 262 EQGVAQAI 269
++ +
Sbjct: 225 ASEISSIL 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 11/161 (6%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ ++ LGR++G G FG YL T+ + + A K + K + E I R L
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRIL 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEG---GELFDRIVARGHYTERAAAAVTKTIVEVV 169
I ++ + LVM+L G +LF+ + + + ++ V
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRV 116
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+ H +HRD+KP+NFL + + IDFGL+ ++
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-18
Identities = 63/300 (21%), Positives = 106/300 (35%), Gaps = 56/300 (18%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE--DVRREVD 107
I+ L ELG G FG +L ++ K L+ A + D +RE +
Sbjct: 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE 95
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-----RIVARGHYTERAAAAVT 162
++ L +HQ+IV + + +V E G+L A+ A
Sbjct: 96 LLTML-QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 163 KTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
+ +++ + +HRDL N L +K DFG+S
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV---VKIGDFGMS------ 205
Query: 213 EKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 258
+I + YY M PE + R + E DVWS GV+L+ I G P++
Sbjct: 206 ---RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262
Query: 259 AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKIE 314
+ I + R P V M +P++R + + V +++
Sbjct: 263 QLSNTEA----IDCITQGRELERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 64/298 (21%), Positives = 110/298 (36%), Gaps = 56/298 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITY--LCTDRENGDAF---ACKSISKKKLRTAVDIEDVRRE 105
E+ + L R LG G FG Y + N + A K++ ++ + D D E
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLME 83
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
I+ HQNIV ++MEL GG+L + + + + +
Sbjct: 84 ALIISKF-NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS---SLAM 139
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
++++ + ++ +HRD+ N L K DFG++
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA--------- 190
Query: 216 SEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
+I + YY M PE + + D WS GV+L+ I G P+ +++
Sbjct: 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKIEF 315
Q V + V R P +N V + M P+ R +L +IE+
Sbjct: 251 NQEV----LEFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 64/299 (21%), Positives = 109/299 (36%), Gaps = 58/299 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITY--LCTDRENGDAF---ACKSISKKKLRTAVDIEDVRRE 105
E+ + L R LG G FG Y + N + A K++ ++ + D D E
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLME 124
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
I+ HQNIV +++EL GG+L + + ++ +
Sbjct: 125 ALIISKF-NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL---AM 180
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++++ + H + HRD+ N L K DFG++
Sbjct: 181 LDLLHVARDIACGCQYLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMA-------- 231
Query: 215 FSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAE 260
+I + YY M PE + + D WS GV+L+ I G P+ ++
Sbjct: 232 -RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290
Query: 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKIEF 315
+ Q V + V R P +N V + M P+ R +L +IE+
Sbjct: 291 SNQEV----LEFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 342
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 67/317 (21%), Positives = 119/317 (37%), Gaps = 56/317 (17%)
Query: 28 IDYGTHHQGNGGHKL---CVLKEPT-------GREIE-ERYELGRELGRGEFGITYLCTD 76
+ Y + H H+L C +P EI E L +LG+G FG ++ T
Sbjct: 146 VAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 205
Query: 77 RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAV 131
A K++ + E +E +M+ L +H+ + V ++ +
Sbjct: 206 NGTTRV-AIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE------PI 253
Query: 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRD 181
++V E G L D + + + ++V M + +HRD
Sbjct: 254 YIVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY-YMAPEVLK-RNYGPEV 238
L+ N L E K DFGL+ + E + P + APE + +
Sbjct: 306 LRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 239 DVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
DVWS G++L + G P+ + V + R +R P+ E+ DL+ +
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWR 419
Query: 298 PDPKRRLTAQQVLGKIE 314
+P+ R T + + +E
Sbjct: 420 KEPEERPTFEYLQAFLE 436
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 53/228 (23%)
Query: 51 REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
E+R+ + R+LG G FG LC GD A KS+ K I D+++E
Sbjct: 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKE 73
Query: 106 VDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
++I+R+L H+NIV K T + + L+ME G L + + +
Sbjct: 74 IEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---------KI 123
Query: 164 TIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
+ + ++ +HRDL N L ++ + +K DFGL+ + +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDK 180
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+ YY APE L + DVWS GV L+
Sbjct: 181 E--------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLH 220
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 44/249 (17%), Positives = 77/249 (30%), Gaps = 48/249 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSIS--KKKLR--TAVDIEDVRREV 106
+I E LG+G F + RE GD K L E
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAA 63
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
+M L H+++V LV E + G L + + I+
Sbjct: 64 SMMSKL-SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---------CINIL 113
Query: 167 EVVQMCH----------KHGVMHRDLKPENFLFANKKETAPL-----KAIDFGLSVFFKP 211
+++ ++ ++H ++ +N L +++ K D G+S+
Sbjct: 114 WKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--- 170
Query: 212 GEKFSEIVGSPYY------MAPEVLK--RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 262
++ + PE ++ +N D WS G L+ I G P A
Sbjct: 171 ------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224
Query: 263 QGVAQAIIR 271
Q Q
Sbjct: 225 QRKLQFYED 233
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 6e-18
Identities = 66/317 (20%), Positives = 118/317 (37%), Gaps = 56/317 (17%)
Query: 28 IDYGTHHQGNGGHKL---CVLKEPT-------GREIE-ERYELGRELGRGEFGITYLCTD 76
+ Y + H H+L C +P EI E L +LG+G FG ++ T
Sbjct: 229 VAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW 288
Query: 77 RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAV 131
A K++ + E +E +M+ L +H+ + V ++ +
Sbjct: 289 NGTTRV-AIKTLKP----GTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE------PI 336
Query: 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRD 181
++V E G L D + + + ++V M + +HRD
Sbjct: 337 YIVTEYMSKGSLLDFL--------KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS-PY-YMAPEVLK-RNYGPEV 238
L+ N L K DFGL+ + E + P + APE + +
Sbjct: 389 LRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 239 DVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297
DVWS G++L + G P+ + V + R +R P+ E+ DL+ +
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQCWR 502
Query: 298 PDPKRRLTAQQVLGKIE 314
+P+ R T + + +E
Sbjct: 503 KEPEERPTFEYLQAFLE 519
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-18
Identities = 62/299 (20%), Positives = 109/299 (36%), Gaps = 73/299 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMR 110
+GRG FG Y T +N A KS+ ++ ++ E IM+
Sbjct: 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 81
Query: 111 HLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
H N+ +CL+ + + +V+ + G+L + I H T+
Sbjct: 82 DF-SHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRNETH---------NPTV 127
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
+++ +HRDL N + E +K DFGL+
Sbjct: 128 KDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA--------- 175
Query: 216 SEIVGSPYY--------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWA 259
++ YY MA E L+ + + + DVWS GV+L+ ++ G PP+
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235
Query: 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKIE 314
+ +L RR P E D + + ML P + R + +++ +I
Sbjct: 236 VNTFDI----TVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-18
Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 15/182 (8%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ RY LGR++G G FG YL TD G+ A K K + E I + +
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMM 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKTIVEVVQM 171
I ++ + +VMEL G L D ++ + + ++ ++
Sbjct: 62 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI--------VGSPY 223
H +HRD+KP+NFL K+ + IDFGL+ ++ I G+
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 224 YM 225
Y
Sbjct: 181 YA 182
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 8e-18
Identities = 61/288 (21%), Positives = 109/288 (37%), Gaps = 54/288 (18%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM 109
E++ E L +ELG G+FG+ L + D A K I + ++ ++ +E M
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKE----GSMSEDEFFQEAQTM 57
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
L H +V + +++V E G L + + + G +++
Sbjct: 58 MKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL---------EPSQLL 107
Query: 170 QMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
+MC+ H +HRDL N L +K DFG++ + ++
Sbjct: 108 EMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC---VKVSDFGMTRY---------VL 155
Query: 220 GSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA 266
Y APEV Y + DVW+ G++++ + G P+ T V
Sbjct: 156 DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215
Query: 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ + R S+ ++ P++R T QQ+L IE
Sbjct: 216 LKVSQ---GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-18
Identities = 70/299 (23%), Positives = 108/299 (36%), Gaps = 54/299 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E + G+ LG G FG T G A ++ K L+ A + E + E+
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD----RIVARGHYTERAAAAVTK 163
IM HL +H+NIV L V ++ E C G+L + + A A T
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 164 TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
+ +++ +HRD+ N L N K DFGL+
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV---AKIGDFGLA------- 211
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWA 259
+I+ Y MAPE + Y + DVWS G++L+ I G+ P+
Sbjct: 212 --RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269
Query: 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKIE 314
V + V D + P A + M +P R T QQ+ ++
Sbjct: 270 IL---VNSKFYKLVKDGYQMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 62/284 (21%), Positives = 105/284 (36%), Gaps = 48/284 (16%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
EI+ + +ELG G+FG+ R D A K I + ++ ++ E +M
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKE----GSMSEDEFIEEAKVMM 74
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+L H+ +V L + ++ E G L + + H ++++
Sbjct: 75 NL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---------RFQTQQLLE 124
Query: 171 MCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-------KPGE 213
MC +HRDL N L ++ +K DFGLS + G
Sbjct: 125 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGS 181
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
KF P + PEVL + + D+W+ GV+++ I G P+ T A+ I
Sbjct: 182 KF------PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ R SE ++ R T + +L I
Sbjct: 236 Q---GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 64/318 (20%), Positives = 112/318 (35%), Gaps = 67/318 (21%)
Query: 33 HHQGNGGHKLCVLKEPTGR---------------EIE-ERYELGRELGRGEFGITYLCTD 76
H+ + L +P + + +L + +G+GEFG L
Sbjct: 155 HYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY 214
Query: 77 RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY----EDDTAVH 132
R N A K ++ + E +M L +H N+V L E+ ++
Sbjct: 215 RGNKVAV-------KCIKNDATAQAFLAEASVMTQL-RHSNLVQL---LGVIVEEKGGLY 263
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDL 182
+V E G L D + +RG +++ + +HRDL
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 183 KPENFLFANKKETAPLKAIDFGLS---VFFKPGEKFSEIVGSPY-YMAPEVLKRN-YGPE 237
N L + E K DFGL+ + K P + APE L+ + +
Sbjct: 316 AARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKKFSTK 366
Query: 238 VDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKML 296
DVWS G++L+ I G P+ + V + + ++ D D+++
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYDVMKNCW 423
Query: 297 DPDPKRRLTAQQVLGKIE 314
D R T Q+ ++E
Sbjct: 424 HLDAATRPTFLQLREQLE 441
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 55/255 (21%), Positives = 82/255 (32%), Gaps = 60/255 (23%)
Query: 51 REI-EERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
I E+ L +LG G FG+ + A K + L ++D REV
Sbjct: 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72
Query: 107 DIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
+ M L H+N+ V L + +V EL G L DR+
Sbjct: 73 NAMHSL-DHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQG--------- 116
Query: 162 TKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + + +HRDL N L A + +K DFGL
Sbjct: 117 HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQ 173
Query: 212 GEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPF 257
+ +Y APE LK R + D W GV L+ + G P+
Sbjct: 174 NDD--------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
Query: 258 WAETEQGVAQAIIRS 272
+ I +
Sbjct: 226 IGLNGSQILHKIDKE 240
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 64/284 (22%), Positives = 112/284 (39%), Gaps = 46/284 (16%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+E + +LG G++G Y ++ A K++ + +++E+ +E +M+
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMK 64
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+ KH N+V L + +++ E G L D + R + V ++
Sbjct: 65 EI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--------RECNRQEVSAVVLLY 115
Query: 171 MCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-------PGE 213
M K +HRDL N L E +K DFGLS G
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGA 172
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
KF P + APE L + + DVW+ GV+L+ I G+ P+ V + +
Sbjct: 173 KF------PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ D+R + E +L+R +P R + ++ E
Sbjct: 227 K---DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 65/305 (21%), Positives = 107/305 (35%), Gaps = 62/305 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E R G+ LG G FG T + A +++ K L+ + E + E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD--------RIVARGHYTERAAA 159
++ +L H NIV L ++ E C G+L + I ++
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 160 AVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209
+ + +++ + +HRDL N L K DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLA--- 192
Query: 210 KPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVP 255
+I Y MAPE + Y E DVWS G+ L+ + G
Sbjct: 193 ------RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 256 PFWAETEQGVA--QAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ G+ + + + R P E+A + M DP +R T +Q+
Sbjct: 247 PY-----PGMPVDSKFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 310 LGKIE 314
+ IE
Sbjct: 299 VQLIE 303
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-17
Identities = 64/284 (22%), Positives = 106/284 (37%), Gaps = 48/284 (16%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
I+ +E+G G+FG+ +L A K+I + A+ ED E ++M
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIRE----GAMSEEDFIEEAEVMM 58
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
L H +V L + + LV E E G L D + + ++
Sbjct: 59 KL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG---------LFAAETLLG 108
Query: 171 MCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-------KPGE 213
MC + V+HRDL N L + +K DFG++ F G
Sbjct: 109 MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGT 165
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
KF P + +PEV Y + DVWS GV+++ + G P+ + V + I
Sbjct: 166 KF------PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
FR S + ++ P+ R ++L ++
Sbjct: 220 T---GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 60/263 (22%), Positives = 89/263 (33%), Gaps = 59/263 (22%)
Query: 31 GTHHQGNGGHKLCVLKEPTGREIEERY-ELGRELGRGEFGITYLCTDRENGDAF----AC 85
G HH + C ++PT EER+ + +LG+G FG LC GD A
Sbjct: 2 GHHHHHHAQLYAC--QDPT--IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 86 KSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGEL 143
K + + D +RE+ I++ L IV + ++ LVME G L
Sbjct: 58 KQL---QHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCL 113
Query: 144 FDRIVARGHYTERAAAAVTKTIVEVVQMC----------HKHGVMHRDLKPENFLFANKK 193
D + ++ +HRDL N L ++
Sbjct: 114 RDFLQRHRA---------RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA 164
Query: 194 ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDV 240
+K DFGL+ + YY APE L + + DV
Sbjct: 165 H---VKIADFGLAKLLPLDKD--------YYVVREPGQSPIFWYAPESLSDNIFSRQSDV 213
Query: 241 WSAGVILY-ILLCGVPPFWAETE 262
WS GV+LY + E
Sbjct: 214 WSFGVVLYELFTYCDKSCSPSAE 236
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 46/244 (18%), Positives = 83/244 (34%), Gaps = 46/244 (18%)
Query: 51 REI-EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
R E + LG G FG + G++ K I + + V
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDH 65
Query: 106 VDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAA 160
+ + L H +I +C + + LV + G L D +
Sbjct: 66 MLAIGSL-DHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRG-------- 110
Query: 161 VTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
++ +HG++HR+L N L + + ++ DFG++
Sbjct: 111 -ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ---VQVADFGVADLLP 166
Query: 211 PGEKFSEIVGS--PY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
P +K + P +MA E + Y + DVWS GV ++ ++ G P+ V
Sbjct: 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226
Query: 266 AQAI 269
+
Sbjct: 227 PDLL 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-17
Identities = 54/253 (21%), Positives = 90/253 (35%), Gaps = 50/253 (19%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVRREVDI 108
++ + +G G FG +++G A K + K+ + D D E+++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEV 78
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD------RIVARGHYTERAAAAVT 162
+ L H NI+ L E ++L +E G L D + + + A T
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 163 KTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
+ +++ + +HRDL N L K DFGLS
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIADFGLS------ 189
Query: 213 EKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 258
+ E Y MA E L Y DVWS GV+L+ I+ G P+
Sbjct: 190 -RGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243
Query: 259 AETEQGVAQAIIR 271
T + + + +
Sbjct: 244 GMTCAELYEKLPQ 256
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-17
Identities = 61/322 (18%), Positives = 127/322 (39%), Gaps = 67/322 (20%)
Query: 28 IDYGTHHQGNGGHKL---CVLKEPTGREIEERYE-------LGRELGRGEFGITYLCTDR 77
+D+ KL C+ +P ++ +E L ++LG G+FG ++ T
Sbjct: 151 VDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYN 210
Query: 78 ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVH 132
++ A K++ ++ +E E ++M+ L +H + V K+ ++
Sbjct: 211 KHTKV-AVKTMKP----GSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTKE------PIY 258
Query: 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDL 182
++ E G L D + ++ + + +++ + +HRDL
Sbjct: 259 IITEFMAKGSLLDFL--------KSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 183 KPENFLFANKKETAPLKAIDFGLSVFF-------KPGEKFSEIVGSPY-YMAPEVLK-RN 233
+ N L + + K DFGL+ + G KF P + APE + +
Sbjct: 311 RAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKF------PIKWTAPEAINFGS 361
Query: 234 YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ + DVWS G++L I+ G P+ + V +A+ R +R E +++
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER---GYRMPRPENCPEELYNIM 418
Query: 293 RKMLDPDPKRRLTAQQVLGKIE 314
+ P+ R T + + ++
Sbjct: 419 MRCWKNRPEERPTFEYIQSVLD 440
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-17
Identities = 40/161 (24%), Positives = 73/161 (45%), Gaps = 9/161 (5%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ Y++GR +G G FG+ + T+ N A K ++ D +R E + L
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 62
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-RIVARGHYTERAAAAVTKTIVEVVQM 171
I + ++ LV++L G L D + ++ + A K ++ VQ
Sbjct: 63 AGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 172 CHKHGVMHRDLKPENFLF--ANKKETAPLKAIDFGLSVFFK 210
H+ +++RD+KP+NFL N K + +DFG+ F++
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-17
Identities = 64/297 (21%), Positives = 109/297 (36%), Gaps = 69/297 (23%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMR 110
+GRG FG Y T +N A KS+ ++ ++ E IM+
Sbjct: 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 145
Query: 111 HLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
H N+ +CL+ + + +V+ + G+L + I H T+
Sbjct: 146 DF-SHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRNETH---------NPTV 191
Query: 166 VEVVQMCH-----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
+++ K V HRDL N + E +K DFGL+ E
Sbjct: 192 KDLIGFGLQVAKGMKFLASKKFV-HRDLAARNCMLD---EKFTVKVADFGLARDMYDKEF 247
Query: 215 FSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
S + MA E L+ + + + DVWS GV+L+ ++ G PP+
Sbjct: 248 DS------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301
Query: 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKIE 314
+ +L RR P E D + + ML P + R + +++ +I
Sbjct: 302 TFDI----TVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 68/307 (22%), Positives = 113/307 (36%), Gaps = 67/307 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E +R +LG+ LGRG FG C++++ K L+ T + + E+
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 108 IMRHLPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFD------RIVARGHYTERA 157
I+ H+ H N+V L + + +++E C+ G L
Sbjct: 83 ILIHIGHHLNVVNL---LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 158 AAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
T+ ++ +HRDL N L + K +K DFGL+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLA- 195
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I P Y MAPE + R Y + DVWS GV+L+ I G
Sbjct: 196 --------RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 254 VPPFWAETEQGVA--QAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQ 307
P+ GV + R + + R P + + + MLD +P +R T
Sbjct: 248 ASPY-----PGVKIDEEFCRRLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFS 299
Query: 308 QVLGKIE 314
+++ +
Sbjct: 300 ELVEHLG 306
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 73/306 (23%), Positives = 109/306 (35%), Gaps = 67/306 (21%)
Query: 43 CVLKEPTGREIE---ERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTA 96
P+ R+ E ER ELGR +G G+FG + + A A K+ K +
Sbjct: 375 DTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSD 432
Query: 97 VDIEDVRREVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARG 151
E +E MR H +I V ++ V ++MELC GEL + R
Sbjct: 433 SVREKFLQEALTMRQF-DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRK 485
Query: 152 HYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAI 201
+ + ++ + +HRD+ N L ++ +K
Sbjct: 486 F---------SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLG 533
Query: 202 DFGLSVFFKPGEKFSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY- 248
DFGLS + S YY MAPE + R + DVW GV ++
Sbjct: 534 DFGLS---------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQ 308
IL+ GV PF V I R P L+ K DP RR +
Sbjct: 585 ILMHGVKPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE 641
Query: 309 VLGKIE 314
+ ++
Sbjct: 642 LKAQLS 647
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 56/228 (24%), Positives = 86/228 (37%), Gaps = 54/228 (23%)
Query: 51 REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
+ EER+ + ++LG+G FG +C D A K + + T + D RE
Sbjct: 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFERE 92
Query: 106 VDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
++I++ L +H NIV K + L+ME G L D +
Sbjct: 93 IEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---------RI 142
Query: 164 TIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
++++Q +HRDL N L N+ +K DFGL+ +
Sbjct: 143 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDK 199
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+ YY APE L + DVWS GV+LY
Sbjct: 200 E--------YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 54/228 (23%), Positives = 86/228 (37%), Gaps = 54/228 (23%)
Query: 51 REIEERY-ELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRRE 105
+ EER+ + ++LG+G FG +C D A K + + T + D RE
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFERE 61
Query: 106 VDIMRHLPKHQNIVCLKD--TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
++I++ L +H NIV K + L+ME G L D +
Sbjct: 62 IEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---------RI 111
Query: 164 TIVEVVQMC----------HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
++++Q +HRDL N L N+ +K DFGL+ +
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDK 168
Query: 214 KFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
+ ++ APE L + DVWS GV+LY
Sbjct: 169 E--------FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 62/302 (20%), Positives = 113/302 (37%), Gaps = 58/302 (19%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREV 106
+EI ELG FG Y ++++ K L+ E+ R E
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK--- 163
+ L +H N+VCL D + ++ C G+L + +V R +++ + +
Sbjct: 64 MLRARL-QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 164 ---TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
+ V + H V+H+DL N L +K +K D GL
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDLGLF---- 175
Query: 211 PGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPP 256
E+ + YY MAPE + + + D+WS GV+L+ + G+ P
Sbjct: 176 -----REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
Query: 257 FWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGK 312
+ + Q V + + + + P P ++ V M++ P RR + + +
Sbjct: 231 YCGYSNQDV----VEMIRNRQVLPCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
Query: 313 IE 314
+
Sbjct: 284 LR 285
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 49/248 (19%), Positives = 86/248 (34%), Gaps = 61/248 (24%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIM 109
E ++ + LG G FG Y G+ A K + ++ + +++ E +M
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVM 71
Query: 110 RHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
+ + ++ +CL T V L+ +L G L D +
Sbjct: 72 ASV-DNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKD---------NIG 115
Query: 165 IVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214
++ C ++HRDL N L + +K DFGL+ EK
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEK 172
Query: 215 FSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAET 261
Y MA E + R Y + DVWS GV ++ ++ G P+
Sbjct: 173 --------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 224
Query: 262 EQGVAQAI 269
++ +
Sbjct: 225 ASEISSIL 232
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 57/246 (23%), Positives = 102/246 (41%), Gaps = 55/246 (22%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+ E +L LG G+FG ++ + A KS+ + ++ + E ++M+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQ----GSMSPDAFLAEANLMK 63
Query: 111 HLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
L +HQ + V ++ ++++ E E G L D + + + + TI
Sbjct: 64 QL-QHQRLVRLYAVVTQE------PIYIITEYMENGSLVDFL--------KTPSGIKLTI 108
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF------ 209
+++ M + +HRDL+ N L + +T K DFGL+
Sbjct: 109 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYT 165
Query: 210 -KPGEKFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGV 265
+ G KF P + APE + + + DVWS G++L I+ G P+ T V
Sbjct: 166 AREGAKF------PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 266 AQAIIR 271
Q + R
Sbjct: 220 IQNLER 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 75/309 (24%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV-----------DI 99
I+ L RELG G FG +L C ++S K + V
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAE---------CYNLSPTKDKMLVAVKALKDPTLAAR 61
Query: 100 EDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAA 159
+D +RE +++ +L +H++IV D + +V E + G+L + A G
Sbjct: 62 KDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 160 AVTK------TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDF 203
+ + +++ + +HRDL N L +K DF
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDF 177
Query: 204 GLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-I 249
G+S ++ + YY M PE + R + E DVWS GVIL+ I
Sbjct: 178 GMS---------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228
Query: 250 LLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLT 305
G P++ + V I + R P V ML +P++RL
Sbjct: 229 FTYGKQPWFQLSNTEV----IECITQGRVLERP---RVCPKEVYDVMLGCWQREPQQRLN 281
Query: 306 AQQVLGKIE 314
+++ +
Sbjct: 282 IKEIYKILH 290
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 73/337 (21%), Positives = 108/337 (32%), Gaps = 78/337 (23%)
Query: 28 IDYGTHHQGNGGHKLCVLKEPT--------------------GREIE-ERYELGRELGRG 66
+ + HH + K P REIE R + + +G G
Sbjct: 1 MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60
Query: 67 EFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD 123
+ G R G A K++ K T D E IM H NI+ L+
Sbjct: 61 DSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQF-DHPNIIRLEG 117
Query: 124 TYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH---------- 173
+V E E G L + TI+++V M
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDG---------QFTIMQLVGMLRGVGAGMRYLS 168
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY--------- 224
G +HRDL N L + K DFGLS + Y
Sbjct: 169 DLGYVHRDLAARNVLVDSNLV---CKVSDFGLSRVLEDDP-------DAAYTTTGGKIPI 218
Query: 225 --MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
APE + R + DVWS GV+++ +L G P+W T + V ++ +R
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE---GYRLPA 275
Query: 281 WPKVSENAKDLVRKMLD---PDPKRRLTAQQVLGKIE 314
L MLD D +R Q++ ++
Sbjct: 276 PMGCPHALHQL---MLDCWHKDRAQRPRFSQIVSVLD 309
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 64/295 (21%), Positives = 109/295 (36%), Gaps = 73/295 (24%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
R +G+G FG+ Y + A KS+ ++ +E RE +MR L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGL-N 80
Query: 115 HQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
H N+ + L + H+++ G+L I + T+ +++
Sbjct: 81 HPNVLALIGIMLP----PEGLPHVLLPYMCHGDLLQFIRSPQR---------NPTVKDLI 127
Query: 170 QMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIV 219
+ +HRDL N + E+ +K DFGL+ +I+
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---------RDIL 175
Query: 220 GSPYY--------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 263
YY A E L+ + + DVWS GV+L+ +L G PP+
Sbjct: 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235
Query: 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKIE 314
+ + RR P P E D + + M DP R T + ++G++E
Sbjct: 236 DL----THFLAQGRRLPQP---EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 58/284 (20%), Positives = 106/284 (37%), Gaps = 52/284 (18%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+ + +L + +G+GEFG L R N A K ++ + E +M
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAV-------KCIKNDATAQAFLAEASVMT 69
Query: 111 HLPKHQNIVCLKDTY----EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
L +H N+V L E+ +++V E G L D + R+
Sbjct: 70 QL-RHSNLVQL---LGVIVEEKGGLYIVTEYMAKGSLVDYL--------RSRGRSVLGGD 117
Query: 167 EVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLS---VFFKPGE 213
+++ + +HRDL N L + E K DFGL+ +
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTG 174
Query: 214 KFSEIVGSPY-YMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
K P + APE L+ + + + DVWS G++L+ I G P+ + V +
Sbjct: 175 KL------PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ ++ D ++++ D R + Q+ ++E
Sbjct: 229 K---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 15/164 (9%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ + +G+++G G FG L + + A K + K R + E + L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQ----LHLEYRFYKQL 61
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGG----ELFDRIVARGHYTERAAAAVTKTIVEV 168
I + +V+EL G +LFD ++ + + ++
Sbjct: 62 GSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDL--CDRTFSLKTVLMIAIQLISR 117
Query: 169 VQMCHKHGVMHRDLKPENFLF--ANKKETAPLKAIDFGLSVFFK 210
++ H +++RD+KPENFL K + IDF L+ +
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 73/326 (22%), Positives = 113/326 (34%), Gaps = 73/326 (22%)
Query: 34 HQGNGGHKLCVLKEPT---------------GREIE-ERYELGRELGRGEFGITY---LC 74
H GNG KL L+ +E++ + + +G GEFG L
Sbjct: 8 HFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK 67
Query: 75 TDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134
+ + A K++ K T D E IM H NI+ L+ V +V
Sbjct: 68 LPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIV 124
Query: 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKP 184
E E G L + T++++V M G +HRDL
Sbjct: 125 TEYMENGSLDSFLRKHDA---------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 175
Query: 185 ENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY-----------MAPEVLK-R 232
N L + K DFGL + E Y +PE + R
Sbjct: 176 RNILINSNLV---CKVSDFGLG-------RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 233 NYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291
+ DVWS G++L+ ++ G P+W + Q V +A+ +R P L
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE---GYRLPPPMDCPAALYQL 282
Query: 292 VRKMLD---PDPKRRLTAQQVLGKIE 314
MLD D R +Q++ ++
Sbjct: 283 ---MLDCWQKDRNNRPKFEQIVSILD 305
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-16
Identities = 64/253 (25%), Positives = 95/253 (37%), Gaps = 62/253 (24%)
Query: 51 REIE-ERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
EI+ ER ELGR +G G+FG + + A A K+ K + E +E
Sbjct: 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEA 67
Query: 107 DIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAV 161
MR H +I V ++ V ++MELC GEL + R +
Sbjct: 68 LTMRQF-DHPHIVKLIGVITENP------VWIIMELCTLGELRSFLQVRKY--------- 111
Query: 162 TKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + ++ + +HRD+ N L ++ +K DFGLS
Sbjct: 112 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLS----- 163
Query: 212 GEKFSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFW 258
+ S YY MAPE + R + DVW GV ++ IL+ GV PF
Sbjct: 164 ----RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219
Query: 259 AETEQGVAQAIIR 271
V I
Sbjct: 220 GVKNNDVIGRIEN 232
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 71/305 (23%), Positives = 121/305 (39%), Gaps = 63/305 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT----DRENGDAF---ACKSISKKKLRTAVDIEDVR 103
E+ +R LG+ LG G FG L D++ + A K + K T D+ D+
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLI 122
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
E+++M+ + KH+NI+ L D +++++E G L + + AR + +
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 164 ------TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
+ ++V + +HRDL N L +K DFGL+
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLA- 238
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I YY MAPE L R Y + DVWS GV+L+ I G
Sbjct: 239 --------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 290
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ + + + + + R P N + + M D P +R T +Q+
Sbjct: 291 GSPYPGVPVEEL----FKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQL 343
Query: 310 LGKIE 314
+ ++
Sbjct: 344 VEDLD 348
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 63/305 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT----DRENGDAF---ACKSISKKKLRTAVDIEDVR 103
E ++ LG+ LG G FG + D++ A K + K T D+ D+
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLV 88
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTK 163
E+++M+ + KH+NI+ L D +++++E G L + + AR + + +
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 164 ------TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
T ++V + +HRDL N L +K DFGL+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLA- 204
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I YY MAPE L R Y + DVWS GV+++ I G
Sbjct: 205 --------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 256
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ + + + + + R P N + + M D P +R T +Q+
Sbjct: 257 GSPYPGIPVEEL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQL 309
Query: 310 LGKIE 314
+ ++
Sbjct: 310 VEDLD 314
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-16
Identities = 58/252 (23%), Positives = 89/252 (35%), Gaps = 62/252 (24%)
Query: 52 EI-EERYELGRELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
I E L R LG G FG Y + A K+ KK T + E E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAV 65
Query: 108 IMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
IM++L H +I + ++ ++MEL GEL + + +
Sbjct: 66 IMKNL-DHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKN---------S 109
Query: 163 KTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212
++ +V +HRD+ N L A+ + +K DFGLS
Sbjct: 110 LKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLS------ 160
Query: 213 EKFSEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWA 259
I YY M+PE + R + DVW V ++ IL G PF+
Sbjct: 161 ---RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217
Query: 260 ETEQGVAQAIIR 271
+ V + +
Sbjct: 218 LENKDVIGVLEK 229
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 34/193 (17%), Positives = 71/193 (36%), Gaps = 28/193 (14%)
Query: 48 PTGREIE----ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR 103
P G+ ++ ++ LG+++G G FG+ YL + A + + +
Sbjct: 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LF 81
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTA----VH--------------LVMELCEGGELFD 145
E+ + + K I + + D + +VME G +L
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK 140
Query: 146 RIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205
G + + + +++V++ H++ +H D+K N L K + D+GL
Sbjct: 141 ISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ-VYLADYGL 199
Query: 206 SVFFKPGEKFSEI 218
S + P +
Sbjct: 200 SYRYCPNGNHKQY 212
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 60/295 (20%), Positives = 98/295 (33%), Gaps = 59/295 (20%)
Query: 51 REIE-ERYELGRELGRGEFGI----TYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE 105
EI + +G GEFG + + A K++ K T D E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGE 96
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
IM H NI+ L+ + ++ E E G L + + ++
Sbjct: 97 AGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---------EFSV 146
Query: 166 VEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF 215
+++V M +HRDL N L + K DFGLS +
Sbjct: 147 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLS-------RV 196
Query: 216 SEIVGSPYY-----------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 262
E Y APE + R + DVWS G++++ ++ G P+W +
Sbjct: 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256
Query: 263 QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD---PDPKRRLTAQQVLGKIE 314
V +AI FR L M+ + RR ++ ++
Sbjct: 257 HEVMKAIND---GFRLPTPMDCPSAIYQL---MMQCWQQERARRPKFADIVSILD 305
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 61/255 (23%), Positives = 87/255 (34%), Gaps = 68/255 (26%)
Query: 54 EERYELGRE--------LGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVR 103
+++ L R+ LG G FG R A K + K+ D E++
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMM 58
Query: 104 REVDIMRHLPKHQNI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAA 158
RE IM L + I VC + + LVME+ GG L +V +
Sbjct: 59 REAQIMHQL-DNPYIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEI---- 107
Query: 159 AAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
+ V ++ H + +HRDL N L N+ K DFGLS
Sbjct: 108 -----PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKA 159
Query: 209 FKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGV 254
+ YY APE + R + DVWS GV ++ L G
Sbjct: 160 LGADD--------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 211
Query: 255 PPFWAETEQGVAQAI 269
P+ V I
Sbjct: 212 KPYKKMKGPEVMAFI 226
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 68/305 (22%), Positives = 118/305 (38%), Gaps = 63/305 (20%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCT----DRENGDAF---ACKSISKKKLRTAVDIEDVR 103
E ++ LG+ LG G FG + D++ A K + K T D+ D+
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLV 134
Query: 104 REVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-----RIVARGHYTERAA 158
E+++M+ + KH+NI+ L D +++++E G L + R + +
Sbjct: 135 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 159 AAVTK-TIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207
+ T ++V + +HRDL N L +K DFGL+
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLA- 250
Query: 208 FFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCG 253
+I YY MAPE L R Y + DVWS GV+++ I G
Sbjct: 251 --------RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 302
Query: 254 VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQQV 309
P+ + + + + + R P N + + M D P +R T +Q+
Sbjct: 303 GSPYPGIPVEEL----FKLLKEGHRMDKP---ANCTNELYMMMRDCWHAVPSQRPTFKQL 355
Query: 310 LGKIE 314
+ ++
Sbjct: 356 VEDLD 360
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 53/237 (22%), Positives = 81/237 (34%), Gaps = 52/237 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E E E G+ LG G FG T ++ K L+ + + E + E+
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFD-------------RIVARGHYT 154
+M L H+NIV L ++L+ E C G+L +
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 155 ERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFG 204
E T +++ + +HRDL N L +K DFG
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFG 217
Query: 205 LSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY 248
L+ +I+ Y MAPE L Y + DVWS G++L+
Sbjct: 218 LA---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 59/247 (23%), Positives = 87/247 (35%), Gaps = 53/247 (21%)
Query: 51 REIEERYELGR-ELGRGEFGITY---LCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
+ + ELG G FG ++ D A K + K+ D E++ RE
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVL--KQGTEKADTEEMMREA 387
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
IM L + IV L + + + LVME+ GG L +V + +
Sbjct: 388 QIMHQL-DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEI---------PVS 436
Query: 167 EVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS 216
V ++ H + +HR+L N L N+ K DFGLS +
Sbjct: 437 NVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALGADD--- 490
Query: 217 EIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETE 262
YY APE + R + DVWS GV ++ L G P+
Sbjct: 491 -----SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 263 QGVAQAI 269
V I
Sbjct: 546 PEVMAFI 552
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 50/242 (20%), Positives = 82/242 (33%), Gaps = 60/242 (24%)
Query: 59 LGRELGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+ELG G FG + A K + K + +++ E ++M+ L +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNP 78
Query: 117 NI-----VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
I +C ++ LVME+ E G L + H ++++
Sbjct: 79 YIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV----------KDKNIIEL 122
Query: 172 CH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGS 221
H + +HRDL N L + K DFGLS + E
Sbjct: 123 VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADEN------- 172
Query: 222 PYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQ 267
YY APE + + + DVWS GV+++ G P+ V
Sbjct: 173 -YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231
Query: 268 AI 269
+
Sbjct: 232 ML 233
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 63/307 (20%), Positives = 97/307 (31%), Gaps = 69/307 (22%)
Query: 55 ERYELGRELGRGEFGITYLCT--DRENGDAF---ACKSISKKKLRTAVDIEDVRREVDIM 109
E R++G G FG + + F A K + K+ +A D +RE +M
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALM 104
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--------------FDRIVARGHYTE 155
+ NIV L + L+ E G+L
Sbjct: 105 AEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 156 RAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205
+ + E + + + +HRDL N L +K DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGL 220
Query: 206 SVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-ILL 251
S I + YY M PE + Y E DVW+ GV+L+ I
Sbjct: 221 S---------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRLTAQ 307
G+ P++ + V I V D P EN + M P R +
Sbjct: 272 YGLQPYYGMAHEEV----IYYVRDGNILACP---ENCPLELYNLMRLCWSKLPADRPSFC 324
Query: 308 QVLGKIE 314
+ ++
Sbjct: 325 SIHRILQ 331
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 61/310 (19%), Positives = 114/310 (36%), Gaps = 68/310 (21%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E + LG+ LG GEFG T +++ K L+ + ++ D+ E +
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGEL--------------FDRIVARGHY 153
+++ + H +++ L D + L++E + G L +R
Sbjct: 79 VLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 154 TERAAAAVTKTIVEVVQMCH----------KHGVMHRDLKPENFLFANKKETAPLKAIDF 203
+ T+ +++ + ++HRDL N L A ++ +K DF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK---MKISDF 194
Query: 204 GLSVFFKPGEKFSEIVGSPYY------------MAPEVLK-RNYGPEVDVWSAGVILY-I 249
GLS ++ Y MA E L Y + DVWS GV+L+ I
Sbjct: 195 GLS---------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 250 LLCGVPPFWAETEQGVA-QAIIRSVLDFRRDPWPKVSENAKDLVRK-MLD---PDPKRRL 304
+ G P+ G+ + + + R P +N + + + ML +P +R
Sbjct: 246 VTLGGNPY-----PGIPPERLFNLLKTGHRMERP---DNCSEEMYRLMLQCWKQEPDKRP 297
Query: 305 TAQQVLGKIE 314
+ +E
Sbjct: 298 VFADISKDLE 307
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 24/181 (13%), Positives = 60/181 (33%), Gaps = 27/181 (14%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIE----DVRREVDIMR 110
+++L R GI Y + +K + ++ ++ + E + +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDS----GPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 111 HLPKHQNIVCLKDTYEDDTA----VH-----------LVMELCEGGELFD--RIVARGHY 153
K + K Y LV+ G L + +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL 156
Query: 154 TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213
+ER+ V +++ ++ H++ +H ++ EN + ++ + +G + + P
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQ-VTLAGYGFAFRYCPSG 215
Query: 214 K 214
K
Sbjct: 216 K 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 35/230 (15%), Positives = 80/230 (34%), Gaps = 38/230 (16%)
Query: 8 PAAAKQGKKKTNKKKQNPFSIDYGTHHQGNGGHKLCVLKEPTGREIEERYELGRELGRGE 67
A Q ++++ K+ G ++ + +++G +G+G
Sbjct: 3 RVKAAQAGRQSSAKRHLAEQFAVGE-----------IITDMAAA----AWKVGLPIGQGG 47
Query: 68 FGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127
FG YL D + ++ + K+ D + E+ + K + I T +
Sbjct: 48 FGCIYLA-DMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL 105
Query: 128 DTA----VH--------------LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEV 168
++M+ G +L A ++ + ++ I+++
Sbjct: 106 KYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDI 164
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
++ H+H +H D+K N L K + +D+GL+ + P
Sbjct: 165 LEYIHEHEYVHGDIKASNLLLNYKNPDQ-VYLVDYGLAYRYCPEGVHKAY 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E +R +LG+ LGRG FG C++++ K L+ T + + E+
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 108 IMRHLPKHQNIVCLK-DTYEDDTAVHLVMELCEGGELFD 145
I+ H+ H N+V L + + +++E C+ G L
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 4e-04
Identities = 41/159 (25%), Positives = 63/159 (39%), Gaps = 40/159 (25%)
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYY----------- 224
+HRDL N L + K +K DFGL+ +I P Y
Sbjct: 213 KCIHRDLAARNILLSEKNV---VKICDFGLA---------RDIYKDPDYVRKGDARLPLK 260
Query: 225 -MAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVA--QAIIRSVLDFRRD 279
MAPE + Y + DVWS GV+L+ I G P+ GV + R + + R
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGTRM 315
Query: 280 PWPKVSENAKDLVRK-MLD---PDPKRRLTAQQVLGKIE 314
P + + + MLD +P +R T +++ +
Sbjct: 316 RAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 52.6 bits (125), Expect = 5e-08
Identities = 28/202 (13%), Positives = 57/202 (28%), Gaps = 48/202 (23%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDI 108
E+ + ++G G FG + + A K I+ + E++ E+ I
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 109 MRHL--------PKHQNIVCLKDTY------------------------------EDDTA 130
+ L + + + L + D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190
+ +V+E GG +++ + A + + + + HRDL N L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL- 195
Query: 191 NKKETAPLKAIDFGLSVFFKPG 212
K+T+ K
Sbjct: 196 --KKTSLKKLHYTLNGKSSTIP 215
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 5e-07
Identities = 36/134 (26%), Positives = 60/134 (44%), Gaps = 28/134 (20%)
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEV 229
H++ +HRD+K N L ++ TA K DFGL+ + + S IVG+ YMAPE
Sbjct: 150 HENHHIHRDIKSANILL-DEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA 206
Query: 230 LKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP-----WPKV 284
L+ P+ D++S GV+L ++ G +D R+P +
Sbjct: 207 LRGEITPKSDIYSFGVVLLEIITG-----------------LPAVDEHREPQLLLDIKEE 249
Query: 285 SENAKDLVRKMLDP 298
E+ + + +D
Sbjct: 250 IEDEEKTIEDYIDK 263
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 8e-07
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 7/88 (7%)
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEV 229
H ++HRD+K N L ++ K DFG+S ++ + + G+ Y+ PE
Sbjct: 156 HTRAIIHRDVKSINILL-DENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY 212
Query: 230 LKRNYGPE-VDVWSAGVILYILLCGVPP 256
+ E DV+S GV+L+ +LC
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.56 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.34 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.29 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.05 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.99 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.73 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.62 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.53 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.31 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.2 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.14 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.11 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.95 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.86 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.86 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.71 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.41 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.66 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.32 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-66 Score=440.10 Aligned_cols=256 Identities=36% Similarity=0.614 Sum_probs=210.4
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
|..+ ++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+|+.+ +|||||++++++...+
T Consensus 9 G~~i-g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 9 GAHI-GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKD 86 (275)
T ss_dssp ------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred CCEe-eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECC
Confidence 4444 4799999999999999999999999999999999877665556677899999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.+|+||||+ +|+|.+.+..++.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+..
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~---vkl~DFGla~~~ 162 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN---VKIADFGLSNIM 162 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC---EEECCSSCC---
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC---EEEeecCCCeec
Confidence 999999999 6799999999889999999999999999999999999999999999999976655 999999999877
Q ss_pred CCCCcccccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 210 KPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.......+.+||+.|||||++.+. ++.++||||+||++|+|++|+.||...+.....+.+.+....+ +..++++
T Consensus 163 ~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~----p~~~s~~ 238 (275)
T 3hyh_A 163 TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL----PKFLSPG 238 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----CTTSCHH
T ss_pred CCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHH
Confidence 666666678999999999998754 4689999999999999999999999888888888887765443 3468999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||.+||+.||++|||+.|+++|+||
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 9999999999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-66 Score=445.98 Aligned_cols=253 Identities=31% Similarity=0.540 Sum_probs=229.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+++|+.+ +|||||+++++|.+.+.+|+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999876555555678899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~---vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC---EEEEEcCCceecCCCCC
Confidence 999999999999999889999999999999999999999999999999999999976655 9999999998764332
Q ss_pred --cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 214 --KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 214 --~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
...+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||...+..+....+.+....+ +..+++++.+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----p~~~s~~~~d 263 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF----PEKFFPKARD 263 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----CTTCCHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----CcccCHHHHH
Confidence 3456799999999999874 58999999999999999999999999988888888888775544 3457999999
Q ss_pred HHHHhcCCCcCCCCCHHH------HhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQ------VLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e------~l~~l~f 315 (315)
||.+||+.||++|||+.| +++|+||
T Consensus 264 li~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F 294 (311)
T 4aw0_A 264 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294 (311)
T ss_dssp HHHHHSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred HHHHHccCCHhHCcChHHHcCCHHHHCCCCc
Confidence 999999999999999987 5889987
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-64 Score=443.89 Aligned_cols=253 Identities=31% Similarity=0.521 Sum_probs=225.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.+.|++++.||+|+||+||+|++..+|+.||+|++..... ...+.+.+|+.+|+.+ +|||||+++++|...+.+||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 4679999999999999999999999999999999976532 2345688999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
||||++||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSSS
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC---EEEecCcCceecCCCC
Confidence 9999999999998876 46999999999999999999999999999999999999987665 999999999876543
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
....+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+....+....+.... ......+..+++++.+|
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~dl 303 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKGF 303 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCCCSCGGGSCHHHHHH
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccccCCHHHHHH
Confidence 3456789999999999987 459999999999999999999999999888887777776543 22334456789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||+.||++|||+.|+|+|+||
T Consensus 304 i~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HHHHcCCChhHCcCHHHHhcCHhh
Confidence 999999999999999999999997
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-65 Score=448.00 Aligned_cols=253 Identities=27% Similarity=0.525 Sum_probs=219.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|++..+|+.||+|++.+... .....+.+.+|+.+|+++ +|||||++++++.+.+.+|+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEE
Confidence 579999999999999999999999999999999976643 334467899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT---VQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC---EEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC---EEEcccccceeecCC
Confidence 99999999999997543 4799999999999999999999999999999999999987665 999999999876543
Q ss_pred C-cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 213 E-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
. .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||...+..+....+.+.... ..+..+++++.+
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---~~~~~~s~~~~~ 255 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---PVSLHYSYDLRS 255 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCCTTSCHHHHH
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---CCCccCCHHHHH
Confidence 2 2345689999999999875 5999999999999999999999999999888888888776432 334578999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
||.+||+.||++|||+.|+|+|+||
T Consensus 256 li~~~L~~dP~~R~s~~e~l~hp~~ 280 (350)
T 4b9d_A 256 LVSQLFKRNPRDRPSVNSILEKGFI 280 (350)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHccCChhHCcCHHHHhcCHHh
Confidence 9999999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-64 Score=433.14 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=215.8
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----CCcEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVH 132 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~~~~~ 132 (315)
|++.+.||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+|+++ +|||||+++++|.. .+.+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEE
Confidence 4788899999999999999999999999999976543 334467899999999999 99999999999864 35689
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+|||++.. ...+||+|||+|+...
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~--~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST--TSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC--CCCEEEEeCcCCEeCC
Confidence 99999999999999998888999999999999999999999998 9999999999999742 2349999999998643
Q ss_pred CCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.....+.+||+.|||||++.+.|+.++|||||||++|||+||+.||....... ....+..... +...+..+++++.
T Consensus 184 -~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~ 260 (290)
T 3fpq_A 184 -ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVK 260 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHH
T ss_pred -CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCCHHHH
Confidence 33446679999999999998889999999999999999999999997654433 3344433321 2223345789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||++|||+.|+|+|+||
T Consensus 261 ~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 261 EIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHccCChhHCcCHHHHhcCccc
Confidence 99999999999999999999999997
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-63 Score=445.18 Aligned_cols=253 Identities=31% Similarity=0.522 Sum_probs=225.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++++.||+|+||+||+|.+..+|+.||||++.... ....+.+.+|+.+|+.+ +|||||+++++|...+.+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT---CSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEE
Confidence 457999999999999999999999999999999997553 23346688999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||||+||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 226 VmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~---vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC---EEECCCTTCEECCSSC
T ss_pred EEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC---EEEecCccceECCCCC
Confidence 99999999999988654 6999999999999999999999999999999999999987665 999999999876543
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
....+.+||+.|||||++. ..|+.++|||||||++|||++|+.||.+....+....+..... .....+..+++++.+|
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dl 380 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGF 380 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHHH
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHHH
Confidence 3456779999999999987 4599999999999999999999999998888887777766532 2334456789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||+.||++|||+.|+|+|+||
T Consensus 381 i~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HHHHcCCChhHCcCHHHHhcCHHh
Confidence 999999999999999999999997
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-63 Score=431.80 Aligned_cols=252 Identities=29% Similarity=0.488 Sum_probs=217.2
Q ss_pred cceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
++|++++.||+|+||+||+|++. .+++.||+|++.+..... .....+.+|+.+|+++ +|||||++++++.+.+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCC-CCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEE
Confidence 57999999999999999999874 467899999997654332 2334688899999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC---EEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC---EEecccccceeccC
Confidence 999999999999999999889999999999999999999999999999999999999987665 99999999986543
Q ss_pred -CCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 -GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 -~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.....+.+||+.|||||++. ..|+.++|||||||++|||+||+.||.+.+..+....+.+....+ +..+++++.
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----p~~~s~~~~ 254 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM----PQFLSPEAQ 254 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC----CCcCCHHHH
Confidence 33445679999999999987 459999999999999999999999999998888888888765443 356899999
Q ss_pred HHHHHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
+||.+||+.||++||| ++|+++|+||
T Consensus 255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred HHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 9999999999999998 5899999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-63 Score=431.08 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=213.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+.|++.+.||+|+||+||+|++..+|+.||+|++..... ..+|+.+++.+ +|||||++++++.+.+.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGL-SSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 469999999999999999999999999999999976432 23699999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||++||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++. .+||+|||+|+.......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS--RAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC--CEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC--EEEEeeCCCCeEccCCCc
Confidence 999999999999998889999999999999999999999999999999999999986553 399999999987654321
Q ss_pred ------ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 215 ------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 215 ------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
....+||+.|||||++.+ .|+.++|||||||++|||++|+.||......+....+....... ...++.++++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI-REIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG-GGSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc-hhcCccCCHH
Confidence 234589999999999874 59999999999999999999999998877777777776654332 2345678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhc
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLG 311 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~ 311 (315)
+.+||.+||+.||++|||+.|+++
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHH
Confidence 999999999999999999999854
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=419.19 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=214.5
Q ss_pred cceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
++|.+.+.||+|+||+||+|.+. .++..||||++... +....++|.+|+++|+++ +|||||++++++.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCC
Confidence 57999999999999999999875 35788999998643 334467899999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 130 AVHLVMELCEGGELFDRIVAR-------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++||||||||+|||++.++.
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~-- 166 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL-- 166 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--
Confidence 999999999999999999764 25999999999999999999999999999999999999987655
Q ss_pred CEEEEeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHh
Q 021233 197 PLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIR 271 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 271 (315)
+||+|||+|+........ ....||+.|||||++. +.++.++|||||||++|||+| |+.||......+....+..
T Consensus 167 -~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 245 (299)
T 4asz_A 167 -VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 245 (299)
T ss_dssp -EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH
T ss_pred -EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999865433222 2356899999999987 569999999999999999999 8999999888888888877
Q ss_pred ccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
... ...+..+|+++.+||.+||+.||++|||+.+++..|
T Consensus 246 ~~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L 284 (299)
T 4asz_A 246 GRV---LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284 (299)
T ss_dssp TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 543 334457899999999999999999999999997654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-61 Score=420.52 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=210.7
Q ss_pred cceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
++|.+.++||+|+||+||+|.+. .++..||||++... +....+.|.+|+.+|+++ +|||||++++++.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTML-QHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence 57999999999999999999875 35788999998643 344567899999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC
Q 021233 130 AVHLVMELCEGGELFDRIVAR---------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~---------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~ 194 (315)
.+++||||+++|+|.+++... .++++..++.++.|++.||.|||+++||||||||+|||++.++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 999999999999999999753 35899999999999999999999999999999999999986655
Q ss_pred CCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHH
Q 021233 195 TAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAI 269 (315)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 269 (315)
+||+|||+|+....... .....||+.|||||++. ..++.++|||||||++|||+| |+.||......+....+
T Consensus 197 ---~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 273 (329)
T 4aoj_A 197 ---VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273 (329)
T ss_dssp ---EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred ---EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999986543322 24567999999999987 569999999999999999999 89999998888888877
Q ss_pred HhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.+.. +...+..+++++.+||.+||+.||++|||+.||+++|+
T Consensus 274 ~~g~---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 274 TQGR---ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp HHTC---CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred HcCC---CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 7653 33445678999999999999999999999999998763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-61 Score=417.21 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=215.8
Q ss_pred cceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.++++++.||+|+||+||+|.+. .+++.||||++.... .....+.|.+|+.+++++ +|||||++++++...+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECC
Confidence 56899999999999999999864 357889999987542 334467899999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 021233 130 AVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~ 193 (315)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++||||||||+|||++.++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 999999999999999999653 3489999999999999999999999999999999999998766
Q ss_pred CCCCEEEEeeccccccCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 021233 194 ETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (315)
. +||+|||+|+...... ......||+.|||||++. +.++.++|||||||++|||+| |..||.+....+....
T Consensus 183 ~---~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 183 N---VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp C---EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred C---EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 5 9999999998653322 234568999999999976 669999999999999999998 8999999888888887
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+..... .+.+..+|+++.+||.+||+.||++|||+.||+++|
T Consensus 260 i~~~~~---~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 260 IRNRQV---LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHcCCC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 766532 334567899999999999999999999999999876
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-61 Score=414.95 Aligned_cols=251 Identities=22% Similarity=0.380 Sum_probs=206.3
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+++++.+.||+|+||+||+|.+. ..||||++.... .+....+.|.+|+.+|+++ +|||||++++++.. +.+++|
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-PTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEEE
Confidence 57899999999999999999864 369999986543 2344567899999999999 99999999998865 568999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||++||+|.+++... ..+++..+..++.|++.||+|||+++||||||||+|||++.++. +||+|||+|+.....
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~---~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT---VKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE---EEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc---EEEeeccCceecccCC
Confidence 9999999999999764 56999999999999999999999999999999999999986655 999999999865432
Q ss_pred --CcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC--CCCCCccC
Q 021233 213 --EKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF--RRDPWPKV 284 (315)
Q Consensus 213 --~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 284 (315)
......+||+.|||||++. +.|+.++|||||||++|||+||+.||...........+....... ....+..+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 266 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNC 266 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTS
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccc
Confidence 2234568999999999985 248999999999999999999999998766555444444332221 22345678
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
++++.+||.+||+.||++|||+.|++++|+
T Consensus 267 ~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 267 PKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp CHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 999999999999999999999999987764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-60 Score=425.61 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=221.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~---- 127 (315)
.+.++|++++.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+|+.+ +|||||++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccc
Confidence 35578999999999999999999999999999999997543 2334456788999999999 99999999999763
Q ss_pred --CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 128 --DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
.+.+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~---~Ki~DFGl 204 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE---LKIGDFGM 204 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC---EEECCCTT
T ss_pred ccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC---EEEeecce
Confidence 367899999995 689999988888999999999999999999999999999999999999986655 99999999
Q ss_pred ccccCCC-----CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC
Q 021233 206 SVFFKPG-----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (315)
Q Consensus 206 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (315)
|+..... ....+.+||+.|||||++.+ .++.++||||+||++|||++|++||.+.+..+....+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9865332 23356799999999999764 4799999999999999999999999999888888877655433221
Q ss_pred CC---------------------------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 DP---------------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ~~---------------------------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ++.+++++.+||.+||..||++|||+.|+|+|+||
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL 348 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence 11 23568999999999999999999999999999997
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-60 Score=409.92 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=196.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-----
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT----- 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~----- 129 (315)
++|++++.||+|+||+||+|++..+|+.||+|++.... .....+.+.+|+.+|+++ +|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccc
Confidence 46999999999999999999999999999999986543 334457799999999999 9999999999987543
Q ss_pred -------cEEEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEE
Q 021233 130 -------AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (315)
Q Consensus 130 -------~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vk 199 (315)
.+|+||||++||+|.+++..... .++..++.++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~---vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc---EE
Confidence 37999999999999999987654 456778999999999999999999999999999999987665 99
Q ss_pred EEeeccccccCCCCc-------------ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHH
Q 021233 200 AIDFGLSVFFKPGEK-------------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 265 (315)
Q Consensus 200 l~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 265 (315)
|+|||+|+....... ....+||+.|||||++.+ .|+.++|||||||++|||++ ||.... +.
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~ 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HH
Confidence 999999987643321 234579999999999874 59999999999999999996 775432 22
Q ss_pred HHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+........+..++..++.+.+||.+||+.||++|||+.|+|+|+||
T Consensus 234 ~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 234 VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 22222111111122233456778899999999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=409.89 Aligned_cols=254 Identities=25% Similarity=0.453 Sum_probs=207.7
Q ss_pred ccccceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.+.++|++++.||+|+||+||+|+++ .+++.||+|.+... ....++.+|+++|+.+.+||||++++++|...
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 46778999999999999999999875 35788999988643 23456889999999997899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+.+|+||||++|++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+. ..+||+|||+|+.
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~--~~~kl~DFGla~~ 167 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL--KKYALVDFGLAQG 167 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCEE
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC--CeEEECcCCCCcc
Confidence 99999999999999999883 599999999999999999999999999999999999997652 2399999999975
Q ss_pred cCCCC-----------------------------cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCC
Q 021233 209 FKPGE-----------------------------KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPF 257 (315)
Q Consensus 209 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~ 257 (315)
..... ...+.+||+.|+|||++.+ .++.++||||+||+++||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 43221 1234579999999999864 4899999999999999999999999
Q ss_pred CCCC-hHHHHHHHHhccc--------------------------------------------------cCCCCCCccCCH
Q 021233 258 WAET-EQGVAQAIIRSVL--------------------------------------------------DFRRDPWPKVSE 286 (315)
Q Consensus 258 ~~~~-~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~ 286 (315)
.... ..+....+..... ......+..+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 6443 3333333321100 001123456889
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||.+||+.||++|||+.|+|+|+||
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 99999999999999999999999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-59 Score=411.24 Aligned_cols=252 Identities=22% Similarity=0.344 Sum_probs=211.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCC-----CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++++.||+|+||+||+|.+... ++.||+|.+.... .....+.+.+|+.+|.++.+|||||+++++|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 46899999999999999999997654 3579999886543 2334567999999999995569999999998764
Q ss_pred -CcEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec
Q 021233 129 -TAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (315)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~ 191 (315)
+.+++|||||++|+|.+++... ..+++..+..++.|++.||+|||+++||||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5789999999999999999753 23899999999999999999999999999999999999987
Q ss_pred CCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHH-H
Q 021233 192 KKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG-V 265 (315)
Q Consensus 192 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~-~ 265 (315)
++. +||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+....+ .
T Consensus 221 ~~~---vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 221 KNV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp GGC---EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCC---EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 665 99999999987644332 23467899999999986 569999999999999999998 999998765444 3
Q ss_pred HHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...+.... +...+..+++++.++|.+||+.||++|||+.+|++||
T Consensus 298 ~~~i~~g~---~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 298 CRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp HHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCC---CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 44444432 3334456899999999999999999999999999886
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=434.22 Aligned_cols=258 Identities=33% Similarity=0.614 Sum_probs=234.5
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+-++|++++.||+|+||+||+|.+..+|+.||+|.+... .....+.+.+|+.+|+.+ +|||||+++++|...+.++
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence 456899999999999999999999999999999998654 234457789999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+. ...+||+|||+|+....
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~-~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCSSCEECCT
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCC-CCCEEEeeccceeEccC
Confidence 99999999999999864 45699999999999999999999999999999999999997542 23499999999998877
Q ss_pred CCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
.......+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+....+....+......+....+..+++++.+
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 777777899999999999874 5899999999999999999999999999999899998888777777777889999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
||.+||+.||.+|||+.|+|+|+||
T Consensus 390 li~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred HHHHHccCChhHCcCHHHHhcCcCc
Confidence 9999999999999999999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-58 Score=430.10 Aligned_cols=252 Identities=27% Similarity=0.454 Sum_probs=215.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHH---HHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE---VDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e---~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+| +.+++.+ +|||||+++++|.+.+.+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEE
Confidence 579999999999999999999999999999999976654333333444444 5566666 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+....
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~---vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC---EEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC---EEecccceeeecCC
Confidence 999999999999999999889999999999999999999999999999999999999986665 99999999987654
Q ss_pred CCcccccccCCCccCchhhc-c-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHhccccCCCCCCccCCH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.. ..+.+||+.|||||++. + .|+.++|+|||||++|||++|++||..... ......+... ....+..+++
T Consensus 345 ~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~----~~~~p~~~S~ 419 (689)
T 3v5w_A 345 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----AVELPDSFSP 419 (689)
T ss_dssp CC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----CCCCCTTSCH
T ss_pred CC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----CCCCCccCCH
Confidence 33 35679999999999985 3 599999999999999999999999975432 2233334333 3334567899
Q ss_pred HHHHHHHHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
++.+||.+||+.||.+|++ +.||++|+||
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 9999999999999999998 7999999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-55 Score=391.69 Aligned_cols=264 Identities=39% Similarity=0.673 Sum_probs=236.2
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC---hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..+.++|++++.||+|+||+||+|.+..+|+.||+|++....... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe
Confidence 456788999999999999999999999999999999997654322 12457899999999999 89999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-CCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~-~~~vkl~Dfg~a 206 (315)
.+..++||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999988888999999999999999999999999999999999999976552 225999999999
Q ss_pred cccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......+....+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 246 (361)
T 2yab_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS 246 (361)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence 88766655667789999999999874 68999999999999999999999999988888888888776666555567789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++.+||.+||..||.+|||+.|+++|+||
T Consensus 247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 999999999999999999999999999997
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=391.06 Aligned_cols=266 Identities=40% Similarity=0.744 Sum_probs=239.2
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
.....+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~ 99 (362)
T 2bdw_A 22 NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQE 99 (362)
T ss_dssp --CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred cCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe
Confidence 3445677899999999999999999999999999999999876543 334457789999999999 99999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
.+..++||||++|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 100 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999999999999888889999999999999999999999999999999999999877666679999999998
Q ss_pred ccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
............||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+......++...+..+++
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 7765555566789999999999874 599999999999999999999999999888888888888777776666778999
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||.+||+.||++|||+.++|+|+||
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 99999999999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=383.07 Aligned_cols=255 Identities=36% Similarity=0.605 Sum_probs=228.4
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
..-++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEE
Confidence 345679999999999999999999999999999999876543 334467788999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNEFTV 166 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSTTCCGGGSS
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC---EEEeeccCceecCC
Confidence 999999999999999988888999999999999999999999999999999999999976655 99999999987776
Q ss_pred CCcccccccCCCccCchhhccc-C-CCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLKRN-Y-GPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~~-~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.......+||+.|+|||++.+. + +.++||||||+++++|++|+.||......+....+.......+ ..+++++.
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~ 242 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCE 242 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHH
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHH
Confidence 6666778999999999998743 4 5789999999999999999999999888888888877654332 35789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||.+|||+.|+++|+||
T Consensus 243 ~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 243 NLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp HHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred HHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 99999999999999999999999997
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=386.72 Aligned_cols=248 Identities=22% Similarity=0.286 Sum_probs=191.3
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC---
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--- 129 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--- 129 (315)
+.++|.+.+.||+|+||+||+|.+. |+.||||++.... ........|+..+.++ +|||||++++++...+
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTW 73 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc----hhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCc
Confidence 3567999999999999999999984 8999999986432 1112234566666778 8999999999997653
Q ss_pred -cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCceEeecCCCCCCEEE
Q 021233 130 -AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--------GVMHRDLKPENFLFANKKETAPLKA 200 (315)
Q Consensus 130 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~--------~iiH~dikp~Nill~~~~~~~~vkl 200 (315)
.+++||||+++|+|.+++... .+++..+..++.|++.||.|||++ +||||||||+|||++.++. +||
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~---~Ki 149 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCI 149 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC---EEE
T ss_pred eEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC---EEE
Confidence 579999999999999999765 699999999999999999999987 9999999999999986655 999
Q ss_pred EeeccccccCCCCc-----ccccccCCCccCchhhcc-------cCCCcchHHHHHHHHHHHhhCCCCCCCC--------
Q 021233 201 IDFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAE-------- 260 (315)
Q Consensus 201 ~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~~l~el~tg~~p~~~~-------- 260 (315)
+|||+|+....... ....+||+.|||||++.+ .++.++|||||||++|||+||..||...
T Consensus 150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~ 229 (303)
T 3hmm_A 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence 99999987643322 234589999999999864 3677999999999999999997765321
Q ss_pred -------ChHHHHHHHHhccccCCCCCCc-----cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 261 -------TEQGVAQAIIRSVLDFRRDPWP-----KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 261 -------~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
........+.... .++..+. .+++.+.+||.+||+.||++|||+.||++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~--~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 292 (303)
T 3hmm_A 230 DLVPSDPSVEEMRKVVCEQK--LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSC--CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred hcccccchHHHHHHHHhccc--CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 1122222222221 1222111 2345789999999999999999999998875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=397.11 Aligned_cols=264 Identities=42% Similarity=0.724 Sum_probs=237.0
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
...+.++|++++.||+|+||+||+|.+..+|+.+|+|++..... .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLL-KHPNIVRLHDSISEEG 83 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSS
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECC
Confidence 45677899999999999999999999999999999999876543 233456789999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
..++||||++||+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.+.....+||+|||++...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999999999999888999999999999999999999999999999999999987655666999999999876
Q ss_pred CCCC-cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 210 KPGE-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 210 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+......++...++.++++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence 5433 3355689999999999875 5999999999999999999999999999999999999888888877778889999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||.+||+.||++|||+.|+|+|+||
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred HHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 9999999999999999999999999997
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=381.32 Aligned_cols=264 Identities=36% Similarity=0.666 Sum_probs=233.4
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC---hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 356778999999999999999999999999999999987654322 22467899999999999 89999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC-CCCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-ETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~-~~~~vkl~Dfg~a 206 (315)
.+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++ ....+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888899999999999999999999999999999999999998665 2335999999999
Q ss_pred cccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.............||+.|+|||++. ..++.++||||||+++++|++|..||......+....+......+....+..++
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence 8876555556678999999999987 468999999999999999999999999888887777777665555444456789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+.+||.+||+.||++|||+.++|+|+||
T Consensus 246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 999999999999999999999999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-55 Score=402.90 Aligned_cols=266 Identities=41% Similarity=0.716 Sum_probs=244.1
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
....+.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++...
T Consensus 20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDK 98 (484)
T ss_dssp CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECS
T ss_pred CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC
Confidence 3456788999999999999999999999999999999999776555556678899999999999 999999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+..++||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.......+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999999999999888899999999999999999999999999999999999997655556699999999988
Q ss_pred cCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
...........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......+..+.+..+++++
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred cccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 77666666778999999999998889999999999999999999999999999988888888887777666778899999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+||.+||+.||.+|||+.++|+|+||
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 999999999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-54 Score=369.34 Aligned_cols=263 Identities=41% Similarity=0.752 Sum_probs=238.6
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
+.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKL-QHPNIVRLHDSIQEESF 79 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCE
Confidence 3567899999999999999999999999999999999876543 334457788999999999 89999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||+++++|.+.+.....+++..++.++.|++.||.|||+.||+||||||+||+++.++....+||+|||.+....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999999999888889999999999999999999999999999999999999877776779999999998776
Q ss_pred CCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.........||+.|+|||++.+ .++.++||||||+++++|++|+.||...........+.......+...+..+++++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 6655566789999999999874 589999999999999999999999999988888888888777777766778999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||++|||+.++++|+||
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (284)
T 3kk8_A 240 SLIDSMLTVNPKKRITADQALKVPWI 265 (284)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSHHH
T ss_pred HHHHHHcccChhhCCCHHHHhcCccc
Confidence 99999999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=383.97 Aligned_cols=255 Identities=30% Similarity=0.522 Sum_probs=223.7
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|++++.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|..++..+.+||||+++++++...+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999766544455567788999999998789999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-C
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-G 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~ 212 (315)
||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|..... .
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~---ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC---EEEccccceeecccCC
Confidence 9999999999999998888999999999999999999999999999999999999976655 99999999986432 3
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......+||+.|+|||++. ..++.++||||||+++|||++|+.||......+....+......++ ..+++++.+|
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~l 254 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGI 254 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHH
Confidence 3345678999999999987 4599999999999999999999999999998888888887655443 3478999999
Q ss_pred HHHhcCCCcCCCCCH------HHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTA------QQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~------~e~l~~l~f 315 (315)
|.+||+.||.+||++ .++++|+||
T Consensus 255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp HHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred HHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 999999999999999 899999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=401.20 Aligned_cols=265 Identities=38% Similarity=0.689 Sum_probs=235.9
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh----------hcHHHHHHHHHHHHhCCCCCCcc
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA----------VDIEDVRREVDIMRHLPKHQNIV 119 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~h~~iv 119 (315)
...+.++|++++.||+|+||+||+|.+..++..||+|++........ ...+.+.+|+.+++.+ +||||+
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv 109 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNII 109 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCC
Confidence 34577899999999999999999999999999999999876543221 3356789999999999 899999
Q ss_pred eeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEE
Q 021233 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (315)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vk 199 (315)
++++++......++||||++|++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++....+|
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999999999998888899999999999999999999999999999999999998777656699
Q ss_pred EEeeccccccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC
Q 021233 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (315)
Q Consensus 200 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (315)
|+|||++.............||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......+...
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 269 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 99999998876666666778999999999998889999999999999999999999999999988888888877666555
Q ss_pred CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.|..+++++.+||.+||+.||.+|||+.|+|+|+||
T Consensus 270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 567789999999999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=378.19 Aligned_cols=253 Identities=30% Similarity=0.550 Sum_probs=225.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999765443444567889999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CCC
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~ 213 (315)
|||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.... ...
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC---EEEeeccchhhcccCCC
Confidence 999999999999998888999999999999999999999999999999999999976655 9999999998643 333
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
.....+||+.|+|||++. ..++.++||||||+++|||++|..||...........+......+ +..+++++.+||
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li 236 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHH
Confidence 445678999999999987 458999999999999999999999999888877777777654433 345799999999
Q ss_pred HHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 293 RKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
.+||+.||++|| ++.++++|+||
T Consensus 237 ~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred HHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 999999999999 99999999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=400.15 Aligned_cols=266 Identities=40% Similarity=0.683 Sum_probs=236.8
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
.....+.++|++++.||+|+||+||+|.+..++..||+|++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 107 (494)
T 3lij_A 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLL-DHPNIMKLYDFFED 107 (494)
T ss_dssp CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe
Confidence 33445778899999999999999999999999999999998765432 23356789999999999 99999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
.+..++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++.
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999999999999888889999999999999999999999999999999999999876666779999999998
Q ss_pred ccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
............||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......+....|..++++
T Consensus 188 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 267 (494)
T 3lij_A 188 VFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG 267 (494)
T ss_dssp ECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred ECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence 77666666677899999999999888999999999999999999999999999999899999888777777777889999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||.+||+.||.+|||+.++|+|+||
T Consensus 268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 268 AKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred HHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 9999999999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=381.59 Aligned_cols=258 Identities=31% Similarity=0.621 Sum_probs=230.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.++|++.+.||+|+||+||+|.+..+++.+|+|.+... ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIA-RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEE
Confidence 3567899999999999999999999999999999998643 23456788999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||++|++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.+. ...+||+|||++....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~-~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC-CCCEEEEECCCCeECC
Confidence 99999999999999997654 699999999999999999999999999999999999997532 3449999999999877
Q ss_pred CCCcccccccCCCccCchhhccc-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.........||+.|+|||++.+. ++.++||||||+++|+|++|..||......+....+......+....++.+++++.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T 1tki_A 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence 66666677899999999998754 79999999999999999999999999988888888888776665555667899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||.+|||+.|+|+|+||
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHHcCCChhHCcCHHHHhcChhh
Confidence 99999999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=369.36 Aligned_cols=261 Identities=44% Similarity=0.798 Sum_probs=234.4
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
..+.++|++.+.||+|+||.||+|.+..++..+|+|.+..... ...+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTD 80 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCe
Confidence 3567889999999999999999999999999999999875432 3457899999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||+++++|.+.+.....+++..++.++.|++.||.|||++||+||||||+||++..++....++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999888889999999999999999999999999999999999999655555669999999998877
Q ss_pred CCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
.........||+.|+|||++.+.++.++||||||+++++|++|..||......+....+.......+...+..+++++.+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 66666677899999999999888999999999999999999999999998888888888777655544444578999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+|.+||+.||++|||+.++|+|+||
T Consensus 241 li~~~l~~dp~~R~s~~~~l~h~~~ 265 (277)
T 3f3z_A 241 LIRRLLTKSPKQRITSLQALEHEWF 265 (277)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred HHHHHccCChhhCcCHHHHhcCHHH
Confidence 9999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=382.98 Aligned_cols=264 Identities=38% Similarity=0.666 Sum_probs=225.9
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc--ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
...+.++|++.+.||+|+||+||+|.+..+++.||+|++...... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS 97 (351)
T ss_dssp -CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE
T ss_pred CCccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 345778999999999999999999999999999999998654322 122467899999999999 99999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 128 DTAVHLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
.+..++||||++|++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999998877643 24899999999999999999999999999999999999987776677999999
Q ss_pred ccccccCCCCc-ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 204 GLSVFFKPGEK-FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 204 g~a~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
|++........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||... .......+........+..+
T Consensus 178 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 178 GVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp TTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHH
T ss_pred cceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccc
Confidence 99987654432 34568999999999987 45899999999999999999999999764 44455566655544444445
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+++++.+||.+||+.||++|||+.++|+|+||
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~ 290 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence 6789999999999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=398.23 Aligned_cols=262 Identities=41% Similarity=0.725 Sum_probs=237.1
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++++ +||||+++++++...+..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEE
Confidence 5778999999999999999999999999999999998654322 23457899999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||||+++++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+....+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999998888899999999999999999999999999999999999998766666799999999987766
Q ss_pred CCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
........||+.|+|||++.+.++.++||||||+++|+|++|..||......+....+......+..+.+..+++++.+|
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 256 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256 (486)
T ss_dssp C----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHH
Confidence 66666778999999999998889999999999999999999999999999988888888887777666778899999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||+.||.+|||+.++|+|+||
T Consensus 257 i~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 257 IRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp HHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred HHHHcCCChhhCcCHHHHhcCHhh
Confidence 999999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=382.29 Aligned_cols=255 Identities=27% Similarity=0.499 Sum_probs=218.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|..++.++.+||||+++++++...+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35799999999999999999999999999999999876555555556788999999987789999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc-CCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~-~~~ 212 (315)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.. ...
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~---ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC---EEEeecceeeecccCC
Confidence 9999999999999998888999999999999999999999999999999999999976655 999999999863 334
Q ss_pred CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCC---------ChHHHHHHHHhccccCCCCCCc
Q 021233 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE---------TEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
......+||+.|+|||++.+ .++.++||||||+++|||++|+.||... ......+.+...... .+.
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----~p~ 283 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----IPR 283 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC----CCT
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC----CCC
Confidence 44566789999999999874 5899999999999999999999999532 222234444444332 334
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCH------HHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTA------QQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~------~e~l~~l~f 315 (315)
.+++++.+||.+||+.||.+||++ .|+++|+||
T Consensus 284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 689999999999999999999985 899999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=378.05 Aligned_cols=261 Identities=44% Similarity=0.747 Sum_probs=211.9
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
....+.++|++.+.||+|+||+||+|.+..+++.||+|++.... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETP 120 (349)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHC-CCTTBCCEEEEEECS
T ss_pred ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhC-CCCCCcceeeeEecC
Confidence 34567788999999999999999999999999999999986542 345688999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+..++||||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++..+....+||+|||++..
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999999999998888899999999999999999999999999999999999998644455699999999987
Q ss_pred cCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHhccccCCCCCCccCCH
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
...........||+.|+|||++.+ .++.++||||||+++|+|++|..||....... ....+...........+..+++
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 655544556789999999999874 58999999999999999999999997665544 5556666555555555678899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||.+||+.||++|||+.++|+|+||
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 309 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWV 309 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 99999999999999999999999999997
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=365.31 Aligned_cols=260 Identities=37% Similarity=0.648 Sum_probs=221.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.++|++.+.||+|+||+||+|.+..++..+|+|.+.... .....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeE
Confidence 46788999999999999999999999999999999987653 233467899999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 132 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
++||||+++++|.+.+.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.+.....+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999998854 3569999999999999999999999999999999999999765555669999999998
Q ss_pred ccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
............||+.|+|||++.+.++.++||||||+++++|++|+.||......+............... ...++++
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 254 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQ 254 (285)
T ss_dssp C----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHH
T ss_pred ecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCHH
Confidence 766555556678999999999998889999999999999999999999999888777766665554433322 2347899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||.+||+.||++|||+.|+|+|+||
T Consensus 255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 255 AVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 9999999999999999999999999997
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-53 Score=366.15 Aligned_cols=254 Identities=29% Similarity=0.493 Sum_probs=221.3
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEE
Confidence 4568999999999999999999999999999999986543 23356789999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCST
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC---EEEeeCCCceecCCc
Confidence 999999999999999765 6999999999999999999999999999999999999986655 999999999876543
Q ss_pred C-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 213 E-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 213 ~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
. ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+...... ....+..+++.+.+
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 248 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRD 248 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHHHH
Confidence 3 334568999999999986 45899999999999999999999999887776666555443322 22234568999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
||.+||+.||++|||+.|+++|+||
T Consensus 249 li~~~l~~dp~~Rps~~ell~h~~~ 273 (297)
T 3fxz_A 249 FLNRCLEMDVEKRGSAKELLQHQFL 273 (297)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HHHHHccCChhHCcCHHHHhhChhh
Confidence 9999999999999999999999997
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=379.15 Aligned_cols=259 Identities=32% Similarity=0.616 Sum_probs=230.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.++|++++.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++......
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEE
Confidence 35578999999999999999999999999999999986542 33456789999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-CCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCC-CCceEEEecccceecC
Confidence 99999999999999987654 699999999999999999999999999999999999997432 2349999999998876
Q ss_pred CCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.........||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+......+....+..+++++.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 665556678999999999987 4589999999999999999999999999888888888887776666666778999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||++|||+.++|+|+||
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWL 308 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccc
Confidence 99999999999999999999999997
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=376.35 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=225.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+.+||||+++++++...+..++
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 46799999999999999999999999999999999765433344567788899999887689999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-C
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-G 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~ 212 (315)
||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... .
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC---EEEeEChhhhhcccCC
Confidence 9999999999999998888999999999999999999999999999999999999976654 99999999986432 2
Q ss_pred CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......+||+.|+|||++.+ .++.++||||||+++|||++|..||......+....+......+ +..+++++.+|
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~l 248 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDL 248 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCC----CcccCHHHHHH
Confidence 33456789999999999874 58999999999999999999999999888888877777654333 34578999999
Q ss_pred HHHhcCCCcCCCCCHH-HHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQ-QVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~-e~l~~l~f 315 (315)
|.+||+.||++||++. ++++|+||
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred HHHHhcCCHhHcCCChHHHHcCccc
Confidence 9999999999999998 99999997
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-53 Score=371.71 Aligned_cols=264 Identities=38% Similarity=0.682 Sum_probs=232.3
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh---hcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..+.++|++.+.||+|+||.||+|.+..+++.||+|.+........ ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec
Confidence 4567889999999999999999999999999999999876543221 2467899999999999 89999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC-CCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET-APLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~-~~vkl~Dfg~a 206 (315)
.+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++.. ..++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 99999999999999999999888889999999999999999999999999999999999999866531 24999999999
Q ss_pred cccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.............||+.|+|||++. ..++.++||||||+++++|++|..||......+....+.......+...+..++
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS 246 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence 8776655556678999999999987 458999999999999999999999999888887777777665544433345688
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+.+||.+||+.||++|||+.++++|+||
T Consensus 247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp HHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 999999999999999999999999999997
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=369.72 Aligned_cols=251 Identities=28% Similarity=0.534 Sum_probs=225.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEE
Confidence 5799999999999999999999999999999999765444445567788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... .
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPD--V 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC---EEECCCSSCEECSS--C
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC---EEEeecCcceecCC--c
Confidence 999999999999998888999999999999999999999999999999999999976655 99999999986543 2
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
....+||+.|+|||++. ..++.++||||||+++|+|++|..||...........+......+ ++.+++++.++|.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~li~ 235 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLS 235 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----CCCCCHHHHHHHH
Confidence 34568999999999987 458999999999999999999999999888888888777765433 3457899999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcccCC
Q 021233 294 KMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+||+.||++|| ++.++++|+||
T Consensus 236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 236 RLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred HHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 99999999999 99999999997
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=372.69 Aligned_cols=254 Identities=27% Similarity=0.499 Sum_probs=220.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++..+.+||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57999999999999999999999999999999998776555556677899999999887899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CCC
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~~ 213 (315)
|||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.... ...
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCGGGCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC---EEEEeccccccccCCCC
Confidence 999999999999988888999999999999999999999999999999999999976655 9999999998643 333
Q ss_pred cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCC---------ChHHHHHHHHhccccCCCCCCcc
Q 021233 214 KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAE---------TEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
.....+||+.|+|||++.+ .++.++||||||+++|||++|+.||... ......+.+...... .+..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----~p~~ 241 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----IPRS 241 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC----CCTT
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC----CCCC
Confidence 4456789999999999874 5899999999999999999999999642 223334444444332 2346
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCH------HHHhcccCC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTA------QQVLGKIEF 315 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~------~e~l~~l~f 315 (315)
+++++.+||.+||+.||.+||++ .++++|+||
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 89999999999999999999995 899999997
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=372.54 Aligned_cols=273 Identities=27% Similarity=0.496 Sum_probs=235.7
Q ss_pred eeeecCCCccccccceeee-eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcce
Q 021233 42 LCVLKEPTGREIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC 120 (315)
Q Consensus 42 ~~~~~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~ 120 (315)
...+.......+.++|.+. +.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++..+..||||++
T Consensus 15 ~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~ 93 (327)
T 3lm5_A 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVIN 93 (327)
T ss_dssp -CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred chhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEE
Confidence 3455667778899999998 899999999999999999999999999876532 33446788999999999977899999
Q ss_pred eEEEEEcCCcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 121 LKDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
+++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.......+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCE
T ss_pred EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999999999988543 569999999999999999999999999999999999999864444559
Q ss_pred EEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC
Q 021233 199 KAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (315)
Q Consensus 199 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (315)
||+|||++.............||+.|+|||++. ..++.++||||||+++++|++|..||......+....+........
T Consensus 174 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 253 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS 253 (327)
T ss_dssp EECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred EEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC
Confidence 999999998776555556678999999999987 5589999999999999999999999999888888888887777777
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+..+++.+.+||.+||+.||++|||+.++|+|+||
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 77777899999999999999999999999999999997
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-53 Score=375.28 Aligned_cols=255 Identities=25% Similarity=0.438 Sum_probs=226.4
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+.+||+|+++++++...+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 45799999999999999999999999999999999765443445567788999999988789999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~ 212 (315)
||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.... ..
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc---EEEEeCCcccccccCC
Confidence 9999999999999998888999999999999999999999999999999999999976655 9999999998643 23
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......+||+.|+|||++. ..++.++||||||+++|||++|+.||......+..+.+......+ +..+++++.+|
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~l 251 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY----PKSMSKEAVAI 251 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC----CCCCCHHHHHH
Confidence 3445678999999999987 458999999999999999999999999888888888887765443 34689999999
Q ss_pred HHHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
|.+||+.||.+||+ +.++++|+||
T Consensus 252 i~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 252 CKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp HHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred HHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 99999999999994 6999999997
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=377.46 Aligned_cols=257 Identities=25% Similarity=0.472 Sum_probs=224.6
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
...-++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE
Confidence 34457899999999999999999999999999999999766544555667899999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH---VHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC---EEEeccceeeecc
Confidence 9999999999999999998888999999999999999999999999999999999999976655 9999999998876
Q ss_pred CCCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHhccccCCCCCCcc
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
.........||+.|+|||++. ..++.++||||||+++|+|++|..||.... .......+..... ..+..
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----~~p~~ 242 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV----TYPSA 242 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC----CCCTT
T ss_pred CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc----CCCCc
Confidence 666667789999999999985 248999999999999999999999997433 3333344443332 23346
Q ss_pred CCHHHHHHHHHhcCCCcCCCCC-HHHHhcccCC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLT-AQQVLGKIEF 315 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps-~~e~l~~l~f 315 (315)
+++++.+||.+||+.||.+||+ +.+++.|+||
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f 275 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence 7899999999999999999998 8999999997
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=379.58 Aligned_cols=254 Identities=35% Similarity=0.563 Sum_probs=219.1
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
.-++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+..+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEE
Confidence 346799999999999999999999999999999998765443344456799999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+ +|+|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDG 161 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC---EEECCSSCTBTTTTS
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC---EEEEEeccceeccCC
Confidence 999999 6799999988888999999999999999999999999999999999999986655 999999999887666
Q ss_pred CcccccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
......+||+.|+|||++.+. .+.++||||||+++|+|++|+.||...........+.. .....+..+++++.+
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS----CVYVMPDFLSPGAQS 237 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS----SCCCCCTTSCHHHHH
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----CCCCCcccCCHHHHH
Confidence 666777899999999998754 37899999999999999999999976544322222211 122233457899999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
||.+||+.||.+|||+.|+++|+||
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHcCCChhHCcCHHHHHhChhh
Confidence 9999999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=375.63 Aligned_cols=260 Identities=36% Similarity=0.620 Sum_probs=225.2
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
....+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+|++++.++.+||||+++++++...
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred cccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 344577899999999999999999999999999999999865432 2346888888887899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CCCCCEEEEeecccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~-~~~~~vkl~Dfg~a~ 207 (315)
+..++||||++||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +....+||+|||++.
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999999999988889999999999999999999999999999999999998544 333459999999998
Q ss_pred ccCCC-CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCC---CChHHHHHHHHhccccCCCCCCc
Q 021233 208 FFKPG-EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWA---ETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.. ....+....+...........+.
T Consensus 169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp ECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred cCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 65433 33455688999999999874 488999999999999999999999975 35566677777777666666778
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+++++.+||.+||+.||++|||+.++++|+||
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 899999999999999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=373.05 Aligned_cols=252 Identities=29% Similarity=0.526 Sum_probs=226.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 46899999999999999999999999999999999766544445567889999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECSSC-
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC---EEEcccccceeccCC-
Confidence 9999999999999998888999999999999999999999999999999999999976655 999999999876432
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
.....||+.|+|||++. ..++.++||||||+++|+|++|..||......+....+......+ +..+++++.++|
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~~~~~~~li 269 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLL 269 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTCCHHHHHHH
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC----CCCCCHHHHHHH
Confidence 34568999999999986 458999999999999999999999999888888888887765433 345789999999
Q ss_pred HHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 293 RKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
.+||+.||.+||+ +.++++|+||
T Consensus 270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred HHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 9999999999998 9999999997
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=383.53 Aligned_cols=258 Identities=31% Similarity=0.480 Sum_probs=224.7
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++++.||+|+||+||+|.+..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEE
Confidence 346899999999999999999999999999999998764433333345688999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|......
T Consensus 146 lV~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~---ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC---EEEeccceeEeeccC
Confidence 999999999999988764 6999999999999999999999999999999999999976655 999999999876544
Q ss_pred Cc--ccccccCCCccCchhhcc-c----CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 213 EK--FSEIVGSPYYMAPEVLKR-N----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 213 ~~--~~~~~gt~~y~aPE~~~~-~----~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.. ....+||+.|+|||++.+ . ++.++||||||+++|||++|+.||......+....+.........+.+..++
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 32 246789999999999753 2 7889999999999999999999999988888888887654333333445789
Q ss_pred HHHHHHHHHhcCCCcCC--CCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKR--RLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~--Rps~~e~l~~l~f 315 (315)
+++.+||.+||..+|.+ ||++.||++|+||
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 99999999999999998 9999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=365.00 Aligned_cols=264 Identities=28% Similarity=0.417 Sum_probs=217.4
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc--ChhcHHHHHHHHHHHHhCC--CCCCcceeEE
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLP--KHQNIVCLKD 123 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~ 123 (315)
+.+..+.++|++++.||+|+||+||+|.+..+++.||+|++...... .......+.+|+.+++.+. +||||+++++
T Consensus 2 p~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp --------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred CCCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 34566788999999999999999999999999999999998754321 1122345677888877763 4999999999
Q ss_pred EEEcCC-----cEEEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 124 TYEDDT-----AVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 124 ~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
++.... ..++||||+. ++|.+++..... +++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~-- 158 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-- 158 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--
Confidence 998755 5899999996 599999987654 999999999999999999999999999999999999976655
Q ss_pred CEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc
Q 021233 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (315)
+||+|||++.............||+.|+|||++. ..++.++||||||+++++|++|+.||......+....+......
T Consensus 159 -~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 159 -VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp -EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred -EEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999998776665566778999999999975 56899999999999999999999999998888877777654332
Q ss_pred CCCCC-----------------------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 FRRDP-----------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~~~~-----------------------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..... .+.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence 22221 13578999999999999999999999999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=387.36 Aligned_cols=260 Identities=35% Similarity=0.594 Sum_probs=230.2
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..+....++|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++..
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVIST 87 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE
Confidence 34455667899999999999999999999999999999999765444444567899999999999 89999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
.+..++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~---vkL~DFG~a~ 164 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSN 164 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC---EEECCCSSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC---eEEEeccchh
Confidence 9999999999999999999988888999999999999999999999999999999999999976655 9999999998
Q ss_pred ccCCCCcccccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
...........+||+.|+|||++.+. .+.++||||||+++|+|++|..||...........+....... +..++
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s 240 (476)
T 2y94_A 165 MMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT----PQYLN 240 (476)
T ss_dssp ECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC----CTTCC
T ss_pred hccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC----CccCC
Confidence 87666656677899999999998754 4789999999999999999999999888777777776654332 34578
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++.+||.+||+.||.+|||+.++++|+||
T Consensus 241 ~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~ 270 (476)
T 2y94_A 241 PSVISLLKHMLQVDPMKRATIKDIREHEWF 270 (476)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence 999999999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=361.68 Aligned_cols=263 Identities=41% Similarity=0.718 Sum_probs=234.7
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
..+.++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCe
Confidence 4567899999999999999999999998999999999875533 234567899999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||+++++|.+.+.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++....+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999999888889999999999999999999999999999999999999876666679999999998766
Q ss_pred CCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
.........+|+.|+|||.+.+.++.++||||||+++++|++|..||......+....+...........+..+++++.+
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred CCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHH
Confidence 55555556789999999999888999999999999999999999999988888877777776655544445678999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+|.+||+.||++|||+.++++|+||
T Consensus 256 li~~~l~~dp~~Rps~~ell~hp~~ 280 (287)
T 2wei_A 256 LIRKMLTFHPSLRITATQCLEHPWI 280 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHcccChhhCcCHHHHhcCHHH
Confidence 9999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=364.38 Aligned_cols=261 Identities=28% Similarity=0.451 Sum_probs=216.2
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..+..+.++|++++.||+|+||+||+|.+. +++.||+|++..... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS 90 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc
Confidence 345567889999999999999999999985 589999999875432 223346788999999999 99999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
.+..++||||+++ +|.+.+.... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~a 166 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLA 166 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTC
T ss_pred CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC---EEEccCcCc
Confidence 9999999999975 8888887654 4999999999999999999999999999999999999986655 999999999
Q ss_pred cccCCC-CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC---
Q 021233 207 VFFKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--- 280 (315)
Q Consensus 207 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 280 (315)
...... .......+|+.|+|||++.+ .++.++||||||+++++|++|+.||......+....+........+..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 167 RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp EETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred eecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 876433 23345678999999999763 489999999999999999999999988877777666655333222211
Q ss_pred -----------------------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 -----------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 -----------------------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 13467899999999999999999999999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=359.66 Aligned_cols=255 Identities=28% Similarity=0.488 Sum_probs=212.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEE
Confidence 479999999999999999999999999999999876542 333356788999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||+++ +|.+.+.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~---~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeecccceecCCcc
Confidence 999976 56555554 567999999999999999999999999999999999999986655 999999999876433
Q ss_pred CcccccccCCCccCchhhcc-c-CCCcchHHHHHHHHHHHhhCCCC-CCCCChHHHHHHHHhccccCCCC----------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPP-FWAETEQGVAQAIIRSVLDFRRD---------- 279 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~---------- 279 (315)
.......||+.|+|||++.+ . ++.++||||||+++++|++|..| |......+....+.+........
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence 33355688999999999863 3 79999999999999999988777 55555555555554432221111
Q ss_pred ---------------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 ---------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ---------------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 123578899999999999999999999999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=373.18 Aligned_cols=255 Identities=27% Similarity=0.513 Sum_probs=215.4
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHH-HhCCCCCCcceeEEEEEcCCcE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM-RHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|..++ +.+ +||||+++++++...+..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEE
Confidence 346899999999999999999999999999999999876655444556677777774 556 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc-C
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-K 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~-~ 210 (315)
|+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.. .
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCBCGGGBC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC---EEEeeCcccccccc
Confidence 999999999999999998888999999999999999999999999999999999999986655 999999999863 3
Q ss_pred CCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
........+||+.|+|||++.+ .++.++||||||+++|||++|..||......+....+......+ .+.+++++.
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~ 267 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL----KPNITNSAR 267 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC----CSSSCHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC----CCCCCHHHH
Confidence 3334456789999999999874 58999999999999999999999999888888888887764433 346889999
Q ss_pred HHHHHhcCCCcCCCCCH----HHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTA----QQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~----~e~l~~l~f 315 (315)
+||.+||+.||.+||++ .++++|+||
T Consensus 268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f 297 (373)
T 2r5t_A 268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297 (373)
T ss_dssp HHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred HHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence 99999999999999987 699999997
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=366.34 Aligned_cols=261 Identities=34% Similarity=0.561 Sum_probs=217.5
Q ss_pred ccccceeee-eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 52 EIEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 52 ~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.+.++|++. +.||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.++.++.+||||+++++++...+.
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 456789985 78999999999999999999999999986542 33457889999999997689999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++....+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 99999999999999999988889999999999999999999999999999999999999877666669999999987653
Q ss_pred CCC--------cccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh--------------
Q 021233 211 PGE--------KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETE-------------- 262 (315)
Q Consensus 211 ~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~-------------- 262 (315)
... ......||+.|+|||++. ..++.++||||||+++++|++|+.||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 221 123456999999999875 3488999999999999999999999976542
Q ss_pred -HHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 263 -QGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 263 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
......+......++...+..+++++.+||.+||+.||++|||+.|+++|+||
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 299 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence 23444555544433333334688999999999999999999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=382.89 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=224.2
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++++.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++...+..
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEE
Confidence 3457899999999999999999999999999999998764333333344588999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||+|....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~---vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC---EEEcchhhhhhcc
Confidence 999999999999999987 467999999999999999999999999999999999999976655 9999999998765
Q ss_pred CCCcc--cccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-CCCC
Q 021233 211 PGEKF--SEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RDPW 281 (315)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 281 (315)
..... ...+||+.|+|||++. +.++.++|||||||++|||++|+.||......+....+........ +..+
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence 44332 3468999999999875 3489999999999999999999999999888888777765432221 2233
Q ss_pred ccCCHHHHHHHHHhcCCCcCC--CCCHHHHhcccCC
Q 021233 282 PKVSENAKDLVRKMLDPDPKR--RLTAQQVLGKIEF 315 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~--Rps~~e~l~~l~f 315 (315)
..+++++.+||.+||..+|++ ||++.|+++|+||
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 568999999999999999988 9999999999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=384.60 Aligned_cols=258 Identities=29% Similarity=0.535 Sum_probs=216.3
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.....++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++...+
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHD 221 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETT
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCC
Confidence 334457899999999999999999999999999999999765444444556788899999999 8999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++||||+++++|.+++.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++. +||+|||+|..
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~---~kl~DFG~a~~ 298 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH---IKITDFGLCKE 298 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC---EEECCCCCCCT
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC---EEEccCCCcee
Confidence 999999999999999999988889999999999999999999998 99999999999999986654 99999999986
Q ss_pred cC-CCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 209 FK-PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 209 ~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.. .........||+.|+|||++. ..++.++||||||+++++|++|+.||...........+......+ +..+++
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~~~ 374 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF----PRTLGP 374 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCH
T ss_pred ccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCC----CccCCH
Confidence 43 233445678999999999986 569999999999999999999999999888888777777664443 345789
Q ss_pred HHHHHHHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
++.+||.+||+.||.+|| ++.|+++|+||
T Consensus 375 ~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 375 EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred HHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 999999999999999999 99999999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=376.93 Aligned_cols=255 Identities=36% Similarity=0.643 Sum_probs=210.6
Q ss_pred cccceeee-eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----
Q 021233 53 IEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (315)
Q Consensus 53 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~---- 127 (315)
+.++|.+. +.||+|+||+||+|.+..+++.||+|++... ..+.+|+.++.++.+||||+++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 44567776 7899999999999999999999999998532 4577899988766699999999999875
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...+++||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 567899999999999999998653 499999999999999999999999999999999999998755456699999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH----HHHHHHHhccccCCCCC
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ----GVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~ 280 (315)
+............+||+.|+|||++. ..++.++|||||||++|+|++|..||...... .....+......++...
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 98766555556778999999999986 56999999999999999999999999765432 23455555555555556
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+..+++++.+||.+||+.||++|||+.++++|+||
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 325 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 325 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 67899999999999999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=370.33 Aligned_cols=257 Identities=35% Similarity=0.637 Sum_probs=203.5
Q ss_pred cccceeee---eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 53 IEERYELG---RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 53 ~~~~y~~~---~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
+.++|++. +.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+.+||||+++++++....
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 34567775 7899999999999999999999999998543 24668899999999966999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
..++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 99999999999999999999888999999999999999999999999999999999999987765556999999999865
Q ss_pred CCCC-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC-------hHHHHHHHHhccccCCCCC
Q 021233 210 KPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-------EQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 210 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~ 280 (315)
.... ......||+.|+|||++. ..++.++||||||+++++|++|..||.... ..+....+......+....
T Consensus 160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (325)
T 3kn6_A 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239 (325)
T ss_dssp CC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHH
T ss_pred CCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccc
Confidence 4432 335567899999999987 458999999999999999999999997543 2345556655555544444
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+..+++++.+||.+||+.||.+|||+.++++|+||
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~ 274 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence 56789999999999999999999999999999997
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-52 Score=360.32 Aligned_cols=261 Identities=29% Similarity=0.461 Sum_probs=218.1
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.+..+.++|++++.||+|+||.||+|.+..++..||+|.+...........+.+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEED 83 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeC
Confidence 3567888999999999999999999999999999999998765555555567899999999999 999999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+..++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~~~ 160 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKA 160 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCSSSTT
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEEeCCCccc
Confidence 999999999999999999998888999999999999999999999999999999999999976655 99999999986
Q ss_pred cCCCC--cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC-CCCCCccC
Q 021233 209 FKPGE--KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-RRDPWPKV 284 (315)
Q Consensus 209 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 284 (315)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||................... .....+.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence 54332 2234579999999999874 58899999999999999999999998887766555444432221 12234568
Q ss_pred CHHHHHHHHHhcCCCcCCCC-CHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRL-TAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rp-s~~e~l~~l 313 (315)
++.+.++|.+||+.||.+|| ++.++++.+
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 99999999999999999999 777666543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=359.64 Aligned_cols=263 Identities=40% Similarity=0.709 Sum_probs=225.1
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC---hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.+.++|++++.||+|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENK 80 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCC
Confidence 35678999999999999999999999999999999987654322 22467899999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-CCCEEEEeecccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~-~~~vkl~Dfg~a~ 207 (315)
+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++. ...++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999999988888999999999999999999999999999999999999986552 2359999999998
Q ss_pred ccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
............+|+.|+|||++. ..++.++||||||+++++|++|..||......+....+...........+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 776555555668999999999987 5589999999999999999999999998888777777766544443333456789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.++|.+||+.||++|||+.++++|+||
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 99999999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=372.66 Aligned_cols=261 Identities=37% Similarity=0.699 Sum_probs=228.4
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC-----hhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++....... ....+.+.+|+.+++.+.+||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34568999999999999999999999899999999986543111 1124568899999999878999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
..+..++||||++|++|.+++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~---ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ---IRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEEEecCcc
Confidence 99999999999999999999988888999999999999999999999999999999999999986655 999999999
Q ss_pred cccCCCCcccccccCCCccCchhhcc-------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (315)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+..........
T Consensus 248 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred cccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 88776666667789999999998752 37889999999999999999999998888777777777665544433
Q ss_pred CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+..+++++.++|.+||+.||++|||+.++++|+||
T Consensus 328 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 455788999999999999999999999999999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=363.24 Aligned_cols=256 Identities=31% Similarity=0.504 Sum_probs=213.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEccccccc-ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
...++|++++.||+|+||.||+|.+. .+++.||+|++...... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc
Confidence 34568999999999999999999985 67899999998765322 223345688899999999 89999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
.+..++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~~ 169 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCK 169 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC---EEECCCSCC-
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc---EEEEeCCccc
Confidence 9999999999999999999998888999999999999999999999999999999999999986655 9999999997
Q ss_pred ccCCC-CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 208 FFKPG-EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 208 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
..... .......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+....... ++.++
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~----p~~~~ 245 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL----PPYLT 245 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC----CTTSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC----CCCCC
Confidence 54322 2334568999999999986 458999999999999999999999999888888777777664433 34578
Q ss_pred HHHHHHHHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+++.+||.+||+.||.+|| ++.++++|+||
T Consensus 246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 9999999999999999999 89999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=357.82 Aligned_cols=261 Identities=38% Similarity=0.669 Sum_probs=230.4
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC------hhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT------AVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++++.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 45678999999999999999999999999999999986543111 122456889999999996699999999999
Q ss_pred EcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...+..++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~ 170 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGF 170 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc---EEEecccc
Confidence 999999999999999999999998888999999999999999999999999999999999999976655 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc-------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (315)
+.............+|+.|+|||++. ..++.++||||||+++++|++|..||...........+.........
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 98776665566678999999999874 24788999999999999999999999988888877877777666665
Q ss_pred CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+..+++++.++|.+||+.||++|||+.++++|+||
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (298)
T 1phk_A 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287 (298)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence 5667889999999999999999999999999999997
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=357.59 Aligned_cols=254 Identities=31% Similarity=0.498 Sum_probs=211.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+ .+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEE
Confidence 4799999999999999999998 6789999999865432 223346788999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||+++ +|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEEeECccccccCccc
Confidence 999975 999988764 56999999999999999999999999999999999999986655 999999999865432
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC------------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------ 278 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 278 (315)
.......+|+.|+|||++.+ .++.++||||||+++++|++|+.||......+....+.+.......
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 23345578999999999863 4899999999999999999999999888877766666543211110
Q ss_pred -------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 -------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 -------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.....+++++.+||.+||+.||++|||+.|+++|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 0123578999999999999999999999999999997
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=372.81 Aligned_cols=258 Identities=34% Similarity=0.599 Sum_probs=221.6
Q ss_pred cccceee--eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 53 IEERYEL--GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 53 ~~~~y~~--~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
+...|.+ .+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 160 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND 160 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCE
Confidence 3445555 678999999999999999999999999987542 23457799999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+..++ ...+||+|||++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD-AKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-TTEEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-CCcEEEEeCCCceec
Confidence 99999999999999988754 3599999999999999999999999999999999999995432 234999999999987
Q ss_pred CCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 210 KPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
..........||+.|+|||++. ..++.++||||||+++++|++|..||......+....+...........+..+++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred CCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 6666556678999999999987 458999999999999999999999999988888888888776666555567789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+||.+||+.||.+|||+.|+|+|+||
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence 999999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=360.73 Aligned_cols=260 Identities=41% Similarity=0.724 Sum_probs=227.9
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTH 80 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCE
Confidence 456789999999999999999999999999999999987542 22345688999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||++..++....++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999888889999999999999999999999999999999999999544455569999999987543
Q ss_pred CCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.. ......||+.|+|||++. ..++.++||||||+++++|++|..||...........+......+....+..+++++.
T Consensus 161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (304)
T 2jam_A 161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK 239 (304)
T ss_dssp CB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred CC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence 32 334557999999999986 4589999999999999999999999998888888888888776666666678899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++|.+||+.||++|||+.++++|+||
T Consensus 240 ~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 240 DFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp HHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHcCCChhHCcCHHHHhcCccc
Confidence 99999999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=366.40 Aligned_cols=256 Identities=30% Similarity=0.516 Sum_probs=214.3
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+.++|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEE
Confidence 45689999999999999999999999999999999865432 22235688999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCEECEET
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC---EEEEEeeccceeccC
Confidence 99999999999999987778999999999999999999999999999999999999976655 999999999765322
Q ss_pred C---cccccccCCCccCchhhcc-c-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 213 E---KFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 213 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
. ......||+.|+|||++.+ . ++.++||||||+++++|++|+.||................ ......+..++++
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSA 237 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-CTTSTTGGGSCHH
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-cccCCccccCCHH
Confidence 2 2345689999999999864 3 4778999999999999999999997665432222222221 1222345678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||.+||+.||++|||+.|+++|+||
T Consensus 238 ~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 238 PLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred HHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 9999999999999999999999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=381.73 Aligned_cols=263 Identities=35% Similarity=0.617 Sum_probs=214.9
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC-----hhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----AVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++....... ......+.+|+.+|+++ +||||+++++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 209 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 209 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence 345678999999999999999999999999999999987654321 12223578999999999 999999999998
Q ss_pred EcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
... ..++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 210 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 210 DAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp ESS-EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred ecC-ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 654 5799999999999999998888899999999999999999999999999999999999998777667799999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhccccCCCCC
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 280 (315)
+.............||+.|+|||++. ..++.++||||||+++++|++|..||...... .....+........+..
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 368 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence 98876555556778999999999874 34788999999999999999999999765433 33344444444444444
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+..+++++.+||.+||+.||++|||+.++|+|+||
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 55789999999999999999999999999999997
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=388.73 Aligned_cols=255 Identities=30% Similarity=0.508 Sum_probs=222.1
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|+.+ +||||+++++++...+..+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEE
Confidence 356799999999999999999999999999999999766544445567788999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+||||++||+|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~---vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH---IRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC---eEEEecccceecc
Confidence 99999999999999986543 999999999999999999999999999999999999976655 9999999998876
Q ss_pred CCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHhccccCCCCCCccCC
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
........+||+.|+|||++.+ .++.++|||||||++|||++|..||..... ......+... +...+..++
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~~~~p~~~s 413 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PEEYSERFS 413 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----CCCCCTTSC
T ss_pred cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----cccCCccCC
Confidence 6655566789999999999874 589999999999999999999999976532 3333333332 233345689
Q ss_pred HHHHHHHHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+++.+||.+||+.||.+|| ++.|+++|+||
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF 448 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGG
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhh
Confidence 9999999999999999999 89999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=376.40 Aligned_cols=259 Identities=26% Similarity=0.455 Sum_probs=220.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|..++..+ +||||+++++++...+..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEE
Confidence 3457899999999999999999999999999999999764433333445688999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~---vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH---IRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC---EEEeechhheecc
Confidence 99999999999999998754 6999999999999999999999999999999999999976655 9999999998765
Q ss_pred CCCcc--cccccCCCccCchhhc--------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-CC
Q 021233 211 PGEKF--SEIVGSPYYMAPEVLK--------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-RD 279 (315)
Q Consensus 211 ~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~ 279 (315)
..... ...+||+.|+|||++. ..++.++|||||||++|||++|+.||......+....+........ +.
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 44332 3468999999999875 3489999999999999999999999998888877777765322211 11
Q ss_pred CCccCCHHHHHHHHHhcCCCcCCC---CCHHHHhcccCC
Q 021233 280 PWPKVSENAKDLVRKMLDPDPKRR---LTAQQVLGKIEF 315 (315)
Q Consensus 280 ~~~~~~~~l~~li~~~l~~~P~~R---ps~~e~l~~l~f 315 (315)
....+++++.+||.+||. +|.+| |++.|+++|+||
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 234689999999999999 99988 699999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=371.63 Aligned_cols=255 Identities=33% Similarity=0.530 Sum_probs=204.5
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++++.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST----TSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc----cccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEE
Confidence 3568999999999999999999999999999999986542 2236688999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. ..+||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~-~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSS-CCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC-ceEEEeecCcccccccc
Confidence 99999999999999988888999999999999999999999999999999999999975433 24899999999865444
Q ss_pred CcccccccCCCccCchhhcc-cCCC-cchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHhccccCCCCCCccCCH
Q 021233 213 EKFSEIVGSPYYMAPEVLKR-NYGP-EVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~~~-~~Di~slG~~l~el~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.......||+.|+|||++.+ .++. ++||||||+++|+|++|+.||..... ......+....... .....+++
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~ 249 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSI--PDDIRISP 249 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCC--CTTSCCCH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCC--CCcCCCCH
Confidence 44456689999999999764 4544 48999999999999999999976543 23333333332222 22335789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||.+||+.||++|||+.|+++|+||
T Consensus 250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 250 ECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 99999999999999999999999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=362.07 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=203.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+++.||+|.+.... .....+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEE
Confidence 57999999999999999999999999999999987543 223346788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 135 MELCEGGELFDRIVAR------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
|||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC---EEECcCcccee
Confidence 99997 4999988754 34899999999999999999999999999999999999986655 99999999987
Q ss_pred cCCC-CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC------
Q 021233 209 FKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD------ 279 (315)
Q Consensus 209 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 279 (315)
.... .......||+.|+|||++.+ .++.++||||||+++++|++|+.||......+....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 6432 23345688999999999864 48999999999999999999999999888877776665432221111
Q ss_pred ------------------------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 ------------------------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ------------------------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f 297 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence 112468899999999999999999999999999997
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=371.49 Aligned_cols=264 Identities=34% Similarity=0.624 Sum_probs=223.5
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc--ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
...+.++|++.+.||+|+||+||+|.+..++..||+|++...... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc
Confidence 345678999999999999999999999999999999998754321 234457899999999999 89999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHH
Q 021233 128 DTAVHLVMELCEGGELFDRIVA----------------------------------------RGHYTERAAAAVTKTIVE 167 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~----------------------------------------~~~l~~~~~~~i~~~l~~ 167 (315)
.+..++||||++|++|.+++.. ...+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999998841 011367788899999999
Q ss_pred HHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-----cccccccCCCccCchhhc---ccCCCcch
Q 021233 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLK---RNYGPEVD 239 (315)
Q Consensus 168 ~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~---~~~~~~~D 239 (315)
||.|||+.||+||||||+||+++.++. ..+||+|||++....... ......||+.|+|||++. ..++.++|
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKS-FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSS-CCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCC-ceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999999975442 249999999997643211 234567999999999975 45899999
Q ss_pred HHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 240 VWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 240 i~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|||||+++|+|++|+.||......+....+...........+..+++++.+||.+||+.||.+|||+.++|+|+||
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 9999999999999999999988888888888777666655566789999999999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=365.30 Aligned_cols=262 Identities=28% Similarity=0.460 Sum_probs=212.0
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
....++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHR 107 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGC-CCTTBCCEEEEEEETTE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCE
Confidence 3455689999999999999999999999999999999975532 223345677899999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCEEEEeeccccc
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVF 208 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~--~~~~vkl~Dfg~a~~ 208 (315)
.++||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999975 9999999888899999999999999999999999999999999999996543 233489999999986
Q ss_pred cCCC-CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCc---
Q 021233 209 FKPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP--- 282 (315)
Q Consensus 209 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 282 (315)
.... .......+|+.|+|||++.+ .++.++||||||+++++|++|..||......+....+...........++
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 5433 23345678999999999864 48999999999999999999999999888877777766543222211111
Q ss_pred -----------------------cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 -----------------------KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 -----------------------~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCccc
Confidence 167899999999999999999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=362.94 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=211.0
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.+..+.++|++++.||+|+||+||+|.+..+++.||+|++..... ..........|+..+..+.+||||+++++++...
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 345677899999999999999999999999999999998765432 2333445566676666666899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
+..++||||+ +++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kl~DFG~a~ 205 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLV 205 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC---EEECCCTTCE
T ss_pred CEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC---EEEccceeee
Confidence 9999999999 669988887644 5999999999999999999999999999999999999977665 9999999998
Q ss_pred ccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
............||+.|+|||++.+.++.++||||||++++||++|..|+.... ....+..... +...+..++++
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~ 280 (311)
T 3p1a_A 206 ELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGYL--PPEFTAGLSSE 280 (311)
T ss_dssp ECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTCC--CHHHHTTSCHH
T ss_pred ecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccCC--CcccccCCCHH
Confidence 776555555667999999999998889999999999999999999977765432 2233333211 12223467899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.++|.+||+.||++|||+.|+|+|+||
T Consensus 281 l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 281 LRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 9999999999999999999999999997
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=355.22 Aligned_cols=254 Identities=34% Similarity=0.575 Sum_probs=220.7
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++.+.||+|+||+||+|.+..++..||+|++.............+.+|+.+++.+ +||||+++++++...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEE
Confidence 346799999999999999999999999999999998765444444567799999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+.+.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~---~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSS 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC---EEECSCCEESCC---
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC---EEEEeccccccCCcc
Confidence 99999999999999988888999999999999999999999999999999999999976655 999999998654332
Q ss_pred CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......||+.|+|||.+.+ .++.++||||||+++++|++|..||......+....+....... +..+++++.+|
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l 237 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDL 237 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC----CTTSCHHHHHH
T ss_pred -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC----CCcCCHHHHHH
Confidence 2345678999999999874 58899999999999999999999999888877777776654332 34578999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||+.||.+|||+.|+++|+||
T Consensus 238 i~~~l~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 238 ISRLLKHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp HHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred HHHHhccChhhCCCHHHHhhCccc
Confidence 999999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=360.05 Aligned_cols=255 Identities=31% Similarity=0.552 Sum_probs=212.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC-----------------------hhcHHHHHHHHHHHH
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-----------------------AVDIEDVRREVDIMR 110 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----------------------~~~~~~~~~e~~~l~ 110 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999999999999999987553211 112356889999999
Q ss_pred hCCCCCCcceeEEEEEc--CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceE
Q 021233 111 HLPKHQNIVCLKDTYED--DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (315)
Q Consensus 111 ~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nil 188 (315)
.+ +||||+++++++.. .+..++||||+++++|.+++. ...+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99 99999999999986 568999999999999987653 346999999999999999999999999999999999999
Q ss_pred eecCCCCCCEEEEeeccccccCCCC-cccccccCCCccCchhhccc----CCCcchHHHHHHHHHHHhhCCCCCCCCChH
Q 021233 189 FANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (315)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 263 (315)
++.++. +||+|||++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|+.||......
T Consensus 170 ~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 170 VGEDGH---IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp ECTTSC---EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ECCCCC---EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 976655 9999999998765433 23456899999999998643 377899999999999999999999887776
Q ss_pred HHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.....+.......+ ..+.+++++.+||.+||+.||++|||+.|+++|+||
T Consensus 247 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 247 CLHSKIKSQALEFP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp HHHHHHHHCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred HHHHHHhcccCCCC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 66666665543332 235689999999999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=366.26 Aligned_cols=263 Identities=36% Similarity=0.619 Sum_probs=219.6
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc-----ChhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+++.+ +||||+++++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEE
Confidence 45678999999999999999999999999999999998754321 122234588999999999 999999999999
Q ss_pred EcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 126 EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
.... .++||||+++++|.+.+.....+++..++.++.|++.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7765 899999999999999998888899999999999999999999999999999999999998777666799999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhccccCCCCC
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~ 280 (315)
+.............||+.|+|||++. ..++.++||||||+++|+|++|..||...... .....+........+..
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 98776554445668999999999863 45889999999999999999999999765433 23344444433333333
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+..+++++.+||.+||+.||++|||+.++++|+||
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~ 278 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCc
Confidence 45679999999999999999999999999999997
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=367.60 Aligned_cols=261 Identities=27% Similarity=0.414 Sum_probs=217.1
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.+ +||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAET 85 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccC
Confidence 346778999999999999999999999999999999999876555555567889999999999 9999999999987654
Q ss_pred c----EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 130 A----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 130 ~----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
. .++||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~ 162 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGI 162 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC---EEECCCSC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC---EEEeeccC
Confidence 3 4999999999999999998888999999999999999999999999999999999999987665 99999999
Q ss_pred ccccCCCC----cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC
Q 021233 206 SVFFKPGE----KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 206 a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (315)
+....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+................
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence 98654332 1234578999999999874 589999999999999999999999998887777666665543333233
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
...+++++.++|.+||+.||++||++.+++.+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l 276 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 276 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence 4568999999999999999999999999887764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-52 Score=372.70 Aligned_cols=260 Identities=32% Similarity=0.522 Sum_probs=208.3
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
+..+.++|++++.||+|+||+||+|.+..+++.||+|++... .........+.+|+.++..+.+||||+++++++...+
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 345678899999999999999999999999999999998654 3344556778899999999956999999999997544
Q ss_pred --cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 130 --AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
..++||||++ ++|.+.+.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++. +||+|||+|+
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH---VKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCE
T ss_pred CCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC---EEecCCcccc
Confidence 7899999997 589888876 46999999999999999999999999999999999999976554 9999999997
Q ss_pred ccCC----------------------CCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH
Q 021233 208 FFKP----------------------GEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ 263 (315)
Q Consensus 208 ~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 263 (315)
.... .......+||+.|+|||++.+ .++.++|||||||+++||++|+.||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 6532 112244689999999999864 5899999999999999999999999988877
Q ss_pred HHHHHHHhccccCCC-------------------------------------------CCCccCCHHHHHHHHHhcCCCc
Q 021233 264 GVAQAIIRSVLDFRR-------------------------------------------DPWPKVSENAKDLVRKMLDPDP 300 (315)
Q Consensus 264 ~~~~~~~~~~~~~~~-------------------------------------------~~~~~~~~~l~~li~~~l~~~P 300 (315)
+....+......... .....+++++.+||.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 777666532211100 0112578999999999999999
Q ss_pred CCCCCHHHHhcccCC
Q 021233 301 KRRLTAQQVLGKIEF 315 (315)
Q Consensus 301 ~~Rps~~e~l~~l~f 315 (315)
++|||+.|+|+|+||
T Consensus 318 ~~R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 318 NKRISANDALKHPFV 332 (388)
T ss_dssp GGSCCHHHHTTSTTT
T ss_pred ccCCCHHHHhCCHHH
Confidence 999999999999997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=353.32 Aligned_cols=259 Identities=36% Similarity=0.593 Sum_probs=216.9
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.+....++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTP 83 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC
Confidence 3445667899999999999999999999989999999998765443444567899999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
+..++||||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||||+||+++.++. ++|+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~dfg~~~~ 160 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNM 160 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC---EEECCCCGGGC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC---EEEeecccccc
Confidence 999999999999999999988888999999999999999999999999999999999999976655 99999999987
Q ss_pred cCCCCcccccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
...........+|+.|+|||.+.+. .+.++||||||+++++|++|..||...........+....... ...+++
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 236 (276)
T 2h6d_A 161 MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI----PEYLNR 236 (276)
T ss_dssp CCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCH
T ss_pred cCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC----chhcCH
Confidence 6655545566889999999998754 3679999999999999999999998887777766666553332 345789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.++|.+||+.||++|||+.++++|+||
T Consensus 237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 237 SVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 99999999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=379.07 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=198.1
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc---
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--- 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--- 127 (315)
..+.++|++++.||+|+||+||+|.+..+++.||+|++... .......+++.+|+.+|+.+ +||||+++++++..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCc
Confidence 35668999999999999999999999999999999998654 33445567899999999999 99999999999843
Q ss_pred --CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 128 --DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 128 --~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
....|+||||+ +++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||+
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~---~kl~DFGl 202 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS---VKVCDFGL 202 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC---EEECCCTT
T ss_pred ccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC---Eeeccccc
Confidence 35789999998 5699999988888999999999999999999999999999999999999976654 99999999
Q ss_pred ccccCCCC----------------------------cccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhh---
Q 021233 206 SVFFKPGE----------------------------KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLC--- 252 (315)
Q Consensus 206 a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~t--- 252 (315)
|+...... .....+||+.|+|||++. ..++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 98654221 224457899999999763 459999999999999999998
Q ss_pred --------CCCCCCCCCh--------------------HHHHHHHHhccccC---------------------------C
Q 021233 253 --------GVPPFWAETE--------------------QGVAQAIIRSVLDF---------------------------R 277 (315)
Q Consensus 253 --------g~~p~~~~~~--------------------~~~~~~~~~~~~~~---------------------------~ 277 (315)
|+++|.+... .+....+....... .
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 6677755431 12222222111000 0
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...++.+++++.+||.+||..||++|||+.|+|+|+||
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 11234568999999999999999999999999999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=358.17 Aligned_cols=257 Identities=30% Similarity=0.562 Sum_probs=213.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|++++.||+|+||+||+|.+..+++.||+|++.... ......+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEE
Confidence 367999999999999999999999999999999886543 2333456788999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC---EEEeeCCCchhccCcc
Confidence 9999999999998888878999999999999999999999999999999999999976554 999999999876533
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-------------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------- 277 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (315)
.......||+.|+|||++.+ .++.++||||||+++++|++|..||......+....+........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 23345688999999999753 589999999999999999999999988877766655543221100
Q ss_pred ------CC--------CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ------RD--------PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ------~~--------~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ..+.+++++.+||.+||+.||++|||+.++++|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 288 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGG
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHH
Confidence 00 024578899999999999999999999999999997
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=369.05 Aligned_cols=257 Identities=19% Similarity=0.283 Sum_probs=212.3
Q ss_pred ccceeeeeeeeee--cceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 54 EERYELGRELGRG--EFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 54 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.++|++++.||+| +||+||+|.+..+++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEE
Confidence 4579999999999 999999999999999999999976543 334467788999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~---~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEcccccceee
Confidence 9999999999999999875 56999999999999999999999999999999999999976654 999999988644
Q ss_pred CCC--------CcccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC--
Q 021233 210 KPG--------EKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF-- 276 (315)
Q Consensus 210 ~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 276 (315)
... .......||+.|+|||++.+ .++.++|||||||++++|++|+.||...........+.......
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 221 11223478999999999864 48999999999999999999999997765544443332211110
Q ss_pred ----------------------------------------CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ----------------------------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ----------------------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+..+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 011234578899999999999999999999999999997
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=379.91 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=208.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
.+.++|++++.||+|+||+||+|.+..+++.||+|++... .......+++.+|+.+++.+ +||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCST
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcc
Confidence 4567899999999999999999999999999999998754 23444567788999999999 999999999999654
Q ss_pred ---CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...++||||+++ +|.+.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~---~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC---EEEEEEEe
Confidence 457999999976 56666643 4999999999999999999999999999999999999986655 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC-----
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----- 279 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 279 (315)
|+............||+.|+|||++. ..++.++|||||||++++|++|+.||.+....+....+.+......+.
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence 98776655566779999999999986 469999999999999999999999999888777766665432221100
Q ss_pred -----------------CC----c------------cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 -----------------PW----P------------KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 -----------------~~----~------------~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+ + ..++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 00 0 014678999999999999999999999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-51 Score=352.69 Aligned_cols=256 Identities=34% Similarity=0.507 Sum_probs=225.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++.+.||+|+||.||+|.+..+++.+|+|.+...........+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEE
Confidence 3457899999999999999999999999999999998776555556677899999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC---EEEEeccCceeccc
Confidence 999999999999999988888999999999999999999999999999999999999986555 99999999987643
Q ss_pred C-CcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 G-EKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. .......||+.|+|||.+.+ .++.++||||||+++++|++|+.||......+....+...... ....+++.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 243 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS----IPKHINPVAA 243 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----CCTTSCHHHH
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC----CccccCHHHH
Confidence 2 23345678999999999864 5899999999999999999999999888877766666554332 2345789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++|.+||+.||++|||+.++++|+||
T Consensus 244 ~li~~~l~~~p~~Rps~~~ll~~~~~ 269 (294)
T 2rku_A 244 SLIQKMLQTDPTARPTINELLNDEFF 269 (294)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHHHHHcccChhhCcCHHHHhhChhe
Confidence 99999999999999999999999886
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=365.21 Aligned_cols=268 Identities=22% Similarity=0.365 Sum_probs=223.9
Q ss_pred ceeeecCCCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC----CCC
Q 021233 41 KLCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----KHQ 116 (315)
Q Consensus 41 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~ 116 (315)
....+....+..+.++|++++.||+|+||+||+|.+..+++.||+|++... ......+..|+.+++.+. .||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 344566777888999999999999999999999999999999999998632 233456788999999994 399
Q ss_pred CcceeEEEEEcCCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC-
Q 021233 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK- 193 (315)
Q Consensus 117 ~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~- 193 (315)
||+++++++...+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999999 889999998764 499999999999999999999999999999999999997421
Q ss_pred ---------------------CCCCEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHh
Q 021233 194 ---------------------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILL 251 (315)
Q Consensus 194 ---------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~ 251 (315)
....+||+|||++..... ......||+.|+|||++. ..++.++||||||+++|+|+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 244599999999986433 234568899999999986 46999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhccccCCCCC---------------------C---------------------ccCCHHHH
Q 021233 252 CGVPPFWAETEQGVAQAIIRSVLDFRRDP---------------------W---------------------PKVSENAK 289 (315)
Q Consensus 252 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~---------------------~~~~~~l~ 289 (315)
+|+.||......+....+.......+... + ...++.+.
T Consensus 254 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 254 TGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred HCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 99999988887776666654432221100 0 01237788
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||++|||+.|+|+|+||
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~hp~f 359 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLKHKFL 359 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HHHHHHhcCChhhCCCHHHHhcCccc
Confidence 99999999999999999999999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=359.22 Aligned_cols=256 Identities=34% Similarity=0.512 Sum_probs=226.2
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeE
Confidence 3456899999999999999999999999999999999876555556677899999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++. ++|+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEY 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC---EEEeeccCceeccc
Confidence 999999999999999988888999999999999999999999999999999999999986655 99999999987643
Q ss_pred C-CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 G-EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~-~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. .......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+....+....... ...+++++.
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 269 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI----PKHINPVAA 269 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC----CTTSCHHHH
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC----CccCCHHHH
Confidence 3 2334567999999999986 458999999999999999999999998888777766666554332 345789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||++|||+.++++|+||
T Consensus 270 ~li~~~l~~dp~~Rps~~ell~~~~~ 295 (335)
T 2owb_A 270 SLIQKMLQTDPTARPTINELLNDEFF 295 (335)
T ss_dssp HHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHHHHHccCChhHCcCHHHHhcCccc
Confidence 99999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=392.56 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=228.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+.+||+|+++++++...+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999765443444567788999999998789999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC-CC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~-~~ 212 (315)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+... ..
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~---ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC---EEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc---EEEeecceeeccccCC
Confidence 9999999999999998888999999999999999999999999999999999999986655 9999999998643 33
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......+||+.|+|||++. ..++.++||||||+++|||++|..||......+..+.+......++ ..+++++.+|
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~l 572 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAI 572 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHH
Confidence 3455678999999999987 5699999999999999999999999999988888888887654433 4589999999
Q ss_pred HHHhcCCCcCCCCCH-----HHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTA-----QQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~-----~e~l~~l~f 315 (315)
|.+||+.||++||++ .||++|+||
T Consensus 573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff 601 (674)
T 3pfq_A 573 CKGLMTKHPGKRLGCGPEGERDIKEHAFF 601 (674)
T ss_dssp HHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred HHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence 999999999999997 999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=351.76 Aligned_cols=256 Identities=32% Similarity=0.586 Sum_probs=224.1
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
....++|++.+.||+|+||.||+|.+..++..||+|++...........+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKR 88 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCE
Confidence 34456899999999999999999999999999999998765433334457799999999999 89999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHAP 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC---EEECCCTTCEECS
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC---EEEecccccccCc
Confidence 9999999999999999998888999999999999999999999999999999999999976655 9999999987654
Q ss_pred CCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.. ......|++.|+|||++.+ .++.++||||||+++++|++|..||......+....+...... .++.+++++.
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 240 (284)
T 2vgo_A 166 SL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK----FPPFLSDGSK 240 (284)
T ss_dssp SS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----CCTTSCHHHH
T ss_pred cc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccC----CCCcCCHHHH
Confidence 32 2345678999999999874 5899999999999999999999999888877776666654333 2345789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++|.+||+.||.+|||+.++++|+||
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~h~~~ 266 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVMEHPWV 266 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred HHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence 99999999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=364.18 Aligned_cols=250 Identities=32% Similarity=0.513 Sum_probs=215.7
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh-----hcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
.+.++|++++.||+|+||+||+|.+..+++.||+|.+........ .....+.+|+.+++.+ +||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 466789999999999999999999999999999999876543221 1234577899999999 9999999999999
Q ss_pred cCCcEEEEEEecCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 127 DDTAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
..+..++||||+.+| +|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~ 176 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGS 176 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc---EEEeeccc
Confidence 999999999999766 99999998888999999999999999999999999999999999999976554 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
+.............||+.|+|||++.+. ++.++||||||+++|+|++|..||..... ........+..
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~~~~~ 246 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYL 246 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCCCSSC
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccCCCcc
Confidence 9887666666677899999999998643 47899999999999999999999965321 11112223345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++++.+||.+||+.||++|||+.++++|+||
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 79999999999999999999999999999997
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=354.90 Aligned_cols=251 Identities=29% Similarity=0.498 Sum_probs=217.8
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
.|...+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEE
Confidence 4888899999999999999999899999999986542 33457789999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-c
Q 021233 136 ELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-K 214 (315)
Q Consensus 136 e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~ 214 (315)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||++....... .
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSSSCC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc---EEEeeeeeeeecccCccc
Confidence 99999999998764 46999999999999999999999999999999999999976655 9999999998764432 3
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....||+.|+|||++. ..++.++||||||+++++|++|+.||...........+...... .......+++++.++|.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 276 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP-KLKNSHKVSPVLRDFLE 276 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCTTGGGSCHHHHHHHH
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CcCccccCCHHHHHHHH
Confidence 34568999999999986 45899999999999999999999999888777766666554322 11223467899999999
Q ss_pred HhcCCCcCCCCCHHHHhcccCC
Q 021233 294 KMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||+.||++|||+.++++|+||
T Consensus 277 ~~l~~dp~~Rps~~ell~hp~~ 298 (321)
T 2c30_A 277 RMLVRDPQERATAQELLDHPFL 298 (321)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHccCChhhCcCHHHHhcChhh
Confidence 9999999999999999999997
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=361.59 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=218.2
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++++.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEE
Confidence 456799999999999999999999999999999998765444444456789999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~-~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||+. |+|.+.+. ....+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAP 206 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE---EEECCCTTCBSSSS
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEeeccCceecCC
Confidence 9999997 58888775 4556999999999999999999999999999999999999986655 99999999976543
Q ss_pred CCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.....||+.|+|||++. +.++.++||||||++++||++|+.||...........+...... ......+++.
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 281 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEY 281 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCCCTTSCHH
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCCCCCCHH
Confidence 23457999999999873 45899999999999999999999999888777666666554322 2223467899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||.+||+.||++|||+.++++|+||
T Consensus 282 l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 9999999999999999999999999885
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=361.20 Aligned_cols=254 Identities=27% Similarity=0.466 Sum_probs=208.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEE
Confidence 4799999999999999999999999999999998654321 1112345799999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||++ ++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC---EEECSSSEEECC----
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC---EEEccCcccccccCCc
Confidence 99997 48989887654 4999999999999999999999999999999999999986655 999999999765432
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC---------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--------- 281 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 281 (315)
.......||+.|+|||++.+ .++.++||||||+++++|++|+.||......+....+.+.........+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 23345578999999999764 4899999999999999999999999998888877777664433322222
Q ss_pred -----------------ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 -----------------PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 -----------------~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 2468899999999999999999999999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=360.04 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=213.4
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~- 129 (315)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTT 81 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTT
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCC
Confidence 4567889999999999999999999999999999999875432 23357788999999999 8999999999998655
Q ss_pred -cEEEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CCCCCEEEEeec
Q 021233 130 -AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDFG 204 (315)
Q Consensus 130 -~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~-~~~~~vkl~Dfg 204 (315)
..++||||+++++|.+++..... +++..++.++.|++.||.|||+.||+||||||+|||+..+ +....+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 78999999999999999986433 9999999999999999999999999999999999998322 233348999999
Q ss_pred cccccCCCCcccccccCCCccCchhhc---------ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHh
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAETE----QGVAQAIIR 271 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~----~~~~~~~~~ 271 (315)
++.............||+.|+|||++. ..++.++||||||+++|+|++|..||..... .+....+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 998876666666678999999999874 4588999999999999999999999964332 333444433
Q ss_pred ccccC---------------------CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 272 SVLDF---------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 272 ~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..... .......+++.+.++|.+||+.||++|||+.|+|+|+
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 32110 0111223556789999999999999999999999886
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=351.03 Aligned_cols=253 Identities=33% Similarity=0.545 Sum_probs=196.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEE
Confidence 4699999999999999999999989999999998755433334457899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC---EEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEEEeecceeeccCCC
Confidence 9999999999999865 56999999999999999999999999999999999999976655 999999999876432
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
.......||+.|+|||.+. ..++.++||||||+++++|++|+.||...........+... ....+..++.++.++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----DYEMPSFLSIEAKDL 242 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS----CCCCCTTSCHHHHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc----ccCCccccCHHHHHH
Confidence 2233467899999999876 45889999999999999999999999766554443332221 122334578999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||+.||++|||+.++++|+||
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred HHHHcccCHhhCCCHHHHhcCccc
Confidence 999999999999999999999997
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=369.21 Aligned_cols=259 Identities=26% Similarity=0.468 Sum_probs=207.8
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-- 128 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-- 128 (315)
..+.++|++++.||+|+||+||+|.+..+++.||+|++... .......+++.+|+.+|+.+ +||||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCC
Confidence 45678999999999999999999999999999999998754 33445567899999999999 899999999999765
Q ss_pred ---CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 129 ---TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
...|+||||++ ++|.+++.....+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---~kL~DFGl 175 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS---VKVCDFGL 175 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTT
T ss_pred CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC---EEEccCCC
Confidence 57999999996 599999988888999999999999999999999999999999999999976554 99999999
Q ss_pred ccccCCCC-----------------------cccccccCCCccCchhh-c-ccCCCcchHHHHHHHHHHHhhCC------
Q 021233 206 SVFFKPGE-----------------------KFSEIVGSPYYMAPEVL-K-RNYGPEVDVWSAGVILYILLCGV------ 254 (315)
Q Consensus 206 a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~-~~~~~~~Di~slG~~l~el~tg~------ 254 (315)
|+...... .....+||+.|+|||++ . ..++.++|||||||+++||++|.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 98764322 13566899999999986 3 45999999999999999999843
Q ss_pred -----CCCCCCC-----------------hHHHHHHHHhcccc-----------------------CCCC----CCccCC
Q 021233 255 -----PPFWAET-----------------EQGVAQAIIRSVLD-----------------------FRRD----PWPKVS 285 (315)
Q Consensus 255 -----~p~~~~~-----------------~~~~~~~~~~~~~~-----------------------~~~~----~~~~~~ 285 (315)
++|.+.. ..+....+...... ..+. .++.++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 3343322 11122222111110 0000 124579
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++.+||.+||+.||++|||+.|+|+|+||
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 365 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYL 365 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence 999999999999999999999999999997
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=361.27 Aligned_cols=255 Identities=28% Similarity=0.479 Sum_probs=216.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-------
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------- 127 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------- 127 (315)
++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence 5799999999999999999999999999999998765432 23345678899999999 89999999999876
Q ss_pred -CCcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 128 -DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
.+..++||||+++ +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC---EEEccchh
Confidence 4568999999975 777777654 56999999999999999999999999999999999999976655 99999999
Q ss_pred ccccCCC-----CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC
Q 021233 206 SVFFKPG-----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR 278 (315)
Q Consensus 206 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 278 (315)
+...... .......||+.|+|||++.+ .++.++||||||+++++|++|..||...........+........+
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9865422 22345678999999998763 4899999999999999999999999998888877777765555544
Q ss_pred CCCccC----------------------------CHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 DPWPKV----------------------------SENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ~~~~~~----------------------------~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..++.. ++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 315 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCc
Confidence 443332 6789999999999999999999999999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=380.05 Aligned_cols=254 Identities=30% Similarity=0.504 Sum_probs=219.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEE
Confidence 46799999999999999999999999999999999766544445567889999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 134 VMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~---vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC---EEEeecceeeec
Confidence 99999999999999764 35999999999999999999999999999999999999986655 999999999876
Q ss_pred CCCCc-ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHhccccCCCCCCcc
Q 021233 210 KPGEK-FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET----EQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 210 ~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
..... ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.... .......+...... .+..
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~----~p~~ 415 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT----YPDK 415 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC----CCTT
T ss_pred cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC----CCcc
Confidence 54433 344589999999999874 58999999999999999999999997653 34444555544332 3356
Q ss_pred CCHHHHHHHHHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
+++++.+||.+||+.||.+||+ +.++++|+||
T Consensus 416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 8999999999999999999996 5899999997
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=347.72 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=213.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.++|++++.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+..+..+.+||||+++++++...+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 466789999999999999999999999999999999876533 2334567888999999988899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--------------
Q 021233 132 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK-------------- 193 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~-------------- 193 (315)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999764 5699999999999999999999999999999999999998654
Q ss_pred --CCCCEEEEeeccccccCCCCcccccccCCCccCchhhccc--CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH
Q 021233 194 --ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269 (315)
Q Consensus 194 --~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 269 (315)
....++|+|||.+....... ...||+.|+|||++.+. ++.++||||||+++++|++|.+|+.... ....+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHH
T ss_pred cCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHH
Confidence 44459999999998764332 34689999999998743 5679999999999999999998774432 23334
Q ss_pred HhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..... +..+..+++++.++|.+||+.||++|||+.++++|+||
T Consensus 241 ~~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 283 (289)
T 1x8b_A 241 RQGRL---PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283 (289)
T ss_dssp HTTCC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred HcCCC---CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence 33322 23345689999999999999999999999999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=360.87 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=211.6
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~- 129 (315)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+++.+|+.+++.+ +||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDET 98 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSS
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCc
Confidence 356778999999999999999999999999999999986542 3344457789999999999 8999999999997653
Q ss_pred -----cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 130 -----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 130 -----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg 173 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE---LKILDFG 173 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCT
T ss_pred cccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC---EEEEeee
Confidence 469999999 7899998876 46999999999999999999999999999999999999976555 9999999
Q ss_pred cccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-----
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR----- 277 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 277 (315)
+++.... ......+|+.|+|||++.+ .++.++|||||||++++|++|+.||.+....+....+.......+
T Consensus 174 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 174 LARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp TCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9987543 2345688999999998764 589999999999999999999999998887766666544322110
Q ss_pred ----------------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ----------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ----------------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...++.+++++.+||.+||+.||++|||+.++|+|+||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 01234578999999999999999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=346.96 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=215.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----CC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DT 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~~ 129 (315)
.+.|++.+.||+|+||+||+|.+..++..||+|.+..... .....+.+.+|+.+++.+ +||||+++++++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCc
Confidence 3469999999999999999999999999999999876543 334467799999999999 99999999999865 45
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
..++||||+++++|.+++.....+++..++.++.|++.||.|||+.| |+||||||+||+++.+ ...+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~--~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST--TSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECC--CCCEEEeeCCCcc
Confidence 68999999999999999998888999999999999999999999999 9999999999999722 2239999999997
Q ss_pred ccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH-HHHhccccCCCCCCccCCH
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ-AIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 286 (315)
..... ......||+.|+|||++.+.++.++||||||+++++|++|+.||.......... .+..... +.......++
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 257 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIP 257 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCH
T ss_pred ccccc-ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--ccccCCCCCH
Confidence 64433 334567999999999988889999999999999999999999998754443333 3332211 1122345678
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.++|.+||+.||.+|||+.++++|+||
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 99999999999999999999999999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=350.89 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=208.5
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.....++|++.+.||+|+||+||+|.+. +..||+|++..... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPP 107 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTT
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECC
Confidence 3445678999999999999999999874 88999999876533 334456789999999999 8999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 130 AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
..++||||+++++|.+++..... +++..++.++.|++.||+|||+.| |+||||||+|||++.++. +||+|||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~---~kL~Dfg 184 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFG 184 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC---EEECCCC
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc---EEECCCC
Confidence 99999999999999999987553 999999999999999999999999 999999999999976555 9999999
Q ss_pred cccccCCCC-cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 205 LSVFFKPGE-KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 205 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+....+..... ......
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~ 262 (309)
T 3p86_A 185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK--RLEIPR 262 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC--CCCCCT
T ss_pred CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCc
Confidence 997544332 2345689999999999874 589999999999999999999999988887766666543322 233345
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+++++.+||.+||+.||.+|||+.++++.|
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 7899999999999999999999999998765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=354.73 Aligned_cols=254 Identities=23% Similarity=0.333 Sum_probs=214.7
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCC---EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
....++|++.+.||+|+||.||+|.+..++. .||+|.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 3456789999999999999999999986554 49999986542 334457799999999999 89999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a 198 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV---CKVSDFGLS 198 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCSSC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC---EEECCCCcc
Confidence 99999999999999999999754 46999999999999999999999999999999999999976554 999999999
Q ss_pred cccCCCCc----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCC
Q 021233 207 VFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (315)
........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+.... ....
T Consensus 199 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---~~~~ 275 (325)
T 3kul_A 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPA 275 (325)
T ss_dssp EECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC---CCCC
T ss_pred cccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC---CCCC
Confidence 87644322 12234577899999987 568999999999999999999 999999888887777776552 2333
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...+++++.+||..||+.||++|||+.++++.|
T Consensus 276 ~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 276 PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 456899999999999999999999999999865
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=357.06 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=205.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC--
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 129 (315)
.+.++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSC
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccc
Confidence 34578999999999999999999999999999999987543 233457799999999999 8999999999986543
Q ss_pred -------------------------------------------------------cEEEEEEecCCCChHHHHHhcCC--
Q 021233 130 -------------------------------------------------------AVHLVMELCEGGELFDRIVARGH-- 152 (315)
Q Consensus 130 -------------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~-- 152 (315)
..++||||+++++|.+++.....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 38999999999999999987644
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-------------ccccc
Q 021233 153 -YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-------------KFSEI 218 (315)
Q Consensus 153 -l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~ 218 (315)
.++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++....... .....
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC---EEEeecCcccccccchhhcccccccccccccccc
Confidence 566778999999999999999999999999999999986654 9999999998765432 22345
Q ss_pred ccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 219 ~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
.||+.|+|||++. ..++.++||||||+++++|++|..|+.. .......+... ..+..+...++++.+||.+||+
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL---KFPLLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT---CCCHHHHHHCHHHHHHHHHHHC
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc---CCCcccccCChhHHHHHHHHcc
Confidence 7999999999986 4589999999999999999998776421 11122222221 1122233467888999999999
Q ss_pred CCcCCCCCHHHHhcccCC
Q 021233 298 PDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 298 ~~P~~Rps~~e~l~~l~f 315 (315)
.||++|||+.|+++|+||
T Consensus 312 ~~p~~Rps~~~~l~~~~f 329 (332)
T 3qd2_B 312 PSPTERPEATDIIENAIF 329 (332)
T ss_dssp SSGGGSCCHHHHHHSTTC
T ss_pred CCCCcCCCHHHHhhchhh
Confidence 999999999999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=362.49 Aligned_cols=257 Identities=22% Similarity=0.267 Sum_probs=218.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEE-----CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
...++|++++.||+|+||+||+|.+ ..++..||+|.+... ........+.+|+.+++.+ +||||+++++++.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF-NHQNIVRCIGVSL 144 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEe
Confidence 4457899999999999999999994 456778999998643 2334456788999999999 9999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEE
Q 021233 127 DDTAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vk 199 (315)
.....++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++....+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999998643 489999999999999999999999999999999999998777666799
Q ss_pred EEeeccccccCC---CCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccc
Q 021233 200 AIDFGLSVFFKP---GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (315)
Q Consensus 200 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 274 (315)
|+|||+++.... ........+|+.|+|||++. ..++.++||||||++++||++ |..||......+....+.....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999975421 12234457789999999876 568999999999999999998 9999998888777777765532
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
......+++.+.+||.+||+.||.+|||+.+++++|+
T Consensus 305 ---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 305 ---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2334568999999999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=362.89 Aligned_cols=259 Identities=32% Similarity=0.550 Sum_probs=213.7
Q ss_pred ccceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEccccccc-ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.++|++++.||+|+||.||+|.+. .+++.||+|++...... .....+.+.+|+.+++.+.+||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 47899999998754321 22234557789999999967999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
..++||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc---EEEeeCCCCeec
Confidence 99999999999999999998888999999999999999999999999999999999999976655 999999999865
Q ss_pred CCCC--cccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 210 KPGE--KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 210 ~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+........+..+..+
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 4322 2234579999999999863 3789999999999999999999999654322222222222222233344568
Q ss_pred CHHHHHHHHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 285 SENAKDLVRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
++.+.+||.+||+.||.+|| |+.++++|+||
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 89999999999999999999 99999999997
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=358.02 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=210.8
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh--hcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA--VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
..++|++++.||+|+||.||+|.+..+|+.||+|++........ .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCc
Confidence 45689999999999999999999999999999999875432211 1124678899999999 89999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++ +|.+.+.... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++...
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSF 162 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCCGGGSTT
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC---EEEEecccceec
Confidence 9999999976 8888887653 5899999999999999999999999999999999999976655 999999999876
Q ss_pred CCC-CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC------
Q 021233 210 KPG-EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP------ 280 (315)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 280 (315)
... .......+|+.|+|||++.+ .++.++||||||+++++|++|.+||......+....+...........
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 433 23455688999999999853 488999999999999999999999998888777777665432221111
Q ss_pred ------------------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 ------------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ------------------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+..+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 13467899999999999999999999999999997
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=358.34 Aligned_cols=260 Identities=39% Similarity=0.691 Sum_probs=190.8
Q ss_pred CCCccccccceeeee-eeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 47 EPTGREIEERYELGR-ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 47 ~~~~~~~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
.+....+.++|++.+ .||+|+||+||+|.+..+++.||+|++... ....+|+..+.++.+||||+++++++
T Consensus 20 ~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--------HHHHHHHHHHHHhcCCCChHHHHHHH
Confidence 344556788999965 699999999999999999999999998542 22334444433334999999999998
Q ss_pred Ec----CCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEE
Q 021233 126 ED----DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLK 199 (315)
Q Consensus 126 ~~----~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vk 199 (315)
.. ....++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++....+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence 76 455899999999999999998764 599999999999999999999999999999999999998766667799
Q ss_pred EEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHH----HHHHHhccc
Q 021233 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV----AQAIIRSVL 274 (315)
Q Consensus 200 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~----~~~~~~~~~ 274 (315)
|+|||++...... ......+|+.|+|||++. ..++.++||||||+++++|++|..||........ ...+.....
T Consensus 172 l~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (336)
T 3fhr_A 172 LTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250 (336)
T ss_dssp ECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred Eeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccc
Confidence 9999999865432 334567899999999986 4588899999999999999999999976554433 222233333
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+...+..+++++.+||.+||+.||.+|||+.++++|+||
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 251 GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 34444556789999999999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-50 Score=357.16 Aligned_cols=254 Identities=24% Similarity=0.366 Sum_probs=215.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEEC-------CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 124 (315)
...++|++++.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+.+||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 34578999999999999999999874 245679999987542 334457799999999999789999999999
Q ss_pred EEcCCcEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceE
Q 021233 125 YEDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (315)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nil 188 (315)
+...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999998653 3789999999999999999999999999999999999
Q ss_pred eecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChH
Q 021233 189 FANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 263 (315)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~ 263 (315)
++.++. +||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|||++ |..||......
T Consensus 236 l~~~~~---~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 236 VTENNV---MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp ECTTCC---EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ECCCCC---EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 976655 99999999986543322 23346678999999876 458999999999999999999 99999888877
Q ss_pred HHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+....+.... +...+..+++++.++|.+||+.||.+|||+.|++++|
T Consensus 313 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 313 ELFKLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp GHHHHHHTTC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7766665543 2334456899999999999999999999999999876
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=357.92 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=213.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEE
Confidence 457999999999999999999999999999999986543 2333356688999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||++......
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc---EEEEeCCCceeecCCc
Confidence 9999999889888877778999999999999999999999999999999999999976654 999999999765432
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-------------
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR------------- 277 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 277 (315)
.......||+.|+|||++.+ .++.++||||||+++++|++|+.||......+....+........
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 23345678999999999864 589999999999999999999999988877666655543211110
Q ss_pred ----C----------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ----R----------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ----~----------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. ..++.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0 0123578999999999999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=349.21 Aligned_cols=252 Identities=27% Similarity=0.499 Sum_probs=210.2
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--CCc
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTA 130 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~ 130 (315)
..++|++++.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++.+..||||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 346899999999999999999999999999999998532 346789999999999569999999999987 677
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||+++++|.+++. .+++..++.++.|++.||.|||++||+||||||+|||++.++. .+||+|||++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC--EEEEEeCCCceEcC
Confidence 899999999999988874 3899999999999999999999999999999999999986552 38999999998776
Q ss_pred CCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHhc-------------cc
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRS-------------VL 274 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~-~~~~~~~~~~~-------------~~ 274 (315)
.........+|+.|+|||++.+ .++.++||||||+++++|++|+.||.... ..+....+... ..
T Consensus 183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 6666666789999999999763 58999999999999999999999995433 22222222111 00
Q ss_pred cC--------------------CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 275 DF--------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 275 ~~--------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. .......+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f 323 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence 00 011122378999999999999999999999999999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=344.12 Aligned_cols=255 Identities=30% Similarity=0.513 Sum_probs=216.0
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+.++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEE
Confidence 45789999999999999999999999999999999865432 23357789999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||.+......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN 158 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCEECEET
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC---EEEeeCCCccccCCC
Confidence 99999999999999987777999999999999999999999999999999999999986555 999999999765322
Q ss_pred C---cccccccCCCccCchhhcc-c-CCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHhccccCCCCCCccCCH
Q 021233 213 E---KFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 213 ~---~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
. ......||+.|+|||.+.+ . ++.++||||||+++++|++|..||....... ....+.... .....+..+++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 236 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDS 236 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC--TTSTTGGGSCH
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc--cccCchhhcCH
Confidence 2 2345678999999999864 3 4778999999999999999999997655432 222222221 11223457899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.++|.+||+.||++|||+.++++|+||
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 237 APLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred HHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 99999999999999999999999999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=360.41 Aligned_cols=254 Identities=27% Similarity=0.451 Sum_probs=209.2
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCC-CCCcceeEEEEEcCCcE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~iv~~~~~~~~~~~~ 131 (315)
..++|++++.||+|+||+||+|.+.. ++.||+|++..... .....+.+.+|+.+++.+.. ||||+++++++...+..
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34579999999999999999999764 89999999876532 33456779999999999943 69999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||| +.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||+++ ..+||+|||++.....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~----~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS----SCEEECCCSSSCCC--
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC----CeEEEEecCccccccC
Confidence 99999 457899999998888999999999999999999999999999999999999952 3499999999987643
Q ss_pred CCc---ccccccCCCccCchhhcc------------cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhcccc
Q 021233 212 GEK---FSEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVLD 275 (315)
Q Consensus 212 ~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~ 275 (315)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... .....+......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 286 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence 322 245689999999999753 5888999999999999999999999765432 334444433222
Q ss_pred CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.......++++.+||.+||+.||.+|||+.|+|+|+||
T Consensus 287 --~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 287 --IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp --CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred --CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 22233457899999999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=360.04 Aligned_cols=252 Identities=29% Similarity=0.450 Sum_probs=209.5
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----- 127 (315)
..++|++++.||+|+||+||+|.+..+|+.||+|++..... ...+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVL-DHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTC-CCTTBCCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHc-CCCCccchhheeeecCccc
Confidence 45689999999999999999999999999999998864421 233799999999 99999999999843
Q ss_pred ---------------------------------CCcEEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 021233 128 ---------------------------------DTAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQ 170 (315)
Q Consensus 128 ---------------------------------~~~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~~l~~~L~ 170 (315)
....++||||+++ +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348899999975 8777665 3456999999999999999999
Q ss_pred HHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHH
Q 021233 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILY 248 (315)
Q Consensus 171 ~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~ 248 (315)
|||+.||+||||||+|||++.+ ...+||+|||+|.............+|+.|+|||++.+ .++.++||||||++++
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSK--DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETT--TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCcCccCccCHHHEEEcCC--CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999999732 22399999999987766666667789999999998764 4899999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhccccCC--------------------CC-----CCccCCHHHHHHHHHhcCCCcCCC
Q 021233 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFR--------------------RD-----PWPKVSENAKDLVRKMLDPDPKRR 303 (315)
Q Consensus 249 el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------------~~-----~~~~~~~~l~~li~~~l~~~P~~R 303 (315)
+|++|+.||......+....+.+...... .. ....+++++.+||.+||+.||++|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999998887777766654221110 00 123478899999999999999999
Q ss_pred CCHHHHhcccCC
Q 021233 304 LTAQQVLGKIEF 315 (315)
Q Consensus 304 ps~~e~l~~l~f 315 (315)
||+.|+|+|+||
T Consensus 314 ~t~~e~l~hp~f 325 (383)
T 3eb0_A 314 INPYEAMAHPFF 325 (383)
T ss_dssp CCHHHHHTSGGG
T ss_pred CCHHHHhcCHHH
Confidence 999999999997
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=360.42 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=203.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC--
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 129 (315)
.+.++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.+ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCST
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccc
Confidence 35678999999999999999999999999999999987542 2344456788999999999 9999999999997654
Q ss_pred ----cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~ 173 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL 173 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCCCC
T ss_pred ccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC---EEEEEeec
Confidence 78999999965 7888875 35899999999999999999999999999999999999986655 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------ 278 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 278 (315)
+.............||+.|+|||++. ..++.++||||||+++++|++|+.||......+....+........+
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 98765544455678999999999987 45899999999999999999999999988877666666543221100
Q ss_pred ------------CC-------------C-------ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ------------DP-------------W-------PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ------------~~-------------~-------~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. . ...++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 322 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI 322 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence 00 0 0115678999999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=345.01 Aligned_cols=255 Identities=23% Similarity=0.282 Sum_probs=196.3
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++++.||+|+||+||+|.+..+++.||+|.+..... .....+.+.++...++.+ +||||+++++++...+..+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEE
Confidence 45789999999999999999999999999999999865422 222223344445556666 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 133 LVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
+||||+++ +|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++. +||+|||++.
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISG 158 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC---EEBCCC----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC---EEEeecCCcc
Confidence 99999975 88777653 45699999999999999999999998 9999999999999976554 9999999998
Q ss_pred ccCCCCcccccccCCCccCchhhc-----ccCCCcchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHhccccCCCCCC
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Di~slG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~ 281 (315)
............||+.|+|||++. ..++.++||||||+++++|++|+.||... .............. .....
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~ 236 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS--PQLPA 236 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--CCCCT
T ss_pred cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--CCccc
Confidence 766555555568999999999962 34888999999999999999999999753 33333333333322 22233
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+++++.++|.+||+.||++|||+.++++|+||
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f 270 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence 4689999999999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=356.37 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=214.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
.+.++|++++.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIE 100 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCcc
Confidence 34578999999999999999999999999999999986432 333457788999999999 899999999999754
Q ss_pred --CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 129 --TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 129 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
...++||||+. ++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~a 175 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLA 175 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTC
T ss_pred ccceEEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC---EEEEeCcce
Confidence 46899999996 5999988664 6999999999999999999999999999999999999976555 999999999
Q ss_pred cccCCCCc----ccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC--
Q 021233 207 VFFKPGEK----FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR-- 278 (315)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 278 (315)
........ .....||+.|+|||++. ..++.++||||||+++++|++|+.||......+....+.........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 86643322 24458999999999864 34899999999999999999999999888777766665432211110
Q ss_pred ---------------------C----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ---------------------D----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ---------------------~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. ..+.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0 124578999999999999999999999999999997
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=359.10 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=199.2
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-- 128 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-- 128 (315)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARS 102 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCc
Confidence 456689999999999999999999999999999999986542 3344567788999999999 899999999999654
Q ss_pred ----CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
...++|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kL~DFG 177 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFG 177 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECC--
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC---EEEeecc
Confidence 5689999999 7799988865 56999999999999999999999999999999999999976554 9999999
Q ss_pred cccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC------
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------ 276 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------ 276 (315)
+++.... ......||+.|+|||++.+ .++.++|||||||++++|++|+.||.+....+....+.+.....
T Consensus 178 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 178 LARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9986532 2345689999999999764 58999999999999999999999999888776666655432211
Q ss_pred -----------------CCC----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 -----------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 -----------------~~~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.. .++.+++++.+||.+||+.||++|||+.++|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~ 315 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhh
Confidence 000 123568899999999999999999999999999997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=345.73 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=214.5
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
....++|++++.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-C
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCe
Confidence 34667899999999999999999999999999999998654 234467899999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKN 167 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC---EEECCCHHHHHH
T ss_pred EEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC---EEEEECCCCccc
Confidence 9999999999999998875 456999999999999999999999999999999999999976655 999999987543
Q ss_pred CCC-CcccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 210 KPG-EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 210 ~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
... .......||+.|+|||++. ..++.++||||||+++++|++|..||...........+....... .....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 246 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT-LLTPS 246 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGG
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-cCCcc
Confidence 111 1223457899999999872 358899999999999999999999998887776666665543221 12235
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+++++.++|.+||+.||++|||+.++++|+||
T Consensus 247 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 279 (302)
T 2j7t_A 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279 (302)
T ss_dssp GSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence 678999999999999999999999999999997
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=357.12 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=216.3
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.+....++|++++.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD 103 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEET
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEEC
Confidence 34556778999999999999999999999999999999987542 334457789999999999 999999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
+..++||||+++++|.+++.....+++..+..++.|++.||.|||+. ||+||||||+|||++.++. ++|+|||++.
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~ 180 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSG 180 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC---EEECCCCCCH
T ss_pred CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC---EEEEECCCCc
Confidence 99999999999999999999888899999999999999999999996 9999999999999986655 9999999987
Q ss_pred ccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH-----------------
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI----------------- 269 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~----------------- 269 (315)
..... ......||+.|+|||++. ..++.++||||||+++++|++|+.||......+....+
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 181 QLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred ccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 54222 223457899999999987 45899999999999999999999999776654432211
Q ss_pred -------------------------HhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 270 -------------------------IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 270 -------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.... ........+++++.+||.+||+.||++|||+.++|+|+||
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 328 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328 (360)
T ss_dssp --------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred CCCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 1111 1111223478899999999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=347.70 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=213.8
Q ss_pred CCCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 47 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
........++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++++.+||||+++++++.
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3344456788999999999999999999999999999999986432 234678999999999978999999999997
Q ss_pred c------CCcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 127 D------DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 127 ~------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
. .+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++. +
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~---~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---V 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC---E
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC---E
Confidence 6 46789999999999999999864 46999999999999999999999999999999999999976555 9
Q ss_pred EEEeeccccccCCCC-cccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHh
Q 021233 199 KAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271 (315)
Q Consensus 199 kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 271 (315)
+|+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...........+..
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 999999997654322 234457899999999974 3488999999999999999999999988776666555544
Q ss_pred ccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
... +......+++.+.+||.+||+.||.+|||+.++++|+||
T Consensus 249 ~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 249 NPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp SCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred Ccc--ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 322 222235678999999999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=368.63 Aligned_cols=247 Identities=18% Similarity=0.238 Sum_probs=200.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC--CCCCcceeE-------EE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLK-------DT 124 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~-------~~ 124 (315)
.++|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.+. +||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 468999999999999999999998899999999998654445555678999995555443 799999998 67
Q ss_pred EEcCCc-----------------EEEEEEecCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCceec
Q 021233 125 YEDDTA-----------------VHLVMELCEGGELFDRIVARGHYTE-------RAAAAVTKTIVEVVQMCHKHGVMHR 180 (315)
Q Consensus 125 ~~~~~~-----------------~~lv~e~~~~~sL~~~l~~~~~l~~-------~~~~~i~~~l~~~L~~lH~~~iiH~ 180 (315)
+...+. .++||||+ +|+|.+++...+.+++ ..++.++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 665543 88999999 6799999987554544 7888899999999999999999999
Q ss_pred CCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCccCchhhc-c-----------cCCCcchHHHHHHHHH
Q 021233 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-R-----------NYGPEVDVWSAGVILY 248 (315)
Q Consensus 181 dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~-----------~~~~~~Di~slG~~l~ 248 (315)
||||+|||++.++. +||+|||+|.... .......| +.|+|||++. . .++.++||||||+++|
T Consensus 231 Dikp~NIll~~~~~---~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 231 YLRPVDIVLDQRGG---VFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCCGGGEEECTTCC---EEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCC---EEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 99999999986654 9999999998643 23445677 9999999976 4 5899999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 249 ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 249 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
||++|+.||...........+ ...+..+++++.+||.+||+.||++|||+.++++|+||
T Consensus 305 elltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp HHHHSSCCC------CCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred HHHHCCCCCcccccccchhhh--------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 999999999654432221111 12235689999999999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=353.18 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=206.5
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-CCcceeEEEEEcCCc
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKDTYEDDTA 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~~~~~~~~ 130 (315)
...++|++++.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.++..+..| +||+++++++...+.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 3456899999999999999999987 4689999999875532 334457789999999999432 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++|||+ .+++|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||+++ + .+||+|||++....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~---~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G---MLKLIDFGIANQMQ 158 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T---EEEECCCSSSCCC-
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C---cEEEeecccccccC
Confidence 9999995 57899999999888999999999999999999999999999999999999962 3 38999999998764
Q ss_pred CCCc---ccccccCCCccCchhhc------------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhccc
Q 021233 211 PGEK---FSEIVGSPYYMAPEVLK------------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSVL 274 (315)
Q Consensus 211 ~~~~---~~~~~gt~~y~aPE~~~------------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~ 274 (315)
.... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||...... .....+....
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~- 237 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN- 237 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT-
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC-
Confidence 3322 23568999999999874 34788999999999999999999999765433 2223332221
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.....+...++++.+||.+||+.||.+|||+.++|+|+||
T Consensus 238 -~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 238 -HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp -SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 2222334567899999999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=350.10 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=207.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||+||+|.+..+++.||+|.+... .....+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEE
Confidence 46899999999999999999999999999999988542 344567899999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN---VVVADFGLARLMVDE 161 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC---EEECCCTTCEECC--
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC---EEEeecccceecccc
Confidence 9999999999999987 456999999999999999999999999999999999999976555 999999999865433
Q ss_pred Ccc---------------cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-----HHHHHHh
Q 021233 213 EKF---------------SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-----VAQAIIR 271 (315)
Q Consensus 213 ~~~---------------~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~ 271 (315)
... ....||+.|+|||++. ..++.++||||||+++|+|++|..||....... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence 211 1457999999999987 458999999999999999999999985432211 0111111
Q ss_pred ccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 272 SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 272 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
. ...+.+++++.++|.+||+.||++|||+.++++.|
T Consensus 242 ~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 242 R------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp H------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred c------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 1 12345788999999999999999999999998765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=358.53 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=213.8
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEE
Confidence 468999999999999999999999899999999986432 233345688999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+++++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~---~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc---EEECcCCCceecCCC
Confidence 999999999999998654 5999999999999999999999999999999999999976554 999999999865433
Q ss_pred Ccc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 213 EKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 213 ~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
... ....+++.|+|||++. +.++.++||||||+++|||++ |..||......+....+.... +...+..++++
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 343 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---RLPCPELCPDA 343 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC---CCCCCTTCCHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCCHH
Confidence 211 1223567899999986 568999999999999999998 999998888776666655432 23334568999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+||.+||+.||++|||+.++++.|
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99999999999999999999998865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=359.82 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=208.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC---
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--- 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--- 128 (315)
....+|++.+.||+|+||+||+|.+..+++.||+|++.... ....+|+++++.+ +||||+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~ 122 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEK 122 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHc-CCCCccceeeEEeccCCC
Confidence 34567999999999999999999999999999999886432 1234699999999 999999999998532
Q ss_pred ---CcEEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEE
Q 021233 129 ---TAVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
...++||||+++ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+
T Consensus 123 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~--~~kl~ 199 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA--VLKLC 199 (420)
T ss_dssp TTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT--EEEEC
T ss_pred CcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC--eEEec
Confidence 236799999976 6666554 2456999999999999999999999999999999999999985433 37999
Q ss_pred eeccccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc----
Q 021233 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD---- 275 (315)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---- 275 (315)
|||+++............||+.|+|||++.+ .++.++|||||||++|||++|+.||......+....+.+....
T Consensus 200 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 200 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp CCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9999987765555566789999999999753 5899999999999999999999999988776666655442111
Q ss_pred --------CCC--------C-----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 --------FRR--------D-----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 --------~~~--------~-----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.. . ..+.+++++.+||.+||+.||.+|||+.|+++|+||
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 000 0 113468999999999999999999999999999997
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=355.03 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=210.6
Q ss_pred cccceeeeeeeeeecceEEEEEE-----ECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 53 IEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..++|++++.||+|+||.||+|. +..+++.||+|++.... .....+.+.+|+.++.++.+||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 45789999999999999999998 44567899999986542 233456799999999999889999999999987
Q ss_pred CC-cEEEEEEecCCCChHHHHHhcCC------------------------------------------------------
Q 021233 128 DT-AVHLVMELCEGGELFDRIVARGH------------------------------------------------------ 152 (315)
Q Consensus 128 ~~-~~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------------ 152 (315)
.+ ..++||||+++|+|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 54 48999999999999999976532
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC---cccc
Q 021233 153 ------------YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSE 217 (315)
Q Consensus 153 ------------l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~ 217 (315)
+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++....... ....
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCGGGSCTTSCTTCEEC--
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc---EEEEeccceeeecccccchhccc
Confidence 899999999999999999999999999999999999986655 9999999998654332 2234
Q ss_pred cccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHh
Q 021233 218 IVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKM 295 (315)
Q Consensus 218 ~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 295 (315)
..||+.|+|||++. ..++.++||||||+++|+|++ |..||................. ....+..+++++.++|.+|
T Consensus 255 ~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--RMRAPDYTTPEMYQTMLDC 332 (359)
T ss_dssp CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC--CCCCCTTCCHHHHHHHHHH
T ss_pred cCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC--CCCCCCCCCHHHHHHHHHH
Confidence 57888999999876 568999999999999999998 9999987664444443333322 2233356889999999999
Q ss_pred cCCCcCCCCCHHHHhccc
Q 021233 296 LDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 296 l~~~P~~Rps~~e~l~~l 313 (315)
|+.||++|||+.+++++|
T Consensus 333 l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 333 WHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp TCSSGGGSCCHHHHHHHH
T ss_pred ccCChhhCCCHHHHHHHH
Confidence 999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=341.85 Aligned_cols=254 Identities=30% Similarity=0.521 Sum_probs=216.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE--cCCcE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--DDTAV 131 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--~~~~~ 131 (315)
.++|++++.||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.+ +||||+++++++. ..+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceE
Confidence 4589999999999999999999999999999999876533 334467799999999999 8999999999874 46789
Q ss_pred EEEEEecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCceEeecCCCCCCEEEEe
Q 021233 132 HLVMELCEGGELFDRIVAR----GHYTERAAAAVTKTIVEVVQMCHKHG-----VMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~~l~~~L~~lH~~~-----iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.| |+||||||+||+++.++. +||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~---~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC---EEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC---EEEec
Confidence 9999999999999998753 24999999999999999999999999 999999999999976555 99999
Q ss_pred eccccccCCCCc-ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC
Q 021233 203 FGLSVFFKPGEK-FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 203 fg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (315)
||.+........ .....||+.|+|||++.+ .++.++||||||+++++|++|..||......+....+...... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~---~~ 236 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RI 236 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---CC
T ss_pred CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc---cC
Confidence 999987654332 234578999999999864 5899999999999999999999999888877777776665432 23
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+++++.++|.+||+.||++|||+.++++++||
T Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 34678999999999999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=353.48 Aligned_cols=257 Identities=24% Similarity=0.353 Sum_probs=218.5
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCC-------CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCccee
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDREN-------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~ 121 (315)
......++|++.+.||+|+||.||+|.+... +..||+|++.... .......+.+|+.+++.+.+||||+++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 3345567899999999999999999997532 3579999986542 334457789999999999889999999
Q ss_pred EEEEEcCCcEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 021233 122 KDTYEDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPE 185 (315)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~ 185 (315)
++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 999999999999999999999999998753 4899999999999999999999999999999999
Q ss_pred ceEeecCCCCCCEEEEeeccccccCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCC
Q 021233 186 NFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAE 260 (315)
Q Consensus 186 Nill~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~ 260 (315)
|||++.++. +||+|||++....... ......+|+.|+|||++. ..++.++||||||+++++|++ |..||...
T Consensus 221 NIll~~~~~---~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 221 NVLVTEDNV---MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GEEECTTCC---EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCc---EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999976654 9999999998654332 223446788999999976 458999999999999999999 99999888
Q ss_pred ChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...+....+..... ...+..+++++.+||.+||+.||++|||+.+++++|
T Consensus 298 ~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 298 PVEELFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp CHHHHHHHHHTTCC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHcCCC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 87777776665432 333456899999999999999999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=342.26 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=220.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...+.|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeE
Confidence 345679999999999999999999999999999999875532 23467899999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++.....
T Consensus 96 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTD 171 (303)
T ss_dssp EEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECBT
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC---EEEeecccceecCc
Confidence 999999999999998864 46999999999999999999999999999999999999976655 99999999976543
Q ss_pred CC-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.. ......||+.|+|||.+. ..++.++||||||+++++|++|..||...........+.... .+.....+++.+.
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~ 248 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLK 248 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC---CCCCCSSCCHHHH
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC---CCCCccccCHHHH
Confidence 32 234567899999999986 458899999999999999999999998877766665555432 2233456899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||.+|||+.++++|+||
T Consensus 249 ~li~~~l~~dp~~Rps~~~ll~~~~~ 274 (303)
T 3a7i_A 249 EFVEACLNKEPSFRPTAKELLKHKFI 274 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHHcCCChhhCcCHHHHhhChhh
Confidence 99999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=336.24 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=214.3
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS----MSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT----BCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC----CcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceE
Confidence 3568999999999999999999876 57789999986543 2346789999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC---VKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC---EEECCTTCEEECCT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC---EEEccCccceecch
Confidence 9999999999999998754 4999999999999999999999999999999999999976655 99999999987654
Q ss_pred CCcc--cccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEKF--SEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.... ....+|+.|+|||.+.+ .++.++||||||+++++|++ |..||...........+....... .+..++++
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 233 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY---RPHLASDT 233 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---CCTTSCHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC---CCCcChHH
Confidence 4322 23355678999999874 58999999999999999999 999998888877777666554322 23457899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+.+++..||+.||++|||+.+++++|+
T Consensus 234 l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (268)
T 3sxs_A 234 IYQIMYSCWHELPEKRPTFQQLLSSIE 260 (268)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=337.72 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=213.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++++.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc----cCHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEE
Confidence 357999999999999999999986 47789999987543 2346799999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC---EEECCTTGGGGBCCH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC---EEecccccccccccc
Confidence 99999999999999754 45899999999999999999999999999999999999976655 999999999865433
Q ss_pred C--cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 213 E--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
. ......+|+.|+|||++. ..++.++||||||+++++|++ |..||......+....+..... ......+++++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 236 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---LYKPRLASTHV 236 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCCTTSCHHH
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc---CCCCCcCCHHH
Confidence 2 123345677899999987 568999999999999999999 9999998888877777765532 23334578999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+++.+||+.||++|||+.+++++|
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~l 261 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQL 261 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHHH
Confidence 9999999999999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=345.34 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=219.1
Q ss_pred ecCCCccccccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcc
Q 021233 45 LKEPTGREIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV 119 (315)
Q Consensus 45 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv 119 (315)
+..+......++|++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++.+ +||||+
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv 89 (314)
T 2ivs_A 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQV-NHPHVI 89 (314)
T ss_dssp -CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBC
T ss_pred cCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhC-CCCcee
Confidence 334455556788999999999999999999973 445889999987542 344457789999999999 999999
Q ss_pred eeEEEEEcCCcEEEEEEecCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHC
Q 021233 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARGH------------------------YTERAAAAVTKTIVEVVQMCHKH 175 (315)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------l~~~~~~~i~~~l~~~L~~lH~~ 175 (315)
++++++...+..++||||+++++|.+++..... +++..++.++.|++.||.|||++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999999986543 88999999999999999999999
Q ss_pred CceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHh
Q 021233 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILL 251 (315)
Q Consensus 176 ~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~ 251 (315)
||+||||||+||+++.++. +||+|||++......... ....+|+.|+|||++. ..++.++||||||+++++|+
T Consensus 170 ~ivH~dikp~NIli~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 246 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRK---MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246 (314)
T ss_dssp TEECCCCSGGGEEEETTTE---EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred CCcccccchheEEEcCCCC---EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHH
Confidence 9999999999999986655 999999999866443322 3345678899999876 45899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 252 C-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 252 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+ |..||...........+.... ....+..+++++.++|.+||+.||++|||+.+++++|
T Consensus 247 t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l 306 (314)
T 2ivs_A 247 TLGGNPYPGIPPERLFNLLKTGH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306 (314)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHhhcCC---cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9 999998887777666665543 2233456899999999999999999999999999876
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=357.00 Aligned_cols=256 Identities=29% Similarity=0.449 Sum_probs=208.7
Q ss_pred CCCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 47 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
...+.....+|++++.||+|+||+||+|.+..++. +|+|++..... ...+|+.+++.+ +||||+++++++.
T Consensus 32 ~~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l-~h~niv~l~~~~~ 102 (394)
T 4e7w_A 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIV-KHPNVVDLKAFFY 102 (394)
T ss_dssp SSSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred CCCCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhC-CCCCcceEEEEEE
Confidence 34456677889999999999999999999876655 88887754321 123699999999 9999999999996
Q ss_pred cCC------cEEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee-cCCCC
Q 021233 127 DDT------AVHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA-NKKET 195 (315)
Q Consensus 127 ~~~------~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~-~~~~~ 195 (315)
..+ ..++||||+++ ++.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 103 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~- 180 (394)
T 4e7w_A 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV- 180 (394)
T ss_dssp EESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE-
T ss_pred ecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc-
Confidence 433 37899999976 4444333 245699999999999999999999999999999999999997 3443
Q ss_pred CCEEEEeeccccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcc
Q 021233 196 APLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 273 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 273 (315)
+||+|||+|+............+|+.|+|||++.+ .++.++|||||||++++|++|+.||.+....+....+.+..
T Consensus 181 --~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 181 --LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp --EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred --EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 89999999988766665666789999999998753 48999999999999999999999999888777666665432
Q ss_pred ccC--------------------CCC-----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 274 LDF--------------------RRD-----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 274 ~~~--------------------~~~-----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
... ... ..+.+++++.+||.+||+.||.+|||+.|+++|+||
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence 110 000 123478999999999999999999999999999997
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=344.36 Aligned_cols=256 Identities=24% Similarity=0.357 Sum_probs=207.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
.-++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEE
Confidence 346799999999999999999999999999999999766544445567899999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF---AYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC---EEEecCccCcccccc
Confidence 99999999999999998888999999999999999999999999999999999999986654 999999998765433
Q ss_pred C--cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 213 E--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. ......||+.|+|||++. ..++.++||||||+++++|++|+.||........ ...............+.+++++.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~ 266 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVAFD 266 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCTHHH
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCHHHH
Confidence 2 223557899999999986 4589999999999999999999999977655433 33333333333334567899999
Q ss_pred HHHHHhcCCCcCCCC-CHHHHhccc
Q 021233 290 DLVRKMLDPDPKRRL-TAQQVLGKI 313 (315)
Q Consensus 290 ~li~~~l~~~P~~Rp-s~~e~l~~l 313 (315)
++|.+||+.||++|| |+.++++.+
T Consensus 267 ~li~~~l~~dP~~Rp~s~~~l~~~l 291 (309)
T 2h34_A 267 AVIARGMAKNPEDRYVTCGDLSAAA 291 (309)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred HHHHHhccCCHHHHHHhHHHHHHHH
Confidence 999999999999999 899988754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=350.66 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=211.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
...++|++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34578999999999999999999973 356789999987542 23345779999999999988999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 021233 127 DDTAVHLVMELCEGGELFDRIVARG-----------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLK 183 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~-----------------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dik 183 (315)
..+..++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999997643 27899999999999999999999999999999
Q ss_pred CCceEeecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCC
Q 021233 184 PENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFW 258 (315)
Q Consensus 184 p~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~ 258 (315)
|+|||++.++. +||+|||++........ .....+|+.|+|||++. ..++.++||||||+++++|+| |..||.
T Consensus 200 p~NIll~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 200 ARNVLVTHGKV---VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp GGGEEEETTTE---EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred hhhEEEcCCCc---EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999986655 99999999986543322 23446788999999876 568999999999999999998 999998
Q ss_pred CCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 259 AETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
................ .......+++++.+||.+||+.||.+|||+.+++++|.
T Consensus 277 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGF--KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp TCCCSHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCCcHHHHHHHHhcCC--CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 7765555544444322 22334567999999999999999999999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=339.72 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=211.6
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChh----cHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV----DIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~----~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
....++|++.+.||+|+||+||+|.+..+++.||+|.+......... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeec
Confidence 34567899999999999999999999999999999998754432221 126789999999999 8999999999997
Q ss_pred cCCcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCC--CCCEEEE
Q 021233 127 DDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKE--TAPLKAI 201 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~--~~~vkl~ 201 (315)
... ++||||+++++|.+.+.... .+++..++.++.|++.||.|||+.| |+||||||+||+++.++. ...+||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 665 69999999999999887543 5999999999999999999999999 999999999999976543 2348999
Q ss_pred eeccccccCCCCcccccccCCCccCchhhc---ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHH--HHHHHhccccC
Q 021233 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGV--AQAIIRSVLDF 276 (315)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~ 276 (315)
|||++.... .......||+.|+|||++. ..++.++||||||+++|+|++|+.||........ ...+... ..
T Consensus 172 Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~ 247 (287)
T 4f0f_A 172 DFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE--GL 247 (287)
T ss_dssp CCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS--CC
T ss_pred CCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc--CC
Confidence 999997543 2345568999999999983 3478899999999999999999999976554433 2333332 23
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.......+++++.++|.+||+.||.+|||+.++++.|
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 3444567899999999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=360.17 Aligned_cols=258 Identities=25% Similarity=0.388 Sum_probs=214.7
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC-----CCCCcceeEEE
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-----KHQNIVCLKDT 124 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~h~~iv~~~~~ 124 (315)
...+..+|++++.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.+. +|+||++++++
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 456778899999999999999999999999999999998643 233456778888888762 56799999999
Q ss_pred EEcCCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 125 YEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
+...+..++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++.++. ..+||+|
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~D 245 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVID 245 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEECC
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEee
Confidence 999999999999996 59999988754 4999999999999999999999999999999999999976543 2389999
Q ss_pred eccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC--
Q 021233 203 FGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD-- 279 (315)
Q Consensus 203 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 279 (315)
||+|..... ......||+.|+|||++. ..++.++|||||||++|||++|..||......+....+..........
T Consensus 246 FG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 246 FGSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccceecCC--cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 999976432 234568999999999976 459999999999999999999999999888777666655432111000
Q ss_pred -----------------------------------------------------CCccCCHHHHHHHHHhcCCCcCCCCCH
Q 021233 280 -----------------------------------------------------PWPKVSENAKDLVRKMLDPDPKRRLTA 306 (315)
Q Consensus 280 -----------------------------------------------------~~~~~~~~l~~li~~~l~~~P~~Rps~ 306 (315)
.....++++.+||.+||+.||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 001236789999999999999999999
Q ss_pred HHHhcccCC
Q 021233 307 QQVLGKIEF 315 (315)
Q Consensus 307 ~e~l~~l~f 315 (315)
.|+|+|+||
T Consensus 404 ~e~L~Hpw~ 412 (429)
T 3kvw_A 404 GQALRHPWL 412 (429)
T ss_dssp HHHHTSTTT
T ss_pred HHHhCChhh
Confidence 999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=346.03 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=213.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEEC-CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC--CCCCcceeEEEEE--
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDR-ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYE-- 126 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~-- 126 (315)
...++|++++.||+|+||.||+|.+. .+++.||+|++....... .....+.+|+.+++.+. +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 45678999999999999999999995 678899999987543222 12234556777766553 7999999999987
Q ss_pred ---cCCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEE
Q 021233 127 ---DDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 127 ---~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
.....++||||++ ++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~---~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC---EEEe
Confidence 5567899999997 59999998754 3999999999999999999999999999999999999976655 9999
Q ss_pred eeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC---
Q 021233 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR--- 277 (315)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--- 277 (315)
|||++.............||+.|+|||++. ..++.++||||||+++++|++|+.||......+....+........
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 999998765444445668899999999976 4589999999999999999999999998887777666654321100
Q ss_pred --------------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 --------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 --------------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+..+++.+.+||.+||+.||++|||+.++++|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 300 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccc
Confidence 01234578999999999999999999999999999997
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=346.49 Aligned_cols=261 Identities=28% Similarity=0.443 Sum_probs=215.8
Q ss_pred CCCccccccceeeeeeeeeecceEEEEEEE-CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC------Ccc
Q 021233 47 EPTGREIEERYELGRELGRGEFGITYLCTD-RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ------NIV 119 (315)
Q Consensus 47 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~------~iv 119 (315)
...+..+.++|++++.||+|+||+||+|.+ ..+++.||+|++... ....+.+.+|+.+++.+ +|+ +++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~ 80 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHL-NTTDPNSTFRCV 80 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHH-HHHCTTCTTCBC
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHh-hhcCCCCceeeE
Confidence 355677889999999999999999999998 457889999998643 23356788899999888 544 599
Q ss_pred eeEEEEEcCCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC---
Q 021233 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE--- 194 (315)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~--- 194 (315)
++++++...+..++||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccc
Confidence 9999999999999999999 889999998765 5899999999999999999999999999999999999976431
Q ss_pred -------------CCCEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCC
Q 021233 195 -------------TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE 260 (315)
Q Consensus 195 -------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~ 260 (315)
...+||+|||++..... ......||+.|+|||++. ..++.++||||||+++++|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 34599999999986433 234568899999999986 46899999999999999999999999888
Q ss_pred ChHHHHHHHHhccccCCC----------------------------------------CCCccCCHHHHHHHHHhcCCCc
Q 021233 261 TEQGVAQAIIRSVLDFRR----------------------------------------DPWPKVSENAKDLVRKMLDPDP 300 (315)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~l~~li~~~l~~~P 300 (315)
...+....+.......+. ......++++.+||.+||+.||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 776655554433221110 0011235778999999999999
Q ss_pred CCCCCHHHHhcccCC
Q 021233 301 KRRLTAQQVLGKIEF 315 (315)
Q Consensus 301 ~~Rps~~e~l~~l~f 315 (315)
.+|||+.|+++|+||
T Consensus 318 ~~Rpt~~ell~hp~f 332 (339)
T 1z57_A 318 AKRITLREALKHPFF 332 (339)
T ss_dssp TTSCCHHHHTTSGGG
T ss_pred ccccCHHHHhcCHHH
Confidence 999999999999997
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=335.44 Aligned_cols=253 Identities=29% Similarity=0.425 Sum_probs=202.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC-hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
.++|++.+.||+|+||.||+|.+. +..||+|++....... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceE
Confidence 357999999999999999999975 8899999987543222 23357789999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCceEeecCCC-----CCCEEEEeec
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG---VMHRDLKPENFLFANKKE-----TAPLKAIDFG 204 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~---iiH~dikp~Nill~~~~~-----~~~vkl~Dfg 204 (315)
+||||+++++|.+++. ...+++..++.++.|++.||.|||+.| |+||||||+||+++.+.. ...++|+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999988885 457999999999999999999999999 999999999999976322 4559999999
Q ss_pred cccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
++........ ....||+.|+|||.+. ..++.++||||||+++++|++|+.||...........+...... ......
T Consensus 162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~ 238 (271)
T 3dtc_A 162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--LPIPST 238 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--CCCCTT
T ss_pred cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--CCCCcc
Confidence 9986543332 3457899999999986 45899999999999999999999999888777666665544332 233456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++++.++|.+||+.||++|||+.+++++|
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 899999999999999999999999999876
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=341.94 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=211.5
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
....++|++.+.||+|+||.||+|.+..+|+.||+|.+... ...+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTD 98 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCE
Confidence 34567899999999999999999999999999999998653 2346789999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~-~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||.+...
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~ 175 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH---AKLADFGVAGQL 175 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEEC
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC---EEEeecccchhh
Confidence 999999999999999987 4556999999999999999999999999999999999999986655 999999999765
Q ss_pred CCCC-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 210 KPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 210 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.... ......||+.|+|||.+. ..++.++||||||+++++|++|..||...........+..... ........++++
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 254 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PTFRKPELWSDN 254 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSSGGGSCHH
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-cccCCcccCCHH
Confidence 4332 234557899999999987 4589999999999999999999999987776655554443321 111223457899
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.++|.+||+.||.+|||+.++++|+||
T Consensus 255 l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 255 FTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 9999999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=341.58 Aligned_cols=258 Identities=20% Similarity=0.288 Sum_probs=213.1
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.+.+|+|++++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 4567789999999999999999999999999999999885432 22457889999999988999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC--CCCEEEEeeccc
Q 021233 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE--TAPLKAIDFGLS 206 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~--~~~vkl~Dfg~a 206 (315)
..++||||+ +++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++. ...+||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 899999998754 5999999999999999999999999999999999999976542 344999999999
Q ss_pred cccCCCCc--------ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHhccc
Q 021233 207 VFFKPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET---EQGVAQAIIRSVL 274 (315)
Q Consensus 207 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~---~~~~~~~~~~~~~ 274 (315)
........ .....||+.|+|||++.+ .++.++||||||+++++|++|+.||.... .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 86643321 245579999999999874 58999999999999999999999997643 3333333322211
Q ss_pred cCC-CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 275 DFR-RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 275 ~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
... ....+.+++++.+++.+||+.||++|||+.++++.+
T Consensus 239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 111 112346789999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=344.56 Aligned_cols=258 Identities=27% Similarity=0.458 Sum_probs=197.2
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCC-CCTTBCCEEEEEESSSCE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCc
Confidence 345689999999999999999999888899999998865432 23346788999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 132 HLVMELCEGGELFDRIVA--------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~--------~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC---EEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC---EEEEec
Confidence 999999999999999874 345899999999999999999999999999999999999976655 999999
Q ss_pred ccccccCCCC------cccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc
Q 021233 204 GLSVFFKPGE------KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (315)
Q Consensus 204 g~a~~~~~~~------~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (315)
|++....... ......||+.|+|||++. ..++.++||||||+++++|++|..||..................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9987654322 123457899999999976 35899999999999999999999999877766555444433222
Q ss_pred CC------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 FR------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ...+..+++++.++|.+||+.||.+|||+.++++|+||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 291 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 11 12235678999999999999999999999999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=347.96 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=216.0
Q ss_pred cccccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
....++|++++.||+|+||.||+|.+. .+++.||+|.+.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE
Confidence 344578999999999999999999987 345889999987542 333457799999999999 999999999999
Q ss_pred EcCCcEEEEEEecCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 021233 126 EDDTAVHLVMELCEGGELFDRIVAR------------------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRD 181 (315)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~d 181 (315)
...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999763 4689999999999999999999999999999
Q ss_pred CCCCceEeecCCCCCCEEEEeeccccccCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCC
Q 021233 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPP 256 (315)
Q Consensus 182 ikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p 256 (315)
|||+||+++.++. +||+|||++....... ......+|+.|+|||++. ..++.++||||||+++|+|++ |..|
T Consensus 200 lkp~NIl~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 200 LATRNCLVGENMV---VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSGGGEEECGGGC---EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCcceEEECCCCe---EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 9999999986655 9999999997653322 223456788999999876 568999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 257 FWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
|......+....+...... .....+++++.++|.+||+.||++|||+.+++++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 277 YYGMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp TTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCChHHHHHHHhCCCcC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 9988887777766654332 23456889999999999999999999999998875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=351.57 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=211.2
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
-.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+ +||||+++++++...+.
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCC
Confidence 456789999999999999999999999999999999987543 2334457788999999999 89999999999987765
Q ss_pred E------EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 131 V------HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 131 ~------~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
. ++||||+. ++|.+.+. ..+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kL~Dfg 189 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE---LKILDFG 189 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECSTT
T ss_pred cccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC---EEEEecC
Confidence 4 99999996 58877763 34999999999999999999999999999999999999976655 9999999
Q ss_pred cccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC------
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------ 276 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------ 276 (315)
++..... ......||+.|+|||++.+ .++.++||||||+++++|++|+.||......+....+.......
T Consensus 190 ~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 190 LARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 9986532 2345678999999999764 58999999999999999999999998887776666654422111
Q ss_pred -----------------CCC----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 -----------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 -----------------~~~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
... .++.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 327 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence 000 123568999999999999999999999999999997
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=340.42 Aligned_cols=256 Identities=27% Similarity=0.498 Sum_probs=203.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcE
Confidence 3456899999999999999999999999999999999765545555667899999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 132 HLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~---~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC---EEEEecccee
Confidence 999999999999998864 455899999999999999999999999999999999999976554 9999999987
Q ss_pred ccCCCC-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC--hHHHHHHHHhccccCCCCCCcc
Q 021233 208 FFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--EQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 208 ~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
...... ......+++.|+|||++. ..++.++||||||+++++|++|..||.... .......+... ..+......
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 262 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPPLPSDH 262 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--CSCCCCTTT
T ss_pred eecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--cCCCCcccc
Confidence 654332 223457899999999976 458999999999999999999999996543 22333333332 222333356
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++++.++|.+||+.||++|||+.++++.+
T Consensus 263 ~~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 263 YSEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 899999999999999999999999998765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=337.40 Aligned_cols=253 Identities=26% Similarity=0.337 Sum_probs=203.7
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCC---CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~- 86 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT- 86 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-
Confidence 34567899999999999999999998653 4569999886532 334457799999999999 9999999999985
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~ 163 (281)
T 1mp8_A 87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLS 163 (281)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECC----
T ss_pred cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC---EEECccccc
Confidence 457899999999999999998654 5999999999999999999999999999999999999987665 999999999
Q ss_pred cccCCCCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 207 VFFKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 207 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
........ .....+|+.|+|||++. ..++.++||||||+++++|++ |..||......+....+..... ...++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~ 240 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPP 240 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCT
T ss_pred cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---CCCCC
Confidence 87644332 22345678899999986 568999999999999999996 9999988887777776665432 23345
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+++++.++|.+||+.||++|||+.+++++|
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 271 (281)
T 1mp8_A 241 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 7899999999999999999999999999876
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=358.19 Aligned_cols=258 Identities=27% Similarity=0.482 Sum_probs=195.0
Q ss_pred cccccceee-eeeeeeecceEEEEEEEC--CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE-
Q 021233 51 REIEERYEL-GRELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE- 126 (315)
Q Consensus 51 ~~~~~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~- 126 (315)
..+.+.|++ .++||+|+||+||+|.+. .+++.||+|++.... ....+.+|+.+|+.+ +||||+++++++.
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-----ISMSACREIALLREL-KHPNVISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-----CCHHHHHHHHHHHHC-CCTTBCCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-----CCHHHHHHHHHHHhc-CCCCeeeEeeEEec
Confidence 456677888 458999999999999976 468899999986442 224688999999999 8999999999995
Q ss_pred -cCCcEEEEEEecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CCC
Q 021233 127 -DDTAVHLVMELCEGGELFDRIVAR---------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KET 195 (315)
Q Consensus 127 -~~~~~~lv~e~~~~~sL~~~l~~~---------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~-~~~ 195 (315)
.....++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+..+ ...
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 46789999999964 888877532 148999999999999999999999999999999999999543 234
Q ss_pred CCEEEEeeccccccCCC----CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCCh-------
Q 021233 196 APLKAIDFGLSVFFKPG----EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETE------- 262 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~------- 262 (315)
..+||+|||+|...... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 55999999999865432 22345689999999999864 489999999999999999999999975543
Q ss_pred --HHHHHHHHhccccCCCCCCcc----------------------------------CCHHHHHHHHHhcCCCcCCCCCH
Q 021233 263 --QGVAQAIIRSVLDFRRDPWPK----------------------------------VSENAKDLVRKMLDPDPKRRLTA 306 (315)
Q Consensus 263 --~~~~~~~~~~~~~~~~~~~~~----------------------------------~~~~l~~li~~~l~~~P~~Rps~ 306 (315)
.+....+...........|.. .++++.+||.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 234444443332222222221 26788999999999999999999
Q ss_pred HHHhcccCC
Q 021233 307 QQVLGKIEF 315 (315)
Q Consensus 307 ~e~l~~l~f 315 (315)
.|+|+|+||
T Consensus 329 ~e~L~hp~f 337 (405)
T 3rgf_A 329 EQAMQDPYF 337 (405)
T ss_dssp HHHHTSGGG
T ss_pred HHHhcChhh
Confidence 999999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=337.34 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=212.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.-.++|++++.||+|+||+||+|.+. ++..||+|++.... ...+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC----CCHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCe
Confidence 34568999999999999999999876 57789999987543 2346789999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVL 171 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC---EEECSTTGGGGBC
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC---EEEcccccccccc
Confidence 999999999999999976 456999999999999999999999999999999999999976555 9999999998654
Q ss_pred CCCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 211 PGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 211 ~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.... .....+|+.|+|||++. ..++.++||||||+++++|++ |+.||......+....+...... ..+..+++
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 248 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---YRPHLASE 248 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred ccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC---CCCCcCCH
Confidence 3321 12335677899999987 568999999999999999998 99999988887777777665332 23345789
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+.++|.+||+.||++|||+.+++++|
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~L 275 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSNI 275 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 999999999999999999999999876
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=344.53 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=195.7
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCC---EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
....++|++++.||+|+||+||+|.+..++. .||+|.+..... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEF-DHPHVAKLVGVSLR 96 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEEC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHC-CCCceehhhceeec
Confidence 3456789999999999999999999876664 899999875532 233467899999999999 99999999999987
Q ss_pred CCcE------EEEEEecCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 021233 128 DTAV------HLVMELCEGGELFDRIVARG------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 128 ~~~~------~lv~e~~~~~sL~~~l~~~~------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~ 195 (315)
.... ++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~- 175 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT- 175 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC-
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC-
Confidence 7654 99999999999999986532 5899999999999999999999999999999999999976654
Q ss_pred CCEEEEeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 021233 196 APLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAII 270 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 270 (315)
+||+|||++......... ....+++.|+|||.+. ..++.++||||||+++++|++ |..||......+....+.
T Consensus 176 --~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 176 --VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp --EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred --EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 999999999865443322 2345677899999986 458999999999999999999 999998888877777666
Q ss_pred hccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCC-------HHHHhcccCC
Q 021233 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLT-------AQQVLGKIEF 315 (315)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps-------~~e~l~~l~f 315 (315)
.... ....+.+++++.+||.+||+.||++||| +.+++.++|+
T Consensus 254 ~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~ 302 (323)
T 3qup_A 254 GGNR---LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302 (323)
T ss_dssp TTCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred cCCC---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhh
Confidence 5432 2334568899999999999999999999 5555555553
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=348.41 Aligned_cols=255 Identities=17% Similarity=0.203 Sum_probs=209.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.+.+||||+++++++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 456789999999999999999999999999999998865422 235889999999998899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC--CCEEEEeeccccc
Q 021233 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET--APLKAIDFGLSVF 208 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~--~~vkl~Dfg~a~~ 208 (315)
++||||+ +++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+|||++.++.. ..+||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 89999999864 569999999999999999999999999999999999999765432 2389999999986
Q ss_pred cCCCCc--------ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHhccccC
Q 021233 209 FKPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDF 276 (315)
Q Consensus 209 ~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~ 276 (315)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||..... .+....+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 543321 245689999999999874 589999999999999999999999987433 33333333322222
Q ss_pred CCCC-CccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 277 RRDP-WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 277 ~~~~-~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+... ...+| ++.+++..||+.||.+||++.++++.+
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 1111 12244 999999999999999999999988754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=341.73 Aligned_cols=253 Identities=22% Similarity=0.353 Sum_probs=204.2
Q ss_pred cccccceeeeeeeeeecceEEEEEE----ECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
....++|++++.||+|+||+||+|. +..+++.||+|++... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe
Confidence 3456789999999999999999998 4567899999998643 334456789999999999 8999999999986
Q ss_pred c--CCcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 127 D--DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 127 ~--~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
. ....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+||
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~---~kl~Df 158 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDF 158 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe---EEEccC
Confidence 4 356899999999999999998754 4999999999999999999999999999999999999987665 999999
Q ss_pred ccccccCCCCc----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH---------------
Q 021233 204 GLSVFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ--------------- 263 (315)
Q Consensus 204 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--------------- 263 (315)
|++........ .....++..|+|||++. ..++.++||||||+++++|++|..|+......
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH
Confidence 99987643322 22345677899999986 56899999999999999999999998543221
Q ss_pred -HHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 264 -GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 264 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.....+.. ......+..+++++.++|.+||+.||++|||+.++++.|
T Consensus 239 ~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 239 FHLIELLKN---NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp HHHHHHHHT---TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHhc---cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 11111111 122334457899999999999999999999999998865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=346.20 Aligned_cols=258 Identities=28% Similarity=0.453 Sum_probs=212.9
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC-
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD- 128 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~- 128 (315)
+..+.++|++.+.||+|+||.||+|.+..+|+.||+|.+... ........+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHF-KHENIITIFNIQRPDS 82 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSC
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccc
Confidence 345678999999999999999999999999999999998643 2334456788999999999 899999999988654
Q ss_pred ----CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 129 ----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 129 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
...++||||+. ++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg 157 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDFG 157 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCT
T ss_pred cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc---EEEEecc
Confidence 67899999996 599998876 46999999999999999999999999999999999999976555 9999999
Q ss_pred cccccCCCCc-----------ccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHh
Q 021233 205 LSVFFKPGEK-----------FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR 271 (315)
Q Consensus 205 ~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 271 (315)
++........ .....||+.|+|||++. ..++.++||||||+++++|++|+.||...........+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 9986543211 12357899999999864 4589999999999999999999999988776655544432
Q ss_pred ccccCC------------------------CC----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 272 SVLDFR------------------------RD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 272 ~~~~~~------------------------~~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...... .. .++.+++++.+||.+||+.||++|||+.++++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence 211110 00 124678999999999999999999999999999997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=342.37 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=212.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC-hhcHHHHHHHHHHHHhCCCCCCcceeEEEEE--cCC
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT-AVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--DDT 129 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--~~~ 129 (315)
+.++|++++.||+|+||.||+|.+..++..||+|++....... ....+.+.+|+.+++.+ +||||+++++++. ..+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence 4568999999999999999999999999999999987653221 23457799999999999 8999999999984 456
Q ss_pred cEEEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 130 AVHLVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
..++||||++++ |.+.+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||.+.
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~dfg~~~ 157 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAE 157 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc---EEeecccccc
Confidence 889999999875 7777765 345999999999999999999999999999999999999986655 9999999998
Q ss_pred ccCCC---CcccccccCCCccCchhhccc---CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 208 FFKPG---EKFSEIVGSPYYMAPEVLKRN---YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 208 ~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
..... .......||+.|+|||++.+. ++.++||||||+++++|++|..||...........+...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~----~~ 233 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA----IP 233 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC----CC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCC----CC
Confidence 75432 222455789999999998642 477999999999999999999999988877777777665433 23
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+++++.++|.+||+.||.+|||+.++++|+||
T Consensus 234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~ 267 (305)
T 2wtk_C 234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF 267 (305)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred CccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 4678999999999999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=352.28 Aligned_cols=261 Identities=28% Similarity=0.424 Sum_probs=214.2
Q ss_pred CCCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-----Cccee
Q 021233 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-----NIVCL 121 (315)
Q Consensus 47 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-----~iv~~ 121 (315)
...+..+.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+..|+.+++.+..|+ +++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 355677788999999999999999999999999999999998643 233456778999988884455 49999
Q ss_pred EEEEEcCCcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCceEeecCCCCCC
Q 021233 122 KDTYEDDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCH--KHGVMHRDLKPENFLFANKKETAP 197 (315)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH--~~~iiH~dikp~Nill~~~~~~~~ 197 (315)
++++...+..++||||+++ +|.+++... ..+++..++.++.|++.||.||| +.||+||||||+|||++.+. ...
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~-~~~ 199 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSA 199 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT-SCC
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC-CCc
Confidence 9999999999999999965 999999875 35999999999999999999999 57999999999999996422 234
Q ss_pred EEEEeeccccccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC
Q 021233 198 LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF 276 (315)
Q Consensus 198 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 276 (315)
+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++++|++|+.||......+....+.......
T Consensus 200 ~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 277 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277 (382)
T ss_dssp EEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999999987643 2345689999999999874 58999999999999999999999999888777766665432211
Q ss_pred CC------------------CCC-----------------c-------------------------cCCHHHHHHHHHhc
Q 021233 277 RR------------------DPW-----------------P-------------------------KVSENAKDLVRKML 296 (315)
Q Consensus 277 ~~------------------~~~-----------------~-------------------------~~~~~l~~li~~~l 296 (315)
+. ..| . ...+++.+||.+||
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 357 (382)
T 2vx3_A 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRML 357 (382)
T ss_dssp CHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHT
T ss_pred CHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhc
Confidence 00 000 0 00137899999999
Q ss_pred CCCcCCCCCHHHHhcccCC
Q 021233 297 DPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 297 ~~~P~~Rps~~e~l~~l~f 315 (315)
+.||++|||+.|+|+|+||
T Consensus 358 ~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 358 DYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp CSCTTTSCCHHHHTTSGGG
T ss_pred CCChhhCCCHHHHhcCccc
Confidence 9999999999999999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=351.90 Aligned_cols=260 Identities=22% Similarity=0.412 Sum_probs=218.8
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhc--------------HHHHHHHHHHHHhCCC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD--------------IEDVRREVDIMRHLPK 114 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~--------------~~~~~~e~~~l~~l~~ 114 (315)
.+....++|++++.||+|+||.||+|.+ +++.||+|.+.......... .+.+.+|+.+++.+ +
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~ 101 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-K 101 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-C
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-C
Confidence 3445667899999999999999999998 79999999987654332221 17899999999999 8
Q ss_pred CCCcceeEEEEEcCCcEEEEEEecCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCC
Q 021233 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDR------IVA--RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPE 185 (315)
Q Consensus 115 h~~iv~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~--~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~ 185 (315)
||||+++++++...+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999998 655 4569999999999999999999999 99999999999
Q ss_pred ceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCccCchhhccc--CCC-cchHHHHHHHHHHHhhCCCCCCCCCh
Q 021233 186 NFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRN--YGP-EVDVWSAGVILYILLCGVPPFWAETE 262 (315)
Q Consensus 186 Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~Di~slG~~l~el~tg~~p~~~~~~ 262 (315)
||+++.++. ++|+|||.+...... ......||+.|+|||++.+. ++. ++||||||+++++|++|..||.....
T Consensus 182 Nil~~~~~~---~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGR---VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSC---EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCc---EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999976655 999999999875433 34556789999999998743 445 99999999999999999999987766
Q ss_pred -HHHHHHHHhccccCCCCC---------------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 263 -QGVAQAIIRSVLDFRRDP---------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 263 -~~~~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+....+.......+... ...+++++.+||.+||+.||.+|||+.++++|+||
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 556666655443332110 14678999999999999999999999999999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=358.86 Aligned_cols=256 Identities=17% Similarity=0.222 Sum_probs=194.7
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC-CCCCcceeE-------EEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-KHQNIVCLK-------DTY 125 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~h~~iv~~~-------~~~ 125 (315)
...|++.+.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.+. +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345999999999999999999999999999999998765545556677888977666663 599987755 455
Q ss_pred EcC-----------------CcEEEEEEecCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCceecC
Q 021233 126 EDD-----------------TAVHLVMELCEGGELFDRIVAR-GHYTERAA------AAVTKTIVEVVQMCHKHGVMHRD 181 (315)
Q Consensus 126 ~~~-----------------~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~------~~i~~~l~~~L~~lH~~~iiH~d 181 (315)
... ...++||||++ ++|.+++... ..++...+ ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 23799999998 7999999864 23555555 67889999999999999999999
Q ss_pred CCCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCC
Q 021233 182 LKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFW 258 (315)
Q Consensus 182 ikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~ 258 (315)
|||+|||++.++. +||+|||+|..... ......+|+.|+|||++.+ .++.++||||||+++|+|++|+.||.
T Consensus 220 ikp~NIll~~~~~---~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 220 FTPDNLFIMPDGR---LMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp CSGGGEEECTTSC---EEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CCHHHEEECCCCC---EEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999986655 99999999986542 2224567799999999864 58999999999999999999999997
Q ss_pred CCChHHHH--HH---HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 259 AETEQGVA--QA---IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 259 ~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
........ .. ............++.+++++.+||.+||+.||++|||+.++|+|+||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 65322100 00 00001112222335789999999999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=346.10 Aligned_cols=258 Identities=22% Similarity=0.281 Sum_probs=214.8
Q ss_pred cccccceeeeeeeeeecceEEEEEE-----ECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 51 REIEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
....++|++++.||+|+||.||+|. +..++..||+|.+... ........+.+|+.+++.+ +||||+++++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 102 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKF-NHQNIVRCIGVS 102 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhC-CCCCCCeEEEEE
Confidence 3456789999999999999999999 5567889999998643 2334456789999999999 999999999999
Q ss_pred EcCCcEEEEEEecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 126 EDDTAVHLVMELCEGGELFDRIVARG-------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++....+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999998753 38999999999999999999999999999999999999876666679
Q ss_pred EEEeeccccccCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhcc
Q 021233 199 KAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (315)
Q Consensus 199 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 273 (315)
+|+|||++....... ......+|+.|+|||++. ..++.++||||||+++++|++ |..||......+....+....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 999999987543222 223456788999999876 568999999999999999998 999998887777666665543
Q ss_pred ccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
. ......+++.+.++|.+||+.||.+|||+.+++++|+
T Consensus 263 ~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 263 R---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 2 2334568999999999999999999999999999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=341.53 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=213.9
Q ss_pred cccceeeeeeeeeecceEEEEEEE-----CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 53 IEERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..++|++.+.||+|+||.||+|.+ ..+++.||+|.+.... .....+.+.+|+.+++++.+||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 346899999999999999999985 4567899999987542 233457799999999999889999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEe
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLF 189 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill 189 (315)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999998654 38999999999999999999999999999999999999
Q ss_pred ecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHH
Q 021233 190 ANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQG 264 (315)
Q Consensus 190 ~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~ 264 (315)
+.++. +||+|||++........ .....+|+.|+|||++. ..++.++||||||+++++|++ |..||.......
T Consensus 179 ~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 THGRI---TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ETTTE---EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cCCCC---EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 86655 89999999987654432 23345678899999876 568999999999999999999 999998776554
Q ss_pred HHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.......... .......+++++.++|.+||+.||.+|||+.+++++|
T Consensus 256 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 256 KFYKMIKEGF--RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp HHHHHHHHTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhccCC--CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 4444443322 2223456899999999999999999999999999876
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=355.25 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=209.6
Q ss_pred CCCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC-------CCCCcc
Q 021233 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP-------KHQNIV 119 (315)
Q Consensus 47 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-------~h~~iv 119 (315)
...+..+.++|++++.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++.+. +|+||+
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 345667788999999999999999999999999999999998643 234567889999999983 178899
Q ss_pred eeEEEEE----cCCcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecC
Q 021233 120 CLKDTYE----DDTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANK 192 (315)
Q Consensus 120 ~~~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~ 192 (315)
++++++. .....++||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 9999987 556899999999 55777776654 4599999999999999999999998 99999999999999765
Q ss_pred C----------------------------------------------CCCCEEEEeeccccccCCCCcccccccCCCccC
Q 021233 193 K----------------------------------------------ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226 (315)
Q Consensus 193 ~----------------------------------------------~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~a 226 (315)
+ ....+||+|||++...... .....||+.|+|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~a 261 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCC
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccC
Confidence 4 1135999999999875432 345578999999
Q ss_pred chhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh------HHHHHHHHhccccCCC---------------------
Q 021233 227 PEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE------QGVAQAIIRSVLDFRR--------------------- 278 (315)
Q Consensus 227 PE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~------~~~~~~~~~~~~~~~~--------------------- 278 (315)
||++. ..++.++|||||||++|+|++|+.||..... ......+.......+.
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 99986 4589999999999999999999999975442 2222222221111000
Q ss_pred -----------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 -----------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 -----------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
......++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 0112335678899999999999999999999999997
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=343.42 Aligned_cols=251 Identities=21% Similarity=0.282 Sum_probs=204.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEE----EEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~----a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
..++|++++.||+|+||+||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC
Confidence 3468999999999999999999998777654 777665332 234457899999999999 999999999999876
Q ss_pred CcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
. .++|+||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~ 165 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAK 165 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCTTHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC---EEEccCccee
Confidence 5 78999999999999999874 46999999999999999999999999999999999999987665 9999999998
Q ss_pred ccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 208 FFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 208 ~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
........ ....+|+.|+|||++. ..++.++||||||+++|+|++ |..||...........+.... ......
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~ 242 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPP 242 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---CCCCCT
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC---CCCCCc
Confidence 76443322 2345678999999976 568999999999999999999 999998887776666655443 222345
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.++.++.+++.+||+.||.+|||+.+++.+|
T Consensus 243 ~~~~~~~~li~~~l~~~p~~Rps~~ell~~l 273 (327)
T 3poz_A 243 ICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 6889999999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=338.53 Aligned_cols=252 Identities=25% Similarity=0.460 Sum_probs=205.2
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----- 127 (315)
+.++|++++.||+|+||.||+|.+..+++.||+|.+... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchh
Confidence 567899999999999999999999999999999998542 23456789999999999 89999999998864
Q ss_pred --------CCcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 128 --------DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 128 --------~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~---~ 155 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---V 155 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---E
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC---E
Confidence 356899999999999999998654 4788999999999999999999999999999999999976655 9
Q ss_pred EEEeeccccccCCC---------------CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCC-
Q 021233 199 KAIDFGLSVFFKPG---------------EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAE- 260 (315)
Q Consensus 199 kl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~- 260 (315)
+|+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++ ||...
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 99999999765321 12234578999999999863 58999999999999999998 55432
Q ss_pred ChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
........+......+++......++.+.++|.+||+.||.+|||+.++++|+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 2233344444444444455556678889999999999999999999999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=351.26 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=205.9
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc--------ChhcHHHHHHHHHHHHhCCCCCCccee
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR--------TAVDIEDVRREVDIMRHLPKHQNIVCL 121 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--------~~~~~~~~~~e~~~l~~l~~h~~iv~~ 121 (315)
...+.++|++.+.||+|+||.||+|.+.. +..||+|.+...... .....+.+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 94 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGL 94 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccce
Confidence 34567899999999999999999999754 999999998654322 122247799999999999 89999999
Q ss_pred EEEEEc-----CCcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 021233 122 KDTYED-----DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 122 ~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~ 195 (315)
++++.. ....++||||++ ++|.+.+.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~- 172 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND- 172 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC-
Confidence 999853 346899999997 58888887543 5999999999999999999999999999999999999976555
Q ss_pred CCEEEEeeccccccCCCCcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcc
Q 021233 196 APLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSV 273 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 273 (315)
+||+|||++.............+|+.|+|||++. ..++.++||||||+++++|++|+.||......+....+....
T Consensus 173 --~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 173 --ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp --EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred --EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 9999999998665555555678899999999876 458999999999999999999999999888777666664422
Q ss_pred ccCC------------------------CC----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 274 LDFR------------------------RD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 274 ~~~~------------------------~~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.... .. ..+.+++.+.+||.+||+.||++|||+.++++|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 320 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence 1110 00 123468889999999999999999999999999997
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=350.25 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=203.4
Q ss_pred cccceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 53 IEERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCC
Confidence 4468999999999999999999876 457789999986542 334456799999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC---EEECcCccccc
Confidence 9999999999999999998654 5999999999999999999999999999999999999976554 99999999986
Q ss_pred cCCCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 209 FKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 209 ~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
....... ....+++.|+|||++. ..++.++||||||+++|||++ |+.||......+....+..... .....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~---~~~~~ 273 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR---LPPPM 273 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---CCCCT
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCc
Confidence 6433211 1224567899999986 568999999999999999998 9999988888777766655422 22344
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+++++.++|.+||+.||.+|||+.++++.|
T Consensus 274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 6789999999999999999999999998765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=341.12 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=214.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEEC-------CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDT 124 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 124 (315)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+.+||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 34578999999999999999999975 356789999987542 334457789999999999889999999999
Q ss_pred EEcCCcEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceE
Q 021233 125 YEDDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFL 188 (315)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nil 188 (315)
+...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 999999999999999999999998653 3899999999999999999999999999999999999
Q ss_pred eecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChH
Q 021233 189 FANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQ 263 (315)
Q Consensus 189 l~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~ 263 (315)
++.++. +||+|||++........ .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......
T Consensus 190 l~~~~~---~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 190 VTENNV---MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp ECTTCC---EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EcCCCC---EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 976554 99999999987654332 22345678899999876 458999999999999999999 99999888877
Q ss_pred HHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+....+..... ......+++++.++|.+||+.||.+|||+.+++++|
T Consensus 267 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 267 ELFKLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HHHHHHHHTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhcCCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 77666665432 233456899999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=338.90 Aligned_cols=249 Identities=18% Similarity=0.255 Sum_probs=206.5
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCC-------CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENG-------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
..++|++.+.||+|+||+||+|.+..++ ..||+|.+... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 81 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKL-SHKHLVLNYGVC 81 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTS-CCTTBCCEEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhC-CCCCEeEEEEEE
Confidence 4568999999999999999999988766 46999998654 234457899999999999 899999999999
Q ss_pred EcCCcEEEEEEecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC-----CEE
Q 021233 126 EDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA-----PLK 199 (315)
Q Consensus 126 ~~~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~-----~vk 199 (315)
...+..++||||+++++|.+++..... +++..++.++.|++.||.|||++||+||||||+|||++.++... .+|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 99999999999999999999999999999999999998765421 289
Q ss_pred EEeeccccccCCCCcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCC-CCCCCCChHHHHHHHHhccccC
Q 021233 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVLDF 276 (315)
Q Consensus 200 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~ 276 (315)
|+|||++..... .....+|+.|+|||++. ..++.++||||||+++|+|++|. +||....... .........
T Consensus 162 l~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~-- 235 (289)
T 4fvq_A 162 LSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRH-- 235 (289)
T ss_dssp ECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTC--
T ss_pred eccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccC--
Confidence 999999875432 23456889999999986 45899999999999999999955 4554444433 333333222
Q ss_pred CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 277 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..+...++++.++|.+||+.||++|||+.+++++|
T Consensus 236 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 270 (289)
T 4fvq_A 236 --QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270 (289)
T ss_dssp --CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 22334578899999999999999999999999876
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=348.83 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=200.1
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc-
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA- 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~- 130 (315)
..-++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+++..+..+ +||||+++++++...+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSS
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhc-CCCCcccHHHhhhccccc
Confidence 34468999999999999999999999999999999885432 2234567788888988 99999999999865333
Q ss_pred ------EEEEEEecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCceEeec-CCCCCC
Q 021233 131 ------VHLVMELCEGGELFDRIV----ARGHYTERAAAAVTKTIVEVVQMCH--KHGVMHRDLKPENFLFAN-KKETAP 197 (315)
Q Consensus 131 ------~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~~l~~~L~~lH--~~~iiH~dikp~Nill~~-~~~~~~ 197 (315)
.++||||+++ +|.+.+. ....+++..++.++.|++.||.||| +.||+||||||+|||++. ++ .
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~---~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG---T 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT---E
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC---c
Confidence 7899999976 5554443 3456899999999999999999999 999999999999999985 33 3
Q ss_pred EEEEeeccccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc
Q 021233 198 LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275 (315)
Q Consensus 198 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 275 (315)
+||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.+....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 99999999987766665566789999999998753 4899999999999999999999999988877777666543211
Q ss_pred CC----------------------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 FR----------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ~~----------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. .......++++.+||.+||+.||.+|||+.|+|+|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 318 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF 318 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence 10 01112256789999999999999999999999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=355.58 Aligned_cols=244 Identities=23% Similarity=0.370 Sum_probs=209.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-cEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-AVH 132 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-~~~ 132 (315)
.++|++.+.||+|+||.||+|.+. ++.||+|++.... ..+.+.+|+.+++++ +||||+++++++.... ..+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceE
Confidence 467999999999999999999986 7899999986542 346799999999999 9999999999987654 799
Q ss_pred EEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+||||+++|+|.+++...+. +++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC---EEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC---EEEeeCCCccccc
Confidence 99999999999999987654 799999999999999999999999999999999999976554 9999999998643
Q ss_pred CCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
... ....+++.|+|||++. ..++.++||||||+++|||++ |..||......+....+.... +...+..+++++
T Consensus 341 ~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---~~~~p~~~~~~l 415 (450)
T 1k9a_A 341 STQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAV 415 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC---CCCCCTTCCHHH
T ss_pred ccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCcCCHHH
Confidence 322 2336788999999986 568999999999999999998 999998887777777666542 334456789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+||.+||+.||.+|||+.+++..|
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999999999999998765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=343.72 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=210.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEE--EEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAF--ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
++|++.+.||+|+||.||+|.+..++..+ |+|.+... ......+.+.+|+.+++++.+||||+++++++...+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 67999999999999999999998888765 88887643 223345678999999999988999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 133 LVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~-- 180 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 180 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--
Confidence 9999999999999997654 6999999999999999999999999999999999999976554
Q ss_pred CEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccc
Q 021233 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVL 274 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 274 (315)
+||+|||++.............+++.|+|||++. ..++.++||||||+++++|++ |..||......+....+....
T Consensus 181 -~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~- 258 (327)
T 1fvr_A 181 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY- 258 (327)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-
T ss_pred -EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC-
Confidence 9999999997543333334456788999999986 458999999999999999998 999998887776666555432
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.......+++++.+||.+||+.||.+|||+.+++++|
T Consensus 259 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 259 --RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp --CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2333456899999999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=343.87 Aligned_cols=258 Identities=29% Similarity=0.443 Sum_probs=208.8
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE---
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--- 126 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--- 126 (315)
+..+.++|++++.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSG 81 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTS
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccc
Confidence 456788999999999999999999999999999999988643 344467789999999999 9999999999874
Q ss_pred -----------cCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 021233 127 -----------DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 127 -----------~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~ 195 (315)
.....++||||++ ++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-- 157 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-- 157 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--
Confidence 3467899999997 599998854 5699999999999999999999999999999999999997433
Q ss_pred CCEEEEeeccccccCCC----CcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH
Q 021233 196 APLKAIDFGLSVFFKPG----EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI 269 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 269 (315)
..+||+|||++...... .......+|+.|+|||.+. ..++.++||||||+++++|++|+.||......+....+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 23899999999865432 1223456789999999875 45899999999999999999999999888776666655
Q ss_pred HhccccC----------------------CCC----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 270 IRSVLDF----------------------RRD----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 270 ~~~~~~~----------------------~~~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....... +.. .++.+++++.+||.+||+.||++|||+.++++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 309 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHH
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccc
Confidence 4432111 000 124578999999999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=335.81 Aligned_cols=252 Identities=28% Similarity=0.446 Sum_probs=206.0
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
|.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEE
Confidence 444559999999999999999999999999986542 33457789999999999 99999999999999999999999
Q ss_pred ecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 137 LCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~---~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|+++++|.+++.... .+++..++.++.|++.||.|||+.||+|+||||+||+++.. ...++|+|||.+.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~--~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT--TCCEEECCTTTCEESCC--
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC--CCCEEEeecccccccCCCC
Confidence 999999999998652 36789999999999999999999999999999999999762 2239999999998764332
Q ss_pred -cccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 214 -KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
......||+.|+|||++.+ .++.++||||||+++++|++|+.||............ .......+..+..+++++.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 256 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK-VGMFKVHPEIPESMSAEAK 256 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH-HHHHCCCCCCCTTSCHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh-hccccccccccccCCHHHH
Confidence 2345578999999999863 3789999999999999999999999754333221111 1111223344567899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++|.+||+.||++|||+.+++.|+||
T Consensus 257 ~li~~~l~~dp~~Rps~~~ll~~~~~ 282 (295)
T 2clq_A 257 AFILKCFEPDPDKRACANDLLVDEFL 282 (295)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHccCChhhCCCHHHHhcChhh
Confidence 99999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=354.85 Aligned_cols=261 Identities=23% Similarity=0.389 Sum_probs=212.2
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
+....++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETT 80 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCC
Confidence 34567899999999999999999999999999999999875432 23357788999999999 8999999999998755
Q ss_pred --cEEEEEEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-CCCCCEEEEee
Q 021233 130 --AVHLVMELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK-KETAPLKAIDF 203 (315)
Q Consensus 130 --~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~-~~~~~vkl~Df 203 (315)
..++||||+++++|.+++..... +++..++.++.|++.||.|||++||+||||||+|||+..+ +....+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 78999999999999999975432 9999999999999999999999999999999999998322 23334899999
Q ss_pred ccccccCCCCcccccccCCCccCchhhc---------ccCCCcchHHHHHHHHHHHhhCCCCCCCC----ChHHHHHHHH
Q 021233 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK---------RNYGPEVDVWSAGVILYILLCGVPPFWAE----TEQGVAQAII 270 (315)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~Di~slG~~l~el~tg~~p~~~~----~~~~~~~~~~ 270 (315)
|++.............||+.|+|||++. ..++.++||||||+++|+|++|+.||... ...+....+.
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred CCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 9998876665556678999999999875 34778999999999999999999999642 2334444444
Q ss_pred hccccC---------------------CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 271 RSVLDF---------------------RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 271 ~~~~~~---------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...... .......+++.+.++|.+||+.||++|||+.++++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 432210 0011123456788999999999999999999997654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=341.09 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=213.0
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCC-----EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGD-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
...++|++.+.||+|+||.||+|.+..++. .||+|.+.... .....+.+.+|+.+++.+.+||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345689999999999999999999876654 79999886542 33445779999999999978999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC
Q 021233 127 DDTAVHLVMELCEGGELFDRIVAR--------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~--------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~ 192 (315)
..+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 999999999999999999998753 357999999999999999999999999999999999999876
Q ss_pred CCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 021233 193 KETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQ 267 (315)
Q Consensus 193 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~ 267 (315)
+. +||+|||++........ .....+|+.|+|||++. ..++.++||||||+++++|++ |..||..........
T Consensus 201 ~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 201 HV---AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GE---EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred Ce---EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 65 89999999986533322 23345678899999876 568999999999999999998 999998766555555
Q ss_pred HHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+...... ......+++++.++|.+||+.||.+|||+.+++++|
T Consensus 278 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 321 (333)
T 2i1m_A 278 KLVKDGYQ--MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321 (333)
T ss_dssp HHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 44443322 223345789999999999999999999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=334.82 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=210.5
Q ss_pred ccceeeee-eeeeecceEEEEEEE--CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 54 EERYELGR-ELGRGEFGITYLCTD--RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 54 ~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.++|++.+ .||+|+||+||+|.+ ..+++.||+|++.... ......+.+.+|+.+++.+ +||||+++++++ ..+.
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCC
Confidence 46799998 999999999999954 4567889999987553 2233457799999999999 899999999999 5567
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.++||||+++++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALR 168 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCTTCEECC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc---EEEccCCcceeec
Confidence 8999999999999999998888999999999999999999999999999999999999987665 8999999998765
Q ss_pred CCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
..... ....+++.|+|||.+. ..++.++||||||+++++|++ |..||......+....+.... .......+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 245 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGC 245 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCC
Confidence 43322 2234578899999986 458899999999999999999 999998888777666665543 22334568
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++++.++|.+||+.||++|||+.++++.|
T Consensus 246 ~~~l~~li~~~l~~dp~~Rps~~~l~~~L 274 (291)
T 1xbb_A 246 PREMYDLMNLCWTYDVENRPGFAAVELRL 274 (291)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999998765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=335.51 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=217.6
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
....++|++.+.||+|+||+||+|.+..++..||+|.+... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPP 83 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCC
Confidence 34567899999999999999999999999999999998643 23457799999999999 89999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 131 VHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++..
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~~l~Dfg~~~~ 160 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRL 160 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC---EEECCCCGGGT
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC---EEEccCcccee
Confidence 999999999999999998643 4899999999999999999999999999999999999976655 99999999987
Q ss_pred cCCCCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 209 FKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 209 ~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
...... .....+|+.|+|||.+. ..++.++||||||+++++|++ |..||...........+.... ....+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 237 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGC 237 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC---CCCCCTTC
T ss_pred ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC---CCCCCCCC
Confidence 654332 23345678899999986 568999999999999999999 999998877776666665542 23344578
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++++.+|+.+||+.||.+|||+.++++.|
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999998765
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=344.58 Aligned_cols=254 Identities=28% Similarity=0.474 Sum_probs=209.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc-
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA- 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~- 130 (315)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSL 98 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhc-CCCCcccHhheEeccccc
Confidence 45678999999999999999999999999999999986542 2334456788999999999 89999999999987654
Q ss_pred -----EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 131 -----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 131 -----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
.++||||+. ++|.+.+.. .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~Dfg~ 172 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE---LKILDFGL 172 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC---EEECSTTC
T ss_pred ccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc---EEEeeccc
Confidence 499999996 588887643 4999999999999999999999999999999999999986555 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhcccc--------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD-------- 275 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------- 275 (315)
+..... ......+|+.|+|||++.+ .++.++||||||+++++|++|+.||......+....+......
T Consensus 173 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 173 ARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred ccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 986532 2345578999999998764 5899999999999999999999999887766655555432110
Q ss_pred ---------------C----CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 ---------------F----RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 ---------------~----~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. ....++.+++++.+||.+||+.||++|||+.++++|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 309 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 0 011234678999999999999999999999999999997
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=343.42 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=213.0
Q ss_pred CCCccccccceeeeeeeeeecceEEEEEEECCCC-CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC------cc
Q 021233 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENG-DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN------IV 119 (315)
Q Consensus 47 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~------iv 119 (315)
...+..+.++|++++.||+|+||+||+|.+..++ ..||+|++... ....+.+.+|+.+++.+ .|++ ++
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~ 85 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKI-KEKDKENKFLCV 85 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHH-HHHCTTSCSCBC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHH-hhcCCCCceeEE
Confidence 4456778899999999999999999999998776 68999998643 23356788899999988 5544 89
Q ss_pred eeEEEEEcCCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC-----
Q 021233 120 CLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK----- 192 (315)
Q Consensus 120 ~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~----- 192 (315)
.+++++...+..++||||+ +++|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||+..+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 567777776653 59999999999999999999999999999999999999543
Q ss_pred -----------CCCCCEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCC
Q 021233 193 -----------KETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE 260 (315)
Q Consensus 193 -----------~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~ 260 (315)
.....+||+|||++..... ......||+.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 1344599999999986433 234568999999999986 46899999999999999999999999888
Q ss_pred ChHHHHHHHHhccccCCC----------------------------------------CCCccCCHHHHHHHHHhcCCCc
Q 021233 261 TEQGVAQAIIRSVLDFRR----------------------------------------DPWPKVSENAKDLVRKMLDPDP 300 (315)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~l~~li~~~l~~~P 300 (315)
...+....+.......+. ......+.++.+||.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 776655555443222110 0001124578899999999999
Q ss_pred CCCCCHHHHhcccCC
Q 021233 301 KRRLTAQQVLGKIEF 315 (315)
Q Consensus 301 ~~Rps~~e~l~~l~f 315 (315)
++|||+.|+|+|+||
T Consensus 323 ~~Rpt~~e~l~hp~f 337 (355)
T 2eu9_A 323 AQRITLAEALLHPFF 337 (355)
T ss_dssp TTSCCHHHHTTSGGG
T ss_pred hhCcCHHHHhcChhh
Confidence 999999999999997
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=343.46 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=207.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCE----EEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDA----FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.++|++++.||+|+||+||+|.+..+++. ||+|.+.... .......+.+|+.+++.+ +||||+++++++. .+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GS 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CC
Confidence 46899999999999999999999888776 6777664332 122234577899999999 9999999999986 45
Q ss_pred cEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++||||+++++|.+++... +.+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~---~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ---VQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC---EEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe---EEECCCCcccc
Confidence 689999999999999999864 46999999999999999999999999999999999999976555 99999999987
Q ss_pred cCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 209 FKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 209 ~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
..... ......+|+.|+|||++. +.++.++||||||+++|+|++ |..||......+....+..... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 241 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER---LAQPQI 241 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---CCCCTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---CCCCCc
Confidence 64432 224456788999999987 568999999999999999999 9999988777766666655432 223345
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++.++.++|.+||+.||.+|||+.+++++|
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l 271 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANEF 271 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHHH
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 788999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=337.97 Aligned_cols=256 Identities=24% Similarity=0.318 Sum_probs=192.4
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
--++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+.++..+++.+ +||||+++++++...+..+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEE
Confidence 34689999999999999999999999999999999875432 122223344455566666 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+||||+ ++.+..+... ...+++..++.++.|++.||.|||+. ||+|+||||+||+++.++. +||+|||++....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLV 176 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC---EEECCCTTC----
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC---EEEEECCCchhcc
Confidence 999999 5566555543 45699999999999999999999995 9999999999999976655 9999999998765
Q ss_pred CCCcccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHhccccCCCCCCcc
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAE-TEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
.........+|+.|+|||++. ..++.++||||||+++++|++|+.||... ...+....+........ .....
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 255 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHMG 255 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSSC
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccCC
Confidence 554455568999999999973 34889999999999999999999999764 34444555544432221 12235
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++++.++|.+||+.||.+|||+.++++|+||
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 78999999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=335.77 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=205.4
Q ss_pred ccccceeeeeeeeeecceEEEEEE----ECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 52 EIEERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
...++|++++.||+|+||.||+|. +..+++.||+|.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNL-YHENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhC-CCCCeeeeeeEEec
Confidence 345679999999999999999998 45678999999987543 334457899999999999 89999999999987
Q ss_pred C--CcEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 128 D--TAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 128 ~--~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
. ...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC---EEECccc
Confidence 6 678999999999999999954 456999999999999999999999999999999999999987665 9999999
Q ss_pred cccccCCCCc----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC--------------hHHH
Q 021233 205 LSVFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET--------------EQGV 265 (315)
Q Consensus 205 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~--------------~~~~ 265 (315)
++........ .....+|..|+|||++. ..++.++||||||+++++|++|..|+.... ....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 9987654432 23456788899999876 458899999999999999999998763221 1111
Q ss_pred HHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
....... ......+..+++++.+||.+||+.||.+|||+.++++.|
T Consensus 252 ~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 252 LVNTLKE--GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp HHHHHHT--TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhc--cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 1111111 122334457899999999999999999999999999865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=336.50 Aligned_cols=257 Identities=23% Similarity=0.422 Sum_probs=201.4
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
+.++...++|++.+.||+|+||+||+|.+. ..+|+|++.... ......+.+.+|+.+++.+ +||||++++++. .
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-T 90 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-C
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-c
Confidence 445667789999999999999999999864 359999987553 2344567799999999999 899999999965 4
Q ss_pred CCcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~ 167 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT---VKIGDFGLA 167 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE---EEECCCC--
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC---EEEccceec
Confidence 55689999999999999998644 45999999999999999999999999999999999999987655 999999999
Q ss_pred cccCC---CCcccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH-hccccCC-
Q 021233 207 VFFKP---GEKFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII-RSVLDFR- 277 (315)
Q Consensus 207 ~~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~- 277 (315)
..... ........||+.|+|||++. ..++.++||||||+++++|++|+.||......+...... .......
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 247 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence 76532 22234567899999999874 347889999999999999999999998765554444443 3322221
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
......+++++.+||.+||+.||.+|||+.++++.|
T Consensus 248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 222346889999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=338.75 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=216.1
Q ss_pred CccccccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEE
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKD 123 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~ 123 (315)
......++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~ 95 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLG 95 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhc-CCCCEeeeEE
Confidence 33456678999999999999999999876 357889999987542 333456788999999999 9999999999
Q ss_pred EEEcCCcEEEEEEecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC
Q 021233 124 TYEDDTAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK 193 (315)
Q Consensus 124 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~ 193 (315)
++...+..++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999998752 3478999999999999999999999999999999999998655
Q ss_pred CCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHH
Q 021233 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQA 268 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~ 268 (315)
. +||+|||++........ .....+|+.|+|||++. ..++.++||||||+++++|++ |..||......+....
T Consensus 176 ~---~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 176 T---VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp C---EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred e---EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 4 99999999976533221 23345688999999986 558999999999999999999 8999988887777776
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+..... ......+++++.++|.+||+.||.+|||+.+++++|
T Consensus 253 ~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 253 VMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp HHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHcCCc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 665432 223356899999999999999999999999999876
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=360.09 Aligned_cols=249 Identities=20% Similarity=0.353 Sum_probs=215.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEE
Confidence 467999999999999999999999889999999986542 2457899999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL---VKVADFGLSRLMTG 370 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC---EEECCTTCEECCTT
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc---EEEeecccceeccC
Confidence 99999999999999864 34899999999999999999999999999999999999976555 99999999987643
Q ss_pred CCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
... .....+++.|+|||++. ..++.++||||||+++|||++ |..||......+....+... .+...+..++++
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 447 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMERPEGCPEK 447 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---CCCCCCTTCCHH
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHH
Confidence 322 12334567899999986 568999999999999999999 99999888777766666543 233445678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+||.+||+.||++|||+.++++.|
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 99999999999999999999998765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=345.57 Aligned_cols=258 Identities=21% Similarity=0.296 Sum_probs=208.5
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
......++|++.+.||+|+||+||+|.+ .+++.||+|.+... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFC-RHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCC
Confidence 3445667899999999999999999996 46899999988654 233457899999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 129 TAVHLVMELCEGGELFDRIVARG----HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV---PKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC---EEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC---EEEeecc
Confidence 99999999999999999886543 4899999999999999999999999999999999999976554 9999999
Q ss_pred cccccCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHH------HHH-Hhcc
Q 021233 205 LSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVA------QAI-IRSV 273 (315)
Q Consensus 205 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~------~~~-~~~~ 273 (315)
++....... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||......+.. ... ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 997643221 223456899999999875 56999999999999999999999999654332111 011 1110
Q ss_pred cc------CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 274 LD------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 274 ~~------~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.. ......+.+++.+.+++.+||+.||++|||+.+++++|+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 00 111122345677899999999999999999999998874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=328.85 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=213.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT----BCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEE
Confidence 357999999999999999999986 57889999987543 2346789999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDD 157 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC---EEECCTTGGGGBCCH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC---EEEcccccccccccc
Confidence 99999999999999865 45899999999999999999999999999999999999976655 999999999865432
Q ss_pred C--cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 213 E--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 213 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
. ......+++.|+|||++. ..++.++||||||+++++|++ |..||......+....+..... ......+++++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~l 234 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---LYKPRLASTHV 234 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---CCCCTTSCHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc---CCCCccCcHHH
Confidence 2 112345677899999987 568999999999999999999 8999988887777776665432 22334578999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+++.+||+.||++|||+.+++++|
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L 259 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQL 259 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999999999999999999999876
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=354.68 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=212.4
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++.+.||+|+||+||+|.+. ++..||+|.+.... ...+.+.+|+.+++.+ +||||+++++++. .+..
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSC
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCcc
Confidence 34568999999999999999999985 47789999987542 3467899999999999 9999999999987 5678
Q ss_pred EEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DFG~a~~~ 334 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV---CKIADFGLARVI 334 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC---EEECSTTGGGGB
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc---EEEeeCCCceEc
Confidence 9999999999999999753 35899999999999999999999999999999999999976554 999999999876
Q ss_pred CCCCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
..... .....+++.|+|||++. +.++.++||||||+++|||++ |+.||......+....+.... +...+..++
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---~~~~~~~~~ 411 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---RMPRPENCP 411 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC---CCCCCTTSC
T ss_pred CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 43221 12234577899999987 569999999999999999999 999999888887777776543 233445789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++.+||.+||+.||++|||+.+++..|
T Consensus 412 ~~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 412 EELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 9999999999999999999999998765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=334.11 Aligned_cols=246 Identities=26% Similarity=0.446 Sum_probs=209.3
Q ss_pred ccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--
Q 021233 50 GREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-- 127 (315)
Q Consensus 50 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-- 127 (315)
+..+.++|++++.||+|+||.||+|.+..+++.||+|.+.... +.+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKL-DHVNIVHYNGCWDGFD 77 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhC-CCCCEEEEeeeEeccc
Confidence 4567789999999999999999999999899999999986432 3467899999999 99999999998864
Q ss_pred --------------CCcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec
Q 021233 128 --------------DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN 191 (315)
Q Consensus 128 --------------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~ 191 (315)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence 34589999999999999999754 56999999999999999999999999999999999999987
Q ss_pred CCCCCCEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 021233 192 KKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII 270 (315)
Q Consensus 192 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 270 (315)
++. ++|+|||++.............||+.|+|||++. ..++.++||||||+++++|++|..|+... ......+.
T Consensus 158 ~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~ 232 (284)
T 2a19_B 158 TKQ---VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232 (284)
T ss_dssp TTE---EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred CCC---EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence 665 9999999998776655555668999999999986 45899999999999999999999887421 22222222
Q ss_pred hccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
... ....+++++.++|.+||+.||.+|||+.+++++|+
T Consensus 233 ~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 233 DGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp TTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 221 22457899999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=340.10 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=204.9
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEE----EEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAF----ACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~----a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
.++|++++.||+|+||+||+|.+..+++.+ |+|.+... ......+.+.+|+.+++.+ +||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC
Confidence 468999999999999999999998888765 55555432 2334567899999999999 8999999999998765
Q ss_pred cEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
.++++||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKL 166 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCTTC---
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC---EEEccCcceeE
Confidence 78999999999999999864 46999999999999999999999999999999999999987665 99999999986
Q ss_pred cCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 209 FKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 209 ~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
...... .....+|+.|+|||++. ..++.++||||||+++|+|++ |..||......+....+..... ......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 243 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---LPQPPI 243 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---CCCCTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence 543322 22345677899999976 458999999999999999999 9999988887777666655432 223456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++++.++|.+||+.||.+|||+.++++.|
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L 273 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELIIEF 273 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 899999999999999999999999999765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=338.47 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=209.7
Q ss_pred cccceeeeeeeeeecceEEEEEEE-----CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 53 IEERYELGRELGRGEFGITYLCTD-----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
..++|++.+.||+|+||+||+|.+ ..+++.||+|.+.... .......+.+|+.++..+.+||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 457899999999999999999985 3467899999987542 233456789999999999779999999999876
Q ss_pred CC-cEEEEEEecCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 021233 128 DT-AVHLVMELCEGGELFDRIVARGH----------------YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (315)
Q Consensus 128 ~~-~~~lv~e~~~~~sL~~~l~~~~~----------------l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~ 190 (315)
.+ ..++||||+++++|.+++..... +++..++.++.|++.||.|||+.||+||||||+||+++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 54 58999999999999999987543 88999999999999999999999999999999999997
Q ss_pred cCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHH
Q 021233 191 NKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (315)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 265 (315)
.++. +||+|||++........ .....+|+.|+|||++. ..++.++||||||+++++|++ |..||........
T Consensus 183 ~~~~---~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 183 EKNV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp GGGC---EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CCCC---EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 6555 99999999986543322 23456788999999876 568999999999999999998 9999977654433
Q ss_pred H-HHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 A-QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 ~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
. ..+.... .......+++++.++|.+||+.||.+|||+.+++++|
T Consensus 260 ~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 305 (316)
T 2xir_A 260 FCRRLKEGT---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305 (316)
T ss_dssp HHHHHHHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhccCc---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 3 3333322 1223345789999999999999999999999999886
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=337.28 Aligned_cols=263 Identities=26% Similarity=0.425 Sum_probs=209.8
Q ss_pred eecCCCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCC-CCCcceeE
Q 021233 44 VLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLK 122 (315)
Q Consensus 44 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-h~~iv~~~ 122 (315)
.+.........++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.++.++.. |+||++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEE
Confidence 3444555666788999999999999999999975 589999999865432 33446778999999999943 69999999
Q ss_pred EEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEe
Q 021233 123 DTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAID 202 (315)
Q Consensus 123 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~D 202 (315)
+++...+..++||| +.+++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||++++ ..+||+|
T Consensus 95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~----~~~kL~D 169 (313)
T 3cek_A 95 DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLID 169 (313)
T ss_dssp EEEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET----TEEEECC
T ss_pred EEeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC----CeEEEee
Confidence 99999999999999 457899999998888999999999999999999999999999999999999963 3489999
Q ss_pred eccccccCCCCc---ccccccCCCccCchhhcc------------cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHH
Q 021233 203 FGLSVFFKPGEK---FSEIVGSPYYMAPEVLKR------------NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVA 266 (315)
Q Consensus 203 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~ 266 (315)
||++........ .....||+.|+|||.+.+ .++.++||||||+++++|++|+.||...... ...
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 999986543322 234578999999999753 5788999999999999999999999765432 222
Q ss_pred HHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 267 QAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+.... .........++++.++|.+||+.||++|||+.++++|+||
T Consensus 250 ~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 250 HAIIDPN--HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp HHHHCTT--SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHhcc--cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 3333221 1222334568899999999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=329.60 Aligned_cols=247 Identities=15% Similarity=0.244 Sum_probs=210.3
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC--CcE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD--TAV 131 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~--~~~ 131 (315)
.++|++.+.||+|+||+||+|.+. ++.||+|++..... .....+.+.+|+.+++.+ +||||+++++++... +..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSC
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCe
Confidence 457999999999999999999985 88999999876532 334456799999999999 899999999999877 788
Q ss_pred EEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 132 HLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.| ++||||||+||+++.++. ++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~---~~l~~~~~~~ 161 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKF 161 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC---EEEEGGGSCC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc---eeEEecccee
Confidence 99999999999999998765 4899999999999999999999999 999999999999976555 8999988876
Q ss_pred ccCCCCcccccccCCCccCchhhccc----CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
.... ....||+.|+|||++.+. ++.++||||||+++|+|++|+.||...........+..... .+..+..
T Consensus 162 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (271)
T 3kmu_A 162 SFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL--RPTIPPG 235 (271)
T ss_dssp TTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC--CCCCCTT
T ss_pred eecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC--CCCCCCC
Confidence 4322 334789999999998642 33479999999999999999999988887777666655432 2334467
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++++.++|.+||+.||++|||+.++++.|
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 899999999999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=329.49 Aligned_cols=253 Identities=24% Similarity=0.293 Sum_probs=210.0
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCC---CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
....++|++.+.||+|+||+||+|.+... +..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC
Confidence 34457899999999999999999987543 3469999987542 334467899999999999 99999999999875
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
. ..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~ 160 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLS 160 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE---EEECCCCGG
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc---EEeCccCCC
Confidence 4 5689999999999999997654 5999999999999999999999999999999999999987665 899999999
Q ss_pred cccCCCCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 207 VFFKPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 207 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
........ .....+++.|+|||++. ..++.++||||||+++++|++ |+.||......+....+..... .....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~---~~~~~ 237 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR---LPKPD 237 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC---CCCCT
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC---CCCCC
Confidence 86543322 23346678899999986 568999999999999999998 9999987777777666655432 22334
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+++.+.++|.+||+.||++|||+.+++++|
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 268 (281)
T 3cc6_A 238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268 (281)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 6789999999999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=331.09 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=211.3
Q ss_pred ccceeeee-eeeeecceEEEEEEEC--CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 54 EERYELGR-ELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 54 ~~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++. .+.
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQ-AEA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhC-CCCCEeEEEEEec-CCC
Confidence 45677777 9999999999999864 457789999987542 334567899999999999 9999999999994 556
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE---EEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC---EEECcccceeee
Confidence 89999999999999998654 45999999999999999999999999999999999999987665 899999999876
Q ss_pred CCCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 210 KPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 210 ~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
...... ....+|+.|+|||++. ..++.++||||||+++++|++ |+.||......+....+.... ....++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~ 237 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPE 237 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---CCCCCTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC---cCCCCCC
Confidence 433321 2335678899999986 558999999999999999998 999998887777666665543 2333457
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+++++.++|.+||+.||++|||+.+++++|+
T Consensus 238 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 238 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 8999999999999999999999999998763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=341.41 Aligned_cols=253 Identities=22% Similarity=0.272 Sum_probs=200.2
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
++...-.++|++++.||+|+||+||+|.+. ++.||+|++.... ........|+.+++++ +||||+++++++..
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~ 89 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGM-KHENILQFIGAEKR 89 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcC-CCCCchhhcceecc
Confidence 333344568999999999999999999876 7899999986432 2234566789999999 89999999999987
Q ss_pred CC----cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCceEeecCC
Q 021233 128 DT----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH----------GVMHRDLKPENFLFANKK 193 (315)
Q Consensus 128 ~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~----------~iiH~dikp~Nill~~~~ 193 (315)
.. ..++||||+++++|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 44 479999999999999999765 599999999999999999999999 999999999999997655
Q ss_pred CCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhcc------cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--
Q 021233 194 ETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLKR------NYGPEVDVWSAGVILYILLCGVPPFWAETE-- 262 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~Di~slG~~l~el~tg~~p~~~~~~-- 262 (315)
. +||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....
T Consensus 169 ~---~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 169 T---ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp C---EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred e---EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 4 99999999976543322 234578999999999864 356788999999999999999999965321
Q ss_pred --------------HHHHHHHHhccccCCCCCC-----ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 263 --------------QGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 263 --------------~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
......+..... .+... ...++++.+||.+||+.||++|||+.++++.|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 313 (322)
T 3soc_A 246 MLPFEEEIGQHPSLEDMQEVVVHKKK--RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313 (322)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCC--CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccchhhhhccCCchhhhhhhhhcccC--CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 111122211111 11111 11245699999999999999999999999876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=343.09 Aligned_cols=254 Identities=30% Similarity=0.499 Sum_probs=211.5
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh---hcHHHHHHHHHHHHhCC-CCCCcceeEE
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLP-KHQNIVCLKD 123 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~-~h~~iv~~~~ 123 (315)
..+..+.++|++.+.||+|+||.||+|.+..+++.||+|.+........ ...+.+.+|+.+++.+. .|+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 4456678899999999999999999999999999999999876543221 12245678999999994 3699999999
Q ss_pred EEEcCCcEEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee-cCCCCCCEEEE
Q 021233 124 TYEDDTAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA-NKKETAPLKAI 201 (315)
Q Consensus 124 ~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~-~~~~~~~vkl~ 201 (315)
++...+..++|+|++.+ ++|.+++.....+++..++.++.|++.||.|||+.||+||||||+|||++ .++. +||+
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~---~kL~ 192 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLI 192 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE---EEEC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC---EEEe
Confidence 99999999999999975 89999999888899999999999999999999999999999999999997 3333 9999
Q ss_pred eeccccccCCCCcccccccCCCccCchhhcc-c-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC
Q 021233 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (315)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (315)
|||++...... ......||+.|+|||++.+ . ++.++||||||+++|+|++|+.||.... .+......
T Consensus 193 Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~---- 261 (320)
T 3a99_A 193 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF---- 261 (320)
T ss_dssp CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC----
T ss_pred eCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccc----
Confidence 99999876533 3345679999999998763 3 4788999999999999999999996431 22222222
Q ss_pred CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+++++.+||.+||+.||++|||+.++++|+||
T Consensus 262 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 234578999999999999999999999999999997
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=348.23 Aligned_cols=258 Identities=14% Similarity=0.180 Sum_probs=195.5
Q ss_pred cccceeeeeeeeeecceEEEEEEECCC-----CCEEEEEEcccccccC--------hhcHHHHHHHHHHHHhCCCCCCcc
Q 021233 53 IEERYELGRELGRGEFGITYLCTDREN-----GDAFACKSISKKKLRT--------AVDIEDVRREVDIMRHLPKHQNIV 119 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~a~K~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~h~~iv 119 (315)
..++|++.+.||+|+||+||+|.+..+ ++.||+|++....... ......+..|+..+..+ +||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCC
Confidence 345899999999999999999998764 5789999976542100 00112233455556666 799999
Q ss_pred eeEEEEEcC----CcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC
Q 021233 120 CLKDTYEDD----TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE 194 (315)
Q Consensus 120 ~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~ 194 (315)
++++++... ...++||||+ |++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~-~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-N 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS-C
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC-C
Confidence 999998764 4589999999 99999999876 569999999999999999999999999999999999999832 2
Q ss_pred CCCEEEEeeccccccCCCCc--------ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHH
Q 021233 195 TAPLKAIDFGLSVFFKPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGV 265 (315)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 265 (315)
...+||+|||+++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||........
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 23499999999976543221 133459999999999874 489999999999999999999999975332221
Q ss_pred -HHHHHhcccc----CCC--CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 -AQAIIRSVLD----FRR--DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 -~~~~~~~~~~----~~~--~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.......... ... .....+++++.+++..||+.||.+||++.++++.+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 1111110000 000 01145789999999999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=337.09 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=206.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCC----CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
...++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK 117 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec
Confidence 34568999999999999999999976543 359999986542 333456789999999999 99999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
.+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||++
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~~ 194 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLS 194 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC-
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc---EEECCCCcc
Confidence 99999999999999999999865 56999999999999999999999999999999999999976554 999999999
Q ss_pred cccCCCCc----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCC
Q 021233 207 VFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (315)
........ .....+|+.|+|||++. ..++.++||||||+++++|++ |..||......+....+.... ....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~---~~~~ 271 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPT 271 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---CCCC
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC---cCCC
Confidence 86543321 12234577899999986 568999999999999999999 999998888777766665542 2233
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...+++++.++|.+||+.||++|||+.+++++|
T Consensus 272 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 456889999999999999999999999998865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=333.11 Aligned_cols=255 Identities=20% Similarity=0.252 Sum_probs=204.2
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCc-ceeEEEEEcCCc
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI-VCLKDTYEDDTA 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-v~~~~~~~~~~~ 130 (315)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.+ +|+++ ..+..++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHh-hcCCCCCccccccCCCCc
Confidence 466789999999999999999999999999999998765422 24588999999999 66554 455555567788
Q ss_pred EEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 89999999 8899999974 446999999999999999999999999999999999999963334445999999999865
Q ss_pred CCCCc--------ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHhccccCC
Q 021233 210 KPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDFR 277 (315)
Q Consensus 210 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~ 277 (315)
..... .....||+.|+|||++.+ .++.++||||||+++++|++|+.||..... ......+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 44322 245679999999999874 589999999999999999999999975322 223333322222211
Q ss_pred -CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 278 -RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 278 -~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
......+++++.+++.+||+.||++|||+.++++.|
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 111245789999999999999999999999998765
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=341.05 Aligned_cols=256 Identities=22% Similarity=0.305 Sum_probs=186.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHH-HHHhCCCCCCcceeEEEEEcCCcE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD-IMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
..++|++++.||+|+||.||+|.+..+++.||+|++.... .......+..|+. +++.+ +||||+++++++...+..
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCce
Confidence 3468999999999999999999999999999999987542 2223345666666 55555 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 132 HLVMELCEGGELFDRIVA-----RGHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
++||||+++ +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++. +||+|||+
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGI 172 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE---EEECCCSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC---EEEccCCC
Confidence 999999975 88887763 45699999999999999999999999 9999999999999986655 99999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc-----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhcc-ccCCC
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK-----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-LDFRR 278 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~-~~~~~ 278 (315)
+.............||+.|+|||++. ..++.++||||||+++++|++|..||...... +....+.... .....
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence 98765544445557999999999973 34899999999999999999999999754321 1111111111 01111
Q ss_pred CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.....+++++.+||.+||+.||++|||+.++++|+||
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~ 289 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence 2234588999999999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=339.34 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=203.2
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE----cC
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE----DD 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~----~~ 128 (315)
..++|++++.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.+ +||||+++++++. ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCC
Confidence 356899999999999999999999999999999988543 344567789999999999 9999999999987 34
Q ss_pred CcEEEEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 129 TAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
...++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC---EEEEecC
Confidence 578999999999999999875 356999999999999999999999999999999999999976655 9999999
Q ss_pred cccccCCCCc----------ccccccCCCccCchhhcc----cCCCcchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHH
Q 021233 205 LSVFFKPGEK----------FSEIVGSPYYMAPEVLKR----NYGPEVDVWSAGVILYILLCGVPPFWAETE--QGVAQA 268 (315)
Q Consensus 205 ~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~----~~~~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~ 268 (315)
++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||..... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 259 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH
Confidence 9876432111 123467999999999753 268999999999999999999999943111 111122
Q ss_pred HHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 269 IIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+. .. ......+.+++++.++|.+||+.||.+|||+.+++++|
T Consensus 260 ~~-~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 260 VQ-NQ--LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HH-CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hh-cc--CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 22 21 12223356899999999999999999999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=333.02 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=204.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEECC-CCC--EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRE-NGD--AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~--~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
...++|++++.||+|+||+||+|.+.. ++. .||+|++...........+.+.+|+.+++.+ +||||+++++++...
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP 93 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC
Confidence 345689999999999999999998643 333 6899998765544455567899999999999 899999999999876
Q ss_pred CcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 TAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
. .++|+||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++. +||+|||++.
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~~ 169 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMR 169 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCTTCE
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC---EEEccccccc
Confidence 5 88999999999999999764 46999999999999999999999999999999999999987665 8999999998
Q ss_pred ccCCCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 208 FFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 208 ~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
........ ....+|+.|+|||++. ..++.++||||||+++++|++ |..||......+....+...... ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~ 247 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--LPRP 247 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--CCCC
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC--CCCC
Confidence 76543321 2346778899999986 458899999999999999999 99999888887777776654332 2234
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..+++++.++|.+||+.||.+|||+.+++++|
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 279 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 56899999999999999999999999999865
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=341.65 Aligned_cols=266 Identities=20% Similarity=0.250 Sum_probs=209.9
Q ss_pred eeeecCCCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCccee
Q 021233 42 LCVLKEPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCL 121 (315)
Q Consensus 42 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~ 121 (315)
...+...+.....++|++.+.||+|+||.||+|.+ .+++.||+|++....... ....+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~ 92 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMA-VHRNLLRL 92 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTC-CCTTBCCC
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhc-cCCCccce
Confidence 34455556667778999999999999999999985 468999999987653222 223688999999999 89999999
Q ss_pred EEEEEcCCcEEEEEEecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCceEeecCCC
Q 021233 122 KDTYEDDTAVHLVMELCEGGELFDRIVARG----HYTERAAAAVTKTIVEVVQMCHKH---GVMHRDLKPENFLFANKKE 194 (315)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~~l~~~L~~lH~~---~iiH~dikp~Nill~~~~~ 194 (315)
++++...+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999998643 389999999999999999999999 9999999999999976555
Q ss_pred CCCEEEEeeccccccCCCC--cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCC-----ChHHHH
Q 021233 195 TAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAE-----TEQGVA 266 (315)
Q Consensus 195 ~~~vkl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~-----~~~~~~ 266 (315)
+||+|||++....... ......||+.|+|||++. ..++.++||||||+++++|++|..||... ......
T Consensus 173 ---~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 173 ---AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp ---EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred ---EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 9999999998764332 234456999999999986 56899999999999999999999999411 111111
Q ss_pred HHHHhcccc----------CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 267 QAIIRSVLD----------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 267 ~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
..+...... .........++++.+++..||+.||.+|||+.+++++|+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111110000 001112234478999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=337.38 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=207.1
Q ss_pred ccceeeeeeeeeecceEEEEEE----ECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE--c
Q 021233 54 EERYELGRELGRGEFGITYLCT----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE--D 127 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~--~ 127 (315)
.++|++++.||+|+||.||+|. +..+++.||+|.+... .....+.+.+|+.+++.+ +||||+++++++. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPG 97 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCC
Confidence 3689999999999999999998 4567899999998654 334456799999999999 9999999999886 4
Q ss_pred CCcEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC---EEEcccccc
Confidence 56789999999999999999863 45999999999999999999999999999999999999987665 999999999
Q ss_pred cccCCCCc----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHH--------------HHH
Q 021233 207 VFFKPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQG--------------VAQ 267 (315)
Q Consensus 207 ~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--------------~~~ 267 (315)
........ .....+|+.|+|||++. ..++.++||||||+++++|++|..||....... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 87654332 13346788899999986 458899999999999999999999985433221 111
Q ss_pred HHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..... .........+++++.+||.+||+.||++|||+.+++++|
T Consensus 255 ~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 298 (327)
T 3lxl_A 255 ELLEE--GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298 (327)
T ss_dssp HHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhhc--ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 11111 122333457899999999999999999999999998775
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=346.56 Aligned_cols=258 Identities=17% Similarity=0.231 Sum_probs=199.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECC---CCCEEEEEEcccccccC--------hhcHHHHHHHHHHHHhCCCCCCcceeE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRT--------AVDIEDVRREVDIMRHLPKHQNIVCLK 122 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~h~~iv~~~ 122 (315)
.++|++.+.||+|+||+||+|.+.. ++..+|+|.+....... ......+.+|+..+..+ +||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence 4689999999999999999999987 78899999887542110 11223466788899998 999999999
Q ss_pred EEEEc----CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 123 DTYED----DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 123 ~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
+++.. ....++||||+ +++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++. ..+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~ 192 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP-DQV 192 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST-TSE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC-CcE
Confidence 99987 77899999999 9999999987778999999999999999999999999999999999999987652 249
Q ss_pred EEEeeccccccCCCC--------cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHH
Q 021233 199 KAIDFGLSVFFKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQA 268 (315)
Q Consensus 199 kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~-~~~~~~~ 268 (315)
||+|||+++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .......
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999997653221 1244579999999999875 48999999999999999999999995422 1111222
Q ss_pred HHhccc-cCCCC-----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 269 IIRSVL-DFRRD-----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 269 ~~~~~~-~~~~~-----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
...... ..+.. ....+++++.++|..||+.||++|||+.++++.|.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 111111 11100 01167899999999999999999999999998764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=339.03 Aligned_cols=254 Identities=28% Similarity=0.482 Sum_probs=200.8
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh---hcHHHHHHHHHHHHhCC---CCCCccee
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---VDIEDVRREVDIMRHLP---KHQNIVCL 121 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~---~h~~iv~~ 121 (315)
..+..+.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.++.++. +|+||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3456678899999999999999999999999999999999975533221 12234567888888874 69999999
Q ss_pred EEEEEcCCcEEEEEEe-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee-cCCCCCCEE
Q 021233 122 KDTYEDDTAVHLVMEL-CEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA-NKKETAPLK 199 (315)
Q Consensus 122 ~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~-~~~~~~~vk 199 (315)
++++...+..++|+|+ +.+++|.+++.....+++..++.++.|++.||.|||+.||+||||||+||+++ .++. ++
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~---~k 180 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC---AK 180 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE---EE
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe---EE
Confidence 9999999999999999 78999999999888899999999999999999999999999999999999997 4443 89
Q ss_pred EEeeccccccCCCCcccccccCCCccCchhhcc-c-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC
Q 021233 200 AIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR 277 (315)
Q Consensus 200 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 277 (315)
|+|||++...... ......||+.|+|||++.+ . .+.++||||||+++++|++|+.||.... .+.....
T Consensus 181 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~--- 250 (312)
T 2iwi_A 181 LIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAEL--- 250 (312)
T ss_dssp ECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCC---
T ss_pred EEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhcc---
Confidence 9999999876543 3345678999999998763 3 3558999999999999999999996431 2222222
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.....+++++.++|.+||+.||++|||+.++++|+||
T Consensus 251 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~ 287 (312)
T 2iwi_A 251 -HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287 (312)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 2334678999999999999999999999999999997
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=349.41 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=207.2
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++++ +||||+++++++.. +..
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-Cce
Confidence 345689999999999999999999864 5679999987543 2346799999999999 99999999999876 678
Q ss_pred EEEEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 132 HLVMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
++||||+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~ 330 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLI 330 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCTTC--
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC---EEECCCccceec
Confidence 999999999999999964 345999999999999999999999999999999999999976554 999999999865
Q ss_pred CCCCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
..... .....+++.|+|||++. +.++.++||||||+++|||++ |+.||......+....+.... +...+..++
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---~~~~~~~~~ 407 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECP 407 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTSC
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 43321 12345678899999876 568999999999999999999 999999888877777766542 233445789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+.+||.+||+.||++|||+.++++.|
T Consensus 408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L 435 (452)
T 1fmk_A 408 ESLHDLMCQCWRKEPEERPTFEYLQAFL 435 (452)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999999999999999999999998765
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=326.16 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=210.5
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++++.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.+ +||||+++++++.. +..
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc----ccHHHHHHHHHHHHhC-CCcCcceEEEEEcC-CCc
Confidence 34568999999999999999999975 56789999986542 2357799999999999 99999999999874 468
Q ss_pred EEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 132 HLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||++...
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLI 159 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC---EEECCCcccccc
Confidence 99999999999999986543 6999999999999999999999999999999999999976554 999999999876
Q ss_pred CCCCcc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
...... ....+++.|+|||.+. +.++.++||||||+++++|++ |+.||......+....+.... .......++
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~ 236 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMVRPDNCP 236 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTCC
T ss_pred cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc---CCCCccccc
Confidence 543321 2345678899999987 568999999999999999999 999998888777776665542 223345689
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++.+++.+||+.||++|||+.++++.|
T Consensus 237 ~~l~~li~~~l~~~p~~Rps~~~l~~~l 264 (279)
T 1qpc_A 237 EELYQLMRLCWKERPEDRPTFDYLRSVL 264 (279)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 9999999999999999999999998765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=333.51 Aligned_cols=253 Identities=19% Similarity=0.279 Sum_probs=202.6
Q ss_pred cccceeeeeeeeeecceEEEEEEECC---CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC--
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeecc
Confidence 35689999999999999999998765 345899999875432 334456789999999999 8999999999998654
Q ss_pred -----cEEEEEEecCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 130 -----AVHLVMELCEGGELFDRIVA------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 130 -----~~~lv~e~~~~~sL~~~l~~------~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. +
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~---~ 186 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT---V 186 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC---E
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc---E
Confidence 45999999999999999853 245999999999999999999999999999999999999976654 9
Q ss_pred EEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhcc
Q 021233 199 KAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSV 273 (315)
Q Consensus 199 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 273 (315)
||+|||++........ .....+++.|+|||.+. ..++.++||||||+++++|++ |..||...........+....
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 266 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence 9999999986543321 23345678899999986 458999999999999999999 999998887777776666543
Q ss_pred ccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
....+..+++++.++|.+||+.||.+|||+.+++++|
T Consensus 267 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 303 (313)
T 3brb_A 267 ---RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303 (313)
T ss_dssp ---CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ---CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2333456889999999999999999999999999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=331.17 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=198.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcc-eeEEEEEcCCc
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIV-CLKDTYEDDTA 130 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv-~~~~~~~~~~~ 130 (315)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++..... .+.+.+|+.+++.+ +|++++ .+..++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHH-TTSTTCCCEEEEEEETTE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHh-cCCCCCCeeeeecCCCCc
Confidence 466789999999999999999999999999999998654422 23478899999999 555544 55555577888
Q ss_pred EEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++....+||+|||++...
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred eEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99999999 8899999985 456999999999999999999999999999999999999943333444999999999865
Q ss_pred CCCCc--------ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH---HHHHHHHhccccCC
Q 021233 210 KPGEK--------FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVLDFR 277 (315)
Q Consensus 210 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~ 277 (315)
..... .....||+.|+|||.+.+ .++.++||||||+++++|++|+.||...... .....+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 43322 235678999999999874 5899999999999999999999999754322 22222222211111
Q ss_pred -CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 278 -RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 278 -~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
......+++++.++|..||+.||++|||+.++++.+
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 111245789999999999999999999999998754
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=335.99 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=205.3
Q ss_pred cccccce-eeeeeeeeecceEEEEEEE----CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEE
Q 021233 51 REIEERY-ELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTY 125 (315)
Q Consensus 51 ~~~~~~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 125 (315)
..+.++| ++++.||+|+||+||++.+ ..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~ 102 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTL-YHEHIIKYKGCC 102 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhC-CCcchhhEEEEE
Confidence 3466666 9999999999999988754 3468899999987542 334467799999999999 899999999999
Q ss_pred Ec--CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 126 ED--DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 126 ~~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
.. ....++||||+++++|.+++... .+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~---~kl~Df 178 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL---VKIGDF 178 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCG
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC---EEECCc
Confidence 87 46789999999999999998765 4999999999999999999999999999999999999976654 999999
Q ss_pred ccccccCCCCc----ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHH--------------
Q 021233 204 GLSVFFKPGEK----FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQG-------------- 264 (315)
Q Consensus 204 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-------------- 264 (315)
|++........ .....+|+.|+|||++.+ .++.++||||||+++++|++|..||.......
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 99987654432 233467888999999874 58899999999999999999999986532210
Q ss_pred HHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
........ .........+++++.+||.+||+.||++|||+.++++.|
T Consensus 259 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 259 RLTELLER--GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp HHHHHHHT--TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHhc--ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 11111111 122334457899999999999999999999999999765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=334.49 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=196.8
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHh--CCCCCCcceeEEEEEc-
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH--LPKHQNIVCLKDTYED- 127 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~~h~~iv~~~~~~~~- 127 (315)
+.+.++|++.+.||+|+||+||+|.+ +++.||+|++... ....+..|.+++.. + +||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVML-RHENILGFIASDMTS 74 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccc
Confidence 45778999999999999999999997 4899999998543 23556677777776 6 89999999998654
Q ss_pred ---CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCceEeecCCCCC
Q 021233 128 ---DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH--------KHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 128 ---~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH--------~~~iiH~dikp~Nill~~~~~~~ 196 (315)
....++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.||+||||||+|||++.++.
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~-- 151 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ-- 151 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--
T ss_pred cCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--
Confidence 3568999999999999999954 46999999999999999999999 999999999999999976554
Q ss_pred CEEEEeeccccccCCCCc-----ccccccCCCccCchhhccc-------CCCcchHHHHHHHHHHHhhC----------C
Q 021233 197 PLKAIDFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCG----------V 254 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~Di~slG~~l~el~tg----------~ 254 (315)
+||+|||++........ .....||+.|+|||++.+. ++.++||||||+++|||++| .
T Consensus 152 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 152 -CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp -EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred -EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999976543322 1334799999999998643 44689999999999999999 8
Q ss_pred CCCCCCCh----HHHHHHHHhccccCCCCCC-----ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 255 PPFWAETE----QGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 255 ~p~~~~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.||..... ............ ..+... ..+++++.+||.+||+.||++|||+.++++.|
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQ-QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSC-CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccC-CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 88854321 122222221111 111111 12457899999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=342.52 Aligned_cols=249 Identities=15% Similarity=0.197 Sum_probs=200.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECC--------CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcce-----
Q 021233 54 EERYELGRELGRGEFGITYLCTDRE--------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVC----- 120 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~----- 120 (315)
.++|++.+.||+|+||.||+|.+.. +++.||+|.+... +.+.+|+.+++++ +||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~ 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRA-AKPLQVNKWKKL 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHH-CCHHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHh-cccchhhhhhhh
Confidence 4689999999999999999999987 4889999998643 3578899999999 8999887
Q ss_pred ----------eEEEEEc-CCcEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCce
Q 021233 121 ----------LKDTYED-DTAVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENF 187 (315)
Q Consensus 121 ----------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Ni 187 (315)
+++++.. .+..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 6677765 67899999999 99999999875 6799999999999999999999999999999999999
Q ss_pred EeecCCCCCCEEEEeeccccccCCCC--------cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCC
Q 021233 188 LFANKKETAPLKAIDFGLSVFFKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFW 258 (315)
Q Consensus 188 ll~~~~~~~~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~ 258 (315)
|++.++. ..+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.
T Consensus 191 l~~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQ-SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEE-EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCC-ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9986551 138999999997654321 1234579999999999874 68999999999999999999999997
Q ss_pred CCC-hHHHHHHHHhccccCCC------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 259 AET-EQGVAQAIIRSVLDFRR------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 259 ~~~-~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
... ................. ..+..+++++.+||.+||+.||++|||+.++++.|
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 331 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNL 331 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHH
Confidence 653 22222222211111111 11235789999999999999999999999998765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=329.01 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=205.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCC---CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE-cCC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDT 129 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-~~~ 129 (315)
..+|++.+.||+|+||+||+|.+..++ ..+|+|.+... ......+.+.+|+.+++++ +||||+++++++. ..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCC
Confidence 457999999999999999999975433 35899987643 2344457789999999999 8999999999864 566
Q ss_pred cEEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---EEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC---EEECccccccc
Confidence 889999999999999999764 45899999999999999999999999999999999999976554 99999999986
Q ss_pred cCCCCc-----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 209 FKPGEK-----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 209 ~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
...... .....+|+.|+|||.+. ..++.++||||||+++++|++ |.+||......+....+...... ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 254 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL---LQP 254 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC---CCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC---CCC
Confidence 543321 23346778899999986 468999999999999999999 66777776666666666554332 223
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..+++.+.+++.+||+.||++|||+.++++.|
T Consensus 255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 45789999999999999999999999999865
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=327.19 Aligned_cols=245 Identities=22% Similarity=0.352 Sum_probs=201.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC-CcE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD-TAV 131 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~-~~~ 131 (315)
..++|++.+.||+|+||+||+|.+. ++.||+|.+... ...+.+.+|+.+++.+ +||||+++++++... +..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCce
Confidence 3468999999999999999999875 889999998643 2356789999999999 899999999997554 578
Q ss_pred EEEEEecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 132 HLVMELCEGGELFDRIVARGH--YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
++||||+++++|.+++..... +++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~Dfg~~~~~ 167 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEA 167 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC---EEECCCCC----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc---EEEeeccccccc
Confidence 999999999999999976543 899999999999999999999999999999999999976554 999999998765
Q ss_pred CCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 210 KPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 210 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
... .....+++.|+|||.+. ..++.++||||||+++++|++ |..||......+....+.... .......++++
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 242 (278)
T 1byg_A 168 SST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPA 242 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---CCCCCTTCCHH
T ss_pred ccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---CCCCcccCCHH
Confidence 432 23346788999999986 568999999999999999998 999998887776666665432 23344578999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.++|.+||+.||++|||+.++++.|
T Consensus 243 l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 243 VYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 99999999999999999999998765
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=344.33 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=204.7
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC----------CCCCcceeE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----------KHQNIVCLK 122 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~----------~h~~iv~~~ 122 (315)
..++|++++.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++++. .|+||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 346899999999999999999999999999999998643 233467888999999883 178999999
Q ss_pred EEEEcCC----cEEEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCceEeecCC--
Q 021233 123 DTYEDDT----AVHLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKH-GVMHRDLKPENFLFANKK-- 193 (315)
Q Consensus 123 ~~~~~~~----~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~-~iiH~dikp~Nill~~~~-- 193 (315)
+++...+ ..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9998654 789999999 88999999864 3499999999999999999999998 999999999999996543
Q ss_pred -CCCCEEEEeeccccccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCC------hHHH
Q 021233 194 -ETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAET------EQGV 265 (315)
Q Consensus 194 -~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~------~~~~ 265 (315)
....+||+|||++...... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.... ....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 2234899999999865432 344578999999999864 58999999999999999999999997543 2222
Q ss_pred HHHHHhccccCC--------------------------------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHH
Q 021233 266 AQAIIRSVLDFR--------------------------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307 (315)
Q Consensus 266 ~~~~~~~~~~~~--------------------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~ 307 (315)
...+.......+ ......+++++.+||.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 223222111110 011234567889999999999999999999
Q ss_pred HHhcccCC
Q 021233 308 QVLGKIEF 315 (315)
Q Consensus 308 e~l~~l~f 315 (315)
|+|+|+||
T Consensus 330 ell~hp~f 337 (373)
T 1q8y_A 330 GLVNHPWL 337 (373)
T ss_dssp HHHTCGGG
T ss_pred HHhhChhh
Confidence 99999997
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=337.52 Aligned_cols=251 Identities=26% Similarity=0.436 Sum_probs=188.4
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE----
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE---- 126 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~---- 126 (315)
.....+|++.+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.+++++.+||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 34456899999999999999999999999999999988543 33445678999999999966999999999994
Q ss_pred ----cCCcEEEEEEecCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCC
Q 021233 127 ----DDTAVHLVMELCEGGELFDRIVA---RGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAP 197 (315)
Q Consensus 127 ----~~~~~~lv~e~~~~~sL~~~l~~---~~~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~ 197 (315)
.....++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||+.| |+||||||+|||++.++.
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--- 176 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--- 176 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC---
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC---
Confidence 3345899999995 699888865 456999999999999999999999999 999999999999986554
Q ss_pred EEEEeeccccccCCCCcc-------------cccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCC
Q 021233 198 LKAIDFGLSVFFKPGEKF-------------SEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAE 260 (315)
Q Consensus 198 vkl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~ 260 (315)
+||+|||++......... ....||+.|+|||++. ..++.++||||||+++|+|++|..||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999876433221 1446899999999873 34788999999999999999999999654
Q ss_pred ChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 261 TEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
...... ..... .......++.+.+||.+||+.||.+|||+.+++++|+
T Consensus 257 ~~~~~~----~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 257 AKLRIV----NGKYS--IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------CC--CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hHHHhh----cCccc--CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 433222 22111 2223456788999999999999999999999998763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=357.14 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=206.6
Q ss_pred cceeeee-eeeeecceEEEEEEECC--CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGR-ELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~-~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
+++.+.+ .||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+|+.+ +||||+++++++.. +..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCe
Confidence 4556666 89999999999998753 45679999987542 234567899999999999 99999999999976 568
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc---EEEeeccCccccc
Confidence 9999999999999999754 35999999999999999999999999999999999999987665 9999999998764
Q ss_pred CCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
..... ....+++.|+|||++. +.++.++||||||+++|||++ |+.||......+....+.... +...+..+
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~---~~~~p~~~ 564 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPEC 564 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC---CCCCCTTC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCCCcC
Confidence 33221 2234568899999986 569999999999999999998 999999888877777776543 23344568
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
++++.+||..||+.||++|||+.++++.|
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L 593 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRM 593 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999999999999998765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=332.84 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=203.9
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccc-cChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVM 135 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 135 (315)
|...+.||+|+||.||+|.+ +++.||+|.+..... ......+.+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEE
Confidence 45558999999999999986 588999999865432 2233457799999999999 9999999999999999999999
Q ss_pred EecCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 136 ELCEGGELFDRIVA---RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 136 e~~~~~sL~~~l~~---~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT---AKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc---EEEeecccccccccc
Confidence 99999999999874 345999999999999999999999999999999999999976554 999999999865433
Q ss_pred Cc---ccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH----Hhccc-------cCCC
Q 021233 213 EK---FSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI----IRSVL-------DFRR 278 (315)
Q Consensus 213 ~~---~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~----~~~~~-------~~~~ 278 (315)
.. .....||+.|+|||.+.+.++.++||||||+++++|++|..||...........+ ..... ....
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 21 2345789999999998888999999999999999999999999765433222111 11100 0111
Q ss_pred CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 279 DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 279 ~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
......++.+.+++.+||+.||.+|||+.+++++|
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 22234567899999999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=358.09 Aligned_cols=244 Identities=21% Similarity=0.298 Sum_probs=206.0
Q ss_pred eeeeeecceEEEEEEEC--CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 61 RELGRGEFGITYLCTDR--ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
+.||+|+||+||+|.+. .+++.||+|++.... ......+.+.+|+.+++++ +||||+++++++.. +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCEEEEEEcc
Confidence 47999999999999653 456889999987543 2334467899999999999 89999999999975 4588999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc----
Q 021233 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---- 214 (315)
Q Consensus 139 ~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~---- 214 (315)
++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~---~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCTTHHHHTTC-------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC---EEEEEcCCccccccCcccccc
Confidence 99999999998888999999999999999999999999999999999999987665 89999999987644322
Q ss_pred ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
.....+|+.|+|||++. ..++.++||||||+++|||++ |+.||......+....+..... ...+..+++++.+||
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~---~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER---MGCPAGCPREMYDLM 605 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---CCCCTTCCHHHHHHH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHH
Confidence 12335678899999987 469999999999999999998 9999998888877777766532 334456899999999
Q ss_pred HHhcCCCcCCCCCHHHHhccc
Q 021233 293 RKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~l 313 (315)
..||+.||++|||+.++++.|
T Consensus 606 ~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp HHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999998765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=326.35 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=204.8
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCC---EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE-
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV- 131 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~- 131 (315)
.|++.+.||+|+||+||+|.+..++. .+|+|.+... ......+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCc
Confidence 57888999999999999999765544 7999988643 2344567889999999999 999999999999866554
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT---VKVADFGLARDIL 175 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---EEECCTTSSCTTT
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc---EEeCcCCCccccc
Confidence 999999999999999986 345899999999999999999999999999999999999976554 9999999997653
Q ss_pred CCC-----cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 211 PGE-----KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 211 ~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
... ......+++.|+|||.+.+ .++.++||||||+++++|++| .+||......+....+..... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 252 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---LPQPEY 252 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---CCCCTT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---CCCCcc
Confidence 322 2234567889999999874 589999999999999999995 555555555555555544332 223356
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++++.+++.+||+.||.+|||+.++++.+
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l 282 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 789999999999999999999999998865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=328.68 Aligned_cols=235 Identities=34% Similarity=0.614 Sum_probs=189.6
Q ss_pred cccceeee-eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----
Q 021233 53 IEERYELG-RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (315)
Q Consensus 53 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~---- 127 (315)
+.++|.+. +.||+|+||.||+|.+..+++.||+|.+... ..+.+|+.++.++.+||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 44557776 7899999999999999999999999998532 4577899998666599999999999876
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++....++|+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 677899999999999999998764 599999999999999999999999999999999999998755456699999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC----CC
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD----PW 281 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~ 281 (315)
+..... ..++.++||||||+++|+|++|..||...........+.......... .+
T Consensus 167 a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (299)
T 3m2w_A 167 AKETTG--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226 (299)
T ss_dssp CEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHH
T ss_pred cccccc--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhc
Confidence 865431 235678999999999999999999997654432221111111111111 11
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+++++.+||.+||+.||.+|||+.|+++|+||
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 4578999999999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=329.67 Aligned_cols=242 Identities=27% Similarity=0.416 Sum_probs=195.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++.+.||+|+||+||+|.+. ++.||+|.+... ...+.+.+|+.+++++ +||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEEE
Confidence 57999999999999999999975 788999998532 3457789999999999 99999999998763 47899
Q ss_pred EEecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 135 MELCEGGELFDRIVARGH---YTERAAAAVTKTIVEVVQMCHK---HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~~l~~~L~~lH~---~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
|||+++++|.+++..... ++...++.++.|++.||.|||+ +||+||||||+||+++.++. .+||+|||++..
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~~kl~Dfg~~~~ 155 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT--VLKICDFGTACD 155 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--EEEECCCCC---
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--EEEEcccccccc
Confidence 999999999999986543 7899999999999999999999 89999999999999986543 279999999975
Q ss_pred cCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH--HHHHHHHhccccCCCCCCccCC
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ--GVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.... .....||+.|+|||++.+ .++.++||||||+++++|++|+.||...... .....+.. ...+.....++
T Consensus 156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 230 (307)
T 2eva_A 156 IQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN---GTRPPLIKNLP 230 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT---TCCCCCBTTCC
T ss_pred cccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc---CCCCCcccccC
Confidence 5322 234568999999999874 5899999999999999999999999754322 22222222 22333445789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+.++|.+||+.||++|||+.+++++|
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 9999999999999999999999998865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=340.47 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=198.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCC---CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE-cCCc
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE-DDTA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~-~~~~ 130 (315)
..|++.+.||+|+||+||+|.+..++ ..||+|.+... ......+.+.+|+.+++++ +||||+++++++. ..+.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC
Confidence 35889999999999999999875432 45899988643 2334567899999999999 8999999999875 4567
Q ss_pred EEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kL~DFG~a~~~ 242 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDM 242 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC---EEEeeccccccc
Confidence 899999999999999998653 4899999999999999999999999999999999999976554 999999999865
Q ss_pred CCCCc-----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 210 KPGEK-----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 210 ~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
..... .....+|+.|+|||++. ..++.++||||||+++|||++ |.+||......+....+..... ...+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~---~~~p~ 319 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---LLQPE 319 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC---CCCCT
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC---CCCCC
Confidence 33221 12345678899999986 568999999999999999999 7888877766666665555432 22334
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.+++.+.++|.+||+.||++|||+.+++++|
T Consensus 320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~L 350 (373)
T 3c1x_A 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 350 (373)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6889999999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=346.66 Aligned_cols=256 Identities=20% Similarity=0.256 Sum_probs=207.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+..+++++.+..++...+..
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~ 78 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN 78 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence 467889999999999999999999999999999998765432 234788999999995567777888888888899
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++....
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999999 8899999985 4569999999999999999999999999999999999999533344459999999998764
Q ss_pred CCCc--------ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHhccccCC-
Q 021233 211 PGEK--------FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETE---QGVAQAIIRSVLDFR- 277 (315)
Q Consensus 211 ~~~~--------~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~- 277 (315)
.... .....||+.|+|||++. ..++.++||||||+++|+|++|+.||..... ......+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 4322 12568999999999987 4589999999999999999999999976543 222222222211111
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
......+++++.+||..||+.||++||++.+|++.|
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L 273 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLF 273 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 111245789999999999999999999999988754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=352.06 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=211.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+|+.+ +|+||+++++++.. +..
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccc
Confidence 345689999999999999999999864 5679999987543 2346799999999999 99999999999876 678
Q ss_pred EEEEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 132 HLVMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~ 413 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLI 413 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCTTSTTTC
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc---EEEcccccceec
Confidence 9999999999999999643 45999999999999999999999999999999999999976554 999999999865
Q ss_pred CCCCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
..... .....++..|+|||++. +.++.++||||||+++|||++ |+.||......+....+.... +......++
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~---~~~~~~~~~ 490 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECP 490 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTCC
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 43211 12234677899999876 569999999999999999999 999999888877777766542 233445789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++.+||.+||+.||++|||+.+|++.|
T Consensus 491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L 518 (535)
T 2h8h_A 491 ESLHDLMCQCWRKEPEERPTFEYLQAFL 518 (535)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999999999999999998765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=329.52 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=205.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEE----CCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 52 EIEERYELGRELGRGEFGITYLCTD----RENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
...++|++++.||+|+||.||+|.+ ..+++.||+|.+... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYS 113 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe
Confidence 4456899999999999999999984 567899999998653 334456799999999999 89999999999876
Q ss_pred CC--cEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 128 DT--AVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 128 ~~--~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
.+ ..++||||+++++|.+++.... .+++..++.++.|++.||.+||+.||+||||||+||+++.++. ++|+|||
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~---~kL~Dfg 190 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFG 190 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCT
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc---EEEecCc
Confidence 43 7899999999999999998764 5999999999999999999999999999999999999987665 9999999
Q ss_pred cccccCCCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH------------HH--
Q 021233 205 LSVFFKPGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ------------GV-- 265 (315)
Q Consensus 205 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~------------~~-- 265 (315)
++......... ....++..|+|||.+. ..++.++||||||+++++|++|..||...... ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 99876544321 2345677899999986 45889999999999999999999988533111 00
Q ss_pred -HHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 -AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
....... .........+++++.++|.+||+.||++|||+.++++.|
T Consensus 271 ~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 271 HLIELLKN--NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp HHHHHHHT--TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhhc--CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0111111 112233457899999999999999999999999998765
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=341.98 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=197.6
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
..+.+.|.+.+.||+|+||+||.+. ..+|+.||+|++... ..+.+.+|+.++..+.+||||+++++++...+.
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 83 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF 83 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred hhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence 3456678888999999999998754 457999999988543 235678899999987689999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC----------
Q 021233 131 VHLVMELCEGGELFDRIVARGHY-------TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK---------- 193 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l-------~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~---------- 193 (315)
.++||||++ ++|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCC
Confidence 999999995 5999999865432 2234578999999999999999999999999999997643
Q ss_pred CCCCEEEEeeccccccCCCCc-----ccccccCCCccCchhhcc--------cCCCcchHHHHHHHHHHHhh-CCCCCCC
Q 021233 194 ETAPLKAIDFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLC-GVPPFWA 259 (315)
Q Consensus 194 ~~~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~~l~el~t-g~~p~~~ 259 (315)
....+||+|||++........ .....||+.|+|||++.+ .++.++|||||||+++||++ |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 344599999999987654321 234579999999998753 48899999999999999999 9999976
Q ss_pred CChHHHHHHHHhccccCCCC---CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 260 ETEQGVAQAIIRSVLDFRRD---PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..... ..+.......... ....+++++.+||.+||+.||.+|||+.++++|+||
T Consensus 243 ~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 243 KYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp TTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred chhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 54433 2333333222211 122356889999999999999999999999999997
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=341.34 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=195.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.+|++.+.||+|+||+||... ..+++.||||++..... ..+.+|+.+++.+.+||||+++++++......++|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~-~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRG-MFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEE-ESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEE-EeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 469999999999999866433 35689999999865432 22567999999987899999999999999999999
Q ss_pred EEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCEEEEeeccccccCC
Q 021233 135 MELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~--~~~~vkl~Dfg~a~~~~~ 211 (315)
|||+. ++|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++.++ ....+||+|||+|.....
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 99996 59999998654 355667789999999999999999999999999999996433 234488999999987653
Q ss_pred CC----cccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCc
Q 021233 212 GE----KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282 (315)
Q Consensus 212 ~~----~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (315)
.. ......||+.|+|||++. ..++.++|||||||++++|++ |..||........ ..+.............
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 254 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NILLGACSLDCLHPEK 254 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHHTTCCCCTTSCTTC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHHhccCCccccCccc
Confidence 32 234567999999999985 347889999999999999999 8999965544332 2222211111111122
Q ss_pred cCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 283 ~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+..+.+||.+||+.||.+|||+.++++|+||
T Consensus 255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 255 HEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp HHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred cccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 345668999999999999999999999999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=329.60 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=195.6
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhC-CCCCCcceeEEEEEc
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL-PKHQNIVCLKDTYED 127 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~h~~iv~~~~~~~~ 127 (315)
....+.++|++++.||+|+||.||+|.+. ++.||+|++... ....+..|.+++..+ .+||||+++++++..
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 34567789999999999999999999985 899999998533 123445555555543 289999999999987
Q ss_pred C----CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCceEeecCCCC
Q 021233 128 D----TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH--------GVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 128 ~----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~--------~iiH~dikp~Nill~~~~~~ 195 (315)
. ...++||||+++++|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~- 180 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT- 180 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC-
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC-
Confidence 7 7899999999999999999765 699999999999999999999998 9999999999999976654
Q ss_pred CCEEEEeeccccccCCCCcc-----cccccCCCccCchhhccc-CCCc------chHHHHHHHHHHHhhC----------
Q 021233 196 APLKAIDFGLSVFFKPGEKF-----SEIVGSPYYMAPEVLKRN-YGPE------VDVWSAGVILYILLCG---------- 253 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~------~Di~slG~~l~el~tg---------- 253 (315)
+||+|||++......... ....||+.|+|||++.+. .+.. +||||||+++|||++|
T Consensus 181 --~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 181 --CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp --EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred --EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999765433221 245799999999998643 4443 8999999999999999
Q ss_pred CCCCCCCCh----HHHHHHHHhccccCCCCCC-----ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 254 VPPFWAETE----QGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 254 ~~p~~~~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..||..... ........... ...+... ..+++++.+||.+||+.||++|||+.+++++|
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCIK-KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTS-CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhhh-ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 677754321 11222222111 1111111 14567899999999999999999999999876
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=359.93 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=210.4
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc------
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------ 127 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------ 127 (315)
.++|++.+.||+|+||+||+|.+..+|+.||+|++... ......+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccC
Confidence 36899999999999999999999999999999988654 2344567799999999999 99999999998765
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeec
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG---HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG 204 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg 204 (315)
.+..++||||++|++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++.++....++|+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 677899999999999999998654 58999999999999999999999999999999999999987776668999999
Q ss_pred cccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH---------HH-----
Q 021233 205 LSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ---------AI----- 269 (315)
Q Consensus 205 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~---------~~----- 269 (315)
.+.............||+.|+|||++. ..++.++||||||+++|+|++|..||.......... .+
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 998876665556678999999999987 568999999999999999999999997643321100 00
Q ss_pred Hhccc------cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 270 IRSVL------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 270 ~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..... ..+......+++.+.++|..||..||++|||+.+++.|+||
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F 301 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHH
Confidence 00000 01111233467899999999999999999999999999997
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=331.45 Aligned_cols=246 Identities=20% Similarity=0.249 Sum_probs=195.3
Q ss_pred ccccceeeeeeeeeecceEEEEEE-----ECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCC--CCCcceeEEE
Q 021233 52 EIEERYELGRELGRGEFGITYLCT-----DRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--HQNIVCLKDT 124 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--h~~iv~~~~~ 124 (315)
...++|++.+.||+|+||+||+|. +..+++.||+|++... ....+..|+.+++.+.. |+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 345689999999999999999994 5677999999998643 24568888999888832 8999999999
Q ss_pred EEcCCcEEEEEEecCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeec--------
Q 021233 125 YEDDTAVHLVMELCEGGELFDRIVA-----RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFAN-------- 191 (315)
Q Consensus 125 ~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~-------- 191 (315)
+...+..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999999974 446999999999999999999999999999999999999976
Q ss_pred CCCCCCEEEEeeccccccC---CCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH
Q 021233 192 KKETAPLKAIDFGLSVFFK---PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ 267 (315)
Q Consensus 192 ~~~~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~ 267 (315)
+.....+||+|||+|.... .........||+.|+|||++.+ .++.++||||||+++|||++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 1224459999999996542 3334456789999999999874 489999999999999999999999854322100
Q ss_pred HHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCC-CHHHHhc
Q 021233 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRL-TAQQVLG 311 (315)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp-s~~e~l~ 311 (315)
.....+.. ...++.+.+++..||+.+|.+|+ ++.++.+
T Consensus 294 ---~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 294 ---KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ---EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred ---eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 00001111 12467889999999999999995 5555443
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=327.19 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=202.8
Q ss_pred CccccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhC-CCCCCcceeEEEEEc
Q 021233 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL-PKHQNIVCLKDTYED 127 (315)
Q Consensus 49 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~h~~iv~~~~~~~~ 127 (315)
.+..+.++|++.+.||+|+||.||+|.+. ++.||+|++... ....+.+|++++..+ .+||||+++++++..
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34567789999999999999999999984 899999998543 245678899998883 289999999999987
Q ss_pred CC----cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCceEeecCCCC
Q 021233 128 DT----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH--------KHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 128 ~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH--------~~~iiH~dikp~Nill~~~~~~ 195 (315)
.. ..++||||+++++|.+++... .+++..++.++.|++.||.||| +.||+||||||+|||++.++.
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~- 185 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT- 185 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC-
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC-
Confidence 75 799999999999999999764 6999999999999999999999 899999999999999976654
Q ss_pred CCEEEEeeccccccCCCCc-----ccccccCCCccCchhhccc-------CCCcchHHHHHHHHHHHhhC----------
Q 021233 196 APLKAIDFGLSVFFKPGEK-----FSEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCG---------- 253 (315)
Q Consensus 196 ~~vkl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~Di~slG~~l~el~tg---------- 253 (315)
+||+|||++........ .....||+.|+|||++.+. ++.++||||||+++|+|++|
T Consensus 186 --~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 186 --CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp --EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred --EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999976544332 2445789999999998643 23689999999999999999
Q ss_pred CCCCCCCC-----hHHHHHHHHhccccCCCCCC-----ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 254 VPPFWAET-----EQGVAQAIIRSVLDFRRDPW-----PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 254 ~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..||.... .......+..... ++... ..+++.+.+||.+||+.||++|||+.+++++|
T Consensus 264 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRKVVCEQKL--RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCC--CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccCccccCcCcccHHHHHHHHHHHHh--CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 78886542 2222233322211 11111 13446799999999999999999999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=350.72 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=209.9
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCC---CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
...++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++. +
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-E 462 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-S
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-c
Confidence 3456899999999999999999998643 4569999876432 334457799999999999 9999999999985 4
Q ss_pred CcEEEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 TAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
+..++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~---vkL~DFG~a~ 539 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSR 539 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCCCCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC---EEEEecCCCe
Confidence 56899999999999999998654 5899999999999999999999999999999999999987665 9999999998
Q ss_pred ccCCCCcc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 208 FFKPGEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 208 ~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
........ ....+|+.|+|||++. ..++.++||||||+++|||++ |..||......+....+..... ...++.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~ 616 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---LPMPPN 616 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC---CCCCTT
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC---CCCCcc
Confidence 76443322 2345678999999986 568999999999999999997 9999998888777777765432 233456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++.+.++|.+||+.||++|||+.++++.|
T Consensus 617 ~~~~l~~li~~~l~~dP~~RPs~~el~~~L 646 (656)
T 2j0j_A 617 CPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646 (656)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 899999999999999999999999998865
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=329.59 Aligned_cols=252 Identities=20% Similarity=0.327 Sum_probs=207.4
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
...++|++.+.||+|+||.||+|.+.. .+|+|++..... .....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCce
Confidence 335689999999999999999999853 499999875432 223345677899999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+||+++ ++ .++|+|||++....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~---~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG---KVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC---CEEEeecCCccccc
Confidence 99999999999999997654 599999999999999999999999999999999999996 23 48999999986542
Q ss_pred C------CCcccccccCCCccCchhhcc----------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccc
Q 021233 211 P------GEKFSEIVGSPYYMAPEVLKR----------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL 274 (315)
Q Consensus 211 ~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 274 (315)
. ........||+.|+|||++.. .++.++||||||+++++|++|..||...........+.....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 1 122234568999999998753 368899999999999999999999988887777666655432
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
.. .....+++++.++|.+||+.||++|||+.++++.|.
T Consensus 261 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 261 PN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp CC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred CC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 22 222357899999999999999999999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=326.01 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=187.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHH--HhCCCCCCcceeEEEEEc----
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIM--RHLPKHQNIVCLKDTYED---- 127 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l--~~l~~h~~iv~~~~~~~~---- 127 (315)
-++|++++.||+|+||.||+|.+ +++.||+|++.... ...+..|..++ ..+ +||||+++++.+..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTAD 82 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTT
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhc-cCcchhhheecccccccC
Confidence 46799999999999999999987 48999999986432 23444454444 446 89999999986542
Q ss_pred -CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCceEeecCCCCCC
Q 021233 128 -DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH---------GVMHRDLKPENFLFANKKETAP 197 (315)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~---------~iiH~dikp~Nill~~~~~~~~ 197 (315)
....++||||+++++|.+++... ..++..++.++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--- 158 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--- 158 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC---
T ss_pred CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc---
Confidence 33578999999999999999765 468999999999999999999999 9999999999999976554
Q ss_pred EEEEeeccccccCCCC---------cccccccCCCccCchhhcc--------cCCCcchHHHHHHHHHHHhhCCCCCCCC
Q 021233 198 LKAIDFGLSVFFKPGE---------KFSEIVGSPYYMAPEVLKR--------NYGPEVDVWSAGVILYILLCGVPPFWAE 260 (315)
Q Consensus 198 vkl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~--------~~~~~~Di~slG~~l~el~tg~~p~~~~ 260 (315)
+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999998654321 1234579999999999864 3567899999999999999997766332
Q ss_pred Ch-----------------HHHHHHHHhccccCCCCCC------ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 261 TE-----------------QGVAQAIIRSVLDFRRDPW------PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 261 ~~-----------------~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.. ........... ..++... ..+++++.+||.+||+.||++|||+.|+++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSRE-KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTS-CCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhccc-ccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 11 11111111111 1111111 12445799999999999999999999998765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=318.45 Aligned_cols=234 Identities=14% Similarity=0.078 Sum_probs=191.2
Q ss_pred CCcc-ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 48 PTGR-EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 48 ~~~~-~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
..|. .+.++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++..+ +||||+++++++.
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVH 101 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEE
Confidence 3444 6778999999999999999999999999999999999876554455567899999999999 9999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 127 DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
..+..|+||||++|++|.+++... .....+..++.|++.||.|||++||+||||||+|||++.++. +||++++
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~---~kl~~~~-- 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD---VVLAYPA-- 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC---EEECSCC--
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC---EEEEecc--
Confidence 999999999999999999998543 456678899999999999999999999999999999987665 7887433
Q ss_pred cccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHH---HHHhccccCCCCCCcc
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQ---AIIRSVLDFRRDPWPK 283 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 283 (315)
|++| ++.++||||||+++|+|++|+.||.......... ..............+.
T Consensus 175 -----------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T 3uqc_A 175 -----------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRD 231 (286)
T ss_dssp -----------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTT
T ss_pred -----------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccC
Confidence 3333 6789999999999999999999997654422110 0001100000112346
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++++.++|.+||+.||++| |+.++++.|
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 89999999999999999999 999999865
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=350.45 Aligned_cols=243 Identities=25% Similarity=0.374 Sum_probs=199.5
Q ss_pred CCccccccceeeeeeeeeecceEEEEEEECC-CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 48 PTGREIEERYELGRELGRGEFGITYLCTDRE-NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 48 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
+.+..+.++|++++.||+|+||+||+|.+.. +++.||+|++... ........+.+|+.++..+ +||||+++++++.
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVE 149 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEe
Confidence 4567788999999999999999999999976 6899999988643 2334456788999999999 8999999999998
Q ss_pred cCCc-----EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEE
Q 021233 127 DDTA-----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 127 ~~~~-----~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
..+. .|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----~~kl~ 223 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----QLKLI 223 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS----CEEEC
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC----cEEEE
Confidence 7655 7999999999999987755 69999999999999999999999999999999999999753 48999
Q ss_pred eeccccccCCCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 202 DFGLSVFFKPGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
|||++...... ....||+.|+|||++.+.++.++||||||+++++|++|..||...... . .. .....
T Consensus 224 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~-~~-~~~~~ 290 (681)
T 2pzi_A 224 DLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------G-LP-EDDPV 290 (681)
T ss_dssp CCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS--------S-CC-TTCHH
T ss_pred ecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc--------c-cc-ccccc
Confidence 99999876433 456799999999998877799999999999999999999888542111 0 00 01111
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcc
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~ 312 (315)
...++.+.++|.+||+.||++||+..+.+.+
T Consensus 291 ~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 321 (681)
T 2pzi_A 291 LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA 321 (681)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence 2346789999999999999999987666654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=332.61 Aligned_cols=245 Identities=17% Similarity=0.217 Sum_probs=189.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-CCcce-------------
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVC------------- 120 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~------------- 120 (315)
+.|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.+ .| +|...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhh
Confidence 4588999999999999999999999999999998755444445567899999999998 54 32211
Q ss_pred --------eEEEEEc-----CCcEEEEEEecCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 021233 121 --------LKDTYED-----DTAVHLVMELCEGGELFDRIVA-------RGHYTERAAAAVTKTIVEVVQMCHKHGVMHR 180 (315)
Q Consensus 121 --------~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~-------~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~ 180 (315)
+..++.. ....+++|+++ +++|.+++.. ...+++..++.++.|++.||.|||++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111 22467777776 6799988852 2237788999999999999999999999999
Q ss_pred CCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCccCchhh----------c-ccCCCcchHHHHHHHHHH
Q 021233 181 DLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL----------K-RNYGPEVDVWSAGVILYI 249 (315)
Q Consensus 181 dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~-~~~~~~~Di~slG~~l~e 249 (315)
||||+|||++.++. +||+|||+++..... .....| +.|+|||++ . ..++.++|||||||++|+
T Consensus 236 DiKp~NILl~~~~~---~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 236 YLRPVDIVLDQRGG---VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCCGGGEEECTTCC---EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCCe---EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 99999999987666 999999998865332 445577 999999988 3 237889999999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 250 LLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 250 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|++|+.||...........+ ...+..+|+++.+||.+||+.||++|||+.++++|+||
T Consensus 310 lltg~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~ 367 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWI--------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 367 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGG--------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred HHHCCCCCCCcchhhhHHHH--------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 99999999765443222211 11234678999999999999999999999999999886
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=332.30 Aligned_cols=250 Identities=16% Similarity=0.212 Sum_probs=195.0
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc-----ChhcHHHHHHHHHHHHhCC--------CCCCcce
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----TAVDIEDVRREVDIMRHLP--------KHQNIVC 120 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~--------~h~~iv~ 120 (315)
.++|++++.||+|+||+||+|++ +|+.||+|++...... .....+.+.+|+.+++.+. .||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999998 5899999999765322 2233477899999999884 3777777
Q ss_pred eEEEEE------------------------------cCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 021233 121 LKDTYE------------------------------DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170 (315)
Q Consensus 121 ~~~~~~------------------------------~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~ 170 (315)
+.+.+. ..+..++||||+++|++.+.+.. ..+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 777643 26789999999999987776644 46899999999999999999
Q ss_pred HHH-HCCceecCCCCCceEeecCCC-----------------CCCEEEEeeccccccCCCCcccccccCCCccCchhhcc
Q 021233 171 MCH-KHGVMHRDLKPENFLFANKKE-----------------TAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232 (315)
Q Consensus 171 ~lH-~~~iiH~dikp~Nill~~~~~-----------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 232 (315)
||| ++||+||||||+|||++.++. ...+||+|||+|+..... ...||+.|+|||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 999999999999999987651 125999999999876432 4489999999999987
Q ss_pred cCCCcchHHHHHHH-HHHHhhCCCCCCCCCh-HHHHHHHHhccccCC---CCCCccCCHHHHHHHHHhcCCCcCCCCCHH
Q 021233 233 NYGPEVDVWSAGVI-LYILLCGVPPFWAETE-QGVAQAIIRSVLDFR---RDPWPKVSENAKDLVRKMLDPDPKRRLTAQ 307 (315)
Q Consensus 233 ~~~~~~Di~slG~~-l~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rps~~ 307 (315)
..+.++|||||+++ .+++++|..||..... ......+........ ...++.+++++.+||.+||+.| |+.
T Consensus 252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~ 326 (336)
T 2vuw_A 252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT 326 (336)
T ss_dssp CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence 77889999998887 6678889999843211 112222222111111 1113357889999999999976 999
Q ss_pred HHh-cccCC
Q 021233 308 QVL-GKIEF 315 (315)
Q Consensus 308 e~l-~~l~f 315 (315)
|+| +|+||
T Consensus 327 e~l~~Hp~f 335 (336)
T 2vuw_A 327 DLLCQHSLF 335 (336)
T ss_dssp HHHHHCGGG
T ss_pred HHHhcCCCc
Confidence 999 99998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=284.52 Aligned_cols=186 Identities=18% Similarity=0.169 Sum_probs=135.1
Q ss_pred eeeeecceEEEEEEECCCCCEEEEEEccccccc-------ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 62 ELGRGEFGITYLCTDRENGDAFACKSISKKKLR-------TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 62 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
.++.|+.|.+..++..-.|+.+++|++.+.... ...+.+++.+|+++|+++..|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456677777777766667999999998754321 2234567999999999998899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-C
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG-E 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~-~ 213 (315)
|||++|++|.+.+...++++.. .|+.||+.||+|+|++|||||||||+|||++.++. +||+|||+|+..... .
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~---vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH---ARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC---EEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC---EEEeecccCeeCCCCCc
Confidence 9999999999999998888765 47899999999999999999999999999987665 999999999876443 3
Q ss_pred cccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhC
Q 021233 214 KFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCG 253 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg 253 (315)
...+.+||+.|+|||++.+.+..++|+||+|++++++.++
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-----------------CCCCTT
T ss_pred cccCceechhhccHHHhCCCCCCcccccccccchhhhccc
Confidence 3456789999999999998888899999999998766554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-30 Score=243.94 Aligned_cols=184 Identities=22% Similarity=0.198 Sum_probs=144.7
Q ss_pred eeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh-----hcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA-----VDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
...+.||+|+||+||+|.. .+..+++|.......... ...+++.+|+.+++++ +||||+++..++...+..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccE
Confidence 4467899999999999954 478899998654333221 1245689999999999 9999996666666777789
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|+.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCCc
Confidence 99999999999998865 5689999999999999999999999999999975 5999999999987543
Q ss_pred Cc--------ccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCC
Q 021233 213 EK--------FSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPF 257 (315)
Q Consensus 213 ~~--------~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~ 257 (315)
.. .....||+.|+|||++.. .|+..+|+||..+-.++-..++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22 135689999999999863 4788899999999998888877766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=202.90 Aligned_cols=147 Identities=22% Similarity=0.296 Sum_probs=115.2
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh---------------hcHHHHHHHHHHHHhCCCCCCcce
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA---------------VDIEDVRREVDIMRHLPKHQNIVC 120 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~~h~~iv~ 120 (315)
.|++.+.||+|+||.||+|.+ .+|+.||+|.+........ .....+.+|+.+++++ + | ++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~ 165 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LA 165 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CC
Confidence 356669999999999999999 7899999999864322111 1346789999999999 4 4 56
Q ss_pred eEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEE
Q 021233 121 LKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKA 200 (315)
Q Consensus 121 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl 200 (315)
+.+++.. +..++||||++|++|.+ +. ......++.|++.||.|||+.||+||||||+|||++ ++. ++|
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~---vkl 233 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG---IWI 233 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE---EEE
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc---EEE
Confidence 6665544 45699999999999988 41 133557999999999999999999999999999998 444 899
Q ss_pred EeeccccccCCCCcccccccCCCccCchhhc
Q 021233 201 IDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231 (315)
Q Consensus 201 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 231 (315)
+|||+|+.. ..++|||.+.
T Consensus 234 ~DFG~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 234 IDFPQSVEV------------GEEGWREILE 252 (282)
T ss_dssp CCCTTCEET------------TSTTHHHHHH
T ss_pred EECCCCeEC------------CCCCHHHHHH
Confidence 999999742 3468888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=175.89 Aligned_cols=141 Identities=16% Similarity=0.167 Sum_probs=107.4
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCE--EEEEEccccccc--C-------------------hhcHHHHHHHHHHHHhC
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLR--T-------------------AVDIEDVRREVDIMRHL 112 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~a~K~~~~~~~~--~-------------------~~~~~~~~~e~~~l~~l 112 (315)
-|++.+.||+|+||.||+|.+..+|+. ||+|++...... . ......+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999998667888 999987543211 0 01123678899999999
Q ss_pred CCCCCc--ceeEEEEEcCCcEEEEEEecCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCC
Q 021233 113 PKHQNI--VCLKDTYEDDTAVHLVMELCEG-G----ELFDRIVARGHYTERAAAAVTKTIVEVVQMCH-KHGVMHRDLKP 184 (315)
Q Consensus 113 ~~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH-~~~iiH~dikp 184 (315)
.|+++ +.+++. +..++||||+.+ | +|.+.... .++..+..++.|++.+|.+|| +.||+||||||
T Consensus 128 -~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 -KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp -HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred -HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 67653 444443 356899999942 3 66655422 235567899999999999999 99999999999
Q ss_pred CceEeecCCCCCCEEEEeecccccc
Q 021233 185 ENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 185 ~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~-----~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID-----KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS-----SEEECCCTTCEET
T ss_pred HHEEEcC-----cEEEEECcccccC
Confidence 9999974 4899999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.9e-20 Score=165.46 Aligned_cols=142 Identities=18% Similarity=0.244 Sum_probs=101.6
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEccccccc-----------ChhcHH--------HHHHHHHHHHhCCCCCC
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR-----------TAVDIE--------DVRREVDIMRHLPKHQN 117 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-----------~~~~~~--------~~~~e~~~l~~l~~h~~ 117 (315)
|++...||.|++|.||+|.+. +|+.||+|++...... ...... ...+|...|.++ .+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 999999999999999999974 6999999987543211 000111 123567777777 3333
Q ss_pred cc--eeEEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCC
Q 021233 118 IV--CLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKET 195 (315)
Q Consensus 118 iv--~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~ 195 (315)
+. ..++. . ..++||||++|++|.++. .......++.|++.+|.+||+.|||||||||.|||++.++..
T Consensus 175 v~vp~p~~~--~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ--S--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE--E--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec--c--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 32 22322 1 237999999998886542 223456788999999999999999999999999999876531
Q ss_pred -------CCEEEEeeccccccC
Q 021233 196 -------APLKAIDFGLSVFFK 210 (315)
Q Consensus 196 -------~~vkl~Dfg~a~~~~ 210 (315)
..+.|+||+.+....
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 126899999887544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=2.3e-14 Score=121.37 Aligned_cols=141 Identities=18% Similarity=0.166 Sum_probs=111.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
..|++...++.|+.+.||++... +..+++|....... .....+.+|+.+++.+..+..++++++++...+..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 45888899999999999999743 68999998764321 11245889999999996677788999999988899999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK---------------------------------------- 174 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~---------------------------------------- 174 (315)
|||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876531 222345788899999999998
Q ss_pred -------------------CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 175 -------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 175 -------------------~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++|+|++|.|||++.+ ..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~---~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG---KVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT---EEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC---cEEEEEEchhccc
Confidence 448999999999999642 2256999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.39 E-value=7.7e-13 Score=111.59 Aligned_cols=135 Identities=14% Similarity=0.154 Sum_probs=97.0
Q ss_pred ceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC-cceeEEEEEcCCcEEEE
Q 021233 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN-IVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~-iv~~~~~~~~~~~~~lv 134 (315)
.|.+....+.|..+.||++.. .+|..+++|..... ....+.+|+.+++.+..+.- +++++++....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 466544444566699999864 45778999986532 12457889999999844422 56789988888889999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------------
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG-------------------------------------- 176 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~-------------------------------------- 176 (315)
|||++|.+|. .. ... ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999998883 11 122 2256677777777777643
Q ss_pred --------------------ceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 177 --------------------VMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 177 --------------------iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
++|+|++|.||+++.+. .+.|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~---~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR---FSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE---EEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc---EEEEEcchhccc
Confidence 99999999999996432 256999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.34 E-value=4e-12 Score=112.60 Aligned_cols=144 Identities=19% Similarity=0.317 Sum_probs=106.0
Q ss_pred eeeeeeeecceEEEEEEECCCCCEEEEEEcc--cccccChhcHHHHHHHHHHHHhCCC-CCCcceeEEEEEcC---CcEE
Q 021233 59 LGRELGRGEFGITYLCTDRENGDAFACKSIS--KKKLRTAVDIEDVRREVDIMRHLPK-HQNIVCLKDTYEDD---TAVH 132 (315)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~--~~~~~~~~~~~~~~~e~~~l~~l~~-h~~iv~~~~~~~~~---~~~~ 132 (315)
.++.|+.|.++.||++... +..+++|... ..... .....+.+|+.+++.+.. +..+++++.++... +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4677899999999998754 5688888765 32211 123468889999999943 34578888888766 4589
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-------------------------------------- 174 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-------------------------------------- 174 (315)
+||||++|.++.+.. ...++......++.+++.+|..||+
T Consensus 118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999999998875421 1236788888999999999999997
Q ss_pred --------------------CCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 175 --------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 175 --------------------~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
..++|+|++|.|||++.++. ..+.|+||+.+...
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~-~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP-RVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS-CEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC-cEEEEECccccccC
Confidence 35899999999999976543 23589999988754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.29 E-value=7.1e-12 Score=108.41 Aligned_cols=185 Identities=18% Similarity=0.230 Sum_probs=123.9
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCC--cceeEEEEEcCC---cEEEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQN--IVCLKDTYEDDT---AVHLV 134 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~--iv~~~~~~~~~~---~~~lv 134 (315)
++.++.|....||++. ..+++|..... .....+.+|+.+++.+..+.. +++++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999863 46888875322 234678999999998844433 345555543333 35899
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK---------------------------------------- 174 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~---------------------------------------- 174 (315)
|++++|.+|.+.... .++......++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999999988764432 47788888888999998888886
Q ss_pred ------------------CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccccccCCCccCchhhc---cc
Q 021233 175 ------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK---RN 233 (315)
Q Consensus 175 ------------------~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~ 233 (315)
..++|+|++|.||+++.+. ...+.|+||+.+.......+.........-.+|+... ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~-~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK-NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT-TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC-CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 1369999999999998641 2236899999987654322221111110002333211 11
Q ss_pred CC------------CcchHHHHHHHHHHHhhCCCCC
Q 021233 234 YG------------PEVDVWSAGVILYILLCGVPPF 257 (315)
Q Consensus 234 ~~------------~~~Di~slG~~l~el~tg~~p~ 257 (315)
|. ...+.|+++.+++.+.+|..+|
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 1258999999999999998876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=4.9e-09 Score=88.78 Aligned_cols=134 Identities=17% Similarity=0.210 Sum_probs=97.8
Q ss_pred eeeeecce-EEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecCC
Q 021233 62 ELGRGEFG-ITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEG 140 (315)
Q Consensus 62 ~lg~G~~g-~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 140 (315)
.+..|..+ .||+......+..+++|.-... ....+.+|+..|+.+..+--+.+++.++...+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445554 7999887767788999975422 2456889999999986554577899999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 021233 141 GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK---------------------------------------------- 174 (315)
Q Consensus 141 ~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~---------------------------------------------- 174 (315)
.++.+..... ......+..+++..|..||+
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8887765432 22234556666666666664
Q ss_pred ------------CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 175 ------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 175 ------------~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++|+|+.+.|||++.++. +-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~---~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKL---IGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEE---EEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeE---EEEEECccccc
Confidence 12799999999999975332 56999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=1.5e-08 Score=87.54 Aligned_cols=140 Identities=19% Similarity=0.245 Sum_probs=96.5
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC--CcceeEEEEE-cCCcEEEEEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ--NIVCLKDTYE-DDTAVHLVME 136 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~iv~~~~~~~-~~~~~~lv~e 136 (315)
++.++.|....||+. +..+++|... .......+.+|+.+|+.+..+- .+++++.+.. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456888988999987 5678888742 2233467899999999995432 3567777774 4566889999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 021233 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH----------------------------------------- 175 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~----------------------------------------- 175 (315)
+++|.++.+.... .++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9999888763221 244555555555555555555542
Q ss_pred -------------------CceecCCCCCceEeecCCCCCC-EEEEeeccccccCC
Q 021233 176 -------------------GVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKP 211 (315)
Q Consensus 176 -------------------~iiH~dikp~Nill~~~~~~~~-vkl~Dfg~a~~~~~ 211 (315)
.++|+|++|.||+++.++.... +.|+||+.+....+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~ 227 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDP 227 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECG
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCH
Confidence 3599999999999976322223 47999998876543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=1.3e-07 Score=84.66 Aligned_cols=81 Identities=19% Similarity=0.188 Sum_probs=51.0
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccc----cChhcHHHHHHHHHHHHhCCCC-CC-cceeEEEEEcCCcEEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL----RTAVDIEDVRREVDIMRHLPKH-QN-IVCLKDTYEDDTAVHL 133 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~~~~e~~~l~~l~~h-~~-iv~~~~~~~~~~~~~l 133 (315)
.+.||.|..+.||++....+++.+++|....... ......+++..|+.+++.+... +. +++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5679999999999997655578899997643211 0012235677899998887432 33 4455543 3345689
Q ss_pred EEEecCCCC
Q 021233 134 VMELCEGGE 142 (315)
Q Consensus 134 v~e~~~~~s 142 (315)
|||+++|..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999997743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=9.5e-08 Score=84.22 Aligned_cols=87 Identities=9% Similarity=0.074 Sum_probs=57.0
Q ss_pred eeeeee-eeecceEEEEEEEC--C----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC--CCcceeEEEEEcC
Q 021233 58 ELGREL-GRGEFGITYLCTDR--E----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDD 128 (315)
Q Consensus 58 ~~~~~l-g~G~~g~Vy~~~~~--~----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~~ 128 (315)
...+.| +.|..+.+|++... . ++..+++|...............+.+|+.+++.+..+ -.+++++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 78888999998653 1 1567889976543200000113577888888888544 2467788887655
Q ss_pred ---CcEEEEEEecCCCChH
Q 021233 129 ---TAVHLVMELCEGGELF 144 (315)
Q Consensus 129 ---~~~~lv~e~~~~~sL~ 144 (315)
+..++|||+++|.++.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3578999999986653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.31 E-value=9.8e-06 Score=70.56 Aligned_cols=75 Identities=12% Similarity=0.123 Sum_probs=42.8
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC-CCcceeEE------EEEcCCcEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH-QNIVCLKD------TYEDDTAVH 132 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h-~~iv~~~~------~~~~~~~~~ 132 (315)
++.|+.|..+.||++... +..+++|..... ...+..|+.+++.|..+ -.+++++. +....+..+
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 455666778999998764 345899987642 13344555555555211 12344443 123456789
Q ss_pred EEEEecCCCCh
Q 021233 133 LVMELCEGGEL 143 (315)
Q Consensus 133 lv~e~~~~~sL 143 (315)
++|+|++|.++
T Consensus 108 ~l~~~i~G~~~ 118 (346)
T 2q83_A 108 VVYDWIEGRPF 118 (346)
T ss_dssp EEEECCCCBCC
T ss_pred EEEEeecCccC
Confidence 99999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.29 E-value=4.9e-06 Score=74.96 Aligned_cols=77 Identities=8% Similarity=0.010 Sum_probs=46.5
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccc--cC----hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL--RT----AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~--~~----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
++.||.|..+.||++.. ++..+++|....... .. ......+..|+..+..-.....+++++.+. .+..++
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 56789999999999964 467899995432110 00 012233444444333211234566777765 456799
Q ss_pred EEEec-CC
Q 021233 134 VMELC-EG 140 (315)
Q Consensus 134 v~e~~-~~ 140 (315)
|||++ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 77
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.20 E-value=8e-06 Score=70.39 Aligned_cols=77 Identities=18% Similarity=0.142 Sum_probs=60.7
Q ss_pred eeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCC--CCcceeEEEEEcCCcEEEEEE
Q 021233 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~~~~~~lv~e 136 (315)
-.+.|+.|....+|+... ++..+++|..... ....+..|+..|+.|... ..+++++.+....+..++|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 356789999999999874 4678889976432 246788999999888433 567889999888888999999
Q ss_pred ecCCCCh
Q 021233 137 LCEGGEL 143 (315)
Q Consensus 137 ~~~~~sL 143 (315)
|++|.++
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.14 E-value=3.4e-05 Score=65.62 Aligned_cols=81 Identities=14% Similarity=0.015 Sum_probs=57.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC--CcceeEEEEEcCCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ--NIVCLKDTYEDDTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~--~iv~~~~~~~~~~~~~ 132 (315)
....-++.+|.|..+.||++.. .+|+.|++|+..... ......+..|+..|+.|.+.. -+++++++. ..+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~---~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA---PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC---CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC---cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 4566678899999999999986 468999999865332 122245788999999885432 245555542 237
Q ss_pred EEEEecCCCCh
Q 021233 133 LVMELCEGGEL 143 (315)
Q Consensus 133 lv~e~~~~~sL 143 (315)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.11 E-value=4.3e-05 Score=61.36 Aligned_cols=136 Identities=14% Similarity=0.040 Sum_probs=89.9
Q ss_pred CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcccc
Q 021233 140 GGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE 217 (315)
Q Consensus 140 ~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~~~ 217 (315)
..||.+.|.. ..+++++++|.++.|.+.+|..+-. ..-..+=+.|..|++..+|. |.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~---V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA---VTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC---EEECC-C-------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc---eeccc-cccc----------
Confidence 4589999875 4579999999999999999887632 22223445568899987776 54432 1110
Q ss_pred cccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcC
Q 021233 218 IVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLD 297 (315)
Q Consensus 218 ~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 297 (315)
.....+.+||......+.+.-|||||+++|..+--..|- .-...+++.|.+||..|..
T Consensus 98 -~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~e---------------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 98 -AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLKE---------------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp ----------CCSSSSSCHHHHHHHHHHHHHHHHTTTCCT---------------------TEEECCCHHHHHHHHHHTT
T ss_pred -ccccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCCc---------------------ccchhhCHHHHHHHHHHHh
Confidence 111235677776545677889999999999887644331 1123578999999999986
Q ss_pred C-------------------------CcCCCCCHHHHhc
Q 021233 298 P-------------------------DPKRRLTAQQVLG 311 (315)
Q Consensus 298 ~-------------------------~P~~Rps~~e~l~ 311 (315)
. .+..|++..+|++
T Consensus 156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp CCC--------------------CCSCCCCCCSHHHHHH
T ss_pred cccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 6 3468899988875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.05 E-value=1.1e-05 Score=69.23 Aligned_cols=73 Identities=10% Similarity=-0.060 Sum_probs=45.9
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec-
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC- 138 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~- 138 (315)
++.|+.|....+|++ ..+++|+...... .. ....+|+.+++.+..+.-.+++++.. .+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~---~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE-EY---INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----C---CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc-ce---eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678988999999998 4588887754311 11 11345777777764333335666543 33346899999
Q ss_pred CCCChH
Q 021233 139 EGGELF 144 (315)
Q Consensus 139 ~~~sL~ 144 (315)
+|.++.
T Consensus 91 ~g~~l~ 96 (301)
T 3dxq_A 91 GAQTMS 96 (301)
T ss_dssp TCEECC
T ss_pred CCccCC
Confidence 776553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2e-05 Score=69.72 Aligned_cols=145 Identities=11% Similarity=0.100 Sum_probs=85.2
Q ss_pred ceeeeeeeeeecceEEEEEEECC-------CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 56 RYELGRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
..+ ++.|..|-...+|++.... ++..+++++.... ........+|..+++.|..+.-.+++++.+.+
T Consensus 52 ~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 52 ELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp GCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred ceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 344 3567678888899988642 3578999986332 12345667899999888555555677776654
Q ss_pred CcEEEEEEecCCCChHH--------------HH---Hhc----C-CCC--HHHHHHHHHHHHH-----------------
Q 021233 129 TAVHLVMELCEGGELFD--------------RI---VAR----G-HYT--ERAAAAVTKTIVE----------------- 167 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~--------------~l---~~~----~-~l~--~~~~~~i~~~l~~----------------- 167 (315)
.+||||++|.+|.. .+ ... + ... +.++..+..++..
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 29999999866531 11 111 0 111 3444555444321
Q ss_pred --HHHHHH----H----CCceecCCCCCceEeecCC-CCCCEEEEeecccccc
Q 021233 168 --VVQMCH----K----HGVMHRDLKPENFLFANKK-ETAPLKAIDFGLSVFF 209 (315)
Q Consensus 168 --~L~~lH----~----~~iiH~dikp~Nill~~~~-~~~~vkl~Dfg~a~~~ 209 (315)
.+..|. . ..++|+|+.+.|||++.+. ....+.|+||..+...
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 233332 2 2489999999999998651 1234899999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.86 E-value=4.2e-05 Score=69.02 Aligned_cols=75 Identities=13% Similarity=0.083 Sum_probs=51.6
Q ss_pred eeeeeeecceEEEEEEECC-------CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 60 GRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
++.|+.|....||++.... ++..+++|+.... ...+.+..|+.+++.|..+.-.+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 5678888889999998653 2578999987321 1114456799999988555444677776543 3
Q ss_pred EEEEecCCCCh
Q 021233 133 LVMELCEGGEL 143 (315)
Q Consensus 133 lv~e~~~~~sL 143 (315)
+|+||++|.+|
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.86 E-value=2.5e-05 Score=67.50 Aligned_cols=139 Identities=17% Similarity=0.169 Sum_probs=76.9
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeEEE------EEcCCcEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDT------YEDDTAVH 132 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~------~~~~~~~~ 132 (315)
++.|+.|....+|++... +..+++|..... ...+.+..|+.++..+..+. .+++++.. ....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 456777888999998764 336889987542 11234667777777763321 13333321 12345678
Q ss_pred EEEEecCCCChHH----H----------HHh-cCC--------CCHHHHHH---------------HHHHHHHHHHHHHH
Q 021233 133 LVMELCEGGELFD----R----------IVA-RGH--------YTERAAAA---------------VTKTIVEVVQMCHK 174 (315)
Q Consensus 133 lv~e~~~~~sL~~----~----------l~~-~~~--------l~~~~~~~---------------i~~~l~~~L~~lH~ 174 (315)
++++|++|.++.. . +.. ... ........ +...+...+..++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999999865421 0 111 001 11110000 01113444555553
Q ss_pred -------CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 175 -------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 175 -------~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
.+++|+|+.+.|||++.+.. +.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~---~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDEL---SGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEE---EEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCce---EEEecchhccC
Confidence 36999999999999975322 47999998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.71 E-value=7.1e-05 Score=65.02 Aligned_cols=143 Identities=15% Similarity=0.097 Sum_probs=72.6
Q ss_pred eeeeeecceE-EEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeEEEEEcCCcEEEEEEec
Q 021233 61 RELGRGEFGI-TYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 61 ~~lg~G~~g~-Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
+.|+.|+... +|+... .++..+++|...... .+.+..|+.+++.+..+. .+++++.+....+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 4565555544 667653 236677777643321 023445677777663332 3556676643333 7899999
Q ss_pred CCCChHHHHHhc--------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHH
Q 021233 139 EGGELFDRIVAR--------------------------GHYTERAAA-------A-V------------TKTIVEVVQMC 172 (315)
Q Consensus 139 ~~~sL~~~l~~~--------------------------~~l~~~~~~-------~-i------------~~~l~~~L~~l 172 (315)
.+.++.+.+... ..+...... . + ...+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 776665433211 012121110 0 0 00111222233
Q ss_pred ------HHCCceecCCCCCceEeecCCC-CCCEEEEeeccccccCCC
Q 021233 173 ------HKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 173 ------H~~~iiH~dikp~Nill~~~~~-~~~vkl~Dfg~a~~~~~~ 212 (315)
+...++|+|+.+.|||++.+.. ...+.|+||+.+......
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~ 221 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRA 221 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTT
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCH
Confidence 1236999999999999975311 123789999988765443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00018 Score=62.21 Aligned_cols=77 Identities=13% Similarity=0.138 Sum_probs=48.9
Q ss_pred eeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeEEE-----EEcCCcEEEE
Q 021233 61 RELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDT-----YEDDTAVHLV 134 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~-----~~~~~~~~lv 134 (315)
..|+ |....||++.. .+|+.+++|...... ...+.+..|..++..+..+. .+++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 77889998764 346679999875321 12356777888888774321 24444443 2234566899
Q ss_pred EEecCCCCh
Q 021233 135 MELCEGGEL 143 (315)
Q Consensus 135 ~e~~~~~sL 143 (315)
|++++|.++
T Consensus 106 ~~~i~G~~~ 114 (328)
T 1zyl_A 106 FPSVGGRQF 114 (328)
T ss_dssp EECCCCEEC
T ss_pred EEecCCCCC
Confidence 999988544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00043 Score=62.81 Aligned_cols=76 Identities=14% Similarity=0.096 Sum_probs=49.9
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEecC
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
++.|+.|-...+|++.....+..+++|+..... .... .-.+|+.+++.|..+.-.+++++.+. + .+|+||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~i---dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEII---NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCS---CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhc---CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeC
Confidence 467888888999999876445788999864321 1111 12579999999855544567777773 2 25999998
Q ss_pred CCCh
Q 021233 140 GGEL 143 (315)
Q Consensus 140 ~~sL 143 (315)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00033 Score=61.68 Aligned_cols=76 Identities=13% Similarity=0.103 Sum_probs=45.7
Q ss_pred eeeeeeecceEEEEEEECC--------CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 60 GRELGRGEFGITYLCTDRE--------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~--------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
++.|+.|....+|++.... .+..+++|+...... .......|..+++.+..+.-++++++.+ . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 4567888888999998653 136888998654311 1112357888888874443345676654 2 2
Q ss_pred EEEEEecCCCCh
Q 021233 132 HLVMELCEGGEL 143 (315)
Q Consensus 132 ~lv~e~~~~~sL 143 (315)
++||||++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999988544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0016 Score=58.43 Aligned_cols=76 Identities=13% Similarity=0.134 Sum_probs=50.1
Q ss_pred eeeeeeecceEEEEEEECCC-------CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 60 GRELGRGEFGITYLCTDREN-------GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~-------~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
++.|..|-...+|++..... +..+++++..... ... -...+|..+++.+..+.-.+++++.+. -+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~---idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKF---YDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CC---CCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chh---cCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 45677788889999987521 5789999865432 111 123568888888754544566776442 27
Q ss_pred EEEEecCCCCh
Q 021233 133 LVMELCEGGEL 143 (315)
Q Consensus 133 lv~e~~~~~sL 143 (315)
.|+||++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998664
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0058 Score=53.07 Aligned_cols=69 Identities=12% Similarity=0.068 Sum_probs=42.3
Q ss_pred eeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCC--CCCcceeEEE------EEcCCcEEEEE
Q 021233 64 GRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK--HQNIVCLKDT------YEDDTAVHLVM 135 (315)
Q Consensus 64 g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--h~~iv~~~~~------~~~~~~~~lv~ 135 (315)
|.|....||++... +| .+++|+...... ..|+.+++.|.. -+++++++.. ....+..+++|
T Consensus 32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~---------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~ 100 (339)
T 3i1a_A 32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD---------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAY 100 (339)
T ss_dssp TSCSSCEEEEEECS-SC-EEEEEEEECSSC---------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEE
T ss_pred cCccccceEEEEeC-CC-CEEEEEecCccc---------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEE
Confidence 33446799998743 35 899997654321 245555555522 2334555432 23456789999
Q ss_pred EecCCCCh
Q 021233 136 ELCEGGEL 143 (315)
Q Consensus 136 e~~~~~sL 143 (315)
+|++|..+
T Consensus 101 ~~i~G~~~ 108 (339)
T 3i1a_A 101 PFIHAPNG 108 (339)
T ss_dssp ECCCCCBT
T ss_pred eccCCCcC
Confidence 99998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0052 Score=54.73 Aligned_cols=33 Identities=30% Similarity=0.413 Sum_probs=25.9
Q ss_pred ceecCCCCCceEeecC---CCCCCEEEEeecccccc
Q 021233 177 VMHRDLKPENFLFANK---KETAPLKAIDFGLSVFF 209 (315)
Q Consensus 177 iiH~dikp~Nill~~~---~~~~~vkl~Dfg~a~~~ 209 (315)
++|+|+.+.|||+..+ .....+.++||..|...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6799999999999642 23455899999988643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.32 E-value=0.054 Score=49.08 Aligned_cols=63 Identities=5% Similarity=0.016 Sum_probs=17.1
Q ss_pred eeeeeeeecceEEEEEEECCCCCEEEE------EEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 59 LGRELGRGEFGITYLCTDRENGDAFAC------KSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~------K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
+.+.|| ||.||++.+.....+||+ |....... .......+.+|+.+++.+ +|||+++.+++-.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENE-QIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccc-cccccCCCcceEE
Confidence 345566 999999998765567888 65543221 223345677888888888 8999999887654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 315 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-85 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-85 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-85 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-84 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-83 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-82 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-82 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-80 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-79 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-78 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-77 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-76 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-74 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-73 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-71 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-71 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-69 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-68 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-67 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-66 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-64 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-63 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-63 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-62 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-62 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-62 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-61 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-60 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-60 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-60 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-59 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-59 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-58 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-57 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-56 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-53 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-46 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 6e-06 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 259 bits (663), Expect = 1e-85
Identities = 85/266 (31%), Positives = 136/266 (51%), Gaps = 7/266 (2%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
E + + Y++ ELG G FG+ + C ++ G F K I+ +D V+ E+
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEI 77
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTI 165
IM L H ++ L D +ED + L++E GGELFDRI A + +E +
Sbjct: 78 SIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
E ++ H+H ++H D+KPEN + K+ + +K IDFGL+ P E + +
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 195
Query: 226 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
APE++ R G D+W+ GV+ Y+LL G+ PF E + Q + R +F D + V
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
S AKD ++ +L +P++RLT L
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDAL 281
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 257 bits (658), Expect = 2e-85
Identities = 103/260 (39%), Positives = 151/260 (58%), Gaps = 4/260 (1%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+I + Y+ LG G F L D+ A K I+KK L + E+ ++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHK 63
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
+ KH NIV L D YE ++L+M+L GGELFDRIV +G YTER A+ + +++ V+
Sbjct: 64 I-KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK 231
H G++HRDLKPEN L+ + E + + DFGLS PG S G+P Y+APEVL
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
+ Y VD WS GVI YILLCG PPF+ E + + + I+++ +F W +S++AKD
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 291 LVRKMLDPDPKRRLTAQQVL 310
+R +++ DP++R T +Q L
Sbjct: 243 FIRHLMEKDPEKRFTCEQAL 262
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 258 bits (660), Expect = 2e-85
Identities = 86/266 (32%), Positives = 135/266 (50%), Gaps = 7/266 (2%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
E + + Y++ ELG G FG+ + T+R G+ FA K + D E VR+E+
Sbjct: 18 EIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEI 74
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIV-ARGHYTERAAAAVTKTI 165
M L +H +V L D +EDD + ++ E GGELF+++ +E A + +
Sbjct: 75 QTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ + H++ +H DLKPEN +F K+ LK IDFGL+ P + G+ +
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFA 192
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
APEV + + G D+WS GV+ YILL G+ PF E + + + + + +
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVL 310
SE+ KD +RK+L DP R+T Q L
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQAL 278
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (651), Expect = 2e-84
Identities = 79/262 (30%), Positives = 142/262 (54%), Gaps = 8/262 (3%)
Query: 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+E+ E+Y + +LGRGEFGI + C + + + K + K D V++E+ I+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN 56
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVV 169
+H+NI+ L +++E + ++ E G ++F+RI ER + + E +
Sbjct: 57 IA-RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEAL 115
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEV 229
Q H H + H D++PEN ++ ++ + +K I+FG + KPG+ F + +P Y APEV
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRS-STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 230 LKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288
+ + D+WS G ++Y+LL G+ PF AET Q + + I+ + F + + ++S A
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 289 KDLVRKMLDPDPKRRLTAQQVL 310
D V ++L + K R+TA + L
Sbjct: 235 MDFVDRLLVKERKSRMTASEAL 256
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 250 bits (640), Expect = 3e-83
Identities = 97/269 (36%), Positives = 138/269 (51%), Gaps = 16/269 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD------IEDVRREVDI 108
E YE LGRG + C + +A K I + E +EVDI
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEV 168
+R + H NI+ LKDTYE +T LV +L + GELFD + + +E+ + + ++EV
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
+ HK ++HRDLKPEN L + +K DFG S PGEK E+ G+P Y+APE
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 229 VL-------KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
++ YG EVD+WS GVI+Y LL G PPFW + + + I+ F W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
S+ KDLV + L P++R TA++ L
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (633), Expect = 5e-82
Identities = 97/263 (36%), Positives = 146/263 (55%), Gaps = 6/263 (2%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKL---RTAVDIEDVRREVDIM 109
+++ Y+ G ELG G+F + C ++ G +A K I K++ R V ED+ REV I+
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 110 RHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVV 169
+ + +H N++ L + YE+ T V L++EL GGELFD + + TE A K I+ V
Sbjct: 68 KEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAP-LKAIDFGLSVFFKPGEKFSEIVGSPYYMAPE 228
H + H DLKPEN + ++ P +K IDFGL+ G +F I G+P ++APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 229 VLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
++ G E D+WS GVI YILL G PF +T+Q + +F + + S
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
AKD +R++L DPK+R+T Q L
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSL 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (630), Expect = 6e-82
Identities = 88/257 (34%), Positives = 138/257 (53%), Gaps = 10/257 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E +E+GR LG+G+FG YL ++++ A K + K +L A +RREV+I HL +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-R 64
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NI+ L + D T V+L++E G ++ + + E+ A + + CH
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RN 233
V+HRD+KPEN L + E LK DFG SV P + + + G+ Y+ PE+++ R
Sbjct: 125 KRVIHRDIKPENLLLGSAGE---LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRM 180
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
+ +VD+WS GV+ Y L G PPF A T Q + I R F V+E A+DL+
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLIS 236
Query: 294 KMLDPDPKRRLTAQQVL 310
++L +P +R ++VL
Sbjct: 237 RLLKHNPSQRPMLREVL 253
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 1e-80
Identities = 82/261 (31%), Positives = 126/261 (48%), Gaps = 12/261 (4%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++ G+ LG G F L + +A K + K+ + + V RE D+M L
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 66
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H V L T++DD ++ + + GEL I G + E T IV ++ H
Sbjct: 67 HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK 231
G++HRDLKPEN L E ++ DFG + P K + VG+ Y++PE+L
Sbjct: 127 KGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
++ D+W+ G I+Y L+ G+PPF A E + Q II+ DF K A+D
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARD 239
Query: 291 LVRKMLDPDPKRRLTAQQVLG 311
LV K+L D +RL +++ G
Sbjct: 240 LVEKLLVLDATKRLGCEEMEG 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 7e-79
Identities = 77/261 (29%), Positives = 126/261 (48%), Gaps = 12/261 (4%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++L + LG G +G L +R +A A K + K+ E++++E+ I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKML-N 61
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+N+V + +L +E C GGELFDRI E A ++ V H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK 231
G+ HRD+KPEN L + LK DFGL+ F+ + +++ G+ Y+APE+LK
Sbjct: 122 IGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 232 RN--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
R + VDVWS G++L +L G P+ ++ + + +PW K+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPL 237
Query: 290 DLVRKMLDPDPKRRLTAQQVL 310
L+ K+L +P R+T +
Sbjct: 238 ALLHKILVENPSARITIPDIK 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 237 bits (606), Expect = 9e-78
Identities = 74/263 (28%), Positives = 117/263 (44%), Gaps = 13/263 (4%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ E+ + RE+G G FG Y D N + A K +S ++ +D+ +EV ++
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
L +H N + + Y + LVME C G V + E AAVT ++ +
Sbjct: 72 L-RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVL- 230
H H ++HRD+K N L + +K DFG + P F VG+PY+MAPEV+
Sbjct: 131 LHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAPANSF---VGTPYWMAPEVIL 184
Query: 231 ---KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287
+ Y +VDVWS G+ L PP + I ++ + SE
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEY 242
Query: 288 AKDLVRKMLDPDPKRRLTAQQVL 310
++ V L P+ R T++ +L
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (604), Expect = 1e-77
Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 11/261 (4%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +++Y ++G+G G Y D G A + ++ ++ E + E+ +MR
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRE 73
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQM 171
K+ NIV D+Y + +VME GG L D +V E AAV + ++ ++
Sbjct: 74 N-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 172 CHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK-PGEKFSEIVGSPYYMAPEVL 230
H + V+HRD+K +N L +K DFG K S +VG+PY+MAPEV+
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
Query: 231 KRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
R YGP+VD+WS G++ ++ G PP+ E I + K+S +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQNPEKLSAIFR 247
Query: 290 DLVRKMLDPDPKRRLTAQQVL 310
D + + LD D ++R +A+++L
Sbjct: 248 DFLNRCLDMDVEKRGSAKELL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 5e-76
Identities = 79/265 (29%), Positives = 123/265 (46%), Gaps = 16/265 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
E+ +E+ ELG G FG Y ++E A K I K ++ED E+DI+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASC- 66
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMC 172
H NIV L D + + + +++E C GG + ++ TE V K ++ +
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL- 230
H + ++HRDLK N LF + +K DFG+S + ++ +G+PY+MAPEV+
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 183
Query: 231 -----KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
R Y + DVWS G+ L + PP V I +S P + S
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWS 242
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVL 310
N KD ++K L+ + R T Q+L
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 227 bits (579), Expect = 5e-74
Identities = 69/269 (25%), Positives = 114/269 (42%), Gaps = 8/269 (2%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T + +RYELG LG G +L D A K + R RRE
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 109 MRHLPKHQNIVCLKDTYEDDTA----VHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
L H IV + DT E +T ++VME +G L D + G T + A V
Sbjct: 61 AAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIAD 119
Query: 165 IVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFG-LSVFFKPGEKFSEIVGSPY 223
+ + H++G++HRD+KP N + + + ++ + + ++G+
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 224 YMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
Y++PE + + DV+S G +LY +L G PPF ++ VA +R
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 283 KVSENAKDLVRKMLDPDPKRRL-TAQQVL 310
+S + +V K L +P+ R TA ++
Sbjct: 240 GLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 1e-73
Identities = 90/270 (33%), Positives = 137/270 (50%), Gaps = 20/270 (7%)
Query: 53 IEERYE-LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
I + Y+ + LG G G ++ + FA K + RREV++
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWR 60
Query: 112 LPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTI 165
+ +IV + D YE+ + +VME +GGELF RI RG +TER A+ + K+I
Sbjct: 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
E +Q H + HRD+KPEN L+ +K+ A LK DFG + + +PYY+
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----DFRRDP 280
APEVL Y D+WS GVI+YILLCG PPF++ ++ + + +F
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
W +VSE K L+R +L +P +R+T + +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 5e-72
Identities = 58/268 (21%), Positives = 110/268 (41%), Gaps = 13/268 (4%)
Query: 50 GREIEERY-ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
G + R+ + E+GRG F Y D E A + +KL T + + + E ++
Sbjct: 3 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEM 61
Query: 109 MRHLPKHQNIVCLKDTYED----DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKT 164
++ L +H NIV D++E + LV EL G L + + + +
Sbjct: 62 LKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 120
Query: 165 IVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
I++ +Q H ++HRDLK +N + +K D GL+ K ++G+P
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL-KRASFAKAVIGTP 177
Query: 223 YYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
+MAPE+ + Y VDV++ G+ + + P+ + S +
Sbjct: 178 EFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDK 236
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
K+++ + + R + + +L
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 9e-72
Identities = 80/269 (29%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E YE+ +G G +G + +G K + + T + + + EV+++R L K
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-K 61
Query: 115 HQNIVCLKDTYED--DTAVHLVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEV 168
H NIV D D +T +++VME CEGG+L I R + E V +
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 169 VQMCHK-----HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFS-EIVGSP 222
++ CH+ H V+HRDLKP N K+ +K DFGL+ F+ VG+P
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARILNHDTSFAKAFVGTP 178
Query: 223 YYMAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
YYM+PE + R Y + D+WS G +LY L +PPF A +++ +A I R
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK---FRRIP 235
Query: 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ S+ +++ +ML+ R + +++L
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 1e-71
Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 49/299 (16%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP 113
++ +E ELG G G+ + + + +G A K I + + RE+ ++
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC- 61
Query: 114 KHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
IV + D + + ME +GG L + G E+ V+ +++ +
Sbjct: 62 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 174 -KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK- 231
KH +MHRD+KP N L ++ E +K DFG+S S VG+ YM+PE L+
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQG 177
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL----------------- 274
+Y + D+WS G+ L + G P + + V
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 275 -----------------------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ P S +D V K L +P R +Q++
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-71
Identities = 71/258 (27%), Positives = 123/258 (47%), Gaps = 9/258 (3%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E + L + LG+G FG +L ++ FA K++ K + D+E E ++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H + + T++ + VME GG+L I + + A I+ +Q H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KFSEIVGSPYYMAPEVLK-R 232
G+++RDLK +N L + +K DFG+ G+ K + G+P Y+APE+L +
Sbjct: 122 KGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
Y VD WS GV+LY +L G PF + E+ + +I + + + AKDL+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLL 234
Query: 293 RKMLDPDPKRRLTAQQVL 310
K+ +P++RL + +
Sbjct: 235 VKLFVREPEKRLGVRGDI 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 216 bits (552), Expect = 7e-69
Identities = 71/265 (26%), Positives = 113/265 (42%), Gaps = 14/265 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR--HL 112
+ + R +GRG FG Y C + G +A K + KK+++ E ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
IVC+ + + +++L GG+L + G ++E I+ ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLKR 232
H V++RDLKP N L E ++ D GL+ F K VG+ YMAPEVL++
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK 179
Query: 233 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290
Y D +S G +L+ LL G PF + + I R L + S +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAVELPDSFSPELRS 238
Query: 291 LVRKMLDPDPKRRLT-----AQQVL 310
L+ +L D RRL AQ+V
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVK 263
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 1e-68
Identities = 79/265 (29%), Positives = 126/265 (47%), Gaps = 20/265 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIED---VRREVDIM 109
+E +Y++G LG G FG Y + A K + K ++ ++ + V EV ++
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 110 RHL-PKHQNIVCLKDTYEDDTAVHLVMELCEGG-ELFDRIVARGHYTERAAAAVTKTIVE 167
+ + ++ L D +E + L++E E +LFD I RG E A + ++E
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
V+ CH GV+HRD+K EN L + LK IDFG K +++ G+ Y P
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGALLKD-TVYTDFDGTRVYSPP 178
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
E + R +G VWS G++LY ++CG PF + E IIR + FR +VS
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFR----QRVS 228
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVL 310
+ L+R L P R T +++
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQ 253
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 1e-67
Identities = 60/274 (21%), Positives = 110/274 (40%), Gaps = 20/274 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
EI + +G+ +G G FG Y + A K ++ T ++ + EV ++R
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLR 59
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVV 169
+H NI+ Y + +V + CEG L+ + + + + + + +
Sbjct: 60 KT-RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMA 226
H ++HRDLK N +K DFGL+ +F ++ GS +MA
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 227 PEVLKRN----YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS--VLDFRRDP 280
PEV++ Y + DV++ G++LY L+ G P+ + ++ +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ K L+ + L R Q+L IE
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 209 bits (532), Expect = 2e-66
Identities = 69/255 (27%), Positives = 124/255 (48%), Gaps = 11/255 (4%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +++ R LG G FG +L R NG +A K + K+ + +E E ++ +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H I+ + T++D + ++M+ EGGELF + + A + ++ H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RN 233
+++RDLKPEN L + +K DFG + + + + G+P Y+APEV+ +
Sbjct: 123 KDIIYRDLKPENILLD---KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVSTKP 177
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
Y +D WS G+++Y +L G PF+ + I+ + L F P +E+ KDL+
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLS 233
Query: 294 KMLDPDPKRRLTAQQ 308
+++ D +RL Q
Sbjct: 234 RLITRDLSQRLGNLQ 248
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-64
Identities = 75/263 (28%), Positives = 126/263 (47%), Gaps = 15/263 (5%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++ + LG+G FG L ++ G +A K + K+ + ++ E ++++ +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-R 63
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H + LK ++ + VME GGELF + +TE A IV ++ H
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLKRN 233
V++RD+K EN + +K DFGL G G+P Y+APEVL+ N
Sbjct: 124 RDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 234 -YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
YG VD W GV++Y ++CG PF+ + + + + I+ + F +S AK L+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236
Query: 293 RKMLDPDPKRRL-----TAQQVL 310
+L DPK+RL A++V+
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVM 259
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 201 bits (511), Expect = 3e-63
Identities = 71/294 (24%), Positives = 123/294 (41%), Gaps = 49/294 (16%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ Y+L R+LGRG++ + + N + K + K + ++RE+ I+ +L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRG 88
Query: 115 HQNIVCLKDTYEDDTA--VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
NI+ L D +D + LV E + T+ I++ + C
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 145
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK- 231
H G+MHRD+KP N + + E L+ ID+GL+ F+ PG++++ V S Y+ PE+L
Sbjct: 146 HSMGIMHRDVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 232 -RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVL---------------- 274
+ Y +D+WS G +L ++ PF+ + I VL
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 275 ------------------DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ VS A D + K+L D + RLTA++ +
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 4e-63
Identities = 73/306 (23%), Positives = 123/306 (40%), Gaps = 49/306 (16%)
Query: 48 PTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVD 107
P E+ +YE ++G+G FG + R+ G A K + + + I RE+
Sbjct: 4 PFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-ALREIK 61
Query: 108 IMRHLPKHQNIVCLKDTYEDDTA--------VHLVMELCEGGELFDRIVARGHYTERAAA 159
I++ L KH+N+V L + + ++LV + CE +T
Sbjct: 62 ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 160 AVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----- 214
V + ++ + H++ ++HRD+K N L LK DFGL+ F +
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLAKNSQPNR 177
Query: 215 FSEIVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS 272
++ V + +Y PE+L +R+YGP +D+W AG I+ + P TEQ I +
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 273 VLDFRRDPWPKV----------------------------SENAKDLVRKMLDPDPKRRL 304
+ WP V A DL+ K+L DP +R+
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 305 TAQQVL 310
+ L
Sbjct: 298 DSDDAL 303
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-62
Identities = 75/300 (25%), Positives = 117/300 (39%), Gaps = 46/300 (15%)
Query: 47 EPTGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREV 106
+ R E Y + +G G FG+ Y ++G+ A K + + K RE+
Sbjct: 12 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNREL 64
Query: 107 DIMRHLPKHQNIVCLKDTY------EDDTAVHLVMELCEGG---ELFDRIVARGHYTERA 157
IMR L H NIV L+ + +D+ ++LV++ A+
Sbjct: 65 QIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY 123
Query: 158 AAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE 217
+ + H G+ HRD+KP+N L +TA LK DFG + GE
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 218 IVGSPYYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLD 275
+ S YY APE++ +Y +DVWSAG +L LL G P F ++ II+ +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 276 FRRDPW-------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
R+ P+ A L ++L+ P RLT +
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-62
Identities = 73/282 (25%), Positives = 112/282 (39%), Gaps = 33/282 (11%)
Query: 58 ELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD--IEDVRREVDIMRHLPKH 115
E LG G+F Y D+ A K I A D RE+ +++ L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SH 59
Query: 116 QNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKH 175
NI+ L D + + + LV + E T A ++ ++ H+H
Sbjct: 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 176 GVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLK--R 232
++HRDLKP N L LK DFGL+ F P ++ V + +Y APE+L R
Sbjct: 120 WILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 233 NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP---------- 282
YG VD+W+ G IL LL VP +++ I ++ + WP
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 283 --------------KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
++ DL++ + +P R+TA Q L
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-62
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 44/296 (14%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
++ RY +G G +G+ D N A K IS + +T + RE+ I+
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKILLR 62
Query: 112 LPKHQNIVCLKDTYEDDTAVHL----VMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+H+NI+ + D T + ++ G +L+ + H + I+
Sbjct: 63 F-RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILR 120
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE----KFSEIVGSPY 223
++ H V+HRDLKP N L + LK DFGL+ P +E V + +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 224 YMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
Y APE++ + Y +D+WS G IL +L P F + I+ + ++
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 282 ---------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
P A DL+ KML +P +R+ +Q L
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 3e-61
Identities = 81/270 (30%), Positives = 135/270 (50%), Gaps = 17/270 (6%)
Query: 55 ERYELGRELGRGEFGITYLC---TDRENGDAFACKSISKKKL-RTAVDIEDVRREVDIMR 110
E +EL + LG G +G +L + + G +A K + K + + A E R E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
H+ + +V L ++ +T +HL+++ GGELF + R +TE IV ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP--GEKFSEIVGSPYYMAPE 228
HK G+++RD+K EN L + + DFGLS F E+ + G+ YMAP+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNG---HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200
Query: 229 VLK---RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
+++ + VD WS GV++Y LL G PF + E+ I R +L ++S
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260
Query: 286 ENAKDLVRKMLDPDPKRRL-----TAQQVL 310
AKDL++++L DPK+RL A ++
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-61
Identities = 58/271 (21%), Positives = 107/271 (39%), Gaps = 22/271 (8%)
Query: 50 GREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
G + + +L + +G+GEFG L R G+ A K I + E +
Sbjct: 1 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASV 53
Query: 109 MRHLPKHQNIVCLKDT-YEDDTAVHLVMELCEGGELFDRIVARGH--YTERAAAAVTKTI 165
M L +H N+V L E+ +++V E G L D + +RG + +
Sbjct: 54 MTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
E ++ + +HRDL N L + K DFGL+ + +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQ--DTGKLPVKWT 167
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
APE L+ + + + DVWS G++L+ + G P+ + V + + ++ D
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDG 224
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
++++ D R + Q+ ++E
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 4e-61
Identities = 61/287 (21%), Positives = 104/287 (36%), Gaps = 36/287 (12%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IEDVRREVDIMRH 111
E E G+ LG G FG T ++ K L+ D E + E+ +M
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH------------------- 152
L H+NIV L ++L+ E C G+L + + ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 153 ----YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208
T + + ++ +HRDL N L + K +K DFGL+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV---VKICDFGLARD 213
Query: 209 FKPGEKFS---EIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQ 263
+ +MAPE L Y + DVWS G++L+ I GV P+
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 264 GVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+I++ F+ D +E +++ D ++R + +
Sbjct: 274 ANFYKLIQN--GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (493), Expect = 3e-60
Identities = 71/262 (27%), Positives = 130/262 (49%), Gaps = 16/262 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++++ + LG G FG L +E+G+ +A K + K+K+ IE E I++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
+V L+ +++D++ +++VME GGE+F + G ++E A IV + H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RN 233
+++RDLKPEN L + ++ DFG + K + + G+P +APE++ +
Sbjct: 160 LDLIYRDLKPENLLIDQQG---YIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILSKG 214
Query: 234 YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293
Y VD W+ GV++Y + G PPF+A+ + + I+ + F S + KDL+R
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLR 270
Query: 294 KMLDPDPKRRL-----TAQQVL 310
+L D +R +
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIK 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 3e-60
Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 34/285 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
++YE ++G G +G + +RE + A K + V RE+ +++ L K
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKEL-K 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H+NIV L D D + LV E C+ G + +++ + CH
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL--K 231
V+HRDLKP+N L E K +FGL+ F P +S V + +Y P+VL
Sbjct: 120 RNVLHRDLKPQNLLINRNGEL---KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 232 RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPW--------- 281
+ Y +D+WSAG I L P F + I R + + W
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 282 ----------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
PK++ +DL++ +L +P +R++A++ L
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-60
Identities = 56/278 (20%), Positives = 99/278 (35%), Gaps = 24/278 (8%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +G G FG +++G K+ + D D E++++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI----------------VARGHYTERAA 158
H NI+ L E ++L +E G L D + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 159 AAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEI 218
+ + + +HRDL N L K DFGLS + K +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIADFGLSRGQEVYVKKTMG 186
Query: 219 VGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILL-CGVPPFWAETEQGVAQAIIRSVLDF 276
+MA E L + Y DVWS GV+L+ ++ G P+ T + + + + +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GY 243
Query: 277 RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
R + + DL+R+ P R + Q+L +
Sbjct: 244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 191 bits (485), Expect = 6e-60
Identities = 82/284 (28%), Positives = 123/284 (43%), Gaps = 34/284 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E+Y ++G G +G+ Y + G+ FA K I +K + RE+ I++ L K
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGI-PSTTIREISILKEL-K 58
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK 174
H NIV L D + LV E + V G A + ++ + CH
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVL--K 231
V+HRDLKP+N L + E LK DFGL+ F P K++ + + +Y AP+VL
Sbjct: 119 RRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 232 RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP--------- 282
+ Y +D+WS G I ++ G P F +E I R + WP
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 283 ----------------KVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ E+ DL+ KML DP +R+TA+Q L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (487), Expect = 6e-60
Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 35/289 (12%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL- 112
+++YE E+G G +G + D +NG F + + REV ++RHL
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 113 -PKHQNIVCLKD-----TYEDDTAVHLVMELCEGGEL-FDRIVARGHYTERAAAAVTKTI 165
+H N+V L D + +T + LV E + + V + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ + H H V+HRDLKP+N L + + K DFGL+ + + +V + +Y
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQI---KLADFGLARIYSFQMALTSVVVTLWYR 182
Query: 226 APEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPK- 283
APEVL ++ Y VD+WS G I + P F ++ I+ + + WP+
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 284 ----------------------VSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ E KDL+ K L +P +R++A L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-59
Identities = 59/267 (22%), Positives = 96/267 (35%), Gaps = 17/267 (6%)
Query: 54 EERYELGRELGRGEFGITYLCTDRE---NGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+ L +LG G FG+ + A K + L ++D REV+ M
Sbjct: 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVV 169
L H+N++ L + +V EL G L DR+ GH+ + + E +
Sbjct: 67 SL-DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 170 QMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----SEIVGSPYYM 225
+HRDL N L A + +K DFGL + +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 226 APEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283
APE LK R + D W GV L+ + G P+ + I + R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE--GERLPRPED 239
Query: 284 VSENAKDLVRKMLDPDPKRRLTAQQVL 310
++ +++ + P+ R T +
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (483), Expect = 2e-59
Identities = 50/275 (18%), Positives = 87/275 (31%), Gaps = 18/275 (6%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ RY LGR++G G FG YL TD G+ A K K + E I + +
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMM 59
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I ++ + +VMEL ++ + + ++ ++
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 173 HKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--------KFSEIVGSPYY 224
H +HRD+KP+NFL K+ + IDFGL+ ++ + + G+ Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 225 MAPEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--- 280
+ D+ S G +L G P+ Q R P
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 281 -WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+ + +
Sbjct: 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-59
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 44/297 (14%)
Query: 49 TGREIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDI 108
T E+ Y + +G G +G D G A K + + ++ + + RE+ +
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRL 70
Query: 109 MRHLPKHQNIVCLKDTYEDD------TAVHLVMELCEGGELFDRIVARGHYTERAAAAVT 162
++H+ +H+N++ L D + D T +LVM G +++ E +
Sbjct: 71 LKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLV 127
Query: 163 KTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSP 222
+++ ++ H G++HRDLKP N E LK +DFGL+ + + V +
Sbjct: 128 YQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ--ADSEMTGYVVTR 182
Query: 223 YYMAPEVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280
+Y APEV+ Y VD+WS G I+ ++ G F + I++ +
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 281 W---------------------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
S A +L+ KML D ++R+TA + L
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (479), Expect = 9e-59
Identities = 64/275 (23%), Positives = 104/275 (37%), Gaps = 18/275 (6%)
Query: 51 REIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISK-KKLRTAVDIEDVRREVDI 108
+EI+ ++ + +G GEFG + G +I K T D E I
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 109 MRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVE 167
M H N++ L+ T V ++ E E G L + G +T + + I
Sbjct: 81 MGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE------IVGS 221
++ +HRDL N L + K DFGLS F +
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196
Query: 222 PYYMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279
+ APE ++ R + DVWS G++++ ++ G P+W T Q V AI + D+R
Sbjct: 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLP 253
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
P L+ D R Q++ ++
Sbjct: 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (475), Expect = 3e-58
Identities = 54/269 (20%), Positives = 104/269 (38%), Gaps = 16/269 (5%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+E + +LG G++G Y ++ A K++ + + ++E+ +E +M+
Sbjct: 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMK 68
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY--TERAAAAVTKTIVEV 168
+ KH N+V L + +++ E G L D + + + I
Sbjct: 69 EI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMA 226
++ K +HRDL N L +K DFGLS + + A
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
PE L N + + DVW+ GV+L+ + + + ++ D+R +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--DYRMERPEGCP 242
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
E +L+R +P R + ++ E
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-58
Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 34/285 (11%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
E ++ ++G G +G+ Y ++ G+ A K I + T RE+ +++ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL-N 59
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCE-GGELFDRIVARGHYTERAAAAVTKTIVEVVQMCH 173
H NIV L D + ++LV E + F A + +++ + CH
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF-KPGEKFSEIVGSPYYMAPEVLKR 232
H V+HRDLKP+N L + +K DFGL+ F P ++ V + +Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 233 N--YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW--------- 281
Y VD+WS G I ++ F ++E I R++ W
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 282 ----------------PKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
P + E+ + L+ +ML DP +R++A+ L
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-57
Identities = 61/270 (22%), Positives = 106/270 (39%), Gaps = 20/270 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
E+ E +L LG G+FG ++ A KS+ + + + E ++M+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMK 63
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEV 168
L +HQ +V L + ++++ E E G L D + T + I E
Sbjct: 64 QL-QHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE--IVGSPYYMA 226
+ + +HRDL+ N L ++ K DFGL+ + E + + A
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSC---KIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE + + + DVWS G++L ++ G P+ T V Q + R +R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNC 235
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
E L+R P+ R T + +E
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-57
Identities = 56/265 (21%), Positives = 100/265 (37%), Gaps = 17/265 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+ +ELG G+FG+ R A K I + + ++ E +M +L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNL-S 57
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI-VARGHYTERAAAAVTKTIVEVVQMCH 173
H+ +V L + ++ E G L + + R + + + K + E ++
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK 231
+HRDL N L ++ +K DFGLS + E + PEVL
Sbjct: 118 SKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 232 RN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ + + D+W+ GV+++ I G P+ T A+ I + R SE
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---GLRLYRPHLASEKVY 231
Query: 290 DLVRKMLDPDPKRRLTAQQVLGKIE 314
++ R T + +L I
Sbjct: 232 TIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 2e-57
Identities = 59/265 (22%), Positives = 105/265 (39%), Gaps = 17/265 (6%)
Query: 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPK 114
+E+G G+FG+ +L N D A K+I + + ED E ++M L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKL-S 58
Query: 115 HQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEVVQMCH 173
H +V L + + LV E E G L D + + + + + E +
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 174 KHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMAPEVLK 231
+ V+HRDL N L + +K DFG++ F + + + +PEV
Sbjct: 119 EACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 232 RN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289
+ Y + DVWS GV+++ + G P+ + V + I FR S +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLASTHVY 232
Query: 290 DLVRKMLDPDPKRRLTAQQVLGKIE 314
++ P+ R ++L ++
Sbjct: 233 QIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-57
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 20/270 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
EI E L +LG+G FG ++ T A K++ + E +E +M+
Sbjct: 13 EIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM----SPEAFLQEAQVMK 67
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEV 168
L +H+ +V L ++ +++V E G L D + + + I
Sbjct: 68 KL-RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYYMA 226
+ + +HRDL+ N L K DFGL+ + E + A
Sbjct: 126 MAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNEYTARQGAKFPIKWTA 182
Query: 227 PEVLKRN-YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE + + DVWS G++L L G P+ + V + R +R P+
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPEC 239
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
E+ DL+ + +P+ R T + + +E
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-57
Identities = 72/272 (26%), Positives = 108/272 (39%), Gaps = 19/272 (6%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVD 107
EI+ ER ELGR +G G+FG + + A A K+ K + E +E
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEAL 60
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIV 166
MR H +IV L ++ V ++MELC GEL + R + +
Sbjct: 61 TMRQF-DHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE--KFSEIVGSPYY 224
+ +HRD+ N L ++ +K DFGLS + + K S+ +
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 225 MAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWP 282
MAPE + R + DVW GV ++ IL+ GV PF V I R P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLPMPP 232
Query: 283 KVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
L+ K DP RR ++ ++
Sbjct: 233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-57
Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 17/262 (6%)
Query: 61 RELGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNI 118
+ELG G FG + A K + K + +++ E ++M+ L + I
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQL-DNPYI 70
Query: 119 VCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVM 178
V + E ++ LVME+ E G L + H ++ + + ++ + +
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 179 HRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF----SEIVGSPYYMAPEVLKRN- 233
HRDL N L + K DFGLS + E + + + APE +
Sbjct: 130 HRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 234 YGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292
+ + DVWS GV+++ G P+ V + + R DL+
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDLM 243
Query: 293 RKMLDPDPKRRLTAQQVLGKIE 314
D + R V ++
Sbjct: 244 NLCWTYDVENRPGFAAVELRLR 265
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-56
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 40/292 (13%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
E+ ERY+ +G G +G D + G A K + + ++ + + RE+ +++H
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKH 73
Query: 112 LPKHQNIVCLKDTYEDDTAV----HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVE 167
+ KH+N++ L D + ++ + + G + IV T+ + I+
Sbjct: 74 M-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 168 VVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMAP 227
++ H ++HRDLKP N E LK +DFGL+ ++ + V + +Y AP
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT--DDEMTGYVATRWYRAP 187
Query: 228 EVL--KRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR-------- 277
E++ +Y VD+WS G I+ LL G F + I+R V
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 278 -------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVL 310
+ + + A DL+ KML D +R+TA Q L
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 181 bits (460), Expect = 4e-56
Identities = 50/277 (18%), Positives = 95/277 (34%), Gaps = 20/277 (7%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
+ Y++GR +G G FG+ + T+ N A K ++ D +R E + L
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLL 57
Query: 113 PKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMC 172
I + ++ LV++L + ++ + A K ++ VQ
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 173 HKHGVMHRDLKPENFLFANK--KETAPLKAIDFGLSVFFKPGE--------KFSEIVGSP 222
H+ +++RD+KP+NFL K + +DFG+ F++ + + G+
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 223 YYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP- 280
YM+ R D+ + G + L G P+ Q R + P
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 281 ---WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
E + + + G
Sbjct: 238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 6e-56
Identities = 62/270 (22%), Positives = 97/270 (35%), Gaps = 20/270 (7%)
Query: 55 ERYELG-RELGRGEFGITYLCTDRENGD--AFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ + ELG G FG R A K + + + D E++ RE IM
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQ 65
Query: 112 LPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQ 170
L + IV L + + + LVME+ GG L +V R A + + ++
Sbjct: 66 L-DNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 123
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE----IVGSPYYMA 226
+ +HRDL N L N+ K DFGLS + + + A
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 227 PEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284
PE + R + DVWS GV ++ L G P+ V I + R + P+
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPPEC 237
Query: 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
L+ + R V ++
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-55
Identities = 63/290 (21%), Positives = 105/290 (36%), Gaps = 32/290 (11%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLR---TAVDIEDVRREVD 107
E R G+ LG G FG T + A +++ K L+ + E + E+
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH--------------- 152
++ +L H NIV L ++ E C G+L + + +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 153 ---YTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209
+ + + + + +HRDL N L + + T K DFGL+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT---KICDFGLARDI 195
Query: 210 KPGEKF---SEIVGSPYYMAPEVLKRNY-GPEVDVWSAGVILYILLC-GVPPFWAETEQG 264
K + +MAPE + E DVWS G+ L+ L G P+
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 265 VAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
+I+ FR D+++ D DP +R T +Q++ IE
Sbjct: 256 KFYKMIKE--GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 3e-54
Identities = 55/285 (19%), Positives = 101/285 (35%), Gaps = 30/285 (10%)
Query: 55 ERYELGRELGRGEFGITYLCTDR-------ENGDAFACKSISKKKLRTAVDIEDVRREVD 107
+R LG+ LG G FG L A K + D+ D+ E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 108 IMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRI----------------VARG 151
+M+ + KH+NI+ L D +++++E G L + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 152 HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211
+ + + + ++ +HRDL N L
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAI 269
+K + +MAPE L R Y + DVWS GV+L+ I G P+ + + + +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 270 IRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
R D + ++R P +R T +Q++ ++
Sbjct: 251 KE---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-53
Identities = 51/270 (18%), Positives = 98/270 (36%), Gaps = 16/270 (5%)
Query: 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IEDVRREVDIMR 110
E ++ + LG G FG Y G+ ++ K+LR A +++ E +M
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMA 66
Query: 111 HLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQ 170
+ + ++ L T + + G L + + + I + +
Sbjct: 67 SV-DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 171 MCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAP 227
++HRDL N L + +K DFGL+ EK +MA
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 228 EVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285
E + R Y + DVWS GV ++ L+ G P+ ++ + + R P +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICT 239
Query: 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315
+ ++ K D R ++++ +
Sbjct: 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 9e-53
Identities = 64/304 (21%), Positives = 113/304 (37%), Gaps = 53/304 (17%)
Query: 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRH 111
+ +RY+ + +G G GI D A K + + + + RE+ +M+
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKC 72
Query: 112 LPKHQNIVCLKDTY------EDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTI 165
+ H+NI+ L + + E+ V+LVMEL + + + + +
Sbjct: 73 V-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQM 128
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYM 225
+ ++ H G++HRDLKP N + + K +DFGL+ + V + YY
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTL---KILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 226 APE-VLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------- 271
APE +L Y VD+WS G I+ ++ F +I
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 272 -------------------------SVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTA 306
S+ + + A+DL+ KML DP +R++
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 307 QQVL 310
L
Sbjct: 306 DDAL 309
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 7e-51
Identities = 53/302 (17%), Positives = 97/302 (32%), Gaps = 42/302 (13%)
Query: 48 PTGREIE---ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVD---IED 101
P +E E R++G G FG + ++ K L+ D
Sbjct: 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62
Query: 102 VRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHY-------- 153
+RE +M + NIV L + L+ E G+L + + + +
Sbjct: 63 FQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 154 ----------------TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAP 197
+ + + + + + +HRDL N L
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--- 178
Query: 198 LKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLC- 252
+K DFGLS + + +M PE + N Y E DVW+ GV+L+ +
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 253 GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGK 312
G+ P++ + V + +L+R P R + +
Sbjct: 239 GLQPYYGMAHEEVIYYVRD---GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 313 IE 314
++
Sbjct: 296 LQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-50
Identities = 59/275 (21%), Positives = 101/275 (36%), Gaps = 21/275 (7%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREV 106
EI + +G GEFG Y + + A K++ K T D E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEA 60
Query: 107 DIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTI 165
IM H NI+ L+ + ++ E E G L + + G ++ + + I
Sbjct: 61 GIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 166 VEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK----FSEIVGS 221
++ +HRDL N L + K DFGLS + + S
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 222 PYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRD 279
+ APE + R + DVWS G++++ ++ G P+W + V +AI FR
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND---GFRLP 233
Query: 280 PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
L+ + + RR ++ ++
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-49
Identities = 58/274 (21%), Positives = 108/274 (39%), Gaps = 23/274 (8%)
Query: 54 EERYELGRELGRGEFGITYLCTDREN---GDAFACKSISKKKLRTAVDIEDVRREVDIMR 110
+GRG FG Y T +N A KS+ ++ ++ E IM+
Sbjct: 26 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMK 83
Query: 111 HLPKHQNIVCLKDT-YEDDTAVHLVMELCEGGELFDRIVARGH-YTERAAAAVTKTIVEV 168
H N++ L + + +V+ + G+L + I H T + + +
Sbjct: 84 DF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG 142
Query: 169 VQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSE-----IVGSPY 223
++ +HRDL N + K +K DFGL+ E S
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 224 YMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281
+MA E L+ + + + DVWS GV+L+ L+ G PP+ + +++ RR
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----RRLLQ 255
Query: 282 PK-VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
P+ + +++ K P + R + +++ +I
Sbjct: 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 5e-48
Identities = 56/284 (19%), Positives = 111/284 (39%), Gaps = 30/284 (10%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRRE 105
E+ E+ + RELG+G FG+ Y + E A K++++ + + E
Sbjct: 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNE 73
Query: 106 VDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGH----------YTE 155
+M+ ++V L ++MEL G+L + + +
Sbjct: 74 ASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 156 RAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-- 213
+ I + + + + +HRDL N + A +K DFG++ +
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYY 189
Query: 214 -KFSEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILY-ILLCGVPPFWAETEQGVAQAII 270
K + + +M+PE LK + DVWS GV+L+ I P+ + + V + ++
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249
Query: 271 RSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
D + +L+R +PK R + +++ I+
Sbjct: 250 E---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 1e-47
Identities = 60/303 (19%), Positives = 105/303 (34%), Gaps = 51/303 (16%)
Query: 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL 112
I L +G+G FG + R G+ A K S ++ R+ E+ L
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERS----WFREAEIYQTVML 54
Query: 113 PKHQNIVCLKDTYEDD----TAVHLVMELCEGGELFDRIVARGHYTERA-------AAAV 161
+H+NI+ D T + LV + E G LFD + E A+ +
Sbjct: 55 -RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGL 113
Query: 162 TKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-----KFS 216
+E+V K + HRDLK +N L D GL+V +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAVRHDSATDTIDIAPN 170
Query: 217 EIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAETEQG----- 264
VG+ YMAPEVL + D+++ G++ + + +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230
Query: 265 ------VAQAIIRSVLDFRRDP-------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLG 311
+ + + V + + P + ++R+ + RLTA ++
Sbjct: 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
Query: 312 KIE 314
+
Sbjct: 291 TLS 293
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 3e-46
Identities = 55/289 (19%), Positives = 107/289 (37%), Gaps = 31/289 (10%)
Query: 52 EIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVR---REVD 107
E +R +LG+ LGRG FG C++++ K L+ + R E+
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 108 IMRHLPKHQNIVCLKD-TYEDDTAVHLVMELCEGGELFDRIVARGHY------------- 153
I+ H+ H N+V L + + +++E C+ G L + ++ +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 154 ---TERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210
T + + + ++ +HRDL N L + K +K DFGL+
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIY 185
Query: 211 PGEKF---SEIVGSPYYMAPEVLKRN-YGPEVDVWSAGVILYILLCGV-PPFWAETEQGV 265
+ + +MAPE + Y + DVWS GV+L+ + P+
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314
++ R + + + +P +R T +++ +
Sbjct: 246 FCRRLKEGTRMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (355), Expect = 6e-40
Identities = 60/317 (18%), Positives = 105/317 (33%), Gaps = 66/317 (20%)
Query: 56 RYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHL--- 112
RY L R+LG G F +L D N A K + K+ T E E+ +++ +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDA 69
Query: 113 -------PKHQNIVCLKDTYED--DTAVHLVMELCEGG---ELFDRIVARGHYTERAAAA 160
+I+ L D + VH+VM G +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 161 VTKTIVEVVQ-MCHKHGVMHRDLKPENFLFANKKETAPLKAI-DFGLSVFFKPGEKFSEI 218
++K ++ + M + G++H D+KPEN L L I L E ++
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 219 VGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAI-------- 269
+ + Y +PEVL +G D+WS +++ L+ G F + +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 270 ------------------------------------IRSVLDFRRDPWPKVSENAKDLVR 293
+ VL + ++ D +
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 294 KMLDPDPKRRLTAQQVL 310
ML DP++R A ++
Sbjct: 310 PMLQLDPRKRADAGGLV 326
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 1e-20
Identities = 43/204 (21%), Positives = 69/204 (33%), Gaps = 25/204 (12%)
Query: 57 YELGRELGRGEFGITYLCTDRENGDAFACK-----SISKKKLRTAVDIEDVR-REVDIMR 110
+G+ +G G+ + C E K S KK++ D D+ + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 111 HLPKHQNIVCLKDTYE----DDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIV 166
+ + + L+ ++MEL + E V I+
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMIL 113
Query: 167 EVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKFSEIVGSPYYMA 226
E V + G++H DL N L + + + IDF SV E + EI+
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGE-EGWREILERDVRNI 168
Query: 227 PEVLKRNYGPEVDVWSAGVILYIL 250
R Y E D+ S I IL
Sbjct: 169 ITYFSRTYRTEKDINS--AIDRIL 190
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 45.2 bits (106), Expect = 6e-06
Identities = 20/136 (14%), Positives = 44/136 (32%), Gaps = 4/136 (2%)
Query: 61 RELGRGEFGITYLCTDRENGDAFACK----SISKKKLRTAVDIEDVRREVDIMRHLPKHQ 116
+E+G G + D+E+ A K + I+ R E + +H
Sbjct: 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV 91
Query: 117 NIVCLKDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG 176
+ + Y D VME ++ + + G + + + + + + +
Sbjct: 92 PHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGKTLFYSSDYA 151
Query: 177 VMHRDLKPENFLFANK 192
+ + K F N
Sbjct: 152 LEPKVKKQLVKQFTNP 167
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 315 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.63 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.4 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.5 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.63 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-64 Score=427.59 Aligned_cols=252 Identities=34% Similarity=0.581 Sum_probs=227.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEE
Confidence 4799999999999999999999999999999999766555555667899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|...... .
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~---~kl~DFG~a~~~~~~-~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSS-R 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCSCSCCCCC-C
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC---EeecccceeeecCCC-c
Confidence 999999999999998888999999999999999999999999999999999999987665 899999999876543 3
Q ss_pred ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+.+....+ +..+++++.+||.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~ 236 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLIS 236 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----CTTSCHHHHHHHH
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC----CccCCHHHHHHHH
Confidence 456789999999999875 58999999999999999999999999888888877777654433 3458999999999
Q ss_pred HhcCCCcCCCCCHHHHhcccCC
Q 021233 294 KMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||+.||++|||+.|+|+|+||
T Consensus 237 ~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 237 RLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp HHTCSSGGGSCCHHHHHTCHHH
T ss_pred HHccCCHhHCcCHHHHHcCcCc
Confidence 9999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-64 Score=437.32 Aligned_cols=262 Identities=39% Similarity=0.732 Sum_probs=219.4
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
+.+.++|++++.||+|+||+||+|.+..+++.||+|++....... ....+.+|+.+|+.+ +||||+++++++.+.+.
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKI-KHPNIVALDDIYESGGH 81 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 356788999999999999999999999999999999997654332 235688999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.|+||||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+...+....+||+|||+|+...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 99999999999999999988889999999999999999999999999999999999999765556669999999998776
Q ss_pred CCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+.+.........++.+|+++.
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 6666667789999999999874 589999999999999999999999999888888888888877776667778999999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||++|||+.|+++|+||
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 99999999999999999999999997
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-63 Score=424.23 Aligned_cols=255 Identities=30% Similarity=0.510 Sum_probs=216.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
-++|++++.||+|+||+||+|++..+|+.||+|++...... ...+.+.+|+.+|+++ +||||+++++++.+.+..|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKML-NHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEE
Confidence 35799999999999999999999999999999998765322 2345689999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~---~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC---EEEccchhheeeccCC
Confidence 9999999999999988778999999999999999999999999999999999999986655 9999999998754332
Q ss_pred ---cccccccCCCccCchhhcc-c-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHH
Q 021233 214 ---KFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENA 288 (315)
Q Consensus 214 ---~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (315)
.....+||+.|+|||++.+ . ++.++|||||||++|||++|+.||................. .....+..+++++
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAP 236 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-TTSTTGGGSCHHH
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CCCCccccCCHHH
Confidence 2355689999999999864 3 46789999999999999999999976654433333332222 2234456789999
Q ss_pred HHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 289 KDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 289 ~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+||.+||+.||++|||+.|+|+|+||
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 999999999999999999999999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-63 Score=425.66 Aligned_cols=262 Identities=36% Similarity=0.665 Sum_probs=236.2
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC---hhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---AVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
+.++|++++.||+|+||+||+|++..+|+.||+|++.+..... ....+.+.+|+.+|+++ +|||||++++++.+.+
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKT 86 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence 6678999999999999999999999999999999987654322 23467899999999999 9999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCC-CCCEEEEeeccccc
Q 021233 130 AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKE-TAPLKAIDFGLSVF 208 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~-~~~vkl~Dfg~a~~ 208 (315)
..++||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. ...+||+|||+|..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999999998888999999999999999999999999999999999999987653 33599999999998
Q ss_pred cCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 209 FKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 209 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
...........||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+....+......+....++.++++
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 246 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHH
Confidence 776666677789999999999874 5899999999999999999999999998888888888777665554455678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+.+||.+||+.||++|||+.|+|+|+||
T Consensus 247 ~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 9999999999999999999999999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-62 Score=421.28 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=222.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++++.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+.+|+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc---ChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEE
Confidence 457999999999999999999999999999999987553 23457799999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||++||+|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 95 vmEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~---vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSTT
T ss_pred EEEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc---Eeeccchhheeecccc
Confidence 99999999999887654 6999999999999999999999999999999999999986655 9999999998765433
Q ss_pred -cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 214 -KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 214 -~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+...... ....+..+++++.+|
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~l 249 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDF 249 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHHH
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHHH
Confidence 3456689999999999874 5899999999999999999999999888877766666554322 223346789999999
Q ss_pred HHHhcCCCcCCCCCHHHHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
|.+||+.||++|||+.|+|+|+||
T Consensus 250 i~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred HHHHccCChhHCcCHHHHhcCHhh
Confidence 999999999999999999999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-62 Score=414.41 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=215.0
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----CCcEE
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----DTAVH 132 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----~~~~~ 132 (315)
|++.+.||+|+||+||+|.+..+++.||+|.+..... .....+.+.+|+++|+++ +||||+++++++.. ...++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEE
Confidence 4788899999999999999999999999999876543 334467799999999999 89999999999864 45689
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHG--VMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~--iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
+||||+++|+|.+++.....+++..++.++.||+.||+|||+++ |+||||||+|||++.+ ...+||+|||+|+...
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~--~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST--TSCEEECCTTGGGGCC
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC--CCCEEEeecCcceecc
Confidence 99999999999999998888999999999999999999999998 9999999999999642 2239999999998644
Q ss_pred CCCcccccccCCCccCchhhcccCCCcchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLKRNYGPEVDVWSAGVILYILLCGVPPFWAETEQG-VAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. .......||+.|+|||++.+.++.++|||||||++|||++|+.||....... ....+..... +.......++++.
T Consensus 167 ~-~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~ 243 (270)
T d1t4ha_ 167 A-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVK 243 (270)
T ss_dssp T-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHH
T ss_pred C-CccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCCHHHH
Confidence 3 3345678999999999998889999999999999999999999997654443 3344433321 1223345789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||++||++|||+.|+|+|+||
T Consensus 244 ~li~~~l~~dp~~R~s~~ell~Hp~f 269 (270)
T d1t4ha_ 244 EIIEGCIRQNKDERYSIKDLLNHAFF 269 (270)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHccCCHhHCcCHHHHhCCccc
Confidence 99999999999999999999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-62 Score=429.86 Aligned_cols=258 Identities=33% Similarity=0.613 Sum_probs=232.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+-++|++++.||+|+||+||+|++..+|+.||+|++.... ....+.+.+|+.+|+++ +|||||++++++.+.+.++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 4468999999999999999999999999999999987542 34457789999999999 8999999999999999999
Q ss_pred EEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+.. ..+||+|||+|+....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~-~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRS-NELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTS-CCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCC-CeEEEeecchheeccc
Confidence 99999999999999854 456999999999999999999999999999999999999975332 3599999999998877
Q ss_pred CCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+...........++.+++++.+
T Consensus 179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 766677899999999999874 5899999999999999999999999998888888888887776666666789999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
||.+||+.||++|||+.|+|+|+||
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~ 283 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWL 283 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTT
T ss_pred HHHHHccCChhHCcCHHHHhcCccc
Confidence 9999999999999999999999997
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-62 Score=421.89 Aligned_cols=253 Identities=32% Similarity=0.543 Sum_probs=223.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+++++++ +||||+++++++.+.+..|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999766554455667899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
|||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~---vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce---EEecccccceecccCCc
Confidence 999999999999998889999999999999999999999999999999999999986655 9999999998764332
Q ss_pred --cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 214 --KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 214 --~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+.+....+ +..+++++.+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~ 239 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKARD 239 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC----CTTCCHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCC----CccCCHHHHH
Confidence 2345689999999999874 58999999999999999999999999888888888887765433 3468999999
Q ss_pred HHHHhcCCCcCCCCCHHH------HhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQ------VLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e------~l~~l~f 315 (315)
||.+||+.||++|||++| +++|+||
T Consensus 240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff 270 (288)
T d1uu3a_ 240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270 (288)
T ss_dssp HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGG
T ss_pred HHHHHccCCHhHCcCHHHHcCCHHHHcCCcc
Confidence 999999999999999987 5778886
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-61 Score=413.00 Aligned_cols=259 Identities=38% Similarity=0.670 Sum_probs=233.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccCh------hcHHHHHHHHHHHHhCCCCCCcceeEEEEEc
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTA------VDIEDVRREVDIMRHLPKHQNIVCLKDTYED 127 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~------~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 127 (315)
.++|++++.||+|+||+||+|++..+|+.||+|++.+...... ...+.+.+|+.+++++..||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4689999999999999999999999999999999976543321 1234688999999999669999999999999
Q ss_pred CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
.+..|+||||++||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~---~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC---eEEccchhee
Confidence 9999999999999999999998889999999999999999999999999999999999999976555 8999999999
Q ss_pred ccCCCCcccccccCCCccCchhhcc-------cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKR-------NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP 280 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 280 (315)
............||+.|+|||.+.+ .++.++||||+||++++|++|+.||...+.......+.+.....+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 8776666667789999999998742 368899999999999999999999999998888888888776666666
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+|+++.+||.+||+.||++|||+.|+|+|+||
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 77899999999999999999999999999999997
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-61 Score=427.60 Aligned_cols=258 Identities=33% Similarity=0.623 Sum_probs=233.4
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+.++|++++.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+|+++ +||||++++++|..++.+|
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 4567999999999999999999999999999999987542 33456788999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||++||+|.+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++... ...+||+|||+|.....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~-~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-CCCEEECCCTTCEECCT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccC-CCeEEEeecccceecCC
Confidence 9999999999998876544 599999999999999999999999999999999999997422 23499999999998877
Q ss_pred CCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKD 290 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (315)
........||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+.+....++...++.+++++.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 766777899999999999874 5899999999999999999999999999998888899888777777777889999999
Q ss_pred HHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 291 LVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 291 li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
||.+||+.||.+|||+.|+|+|+||
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred HHHHHccCChhHCcCHHHHhcCHhh
Confidence 9999999999999999999999997
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-62 Score=422.98 Aligned_cols=253 Identities=29% Similarity=0.429 Sum_probs=224.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.+.|++++.||+|+||+||+|++..+++.||||++...........+.+.+|+.+|+++ +|||||++++++...+..++
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEE
Confidence 45699999999999999999999999999999999876555555567799999999999 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
||||+++|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~---~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAP-- 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE---EEECCCTTCBSSSS--
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC---EEEeecccccccCC--
Confidence 9999999999888777888999999999999999999999999999999999999987655 89999999986543
Q ss_pred cccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.....||+.|+|||++. +.|+.++|||||||++|||++|..||......+....+....... .....+++++.
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~s~~~~ 244 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--LQSGHWSEYFR 244 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CSCTTSCHHHH
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--CCCCCCCHHHH
Confidence 23468999999999974 348999999999999999999999999888877777776654332 22346899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||++|||+.|+|+|+||
T Consensus 245 ~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 245 NFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 99999999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-62 Score=418.78 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=221.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
+.|++++.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+++|+++ +|||||++++++...+..++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEE
Confidence 5699999999999999999999999999999998654 233456788999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
|||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|......
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~---~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTI 164 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC---EEEEechhhhccCCCc
Confidence 999999999998765 456999999999999999999999999999999999999987665 899999999764322
Q ss_pred CcccccccCCCccCchhhc------ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCH
Q 021233 213 EKFSEIVGSPYYMAPEVLK------RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSE 286 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~------~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (315)
.......||+.|+|||++. ..++.++|||||||++|||++|+.||......+....+....... ...+..+++
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~ 243 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSS 243 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-CSSGGGSCH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCccccCCH
Confidence 2234568999999999873 347899999999999999999999999888888887777664322 233457899
Q ss_pred HHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 287 NAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 287 ~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
++.+||.+||+.||++|||+.|+|+|+||
T Consensus 244 ~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 244 NFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 99999999999999999999999999997
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-61 Score=412.21 Aligned_cols=253 Identities=30% Similarity=0.524 Sum_probs=210.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--CCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 132 (315)
++|++++.||+|+||+||+|++..+|+.||+|.+..... .....+.+.+|+++++++ +||||+++++++.+ .+.+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 579999999999999999999999999999999977644 334467799999999999 99999999999864 46789
Q ss_pred EEEEecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCceEeecCCCCCCEEEEee
Q 021233 133 LVMELCEGGELFDRIVA----RGHYTERAAAAVTKTIVEVVQMCHKHG-----VMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~~l~~~L~~lH~~~-----iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.| |+||||||+|||++.++. +||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~---vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC---EEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc---EEEeec
Confidence 99999999999998863 456999999999999999999999976 999999999999987655 999999
Q ss_pred ccccccCCCC-cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 204 GLSVFFKPGE-KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 204 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
|+|+...... ......||+.|+|||++. ..++.++|||||||++|||+||+.||......+....+...... ..+
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~---~~~ 235 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR---RIP 235 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---CCC
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC---CCC
Confidence 9998765443 335578999999999987 45899999999999999999999999988888877777765432 234
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
..+++++.+||.+||+.||.+|||+.|+|+|+|.
T Consensus 236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 5689999999999999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-61 Score=419.42 Aligned_cols=253 Identities=30% Similarity=0.550 Sum_probs=229.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+|+.+ +||||+++++++.+.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccc
Confidence 4799999999999999999999999999999999876554555678899999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC-CC
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP-GE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~-~~ 213 (315)
|||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.... ..
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~---vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC---EEEeecccccccccCCc
Confidence 999999999999999889999999999999999999999999999999999999987655 99999999987543 34
Q ss_pred cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 214 KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
.....+||+.|+|||++. ..++.++|||||||++|||++|+.||...+..+....+......+ +..+++++.+||
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~dli 236 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLL 236 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC----CccCCHHHHHHH
Confidence 456679999999999987 459999999999999999999999999999888888887765443 456899999999
Q ss_pred HHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 293 RKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 293 ~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
.+||++||.+||+ +.|+++|+||
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred HhhccCCchhhcccccccHHHHHcCccc
Confidence 9999999999995 9999999997
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-60 Score=413.99 Aligned_cols=251 Identities=28% Similarity=0.528 Sum_probs=227.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeE
Confidence 4799999999999999999999999999999999766544455678899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||++||+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~---vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPDV-- 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC---EEECCCSSCEECSSC--
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC---EEEecCccceEeccc--
Confidence 999999999999999888999999999999999999999999999999999999986655 999999999876433
Q ss_pred ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+....+.+....+ ++.+++++.++|.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~ 233 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLS 233 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC----CTTSCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC----CCCCCHHHHHHHH
Confidence 345789999999999875 58999999999999999999999999988888888887765433 3468999999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcccCC
Q 021233 294 KMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+||..||.+|| |++++++|+||
T Consensus 234 ~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 234 RLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp HHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred HHhhhCHHhccccchhhHHHHHcCccc
Confidence 99999999996 99999999997
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-61 Score=418.12 Aligned_cols=258 Identities=31% Similarity=0.612 Sum_probs=231.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+-++|++++.||+|+||+||+|.+..+++.||+|++.... .+...+.+|+++|+.+ +||||++++++|.+.+.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIA-RHRNILHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEE
Confidence 35578999999999999999999999999999999997542 2345688999999999 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~-~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC-ceEEEEcccchhhccc
Confidence 99999999999999998665 699999999999999999999999999999999999997543 3459999999999876
Q ss_pred CCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 211 PGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 211 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
.........+|+.|+|||.+. ..++.++|||||||++|+|++|..||......+....+.+....++...++.+++++.
T Consensus 156 ~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 235 (321)
T d1tkia_ 156 PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235 (321)
T ss_dssp TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence 666666778999999999986 4589999999999999999999999999999888888888776665555667899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+||.+||+.||++|||+.|+|+|+||
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhh
Confidence 99999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-61 Score=421.57 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=212.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
.+++|++++.||+|+||+||+|++..+|+.||+|++.... .....+.+.+|+.+|+.+ +|||||+++++|...+.++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEE
Confidence 4678999999999999999999999999999999987542 233457789999999999 9999999999999999999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
+||||++||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.++. +||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~---vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC---EEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC---EEEeeCCCccccCC
Confidence 999999999999999988889999999999999999999997 59999999999999986655 99999999986533
Q ss_pred CCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHh-------------------
Q 021233 212 GEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIR------------------- 271 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~------------------- 271 (315)
. ...+.+||+.|+|||++.+ .|+.++||||+||+++||++|+.||..............
T Consensus 158 ~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 S-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp H-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred C-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2 2345689999999999874 699999999999999999999999976543321110000
Q ss_pred -------------------ccc-cC-CCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 272 -------------------SVL-DF-RRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 272 -------------------~~~-~~-~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
... .. +..+...++.++.+||.+||+.||.+|||+.|+|+|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhh
Confidence 000 00 001112367899999999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-59 Score=414.84 Aligned_cols=251 Identities=28% Similarity=0.514 Sum_probs=226.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+|+.||+|++.+.........+.+.+|+.+|+.+ +||||+++++++......++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccc
Confidence 5799999999999999999999999999999999766554555677899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
|||+.||+|.+.+...+.+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~---ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECSSC--
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC---EEeeeceeeeecccc--
Confidence 999999999999998889999999999999999999999999999999999999976654 999999999876433
Q ss_pred ccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHHH
Q 021233 215 FSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVR 293 (315)
Q Consensus 215 ~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 293 (315)
.....||+.|||||++.+ .++.++|||||||++|+|+||+.||...........+...... .+..+++++.+||.
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~----~p~~~s~~~~~li~ 270 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR----FPSHFSSDLKDLLR 270 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----CCTTCCHHHHHHHH
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC----CCccCCHHHHHHHH
Confidence 345689999999999874 5899999999999999999999999988888888888776443 33568999999999
Q ss_pred HhcCCCcCCCC-----CHHHHhcccCC
Q 021233 294 KMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 294 ~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+||+.||.+|+ |+.++++|+||
T Consensus 271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred HHhhhCHHhccccccccHHHHHcCccc
Confidence 99999999994 99999999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.7e-59 Score=414.44 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=217.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHH---HHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRRE---VDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e---~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+| +.+++.+ +|||||++++++...+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence 469999999999999999999999999999999876544333333444444 6666666 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 132 HLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
|+||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~---iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC---EEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc---EEEeeeceeeecCC
Confidence 999999999999999998888999999999999999999999999999999999999976655 99999999987654
Q ss_pred CCcccccccCCCccCchhhc-c-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK-R-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. ......||+.|+|||++. + .++.++|||||||++|||+||+.||......+.. .+.+.........+..+++++.
T Consensus 160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH-HHHHHSSSCCCCCCSSSCHHHH
T ss_pred C-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcccCCCCCCCCCCHHHH
Confidence 3 334568999999999985 3 4899999999999999999999999765544332 2333333444455567999999
Q ss_pred HHHHHhcCCCcCCCCC-----HHHHhcccCC
Q 021233 290 DLVRKMLDPDPKRRLT-----AQQVLGKIEF 315 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps-----~~e~l~~l~f 315 (315)
+||.+||+.||++||| ++|+++|+||
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 9999999999999999 7999999997
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-60 Score=416.54 Aligned_cols=255 Identities=35% Similarity=0.636 Sum_probs=214.9
Q ss_pred cccceeeee-eeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc----
Q 021233 53 IEERYELGR-ELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED---- 127 (315)
Q Consensus 53 ~~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~---- 127 (315)
+-++|+++. .||+|+||+||+|.+..+++.||+|++... ..+.+|+.++.++.+||||++++++|.+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 446798875 699999999999999999999999998532 5678899998766689999999999875
Q ss_pred CCcEEEEEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 128 DTAVHLVMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 128 ~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
+..+|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++....+||+|||+
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccce
Confidence 467899999999999999998653 599999999999999999999999999999999999998777677799999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhc----cccCCCCC
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS----VLDFRRDP 280 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 280 (315)
|+............||+.|+|||++.+ .++.++|||||||++|+|+||+.||.+.........+... ...++...
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 998776666677899999999999874 5999999999999999999999999766544443333322 22233333
Q ss_pred CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+..+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence 45689999999999999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-59 Score=407.42 Aligned_cols=253 Identities=28% Similarity=0.456 Sum_probs=223.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHH-hCCCCCCcceeEEEEEcCCcEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMR-HLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~-~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
++|++++.||+|+||+||+|.+..+++.||+|++.+.........+.+..|..++. .+ +||||+++++++.+.+..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHT-TCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhC-CCCcEEEEEEEEccCCceeE
Confidence 47999999999999999999999999999999997654444445566777777766 56 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC-
Q 021233 134 VMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG- 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~- 212 (315)
||||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+++++. +||+|||+|+.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~---~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc---eeccccchhhhccccc
Confidence 9999999999999998888999999999999999999999999999999999999986655 899999999865443
Q ss_pred CcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHH
Q 021233 213 EKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDL 291 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 291 (315)
.......||+.|+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+...... .+..+++++.+|
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~----~p~~~s~~~~dl 233 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF----YPRWLEKEAKDL 233 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----CCTTSCHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC----CCccCCHHHHHH
Confidence 3345568999999999987 46999999999999999999999999998888888877765433 334689999999
Q ss_pred HHHhcCCCcCCCCCHH-HHhcccCC
Q 021233 292 VRKMLDPDPKRRLTAQ-QVLGKIEF 315 (315)
Q Consensus 292 i~~~l~~~P~~Rps~~-e~l~~l~f 315 (315)
|.+||+.||++|||+. ++++|+||
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred HHHhcccCCCCCcCHHHHHHhCchh
Confidence 9999999999999995 89999997
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.2e-59 Score=399.61 Aligned_cols=259 Identities=28% Similarity=0.431 Sum_probs=219.9
Q ss_pred cccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC-
Q 021233 51 REIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT- 129 (315)
Q Consensus 51 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~- 129 (315)
..+.++|++.+.||+|+||+||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||+++++++...+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETP 81 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccC
Confidence 35678999999999999999999999999999999999876655566667899999999999 9999999999987643
Q ss_pred ---cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 130 ---AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 130 ---~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
..|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||.+
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~---~~l~d~~~~ 158 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIA 158 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC---EEECCCTTC
T ss_pred CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc---ceeehhhhh
Confidence 37999999999999999998889999999999999999999999999999999999999987666 899999998
Q ss_pred cccCCCC----cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 207 VFFKPGE----KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 207 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
....... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||......+....+.......+...+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence 7553322 2345689999999999874 5899999999999999999999999988888777777766555444556
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCC-CHHHHhccc
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRL-TAQQVLGKI 313 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rp-s~~e~l~~l 313 (315)
+.+|+++.++|.+||++||++|| |++++++.|
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 77999999999999999999999 788887654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-59 Score=402.12 Aligned_cols=253 Identities=27% Similarity=0.391 Sum_probs=211.1
Q ss_pred eeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChh--cHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEE
Q 021233 59 LGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV--DIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVME 136 (315)
Q Consensus 59 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 136 (315)
.++.||+|+||+||+|++..+|+.||+|++......... ..+.+.+|+.+|+.+ +||||+++++++...+..++|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhh
Confidence 468899999999999999999999999998765432211 134688999999999 99999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-cc
Q 021233 137 LCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE-KF 215 (315)
Q Consensus 137 ~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~-~~ 215 (315)
|+.++++......+..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|....... ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~---~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCCGGGSTTTSCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc---cccccCccccccCCCcccc
Confidence 9988777766666667999999999999999999999999999999999999986655 9999999998764433 33
Q ss_pred cccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC-------------
Q 021233 216 SEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP------------- 280 (315)
Q Consensus 216 ~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------- 280 (315)
....||+.|+|||++. ..++.++|||||||++|||++|..||......+....+.+.........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 4568999999999875 3479999999999999999999999999888887777765432221111
Q ss_pred -----------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 -----------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 -----------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 13468899999999999999999999999999997
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-59 Score=396.57 Aligned_cols=252 Identities=23% Similarity=0.419 Sum_probs=206.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||+||+|++. ..||||++..... .....+.+.+|+.+|.++ +|||||++++++.. +..++
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cEEEE
Confidence 357999999999999999999753 4699999876533 334567899999999999 99999999998754 56899
Q ss_pred EEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+++|+|.+++... ..+++..+..++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~---~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS---EEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC---EEEccccceeecccc
Confidence 99999999999999764 45999999999999999999999999999999999999987655 899999999765432
Q ss_pred C---cccccccCCCccCchhhc----ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH-hccccC-CCCCCcc
Q 021233 213 E---KFSEIVGSPYYMAPEVLK----RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAII-RSVLDF-RRDPWPK 283 (315)
Q Consensus 213 ~---~~~~~~gt~~y~aPE~~~----~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~-~~~~~~~ 283 (315)
. ......||+.|||||++. +.++.++|||||||++|||+||+.||............. +..... .......
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 2 234568999999999985 237899999999999999999999998766555444443 332211 1223456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
+|+++.+||.+||+.||++|||+.+++++|+
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 8999999999999999999999999998875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.2e-58 Score=396.80 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=204.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCC---EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGD---AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.++|++.+.||+|+||+||+|.+..+++ .||+|.+.... .....+.+.+|+.+|+++ +|||||++++++...+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCE
Confidence 3579999999999999999999876664 58888876432 334456799999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++|+|.+++... +.+++..++.++.|++.||.|||+++|+||||||+|||++.++. +||+|||+|+..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~---~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc---EEECCcccceEc
Confidence 99999999999999988764 45999999999999999999999999999999999999976555 999999999876
Q ss_pred CCCCcc------cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCC
Q 021233 210 KPGEKF------SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPW 281 (315)
Q Consensus 210 ~~~~~~------~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (315)
...... ....||+.|+|||.+. +.++.++|||||||++|||+| |+.||......+....+.+.. +.+.+
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~---~~~~~ 255 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY---RLPPP 255 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---CCCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCC
Confidence 443221 1235788999999986 569999999999999999998 899999888887777776542 33445
Q ss_pred ccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 282 PKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 282 ~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..+++++.+||.+||+.||++|||+.|+++.|
T Consensus 256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 67899999999999999999999999998775
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-58 Score=396.79 Aligned_cols=249 Identities=20% Similarity=0.320 Sum_probs=212.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+++.+|+.+|+++ +|||||++++++...+..++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEE
Confidence 357999999999999999999999999999999986542 3457899999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~---~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTG 167 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCCTTTCCS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc---EEEccccceeecCC
Confidence 99999999999999764 45899999999999999999999999999999999999987655 99999999987654
Q ss_pred CCcc--cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCC-CCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEKF--SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFW-AETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~~--~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.... ....||+.|+|||++. +.++.++|||||||++|||++|..||. ..........+... .+...+..++++
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~ 244 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD---YRMERPEGCPEK 244 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT---CCCCCCTTCCHH
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC---CCCCCCccchHH
Confidence 4322 3346789999999876 569999999999999999999766654 44444444444332 334455678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+||.+||+.||++|||+.++++.|
T Consensus 245 l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 245 VYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 99999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-58 Score=388.83 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=204.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+. ++..||||++.... ...+++.+|+++++++ +||||+++++++...+..++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc----CcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEE
Confidence 47999999999999999999986 57789999987532 3357799999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++|+|.+++... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++. +||+|||+|+......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~---~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC---EEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC---eEecccchheeccCCC
Confidence 9999999999998755 45899999999999999999999999999999999999987665 9999999998764433
Q ss_pred c--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 214 K--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 214 ~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. .....||+.|+|||++. ..++.++||||||+++|||+| |.+||......+....+..... ...+..+++++.
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---LYKPRLASTHVY 232 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC---CCCCTTSCHHHH
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC---CCCccccCHHHH
Confidence 2 23457899999999987 469999999999999999999 5777777777677777666432 333456789999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccc
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+||.+||+.||++|||+.|++++|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHH
Confidence 999999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-58 Score=401.37 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=212.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCC-----EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGD-----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT 129 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 129 (315)
++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.++.++.+|||||++++++...+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 579999999999999999999875543 68999886543 23345678999999999878999999999999999
Q ss_pred cEEEEEEecCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 021233 130 AVHLVMELCEGGELFDRIVARG-----------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPEN 186 (315)
Q Consensus 130 ~~~lv~e~~~~~sL~~~l~~~~-----------------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~N 186 (315)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||++|||||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 9999999999999999997542 38899999999999999999999999999999999
Q ss_pred eEeecCCCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCC
Q 021233 187 FLFANKKETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAET 261 (315)
Q Consensus 187 ill~~~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~ 261 (315)
||++.++. +||+|||+|+....... .....||+.|+|||++. +.++.++|||||||++|||+| |..||.+..
T Consensus 195 ill~~~~~---~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 195 VLVTHGKV---VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp EEEETTTE---EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccccCCe---EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99987655 99999999986543332 23457899999999876 669999999999999999998 899998776
Q ss_pred hHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 262 EQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.......+.+.. .+.+.+..+++++.+||.+||+.||++|||+.||+++|
T Consensus 272 ~~~~~~~~~~~~--~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 272 VDANFYKLIQNG--FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CSHHHHHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHhcC--CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 665555555543 23344567899999999999999999999999999986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-58 Score=392.62 Aligned_cols=250 Identities=30% Similarity=0.500 Sum_probs=211.9
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChh---cHHHHHHHHHHHHhCC-CCCCcceeEEEEEcC
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAV---DIEDVRREVDIMRHLP-KHQNIVCLKDTYEDD 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~---~~~~~~~e~~~l~~l~-~h~~iv~~~~~~~~~ 128 (315)
++++|++.+.||+|+||+||+|++..+|+.||+|++.+....... ...++.+|+.+++++. .||||+++++++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 467899999999999999999999999999999999765433221 2234678999999983 389999999999999
Q ss_pred CcEEEEEEecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 TAVHLVMELCEG-GELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 ~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
+..++||||+.+ +++.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+. ..+||+|||+|.
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~--~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR--GELKLIDFGSGA 159 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCE
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC--CeEEECccccce
Confidence 999999999975 67888888888899999999999999999999999999999999999998543 238999999998
Q ss_pred ccCCCCcccccccCCCccCchhhcc-c-CCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKR-N-YGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.... .......||+.|+|||++.+ . ++.++|||||||++|+|++|+.||... ..+.+.... ..+.+|
T Consensus 160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~----~~~~~s 228 (273)
T d1xwsa_ 160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF----FRQRVS 228 (273)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCC----CSSCCC
T ss_pred eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccC----CCCCCC
Confidence 6543 33456789999999999863 3 567899999999999999999999652 233343332 334689
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+++.+||.+||+.||++|||+.|+|+|+||
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 999999999999999999999999999997
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-57 Score=391.52 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=212.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+++|+++ +||||+++++++...+..++|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEE
Confidence 479999999999999999999999999999999975532 233457889999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 135 MELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
|||+.+ ++.+.+.. ...+++..++.++.|++.||+|||++|||||||||+|||++.++. +||+|||.|+.....
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~---~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSTTHHHHHCCC
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc---ceeccCCcceeccCC
Confidence 999966 55455443 345999999999999999999999999999999999999976554 899999999876543
Q ss_pred -CcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCC---------
Q 021233 213 -EKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDP--------- 280 (315)
Q Consensus 213 -~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 280 (315)
.......||+.|+|||.+. ..++.++|||||||++|+|++|+.||......+....+.+.........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 3345568999999999865 3368999999999999999999999998887777666654322211111
Q ss_pred ----------------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 281 ----------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 281 ----------------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 12467899999999999999999999999999997
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-57 Score=383.44 Aligned_cols=247 Identities=22% Similarity=0.348 Sum_probs=215.8
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|+++ ++..||||.+.... ...+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc----CCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEE
Confidence 47999999999999999999985 67899999987543 2346799999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC
Q 021233 135 MELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~ 213 (315)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~---~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC---EEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc---EEECcchhheeccCCC
Confidence 999999999998764 456999999999999999999999999999999999999976554 9999999998654433
Q ss_pred c--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 214 K--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 214 ~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. .....||+.|+|||.+. ..++.++||||||+++|||+| |+.||...+..+....+.+.. +...+..+++++.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~---~~~~p~~~~~~l~ 231 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL---RLYRPHLASEKVY 231 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC---CCCCCTTCCHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC---CCCCcccccHHHH
Confidence 2 23457899999999987 569999999999999999998 899999988888887777643 3334567899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccc
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+||.+||+.||++|||+.+++++|
T Consensus 232 ~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 232 TIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHh
Confidence 999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=388.31 Aligned_cols=249 Identities=25% Similarity=0.321 Sum_probs=210.6
Q ss_pred cceeeeee-eeeecceEEEEEEECCC--CCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGRE-LGRGEFGITYLCTDREN--GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~~-lg~G~~g~Vy~~~~~~~--~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
++|.+.+. ||+|+||+||+|.++.+ +..||||++.... .....+++.+|+++|+++ +|||||++++++.. +.+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeE
Confidence 46888884 99999999999987643 4579999986542 344567899999999999 99999999999875 468
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~---~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE---EEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc---eeeccchhhhccc
Confidence 9999999999999987654 56999999999999999999999999999999999999987665 8999999998765
Q ss_pred CCCc----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 211 PGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 211 ~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
.... .....||+.|+|||++. +.++.++|||||||++|||+| |+.||......+....+.++. ++..++.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~---~~~~p~~~ 237 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPEC 237 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---CCCCCTTC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---CCCCCCcC
Confidence 4332 23456889999999986 569999999999999999998 999999888777777776543 33445678
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
|+++.+||.+||+.||++|||+.+|++.|
T Consensus 238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L 266 (285)
T d1u59a_ 238 PPELYALMSDCWIYKWEDRPDFLTVEQRM 266 (285)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 99999999999999999999999997654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=387.44 Aligned_cols=243 Identities=22% Similarity=0.314 Sum_probs=204.9
Q ss_pred eeeeeecceEEEEEEECC--CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEEEEec
Q 021233 61 RELGRGEFGITYLCTDRE--NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLVMELC 138 (315)
Q Consensus 61 ~~lg~G~~g~Vy~~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 138 (315)
+.||+|+||+||+|.+.. +++.||+|++.... .+....+.+.+|+.+|+++ +|||||++++++..+ ..++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC-CEEEEEEcC
Confidence 469999999999998653 45789999986543 2334467899999999999 999999999998654 578999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCcc---
Q 021233 139 EGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEKF--- 215 (315)
Q Consensus 139 ~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~~--- 215 (315)
++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+........
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~---~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc---ccccchhhhhhcccccccccc
Confidence 99999999998888999999999999999999999999999999999999987666 899999999876543322
Q ss_pred -cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHHHHH
Q 021233 216 -SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLV 292 (315)
Q Consensus 216 -~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (315)
....||+.|+|||++. +.++.++|||||||++|||+| |+.||......+....+.+.. ++..+..+|+++.+||
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~---~~~~p~~~~~~~~~li 243 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---RMGCPAGCPREMYDLM 243 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTCCHHHHHHH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC---CCCCCcccCHHHHHHH
Confidence 3357899999999986 568999999999999999998 899999888877777666542 3344567899999999
Q ss_pred HHhcCCCcCCCCCHHHHhcc
Q 021233 293 RKMLDPDPKRRLTAQQVLGK 312 (315)
Q Consensus 293 ~~~l~~~P~~Rps~~e~l~~ 312 (315)
.+||+.||++|||+.+|+..
T Consensus 244 ~~cl~~dp~~RPs~~~i~~~ 263 (277)
T d1xbba_ 244 NLCWTYDVENRPGFAAVELR 263 (277)
T ss_dssp HHHTCSSTTTSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=385.80 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=208.5
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++++.||+|+||+||+|.++ +++.||||++.... ...+.+.+|+.+++++ +|||||++++++.. +..++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc----CCHHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeEE
Confidence 468999999999999999999975 57889999986542 3357799999999999 99999999998755 56799
Q ss_pred EEEecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVAR--GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||+|+....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~---~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc---eeeccccceEEccC
Confidence 99999999999877533 35999999999999999999999999999999999999986655 99999999987654
Q ss_pred CCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
... .....||+.|+|||++. +.++.++|||||||++|||+|| .+|+......+..+.+.... +...+..++++
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~---~~~~p~~~~~~ 238 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMVRPDNCPEE 238 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTCCHH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---CCCCcccChHH
Confidence 432 23457899999999987 5699999999999999999995 56666666666666666543 33344578999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+||.+||+.||++|||+.++++.|
T Consensus 239 l~~li~~cl~~~P~~Rpt~~ei~~~L 264 (272)
T d1qpca_ 239 LYQLMRLCWKERPEDRPTFDYLRSVL 264 (272)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence 99999999999999999999998854
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-57 Score=391.12 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=212.1
Q ss_pred cccceeeeeeeeeecceEEEEEEECCC-CCEEEEEEcccccccChhcHHHHHHHHHHHHhCC--CCCCcceeEEEEEc--
Q 021233 53 IEERYELGRELGRGEFGITYLCTDREN-GDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP--KHQNIVCLKDTYED-- 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~h~~iv~~~~~~~~-- 127 (315)
.+++|++++.||+|+||+||+|++..+ ++.||+|++....... .....+.+|+.+++.|. +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 357899999999999999999999765 5679999987653322 22234556777766652 79999999999853
Q ss_pred ---CCcEEEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEee
Q 021233 128 ---DTAVHLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDF 203 (315)
Q Consensus 128 ---~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Df 203 (315)
....+++|||++++++...... ...+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~---~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC---eeecch
Confidence 3568999999988766544443 345899999999999999999999999999999999999986665 899999
Q ss_pred ccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCC-----
Q 021233 204 GLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFR----- 277 (315)
Q Consensus 204 g~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 277 (315)
|++.............||+.|+|||++. ..++.++||||+||++|||++|+.||...+..+....+.+......
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 9998766556667789999999999976 5699999999999999999999999998888877777654322111
Q ss_pred ------------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ------------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ------------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+..+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 01234578999999999999999999999999999997
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-56 Score=384.56 Aligned_cols=255 Identities=31% Similarity=0.479 Sum_probs=213.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|.+. +|+.||+|++..... .....+++.+|+.+|+++ +||||+++++++...+..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEE
Confidence 58999999999999999999985 789999999976543 233457899999999999 899999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCCc
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGEK 214 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~~ 214 (315)
+|++.++.+.......+.+++..++.++.||+.||+|||+.||+||||||+|||++.++. +||+|||.|........
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~---~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC---EEecccccceecccCcc
Confidence 999987666666666777999999999999999999999999999999999999987655 89999999987654332
Q ss_pred -ccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC-------------
Q 021233 215 -FSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------------- 278 (315)
Q Consensus 215 -~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 278 (315)
.....+++.|+|||.+. ..++.++|||||||+++||++|+.||......+....+.........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 34457899999999975 34799999999999999999999999888777776666543222111
Q ss_pred ------------CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ------------DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ------------~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
...+.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 1124568899999999999999999999999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=379.22 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=202.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCC----CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENG----DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
+.|++.++||+|+||+||+|.+..++ ..||||.+.... .......+.+|+.+++++ +|||||++++++...+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCc
Confidence 46999999999999999999987554 469999986542 233456789999999999 99999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+.++++.+.+... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++. +||+|||+|+..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~---~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe---EEEcccchhhcc
Confidence 99999999999999888755 46999999999999999999999999999999999999986655 999999999876
Q ss_pred CCCCc----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHhccccCCCCCCcc
Q 021233 210 KPGEK----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPWPK 283 (315)
Q Consensus 210 ~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (315)
..... .....||+.|+|||++. +.++.++||||||+++|||+++ .+|+......+....+... .+++.+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~---~~~~~~~~ 237 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMD 237 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc---CCCCCchh
Confidence 43322 22346899999999886 5699999999999999999995 4555555666565555543 23344456
Q ss_pred CCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 284 VSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 284 ~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++++.+||.+||+.||++|||+.||++.|
T Consensus 238 ~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 238 CPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp CBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred hHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 899999999999999999999999998765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-56 Score=378.72 Aligned_cols=250 Identities=27% Similarity=0.349 Sum_probs=203.6
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCC---CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.++|++++.||+|+||+||+|.+..++ ..||+|.+... ......+.+.+|+.+++++ +||||+++++++. ++.
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCe
Confidence 368999999999999999999986543 46888887543 2344467799999999999 9999999999996 467
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||+++.++. +||+|||+|+..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~---~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc---EEEccchhheec
Confidence 89999999999999987654 45999999999999999999999999999999999999987666 999999999875
Q ss_pred CCCCc--ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 210 KPGEK--FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 210 ~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
..... .....||+.|+|||++. +.++.++|||||||++|||++ |.+||......+....+.... +.+.++.+|
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~---~~~~~~~~~ 235 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCP 235 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC---CCCCCTTCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---CCCCCCCCC
Confidence 43322 23457899999999987 569999999999999999998 899999888888877776643 234556789
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++.+||.+||+.||++|||+.||+++|
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=382.98 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=206.5
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCC----EEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGD----AFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
.+|++++.||+|+||+||+|.+..+|+ .||+|.+... ......+.+.+|+.+++++ +|||||++++++.+. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-C
Confidence 369999999999999999999987776 4777876543 2334467899999999999 999999999999875 5
Q ss_pred EEEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccccc
Q 021233 131 VHLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFF 209 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~ 209 (315)
.++++||+.+++|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~---~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC---eEeeccccceec
Confidence 67888999999999888764 46999999999999999999999999999999999999987665 899999999876
Q ss_pred CCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 210 KPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 210 ~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
...... ....||+.|+|||++. +.++.++||||||+++|||+| |.+||......+....+.... +...++.+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~---~~~~p~~~ 238 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---RLPQPPIC 238 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC---CCCCCTTB
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCCccc
Confidence 543322 3346899999999876 569999999999999999998 899998887777766666543 23344578
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
++++.+||.+||+.||.+|||+.+++.+|+
T Consensus 239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 239 TIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 999999999999999999999999998763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=383.13 Aligned_cols=256 Identities=27% Similarity=0.445 Sum_probs=211.4
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-------
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------- 127 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------- 127 (315)
++|++++.||+|+||+||+|++..+|+.||||++..... ......++.+|+.+|+++ +|||++++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 689999999999999999999999999999999876543 233457788999999999 89999999998854
Q ss_pred -CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 -DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
....++||||+.++++.........+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~---~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc---EEeeeccee
Confidence 3468999999987666555555567999999999999999999999999999999999999987655 999999999
Q ss_pred cccCCCC-----cccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCC
Q 021233 207 VFFKPGE-----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRD 279 (315)
Q Consensus 207 ~~~~~~~-----~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 279 (315)
....... .....+||+.|+|||++. ..++.++|||||||+++||++|+.||.+.........+.+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 7654322 223457999999999975 358999999999999999999999999888877777776655443333
Q ss_pred CCcc----------------------------CCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 280 PWPK----------------------------VSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 280 ~~~~----------------------------~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.+.. .++++.+||.+||+.||++|||+.|+|.|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence 2211 26678899999999999999999999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=386.04 Aligned_cols=251 Identities=28% Similarity=0.407 Sum_probs=208.9
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc------C
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED------D 128 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~------~ 128 (315)
-+|+.+++||+|+||+||+|++..+|+.||+|++..... ...+|+.+|+++ +||||++++++|.. .
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCc
Confidence 369999999999999999999999999999999865431 234799999999 99999999999853 3
Q ss_pred CcEEEEEEecCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 129 TAVHLVMELCEGGELFDRI---VARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l---~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
.++++||||++++.+.... .....+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~--~~kl~DFG~ 169 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA--VLKLCDFGS 169 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC--CEEECCCTT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC--ceeEecccc
Confidence 3578999999765433332 23456999999999999999999999999999999999999976543 389999999
Q ss_pred ccccCCCCcccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC-------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------- 276 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 276 (315)
+..........+..||+.|+|||.+. ..++.++||||+||++|||++|+.||......+....+.+.....
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 98877666667778999999999865 358999999999999999999999998888777666654321110
Q ss_pred ----------C--------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ----------R--------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ----------~--------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
+ ....+.+++++.+||.+||..||++|||+.|+|+|+||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 0 01123578999999999999999999999999999997
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-56 Score=384.54 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=210.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCE--EEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDA--FACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
++|++.+.||+|+||+||+|++..++.. ||||.+... ......+.+.+|+++|.++.+||||+++++++...+..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 5799999999999999999999887765 667766432 233345679999999999867999999999999999999
Q ss_pred EEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCC
Q 021233 133 LVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETA 196 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~ 196 (315)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~-- 165 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-- 165 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--
Confidence 999999999999998653 45899999999999999999999999999999999999987655
Q ss_pred CEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCC-CCCCCCChHHHHHHHHhccc
Q 021233 197 PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWAETEQGVAQAIIRSVL 274 (315)
Q Consensus 197 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~ 274 (315)
+||+|||+|+............||+.|+|||.+. +.++.++||||||+++|||++|. +||...+..+....+.+.
T Consensus 166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-- 242 (309)
T d1fvra_ 166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-- 242 (309)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT--
T ss_pred -eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc--
Confidence 8999999998765444445567899999999986 56999999999999999999965 578777777766666554
Q ss_pred cCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 275 DFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 275 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
.++..+..+++++.+||.+||+.||++|||+.||+++|
T Consensus 243 -~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 33445567899999999999999999999999999876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-56 Score=377.36 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=204.1
Q ss_pred cceeeeeeeeeecceEEEEEEECCC-C--CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 55 ERYELGRELGRGEFGITYLCTDREN-G--DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~-~--~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
++|++.+.||+|+||.||+|.+..+ + ..||+|++...........+++.+|+.+|+++ +||||+++++++.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cch
Confidence 5799999999999999999986533 3 36899998776555555567899999999999 99999999999976 467
Q ss_pred EEEEEecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVAR-GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+++++|.+.+... +.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~---vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc---eeeccchhhhhcc
Confidence 8999999999999877654 46999999999999999999999999999999999999987665 9999999999765
Q ss_pred CCCcc----cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccC
Q 021233 211 PGEKF----SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKV 284 (315)
Q Consensus 211 ~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (315)
..... ....|+..|+|||++. ..++.++||||||+++|||+| |..||......+....+.+... +++.++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~ 240 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE--RLPRPEDC 240 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC--CCCCCTTC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC--CCCCcccc
Confidence 44322 3346788999999987 458999999999999999998 8999999888888887776533 33445678
Q ss_pred CHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 285 SENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 285 ~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
|+++.+||.+||+.||++|||+.+|+..|
T Consensus 241 ~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999999999999998654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.9e-55 Score=381.55 Aligned_cols=250 Identities=27% Similarity=0.514 Sum_probs=209.0
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc--CCcEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED--DTAVH 132 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 132 (315)
++|++++.||+|+||+||+|++..+|+.||+|++... ..+++.+|+++|+.+..||||++++++|.. ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 5799999999999999999999999999999998643 246788999999999669999999999974 45799
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
+||||+++++|.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|+.....
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~--~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCGGGCEECCTT
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC--eeeecccccceeccCC
Confidence 999999999987653 46999999999999999999999999999999999999986543 3899999999987766
Q ss_pred CcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHhcc-------------cc-
Q 021233 213 EKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQ-GVAQAIIRSV-------------LD- 275 (315)
Q Consensus 213 ~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~-------------~~- 275 (315)
.......+|+.|+|||.+.+ .++.++||||+||++++|++|+.||...... +....+.... ..
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 66677789999999999763 4799999999999999999999999655432 2222221110 00
Q ss_pred -------------------CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 276 -------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 276 -------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
........+++++.+||.+||+.||++|||++|+|+|+||
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0111223478899999999999999999999999999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-55 Score=378.43 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=213.8
Q ss_pred ccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++++.||+|+||+||+|++. .+++.||||++.... .....+++.+|+.+++++ +||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEF-DNPNIVKLLGVCAVG 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhc-CCCCcccceeeeccC
Confidence 357999999999999999999975 345789999987542 333456799999999999 999999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 021233 129 TAVHLVMELCEGGELFDRIVARG------------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKP 184 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~------------------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp 184 (315)
+..+++|||+++|+|.+++.... .+++..++.++.|++.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 99999999999999999986432 388999999999999999999999999999999
Q ss_pred CceEeecCCCCCCEEEEeeccccccCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCC-CCCCC
Q 021233 185 ENFLFANKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGV-PPFWA 259 (315)
Q Consensus 185 ~Nill~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~-~p~~~ 259 (315)
+|||++.++. +||+|||+|+...... ......||+.|+|||.+. ..++.++|||||||++|||++|. +||..
T Consensus 169 ~NILld~~~~---~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 169 RNCLVGENMV---VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGEEECGGGC---EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cceEECCCCc---EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 9999986655 9999999998654332 224567889999999987 46999999999999999999985 68888
Q ss_pred CChHHHHHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 260 ETEQGVAQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
....+....+..... +..+..+++++.+||.+||+.||++|||+.||++.|
T Consensus 246 ~~~~e~~~~v~~~~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp SCHHHHHHHHHTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHcCCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 888888877766543 334457899999999999999999999999998865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-55 Score=372.53 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=202.2
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~l 133 (315)
.++|++.+.||+|+||+||+|++.. ++.||||++.... ...+.+.+|+.+++++ +|||||++++++.. +..++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~----~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc----CCHHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEE
Confidence 3579999999999999999999865 4679999986542 2357799999999999 99999999999854 56789
Q ss_pred EEEecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVA--RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~---~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc---EEEcccchhhhccC
Confidence 9999999999988754 346999999999999999999999999999999999999987655 99999999987643
Q ss_pred CC--cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHhccccCCCCCCccCCHH
Q 021233 212 GE--KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSEN 287 (315)
Q Consensus 212 ~~--~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (315)
.. ......||+.|+|||++. +.++.++||||||+++|||++| .+|+......+....+.+.. +.+.+..++++
T Consensus 166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~---~~~~~~~~~~~ 242 (285)
T d1fmka3 166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPCPPECPES 242 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---CCCCCTTSCHH
T ss_pred CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---CCCCCcccCHH
Confidence 32 223457899999999986 5699999999999999999995 55555666666666665542 33445678999
Q ss_pred HHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 288 AKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 288 l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+.+||.+||+.||++|||+.+|++.|
T Consensus 243 l~~li~~cl~~dP~~Rps~~~i~~~L 268 (285)
T d1fmka3 243 LHDLMCQCWRKEPEERPTFEYLQAFL 268 (285)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 99999999999999999999998743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-55 Score=384.81 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=208.8
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC--
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT-- 129 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~-- 129 (315)
.+.++|++++.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+|+.+ +|||||+++++|...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence 36789999999999999999999999999999999997543 3444567789999999999 9999999999997654
Q ss_pred ----cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecc
Q 021233 130 ----AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGL 205 (315)
Q Consensus 130 ----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~ 205 (315)
.+++||||+ +.+|..... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~---~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE---LKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc---cccccccc
Confidence 579999999 557766664 457999999999999999999999999999999999999986665 89999999
Q ss_pred ccccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC-------
Q 021233 206 SVFFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------- 276 (315)
Q Consensus 206 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 276 (315)
|+.... ......||+.|+|||++.+ .++.++||||+||++++|++|+.||...........+.......
T Consensus 168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 987643 3456689999999998753 47899999999999999999999998887666555443322111
Q ss_pred ----------------CC----CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 ----------------RR----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 ----------------~~----~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ...+.+++++.+||.+||..||++|||+.|+|+|+||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 11 1234578999999999999999999999999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-55 Score=377.89 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=199.7
Q ss_pred cceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC-
Q 021233 55 ERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD- 128 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~- 128 (315)
++|++++.||+|+||.||+|.+.. +++.||+|++.... .....+.+.+|..++.++.+|+||+.+++++...
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 579999999999999999999754 34689999986543 2334567888999998887899999999988654
Q ss_pred CcEEEEEEecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecC
Q 021233 129 TAVHLVMELCEGGELFDRIVAR----------------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANK 192 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~ 192 (315)
...++||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 5689999999999999999753 238899999999999999999999999999999999999866
Q ss_pred CCCCCEEEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHH
Q 021233 193 KETAPLKAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQ 267 (315)
Q Consensus 193 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~ 267 (315)
+. +||+|||+|+....... .....||+.|+|||++. +.++.++|||||||++|||+|| .+||......+...
T Consensus 171 ~~---~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 171 NV---VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp GC---EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred Cc---EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 55 99999999986543322 24567999999999986 5599999999999999999986 56786655444443
Q ss_pred HHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccC
Q 021233 268 AIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIE 314 (315)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~ 314 (315)
...... .++..+..+++++.+||.+||+.||++|||+.|+++||+
T Consensus 248 ~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 248 RRLKEG--TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp HHHHHT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcC--CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 333322 223344568999999999999999999999999999873
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=384.53 Aligned_cols=258 Identities=32% Similarity=0.555 Sum_probs=219.8
Q ss_pred cceeeeeeeeeecceEEEEEEEC---CCCCEEEEEEccccccc-ChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCc
Q 021233 55 ERYELGRELGRGEFGITYLCTDR---ENGDAFACKSISKKKLR-TAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTA 130 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 130 (315)
++|++++.||+|+||+||+|.+. .+|+.||+|++.+.... .....+.+.+|+.+++++.+||||+++++++.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999873 46899999998765432 223346688999999999444899999999999999
Q ss_pred EEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 131 VHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 131 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
.+++|||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~---vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC---EEEeeccchhhhc
Confidence 9999999999999999998888999999999999999999999999999999999999987655 9999999998654
Q ss_pred CCC--cccccccCCCccCchhhcc---cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCCCCCccCC
Q 021233 211 PGE--KFSEIVGSPYYMAPEVLKR---NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 211 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
... ......|++.|++||.+.+ .++.++|||||||+||+|++|+.||......+....+.+.........+..++
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 332 2345689999999998753 37889999999999999999999998776665555555554444555556789
Q ss_pred HHHHHHHHHhcCCCcCCCC-----CHHHHhcccCC
Q 021233 286 ENAKDLVRKMLDPDPKRRL-----TAQQVLGKIEF 315 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rp-----s~~e~l~~l~f 315 (315)
+++.+||.+||++||++|| |++|+++|+||
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 9999999999999999999 48999999997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=371.91 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=216.2
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVHLV 134 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 134 (315)
++|++++.||+|+||+||+|++..+++.||||++..... ......++.+|+.+|+.+ +||||+++++++......++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEE
Confidence 479999999999999999999999999999999866532 334467899999999999 999999999999999999999
Q ss_pred EEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCCC-
Q 021233 135 MELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPGE- 213 (315)
Q Consensus 135 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~~- 213 (315)
++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||.|.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~---~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc---eeeeecchhhcccCCCc
Confidence 999999999888888888999999999999999999999999999999999999986655 8999999998765443
Q ss_pred cccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCC-CCChHHHHHHHHhccccCC-------------
Q 021233 214 KFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFW-AETEQGVAQAIIRSVLDFR------------- 277 (315)
Q Consensus 214 ~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~------------- 277 (315)
......+++.|+|||.+.. .++.++|||||||+++||++|+.||. .....+....+........
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 3344467788999998763 37899999999999999999998864 4444444454433222211
Q ss_pred ------------CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 278 ------------RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 278 ------------~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
....+.+++++.+||.+||+.||.+|||++|+|+|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 11123568899999999999999999999999999998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-55 Score=370.20 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=202.6
Q ss_pred cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-CCcEEE
Q 021233 55 ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTAVHL 133 (315)
Q Consensus 55 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~~~~~l 133 (315)
++|++++.||+|+||+||+|.+. |+.||||++..+ ...+.+.+|+++++++ +||||+++++++.+ .+.+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEE
Confidence 47999999999999999999985 789999998643 2346799999999999 99999999999854 466899
Q ss_pred EEEecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCC
Q 021233 134 VMELCEGGELFDRIVARG--HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKP 211 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~ 211 (315)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++.++. +||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~---~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC---EEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC---EeecccccceecCC
Confidence 999999999999987543 4899999999999999999999999999999999999987665 89999999986543
Q ss_pred CCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHhccccCCCCCCccCCHHHH
Q 021233 212 GEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGVAQAIIRSVLDFRRDPWPKVSENAK 289 (315)
Q Consensus 212 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 289 (315)
. .....+|+.|+|||++. +.++.++||||||+++|||+| |++||......+....+.+. .+++.++.+++++.
T Consensus 156 ~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 156 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG---YKMDAPDGCPPAVY 230 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---CCCCCCTTCCHHHH
T ss_pred C--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---CCCCCCccCCHHHH
Confidence 2 34457889999999876 669999999999999999998 78999888887777777654 33445567899999
Q ss_pred HHHHHhcCCCcCCCCCHHHHhccc
Q 021233 290 DLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 290 ~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+||.+||+.||.+|||+.+++++|
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHHHH
Confidence 999999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=381.20 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=207.5
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC---
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--- 129 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--- 129 (315)
++.+|++++.||+|+||+||+|++..+|+.||||++.+.. .....+.+.+|+.+|+.+ +||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTT
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccc
Confidence 5578999999999999999999999999999999987542 334456788999999999 9999999999997543
Q ss_pred -cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 130 -AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 130 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..+++++|+.+++|.+++... .+++..++.++.|++.||+|||++|||||||||+|||+++++. +||+|||+|..
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~---~kl~DfG~a~~ 158 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARV 158 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCEE
T ss_pred cceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC---EEEcccCceee
Confidence 234445566689999999764 6999999999999999999999999999999999999986554 99999999986
Q ss_pred cCCCC----cccccccCCCccCchhhc--ccCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccC------
Q 021233 209 FKPGE----KFSEIVGSPYYMAPEVLK--RNYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDF------ 276 (315)
Q Consensus 209 ~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------ 276 (315)
..... .....+||+.|+|||++. ..++.++||||+||++++|++|+.||......+............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 54332 234567899999999875 347899999999999999999999998877655554443221110
Q ss_pred --------------C---C----CCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 277 --------------R---R----DPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 277 --------------~---~----~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. . ..++.+++++.+||.+||+.||++|||+.|+|+|+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 0 0 0134578899999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=373.57 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=210.1
Q ss_pred ccceeeeeeeeeecceEEEEEEECCCC-------CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEE
Q 021233 54 EERYELGRELGRGEFGITYLCTDRENG-------DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYE 126 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 126 (315)
.++|++++.||+|+||.||+|++..++ ..||+|++.... .......+.+|...+.++.+|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 468999999999999999999876543 479999987543 33445778889999999878999999999999
Q ss_pred cCCcEEEEEEecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 021233 127 DDTAVHLVMELCEGGELFDRIVARG----------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (315)
Q Consensus 127 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~ 190 (315)
+++..++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+||||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeec
Confidence 9999999999999999999997542 489999999999999999999999999999999999998
Q ss_pred cCCCCCCEEEEeeccccccCCCC---cccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHH
Q 021233 191 NKKETAPLKAIDFGLSVFFKPGE---KFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (315)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 265 (315)
.++. +||+|||+++...... ......+|+.|+|||.+. +.++.++||||||+++|||++ |.+||........
T Consensus 170 ~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 170 EDNV---MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp TTCC---EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred CCCC---eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 7665 8999999998664332 234467899999999876 679999999999999999998 7899988887776
Q ss_pred HHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...+.... ++..+..+++++.+||.+||+.||++|||+.||++.|
T Consensus 247 ~~~i~~~~---~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 247 FKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHTTC---CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHcCC---CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 66665432 3344567899999999999999999999999999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-54 Score=372.61 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=213.3
Q ss_pred ccceeeeeeeeeecceEEEEEEEC-----CCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDR-----ENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++++.+|||||++++++...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 368999999999999999999863 456789999987543 3344567899999999997799999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEee
Q 021233 129 TAVHLVMELCEGGELFDRIVARG------------------HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFA 190 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~ 190 (315)
...++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++++||||||+||+++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999987543 488999999999999999999999999999999999998
Q ss_pred cCCCCCCEEEEeeccccccCCCCcc---cccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhh-CCCCCCCCChHHH
Q 021233 191 NKKETAPLKAIDFGLSVFFKPGEKF---SEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLC-GVPPFWAETEQGV 265 (315)
Q Consensus 191 ~~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 265 (315)
.++. ++++|||.++........ ....||+.|+|||++. +.++.++||||||+++|||+| |.+||......+.
T Consensus 180 ~~~~---~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 180 HGRI---TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp TTTE---EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred ccCc---ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 6655 899999999876543322 3457899999999987 568999999999999999998 6666766666555
Q ss_pred HHHHHhccccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 266 AQAIIRSVLDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
...+.+.. .++..+..+++++.+||.+||+.||++|||+.+|++.|
T Consensus 257 ~~~~i~~~--~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 257 FYKMIKEG--FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp HHHHHHHT--CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcC--CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 55555442 23344456899999999999999999999999999876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=378.05 Aligned_cols=255 Identities=26% Similarity=0.356 Sum_probs=200.0
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED----- 127 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~----- 127 (315)
+.++|++++.||+|+||+||+|++..+|+.||||++..... +.....++.+|+.+++++ +||||++++++|..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~ 92 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLE 92 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccc
Confidence 44789999999999999999999999999999999976543 344556789999999999 89999999999963
Q ss_pred -CCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccc
Q 021233 128 -DTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLS 206 (315)
Q Consensus 128 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a 206 (315)
...+|+||||+.++ +.+.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++. ++++|||++
T Consensus 93 ~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~---~kl~df~~~ 166 (355)
T d2b1pa1 93 EFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLA 166 (355)
T ss_dssp TCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC-
T ss_pred cCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc---eeeechhhh
Confidence 36889999999764 44444 346999999999999999999999999999999999999986655 899999999
Q ss_pred cccCCCCcccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC-------
Q 021233 207 VFFKPGEKFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------- 278 (315)
Q Consensus 207 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 278 (315)
+............+|+.|+|||++.+ .++.++||||+||++++|++|+.||...........+........+
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred hccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 87766666677789999999999874 5899999999999999999999999887766665555432221000
Q ss_pred ---------------CC----------------CccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ---------------DP----------------WPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ---------------~~----------------~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
.. ....++++.+||.+||+.||++|||++|+|+|+||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 00 01135678999999999999999999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=377.59 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=210.7
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC----
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD---- 128 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~---- 128 (315)
+.++|++++.||+|+||+||+|++..+|+.||||++.+.. .+....+++.+|+.+|+.+ +|||++++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccc
Confidence 4578999999999999999999999999999999997653 3344456788999999999 999999999998633
Q ss_pred -CcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeecccc
Q 021233 129 -TAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSV 207 (315)
Q Consensus 129 -~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~ 207 (315)
...+++++|+.|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +|++|||.|.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~---~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCC----
T ss_pred cCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc---ccccccchhc
Confidence 334666777789999998854 46999999999999999999999999999999999999987655 8999999997
Q ss_pred ccCCCCcccccccCCCccCchhhcc--cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhccccCCC-------
Q 021233 208 FFKPGEKFSEIVGSPYYMAPEVLKR--NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRSVLDFRR------- 278 (315)
Q Consensus 208 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------- 278 (315)
... .......||+.|+|||.+.+ .++.++|||||||++++|++|+.||.+.........+.+.......
T Consensus 170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 543 33455678999999998653 4789999999999999999999999988877766666544322110
Q ss_pred ----------------C----CCccCCHHHHHHHHHhcCCCcCCCCCHHHHhcccCC
Q 021233 279 ----------------D----PWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKIEF 315 (315)
Q Consensus 279 ----------------~----~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l~f 315 (315)
. .+..+++++.+||.+||+.||.+|||+.|+|+|+||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f 304 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence 0 123578999999999999999999999999999997
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=367.02 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=213.4
Q ss_pred ccceeeeeeeeeecceEEEEEEECC-----CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 54 EERYELGRELGRGEFGITYLCTDRE-----NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 54 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++|++++.||+|+||+||+|.+.. ++..||||++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecC
Confidence 3689999999999999999998752 35789999987542 334456789999999999 899999999999999
Q ss_pred CcEEEEEEecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCE
Q 021233 129 TAVHLVMELCEGGELFDRIVAR----------GHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPL 198 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~v 198 (315)
+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++. +
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~---~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---V 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC---E
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce---E
Confidence 9999999999999999988642 23688999999999999999999999999999999999976554 9
Q ss_pred EEEeeccccccCCCCc---ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHhcc
Q 021233 199 KAIDFGLSVFFKPGEK---FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCG-VPPFWAETEQGVAQAIIRSV 273 (315)
Q Consensus 199 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~ 273 (315)
||+|||+|+....... .....||+.|+|||.+. +.++.++||||||+++|||+|| .+||......+....+.+..
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999986543322 23446899999999976 5688999999999999999998 58888888888877776643
Q ss_pred ccCCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 274 LDFRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 274 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
..+.+..+++.+.++|.+||+.||++|||+.+|+++|
T Consensus 253 ---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 253 ---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 2334457899999999999999999999999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-53 Score=366.29 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=201.3
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.++++|++++.||+|+||+||+|++..+|+.||||++..... .+.+..|+++++.+..|++|+.+.+++...+..
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 356789999999999999999999999999999998765422 234788999999994455566777777888899
Q ss_pred EEEEEecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccC
Q 021233 132 HLVMELCEGGELFDRIVA-RGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFK 210 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~ 210 (315)
++||||+. ++|.+.+.. ...+++..+..++.|++.||+|||++||+||||||+|||++..+....++|+|||+|+...
T Consensus 79 ~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 79 VMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99999994 566666654 4569999999999999999999999999999999999999776666679999999998764
Q ss_pred CCC--------cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHhc---cccC-C
Q 021233 211 PGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQGVAQAIIRS---VLDF-R 277 (315)
Q Consensus 211 ~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~---~~~~-~ 277 (315)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..||...........+... .... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 332 2245689999999999875 5999999999999999999999999766544333322111 1111 1
Q ss_pred CCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 021233 278 RDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLG 311 (315)
Q Consensus 278 ~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~ 311 (315)
+.....+|+++.++|..||+.||++||++.++.+
T Consensus 238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~ 271 (299)
T d1ckia_ 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271 (299)
T ss_dssp HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHH
T ss_pred hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1123468999999999999999999999986643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=363.42 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=200.1
Q ss_pred eeeeeeeeecceEEEEEEECCCC---CEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEc-CCcEEE
Q 021233 58 ELGRELGRGEFGITYLCTDRENG---DAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYED-DTAVHL 133 (315)
Q Consensus 58 ~~~~~lg~G~~g~Vy~~~~~~~~---~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~-~~~~~l 133 (315)
.+.++||+|+||+||+|.+..++ ..||||.+... ......+++.+|+++|.++ +||||+++++++.. ++..++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEE
Confidence 34578999999999999987543 35899988643 3455567899999999999 89999999999765 568999
Q ss_pred EEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEEeeccccccCCC
Q 021233 134 VMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAIDFGLSVFFKPG 212 (315)
Q Consensus 134 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~~~~~ 212 (315)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+|+||||||+|||+++++. +||+|||+++.....
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~---~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDK 183 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---EEECSSGGGCCTTTT
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC---EEEecccchhhcccc
Confidence 999999999999887544 4788899999999999999999999999999999999976554 999999999876433
Q ss_pred Cc-----ccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHhccccCCCCCCccCC
Q 021233 213 EK-----FSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAET-EQGVAQAIIRSVLDFRRDPWPKVS 285 (315)
Q Consensus 213 ~~-----~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 285 (315)
.. .....||+.|+|||.+. +.++.++||||||+++|||+||..||.... ..+....+..+. ++..++.++
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~---~~~~p~~~~ 260 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---RLLQPEYCP 260 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC---CCCCCTTCC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC---CCCCcccCc
Confidence 22 23356899999999876 669999999999999999999777765433 333444444432 233445688
Q ss_pred HHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 286 ENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 286 ~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
+++.+||.+||+.||++|||+.||+++|
T Consensus 261 ~~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 261 DPLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999999886
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-51 Score=354.02 Aligned_cols=254 Identities=20% Similarity=0.288 Sum_probs=206.6
Q ss_pred ccccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcE
Q 021233 52 EIEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAV 131 (315)
Q Consensus 52 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 131 (315)
.+.++|++++.||+|+||+||+|++..+|+.||+|++.... ..+.+.+|++.++.+.+++|++.+++++......
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 45678999999999999999999999999999999875432 1234778999999996679999999999999999
Q ss_pred EEEEEecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCC--CCCCEEEEeeccccc
Q 021233 132 HLVMELCEGGELFDRIVARG-HYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKK--ETAPLKAIDFGLSVF 208 (315)
Q Consensus 132 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~--~~~~vkl~Dfg~a~~ 208 (315)
++||||+ +++|.+++...+ .++...+..++.|++.||+|||++||+||||||+|||++... ....+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 679999887654 599999999999999999999999999999999999997532 234599999999986
Q ss_pred cCCCC--------cccccccCCCccCchhhcc-cCCCcchHHHHHHHHHHHhhCCCCCCCCChH---HHHHHHHhcccc-
Q 021233 209 FKPGE--------KFSEIVGSPYYMAPEVLKR-NYGPEVDVWSAGVILYILLCGVPPFWAETEQ---GVAQAIIRSVLD- 275 (315)
Q Consensus 209 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~- 275 (315)
..... ......||+.|||||++.+ .++.++||||||+++|||++|..||...... .....+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 54321 2345689999999999875 5999999999999999999999999754332 222222221111
Q ss_pred CCCCCCccCCHHHHHHHHHhcCCCcCCCCCHHHHhc
Q 021233 276 FRRDPWPKVSENAKDLVRKMLDPDPKRRLTAQQVLG 311 (315)
Q Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~e~l~ 311 (315)
......+.+|+++.+++..|+..+|++||+...+.+
T Consensus 236 ~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 111223568899999999999999999999876654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=355.06 Aligned_cols=248 Identities=21% Similarity=0.275 Sum_probs=190.2
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCC---
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDT--- 129 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~--- 129 (315)
+.++|.+.+.||+|+||+||+|++ +|+.||||++.... ......+.|+..+..+ +||||+++++++...+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVML-RHENILGFIAADNKDNGTW 73 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcc
Confidence 357899999999999999999997 48999999986432 1112233455555667 8999999999997543
Q ss_pred -cEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCceEeecCCCCCCEEE
Q 021233 130 -AVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK--------HGVMHRDLKPENFLFANKKETAPLKA 200 (315)
Q Consensus 130 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~--------~~iiH~dikp~Nill~~~~~~~~vkl 200 (315)
..++||||+++|+|.+++.+. .+++..++.++.+++.||.|+|+ +||+||||||+|||++.++. +||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~---~Kl 149 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCI 149 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC---EEE
T ss_pred eEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC---eEE
Confidence 579999999999999999765 69999999999999999999996 59999999999999976655 999
Q ss_pred EeeccccccCCCC-----cccccccCCCccCchhhccc-------CCCcchHHHHHHHHHHHhhCCCCCCCCC-------
Q 021233 201 IDFGLSVFFKPGE-----KFSEIVGSPYYMAPEVLKRN-------YGPEVDVWSAGVILYILLCGVPPFWAET------- 261 (315)
Q Consensus 201 ~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~Di~slG~~l~el~tg~~p~~~~~------- 261 (315)
+|||++....... ......||+.|+|||++.+. ++.++|||||||+||||+||..||....
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred EecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 9999998764432 22356899999999998642 5678999999999999999988763211
Q ss_pred --------hHHHHHHHHhccccCCCCCCc-----cCCHHHHHHHHHhcCCCcCCCCCHHHHhccc
Q 021233 262 --------EQGVAQAIIRSVLDFRRDPWP-----KVSENAKDLVRKMLDPDPKRRLTAQQVLGKI 313 (315)
Q Consensus 262 --------~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~P~~Rps~~e~l~~l 313 (315)
............ .++..+. ..+..+.+|+.+||+.||++|||+.||+++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQK--LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSC--CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred hcccccchHHHHHHHHhccc--cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 111222222111 1122111 1234689999999999999999999998876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-46 Score=329.78 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=195.3
Q ss_pred ccccc-cceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCC----------CCCCc
Q 021233 50 GREIE-ERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLP----------KHQNI 118 (315)
Q Consensus 50 ~~~~~-~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~----------~h~~i 118 (315)
|+.+. ++|++++.||+|+||+||+|++..+|+.||||++.+.. ...+.+.+|+.+++.+. .|+||
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i 82 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 82 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence 45554 46999999999999999999999999999999987542 22456788999888872 25789
Q ss_pred ceeEEEEEc--CCcEEEEEEecCCCChHHH-HH--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCceEeecC
Q 021233 119 VCLKDTYED--DTAVHLVMELCEGGELFDR-IV--ARGHYTERAAAAVTKTIVEVVQMCHK-HGVMHRDLKPENFLFANK 192 (315)
Q Consensus 119 v~~~~~~~~--~~~~~lv~e~~~~~sL~~~-l~--~~~~l~~~~~~~i~~~l~~~L~~lH~-~~iiH~dikp~Nill~~~ 192 (315)
+++++++.. ....+++++++..+..... .. ....+++..++.++.|++.||.|||+ .||+||||||+|||++.+
T Consensus 83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV 162 (362)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeecc
Confidence 999998864 4566777777654443322 22 23458999999999999999999998 899999999999999765
Q ss_pred CCCC---CEEEEeeccccccCCCCcccccccCCCccCchhhc-ccCCCcchHHHHHHHHHHHhhCCCCCCCCChH-----
Q 021233 193 KETA---PLKAIDFGLSVFFKPGEKFSEIVGSPYYMAPEVLK-RNYGPEVDVWSAGVILYILLCGVPPFWAETEQ----- 263 (315)
Q Consensus 193 ~~~~---~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~----- 263 (315)
+... .++++|||.|..... ......||+.|+|||++. ..++.++||||+||++++|++|+.||......
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 4322 289999999986532 234568999999999876 56899999999999999999999999644321
Q ss_pred -HHHHHHHhcccc--------------------------------------CCCCCCccCCHHHHHHHHHhcCCCcCCCC
Q 021233 264 -GVAQAIIRSVLD--------------------------------------FRRDPWPKVSENAKDLVRKMLDPDPKRRL 304 (315)
Q Consensus 264 -~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 304 (315)
+........... .....+...++++.+||.+||+.||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 111111110000 00011123467789999999999999999
Q ss_pred CHHHHhcccCC
Q 021233 305 TAQQVLGKIEF 315 (315)
Q Consensus 305 s~~e~l~~l~f 315 (315)
|+.|+|+|+||
T Consensus 321 ta~e~L~Hp~f 331 (362)
T d1q8ya_ 321 DAGGLVNHPWL 331 (362)
T ss_dssp CHHHHHTCGGG
T ss_pred CHHHHhcCccc
Confidence 99999999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=4.2e-28 Score=194.80 Aligned_cols=168 Identities=21% Similarity=0.232 Sum_probs=123.2
Q ss_pred eeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccC---------------hhcHHHHHHHHHHHHhCCCCCCccee
Q 021233 57 YELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRT---------------AVDIEDVRREVDIMRHLPKHQNIVCL 121 (315)
Q Consensus 57 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---------------~~~~~~~~~e~~~l~~l~~h~~iv~~ 121 (315)
+.+.+.||+|+||+||+|.+. +|+.||+|++....... .........|...+.++ .+.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 457899999999999999985 68999999875322110 01123456688999999 89999888
Q ss_pred EEEEEcCCcEEEEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCceEeecCCCCCCEEEE
Q 021233 122 KDTYEDDTAVHLVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHKHGVMHRDLKPENFLFANKKETAPLKAI 201 (315)
Q Consensus 122 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~~~iiH~dikp~Nill~~~~~~~~vkl~ 201 (315)
+++.. .+++|||+++..+.+ ++...+..++.|++.+|.|||++||+||||||+|||++++ . ++|+
T Consensus 80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~---~~li 144 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-G---IWII 144 (191)
T ss_dssp EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-E---EEEC
T ss_pred EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-C---EEEE
Confidence 76532 379999998865533 4556677899999999999999999999999999999743 2 7999
Q ss_pred eeccccccCCCCcccccccCCCccC------chhhcccCCCcchHHHHHHHHH
Q 021233 202 DFGLSVFFKPGEKFSEIVGSPYYMA------PEVLKRNYGPEVDVWSAGVILY 248 (315)
Q Consensus 202 Dfg~a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~Di~slG~~l~ 248 (315)
|||.|.......... |.. .+.+.+.|+.++|+||+.--++
T Consensus 145 DFG~a~~~~~~~~~~-------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-------ILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHH-------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHH-------HHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 999997654332211 111 1233456899999999865443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.95 E-value=1.1e-09 Score=90.31 Aligned_cols=143 Identities=19% Similarity=0.174 Sum_probs=96.7
Q ss_pred cccceeeeeeeeeecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcCCcEE
Q 021233 53 IEERYELGRELGRGEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDDTAVH 132 (315)
Q Consensus 53 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 132 (315)
+-+.|+..+..+.++.+.||++. .++..+++|......... ...+.+|...+..+..+--+++++.+....+..+
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred hhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 34567777766555567999986 346778888775443222 2357789999888855545778899988889999
Q ss_pred EEEEecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 021233 133 LVMELCEGGELFDRIVARGHYTERAAAAVTKTIVEVVQMCHK-------------------------------------- 174 (315)
Q Consensus 133 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~~l~~~L~~lH~-------------------------------------- 174 (315)
+||++++|.++.+..... .....++.+++..|..||+
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 999999998775543211 1122334444444444543
Q ss_pred ---------------------CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 175 ---------------------HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 175 ---------------------~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
..++|+|+.|.|||+++++. +-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~---~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV---SGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE---EEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce---EEEeechhccc
Confidence 13799999999999975332 45999998763
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.63 E-value=5.9e-08 Score=84.62 Aligned_cols=82 Identities=18% Similarity=0.186 Sum_probs=52.0
Q ss_pred eeeeeeecceEEEEEEECCCCCEEEEEEcccccc----cChhcHHHHHHHHHHHHhCCCC--CCcceeEEEEEcCCcEEE
Q 021233 60 GRELGRGEFGITYLCTDRENGDAFACKSISKKKL----RTAVDIEDVRREVDIMRHLPKH--QNIVCLKDTYEDDTAVHL 133 (315)
Q Consensus 60 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~~~~e~~~l~~l~~h--~~iv~~~~~~~~~~~~~l 133 (315)
.+.||.|....||++.+..+++.+++|....... ......++...|+..|+.+..+ ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998877788999996543111 1122345567788888877443 234555544 3445679
Q ss_pred EEEecCCCCh
Q 021233 134 VMELCEGGEL 143 (315)
Q Consensus 134 v~e~~~~~sL 143 (315)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.40 E-value=2.9e-07 Score=74.92 Aligned_cols=76 Identities=11% Similarity=0.135 Sum_probs=52.3
Q ss_pred eeeeecc-eEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeEEEEEcCCcEEEEEEecC
Q 021233 62 ELGRGEF-GITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLKDTYEDDTAVHLVMELCE 139 (315)
Q Consensus 62 ~lg~G~~-g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~~~~~~~~~~~lv~e~~~ 139 (315)
.+..|.. +.||+... ..+..+++|...... ...+..|+..++.+..+. .+++++.+....+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 3444543 68999875 456778888754332 234677888887763332 26678888888889999999999
Q ss_pred CCChH
Q 021233 140 GGELF 144 (315)
Q Consensus 140 ~~sL~ 144 (315)
|.++.
T Consensus 90 G~~~~ 94 (255)
T d1nd4a_ 90 GQDLL 94 (255)
T ss_dssp SEETT
T ss_pred ccccc
Confidence 86663
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.75 E-value=5.7e-05 Score=65.23 Aligned_cols=78 Identities=13% Similarity=0.084 Sum_probs=53.6
Q ss_pred ceeeeeeeeeecceEEEEEEECC-------CCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCCCcceeEEEEEcC
Q 021233 56 RYELGRELGRGEFGITYLCTDRE-------NGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQNIVCLKDTYEDD 128 (315)
Q Consensus 56 ~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 128 (315)
.++ ++.|+.|---.+|++.... .+..|++++.... .......+|..+++.++.+.-.+++++++.+
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~- 116 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG- 116 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-
Confidence 344 4678888888999998653 2356777766421 1223466799999988666555678887753
Q ss_pred CcEEEEEEecCCCCh
Q 021233 129 TAVHLVMELCEGGEL 143 (315)
Q Consensus 129 ~~~~lv~e~~~~~sL 143 (315)
.+|+||++|.+|
T Consensus 117 ---g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ---GRLEEYIPSRPL 128 (395)
T ss_dssp ---EEEECCCCEEEC
T ss_pred ---ceEEEEeccccC
Confidence 589999987555
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.50 E-value=0.00016 Score=60.57 Aligned_cols=72 Identities=13% Similarity=0.127 Sum_probs=45.9
Q ss_pred ecceEEEEEEECCCCCEEEEEEcccccccChhcHHHHHHHHHHHHhCCCCC-CcceeE-----EEEEcCCcEEEEEEecC
Q 021233 66 GEFGITYLCTDRENGDAFACKSISKKKLRTAVDIEDVRREVDIMRHLPKHQ-NIVCLK-----DTYEDDTAVHLVMELCE 139 (315)
Q Consensus 66 G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~-~iv~~~-----~~~~~~~~~~lv~e~~~ 139 (315)
+.--.||++.. ++|..+++|+..... ...+.+..|...+..|..+. -++..+ ..+...+..+.++++++
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 33468999985 568899999875431 23466888988888873221 111111 12345667889999998
Q ss_pred CCC
Q 021233 140 GGE 142 (315)
Q Consensus 140 ~~s 142 (315)
|..
T Consensus 108 G~~ 110 (325)
T d1zyla1 108 GRQ 110 (325)
T ss_dssp CEE
T ss_pred CcC
Confidence 743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.63 E-value=0.0063 Score=50.02 Aligned_cols=31 Identities=32% Similarity=0.467 Sum_probs=25.1
Q ss_pred CCceecCCCCCceEeecCCCCCCEEEEeeccccc
Q 021233 175 HGVMHRDLKPENFLFANKKETAPLKAIDFGLSVF 208 (315)
Q Consensus 175 ~~iiH~dikp~Nill~~~~~~~~vkl~Dfg~a~~ 208 (315)
.|+||+|+.++||+++.+.. .-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v---~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDEL---SGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEE---EEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccc---eeEeccccccc
Confidence 47999999999999975433 47999998753
|